prednisone has been researched along with Hodgkin Disease in 1791 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Hodgkin Disease: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study was undertaken to systematically evaluate the agreement rates among single photon emission computed tomography using gallium-67 (Ga-67 SPECT), lymphangiography (LAG), and computed axial tomography (CT) scan findings for Hodgkin disease and to correlate radiologic findings with clinical outcome." | 9.09 | Agreement rates among single photon emission computed tomography using gallium-67, computed axial tomography and lymphangiography for Hodgkin disease and correlation of image findings with clinical outcome. ( Allen, PK; Choe, JG; Cox, JD; Edmund, E; Ha, CS; Kong, JS; Oh, YK, 2000) |
| "In the last two decades, it has become evident that secondary leukemias after Hodgkin's disease (HD) are mainly caused by the treatment with alkylating agents, especially mechlorethamine." | 9.08 | Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group. ( Creutzig, U; Gadner, H; Harbott, J; Mann, G; Riepenhausen, M; Ritter, J; Schellong, G, 1997) |
| "In a pilot study, Cancer and Leukemia Group B (CALGB) incorporated etoposide into primary combination therapy for advanced Hodgkin disease." | 9.07 | Etoposide in combination as first-line chemotherapy for advanced Hodgkin disease. A Cancer and Leukemia Group B study. ( Anderson, JR; Barcos, M; Burns, LJ; Cooper, MR; Gottlieb, AJ; Kirshner, JJ; Parker, B; Peterson, BA, 1993) |
| "Colorectal cancer surveillance should be considered for HL survivors who received Infradiaphragmatic radiotherapy and a high cumulative procarbazine dose." | 7.85 | Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors. ( Aleman, BM; de Boer, JP; De Bruin, ML; Janus, CP; Kremer, LC; Krol, AD; Louwman, MW; Schaapveld, M; van der Maazen, RW; van Eggermond, AM; van Leerdam, ME; van Leeuwen, FE; Visser, O; Zijlstra, JM, 2017) |
| "A case of hyperpyrexia induced by procarbazine in a child with Hodgkin's disease, neurofibromatosis, and pectus excavatum deformity is presented." | 7.68 | Cytotoxic drug-induced fever: a report on procarbazine-induced hyperpyrexia. ( Akyol, H; Akyüz, C; Büyükpamukçu, M; Sarialioğlu, F, 1990) |
| "Thirty-eight patients with advanced Hodgkin disease were treated with a combination of cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) from 1970 to 1973 and followed prospectively." | 7.67 | Chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for Hodgkin disease: fourteen-year follow-up results. ( Bloomfield, CD; Dusenbery, KE; Peterson, BA, 1988) |
| "A 34-year-old woman who had had intractable pruritus for 2 years experienced dramatic relief from the symptom under treatment with cimetidine." | 7.66 | [Pruritus in Hodgkin's disease responding to cimetidine]. ( Graf, W; Stäubli, M; Straub, PW, 1981) |
| "Dexverapamil was escalated eight dose levels, from 240 to 1,200 mg/m2/d." | 6.68 | Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy. ( Bates, SE; Bryant, G; Fojo, A; Herdt, J; Jaffe, ES; Regis, J; Steinberg, SM; Wilson, WH; Wittes, RE; Zhan, Z, 1995) |
| "Lamivudine is a nucleoside analogue that can directly suppress HBV replication." | 5.31 | Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy. ( Motta, M; Pelizzari, A; Puoti, M; Rossi, G, 2001) |
| "A 26-year-old woman with Hodgkin's disease was treated with multiple-agent chemotherapy at 26 weeks' gestation." | 5.26 | MOPP (nitrogen mustard, vincristine, procarbazine, and prednisone) given during pregnancy. ( Jones, RT; Weinerman, BH, 1979) |
| "A patient with Hodgkin's disease and renal insufficiency became deaf while being treated with high dose oral furosemide." | 5.26 | Deafness associated with oral furosemide. ( de Quesada, AM; Pickering, MJ; Rifkin, SI; Shires, DL, 1978) |
| "45%, respectively, in Hodgkin's disease, and 85% vs." | 5.25 | Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients. ( Barros, CA; Morgenfeld, MC; Palau, M; Pavlovsky, A; Pavlovsky, S; Somoza, N; Suarez, A, 1975) |
| "The GPOH-HD (Gesellschaft für Pädiatrische Onkologie und Hämatologie-Hodgkin Disease) strategy for children and adolescents with intermediate and advanced stage Hodgkin lymphoma is based on two induction cycles of OEPA (vincristine, etoposide, prednisone, doxorubicin) followed by COPP (cyclophosphamide, vincristine, procarbazine, prednisone) or COPDAC (cyclophosphamide, vincristine, prednisone, dacarbazine) consolidation." | 5.20 | Feasibility of VECOPA, a dose-intensive chemotherapy regimen for children and adolescents with intermediate and advanced stage Hodgkin lymphoma: results of the GPOH-HD-2002/VECOPA pilot trial. ( Bernstädt, M; Berthold, F; Burdach, S; Eggert, A; Frühwald, MC; Hasenclever, D; Holzendorf, V; Jürgens, H; Klingebiel, T; Körholz, D; Mauz-Körholz, C; Metzler, M; Müller, HL, 2015) |
| "To determine whether epoetin alfa reduces anemia-related fatigue, improves other aspects of health-related patient-recorded outcomes (PROs), reduces the number of RBC transfusions, and has an impact on freedom from treatment failure (FFTF) and overall survival (OS) in patients with advanced-stage Hodgkin's lymphoma (HL)." | 5.14 | Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial. ( Borchmann, P; Diehl, V; Engert, A; Flechtner, HH; Fuchs, M; Haverkamp, H; Josting, A; Lohri, A; Nogova, L; Rank, A; Sökler, M; Sturm, I; Topp, MS; Villalobos, M; Vogelhuber, M; Zenz, T; Zijlstra, J, 2010) |
| "Fifty-six patients with newly diagnosed Stage II-IV Hodgkin disease, ages 18-77 years, were randomized to receive GM-CSF (5 microg/kg subcutaneously) or placebo from Day 7 to Day 4 before each chemotherapy administration (6 cycles of a hybrid of mechlorethamine, vincristine, procarbazine, and prednisone with doxorubicin, bleomycin, vinblastine, and dacarbazine)." | 5.09 | Short term treatment with Escherichia coli recombinant human granulocyte-macrophage-colony stimulating factor prior to chemotherapy for Hodgkin disease. ( Aglietta, M; Amadori, S; Botto, B; Cantonetti, M; Castoldi, GL; Dammacco, F; Fagioli, F; Ferrara, R; Levis, A; Montemurro, F; Racanelli, V; Teofili, L; Volta, C, 2000) |
| "This study was undertaken to systematically evaluate the agreement rates among single photon emission computed tomography using gallium-67 (Ga-67 SPECT), lymphangiography (LAG), and computed axial tomography (CT) scan findings for Hodgkin disease and to correlate radiologic findings with clinical outcome." | 5.09 | Agreement rates among single photon emission computed tomography using gallium-67, computed axial tomography and lymphangiography for Hodgkin disease and correlation of image findings with clinical outcome. ( Allen, PK; Choe, JG; Cox, JD; Edmund, E; Ha, CS; Kong, JS; Oh, YK, 2000) |
| "In the last two decades, it has become evident that secondary leukemias after Hodgkin's disease (HD) are mainly caused by the treatment with alkylating agents, especially mechlorethamine." | 5.08 | Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group. ( Creutzig, U; Gadner, H; Harbott, J; Mann, G; Riepenhausen, M; Ritter, J; Schellong, G, 1997) |
| "9 years, range, 1-15 years) received the AIEOP-MH 1983 Hodgkin disease protocol of low-dose radiation therapy (20-25 Gy), with three cycles of adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) for children with early-stage and favorable disease, and with alternating cycles of an eight non-cross-resistant drug combination regimen (nitrogen mustard, vincristine, procarbazine, and prednisone [MOPP]/ABVD) for 6 months for those with bulky and unfavorable disease." | 5.07 | Treatment of pediatric Hodgkin disease tailored to stage, mediastinal mass, and age. An Italian (AIEOP) multicenter study on 215 patients. ( Bontempi, N; Burnelli, R; Carli, M; Comelli, A; Di Tullio, MT; Pileri, S; Rosati, D; Sotti, G; Testi, AM; Vecchi, V, 1993) |
| "In a pilot study, Cancer and Leukemia Group B (CALGB) incorporated etoposide into primary combination therapy for advanced Hodgkin disease." | 5.07 | Etoposide in combination as first-line chemotherapy for advanced Hodgkin disease. A Cancer and Leukemia Group B study. ( Anderson, JR; Barcos, M; Burns, LJ; Cooper, MR; Gottlieb, AJ; Kirshner, JJ; Parker, B; Peterson, BA, 1993) |
| "Survivors of advanced Hodgkin disease, who were assigned randomly to treatment by mechlorethamine, vincristine, procarbazine, and prednisone (MOPP); doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD); or MOPP alternating with ABVD in a clinical trial of the Cancer and Leukemia Group B (protocol 8251), were compared in terms of their psychosocial adaptation and psychosexual function an average of 2." | 5.07 | Comparison of psychosocial adaptation and sexual function of survivors of advanced Hodgkin disease treated by MOPP, ABVD, or MOPP alternating with ABVD. ( Anderson, J; Canellos, GP; Cella, DF; Cherin, E; Cooper, MR; Henderson, ES; Kornblith, AB; Kosty, MP; Tross, S; Zuckerman, E, 1992) |
| " Patients were randomized in the Southwest Oncology Group (later the Pediatric Oncology Group [POG] to involved-field (IF) radiotherapy alone or IF radiotherapy followed by six courses of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP) chemotherapy; patients in the Children's Cancer Study Group (CCSG) and Cancer and Leukemia Group B (CALGB) were randomized to receive extended-field (EF) radiotherapy or IF radiotherapy followed by six courses of MOPP." | 5.06 | The intergroup Hodgkin's disease in children. A study of stages I and II. ( Fryer, C; Fuller, LM; Gehan, EA; Gilchrist, GS; Hanson, W; Hays, DM; Heller, R; Johnston, J; Kennedy, P; Sullivan, MP, 1990) |
| " The authors describe a patient with Hodgkin's disease who developed an atypical aortic dissection while receiving MOPP/ABV chemotherapy (nitrogen mustard, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine)." | 4.79 | Aortic dissection in a patient receiving chemotherapy for Hodgkin's disease--a case report. ( Bavaria, JE; Crooks, GW; Golden, MA; Holland, GA; Vaughn, DJ, 1997) |
| " After a median follow-up of more than 6 years following MOPP (mechlorethamine/vincristine/procarbazine/prednisone) chemotherapy with or without radiotherapy, 5% of patients with Hodgkin's disease developed second primaries, 60% of which were leukemias." | 4.78 | Cytotoxic chemotherapy-induced second primary neoplasms: clinical aspects. ( Petru, E; Schmähl, D, 1991) |
| " The risk of treatment-induced acute leukemias as well as sterility can be avoided or greatly decreased with drug combinations not including procarbazine HCI and alkylating agents." | 4.77 | Chemotherapy of malignant lymphomas. ( Bonadonna, G, 1985) |
| "Colorectal cancer surveillance should be considered for HL survivors who received Infradiaphragmatic radiotherapy and a high cumulative procarbazine dose." | 3.85 | Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors. ( Aleman, BM; de Boer, JP; De Bruin, ML; Janus, CP; Kremer, LC; Krol, AD; Louwman, MW; Schaapveld, M; van der Maazen, RW; van Eggermond, AM; van Leerdam, ME; van Leeuwen, FE; Visser, O; Zijlstra, JM, 2017) |
| "The proportion of intravenous drug abusers (IVDA) in HIV-HD (38%) is higher than in French HIV-infected population as a whole (20." | 3.78 | Human immunodeficiency virus associated Hodgkin's disease: report of 45 cases from the French Registry of HIV-Associated Tumors. ( Andrieu, JM; Brice, P; Colonna, P; Gastaut, JA; Lévy, R; Raphaël, M; Taillan, B; Tourani, JM, 1995) |
| " We describe a 5-year-old boy with stage IV HD, successfully treated with MOPP (mechlorethamine, vincristine, procarbazine, and prednisone)/ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) chemotherapy followed by 35 Gy mantle radiotherapy who developed primary hyperparathyroidism because of benign PTA at the age of 20 years, and died of CS in thoracic vertebrae at the age of 22 years." | 3.76 | Parathyroid adenoma and chondrosarcoma after treatment of pediatric Hodgkin disease. ( Albayrak, M; Coskun, U; Gursel, T; Kaya, Z; Keskin, EY; Kocak, U; Uluoglu, O, 2010) |
| "The authors would like to underline the very rare coincidence of Hodgkin's disease and nephrotic syndrome, the lack of remission after routine prednisone administration and disappearance of nephrotic proteinuria after anticancer therapy." | 3.74 | Hodgkin's disease--the rare cause of nephrotic syndrome in children. ( Brodkiewicz, A; Peregud-Pogorzelski, J; Szychot, E; Zakowska, A, 2008) |
| "4% of the women receiving eight cycles of dose-escalated bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone (BEACOPP) had continuous amenorrhea." | 3.73 | Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group. ( Behringer, K; Breuer, K; Diehl, V; Engert, A; Klimm, B; May, M; Nogova, L; Reineke, T; Schmitz, T; Wildt, L, 2005) |
| "The objective of this research was to determine whether Novantrone, Oncovin, Velban, and Prednisone (NOVP) combination chemotherapy for Hodgkin's disease increases the frequencies of the specific types of aneuploid sperm that might elevate the risk of fathering a child with one of the major clinical aneuploidy syndromes, i." | 3.72 | NOVP chemotherapy for Hodgkin's disease transiently induces sperm aneuploidies associated with the major clinical aneuploidy syndromes involving chromosomes X, Y, 18, and 21. ( Bishop, JB; Frias, S; Hagemeister, FB; Lowe, XR; Meistrich, ML; Shelby, MD; Van Hummelen, P; Wyrobek, AJ, 2003) |
| " After a course of high-dose methylprednisolone therapy with a diagnosis of Evans syndrome, complete response for thrombocytopenia and partial response for anemia was achieved." | 3.70 | Immune thrombocytopenia and hemolytic anemia as a presenting manifestation of Hodgkin disease. ( Ertem, M; Gözdaşoğlu, S; Uysal, Z; Yavuz, G, 2000) |
| "Forty-six previously untreated children with stage I-II Hodgkin disease received four to six courses of cyclophosphamide, oncovin, procarbazine, and prednisone (COPP) alternating with doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD), tailored according to clinical response." | 3.69 | Hodgkin disease in children: reduced tailored chemotherapy for stage I-II disease. ( Cohen, IJ; Goshen, Y; Loven, D; Saab, A; Stark, B; Tamary, H; Yaniv, I; Zaizov, R, 1996) |
| "Outpatient adherence to oral medication regimens was evaluated in 50 adolescents and young adults with cancer: 21 patients with acute lymphoblastic leukemia or Hodgkin disease who were to take prednisone as a component of their chemotherapy regimen, and 29 patients with Hodgkin disease whose chemotherapy had been discontinued and who were to take penicillin for postsplenectomy prophylaxis." | 3.68 | Therapeutic adherence to oral medication regimens by adolescents with cancer. I. Laboratory assessment. ( Chasalow, F; Festa, RS; Lanzkowsky, P; Tamaroff, MH, 1992) |
| "A case of hyperpyrexia induced by procarbazine in a child with Hodgkin's disease, neurofibromatosis, and pectus excavatum deformity is presented." | 3.68 | Cytotoxic drug-induced fever: a report on procarbazine-induced hyperpyrexia. ( Akyol, H; Akyüz, C; Büyükpamukçu, M; Sarialioğlu, F, 1990) |
| " Congestive heart failure resulting in death occurred in one case given 315mg /m2 of adriamycin and then 90 mg/m2 of mitoxantrone." | 3.67 | [Adriamycin-based combination chemotherapy in the treatment of advanced malignant lymphoma. A progress report]. ( Hattori, M; Honda, T; Sampi, K, 1984) |
| "From January 1980 to September 1986, 50 patients with Hodgkin disease, clinical stages (CS) IIIB (26 cases) and IVB (24 cases) were treated by three cycles of mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) chemotherapy, followed by high-dose (40 Gy) (sub)total lymphoid irradiation, including the spleen." | 3.67 | Advanced Hodgkin disease (clinical stages IIIB and IV): low relapse rate after brief chemotherapy followed by high-dose total lymphoid irradiation. ( Afiane, M; Andrieu, JM; Belhadj-Merzoug, K; Colonna, P; Ghouadni, R; Krisch, C; Kubisz, P; Laugier, A; Tourani, JM; Zouaoui-Benhadji, Z, 1989) |
| "Thirty-eight patients with advanced Hodgkin disease were treated with a combination of cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) from 1970 to 1973 and followed prospectively." | 3.67 | Chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for Hodgkin disease: fourteen-year follow-up results. ( Bloomfield, CD; Dusenbery, KE; Peterson, BA, 1988) |
| "Eighteen children with Hodgkin disease (16 previously untreated; two relapsed) were treated with MOPP chemotherapy (nitrogen mustard, vincristine, prednisone, procarbazine) only." | 3.66 | Results of treatment of 18 children with Hodgkin disease with MOPP chemotherapy as the only treatment modality. ( Ekert, H; Waters, KD, 1983) |
| "A 34-year-old woman who had had intractable pruritus for 2 years experienced dramatic relief from the symptom under treatment with cimetidine." | 3.66 | [Pruritus in Hodgkin's disease responding to cimetidine]. ( Graf, W; Stäubli, M; Straub, PW, 1981) |
| " Since on both occasions her Toxoplasma dye test titer was 1 : 8000 or higher, she was treated on suspicion of toxoplasmosis with sulfadizine and pyrimethamine." | 3.66 | Immune competence in a patient with Hodgkin's disease and relapsing toxoplasmosis. ( Amare, M; Frenkel, JK; Larsen, W, 1978) |
| "Three patients with Hodgkin disease, eight with non-Hodgkin lymphoma, and one with chronic lymphocytic leukemia refractory to conventional combination chemotherapy were treated for remission induction with a new kinetically designed four-drug combination consisting of bleomycin, vincristine, adriamycin, and prednisone and given the acronym "BOAP." | 3.66 | A kinetically designed chemotherapeutic regimen for advanced refractory lymphoma patients. ( Braine, HG; Coltman, CA; Kerr, RO; Rossof, AH, 1978) |
| "Four patients with malignant lymphoma who were treated with multiple courses of combination chemotherapy, consisting of cyclophosphamide, Oncovin, procarbazine, and prednisone (COPP), developed avascular necrosis of the femoral head(s)." | 3.65 | Avascular necrosis of the femoral head with combination therapy. ( Desser, RK; Miller, JB; Roth, DG; Sweet, DL; Ultmann, JE, 1976) |
| "Intersitial pneumonia and pulmonary fibrosis developed in a 72-year-old man during therapy with cyclophosphamide, vincristine, and prednisone." | 3.65 | Cyclophosphamide therapy and interstitial pulmonary fibrosis. ( Patel, AR; Rao, KP; Rhee, HL; Sassoon, H; Shah, PC, 1976) |
| "A case of human fetal renal maldevelopment following the administration of nitrogen mustard, vincristine, procarbazine, and prednisone in early pregnancy for therapy of Hodgkin's disease is reported." | 3.65 | Fetal renal malformation following treatment of Hodgkin's disease during pregnancy. ( Mellman, WJ; Mennuti, MT; Shepard, TH, 1975) |
| " Seventeen patients with Hodgkin's disease and 15 with non-Hodgkin's lymphoma were subjected to nontherapeutic splenectomy as part of the staging procedure prior to their initial treatment with MOPP (nitrogen mustard, vincristine, procarbazine, and prednisone) or CVP (cyclophosphamide, vincristine, and prednisone) chemotherapy, respectively." | 3.65 | Effect of splenectomy on tolerance to combination chemotherapy in patients with lymphoma. ( Canellos, GP; DeVita, VT; Ihde, DC; Young, RC, 1976) |
| "In adults with advanced-stage Hodgkin's lymphoma, the CD30-directed antibody-drug conjugate brentuximab vedotin combined with multiagent chemotherapy has been shown to have greater efficacy, but also more toxic effects, than chemotherapy alone." | 3.11 | Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma. ( Castellino, SM; Charpentier, AM; Cho, S; Dave, H; Henderson, TO; Hodgson, D; Hoppe, BS; Horton, T; Keller, FG; Kelly, KM; McCarten, K; Parsons, SK; Pei, Q; Punnett, A; Wu, Y, 2022) |
| "Survivors of Hodgkin lymphoma (HL) have an increased risk of subsequent malignant neoplasms (SMNs)." | 3.01 | Subsequent malignant neoplasms among children with Hodgkin lymphoma: a report from the Children's Oncology Group. ( Bush, R; Buxton, A; Constine, LS; Friedman, DL; Giulino-Roth, L; Kelly, KM; Pei, Q; Schwartz, CL; Wolden, SL; Wu, Y, 2021) |
| "Patients with advanced-stage Hodgkin lymphoma (HL) demonstrated excellent 2-year progression-free survival (PFS) after receiving positron emission tomography (PET)-adapted therapy on SWOG S0816." | 2.90 | Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma. ( Barr, PM; Bartlett, NL; Evens, AM; Friedberg, JW; Hsi, ED; Kahl, BS; Knopp, MV; LaCasce, AS; LeBlanc, M; Leonard, JP; Li, H; Moskowitz, CH; Rimsza, LM; Schöder, H; Smith, SM; Stephens, DM; Straus, DJ, 2019) |
| "While patients with early-stage Hodgkin lymphoma (HL) have an excellent outcome with combined treatment, the radiation therapy (RT) dose and treatment with chemotherapy alone remain questionable." | 2.87 | Comparison of 36 Gy, 20 Gy, or No Radiation Therapy After 6 Cycles of EBVP Chemotherapy and Complete Remission in Early-Stage Hodgkin Lymphoma Without Risk Factors: Results of the EORT-GELA H9-F Intergroup Randomized Trial. ( Aleman, BMP; André, M; Audouin, J; Beijert, M; Bordessoule, D; Bouabdallah, K; Boulat, O; Christian, B; de Jong, D; Eghbali, H; Fermé, C; Gabarre, J; Gaillard, I; Girinsky, T; Gonzalez, H; Hélias, P; Henry-Amar, M; Jaubert, J; Lugtenburg, PJ; Lybeert, MLM; Morschhauser, F; Noordijk, EM; Ong, F; Quittet, P; Roesink, JM; Stamatoullas, A; Tertian, G; Thomas, J; Tirelli, U; van der Maazen, RWM; Vranovsky, A, 2018) |
| "Nodular lymphocyte Hodgkin lymphoma (NLPHL) is a rare disease for which the optimal therapy is unknown." | 2.84 | Encouraging activity for R-CHOP in advanced stage nodular lymphocyte-predominant Hodgkin lymphoma. ( Cheah, CY; Dabaja, B; Fanale, MA; Fayad, LE; Fowler, NH; Hagemeister, FB; Horowitz, SB; Lai, CM; Lee, HJ; McLaughlin, P; Medeiros, LJ; Milgrom, SA; Nastoupil, L; Neelapu, SS; Oki, Y; Pinnix, CC; Rich, A; Rodriguez, MA; Romaguera, JE; Samaniego, F; Turturro, F; Wang, ML; Westin, JR; Younes, A, 2017) |
| "For early-stage Hodgkin lymphoma (HL), optimal chemotherapy regimen and the number of cycles to be delivered remain to settle down." | 2.84 | ABVD or BEACOPP ( Anglaret, B; Audhuy, B; Bologna, S; Bouabdallah, R; Brice, P; Brière, J; Carde, P; Casasnovas, O; de Jong, D; de Weerdt, O; Delarue, R; Eghbali, H; Fermé, C; Henry-Amar, M; Janvier, M; Lugtenburg, PJ; Lybeert, MLM; Marjanovic, Z; Noordijk, EM; Raemaekers, JMM; Reman, O; Salles, G; Sebban, C; Spina, M; Tersteeg, RJHA; Thomas, J; Thyss, A; van Imhoff, GW; Vranovsky, A, 2017) |
| "Relapses were characterized without respect to site (initial, new, or both; and initial bulk or initial nonbulk), and involved field radiation therapy field (in-field, out-of-field, or both)." | 2.80 | Patterns of relapse from a phase 3 Study of response-based therapy for intermediate-risk Hodgkin lymphoma (AHOD0031): a report from the Children's Oncology Group. ( Chen, L; Constine, LS; Dharmarajan, KV; FitzGerald, TJ; Friedman, DL; Iandoli, M; Kessel, SK; McCarten, KM; Schwartz, CL; Wolden, SL, 2015) |
| "In patients with early unfavorable Hodgkin's lymphoma (HL), combined modality treatment with four cycles of ABVD (adriamycin, bleomycin, vinblastine, and dacarbazine) and 30 Gy involved-field radiotherapy (IFRT) results in long-term tumor control of approximately 80%." | 2.77 | Dose-intensification in early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD14 trial. ( Borchmann, P; Diehl, V; Eich, HT; Engert, A; Fuchs, M; Greil, R; Klimm, B; Kral, Z; Lohri, A; Markova, J; Meissner, J; Mueller, RP; Plütschow, A; Soekler, M; Stein, H; Topp, MS; von Tresckow, B; Zijlstra, JM, 2012) |
| "Eighty-eight eligible patients with Hodgkin lymphoma stage I and II (<3 nodal sites, no B symptoms, mediastinal bulk, or extranodal extension) enrolled between March 3, 2000, and December 9, 2008." | 2.77 | Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma. ( Billett, AL; Billups, CA; Donaldson, SS; Friedmann, A; Howard, SC; Hudson, MM; Krasin, MJ; Kun, LE; Larsen, EC; Link, MP; Marcus, KJ; Metzger, ML; Tarbell, N; Weinstein, HJ; Wu, J; Yock, TI, 2012) |
| "Approximately 20% of all Hodgkin lymphoma (HL) patients are older than 60 years and have a poor prognosis, mainly because of increased treatment-related toxicity resulting in reduced overall dose intensity and more treatment-related mortality." | 2.76 | Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma. ( Böll, B; Borchmann, P; Bredenfeld, H; Eich, HT; Eichenauer, DA; Engert, A; Fuchs, M; Geissler, M; Görgen, H; Graeven, U; Halbsguth, T; Keller, U; Kremers, S; Markova, J; Soekler, M; Trenn, G; von Tresckow, B, 2011) |
| "After MOPP-Bleo induction for advanced Hodgkin lymphoma, ABVD provides better consolidation than local RT." | 2.74 | Radiation therapy compared with chemotherapy for consolidation of chemotherapy-induced remission of advanced Hodgkin lymphoma: a study by the Eastern Co-operative Oncology Group (E1476) with >20 years follow-up. ( Bennett, JM; Glick, JH; Hong, F; Wiernik, PH, 2009) |
| "One hundred ten children with low-risk Hodgkin's disease were treated with four cycles of VAMP and 15 Gy IFRT for those who achieved a complete response (CR) or 25." | 2.73 | Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease. ( Billett, AL; Brain, S; Donaldson, SS; Hudson, MM; Hurwitz, CA; Krasin, M; Kun, LE; Link, MP; Marcus, KC; Rai, SN; Tarbell, NJ; Weinstein, HJ; Young, JA, 2007) |
| "Three plasma samples and a 24-hour urine collection for day 1 of the first three cycles of chemotherapy were analysed in 30 patients, and the pharmacokinetic parameters of the respective drugs were estimated by population pharmacokinetic methods (nonlinear mixed-effects model [NONMEM] software)." | 2.73 | Population pharmacokinetics of the BEACOPP polychemotherapy regimen in Hodgkin's lymphoma and its effect on myelotoxicity. ( Busse, D; Diehl, V; Engert, A; Fuhr, U; Hempel, G; Jaehde, U; Jetter, A; Josting, A; Kasel, D; Klimm, B; Merkel, U; Reif, S; Rietbrock, S; Schwab, M; Wilde, S, 2007) |
| "Patients with Stage III or IV Hodgkin's lymphoma or Stage IIB with risk factors participated in this single-arm, multicenter pilot study." | 2.73 | Radiotherapy does not influence the severe pulmonary toxicity observed with the administration of gemcitabine and bleomycin in patients with advanced-stage Hodgkin's lymphoma treated with the BAGCOPP regimen: a report by the German Hodgkin's Lymphoma Stud ( Bredenfeld, H; Diehl, V; Eich, HT; Engert, A; Macann, A; Müller, RP, 2008) |
| "Treatment of early-stage Hodgkin's disease is usually tailored in line with prognostic factors that allow for reductions in the amount of chemotherapy and extent of radiotherapy required for a possible cure." | 2.73 | Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease. ( Baars, JW; Berger, F; Blanc, M; Bosq, J; Brice, P; Carde, P; Carrie, C; Creemers, GJ; Diviné, M; Eghbali, H; Fermé, C; Gabarre, J; Girinsky, T; Gyan, E; Hagenbeek, A; Henry-Amar, M; Jaubert, J; Kluin-Nelemans, JC; Lederlin, P; Lugtenburg, PJ; Meerwaldt, JH; Monconduit, M; Noordijk, EM; Poortmans, P; Raemaekers, JM; Reman, O; Rieux, C; Salles, G; Thomas, J; Tirelli, U; Van den Neste, E; van't Veer, MB; Vié, B; Viseu, F; Walewski, JA, 2007) |
| "The causes of death were Hodgkin's lymphoma in 36 patients, second neoplasms in 12, cardiorespiratory diseases in 4, pulmonary diseases in 2, and unknown in 6." | 2.72 | MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors. ( Broglia, C; Cavanna, L; Chisesi, T; Corazza, GR; Corbella, F; Federico, M; Gobbi, PG; Iannitto, E; La Sala, A; Levis, A; Molica, S; Pavone, V; Sacchi, S; Valentino, F, 2006) |
| "Forty-one patients with high-risk Hodgkin's lymphoma were randomized to receive pegfilgrastim (6 mg) on day 4 or 8 of each cycle." | 2.72 | Pegfilgrastim support for full delivery of BEACOPP-14 chemotherapy for patients with high-risk Hodgkin's lymphoma: results of a phase II study. ( Bacon, P; Berger, D; Bredenfeld, H; Diehl, V; Döhner, H; Easton, V; Engert, A; Ho, AD; Schmitz, N; Skacel, T, 2006) |
| "In early-stage Hodgkin's lymphoma (HL), subtotal nodal irradiation (STNI) and combined chemotherapy/radiotherapy produce high disease control rates but also considerable late toxicity." | 2.72 | Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials. ( Aleman, BM; Bosq, J; Carde, P; Dupouy, N; Eghbali, H; Girinsky, T; Hagenbeek, A; Henry-Amar, M; Kluin-Nelemans, JC; Krol, AD; Monconduit, M; Noordijk, EM; Pény, AM; Raemaekers, JM; Thomas, J; Tirelli, U; Verschueren, TA; Vovk, M, 2006) |
| "A German Hodgkin's lymphoma (HL) study group designed the BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisolone) regimen." | 2.72 | Multicentre phase II study of the baseline BEACOPP regimen for patients with advanced-stage Hodgkin's lymphoma. ( Aoki, S; Hirano, M; Miura, I; Niitsu, N; Okamoto, M; Tamaru, J; Tomita, N, 2006) |
| "Adult patients (N = 856) with advanced Hodgkin's disease were randomly assigned to treatment with ABVD or MOPP/ABV." | 2.71 | Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial. ( Canellos, GP; Connors, JM; Duggan, DB; Fisher, RI; Glick, JH; Johnson, JL; Peterson, BA; Petroni, GR, 2003) |
| "One hundred patients with Hodgkin's disease (97 with stage I-II disease at presentation) who relapsed after radiation therapy alone were salvaged with either MOPP or ABVD." | 2.71 | Comparison of MOPP versus ABVD as salvage therapy in patients who relapse after radiation therapy alone for Hodgkin's disease. ( Fisher, DC; Li, S; Mauch, PM; Neuberg, D; Ng, AK; Silver, B; Stevenson, MA, 2004) |
| "Gemcitabine was given at a starting dose of 800 mg/m(2) on days 1 and 4 of each cycle." | 2.71 | Severe pulmonary toxicity in patients with advanced-stage Hodgkin's disease treated with a modified bleomycin, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone, and gemcitabine (BEACOPP) regimen is probably related to the combination o ( Bredenfeld, H; Diehl, V; Engert, A; Franklin, J; Fries, S; Josting, A; Mailänder, V; Nogova, L; Oertel, J, 2004) |
| "Elderly patients with Hodgkin's lymphoma (HL) have a worse outcome than young patients." | 2.70 | Treatment of elderly Hodgkin's lymphoma patients with a novel 5-drug regimen (ODBEP): a phase II study. ( Connors, JM; Gascoyne, R; Klasa, RJ; Macpherson, N; O'Reilly, SE; Voss, N, 2002) |
| "Patients who were PCR-positive for B-cell leukemia-lymphoma 2 (bcl-2) gene rearrangement [t(14;18)] were evaluated for responses to rituximab alone or combined with CHOP." | 2.70 | Clearing of cells bearing the bcl-2 [t(14;18)] translocation from blood and marrow of patients treated with rituximab alone or in combination with CHOP chemotherapy. ( Alkuzweny, B; Czuczman, MS; Gordon, L; Grillo-López, AJ; LoBuglio, AF; Maloney, D; McLaughlin, P; Rosenberg, J; Saleh, M; White, CA, 2001) |
| "Thirty-three evaluable patients with Hodgkin's disease who failed radiotherapy were treated on this phase II study with bleomycin, lomustine, cyclophosphamide, vincristine, procarbazine and prednisone given every 28 days for a minimum of eight courses." | 2.70 | Bleomycin, lomustine, cyclophosphamide, vincristine, procarbazine and prednisone (BLEO-CCVPP) in patients with Hodgkin's disease who relapsed after radiotherapy alone: a long-term follow-up study of the Eastern Cooperative Oncology Group (E3481). ( Bennett, JM; Glick, JH; Habermann, TM; Leong, T; Neiman, RS; Oken, MM; Schuster, S; Wiernik, PH, 2001) |
| "Successful treatment of advanced-stage Hodgkin's disease (HD) may critically depend on dose intensity." | 2.70 | Cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) for advanced-stage Hodgkin's disease: CALGB 8856. ( Barcos, M; Cooper, MR; Frei, E; Johnson, JL; Lester, EP; Millard, FE; Omura, GA; Peterson, BA; Petroni, GR, 2001) |
| "Alternating COPP/ABVD and rapid alternating COPP/ABV/IMEP in combination with extended-field radiotherapy are equally effective in intermediate-stage Hodgkin's lymphoma and produce excellent long-term treatment results." | 2.70 | Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5. ( Anselmo, AP; Brosteanu, O; Diehl, V; Doelken, G; Duehmke, E; Engert, A; Franklin, J; Georgii, A; Greil, R; Hasenclever, D; Herrmann, R; Josting, A; Kirchner, H; Koch, P; Koch, T; Lathan, B; Loeffler, M; Munker, R; Paulus, U; Pfistner, B; Pfreundschuh, M; Rueffer, U; Schalk, KP; Sieber, M; Tesch, H; Wolf, J, 2002) |
| " Further follow-up is required to assess the effect of dosage and the effect on survival and late toxicities." | 2.69 | BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group. ( Bischoff, H; Diehl, V; Duehmke, E; Engert, A; Franklin, J; Georgii, A; Glunz, A; Haedicke, C; Hasenclever, D; Hermann, R; Holmer, L; Krause, S; Lathan, B; Loeffler, M; Paulus, U; Pfreundschuh, M; Rueffer, JU; Sextro, M; Sieber, M; Stappert-Jahn, U; Tesch, H; von Kalle, K; Winnerlein-Trump, E; Wolf, J; Wulf, G, 1998) |
| "Management of advanced-stage Hodgkin's disease with a MOPP/ABV hybrid regimen (mechlorethamine, vincristine, procarbazine, prednisone, Adriamycin, bleomycin and vinblastine) has yielded a high complete response rate (75-85%)." | 2.69 | Two different schedules for integrating filgrastim as adjuvant therapy in the treatment of patients with advanced stage Hodgkin's lymphoma receiving MOPP/ABV hybrid chemotherapy. ( Bélanger, D; Bergeron, M; Cantin, G; Couture, F; Desjardins, L; Dufresne, J; Gyger, M; Hewitt, LA; L'Espérance, B; Lacroix, L; Ouellet, PA; Pirc, L; Yelle, L, 1999) |
| "The treatment of advanced Hodgkin's disease (HD) with chemotherapy (CTx) alone or combined modality treatments has been controversial." | 2.69 | Comparison of chemotherapy to radiotherapy as consolidation of complete or good partial response after six cycles of chemotherapy for patients with advanced Hodgkin's disease: results of the groupe d'études des lymphomes de l'Adulte H89 trial. ( Berger, F; Bordessoule, D; Brice, P; Caillot, D; Diviné, M; Fermé, C; Ferrant, A; Gabarre, J; Hennequin, C; Lederlin, P; Lepage, E; Moullet, I; Sebban, C, 2000) |
| "Mitoxantrone is an active agent in lymphoma that is not generally used in first-line treatment." | 2.69 | CN3OP: an active regimen in patients with relapsed/refractory Hodgkin's lymphoma. ( Kraszewska, E; Krzyzanowska, JB; Lampka, E; Meder, J; Miśkiewicz, Z; Romejko-Jarosińska, J; Walewski, J, 2000) |
| " Despite increased hematotoxicity, moderate dose escalation is safe for the majority of the patients with G-CSF assistance and standard supportive treatment." | 2.69 | Acute hematologic toxicity and practicability of dose-intensified BEACOPP chemotherapy for advanced stage Hodgkin's disease. German Hodgkin's Lymphoma Study Group (GHSG). ( Diehl, V; Engel, C; Loeffler, M; Schmitz, S; Tesch, H, 2000) |
| "Patients with Hodgkin's disease (HD) who fail to enter a complete remission after an initial course of combination chemotherapy are usually considered to have an induction failure (IF); this subset of patients has an extremely poor outcome with further conventional therapy." | 2.68 | High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy. ( Barnett, MJ; Fairey, RN; Hogge, DE; Klasa, RJ; Klingemann, HG; Nantel, SH; Reece, DE; Shepherd, JD; Sutherland, HJ; Voss, NJ, 1995) |
| "Dexverapamil was escalated eight dose levels, from 240 to 1,200 mg/m2/d." | 2.68 | Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy. ( Bates, SE; Bryant, G; Fojo, A; Herdt, J; Jaffe, ES; Regis, J; Steinberg, SM; Wilson, WH; Wittes, RE; Zhan, Z, 1995) |
| "Patients with Hodgkin's disease were treated with ChlVPP chemotherapy: days 1-14: chlorambucil: 6 mg/m2/day, procarbazine: 100 mg/m2/day, prednisone or prednisolone: 40 mg/day; Days 1, 8: vinblastine: 6 mg/m2/day." | 2.68 | ChlVPP therapy for Hodgkin's disease: experience of 960 patients. The International ChlVPP Treatment Group. ( , 1995) |
| "Six patients (4 with Hodgkin's disease) achieved a complete response (CR) (35%; 95% CI: 14-62%)." | 2.68 | Infusional chemotherapy (EPOCH) in patients with refractory or relapsed lymphoma. ( Carrión, JR; García Arroyo, FR; Salinas, P, 1995) |
| "Treatment of both Hodgkin's disease (HD) and high-grade non-Hodgkin's lymphoma (HG-NHL) with bulky presentation at diagnosis frequently results in residual masses detected radiologically." | 2.68 | Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma. ( Babini, L; Barbieri, E; Battista, G; Bendandi, M; Canini, R; Fanti, S; Frezza, G; Gherlinzoni, F; Gozzetti, A; Merla, E; Monetti, N; Pisi, P; Rimondi, MR; Tura, S; Zinzani, PL; Zompatori, M, 1996) |
| "Fourteen had Hodgkin's and four non-Hodgkin's lymphoma." | 2.68 | Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy. ( Avivi, I; Ben-Shahar, M; Blumenfeld, Z; Epelbaum, R; Haim, N; Linn, S, 1996) |
| "We evaluated sperm aneuploidy using multi-colour fluorescence in situ hybridization (FISH), and found approximately 5-fold increases in sperm with disomies, diploidies and complex genotypes involving chromosome X, Y and 8." | 2.68 | Chemotherapy induces transient sex chromosomal and autosomal aneuploidy in human sperm. ( Cassel, MJ; Eskenazi, B; Hagemeister, FB; Meistrich, ML; Moore, D; Robbins, WA; Weier, HU; Wilson, G; Wyrobek, AJ, 1997) |
| "Two cases developed a second malignancy." | 2.68 | Treatment of childhood Hodgkin's disease without radiotherapy. ( Behrendt, H; van den Berg, H; Zsiros, J, 1997) |
| "With the success of treatment for Hodgkin disease in children, future research needs to be focused in reducing toxicity without altering the excellent actual outcome." | 2.68 | Hodgkin disease in children: results of a prospective randomized trial in a single institution in Argentina. ( Alderete, D; Alfaro, E; Casak, S; Chantada, G; Felice, MS; Gallo, G; Quinteros, R; Sackmann-Muriel, F; Scopinaro, M; Zubizarreta, P, 1997) |
| "Eighty patients presented with Hodgkin's disease and a mediastinal mass greater than one third the greatest chest diameter on chest radiograph." | 2.68 | Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease. ( Bastian, AW; DeVita, VT; Duffey, PL; Glatstein, E; Hubbard, SM; Ihde, DC; Jaffe, ES; Longo, DL; Wilson, WH; Wittes, RE; Young, RC, 1997) |
| "(mean 43 yr." | 2.68 | [A trial of applying an oily suspension of bleomycin endolymphatically in patients with Hodgkin's disease of the extraperitoneal lymph nodes]. ( Ziółko, E, 1997) |
| "A retrospective review of patients with Hodgkin's disease treated at Stanford University Medical Center was undertaken to determine if, within the pediatric population, children < or = 10 years of age have a unique prognosis and response to treatment." | 2.67 | Hodgkin's disease in the very young. ( Cleary, SF; Donaldson, SS; Link, MP, 1994) |
| "Of our 19 patients with Hodgkin's disease (age range, 6 to 20 years) treated with this regimen, 2 had clinical stage I disease, 10 had stage II, 6 had stage III, and 1 had stage IV." | 2.67 | Vancouver hybrid: preliminary experience in the treatment of Hodgkin's disease in childhood and adolescence. ( Arndt, CA; Chen, MG; Gilchrist, GS; Khan, SP; Matsumoto, JM; O'Fallon, WM; Schomberg, PJ; Smithson, WA, 1994) |
| "Twenty-four patients with Hodgkin's disease refractory or resistant to at least two chemotherapy regimens were enrolled in this study." | 2.67 | Vinorelbine: an active drug for the management of patients with heavily pretreated Hodgkin's disease. ( Balzarini, L; Bonadonna, G; Bonfante, V; Devizzi, L; Santoro, A; Valagussa, P; Viviani, S, 1994) |
| "In successfully treated patients with Hodgkin's disease the described changes are of minor significance." | 2.67 | [Late cardiac toxicity in Hodgkin's disease. A study with pulsed Doppler echocardiography]. ( Behles, C; Kreuser, ED; Schröder, K; Schröder, R; Thiel, E; Uhrig, A; Völler, H, 1993) |
| "Patients with PSIII 1A Hodgkin's disease treated with RT have a significantly higher risk of relapse and potentially a poorer survival compared with patients treated with CMT." | 2.67 | Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy. ( Canellos, GP; Coleman, CN; Kalish, LA; Marcus, KC; Mauch, PM; Rosenthal, DS; Shulman, LN, 1994) |
| "65 adult patients with Hodgkin's disease were treated acc." | 2.67 | [Early results of the treatment of Hodgkin's disease in adults using the seven-drug cytostatic protocol]. ( Filip, A; Gabryś, K; Kotlarek-Haus, S; Kuliszkiewicz-Janus, M; Wołowiec, D, 1992) |
| "Modern treatment plans for early staged Hodgkin's disease must focus on optimal disease-free survival results without laparotomy, minimal acute toxicity, and reduced long-term complications." | 2.67 | NOVP and radiotherapy for early-staged Hodgkin's disease: an interim analysis. ( Cabanillas, F; Fuller, L; Hagemeister, FB; McLaughlin, P; Rodriguez, M; Romaguera, J; Swan, F, 1992) |
| "Relapses were most frequent in previously involved unirradiated areas." | 2.67 | Management of relapse and survival in advanced stage Hodgkin's disease: the EORTC experience. ( Breed, WP; Burgers, JM; Carde, P; de Pauw, BE; Hagenbeek, A; Henry-Amar, M; Monconduit, M; Somers, R; Tarayre, M; Thomas, J, 1991) |
| " EPVP II is given every 21 days with increased dosage and increased intensity of epirubicin." | 2.67 | Novel combination of epirubicin, bleomycin, vinblastine and prednisone (EBVP II) before radical radiotherapy in localized stages (I-IIIA) of Hodgkin's disease. Early results in 100 consecutive patients. Pierre-et-Marie-Curie Group. ( Blanc, CM; David, B; Eghbali, H; Hoerni, B; Orgerie, MB; Rojouan, J; Zittoun, R, 1991) |
| "Eighty patients with advanced Hodgkin's disease were randomized either to treatment with combination of doxorubicin, bleomycin, vinblastine, and prednisone (ABVP), alternating with lomustine, vincristine, procarbazine, and prednisone (LOPP)--Group A, or to combination of cyclophosphamide, vincristine, procarbazine, prednisone, and low dose of bleomycin (COPP-Bleo)--Group B." | 2.67 | Comparison of two non-cross-resistant combinations (ABVP/LOPP) with COPP plus bleomycin in the treatment of advanced Hodgkin's disease. ( Bohunický, L; Fuchsberger, P; Gyárfás, J; Koza, I; Mardiak, J; Mociková, K; Spánik, S; Sufliarsky, J; Svancárová, L; Thalmeinerová, Z, 1991) |
| "58% of the non-Hodgkin's lymphomas occurred in patients with marked immunodeficiency, 85% were high grade malignancies and 47% had primary extranodal disease." | 2.67 | [Malignant lymphoma associated with HIV infection]. ( Becker, K; Clemens, MR; Fischer, T; Helm, EB; Knauf, W; Mitrou, PS; Pohl, C; Schrappe-Bächer, M; Serke, M; Westerhausen, M, 1991) |
| "Etoposide was included because of its known efficacy in relapsed Hodgkin's disease and to evaluate for synergy with an alkylating agent and vincristine." | 2.67 | Phase II study of MOPLACE chemotherapy for patients with previously treated Hodgkin's disease: a CALGB study. ( Barcos, M; Cooper, MR; Gottlieb, AJ; McCarroll, K; Norton, L; Schulman, P, 1990) |
| "Advanced classical Hodgkin lymphoma (cHL) is a rare lymphoid disease characterized by the presence of Hodgkin and Reed-Sternberg (HRS) cells." | 2.66 | Contemporary treatment options for a classical disease: Advanced Hodgkin lymphoma. ( Brown, AM; Devata, S; Marini, BL; Nachar, VR; Perissinotti, AJ; Reid, JH, 2020) |
| "In patients with stage IV Hodgkin's disease mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) was randomly tested against MOPP alternated monthly with doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD)." | 2.66 | Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results. ( Bonadonna, G; Santoro, A; Valagussa, P, 1986) |
| "In 1982 a French cooperative study for Hodgkin's disease was designed to minimize adverse side effects of therapy in childhood." | 2.66 | [Treatment of Hodgkin's disease in children with chemotherapy and low-dose radiation]. ( Lemerle, J; Leverger, G; Oberlin, O; Schaison, G, 1987) |
| "Untreated patients with Hodgkin's lymphoma in stages I-IIIA with risk factors (large mediastinal mass, massive splenic involvement, extranodal disease) were entered into the HD1 protocol and received a combined chemo-radiotherapy [2 X (COPP + ABVD) + 40 Gy extended field irradiation (EF) vs 2 X (COPP + ABVD) + 20 Gy EF]." | 2.66 | Chemotherapy of Hodgkin's lymphoma with alternating cycles of COPP (cyclophosphamide, vincristin, procarbazine, prednisone) and ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine). Results of the HD1 and HD3 trials of the German Hodgkin Study Group ( Diehl, V; Gerhartz, H; Hiller, E; Kirchner, H; Löffler, M; Petsch, S; Pfreundschuh, M; Rühl, U; Schoppe, W; Wilmanns, W, 1989) |
| "With such an attitude towards Hodgkin's disease in children it is advisable to abandon exploration laparotomy with splenectomy depriving the patient of the massive depot of humoral (B cell) immunity and creating the danger of an aggressive course of intercurrent infections in splenectomized children affected with Hodgkin's disease." | 2.66 | [Evaluation of 5-year results of the scheduled treatment of lymphogranulomatosis in children]. ( Goldobenko, GV; Makhomova, LA; Poliakov, VE; Susuleva, NA; Tsygankin, VI, 1989) |
| "Fifty-three children with Hodgkin's disease were clinically staged and treated with chemotherapy alone." | 2.66 | Treatment with MOPP or ChlVPP chemotherapy only for all stages of childhood Hodgkin's disease. ( Ekert, H; Mauger, D; Smith, PJ; Toogood, I; Waters, KD, 1988) |
| "A total of 277 patients with untreated Hodgkin's disease, clinical stages I-II, were randomized to cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) alone for 6 monthly cycles or to CVPP plus radiation therapy (RT), 3,000 rad, to involved areas (CVPP plus RT)." | 2.66 | Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage I-II Hodgkin's disease. ( Corrado, C; Garcia, I; Magnasco, O; Maschio, M; Montero, C; Muriel, FS; Pavlovsky, S; Sanahuja, FL; Santarelli, MT; Schwartz, L, 1988) |
| "The H5 study of supradiaphragmatic Hodgkin's disease in clinical stages I-II consisted of two controlled trials adapted to patients considered to have either favorable or unfavorable characteristics, based on prognostic factors identified in two former studies by the European Organization for Research and Treatment of Cancer." | 2.66 | Comparison of total nodal irradiation versus combined sequence of mantle irradiation with mechlorethamine, vincristine, procarbazine, and prednisone in clinical stages I and II Hodgkin's disease: experience of the European Organization for Research and Tr ( Burgers, JM; Carde, P; Cosset, JM; Hagenbeek, A; Hayat, M; Meerwaldt, JH; Monconduit, M; Sizoo, W; Somers, R; van der Schueren, E, 1988) |
| "Of the 188 patients with Hodgkin's disease, 157 achieved a complete response (CR) (84%), and 66% of them (101 patients) have remained disease-free more than 10 years from the end of treatment." | 2.66 | Twenty years of MOPP therapy for Hodgkin's disease. ( DeVita, VT; Duffey, PL; Hubbard, SM; Jaffe, ES; Longo, DL; Wesley, M; Young, RC, 1986) |
| "299 patients with stage III or IV Hodgkin's disease were randomised to receive cyclical chemotherapy with MOPP (mustine, Oncovin, procarbazine, prednisone) or LOPP (Leukeran substituted for mustine)." | 2.66 | Randomised study of MOPP (mustine, Oncovin, procarbazine, prednisone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease. British National Lymphoma Investigation. ( Hancock, BW, 1986) |
| "Three patients with remission of Hodgkin's disease after involved-field (two) and extended-field (one) radiotherapy died from cardiovascular disease that could only be attributed to the prior radiotherapy." | 2.66 | Treatment of stages I and II Hodgkin's disease with three different therapeutic modalities. ( Caravelli, J; Cirrincione, C; Cunningham, I; Koziner, B; McCormick, B; Mertelsmann, R; Myers, J; Nisce, LZ; Redman, J; Straus, DJ, 1986) |
| "From 1976 to 1981, 335 patients with untreated Hodgkin's disease, clinical stages I, II, and IIIA, have been treated by MOPP (nitrogen mustard, vincristine, procarbazine, prednisone) chemotherapy, three to six cycles according to the prognostic factors, combined with radiotherapy." | 2.66 | Extended versus involved fields irradiation combined with MOPP chemotherapy in early clinical stages of Hodgkin's disease. ( Audebert, A; Bernadou, A; Diebold, J; Eghbali, H; Hoerni, B; Krulik, M; Merle-Béral, H; Parlier, Y; Rojouan, J; Zittoun, R, 1985) |
| " From 1976 to 1979 patients with Stage IV disease were treated wither with MOPP or with MOPP plus bleomycin at low dosage (B-MOPP); the incidence of complete remission was not significantly different in the two groups of patients (52 vs." | 2.65 | Combination chemotherapy for stage IV Hodgkin's disease (Report no 14). ( Goldman, JM, 1981) |
| "Eighteen patients with advanced Hodgkin's disease, refractory to combination chemotherapy with nitrogen mustard, vincristine, prednisone, and procarbazine (MOPP), were treated with vinblastine, doxorubicin (Adriamycin), bleomycin, CCNU, and dacarbazine (DTIC) (VABCD)." | 2.65 | Treatment of MOPP-refractory Hodgkin's disease with vinblastine, doxorubicin, bleomycin, CCNU, and dacarbazine. ( Bond, WH; Chenoweth, L; Einhorn, LH; Stevens, EE; Williams, SD, 1983) |
| "Seven patients with active Hodgkin's lymphoma who had relapsed 4-39 months following six or more cycles of MOPP were treated with a combination of vinblastine-bleomycin-cis-platin (VBP)." | 2.65 | Vinblastine, bleomycin, and cis-platin as salvage therapy for MOPP treated patients with Hodgkin's lymphoma. ( Clamon, GH; Corder, MP; Wiesenfeld, M, 1984) |
| "Forty-seven patients with advanced Hodgkin's disease were entered in a prospective, randomized trial comparing MOPP (mechlorethamine, vincristine, procarbazine, and prednisone) with a regimen containing lomustine (CCNU), vinblastine, and prednisone (CCNU-VP)." | 2.65 | Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone. ( Bateman, JR; Hum, GJ; Liebman, HA; Ryden, VM; Sheehan, WW, 1983) |
| " There were no differences in dosage of these two agents between patients who remain alive in CR and those who relapsed and died." | 2.65 | Simultaneous low-dose radiation and low-dose chemotherapy in the treatment of advanced Hodgkin's disease. ( Gomez, GA; Han, T; Henderson, ES; Ozer, H; Panahon, AM; Stutzman, L, 1984) |
| "Of 209 Hodgkin's disease patients treated at least 6 months with a five-drug combination of induction chemotherapy and having a complete remission, four patients developed acute myelogenous leukemia (AML) as a second malignant neoplasm." | 2.65 | Acute myelogenous leukemia as a second malignant neoplasm following the successful treatment of advanced Hodgkin's disease. ( Bartolucci, AA; Durant, JR; Gams, RA; Liu, C, 1983) |
| "Advanced Hodgkin's disease appears to be curable by chemotherapy." | 2.65 | Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute. ( Berard, CW; Canellos, GP; Carbone, PP; DeVita, VT; Frei, E; Hubbard, SM; Moxley, JH; Simon, RM; Young, RC, 1980) |
| "Thirty seven Hodgkin's lymphoma patients with recurrence after first remission induced by radiation therapy and/or chemotherapy with mustine, oncovin, procarbazine and prednisolone (MOPP) were randomised to treat with a new combination chemotherapy comprising of doxorubicin, oncovin, procarbazine and prednisolone (DOPP)." | 2.65 | A new combination chemotherapy for recurrent Hodgkin's lymphoma. ( Ahmed, Q; Rahim, MA; Sarma, SK, 1982) |
| "We conclude that (1) survival of Hodgkin's disease of childhood has shown a rather marked improvement during the last decade and this progress is probably due to the use of combined multidrug chemotherapy administered under collaborative controlled clinical trials; (2) preliminary evaluation of the results of CVPP and CCVPP therapy shows that the latter combination (CCVPP) neither increases the percent of patients achieving complete remission nor prolongs relapse-survival in Hodgkin's disease of childhood: and (3) all stages of childhood Hodgkin's disease can be successfully managed with multidrug chemotherapy alone." | 2.65 | Hodgkin's disease in childhood: therapy results in Argentina. ( Bonesana, AC; Kvicala, R; Morgenfeld, M; Ojeda, F; Papendieck, C; Pavlovsky, S; Penchansky, L; Sackmann-Muriel, F; Schwartz, L; Sica, M, 1981) |
| "Twenty-one patients with advanced Hodgkin's disease resistant to MOPP (mechlorethamine, vincristine, procarbazine, prednisone) were treated with ABVD (adriamycin, bleomycin, vinblastine, dacarbazine)." | 2.65 | Prolonged disease-free survival in MOPP-resistant Hodgkin's disease after treatment with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD). ( Bonadonna, G; Santoro, A, 1979) |
| "No deaths from Hodgkin's disease have occurred in patients who received combined modality therapy, whereas 24 per cent of the patients who received radiotherapy alone have died with active disease." | 2.65 | Combined modality treatment of Hodgkin's disease confined to lymph nodes. Results eight years later. ( Diggs, C; Gustafson, J; Schimpff, SC; Wiernik, PH, 1979) |
| "117 patients with stage IIIA Hodgkin's disease were randomly allocated for treatment in a multicentre trial comparing the results of total nodal irradiation (T." | 2.64 | Initial treatment of stage IIIA Hodgkin's disease. Comparison of radiotherapy with combined chemotherapy. British National Lymphoma Investigation. ( , 1976) |
| "Thirty-seven patients with advanced Hodgkin's disease have been treated for greater than or equal to 3 months with a protocol consisting of alternate monthly courses of MOPP (mechlorethamine, Oncovin [vincristine], procarbazine, and prednisone) and ABDV (adriamycin, bleomycin, DTIC, and vinblastine) with local radiotherapy (RT) to areas of originally bulky disease." | 2.64 | Eight-drug combination chemotherapy (MOPP and ABDV) and local radiotherapy for advanced Hodgkin's Disease. ( Case, DC; Clarkson, BD; Lee, BJ; Nisce, L; Young, CW, 1976) |
| "Thirty-four children with Hodgkin's disease were treated during the years 1969--75." | 2.64 | MVPP chemotherapy combined with radiotherapy in the treatment of Hodgkin's disease in children. ( Armata, J; Borkowski, W; Depowska, T; Depowski, M; Kaczor, Z; Stopyrowa, J; Strzeszynski, J, 1978) |
| "Prednisone seems to be an important component of the MOPP combination in the management of stage IV Hodgkin's disease." | 2.64 | Value of prednisone in combination chemotherapy of stage IV Hodgkin's disease. Report from the British National Lymphoma Investigation. ( , 1975) |
| "204 patients with Hodgkin's disease not previously treated were given vincristine, chlormethine, procarbazine and prednisone (protocol H2-65) for six months, followed by monthly vinblastine injections." | 2.64 | [Polychemotherapy of Hodgkin's disease (author's transl)]. ( Auclerc, G; Bernard, J; Boiron, M; Chastang, CL; Chelloul, N; Delbrück, H; Jacquillat, CL; Weil, M, 1975) |
| "Primary osseous Hodgkin's lymphoma is a very rare entity." | 2.55 | [Primary osseous Hodgkin's lymphoma of the sacrum: A diagnostic and therapeutic challenge]. ( Bouaouina, N; Fourati, N; Kanoun Belajouza, S; Khlif, A; Regaieg, H, 2017) |
| "Hodgkin lymphoma is a rare lymphoid malignancy affecting ∼9,200 new patients in the United States annually." | 2.53 | Hodgkin lymphoma: MOPP chemotherapy to PD-1 blockade and beyond. ( Ansell, SM, 2016) |
| "Treating Hodgkin lymphoma by using chemotherapy with or without radiotherapy is highly successful, with substantially fewer deaths from lymphoma than from other causes in recent studies of both early-stage and advanced-stage disease." | 2.53 | Response-adapted frontline therapy for Hodgkin lymphoma: are we there yet? ( Johnson, PW, 2016) |
| "He was diagnosed with stage II Hodgkin's lymphoma at the age of 15, and we considered the possibility of newly emerged CNS lymphoma occurring in the immunosuppressive condition after the treatment of Hodgkin's lymphoma." | 2.52 | Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) after treatment for Hodgkin's lymphoma. ( Hirose, S; Mashima, K; Mori, T; Okamoto, S; Shimizu, T; Suzuki, N; Suzuki, S; Yamada, S, 2015) |
| "The key question in advanced-stage Hodgkin lymphoma for many years now has been, should intensified chemotherapy be applied upfront or be reserved for relapsing patients." | 2.50 | Early intensification treatment approach in advanced-stage Hodgkin lymphoma. ( Borchmann, P, 2014) |
| "We describe the association of Hodgkin's lymphoma with a syndrome characterized by cholestasis, aminotransferase elevation and an histological picture of bile duct loss." | 2.50 | Complete remission of paraneoplastic vanishing bile duct syndrome after the successful treatment of Hodgkin's lymphoma: a case report and review of the literature. ( Aglietta, M; Boccone, P; Caravelli, D; Carnevale Schianca, F; D'Ambrosio, L; De Rosa, G; Grignani, G; Manca, A; Nuzzo, A; Rota Scalabrini, D; Tolomeo, F, 2014) |
| "We discuss the characteristics of breast cancer that occurs after Hodgkin's lymphoma and also treatment options that could be implemented." | 2.44 | Breast cancer after treatment of Hodgkin's lymphoma: general review. ( Alm El-Din, MA; El-Badawy, SA; Taghian, AG, 2008) |
| "The majority of patients with advanced Hodgkin's lymphoma are cured with currently available therapy, such as ABVD (Adriamycin [doxorubicin], bleomycin, vinblastine, and dacarbazine)." | 2.44 | Is BEACOPP better than ABVD? ( Cheson, BD, 2007) |
| "Current therapy for Hodgkin disease is aimed at high cure rates and optimal survivorship." | 2.44 | Risk, cure and complications in advanced hodgkin disease. ( Horning, SJ, 2007) |
| "Primary treatment of advanced Hodgkin's disease." | 2.43 | [Primary treatment of advanced Hodgkin's disease]. ( Illés, A; Molnár, Z; Udvardy, M, 2005) |
| "Advanced Hodgkin's disease is usually treated with six or more cycles of combination chemotherapy." | 2.43 | An unusual case of spontaneous remission of Hodgkin's disease after a single cycle of COPP-ABV chemotherapy followed by infectious complications. ( Bang, SM; Cheong, JW; Hahn, JS; Yang, WI, 2005) |
| "We describe a 59-years-old woman with limbic encephalitis, not explained by other causes, preceding diagnosis of Hodgkin's disease." | 2.42 | [Hodgkin's disease manifesting as paraneoplastic limbic encephalitis]. ( Bernard, P; Flocard, F; Kadouri, A; Talarmin, F; Vinzio, S, 2003) |
| "Erythema nodosum is the most frequent clinicopathological variant of the panniculitides." | 2.42 | [Erythema nodosum association with malignant lymphoma]. ( Griniūte, R; Pileckyte, M, 2003) |
| "There are two major goals in advanced Hodgkin's disease: (1) to improve the cure rate and (2) to reduce acute and long-term toxicities." | 2.41 | Treatment of advanced stage Hodgkin's disease. ( Diehl, V; Sieber, M; Tesch, H, 2001) |
| "Four of five patients with Hodgkin's disease (HD) will be cured with modern treatment strategies, depending on stage and risk factor profile." | 2.41 | New treatments for Hodgkin's disease. ( Diehl, V; Glossmann, JP; Josting, A, 2002) |
| "Relapses have been recorded from three years to twenty years, although few very late forms are registered." | 2.40 | Relapse of Hodgkin's disease after 10 years of complete remission: case report. ( Mwanda, OW; Othieno-Abinya, N, 1998) |
| "The patients with advanced-stage Hodgkin's disease who did not achieve a complete remission from their initial treatment with combination chemotherapy have a dismal prognosis." | 2.40 | [The management of Hodgkin's disease with chemotherapy or combined modality treatment]. ( Shimoyama, M; Tsushita, K; Utsumi, M, 1998) |
| "A patient who developed Hodgkin's disease after an 11-year remission of marginal zone B-cell (MZB) lymphoma (low grade B-cell lymphoma of mucosa-associated lymphoid tissue type) is presented." | 2.40 | Hodgkin's disease following extranodal marginal zone B-cell lymphoma in remission. ( Hara, K; Shimizu, K; Yatabe, Y, 1999) |
| "A case of primary intracerebral Hodgkin's disease (HD) without dural attachment in a 54-year-old immunocompetent patient is described." | 2.40 | Primary intracerebral Hodgkin's disease: report of a case with Epstein-Barr virus association and review of the literature. ( Bendszus, M; Klein, R; Kreipe, H; Müllges, W; Roggendorf, W; Woydt, M, 1999) |
| "80% or more of patients suffering from Hodgkin's lymphoma (HD) of limited stage are cured with modern treatment." | 2.39 | [Current therapy concepts in early and intermediate stages of Hodgkin diseases in adults]. ( Glanzmann, C; Stahel, R, 1995) |
| "Death still occurs in Hodgkin's disease (HD) patients with advanced stages, but also in early stages." | 2.39 | [Hodgkin disease: should high-risk patients be selected and chemotherapy be intensified?]. ( Carde, P, 1995) |
| "Malignant lymphoma is classified into the following five major categories: aggressive lymphoma, indolent B-lymphoma, Hodgkin's disease, T-lymphoblastic lymphoma and adult T-cell leukemia-lymphoma (ATL)." | 2.39 | [Recent progress in the chemotherapy of malignant lymphoma]. ( Tobinai, K, 1995) |
| "In most patients with newly diagnosed Hodgkin's disease, initial therapy is curative." | 2.39 | Hodgkin's disease: management of first relapse. ( Horning, SJ; Yuen, AR, 1996) |
| "The association between Hodgkin's disease and pregnancy is rare." | 2.38 | [Hodgkin's disease and pregnancy. 3 case reports and a review of the literature]. ( Abboud, J; Chahine, G; Nasnas, R; Nasrallah, T, 1993) |
| "Treatment results of Hodgkin's disease have been improved by polychemotherapy." | 2.38 | Dose-escalation study for the treatment of Hodgkin's disease. The German Hodgkin Study Group (GHSG). ( Diehl, V, 1993) |
| "Thoracic and abdominal irradiation for Hodgkin's disease was performed concomitantly with chemotherapy for the non-Hodgkin's lymphoma." | 2.38 | Cerebral non-Hodgkin's lymphoma discovered when treating Hodgkin's disease. ( Bergeron, C; Chatel, M; Darcel, F; Edan, C; Faivre, J; Jouan, H; Le Moine, P; Le Prise-Fleury, E; Patte, C; Tass, P, 1993) |
| "Thymic hyperplasia was noted after treatment was initiated or completed in all but two patients; and all did well, with one exception: a 17 year-old boy who was inadvertently treated for relapsed Hodgkin disease and who died of fibrinous pneumonitis and nocardia, with pathologic CR noted at autopsy." | 2.38 | Thymic hyperplasia with hemorrhage simulating recurrent Hodgkin disease after chemotherapy-induced complete remission. ( Erner, SM; Keller, SM; Langer, CJ, 1992) |
| "The cases of 63 children treated for Hodgkin's disease were retrospectively evaluated according to clinical and laboratory characteristics at initial appearance, clinical and pathologic staging, and treatment for their effects on survival and disease-free survival." | 2.38 | Hodgkin's disease in children: correlation of clinical characteristics, staging procedures, and treatment at the University of Minnesota. ( Aeppli, D; Day, DL; Heise, R; Lee, CK; McClain, KL; Woods, WG, 1990) |
| "Treatment of disseminated Hodgkin's disease still fails in about 50 percent of the cases." | 2.38 | [Treatment of relapses and failures in disseminated Hodgkin's disease]. ( Bastion, Y; Coiffier, B; Tigaud, JD, 1991) |
| "A case of Hodgkin's disease associated from the start with visceral leishmaniasis in the absence of antitumoral treatment shows that leishmaniasis is a severe opportunistic infection in endemic areas and can be masked by the tumoral syndrome of an underlying pathology." | 2.38 | [Visceral leishmaniasis associated with Hodgkin's disease: diagnostic difficulties]. ( Blanc, AP; Jacquème, P; Magnan, A; Poirier, R; Redding, E; Sudan, N, 1991) |
| "Cutaneous manifestations of Hodgkin's disease are relatively uncommon." | 2.38 | Hodgkin's disease presenting in the skin: case report and review of the literature. ( Hayes, TG; Rabin, VR; Rosen, T; Zubler, MA, 1990) |
| "Ten patients developed SANLL between the 34th and 123rd month of CR." | 2.38 | Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin's disease. ( Andrieu, JM; Coscas, Y; Fermanian, J; Flandrin, G; Ifrah, N; Payen, C, 1990) |
| "Pulmonary toxicity is a well recognised side effect of anticancer agents particularly bleomycin, cyclophosphamide, methotrexate, and busulphan." | 2.38 | Pulmonary toxicity following MOPP chemotherapy. ( Byrne, MJ; Cohney, SJ; Millward, MJ; Ryan, GF, 1990) |
| "A case of retroperitoneal Hodgkin's disease with dysuria is reported." | 2.38 | [A case of retroperitoneal Hodgkin's disease with dysuria]. ( Hosomi, M; Koide, T; Maeda, O; Matsumiya, K; Takaha, M, 1990) |
| "As salvage therapy in non-Hodgkin's lymphoma (NHL), IMV-Bleo (ifosfamide, methotrexate, etoposide, bleomycin) produced a complete remission (CR) rate of 41% and seemed to be particularly effective in patients with suboptimal response to first-line treatment." | 2.38 | European experience with ifosfamide in lymphomas. ( Diehl, V; Schaadt, M; von Kalle, AK, 1989) |
| "Chemotherapy of malignant lymphomas has accomplished a significant progress during the two decades." | 2.38 | [Current status of chemotherapy in the treatment of malignant lymphomas]. ( Hayashi, K; Kimura, I; Mizuta, J; Murashima, M; Ohnoshi, T; Tada, A; Tagawa, S; Ueno, K, 1989) |
| "The outlook for patients with Hodgkin's disease has improved dramatically over the past 20 years." | 2.37 | Hodgkin's disease. ( Portlock, CS, 1984) |
| "Two patients developed non-Hodgkin's lymphoma (NHL) six and ten years after radiotherapy and chemotherapy for Hodgkin's disease nodular sclerosis type." | 2.37 | Non Hodgkin's lymphomas following chemoradiotherapy for Hodgkin's disease. Two new cases and a review of the literature. ( Cuesta, B; Gómez-Bezares, MC; Idoate, MA; Marigil, MA; Pardo-Mindan, FJ; Rocha, E, 1986) |
| "This article reports a patient with Hodgkin's disease in remission after combined modality therapy who developed metastatic pulmonary osteosarcoma, subsequently found to originate in soft tissue of the mediastinum, within a field irradiated 11 years previously." | 2.37 | Mediastinal osteosarcoma with extension to lungs in a patient treated for Hodgkin's disease. ( Andres, DF; Catanese, J; Dorfman, HD; Dutcher, JP; Wiernik, PH, 1988) |
| "Patients with advanced Hodgkin's disease not achieving a complete remission with initial MOPP therapy are significantly less responsive to adriamycin and nitrosourea-containing regimens than patients with relapsing disease following a complete remission with MOPP." | 2.37 | Semantics and the chemotherapy of Hodgkin's disease--resistance is not relapse: alternative chemotherapy lacks effectiveness for disease not totally responsive to initial MOPP treatment. ( Coleman, M; Friedlander, RJ, 1988) |
| "Most patients with early-stage Hodgkin's disease can now be cured by one of several therapeutic approaches." | 2.37 | Early-stage Hodgkin's disease: current approaches to treatment. ( MacKenzie, R; Rusthoven, JJ, 1985) |
| "The prognosis of patients with Hodgkin's disease has dramatically improved over the past few decades." | 2.37 | Current management of Hodgkin's disease. ( Behrens, BC; DeVita, VT; Young, RC, 1985) |
| "We report a rare case of a patient with Hodgkin lymphoma who developed grade 2 immune-related pneumonitis, requiring long-term low-dose glucocorticoid maintenance therapy, during which pneumonitis disappeared, and complete response was achieved." | 1.91 | Immune-related pneumonitis requiring low-dose prednisone maintenance in one patient with durable complete response. ( Gao, Q; Li, T; Ma, B; Zhao, L; Zhou, Y, 2023) |
| "Patients with bulky stage I/II classic Hodgkin lymphoma (cHL) are typically treated with chemotherapy followed by radiation." | 1.91 | Positron Emission Tomography-Adapted Therapy in Bulky Stage I/II Classic Hodgkin Lymphoma: CALGB 50801 (Alliance). ( Abramson, J; Bartlett, NL; Blum, K; Bogart, J; Cheson, B; Dockter, T; Hsi, E; Kostakoglu, L; LaCasce, AS; Leonard, JP; Ruppert, AS; Schöder, H; Wagner-Johnston, N, 2023) |
| "Nodular Lymphocyte predominant Hodgkin lymphoma (NLPHL) are rare lymphomas in pediatric patients comprising less than 10 % of all Hodgkin lymphoma (HL)." | 1.91 | [Strategy of the French Society of Childhood Cancer (SFCE) for pediatric nodular lymphocyte predominant lymphoma]. ( Boudjemaa, S; Dourthe, ME; Ducou Le Pointe, H; Garnier, N; Haouy, S; Jo Molina, T; Landman-Parker, J; Leblanc, T; Minard-Colin, V; Montravers, F; Rigaud, C; Simonin, M, 2023) |
| "Childbirth rates in classical Hodgkin lymphoma (cHL) survivors have historically been reduced compared to the general population." | 1.91 | Reproduction patterns among classical Hodgkin lymphoma survivors treated with BEACOPP and ABVD in Sweden, Denmark and Norway-A population-based matched cohort study. ( El-Galaly, TC; Eloranta, S; Entrop, JP; Fosså, A; Glimelius, I; Holte, H; Jakobsen, LH; Marklund, A; Molin, D; Smedby, KE; Smeland, KB; Weibull, CE; Øvlisen, AK, 2023) |
| "Taken together, contemporary Hodgkin lymphoma-directed treatment approaches result in excellent outcomes for patients with newly diagnosed early-stage NLPHL and, thus, represent valid treatment options." | 1.91 | Interim PET-guided treatment for early-stage NLPHL: a subgroup analysis of the randomized GHSG HD16 and HD17 studies. ( Baues, C; Borchmann, P; Bühnen, I; Dietlein, M; Eich, HT; Eichenauer, DA; Engert, A; Fuchs, M; Greil, R; Hartmann, S; Hertenstein, B; Just, M; Kaul, H; Kobe, C; Moccia, A; Topp, MS; von Tresckow, B; Zijlstra, JM, 2023) |
| "Management of classical Hodgkin lymphoma in older patients is challenging due to poor tolerance of the chemotherapy regimens used in younger patients." | 1.91 | 'ACOPP' chemotherapy for older and less fit patients with Hodgkin lymphoma-A multicentre, retrospective study. ( Ferguson, G; Haynes, E; Hopkins, D; Leach, M; McKay, P; Murray, J; Osborne, W; Parsons, K; Quinn, D; Robertson, E; Wilson, MR, 2023) |
| "FRONTLINE THERAPY FOR CLASSICAL HODGKIN LYMPHOMA PATIENTS." | 1.91 | [Frontline therapy for classical Hodgkin lymphoma patients]. ( Casasnovas, O; Rossi, C, 2023) |
| "Nintedanib is a tyrosine kinase inhibitor used successfully in the treatment of idiopathic pulmonary fibrosis and there is no information about its use in BIP treatment." | 1.72 | Bleomycin-induced Pneumonitis in a Child Treated With Nintedanib: Report of the First Case in a Childhood. ( Arikoglu, T; Balci, Y; Citak, EC; Gundogan, BD; Taskinlar, S, 2022) |
| "After contemporary treatment of ES-HL, relapse mostly occurred > 12 months after first diagnosis." | 1.62 | Relapse After Early-Stage, Favorable Hodgkin Lymphoma: Disease Characteristics and Outcomes With Conventional or High-Dose Chemotherapy. ( Baues, C; Behringer, K; Borchmann, P; Bröckelmann, PJ; Engert, A; Fuchs, M; Guhl, T; Moccia, AA; Müller, H; Pabst, T; Rank, A; Soekler, M; Vieler, T; von Tresckow, B, 2021) |
| "The most frequent pathologies were Hodgkin's lymphoma and breast cancer." | 1.62 | Evaluation of ovarian reserve before and after chemotherapy. ( Ayadi, M; Bahri, O; Berjeb, KK; Braham, M; Chakroun, N; Chtourou, S; Debbabi, L; Fadhlaoui, A; Hamdoun, M; Hannachi, H; Kacem, K; Zemni, Z; Zhioua, F, 2021) |
| "Composite lymphoma is a rare entity where two or more distinct subtypes of lymphoma coexist within a single organ or tissue." | 1.62 | Composite lymphoma of T-cell rich, histiocyte-rich diffuse large B-cell lymphoma and nodular lymphocyte predominant Hodgkin lymphoma: a case report. ( Alhoulaiby, S; Alshehabi, Z; Esper, A; Zuhri Yafi, R, 2021) |
| "During workup a Stage IV Hodgkin lymphoma was discovered." | 1.56 | A case report of Hodgkin lymphoma in a patient treated with ustekinumab for psoriasis. ( Charakopoulos, E; Diamantopoulos, PT; Giannakopoulou, N; Hatzidavid, S; Spyrou, I; Viniou, NA, 2020) |
| "Findings in rodents indicate that chromosomal aberrations can be induced in male germ cells by genotoxic exposures and transmitted to offspring and future generations with effects on development, fertility and health." | 1.56 | Meiotic susceptibility for induction of sperm with chromosomal aberrations in patients receiving combination chemotherapy for Hodgkin lymphoma. ( Frias, S; Meistrich, ML; Van Hummelen, P; Wyrobek, AJ, 2020) |
| "Treatment options for Hodgkin's Lymphoma differ among various study groups and there is still no consensus regarding the standard treatment for Hodgkin's lymphoma." | 1.51 | Retrospective analysis of clinical features and treatment outcomes of children with Hodgkin's Lymphoma treated with different chemotherapy protocols at a tertiary care center in Pakistan. ( Asad, M; Mehreen, A; Ria, S; Sindhu, II; Wali, RM, 2019) |
| "Reporting the first case of localized Hodgkin lymphoma treated with protontherapy in France." | 1.51 | Protontherapy versus best photon for mediastinal Hodgkin lymphoma: Dosimetry comparison and treatment using ILROG guidelines. ( Abbassi, LM; Arsène-Henry, A; Dendale, R; Goudjil, F; Kirova, YM, 2019) |
| "In Tunisia, the management of Adult Hodgkin's Lymphoma (HL) has been standardized since 1999." | 1.48 | [Tunisian National Protocol for Adult Hodgkin's Lymphoma Treatment: Results of a therapeutic regimen adapted to the 2-cycle CT response, about 444 patients]. ( Ben Lakhal, R; BenAhmed, S; BenOthmen, T; BenSalah, H; BenYoussef, Y; Bouaouina, N; Daoued, J; Elloumi, M; Ezzaier, F; Frikha, H; Frikha, M; Hdiji, S; Khelif, A; Laatiri, MA; Ladeb, S; Maalej, M; Meddeb, B; Messai, T; Mezlini, A; Mokrani, A; Msaddek, F; Tebra, S; Toumi, N; Zriba, S, 2018) |
| "The development of osteonecrosis is strictly related to the chemotherapy protocol adopted and the number of cycles received, with a strong correlation between the dose of corticosteroids included in the BEACOPP scheme and this complication." | 1.46 | Osteonecrosis detected by whole body magnetic resonance in patients with Hodgkin Lymphoma treated by BEACOPP. ( Albano, D; Brancatelli, G; Galia, M; Grassedonio, E; La Grutta, L; Lagalla, R; Midiri, M; Mulè, A; Patti, C, 2017) |
| "Osteonecrosis is a well-recognized complication in patients treated with corticosteroids." | 1.46 | Whole-body MRI reveals high incidence of osteonecrosis in children treated for Hodgkin lymphoma. ( Beishuizen, A; Bruin, MC; de Lange, C; Enríquez, G; Granata, C; Kwee, TC; Littooij, AS; Nievelstein, RA; Verbeke, JI; Zennaro, F, 2017) |
| "Patients who survive Hodgkin lymphoma (HL) are at increased risk of secondary neoplasms (SNs)." | 1.43 | Secondary Neoplasms in Children with Hodgkin's Lymphoma Receiving C-MOPP and Radiotherapy: Presentation of Four Cases. ( Çavdar, A; Ceyhan, K; Deda, H; Gökçora, İH; Gözdaşoğlu, S; Işıkman, E; Pamir, A; Taçyıldız, N; Uluoğlu, Ö; Ünal, E; Yavuz, G, 2016) |
| "Classical Hodgkin lymphomas (cHLs) include small numbers of malignant Reed-Sternberg cells within an extensive but ineffective inflammatory/immune cell infiltrate." | 1.43 | PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome. ( Advani, RH; Armand, P; Chapuy, B; Connelly, CF; Daadi, SE; de Jong, D; Freeman, GJ; Homer, H; Hoppe, RT; Ligon, AH; Natkunam, Y; Neuberg, DS; Redd, RA; Rodig, SJ; Roemer, MG; Shipp, MA; Sun, HH, 2016) |
| "Adaptation of patients with Hodgkin's lymphoma can take place only after successful treatment, the probability of relapse and fear of repeated courses strongly interfere with this process, especially in the first years after its closure." | 1.42 | [Hodgkin's lymphoma and radiotherapy]. ( Datsenko, PV; Panshin, GA, 2015) |
| "To investigate the efficacy and safety of Rituximab combined with second line regimen for treatment of relapsed and refractory Hodgkin lymphoma." | 1.42 | [Rituximab combined with second line regimens for treatment of seven relapsed and refractory Hodgkin lymphoma patients]. ( Li, H; Liu, H; Qiu, L; Xiong, W; Yi, S; Zou, D, 2015) |
| "Bleomycin and RT may cause lung injury in a small, but significant fraction of HL patients." | 1.40 | Pulmonary damage in Hodgkin's lymphoma patients treated with sequential chemo-radiotherapy: Predictors of radiation-induced lung injury. ( Cella, L; Conson, M; D'Avino, V; Di Biase, A; Liuzzi, R; Pacelli, R; Picardi, M; Pugliese, N; Salvatore, M; Solla, R, 2014) |
| "Therapy-related acute myeloid leukemia and myelodysplastic syndromes (t-AML/MDS) represent severe late effects in patients treated for Hodgkin lymphoma (HL)." | 1.40 | Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group. ( Behringer, K; Böll, B; Borchmann, P; Diehl, V; Eichenauer, DA; Engert, A; Franklin, J; Fuchs, M; Halbsguth, T; Haverkamp, H; Klimm, B; Rothe, A; Sasse, S; Thielen, I; von Tresckow, B, 2014) |
| "Hodgkin's disease has been associated with a variety of cutaneous symptoms." | 1.40 | [Stevens-Johnson syndrome and Hodgkin's disease: A fortuitous association or paraneoplastic syndrome?]. ( Barbaud, A; Bursztejn, AC; Cribier, B; Cuny, JF; Levy, E; Schmutz, JL; Schoeffler, A; Weinborn, M, 2014) |
| "To quantify the incidence of thyroid cancer after Hodgkin lymphoma (HL) and determine disease characteristics, risk factors, and treatment outcomes." | 1.40 | Thyroid malignancies in survivors of Hodgkin lymphoma. ( Chen, YH; Marcus, KJ; Michaelson, EM; Ng, AK; Silver, B; Stevenson, MA; Tishler, RB, 2014) |
| "Azathioprine was withdrawn." | 1.40 | Hodgkin's lymphoma rectosigmoid in a patient with ulcerative colitis on long-term azathioprine therapy. ( Khuroo, MS, 2014) |
| "The majority of patients with advanced Hodgkin lymphoma are cured with current standard therapy such as Adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD)." | 1.40 | Which Hodgkin's patients in the Unites States should be treated with BEACOPP? ( Cheson, BD, 2014) |
| "Seventy-five Hodgkin lymphoma and non-Hodgkin lymphoma patients and a control group of 257 fertile men." | 1.40 | Impact of lymphoma treatments on spermatogenesis and sperm deoxyribonucleic acid: a multicenter prospective study from the CECOS network. ( Auger, J; Berthaut, I; Brugnon, F; Bujan, L; Daudin, M; Hennebicq, S; Moinard, N; Rives, N; Saias, J; Szerman, E; Walschaerts, M, 2014) |
| "As consequence of cardiac arrest and cardiopulmonary resuscitation the surgical procedure was limited to total gastrectomy, feeding jejustomy and esophageal drainage through nasoesophageal catherization." | 1.40 | [Necrotizing gastritis in a patient in severe neutropenia]. ( Dedecjus, M; Lech-Marańda, E; Pielaciński, K; Prochorec-Sobieszek, M; Szczepanik, AB; Warzocha, K, 2014) |
| "Hodgkin lymphomas (HL) and non Hodgkin lymphomas (NHL) are frequently associated to acquired immunodeficiency syndrome in adults." | 1.39 | [Lymphomas associated with HIV infection in patients at the Hospital San Borja Arriarán /Fundación Arriarán 2001-2008, Santiago, Chile]. ( Carmona, J; Cortés, C; García, H; Pizarro, A; Riquelme, A, 2013) |
| "To assess therapy-related acute myeloid leukemia/myelodysplastic syndrome (t-AML/MDS) risk in patients treated for Hodgkin lymphoma (HL) on successive generations of Stanford clinical trials." | 1.39 | Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials. ( Advani, RH; Balise, R; Greenberg, PL; Hoppe, RT; Horning, SJ; Koontz, MZ; Rosenberg, SA, 2013) |
| "Based on the treatment results of 300 Hodgkin lymphoma patients the authors formulated the basic approaches for radiation treatment in ABVD and BEACOPP-21 chemotherapy regimens recipients." | 1.38 | [The optimal total focal radiotherapy dosage after first-line chemotherapy in patients with Hodgkin lymphoma]. ( Datsenko, PV; Evstikheev, ÉV; Golub, SV; Gombolevskiĭ, VA; Ivashin, AV; Pan'shin, GA; Sotnikov, VM, 2012) |
| "Ductal invasive carcinoma and ductal carcinoma in situ represented, respectively, 51 cases (71%) and 14 cases (19%)." | 1.38 | Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option. ( Belin, L; Bollet, MA; Campana, F; Decaudin, D; Fourquet, A; Haberer, S; Kirova, YM; Le Scodan, R; Moisson, P; Pierga, JY; Reyal, F; Savignoni, A; Stevens, D, 2012) |
| "We document a high incidence of aseptic bone necrosis, possibly related to prednisolone." | 1.38 | Two escalated followed by six standard BEACOPP in advanced-stage high-risk classical Hodgkin lymphoma: high cure rates but increased risk of aseptic osteonecrosis. ( Aurlien, E; Blystad, AK; Fiskvik, IH; Fosså, A; Hole, KH; Holte, H; Ikonomou, IM; Kolstad, A; Lauritzsen, GF, 2012) |
| "Therapy of Hodgkin lymphoma (HL) is designed to prolong survival and minimize toxicity." | 1.38 | A 10-year experience with treatment of high and standard risk Hodgkin disease: six cycles of tailored BEACOPP, with interim scintigraphy, are effective and female fertility is preserved. ( Avivi, I; Bar-Shalom, R; Ben-Shachar, M; Blumenfeld, Z; Dann, EJ; Epelbaum, R; Gaitini, D; Goor, O; Libster, D; Rowe, JM, 2012) |
| "Acquired ichthyosis is a rare condition that can reveal an unsuspected haematological malignancy, thus allowing early diagnosis and management." | 1.38 | [Acquired ichthyosis and haematological malignancies: five cases]. ( Baybay, H; Berrady, R; Bono, W; El Hatimi, A; Gallouj, S; Khammar, Z; Lahlou, M; Lamchachti, L; Mernissi, FZ, 2012) |
| "Twelve women (12%) experienced 13 miscarriages after a median of 50 months (range, 13-120) from the end of therapy." | 1.38 | Impact of different treatment approaches on pregnancy outcomes in 99 women treated for Hodgkin lymphoma. ( Alfò, M; Annechini, G; Cavalieri, E; De Sanctis, V; Enrici, RM; Filippone, FR; Minniti, G; Muni, R; Osti, MF; Pulsoni, A; Valeriani, M, 2012) |
| "The treatment results of 296 Hodgkin's disease patients receiving ABVD or BEACOPP-21 chemotherapy with consequent EFRT demonstrate CR/PR > or = 80% and 99% local disease control rate." | 1.38 | [The optimal radiation volume after first-line chemotherapy in Hodgkin lymphoma]. ( Datsenko, PV; Evstikheev, ÉV; Golub, SV; Gombolevskiĭ, VA; Ivashin, AV; Pan'shin, GA; Sotnikov, VM, 2012) |
| " Prospective pharmacokinetic studies to devise a rational dosing strategy for vinblastine in patients receiving ritonavir/lopinavir are warranted." | 1.38 | Incidence, predictors and significance of severe toxicity in patients with human immunodeficiency virus-associated Hodgkin lymphoma. ( Boro, J; Cheung, MC; Ezzat, HM; Harris, M; Hicks, LK; Leitch, HA; Lima, VD; Montaner, JS, 2012) |
| "Hodgkin lymphoma is an easily curable malignancy in the pediatric age group and is less frequently observed in Japan." | 1.38 | [Retrospective analysis of 157 patients with pediatric Hodgkin lymphoma in Japan: investigation by four pediatric cancer study groups]. ( Horibe, K; Inada, H; Kobayashi, R; Koga, Y; Kumagai, M; Mimaya, J; Mori, T; Nakazawa, A; Takimoto, T; Tsurusawa, M, 2012) |
| "Differences between Hodgkin's lymphoma (HL) patients in China and Western countries are known to exist, but data on Chinese patients with HL are limited." | 1.38 | Clinical characteristics of the patients with Hodgkin's lymphoma involving extranodal sites. ( Huang, JJ; Jiang, WQ; Li, ZM; Xia, Y; Zhu, YJ, 2012) |
| "Hodgkin Disease is one of the common lymphoma subtypes: every year over 750 new cases are diagnosed in Poland." | 1.38 | [Escalated BEACOPP as an alternative in high risk Hodgkin lymphoma]. ( Giza, A; Jurczak, W; Krochmalczyk, D; Skotnicki, AB; Sobociński, M, 2012) |
| " Primary therapies were divided into four groups: radiotherapy alone, moderately dosed COPP/ABVD-like chemotherapies for intermediate and advanced stages and BEACOPP escalated." | 1.37 | Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL--experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesis. ( Diehl, V; Engert, A; Franklin, J; Hasenclever, D; Josting, A; Loeffler, M; Scholz, M, 2011) |
| "The diagnosis was Hodgkin's disease." | 1.36 | Hodgkin's lymphoma variant of Richter's syndrome. ( Curić-Jurić, S; Kelcec, IB; Kojić-Katović, S; Maricević, I; Tomas, D; Vasilj, A; Zokvić, E, 2010) |
| "By October 2008, cardiac diseases (CD) had been diagnosed in 50 of 1,132 patients aged 15." | 1.36 | Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies. ( Bölling, T; Brämswig, J; Bruch, C; Dieckmann, K; Dörffel, W; Heinecke, A; Kotthoff, S; Pötter, R; Riepenhausen, M; Schellong, G; Vogt, J, 2010) |
| "The majority of patients with Hodgkin's disease can be cured by combination of polychemotherapy and radiotherapy (RT) that can produce late toxic pulmonary and cardiac effects which often remain at a subclinical level." | 1.36 | Cardiopulmonary toxicity of different chemoradiotherapy combined regimens for Hodgkin's disease. ( Bonfante, V; Busia, A; Laffranchi, A; Villani, F; Viviani, S, 2010) |
| "Azoospermia was observed in 90% of patients treated with chemotherapy alone, 67% of those treated with combined modality and 11% of those treated with radiotherapy alone (P < 0." | 1.35 | Assessment of male fertility in patients with Hodgkin's lymphoma treated in the German Hodgkin Study Group (GHSG) clinical trials. ( Behringer, K; Diehl, V; Engert, A; Fuchs, M; Halbsguth, T; Josting, A; Nogova, L; Reineke, T; Sieniawski, M, 2008) |
| "Hodgkin lymphoma is a highly curable malignancy, but treatment outcome might be influenced by inherited gene polymorphisms determining anticancer agent metabolism." | 1.35 | Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis. ( Brice, P; Casasnovas, O; Cazeneuve, C; Gabarre, J; Koscielny, S; Lenoir, G; Morschhauser, F; Ribrag, V; Salles, G; Stamatoullas, A, 2009) |
| "The behavior of Hodgkin's lymphoma (HL) is different in developing countries, perhaps due to differences in epidemiology and population access to health care." | 1.35 | Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study. ( Alves, AC; Baiocchi, OC; Oliveira, JS; Souza, EM; Zanichelli, MA, 2009) |
| "Adolescent patients with Hodgkin's lymphoma (HL) are treated either in pediatric, or in adult oncological wards." | 1.35 | [Hodgkin's lymphoma in adolescents: where to treat it--in an adult or pediatric institution?]. ( Csóka, M; Deák, B; Gergely, L; Illés, A; Jakab, Z; Keresztes, K; Kovács, G; Molnár, Z; Müller, J; Rosta, A; Schneider, T; Simon, Z; Várady, E, 2008) |
| " Since survival rates for patients receiving risk-adapted programs (DAL-Hd, SPBLKH-05) were higher than in control (MOPP), relevant protocols using lower drug dosage should be recommended in groups of favorable and intermediate risk." | 1.35 | [Use of risk-adapted programs of treatment of Hodgkin's disease in children and adolescents]. ( Kuleva, SA, 2008) |
| "Therefore, 126 patients suffering from Hodgkin's disease were investigated after a follow-up of at least 5 years from the completion of the combined treatment." | 1.35 | Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease. ( Bonfante, V; Busia, A; Laffranchi, A; Villani, F; Villani, M; Viviani, S, 2009) |
| "According to the stage of the Hodgkin's disease and the patient's age the modification of the therapy was introduced." | 1.35 | Long-term survival of patients treated for Hodgkin's disease in 1971-1996 depending on the clinical stage of the disease, patient's fertility after therapy and cause of death analysis. ( Blomannova, E; Dienstbier, Z; Fridrichova, M; Loucka, M; Skala, E, 2009) |
| "Peliosis hepatis is associated with numerous infectious and neoplastic diseases, but also occurs as a result of toxic liver damage." | 1.35 | First reported case of disease: peliosis hepatis as cardinal symptom of Hodgkin's lymphoma. ( Adler, G; Bommer, M; Dikopoulos, N; Klaus, J; Kleger, A; Kunze, M; Leithaeuser, F; Wegener, M, 2009) |
| "Relative risks (RRs) of stomach cancer and the radiation-related excess relative risk (ERR) per gray were calculated by conditional logistic regression analysis." | 1.35 | Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy. ( Aleman, BM; Besseling, G; de Bruin, ML; de Wit, R; Gietema, JA; Hauptmann, M; Kerst, JM; Noordijk, EM; Ribot, JG; van 't Veer, MB; van den Belt-Dusebout, AW; van Leeuwen, FE, 2009) |
| " It is suggested that total focal dosage used after chemotherapy be reviewed since total dosage for the entire lymph collector in excess of 30 Gy might contribute to hazards of cardiopathology." | 1.35 | [Multivariate analysis of risk of cardiac complications in Hodgkin's lymphoma]. ( Bozhenko, VK; Datsenko, PV; Ivashin, AV; Mel'nik, IuD; Pan'shin, GA; Podol'skiĭ, PN; Sotnikov, VM, 2009) |
| "Pediatric Hodgkin lymphoma (HL) has a cure rate of more than 80% in high-income countries (HIC)." | 1.34 | Comparison of treatment outcomes of childhood Hodgkin lymphoma in two US centers and a center in Recife, Brazil. ( Barros, C; Howard, SC; Hsu, SC; Hudson, MM; Lins, M; Maciel, K; Metzger, ML; Pedrosa, F; Pedrosa, M; Pui, CH; Ribeiro, RC, 2007) |
| "The treatment results of our Hodgkin's disease patients improved, additionally we showed that patients with early stage favourable disease the treatment toxicity should be reduced, while patients with advanced, unfavourable prognosis (10% of all patients) aggressive primary treatment should be used even with more severe side effects and complications." | 1.34 | [Our experiences in treating patients with Hodgkin disease in the last decade]. ( Gergely, L; Illés, A; Keresztes, K; Miltényi, Z; Ress, Z; Simon, Z; Vadász, G; Váróczy, L, 2007) |
| "A woman with Hodgkin's disease and her gestational carrier." | 1.34 | Live birth after the transfer of human embryos developed from cryopreserved oocytes harvested before cancer treatment. ( Brown, SE; Brubaker, C; Nguyen, K; Reddy, V; Winslow, KL; Yang, D, 2007) |
| "Hodgkin lymphoma is a highly curable disease." | 1.34 | [Hodgkin lymphoma in Chile: experience of the national adult cancer program]. ( Aspillaga, A; Cabrera, ME; Cerda, B; García, H; Hales, C; León, A; Lois, V; Meneses, P; Merino, C; Oliva, J; Peña, K; Rojas, H; Rosas, J; Rossle, A; Vittini de, C, 2007) |
| "Hodgkin lymphoma is considered a common type of non-AIDS defining tumor among patients infected with HIV, commonly presenting as a widespread disease and with different pathologic features compared with Hodgkin lymphoma in the general population." | 1.34 | Hodgkin lymphoma among patients infected with HIV in post-HAART era. ( Buccheri, V; Calore, EE; Chamone, DA; Pessoa, VP; Pracchia, LF; Tanaka, PY, 2007) |
| "Cure rates of Hodgkin's disease (HD) with chemotherapy and/or radiotherapy are high." | 1.34 | [Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab]. ( Al-Ali, HK; Niederwieser, D; Wittekind, C, 2007) |
| "The treatment strategies of Hodgkin's lymphoma (HL) are different according to clinical stage and risk factors, yet the optimal treatment strategy remains unclear." | 1.34 | [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases]. ( Hu, DS; Hu, S; Song, QB; Tan, WY; Wei, L; Zeng, FY; Zhou, LQ, 2007) |
| "More than 80% of those diagnosed with Hodgkins disease (HD) will survive long-term." | 1.33 | Fertility in males treated for Hodgkins disease with COPP/ABV hybrid. ( Carlson, CA; Ginsberg, JP; Hobbie, WL; Meadows, AT; Ogle, SK, 2005) |
| "Patients with early stage favorable Hodgkin's disease who relapse after extended field radiotherapy have satisfactory results." | 1.33 | BEACOPP and COPP/ABVD as salvage treatment after primary extended field radiation therapy of early stage Hodgkins disease - results of the German Hodgkin Study Group. ( Ballova, V; Diehl, V; Franklin, J; Glossmann, J; Josting, A; Nogova, L; Rüffer, JU; Sieber, M, 2005) |
| "Those with limited stage Hodgkin lymphoma should be treated with brief chemotherapy, only augmented with involved field irradiation if an early complete remission is not achieved." | 1.33 | Evolving approaches to primary treatment of Hodgkin lymphoma. ( Connors, JM, 2005) |
| "Of the 13 cases, 5 were Hodgkin's disease (HD), and 8 were non-Hodgkin's lymphoma (NHL)." | 1.33 | [Clinical analysis of reactive thymic hyperplasia following chemotherapy for childhood malignant lymphoma]. ( Ling, JY; Sun, XF; Wang, ZH; Xia, Y; Zhen, ZJ, 2006) |
| "Actuarial risk of second malignancy for adolescents and adults was not different (P = ." | 1.33 | Hodgkin's lymphoma in adolescents. ( Connors, JM; Foltz, LM; Song, KW, 2006) |
| "Of 6 patients who developed recurrence, 3 (7." | 1.33 | [Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease]. ( Han, JZ; Jin, J; Li, YX; Liu, XF; Liu, YP; Song, YW; Wang, SL; Wang, WH; Yu, ZH; Zhou, LQ, 2006) |
| "To quantify the incidence of radiation pneumonitis (RP) in a modern Hodgkin's lymphoma (HL) cohort, and to identify any clinically relevant parameters that may influence the risk of RP." | 1.33 | Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin's lymphoma. ( Gospodarowicz, MK; Heaton, R; Hodgson, DC; Koh, ES; Pintilie, M; Sun, A; Tran, TH; Tsang, R; Wells, W, 2006) |
| "Currently, 60% patients with advanced Hodgkin's lymphoma could be cured by receiving standard treatments." | 1.33 | [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma]. ( Fu, XH; Huang, HQ; Huang, Y; Lin, TY; Sun, XF; Wang, B; Wang, SS; Xu, RH; Zhang, L, 2006) |
| "Elderly patients with Hodgkin's lymphoma carry a worse prognosis than younger patients because of a higher incidence of advanced stages, a worse performance status and the intolerance of full-dose curative treatment." | 1.33 | Hodgkin's lymphoma in the elderly: the results of 10 years of follow-up. ( Feltl, D; Vítek, P; Zámecník, J, 2006) |
| "Intracraneal manifestations of Hodgkin's Disease (HD) are extremely rare, with an estimated incidence rate of approximately 0." | 1.33 | [Limphomatous meningitis as recurrence site in Hodgkin's disease]. ( Corrado, C; Greco, M; Niccodemi, C; Presas, J; Valsecchi, M; Winkel, M, 2006) |
| "We describe a case of Hodgkin lymphoma developing in a 9-year-old girl with polyarticular, rheumatoid factor-positive juvenile idiopathic arthritis treated with methotrexate (MTX), prednisone, and naproxen for 5 years." | 1.33 | Epstein-Barr virus associated Hodgkin lymphoma in a 9-year-old girl receiving long-term methotrexate therapy for juvenile idiopathic arthritis. ( Abukawa, D; Ichinohazama, R; Imaizumi, M; Nakano, K; Sato, A; Takeyama, J, 2006) |
| "Barriers to using online cancer information are environmental (hardware, connection speeds, time), personal (poor computer literacy and lack of awareness of appropriate sites) and economic (costs of journal subscriptions)." | 1.33 | Information sources used by New South Wales cancer clinicians: a qualitative study. ( Lowinger, JS; Pearson, S-; Ringland, C; Stark, H; Tan, EL; Ward, R, 2006) |
| "In patients with advanced Hodgkin's disease, consolidation RT improved survival." | 1.32 | Analysis of treatment results in advanced Hodgkin's disease: the case for adjuvant radiotherapy. ( Dyduch, M; Korzeniowski, S; Skolyszewski, J; Sokolowski, A, 2003) |
| "Treatment strategies in Hodgkin's disease have an impact on different risk factors." | 1.32 | Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Trial DAL-HD-90. ( Dieckmann, K; Heinzl, H; Hofmann, J; Pötter, R; Schellong, G; Wagner, W, 2003) |
| "To collect second cancers in patients treated for Hodgkin disease (HD) during adolescence and young adulthood at Salah Azaïz Institute of Tunis." | 1.32 | [Second malignancies following Hodgkin's disease treatment in Tunisia. Retrospective study of 26 cases observed at the institute Salah-Azaïz]. ( Belhaj Ali, Z; Benna, F; Besbes, M; Bouaouina, N; Boussen, H; Gammoudi, A; Ghilen, L; Kochbati, L; Maalej, M; Rahal, K, 2003) |
| "Children treated for Hodgkin disease are at risk for gonadal damage." | 1.32 | Decreasing the number of MOPP courses reduces gonadal damage in survivors of childhood Hodgkin disease. ( Behrendt, H; Furstner, F; van den Berg, H; van den Bos, C, 2004) |
| "However complicating classical Hodgkin lymphoma (CHL) was noted inside the lesion." | 1.32 | Composite lymphoma arising in the parotid gland: a case report. ( Abe, M; Kuroda, M; Mizoguchi, Y; Nishio, T; Saito, S; Sakurai, K; Urano, M, 2004) |
| " This observation suggests a strategy of individualized dosing adapted to hematotoxicity." | 1.32 | Low acute hematological toxicity during chemotherapy predicts reduced disease control in advanced Hodgkin's disease. ( Brosteanu, O; Diehl, V; Hasenclever, D; Loeffler, M, 2004) |
| "One Stage IV patient has died with Hodgkin's disease 28 months after treatment with combination therapy." | 1.32 | Pediatric Hodgkin's disease. ( Bertolone, S; Koerner, P; Oliapuram Jose, B; Paris, KJ; Patel, CC; Silverman, CL; Spanos, WJ; Yashar, CM, 2004) |
| "Lymphoma is a malign disease of the lymphoid system." | 1.32 | Cyclooxygenase-2 (Cox-2) expression in lymphomas. ( Erdoğan, S; Ergin, M; Hakverdi, S; Hazar, B; Seyrek, E; Tuncer, I, 2004) |
| "Multivariate analysis retained enlarged spleen, involvement of three or more lymph node areas, and bulky disease as significant risk factors for spleen involvement." | 1.32 | Significance of splenomegaly in childhood Hodgkin disease. ( Arya, LS; Bakhshi, S; Dawar, R; Dinand, V; Singh, R; Thavaraj, V, 2004) |
| "The patient had suffered from relapsing ulcerative colitis for 6 years before he developed Hodgkin s lymphoma." | 1.31 | Hodgkin s disease with nephrotic syndrome as a complication of ulcerative colitis: case report. ( Basić-Jukić, N; Jakić-Razumović, J; Radman, I; Roncević, T, 2002) |
| "In the Swedish National Care Programme for Hodgkin's lymphoma (HL) a less intensive chemotherapy regimen with individualized dosing (LVPP/OEPA) was introduced in 1989." | 1.31 | Patients above sixty years of age with Hodgkin's lymphoma treated with a new strategy. ( Enblad, G; Glimelius, B; Gustavsson, A; Sundström, C, 2002) |
| "We followed-up 33 patients with non-Hodgkin's lymphoma or with Hodgkin's disease during the years 1987-1997 who were referred for semen cryopreservation." | 1.31 | Follow-up of sperm concentration and motility in patients with lymphoma. ( Botchan, A; Hauser, R; Paz, G; Tal, R; Yavetz, H; Yogev, L, 2000) |
| "We transplanted 42 patients with Hodgkin's disease between 1990-1998." | 1.31 | [High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer]. ( Avigdor, A; Ben-Bassat, I; Grotto, I; Hardan, I; Raanani, P; Shpilberg, O, 2000) |
| "We describe a patient who presented with autoimmune hemolytic anemia and small bowel obstruction secondary to a malignant stromal tumor (leiomyosarcoma) of the jejunum, 25 years postchemotherapy and radiation treatment for stage IIA Hodgkin's disease." | 1.31 | Autoimmune hemolytic anemia associated with postirradiation malignant stromal tumor (leiomyosarcoma) of the jejunum. ( Bobrow, S; Fiedler, P; Lee, KH; Passarelli, J, 2000) |
| "Risk of lung cancer was borderline significantly greater in patients treated with mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) chemotherapy than those who did not receive this treatment (relative risk [RR] = 1." | 1.31 | Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment. ( Allerton, R; Barber, JA; Cunningham, D; Horwich, A; Linch, DC; Lister, TA; Rohatiner, AZ; Schoemaker, MJ; Swerdlow, AJ; Vaughan Hudson, G; Williams, MV, 2001) |
| "Today, 80% of patients with advanced Hodgkin's disease may be cured, with low rate of long-term toxicity." | 1.31 | [The chemotherapeutic treatment of advanced Hodgkin's disease]. ( Ben-Arie, Y; Ben-Shahar, M; Cohen, Y; Epelbaum, R; Faraggi, D; Haim, N; Sharabi-Nov, A; Valtuch, I, 2001) |
| "A 12-year-old boy with Hodgkin's disease developed left peroneal nerve palsy during combination therapy with chemotherapy and low-dose irradiation." | 1.31 | Peroneal mononeuropathy in pediatric Hodgkin's disease. ( Baba, K; Harigaya, H; Matsubara, K; Nigami, H; Osaki, M, 2000) |
| " A frequent problem is relapse of disease when corticosteroid dosage is tapered off." | 1.31 | Successful treatment of bronchiolitis obliterans organizing pneumonia with low-dose methotrexate in a patient with Hodgkin's disease. ( Breitbart, A; Egerer, G; Goldschmidt, H; Ho, AD; Möller, P; Spaeth, A; Witzens, M, 2001) |
| "Lamivudine is a nucleoside analogue that can directly suppress HBV replication." | 1.31 | Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy. ( Motta, M; Pelizzari, A; Puoti, M; Rossi, G, 2001) |
| "There were no deaths from Hodgkin's disease." | 1.31 | Subdiaphragmatic Hodgkin's disease: the University of Florida experience. ( Colgan, ME; Hull, MC; Mendenhall, NP, 2002) |
| "A total of 128 patients with advanced Hodgkin's disease was included in this study." | 1.31 | [Treatment of advanced Hodgkin's disease: an analysis of 128 cases]. ( Feng, F; Wang, Q; Zhou, L, 2000) |
| " Despite prompt initiation of antimycotic therapy the outcome was fatal; dosage of conventional and liposomal amphotericin B was limited due to treatment-related toxicities." | 1.31 | A novel type of metastatically spreading subcutaneous aspergillosis without epidermal lesions following allogeneic stem cell transplantation. ( Bethe, U; Cornely, OA; Pels, H; Ritzkowsky, A; Seibold, M; Soehngen, D; Toepelt, K, 2001) |
| "Procarbazine is a chemotherapy methylating agent that has been used in combination with other drugs, perhaps most successfully in the treatment of Hodgkin's disease." | 1.31 | Pulmonary toxicity secondary to procarbazine. ( Mahmood, T; Mudad, R, 2002) |
| "Concerning ANLL, the MOPP regimen was significantly associated with a higher risk: 3." | 1.31 | Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation. ( Andrieu, JM; Colonna, P; Delwail, V; Jais, JP, 2002) |
| "The relative risk of second cancers overall was 27." | 1.30 | Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital. ( Barber, JA; Cunningham, D; Horwich, A; Milan, S; Omar, RZ; Swerdlow, AJ, 1997) |
| "Thirty untreated patients with advanced Hodgkin's disease stage IIB IV according to the Ann Arbor classification were treated with the time intensified BEACOPP regimen." | 1.30 | BEACOPP: an intensified chemotherapy regimen in advanced Hodgkin's disease. The German Hodgkin's Lymphoma Study Group. ( Adler, M; Diehl, V; Hasenclever, D; Koch, P; Lathan, B; Lieberz, D; Loeffler, M; Pfreundschuh, M; Rüffer, U; Sieber, M; Tesch, H, 1997) |
| "Patients treated for Hodgkin's disease and non-Hodgkin lymphomas were followed for 5 years after start of therapy." | 1.30 | Five-year follow-up of saliva in patients treated for lymphomas. ( Keinànen, S; Laine, P; Lindqvist, C; Meurman, JH; Pyrhönen, S; Teerenhovi, L, 1997) |
| "Childhood Hodgkin's disease (HD) in low-income countries has been reported to have distinct presenting features, including a high prevalence of the mixed cellularity subtype, which also seems to be associated with poorer prognosis." | 1.30 | Treatment of childhood Hodgkin's disease with COPP or COPP-ABV (hybrid) without radiotherapy in Nicaragua. ( Baez, F; Biondi, A; Casanova, M; Cavalli, F; Conter, V; Flores, A; Gutierrez, T; Malta, A; Masera, G; Ocampo, E; Pacheco, C; Palacios, R; Riva, L; Sala, A; Sessa, C; Silvestri, D, 1997) |
| "Sixteen patients with Hodgkin's disease were treated with MOPP/ABVD and filgrastim support between January 1992 and March 1994." | 1.30 | G-CSF (filgrastim) as an adjunct to MOPP/ABVD therapy in Hodgkin's disease. ( Gustavsson, A, 1997) |
| "In this series, risk factors for second cancer were age >/=40 years (RR = 3." | 1.30 | Treatment-related deaths and second cancer risk after autologous stem-cell transplantation for Hodgkin's disease. ( André, M; Attal, M; Bastion, Y; Blaise, D; Cahn, JY; Colombat, P; Fermé, C; Fleury, J; Gisselbrecht, C; Henry-Amar, M; Kuentz, M; Milpied, N; Nedellec, G; Pico, JL, 1998) |
| "Patients treated with radiotherapy for Hodgkin's disease have a considerable risk for a second cancer in long-term follow-up." | 1.30 | Second cancer among long-term survivors from Hodgkin's disease. ( Joensuu, H; Muhonen, T; Nyandoto, P, 1998) |
| "Risk of leukemia was 0." | 1.30 | The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-con ( Anselmo, AP; Baroni, CD; Bernasconi, C; Brusamolino, E; Klersy, C; Lazzarino, M; Lunghi, F; Mandelli, F; Maurizi-Enrici, R; Orlandi, E; Pagnucco, G; Santoro, M, 1998) |
| "Etoposide is a newer antineoplastic agent that is effective in the treatment of HD." | 1.30 | The effects of etoposide on testicular function in boys treated for Hodgkin's disease. ( Brämswig, JH; Gerres, L; Jürgens, H; Schellong, G; Schlegel, W, 1998) |
| "The nephrotic syndrome is a rare complication of Hodgkin's disease." | 1.30 | [Clinical case of the month. The association of Hodgkin's disease and nephrotic syndrome]. ( Baron, F; Beguin, Y; Fassotte, MF; Fillet, G; Hermanne, JP, 1998) |
| "Two had cutaneous non-Hodgkin's lymphoma while one had Hodgkin's lymphoma." | 1.30 | HIV-associated lymphoma: report of three cases. ( Mwangi, JW, 1999) |
| "Hodgkin's disease is curable in the majority of patients, although a proportion of patients are resistant to or relapse after initial therapy." | 1.30 | High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML. ( Devereux, S; Goldstone, AH; Gregory, W; Hancock, B; Harrison, CN; Hoskin, P; Hudson, GV; Linch, DC; MacMillan, AK; Milligan, D; Newland, AC; Winfield, D, 1999) |
| "All cases with lymphadenitis were still alive at the end of the study, while survival progressively decreased in the Hodgkin's type." | 1.30 | Survival of patients with HTLV-I-associated lymph node lesions. ( Haraoka, S; Kanda, M; Kawasaki, C; Kikuchi, M; Ohshima, K; Sato, K; Simazaki, T; Suzumiya, J, 1999) |
| "Optimal treatment for Hodgkin's disease during childhood is unknown." | 1.30 | Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy. ( Farah, RA; Geara, F; Hajjar, T; Khogali, M; Muwakkit, S; Nabbout, B; Shabb, NS, 1999) |
| "28 patients suffering from advanced Hodgkin's disease were treated according to protocol containing 7 cytostatic drugs including methotrexate and corticosteroids, but not cyclophosphamide, chlormethine or procarbazine." | 1.29 | [Evaluation of early treatment results in Hodgkin's disease during the cytostatic protocol containing methotrexate]. ( Gabryś, K; Kotlarek-Haus, S; Potoczek, S, 1995) |
| "Patients whose Hodgkin's disease is refractory to standard combination chemotherapy usually have a poor prognosis." | 1.29 | Continuous infusion ABDIC therapy for relapsed or refractory Hodgkin's disease. ( al-Katib, A; Andersen, J; Bishop, CR; Hussein, ME; Karanes, C; Khanuja, PS; Smith, MR, 1994) |
| "Management of Hodgkin's disease (HD) and large mediastinal adenopathy (LMA) usually includes intensive chemotherapy (CT) with or without radiation therapy (XT) regardless of stage." | 1.29 | Hodgkin's disease with a mediastinal mass greater than 10 cm: results of four different treatment approaches. ( Allen, PK; Besa, P; Cabanillas, F; Cox, JD; Hagemeister, FB; McLaughlin, P; Preti, A; Rodriguez, A; Swan, F, 1994) |
| "In patients with advanced Hodgkin's disease (HD), the alternation of MOPP with ABVD or hybrid MOPP/ABVD are associated with a high CR rate and a high probability of 5-year survival." | 1.29 | Hybrid MOPP/ABVD and radiotherapy in advanced Hodgkin's disease. ( Aversa, S; Bianco, A; Chiarion Sileni, V; Fiorentino, MV; Mazzarotto, R; Pappagallo, GL; Salvagno, L; Scarzello, G; Sorarù, M; Sotti, G, 1995) |
| "We report a 54-year-old patient with Hodgkin's disease who achieved a complete remission after combined modality treatment." | 1.29 | Factor VIII inhibitor prior to and during secondary acute nonlymphocytic leukemia in a patient with cured Hodgkin's disease. ( Bendandi, M; Cantagalli, F; Macchi, S; Mancino, A; Simoncelli, F; Stefanati, V; Tura, S; Visani, G; Zaccaria, A; Zinzani, PL, 1995) |
| "Treatment of Hodgkin's disease resulted in complete remission and complete disappearance of the pontine abnormality." | 1.29 | Hodgkin's disease associated with central pontine myelinolysis. ( Carrol, CL; Chintagumpala, MM; Dreyer, ZE; Fishman, MA; Mahoney, DH; McClain, K; Steuber, CP, 1993) |
| "Between 1980 and 1988, 48 patients with Hodgkin's disease who had large mediastinal masses were treated at Stanford University." | 1.29 | Hodgkin's disease with bulky mediastinal involvement: effective management with combined modality therapy. ( Behar, RA; Hoppe, RT; Horning, SJ, 1993) |
| "Management of early stages of Hodgkin's disease requires development of treatment programs that are nominally toxic, with a low likelihood of sterility and secondary malignancies, both associated with alkylating agents." | 1.29 | Are alkylating agents a necessary component in the therapy of Hodgkin's disease. ( Hagemeister, FB, 1993) |
| "Anderson Cancer Center for treatment of Hodgkin's disease [HD]." | 1.29 | A new chemotherapy regimen for treatment of Hodgkin's disease associated with minimal genotoxicity. ( Bailey, NM; Cabanillas, FF; Fuller, LM; Gabriel, GJ; Hagemeister, FB; Kattan, MW; Liang, JC; Wang, RY, 1993) |
| "The occurrence of HIV associated non-Hodgkin's lymphoma (NHL) is a well recognized event." | 1.29 | Hodgkin's disease and non-Hodgkin's lymphoma in an HIV positive patient. ( Brody, J; Goh, JC; Kaplan, MH; Koduru, P; Lichtman, SM; Susin, M, 1993) |
| "60 cases of Hodgkin's lymphoma were treated with combined chemotherapy and radiotherapy." | 1.29 | [Effectiveness of chemotherapy and radiotherapy in 60 cases of Hodgkin's lymphoma]. ( Wang, H; Yong, WB; Zhu, XM, 1993) |
| "A case of a 12 year old girl with Hodgkin's disease is described." | 1.29 | [Cardiomyopathy in the course of treating Hodgkin's disease in a 12-year old girl]. ( Hryniewicz, A; Rosłan, K; Wójtowicz, J, 1993) |
| "Patients with Hodgkin's disease whose initial complete remissions (CR) after primary chemotherapy were longer than 1 year are thought to have better prognoses than patients whose initial remissions were shorter than 1 year." | 1.29 | Late relapses in Hodgkin's disease: outcome of patients relapsing more than twelve months after primary chemotherapy. ( Aversa, SM; Bianco, A; Chiarion Sileni, V; Fiorentino, MV; Pappagallo, GL; Salvagno, L; Sorarù, M, 1993) |
| "A past history of treated Hodgkin disease is a factor of risk for breast cancer and suggests the need for annual mammography screening 10 years after the end of treatment." | 1.29 | [Breast cancer after treatment of Hodgkin's disease]. ( Blanchot, J; Dugast, J; Grall, JY; Le Prise, E; Levêque, J; Meunier, B; Poulain, P, 1995) |
| "A case of Hodgkin's disease with isolated cerebral relapse is reported here." | 1.29 | Meningioma-like cerebral relapse of Hodgkin's disease. ( Catarini, M; Discepoli, G; Leoni, P; Montillo, M; Rychlicki, F; Scarpelli, M, 1994) |
| "Thirteen patients have died of their second malignancy, including two of a third malignancy, while four have been followed for less than one year." | 1.29 | Second malignant neoplasms in patients with Hodgkin's disease. ( Atkinson, CH; Colls, BM; Fitzharris, BM; Robinson, BA, 1994) |
| "The risk of second cancer was analyzed (1) relative to the general population and (2) between risk subgroups using the Cox proportional hazards model." | 1.29 | Second primary cancers in patients continuously disease-free from Hodgkin's disease: a protective role for the spleen? ( Bodis, S; Bosq, J; Cosset, JM; Dietrich, PY; Hayat, M; Henry-Amar, M, 1994) |
| " Comparison of the dose-response relationships for humans and rats indicates that, under conditions of no depletion of O6-alkylguanine-DNA alkyltransferase (AGT), O6-meG accumulates in blood leukocyte DNA of humans at a rate which is only approximately 2-fold lower than in rats, implying that, to the extent to which O6-meG contributes to the genotoxic activity of procarbazine, human susceptibility to it is likely to be comparable to that of the rat." | 1.29 | Comparative dosimetry of O6-methylguanine in humans and rodents treated with procarbazine. ( Boussiotis, VA; Kyrtopoulos, SA; Pangalis, GA; Souliotis, VL; Valavanis, C, 1994) |
| "Two cases of malignant schwannoma are reported 13 and 15 years following combined modality treatment for Hodgkin's disease." | 1.29 | Malignant schwannoma following treatment for Hodgkin's disease. ( Bridges, LR; Cartwright, SC; Dodwell, DJ; Fisher, PM; Stone, J, 1994) |
| "The association of Hodgkin's disease and minimal-change nephrotic syndrome is well established." | 1.29 | The successful treatment of recurrent nephrotic syndrome with the MOPP regimen in a patient with a remote history of Hodgkin's disease. ( Delmez, JA; Kissane, JM; Safdar, SH, 1994) |
| "Cardiotoxicity is a well recognized side effect of anthracyclines (doxorubicin and epirubicin) or antracenadiones (mitoxantrone) at cumulative or high doses." | 1.29 | Late cardiac toxicity of doxorubicin, epirubicin, and mitoxantrone therapy for Hodgkin's disease in adults. ( Arévila, N; Avilés, A; Díaz Maqueo, JC; García, R; Gómez, T; Nambo, MJ, 1993) |
| "Two patients developed breast cancer 14 and 8 years after treatment of Hodgkin's disease." | 1.29 | Breast cancer developing after therapy for Hodgkin's disease. ( Cascinu, S; Catalano, G; Fedeli, A, 1993) |
| "Following irradiation alone, secondary acute nonlymphocytic leukemia (ANLL) is uncommon; following chemotherapy alone, the risk is increased, but not as much as when combined modality treatments are used." | 1.29 | Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease. ( Brusamolino, E; Fiacchini, M; Gobbi, PG; Tura, S; Zinzani, PL, 1993) |
| "More than 50% of patients with non Hodgkin's lymphomas (NHL) are long-term survivors." | 1.29 | [Semen preservation and gonadal toxicity in the treatment of non Hodgkin lymphoma. Experience at the Gustave-Roussy Institute from 1980 to 1993]. ( Auger, J; Bendahmane, B; Decaudin, D; Koscielny, S; Munck, JN; Naccache, P, 1996) |
| "Pediatric patients treated for Hodgkin disease with the combination of RT and CT suffer a small but significant decrease in their final height SDS." | 1.29 | Growth and final height after treatment for childhood Hodgkin disease. ( Heller, G; Papadakis, V; Sklar, C; Tan, C, 1996) |
| "Cholestasis was observed in all cases; in most patients a moderate increase in the transaminase activity was also seen." | 1.29 | Hodgkin's disease presenting as a cholestatic febrile illness: incidence and main characteristics in a series of 421 patients. ( Briones, J; Bruguera, M; Cervantes, F; Font, C; Grau, JM; Montserrat, E; Rozman, C, 1996) |
| "We describe two cases of Hodgkin's disease after heart and heart/lung transplants respectively." | 1.29 | Hodgkin's disease after cardiac transplant: a report of two cases. ( Hood, IM; Mahendra, P; Marcus, RE; McNeil, K, 1996) |
| "We present a case of Hodgkin's disease of the mastoid associated with upper cervical lymph node involvement without disseminated disease." | 1.29 | Hodgkin's disease of middle ear and mastoid. ( Esteban, F; Hierro, C; Jimenez, JM; López-Lacomba, D; Solanellas, J; Soldado, L, 1996) |
| "20 patients in early stages (I-IIB) Hodgkin's disease were treated with smaller than commonly used doses of cytostatics and radiation." | 1.29 | [Preliminary results of conservative combination radiotherapy and chemotherapy in early stages of Hodgkin's disease]. ( Dubowik, R; Gabryś, K; Urbaniak-Kujda, D, 1996) |
| "We report a new case of coincidence of chronic lymphocytic leukemia (CLL) and mixed cellularity Hodgkin's disease (HD) in the same lymph node." | 1.29 | [Coexistence of chronic lymphoid leukemia and Hodgkin's disease. Immunohistochemical study]. ( Fresno, MF; González, M; Herrero, A; Pérez del Río, MJ; Ramírez, A; Veiga, M, 1996) |
| "Results of recent trials in Hodgkin's disease suggest that the cure rates which increased considerably between 1960 and 1980 have reached a plateau." | 1.28 | The Second International Symposium on Hodgkin's Disease. Workshop III: Recommendations for future clinical trials. ( Diehl, V; Hasenclever, D; Lathan, B; Löffler, M; Pfreundschuh, M; Rüffer, U, 1992) |
| "Four patients with fresh Hodgkin's disease were treated with MOPP/ABV hybrid regimen using nitrogen mustard-N-oxide hydrochloride (NH2-O)." | 1.28 | [Four cases of Hodgkin's disease treated with MOPP/ABV hybrid regimen using nitrogen mustard-N-oxide hydrochloride]. ( Kodo, H; Kozai, Y; Ohyama, T; Tomori, G, 1992) |
| "We report about two cases of cancer of the testis occurring 2 and 7 years after Hodgkin's disease treated with combined chemotherapy and radiation therapy." | 1.28 | [Cancer of the testis after Hodgkin's disease. Apropos of 2 cases]. ( Averous, M; Chevallier, P; Grasset, D; Guiter, J; Iborra, F; Lavabre-Bertrand, T; Rebillard, X; Robert, M, 1992) |
| "2) Non-Hodgkin's lymphoma has not appeared in any of the patients in this series." | 1.28 | [Second neoplasms as a late complication of the treatment of Hodgkin's disease]. ( Alvarez, A; Colomé, JA; del Potro, E; Díaz Mediavilla, J; González, FA; Martínez, R; Morales, MD; Villegas, A, 1992) |
| "The authors concluded that in pediatric Hodgkin's disease, a MM with a MMR greater than or equal to 0." | 1.28 | Mediastinal masses in children with Hodgkin's disease. An analysis of the Children's Hospital of Philadelphia and the Hospital of the University of Pennsylvania experience. ( D'Angio, GJ; Goldwein, JW; Lange, B; Maity, A, 1992) |
| "Three patients with Hodgkin's disease, mixed cellularity subtype, plus infection by human immunodeficiency virus are presented." | 1.28 | [Hodgkin's disease and infection with human immunodeficiency virus]. ( Auguet Quintillá, T; Gallén Castillo, M; Pedro-Botet Montoya, J; Planas Domingo, J, 1992) |
| "Systemic symptoms of Hodgkin's disease were present for 6 months, and rapidly developing patchy hair loss of the scalp was present for 2 weeks prior to presentation." | 1.28 | Simultaneously occurring alopecia areata and Hodgkin's lymphoma: complete remission of both diseases with MOPP/ABV chemotherapy. ( Berk, MA; Chan, PD; Kucuk, O; Singh, S, 1992) |
| "Information about elderly patients with acute lymphoblastic leukemia is scarce." | 1.28 | [Treatment of elderly patients with hematological malignancies]. ( Mizoguchi, H; Saito, H, 1992) |
| "20 untreated Hodgkin's disease patients and 1 patient relapsing after radiotherapy (17 stage IIB-IV and 4 stage I-IIA) were given doxorubicin, bleomycin, etoposide and prednisone on a 21-day cycle." | 1.28 | ABEP as primary chemotherapy for Hodgkin's disease. ( Alberto, P; Mermillod, B; Zulian, GB, 1992) |
| "We report a male homosexual with AIDS and Hodgkin's lymphoma, who presented with gingival involvement." | 1.28 | Hodgkin's disease involving the gingiva in AIDS. ( Kittas, C; Laskaris, G; Scully, C; Stergiou, G, 1992) |
| "Group two included Hodgkin's disease patients who were treated 12-24 years previously and have been continuously free of disease." | 1.28 | The frequency of translocations after treatment for Hodgkin's disease. ( Brown, JM; Evans, JW; Mori, M; Smith, LM, 1992) |
| "In three patients with advanced Hodgkin's disease treated with combination chemotherapy (MOPP) incorporating vincristine, and receiving at the same time a fixed daily dose of 8000 U of rHu-EPO subcutaneously for 10 to 15 days because of myelosuppressive anemia, myeloaspirates were performed one week before and 24 hours after the administration of vincristine." | 1.28 | Selective metaphasic arrest of erythroblasts by vincristine in patients receiving high doses of recombinant human erythropoietin for myelosuppressive anemia. ( Marmont, AM, 1992) |
| " All other disease stages will require a different strategy that should consist of radiotherapy combined with short-term effective regimens, such as ABVD (doxorubicin, bleomycin, vinblastine and decarbazine) or VBM (vinblastine, bleomycin and methotrexate) to reduce the incidence of MOPP-associated gonadal dysfunction and leukaemogenesis." | 1.28 | Early stage Hodgkin's disease: ten-year results of a non-randomised study with radiotherapy alone or combined with MOPP. ( Banfi, A; Bonadonna, G; Bonfante, V; Devizzi, L; Santoro, A; Tesoro Tess, JD; Valagussa, P; Viviani, S; Zanini, M; Zucali, R, 1992) |
| " In a multivariate analysis where both disease-related and treatment-related factors were taken into account drug dosage remained a significant prognostic factor." | 1.28 | Treatment of Hodgkin's disease with MOPP chemotherapy: effect of dose and schedule modification on treatment outcome. ( Bezwoda, MA; Bezwoda, WR; Dansey, R, 1990) |
| "Three patients with Stage III or IVB Hodgkin's disease were cured with MOPP (regimen of nitrogen mustard, Oncovin, prednisone, and procarbazine) and/or B-DOPA (regimen of bleomycin, dacarbazine, Oncovin, prednisone, and Adriamycin)." | 1.28 | Secondary uncommon solid neoplasms in cured Hodgkin's disease and follow-up of the original B-DOPA chemotherapy patient group. ( Lokich, JJ, 1990) |
| "Forty-nine patients with Hodgkin's disease who relapsed after a first complete remission of more than 12 months following primary chemotherapy were treated with salvage therapy regimens." | 1.28 | Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission. ( Bonadonna, G; Bonfante, V; Negretti, E; Santoro, A; Valagussa, P; Viviani, S, 1990) |
| "Reports on salvage treatments for Hodgkin's disease in first relapse after primary chemotherapy should include data on the proportion of patients having stage IV disease at diagnosis, B symptoms at relapse, and a time from primary treatment to relapse of less than 1 year." | 1.28 | Outcome of treatment of first relapse of Hodgkin's disease after primary chemotherapy: identification of risk factors from the British Columbia experience 1970 to 1988. ( Barnett, M; Connors, JM; Fairey, RN; Lohri, A; O'Reilly, SE; Phillips, GL; Reece, D; Voss, N, 1991) |
| "Sixty-three cases of Hodgkin's disease in intravenous drug users (IVDUs) have been collected by the Italian Cooperative Group on AIDS-Related Tumors (GICAT)." | 1.28 | Hodgkin's disease in 63 intravenous drug users infected with human immunodeficiency virus. Gruppo Italiano Cooperativo AIDS & Tumori (GICAT). ( Foà, R; Gavosto, F; Monfardini, S; Tirelli, U; Vaccher, E, 1991) |
| "Twenty four patients diagnosed with Hodgkin's disease were introduced to our studies." | 1.28 | Serum antithrombin III and alpha-2-antiplasmin concentrations in patients with Hodgkin's disease in the course of chemotherapy. ( Dabrowska, M; Kemona, H; Kiluk, S; Kretowska, J; Prokopowicz, J, 1991) |
| "While current medical therapies for Hodgkin's disease are usually quite effective, it has become increasingly clear that some of the therapies utilized carry an inherent risk for the induction of secondary malignancies." | 1.28 | In vivo somatic mutation in the lymphocytes of Hodgkin's disease patients. ( Caggana, M; Coleman, CN; Kelsey, KT; Liber, HL; Mauch, PM, 1991) |
| "Sixty-two patients with advanced-stage Hodgkin's disease and a median age of 12 years (range, 3 to 22 years) were treated with four cycles of mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) alternating with four cycles of doxorubicin, vinblastine, bleomycin, and dacarbazine (ABVD) followed by low-dose radiotherapy (RT)." | 1.28 | Intensive chemotherapy and low-dose radiotherapy for the treatment of advanced-stage Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study. ( Behm, FG; Brecher, M; Cantor, A; Chauvenet, A; Leventhal, BG; Marcus, R; Ternberg, J; Weiner, MA; Wharam, M, 1991) |
| "In a random HIV-seropositive population, malignant lymphomas were diagnosed in 31 patients, of whom 24 (77%) had non-Hodgkin lymphoma (NHL) and 7 (23%) Hodgkin lymphoma (HL)." | 1.28 | Malignant lymphomas in HIV-seropositive patients. Frequency, features, and prognosis. Report on 31 cases. ( Cervos-Navarro, J; Dienemann, D; Jautzke, G; Langford, A; Pohle, HD; Ruf, B; Schürmann, D; Stein, H, 1991) |
| "We report preliminary results of treatment of Hodgkin disease according to the National Protocol on Antineoplastic Drugs." | 1.28 | [Treatment of Hodgkin's disease. National Protocol of Antineoplastic Drugs: preliminary report]. ( Cao, C; García, H; Gutiérrez, J; Osorio, G; Vacarezza, R, 1991) |
| "The peak incidence of Hodgkin's disease occurs during the reproductive age, and its association with pregnancy is at a rate of between 1:1,000-1:6,000." | 1.28 | Maternal and foetal outcome following Hodgkin's disease in pregnancy. ( Degendorfer, P; Koren, G; Lishner, M; Panzarella, T; Sutcliffe, SB; Zemlickis, D, 1992) |
| "The patient remains free of Hodgkin's disease 34 months after completion of chemotherapy." | 1.28 | Transient reversal of bone marrow aplasia associated with lymphocyte depleted Hodgkin's disease after combination chemotherapy. ( Connaghan, DG; Johnston, PG; Longo, DL; Ruscetti, FW; Sullivan, FJ, 1991) |
| "Radiation pneumonitis was seen in 3% of patients receiving radiation therapy alone." | 1.28 | Thoracic irradiation in Hodgkin's disease: disease control and long-term complications. ( Mauch, P; Tarbell, NJ; Thompson, L, 1990) |
| "Chemotherapy for Hodgkin's disease causes a high and apparently dose-related incidence of testicular dysfunction in prepubertal as well as in pubertal boys affecting Leydig cell function as well as spermatogenesis." | 1.28 | The effects of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for Hodgkin's disease during childhood or adolescence. ( Brämswig, JH; Heiermann, E; Heimes, U; Nieschlag, E; Schellong, G; Schlegel, W, 1990) |
| "The progeny of patients treated for Hodgkin's disease appear normal and no excess fetal wastage has been noted." | 1.28 | Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: the Stanford experience. ( Donaldson, SS; Ortin, TT; Shostak, CA, 1990) |
| " From June 1988 to December 1989, 27 previously untreated patients with early-staged Hodgkin's disease with adverse features for disease-free survival received combined-modality therapy." | 1.28 | NOVP: a novel chemotherapeutic regimen with minimal toxicity for treatment of Hodgkin's disease. ( Cabanillas, F; Hagemeister, FB; Liang, JC; McLaughlin, P; Meistrich, ML; Redman, JR; Rodríguez, MA; Romaguera, JE; Swan, F; Velásquez, WS, 1990) |
| "A patient with advanced Hodgkin's disease being treated with MOPP chemotherapy presented with delayed life-threatening pulmonary toxicity secondary to procarbazine." | 1.28 | Delayed life-threatening pneumonitis secondary to procarbazine. ( Alvarez, S; Ancalmo, N; Brooks, BJ; Grinton, SF; Hendler, NB, 1990) |
| " There were three fatal toxic events, two due to viral infection and one to a second malignant tumor (NHL)." | 1.28 | Hodgkin's disease in children: treatment with MOPP and low-dose, extended field irradiation without laparotomy. Late results and toxicity. ( Berry, M; Blanchette, V; Chan, H; Doherty, M; Doyle, J; Freedman, M; Greenberg, M; Jenkin, D; Panzarella, T; Saunders, F, 1990) |
| "Since pediatric Hodgkin's disease is a curable malignancy, it is essential to limit treatment sequelae." | 1.28 | Pediatric Hodgkin's disease: pulmonary, cardiac, and thyroid function following combined modality therapy. ( Donaldson, SS; Link, MP; Mefferd, JM, 1989) |
| "Eight patients with refractory Hodgkin's disease received intensive combination chemotherapy conditioning with cyclophosphamide, carmustine (BCNU), and etoposide (VP 16-213), and allogeneic marrow transplants." | 1.28 | Allogeneic marrow transplantation for refractory Hodgkin's disease. ( Barnett, MJ; Connors, JM; Fay, JW; Herzig, GP; Herzig, RH; Klingemann, HG; Phillips, GL; Reece, DE; Shepherd, JD; Wolff, SN, 1989) |
| "Seventeen patients with advanced stage Hodgkin's disease who relapsed or failed to respond to multiple regimens of combination chemotherapy (mostly Mechlorethamine, Vincristine, Procarbarzine, Prednisone and Adriamycin, Bleomycin, Vinblastine, Dacarbazine) were treated with accelerated hyperfractionated total lymphoid irradiation (TLI) and high-dose chemotherapy followed by autologous bone marrow transplantation (AuBMT)." | 1.28 | Total lymphoid irradiation, high-dose chemotherapy and autologous bone marrow transplantation for chemotherapy-resistant Hodgkin's disease. ( Clarkson, B; Fuks, Z; Gulati, S; Shank, B; Yahalom, J, 1989) |
| "Neoadjuvant chemotherapy in Hodgkin's disease has improved survival time and tolerance to irradiation, allowing a lowering of the total doses used and the volumes irradiated." | 1.28 | [Radiotherapy with neoadjuvant chemotherapy]. ( Alapetite, C; Baillet, F; Dessard-Diana, B; Housset, M; Jacquillat, C; Michel-Langlet, P, 1989) |
| "A 58-year-old man with Hodgkin's disease exhibited erythrodermia due to allergic reaction to vincristine sulfate (VCR) and vindesine sulfate (VDS)." | 1.28 | [A case of Hodgkin's disease exhibiting erythrodermia probably due to allergic reaction to vinca alkaloids]. ( Kosaka, M; Matsumoto, N; Okagawa, K; Saito, S; Yoshimoto, K, 1989) |
| "Hence a diagnosis of Hodgkin's disease (HD) stage IVB was made." | 1.28 | [Hodgkin's disease diagnosed from the numerous Reed-Sternberg cells in the bone marrow]. ( Abe, T; Hasegawa, Y; Mori, N; Nakazawa, M; Noguchi, Y; Yoda, Y, 1989) |
| " The predictive value of mechlorethamine dosage with regard to OS was retained in an analysis restricted to the patients receiving greater than or equal to six cycles of chemotherapy." | 1.28 | Dose intensity of MOPP chemotherapy and survival in Hodgkin's disease. ( de Meijer, AJ; Dekker, AW; Haanen, C; van Rijswijk, RE; Verbeek, J, 1989) |
| "At Kanazawa University 28 patients with Hodgkin's disease were treated between 1975 and 1988." | 1.28 | [Hodgkin's disease]. ( Nakamura, S; Ohtake, S, 1989) |
| "Fifty-three patients with advanced Hodgkin's disease, most of them previously treated, received 8 to 16 courses of modified MOPP regimens (nitrogen mustard replaced by trichlormethine in arm A, with addition of vinblastine to the 4-drug regimen in arm B, and alternation of three drugs--trichlormethine, vincristine, and prednisone--with probably non-cross resistant two drugs--vinblastine and procarbazine in arm C)." | 1.28 | Treatment of advanced Hodgkin's disease with modified MOPP regimens. A long-term observation. ( Bohunický, L; Cerný, V; Gyárfás, J; Koza, I; Mardiak, J; Svancárová, L, 1989) |
| "Between 1979 and 1987, 28 children with Hodgkin's disease were treated with MOPP (nitrogen mustard, Oncovin, prednisone, procarbazine) combination chemotherapy without radiotherapy." | 1.28 | MOPP therapy in children with Hodgkin's disease. ( Madanat, FF, 1989) |
| "A patient with hypogonadotropic hypogonadism owing to endogenous gonadotropin releasing hormone deficiency, who developed Hodgkin's disease is described." | 1.28 | Is androgen substitution necessary in hypogonadal patients when they are treated with chemotherapy for malignant diseases? ( Nikolaou, N; Orfanos, S; Pavlidis, N; Tolis, C; Tolis, G, 1989) |
| " The CVPP schedule gave: (1) a constant drug dosage for each patient independent of body surface or weight; and (2) a total drug dosage dependent on haematological tolerance, since the treatment was given for 21 days or until the leukocyte count dropped to 2 x 10(9) l-1." | 1.28 | Influence of dose intensity and density on therapeutic and toxic effects in Hodgkin's disease. ( Bonichon, F; Chauvergne, J; de Mascarel, I; Eghbali, H; Hoerni, B; Lagarde, P, 1989) |
| "Hodgkin's disease is one of the most curable cancers thanks to progress in radiotherapy and multi-drug chemotherapy regimens such as mechloretamine-vincristine-procarbazine-prednisone, best known as MOPP." | 1.28 | Ten-year nodular sclerosis Hodgkin's disease and second malignancies. ( Mirimanoff, RO; Zulian, GB, 1989) |
| "Forty-seven cases of adult non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD) seen at the University of Benin Teaching Hospital between 1975 and 1987 have been analysed with respect to the presenting features, management and survival." | 1.28 | The malignant lymphomas in Benin City, Nigeria. ( Adedeji, MO, 1989) |
| "Four patients with Hodgkin's disease and bone marrow fibrosis are presented in whom the clinical presentation was dominated by cytopenias; this was associated with a delayed diagnosis for an average of 20 months." | 1.28 | Hodgkin's disease presenting as myelofibrosis. ( Crawford, J; Kaufman, RE; Laszlo, J; Meadows, LM; Moore, JO; Rosse, WR, 1989) |
| "Skin involvement with Hodgkin's disease is rare." | 1.28 | Cutaneous Hodgkin's disease in a patient with human immunodeficiency virus infection. ( Jacobs, SR; Shaw, MT, 1989) |
| "The Hodgkin's disease was insensitive to conventional MOPP chemotherapy in two of two, and was sensitive to combined MOPP-Bleomycin in one patient." | 1.27 | Hodgkin's disease in renal transplant recipients. ( Doyle, TJ; Maeda, K; Saeed, SM; Tilchen, EJ; Venkatachalam, KK, 1983) |
| "Fourteen patients with Hodgkin's disease resistant to ABVD were treated with MOPP chemotherapy (nitrogen mustard, vincristine, procarbazine, prednisone)." | 1.27 | MOPP treatment of resistant Hodgkin's disease following ABVD failure. ( Anselmo, AP; Cimino, G; Mandelli, F; Marzullo, A; Maurizi Enrici, R; Mauro, F; Papa, G, 1983) |
| "Bone and soft tissue sarcomas have rarely been observed after treatment of Hodgkin's disease, and only a few cases are described in the literature." | 1.27 | Bone and soft tissue sarcomas in the follow-up of Hodgkin's disease. ( Banfi, A; Zanini, M; Zucali, R, 1983) |
| "Of 10 patients with non-Hodgkin's lymphoma 2 achieved complete remission and 5 a partial response." | 1.27 | Treatment of refractory lymphoproliferative diseases with daily, low-dose vincristine, continuous infusion of bleomycin, and high-dose prednisone. ( Gomez, GA; Han, T; Henderson, ES; Ozer, H, 1984) |
| "Although most patients with Hodgkin's disease refractory to MOPP treatment will respond to either ABVD or B-CAVe chemotherapy, subsequent long-term disease-free survival is unusual." | 1.27 | Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe. ( Harker, WG; Kushlan, P; Rosenberg, SA, 1984) |
| "The results of 111 children with Hodgkin's disease, who were treated with chemotherapy of different intensity and reduced radiotherapy (Cooperative Therapy Study HD 82, 12/81 - 9/83) are presented." | 1.27 | [Graded chemotherapy and reduced radiotherapy in Hodgkin's disease in childhood. Intermediate report on the cooperative HD 82 therapy study]. ( Schellong, G; Strauch, S; Wannenmacher, M, 1984) |
| "A patient in whom an unusually severe Hodgkin's disease was complicated by subacute motor neuronopathy is described." | 1.27 | An unusually severe subacute motor neuronopathy in Hodgkin's disease. ( Longhi, C; Massini, R; Pelosio, A; Recine, U, 1984) |
| "In two patients Hodgkin's lymphoma was discovered and in a third histiocytic lymphoma." | 1.27 | Hodgkin's and non-Hodgkin's lymphomas masquerading as "idiopathic" liver granulomas. ( Aderka, D; Avidor, I; Kraus, M; Pinkhas, J; Sidi, Y; Weinberger, A, 1984) |
| "A 30 years old man having Hodgkin's disease was treated successfully by means of chemotherapy and radiotherapy." | 1.27 | [Myocardial infarction after mediastinal radiotherapy of Hodgkin's disease]. ( Callén, L; Fuertes, MA; Gutiérrez, M; Peleato, A; Poderós, C; Polo, J; Rodrigo, G; Tres, A, 1984) |
| "The example of Hodgkin's lymphoma staging and treatment selection is used." | 1.27 | A decision-analysis methodology for consideration of morbidity factors in clinical decision-making. ( Corder, MP; Ellwein, LB, 1984) |
| "The patients would have symptomatic Hodgkin's lymphoma." | 1.27 | Comparison of treatments for symptomatic Hodgkin's lymphoma employing decision analysis. ( Corder, MP; Ellwein, LB, 1984) |
| "Thirty-four subsequent second malignant neoplasms were observed in 33 patients among those treated for Hodgkin's disease." | 1.27 | Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience. ( DeVita, VT; Glatstein, E; Kelley, PA; Kinsella, TJ; Makuch, RW; Tester, WJ; Waller, B, 1984) |
| "A patient suffering from Hodgkin's disease exhibiting acute allergic reaction to vincristine sulfate with mild to moderate dermatologic and cardiovascular signs is described." | 1.27 | Acute allergic reaction due to vincristine sulfate. A case report. ( Gassel, WD; Gropp, C; Havemann, K, 1984) |
| "This case of optic neuropathy is supposed to be a rare example of involvement of the 2nd cranial nerve due to vinca alkaloids." | 1.27 | Transient optic neuropathy secondary to MOPP chemotherapy in Hodgkin's disease: report of a case. ( Guidelli Guidi, S; Maccolini, E; Oddo Bravetti, G; Serra, L; Vecchi, V, 1984) |
| "Secondary tumors were noted in 8 out of 675 patients with Hodgkin's disease during remission following treatment." | 1.27 | [Secondary malignant tumors following treatment of Hodgkin's disease]. ( Shishkin, IP, 1984) |
| "We report the second case of Hodgkin's disease associated with thrombotic thrombocytopenic purpura (TTP)." | 1.27 | [Thrombotic thrombopenic purpura associated with Hodgkin's disease]. ( Bousser, J; Diebold, J; Dumoulin-Lagrange, M; Samama, M; Tulliez, M, 1983) |
| "Appropriate management of Hodgkin's disease is based on both the stage of disease and the specific anatomic sites of involvement within each stage." | 1.27 | Diagnosis and management of Hodgkin's disease in the adult. ( Fuller, LM; Hagemeister, FB, 1983) |
| "Hodgkin disease was confirmed histologically in three, and confirmed by electron microscopy in two." | 1.27 | Simultaneous occurrence of mycosis fungoides and Hodgkin disease: clinical and histologic correlations in three cases with ultrastructural studies in two. ( Amorosi, EL; Hawkins, KA; Ramsey, D; Schinella, R; Schwartz, M; Silber, R; Weintraub, AH, 1983) |
| "In 164 patients with Hodgkin's disease staged between 1973 and 1979 the response to the 3 initial cycles of multiagent chemotherapy was evaluated as a prognosticator of survival." | 1.27 | Early response to chemotherapy as a prognostic factor in Hodgkin's disease. ( Bierling, P; Brun, B; Dreyfus, B; Farcet, JP; Imbert, M; Kuentz, M; Le Bezu, M; Lebourgeois, JP; Reyes, F; Rochant, H; Vernant, JP, 1983) |
| "Patients who had a relapse of Hodgkin's disease did not have an increased incidence of second malignancy." | 1.27 | Second malignancy complicating Hodgkin's disease. ( Mercier, JP; Tawil, E, 1983) |
| "Of 157 patients with Hodgkin's disease treated between 1970 and 1981 an assessment of the clinical course was possible in 134 cases." | 1.27 | [Recurrence in Hodgkin's disease: incidence, therapy and prognosis. (Experience with 134 patients)]. ( Denz, H; Huber, H; Lechleitner, M; Peer, L; Peschel, C, 1983) |
| "The rate of recurrence formation was found to be in a significant correlation with general symptoms, age, size of the largest cluster of involved lymph nodes, combination of drugs and type of consolidating therapy." | 1.27 | [Peculiarities of the recurrence of lymphogranulomatosis in children following combined chemotherapy]. ( Kharatishvili, ZV; Kolygin, BA, 1983) |
| "A patient with primary Hodgkin's disease of the lung is described." | 1.27 | Primary Hodgkin's disease of the lung. Case report and review of the literature. ( Czembirek, H; Homan, R; Lechner, K; Moritz, H; Neumann, E; Resch, F, 1983) |
| "Radiation pericarditis was accompanied either by feebly marked signs or no signs at all." | 1.27 | [Radiation pericarditis following treatment of lymphogranulomatosis]. ( Baĭsogolov, GD; Shapiro, IB; Shishkin, IP, 1983) |
| "There was no significant difference in recurrence rates between patients without mediastinal mass and patients with a small mass, and in these patients adjuvant chemotherapy MOPP after radiotherapy showed an evident benefit in reducing the relapse rate." | 1.27 | Prognostic significance of large mediastinal involvement in Hodgkin's disease. ( Baccarani, M; Cantore, M; Dominici, G; Emiliani, E; Faedi, M; Fiacchini, M; Frezza, G; Lauria, F; Mazza, P; Sciascia, R, 1983) |
| "A dose-response analysis of the results of MOPP chemotherapy in 132 patients with Hodgkin's disease was carried out." | 1.27 | A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy. ( Carde, P; MacKintosh, FR; Rosenberg, SA, 1983) |
| "Six patients with Hodgkin's disease who failed MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy, with recurrences confined to lymph node areas, are reported." | 1.27 | Radiation as salvage therapy for patients with Hodgkin's disease relapsing after MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy. ( Baldwin, PE; Diehl, LF; Dorn, RV; Hurwitz, M; Kimball, DB; Perry, DJ; Terebelo, H, 1983) |
| "Seventy patients with advanced Hodgkin's disease, 54 with new disease, and 16 in first relapse after initial radiotherapy, have been treated with a seven-drug, 8-month program: MOPP (nitrogen mustard, vincristine, procarbazine, prednisone)/ABV (Adriamycin [Adria Laboratories of Canada, Mississauga, Ontario], bleomycin, vinblastine) hybrid." | 1.27 | MOPP/ABV hybrid program: combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin's disease. ( Connors, JM; Klimo, P, 1985) |
| "Eight patients with disseminated Hodgkin's disease resistant to MOPP (mechlorethamine, vincristine, procarbazine, and prednisone) chemotherapy were treated with high-dose chemoradiotherapy and marrow transplantation from an HLA-identical sibling." | 1.27 | Allogeneic marrow transplantation in the treatment of MOPP-resistant Hodgkin's disease. ( Appelbaum, FR; Buckner, CD; Clift, RA; Deeg, HJ; Neiman, PE; Sanders, JE; Stewart, P; Storb, R; Sullivan, KM; Thomas, ED, 1985) |
| "A strategy for treatment of malignant lymphoma requires fundamentally a field of multidisciplinary treatment including mainly radiotherapy and chemotherapy in a collaboration with surgical procedure and immunotherapeutic maneuver." | 1.27 | [Malignant lymphoma]. ( Kita, K; Shirakawa, S; Tanaka, I, 1985) |
| " It is noteworthy that in all subsets, ABVD (Adriamycin + bleomycin + vinblastine + dacarbazine), either combined with irradiation or alternated with MOPP (mechlorethamine + vincristine + procarbazine + prednisone), yielded superior results compared with MOPP with or without irradiation." | 1.27 | Prognosis of bulky Hodgkin's disease treated with chemotherapy alone or combined with radiotherapy. ( Bonadonna, G; Santoro, A; Valagussa, P, 1985) |
| "Sixty-eight patients with Hodgkin's disease stage III and IV were evaluated after three out of six MOPP cycles." | 1.27 | Prognostic value of response after three MOPP cycles in Hodgkin's disease--stage III and IV. ( Barbot, A; Le Fur, R; Menard, JF; Monconduit, M; Piguet, H; Tilly, H, 1987) |
| "Five hundred and seven patients with Hodgkin's lymphoma (HL), forming the basis of our 18 years experience, are retrospectively analyzed." | 1.27 | Hodgkin's disease (HD): a historical perspective. ( Baccarani, M; Bandini, G; Emiliani, E; Fiacchini, M; Gobbi, M; Lauria, F; Mazza, P; Tura, S; Verlicchi, F; Zinzani, PL, 1986) |
| "The prognosis of malignant lymphomas has been transformed since the introduction of this drug in the chemotherapeutic protocols: the level of complete remission increased from 25% with CVP protocols to 50% with CHOP-types protocols, and to more than 70% with intensive chemotherapy protocols (m-BACOD, LNH-80)." | 1.27 | [Contribution of anthracyclines in treatment of lymphoproliferative disorders]. ( Coiffier, B, 1987) |
| "Most of the children with Hodgkin's disease diagnosed before or during puberty can be cured with chemotherapy alone, and thus will not suffer from the damaging late effects of radiotherapy." | 1.27 | Treatment of Hodgkin's disease in children with or without radiotherapy. ( Behrendt, H; Van Bunningen, BN; Van Leeuwen, EF, 1987) |
| "Thirty eight patients with Hodgkin's disease, stage I to IIIA, previously untreated, received three courses of this regimen before radical radiotherapy." | 1.27 | [The combination of epirubicin, bleomycin, vinblastine and prednisone (EBVP) before radiotherapy in localized stages of Hodgkin's disease. Phase II trials]. ( Audebert, A; Blanc, CM; David, B; Debray, J; Eghbali, H; Hoerni, B; Rojouan, J; Zittoun, R, 1987) |
| "Thirty-two patients with advanced Hodgkin's lymphoma resistant to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) were treated with a salvage chemotherapy regimen consisting of lomustine, etoposide, vindesine, and dexamethasone (CEVD)." | 1.27 | Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the Ge ( Diehl, V; Fuchs, R; Loeffler, M; Pflüger, KH; Pfreundschuh, MG; Schoppe, WD, 1987) |
| "The observed cure rates in childhood Hodgkin's disease (85 to 95%) and the knowledge of late complications of treatments, radiotherapy as well as chemotherapy, lead to studies aiming at decreasing the treatment burden without compromising these good results." | 1.27 | [Hodgkin's disease in children. Current therapeutic strategies]. ( Habrand, JL; Lemerle, J; Leverger, G; Oberlin, O; Olive, D; Schaison, G; Zucker, JM, 1988) |
| "In 82 children affected with Hodgkin's disease, in whom a complete remission was obtained, the first relapses occurred in 13 patients, their outcome was a follows: one child died of relapse and in 12 others second complete remissions were achieved." | 1.27 | Is first salvage chemotherapy the last-line chemotherapy in children with Hodgkin's disease? A tentative answer based on long observation of two patients. ( Armata, J; Balwierz, W; Moryl-Bujakowska, A; Pekacki, A, 1987) |
| "Results of treatment of 25 Hodgkin's disease patients at Kyushu University Hospital from 1981 to 1985 were reviewed." | 1.27 | [Improved survival rates in Hodgkin's disease]. ( Hayabuchi, N; Hirata, H; Ishii, E; Jingu, K; Kikuchi, M; Komiyama, S; Masuda, K; Miyoshi, M; Nishimura, J; Shibuya, T, 1988) |
| "Fifty patients with recurrent Hodgkin's disease have been treated with high-dose therapy followed by autologous bone marrow transplantation." | 1.27 | High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report. ( Carella, AM; Cimino, G; Congiu, AM; Coser, P; Gaozza, E; Mangoni, L; Mazza, P; Meloni, G; Ricci, P; Visani, G, 1988) |
| "Fifty patients with Hodgkin's disease stage I to IIIA, previously untreated, received three courses of this regimen before radiotherapy." | 1.27 | [New combination of epirubicine, bleomycin, vinblastine and prednisone (EBVP II) before radiotherapy in localized stages of Hodgkin's disease. Phase II trial in 50 patients]. ( Blanc, CM; David, B; Eghbali, H; Hoerni, B; Orgerie, MB; Rojouan, J; Zittoun, R, 1988) |
| "A patient is described who developed Hodgkin's disease 16 years after treatment of Wilms' tumor with radiation and actinomycin D." | 1.27 | Hodgkin's disease following Wilms' tumor: a case report. ( Bell, BA; Esseltine, DW; Freeman, CR, 1987) |
| "Eight patients with Hodgkin's disease who were seropositive to human immunodeficiency virus (HIV), 6 of them being heroin addicts and one a homosexual, were studied." | 1.27 | Hodgkin's disease in HIV-infected patients. ( Alfonso, PG; Altozano, JG; Carretero, JM; Galindo, RC; Gomez, LP; Manga, GP; Sañudo, EF, 1988) |
| "This case shows that relapse of Hodgkin's disease may occur after a 10 year interval and furthermore it may preceded by nephrotic syndrome." | 1.27 | Glomerulonephritis preceding late relapse of Hodgkin's disease. ( Lynn, WA; Marcus, RE, 1988) |
| "Two patients developed breast cancer after treatment of Hodgkin's disease." | 1.27 | Mammary carcinoma developing after radiotherapy and chemotherapy for Hodgkin's disease. ( Anderson, T; Cox, JD; Gillin, M; Greenberg, M; Janjan, NA; Schewe, K; Wilson, JF, 1988) |
| "Two hundred ninety patients with Hodgkin's disease pathologic stage (PS) I or II were treated in the prospective randomized trial of the Danish National Hodgkin Study (see Appendix) with radiotherapy +/- adjuvant combination chemotherapy." | 1.27 | Tumor burden as the most important prognostic factor in early stage Hodgkin's disease. Relations to other prognostic factors and implications for choice of treatment. ( Clausen, NT; Cold, S; Nissen, NI; Nordentoft, AM; Specht, L, 1988) |
| "Seven patients with autoimmune hemolytic anemia (AIHA) associated with an underlying lymphoproliferative disorder were treated with intravenous immunoglobulin." | 1.27 | Rapid transient reversal of anemia and long-term effects of maintenance intravenous immunoglobulin for autoimmune hemolytic anemia in patients with lymphoproliferative disorders. ( Besa, EC, 1988) |
| "We have described a patient with Hodgkin's disease who had fever and pulmonary infiltrates after treatment with mantle x-ray therapy and two courses of MOPP." | 1.27 | Gallium citrate Ga 67 accumulation in pulmonary lesions after chemotherapy (MOPP). ( Davenport, OL; Huskison, WT; Wells, JD, 1986) |
| "Eleven patients with Hodgkin's disease refractory to chemotherapy were treated with six cycles of intermediate-dose methotrexate with calcium leucovorin rescue, followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (MTX-CHOP)." | 1.27 | Salvage chemotherapy for advanced Hodgkin's disease. ( Garbes, ID; Gomez, GA; Han, T; Henderson, ES, 1987) |
| "Nineteen patients with Hodgkin's disease who relapsed primarily in nodal sites after intensive combination chemotherapy were retreated with wide-field radiation therapy alone or with additional chemotherapy between January 1971 and December 1984." | 1.27 | Wide-field radiation therapy alone or with chemotherapy for Hodgkin's disease in relapse from combination chemotherapy. ( Mauch, P; Rosenthal, D; Skarin, A; Tarbell, N; Weinstein, H, 1987) |
| "In 41 patients with Hodgkin's disease nitroblue tetrazolium (NBT) dye reduction with resting and stimulated granulocytes, before, in the course and after chemotherapy was examined." | 1.27 | Nitroblue tetrazolium test in patients with Hodgkin's disease in the course of chemotherapy. ( Kemona, H; Kiluk, S; Prokopowicz, J; Wysocka, J, 1987) |
| "Of 244 patients with Hodgkin's disease, 126 (52%) had an abnormal mediastinum." | 1.27 | Observations on the treatment of mediastinal masses in Hodgkin's disease emphasizing site of failure. ( Chan, PY; Hintz, BL; Kagan, AR; McMahon, J; Nussbaum, H; Rao, AR; Ryoo, MC; Wollin, M, 1987) |
| "A case of recurrent Hodgkin's disease of the "sarcomatoid" or "syncytial variant" type was seen that occurred as an extension from the mediastinum to a previously uninvolved extranodal site (breast) and pericardium after treatment of classical nodular sclerosing Hodgkin's disease based in the lymph nodes." | 1.27 | Recurrent "syncytial variant" of Hodgkin's disease: an immunohistologic diagnosis. ( Blaustein, JC; Lewkow, L, 1987) |
| "A patient seen at presentation for Hodgkin's disease (HD) at stage IV B was successfully treated with MOPP." | 1.27 | Gastric non-Hodgkin's lymphoma after successful treatment of Hodgkin's disease. ( Eridani, S; Singh, AK, 1986) |
| "Hodgkin's disease is characterized by its peculiar histopathology and by the early and consistent existence of impaired cell-mediated immunity, although its oncogenetic mechanisms still remains unsolved." | 1.27 | [Clinical features and treatment of Hodgkin's disease]. ( Kita, K; Kobayashi, T; Ohno, T; Shirakawa, S, 1986) |
| "In addition, acute renal failure developed in both patients, and myolysis in one." | 1.27 | Purpura fulminans in pneumococcal sepsis. ( Berneman, ZN; Bieger, R; Bridts, C; Buyssens, N; Hautekeete, ML; Peetermans, ME; Stevens, WJ, 1986) |
| "Localized pneumonitis and fibrosis are well-known sequelae of this treatment." | 1.27 | Unusual thoracic radiographic findings in children treated for Hodgkin's disease. ( Jochelson, MS; Tarbell, NJ; Weinstein, HJ, 1986) |
| "We report here a case of Hodgkin's disease that progressed untreated for almost four years by virtue of a delayed diagnosis before constitutional symptoms developed." | 1.27 | A rare opportunity to observe aspects of the natural history of untreated Hodgkin's disease. ( Haines, IE; Schwarz, MA, 1986) |
| "94 patients with Hodgkin's disease PS I or II, treated during the period 1969-78 and followed until death, or from 33 to 136 months after initiation of therapy, were analysed." | 1.27 | Prognostic significance of tumour burden in Hodgkin's disease PS I and II. ( Nissen, NI; Specht, L, 1986) |
| "The results of treatment of I-II stage Hodgkin's disease in children aged 2-14 have been studied." | 1.27 | [The role of radiotherapy in the treatment of stage I-II Hodgkin's disease in children]. ( Chikrizov, SI; Kanaev, SV; Kolygin, BA; Malinin, AP, 1986) |
| "Central nervous system involvement with Hodgkin's disease is extremely rare and is almost always a late complication in patients who have widely disseminated disease in the usual nodal sites." | 1.27 | Hodgkin's disease presenting with isolated craniospinal involvement. ( Bender, BL; Mayernik, DG, 1986) |
| "Thymic hyperplasia is a poorly understood, apparently benign process that may be confused with recurrent lymphoma." | 1.27 | Thymic hyperplasia masquerading as recurrent Hodgkin's disease: case report and review of the literature. ( Edington, H; Longo, DL; Pass, H; Roth, JA; Salwitz, J, 1986) |
| "A case of thymic Hodgkin's disease presenting with an anterior mediastinal mass is reported." | 1.27 | Cystic degeneration of thymic Hodgkin's disease following radiation therapy. ( Haas, A; Kim, HC; Lewis, R; Nosher, J; Sweeney, W, 1985) |
| "Thirty-four patients with Hodgkin's disease and non-Hodgkin's lymphoma underwent therapeutic splenectomies to improve hematologic tolerance for chemotherapy." | 1.27 | The potential benefits of therapeutic splenectomy for patients with Hodgkin's disease and non-Hodgkin's lymphomas. ( Cox, RS; Hoppe, RT; Jacobs, C; Rosenberg, SA; Schreiber, DP, 1985) |
| " Demonstration of systemic signs, bioptically confirmed bone-marrow infiltration and suboptimal cytostatic dosage correlated significantly with a lower full-remission rate." | 1.27 | [Chemotherapy of advanced lymphogranulomatosis. Results of MOPP/COPP treatment at the West German Tumor Center, Essen]. ( Becher, R; Höffken, K; Ippisch, A; Pfeiffer, R; Schmidt, CG; Seeber, S, 1985) |
| "Intracranial hodgkin's disease, an extremely uncommon finding, is reported in a 21-year-old man." | 1.27 | Hodgkin's disease, intracranial involvement. Report of a case and review of the literature. ( Enriquez, R; Papac, R; Vera, R, 1985) |
| "Br." | 1.27 | [Pregnancy and fetal development after therapy of Hodgkin's disease]. ( Slanina, J; Spratler, J; Wannenmacher, M, 1985) |
| "47 patients with advanced Hodgkin's disease (stage IIIB or IV) and mediastinal involvement, treated during the period 1969-78 and followed till death or from 36 to 126 months after initiation of therapy, were analysed." | 1.27 | Therapeutic implications of mediastinal involvement in advanced Hodgkin's disease. ( Nissen, NI; Specht, L; Walbom-Jørgensen, S, 1985) |
| "Twenty-one percent of all Hodgkin's disease in India was seen in the pediatric age groups at the Tata Memorial Hospital (Bombay, India)." | 1.27 | Pediatric Hodgkin's disease in India. ( Advani, S; Desai, P; Dinshaw, K; Nair, C; Notani, P; Pande, S; Ramakrishnan, G; Rao, DN; Rao, R; Talvalkar, G, 1985) |
| "Three cases of primary gastric Hodgkin's disease confirmed by pathology are reported." | 1.27 | [Primary gastric Hodgkin's disease]. ( Bo, YK, 1985) |
| "Twenty-two patients with Hodgkin's disease were treated at Kanazawa University between 1975 and 1982." | 1.27 | [The role of radiotherapy in the treatment of Hodgkin's disease]. ( Chohtoh, S; Hirose, J; Kamimura, R; Kobayashi, A; Nakamura, S; Nishijima, H; Ohtake, S; Saito, Y; Takashima, T; Yoshida, T, 1985) |
| "One patient with Hodgkin's disease involving the liver is alive at 36 months with further therapy." | 1.26 | Adriamycin, bleomycin, DIC, CCNU, and prednisone (ABDIC) chemotherapy in MOPP-resistant Hodgkin's disease. ( Gamble, JF; Loh, KK; Rodgers, RW; Shullenberger, CC, 1980) |
| " Reduced drug dosage was associated with treatment failure in 19 out of 37 patients receiving suboptimal chemotherapy compared to only four of 27 patients in the relapse-free group (P less than 0." | 1.26 | Factors affecting relapse following chemotherapy for Hodgkin's disease. ( Hudson, GV; Jelliffe, AM; Yarnold, JR, 1982) |
| "The eight patients who reported pretreatment nausea had more extensive disease than the other patients and had received twice as much chemotherapy." | 1.26 | Pretreatment nausea in cancer chemotherapy: a conditioned response? ( Carli, T; Curtis, GC; Kleinman, PD; Nesse, RM, 1980) |
| "50 patients with Hodgkin's disease were treated with MOPP chemotherapy." | 1.26 | [Results with MOPP combination chemotherapy in Hodgkin's disease (author's transl)]. ( Neumann, E, 1981) |
| "Thirty-six patients with advanced Hodgkin's disease who were treated primarily with MOPP were evaluated to determine the reasons for MOPP failure." | 1.26 | Reasons for failure of MOPP to cure Hodgkin's disease: The importance of dose and schedule. ( Armitage, JO; Corder, MP, 1982) |
| "A patient with Hodgkin's disease developed acute radiation pneumonia four months after completion of mantle radiotherapy and during cyclical adjuvant chemotherapy." | 1.26 | Radiation pneumonia complicating adjuvant cytotoxic chemotherapy. ( Manoharan, A; Schonell, M, 1980) |
| "A case of Hodgkin's disease is reported in which acute promyelocytic leukaemia developed within 5 months of initiation of chemotherapy." | 1.26 | Hodgkin's disease and acute promyelocytic leukaemia. A case report. ( King, JB; Rosenstrauch, WJ; Steytler, JG; van der Merwe, AM; van Eeden, PJ, 1980) |
| "Long-term survivors of advanced diffuse histiocytic lymphoma treated with comparable chemotherapy, who served as a control population, had significantly higher percentages of E rosettes and no reduction in mitogen-induced lymphocyte proliferation." | 1.26 | Persistent immunologic abnormalities in long-term survivors of advanced Hodgkin's disease. ( Bostick, F; DeVita, VT; Fisher, RI; Howser, DM; Hubbard, SM; Vanhaelen, C; Young, RC, 1980) |
| "Thirty-eight patients with advanced Hodgkin's disease were treated with a combination of cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP); the minimum period of observation for surviving patients was five years." | 1.26 | Long-term survival of patients with Hodgkin's disease. Treatment with cyclophosphamide, vinblastine, procarbazine, and prednisone. ( Bloomfield, CD; Gibbs, GE; Kennedy, BJ; Peterson, BA; Vosika, G, 1981) |
| "Persistent amenorrhea has occurred in 11 of 24 patients (46 percent) treated with MOPP alone or MOPP plus radiation excluding the pelvis." | 1.26 | Long-term follow up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's disease. ( DeVita, VT; Hubbard, SM; Schilsky, RL; Sherins, RJ; Wesley, MN; Young, RC, 1981) |
| "Stage II Hodgkin's disease probably should be divided into two substages requiring different treatment." | 1.26 | [The current state of curability of Hodgkin's disease]. ( Streuli, RA; Ultmann, JE, 1981) |
| "The pancytopenia was reversed by glucocorticosteroid therapy but recurred when steroids were tapered." | 1.26 | Hodgkin's disease presenting as steroid-responsive pancytopenia. ( Doolittle, CH; Kaplan, HG, 1980) |
| "We present a case of Hodgkin's disease and extensive skin infiltration with a favorable outcome." | 1.26 | Skin infiltration in Hodgkin's disease. ( Abt, AB; Gordon, RA; Lookingbill, DP, 1980) |
| "58 patients with early stages of Hodgkin's disease (I, II, III l) were treated by 3 courses of MOPP chemotherapy followed by extended field irradiation." | 1.26 | [Comments about use of polychemotherapy MOPP associated with radiotherapy in the treatment of early stages of Hodgkin's disease. Preliminary report of 58 patients (author's transl)]. ( Alaoui, Y; Baillet, F; Brun, B; Dreyfus, B; Kuentz, M; Maylin, C; Pierquin, B; Reyes, F; Rochant, H; Vernant, JP, 1980) |
| "Thirty South African children with Hodgkin's disease were studied over a 7-year period (1970 - 1977)." | 1.26 | Hodgkin's disease in South African children. ( Clinton, C; de Moor, NG; Jacobson, RJ; Klappenbach, RS; Wong, O, 1981) |
| "In 18 patients with advanced Hodgkin's disease, refractory to previous 'C-MOPP' treatment, a new therapeutic protocol of adriamycin, DTIC, CCNU and bleomycin was introduced." | 1.26 | [Post-MOPP chemotherapy of Hodgkin's disease (author's transl)]. ( Bruntsch, U; Gallmeier, WM; Osieka, R; Schmidt, CG; Seeber, S, 1976) |
| "15 patients with malignant lymphomas (stage III B or IV) who had become resistant to previous combination chemotherapy were treated with DTIC." | 1.26 | Imidazole carboxamide (DTIC) in the treatment of advanced lymphomas. Efficacy of DTIC in cases which fail to respond to conventional chemotherupetic combinations. ( Donner, L; Klener, P, 1977) |
| "Twenty-four patients with advanced Hodgkin's disease, resistant to the MOPP regimen, were treated with a combination of Adriamycin, bleomycin, dacarbazine and vinblastine (ABDV)." | 1.26 | Combination chemotherapy of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, dacarbazine and vinblastine (ABDV). ( Case, DC; Lee, BJ; Young, CW, 1977) |
| "Our present knowledge of Hodgkin's disease is briefly reviewed and the prognostic importance of histologic subtype and stage is demonstrated." | 1.26 | [Hodgkin's disease: classification, staging, therapy]. ( Wewerka, JR, 1978) |
| "Of 14 splenectomized patients with Hodgkin's disease who were treated with total nodal irradiation and combination chemotherapy (MOPP), fulminant sepsis developed in three (21." | 1.26 | Fulminant sepsis after the successful treatment of Hodgkin's disease. ( Aisenberg, AC; Weitzman, S, 1977) |
| "The ideal management of stage IIB Hodgkin's disease is less certain; it is our plan to study the efficacy of combined modality treatment." | 1.26 | Stages IIB and IIIB Hodgkin's disease. Results of combined modality treatment. ( Goldstein, M; Goodman, R; Hellman, S; Mauch, P; Piro, A; Rosenthal, D; Tullis, J, 1977) |
| "Thirty-two patients with Hodgkin's disease who relapsed after a first complete remission induced by nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) were retreated with MOPP chemotherapy." | 1.26 | Prolonged disease-free survival in Hodgkin's disease with MOPP reinduction after first relapse. ( DeVita, VT; Fisher, RI; Hubbard, SP; Simon, R; Young, RC, 1979) |
| "Malignant myelosclerosis or acute myelofibrosis is a rare acute myeloproliferative disorder characterized by pancytopenia, myeloblastosis and marrow fibrosis." | 1.26 | Malignant myelosclerosis (acute myelofibrosis): report of two cases following cytotoxic chemotherapy. ( Ali, NO; Janes, WO, 1979) |
| "A 26-year-old woman with Hodgkin's disease was treated with multiple-agent chemotherapy at 26 weeks' gestation." | 1.26 | MOPP (nitrogen mustard, vincristine, procarbazine, and prednisone) given during pregnancy. ( Jones, RT; Weinerman, BH, 1979) |
| "The link between ulcerative colitis, the chronic hepatopathy and the development of Hodgkin's disease that could have arisen as a consequence of the prolonged immunosuppressive treatment are discussed." | 1.26 | [Hodgkin's disease developing in the course of a chronic liver disease with ulcerative colitis immunosuppressed with azathioprine]. ( Findor, JA; Orbuch, SJ, 1979) |
| "A patient with Hodgkin's disease and renal insufficiency became deaf while being treated with high dose oral furosemide." | 1.26 | Deafness associated with oral furosemide. ( de Quesada, AM; Pickering, MJ; Rifkin, SI; Shires, DL, 1978) |
| "Despite the dramatic response of Hodgkin's disease to intensive chemotherapy, the skin lesion was rapidly transformed into squamous cell carcinoma in 10 weeks." | 1.26 | Rapid development of keratoacanthoma and accelerated transformation into squamous cell carcinoma of the skin: a mutagenic effect of polychemotherapy in a patient with Hodgkin's disease? ( Poleksic, S; Yeung, KY, 1978) |
| "After 12 cycles of MOPP therapy for Hodgkin's Disease, an adolescent black male developed hemorrhagic cystitis, which clinically and histologically was similar to that induced by cyclophosphamide." | 1.26 | Hemorrhagic cystitis with MOPP therapy. ( Royal, JE; Seeler, RA, 1978) |
| "Gynecomastia was not associated with an increase in either serum estradiol or prolactin concentrations." | 1.26 | Gynecomastia and gonadal dysfunction in adolescent boys treated with combination chemotherapy for Hodgkin's disease. ( Olweny, CL; Sherins, RJ; Ziegler, JL, 1978) |
| "Between 1967 and 1977, 48 patients with Hodgkin's disease under 16-years-old were treated with MOPP chemotherapy alone at the Uganda Cancer Institute because radiotherapy facilities are not available." | 1.26 | Childhood Hodgkin's disease in Uganda: a ten year experience. ( Katongole-Mbidde, E; Kiire, C; Lwanga, SK; Magrath, I; Olweny, CL; Ziegler, JL, 1978) |
| "A case of nodulat sclerosing Hodgkin's disease in an elderly woman is presented." | 1.26 | Cutaneous Hodgkin's disease: indolent course and control with chemotherapy. ( Rubins, J, 1978) |
| "Sixty-three patients with Hodgkin's disease, in stages I or II, asymptomatic (A) or symptomatic (B), were diagnosed and followed at the Chaim Sheba Medical Center from 1969 to 1976." | 1.26 | Selective splenectomy in Hodgkin's disease, stages I and II. Results of treatment. ( Aghai, E; Ben-Bassat, I; Berkowicz, M; Brenner, H; Hulu, N; Many, A; Ramot, B; Rath, P, 1978) |
| "Procarbazine may have been the responsible agent." | 1.26 | Diffuse pulmonary disease after therapy with nitrogen mustard, vincristine, procarbazine, and prednisone. ( Armstrong, JD; Farney, RJ; Hammer, S; Morris, AH, 1977) |
| "Fifty patients with advanced Hodgkin's disease were treated with a combination of cyclophosphamide, vinblastine, procarbazine and prednisone (CVPP) in a 21-day cyclic regimen." | 1.26 | Cyclophosphamide, vinblastine, procarbazine and prednisone with CCNU and vinblastine maintenance for advanced Hodgkin's disease. ( Diggs, CH; Kvols, LK; Levi, JA; Wiernik, PH, 1977) |
| "Study 81 cases of Hodgkin's disease at stages I, II or III led to the following conclusions from a therapeutic standpoint (in relation to the apparent results obtained): The addition of chemotherapy on the form of three courses of MOPP before irradiation improved the results of the latter on the one hand and, principally, by reducing the number of failures and, secondly, by reducing the complications." | 1.26 | [81 cases of Hodgkin's disease treated with extensive radiotherapy, including 65 with primary MOPP chemiotherapy (author's transl)]. ( Baillet, F; Brun, B; Dreyfus, B; Maylin, C; Mazeron, JJ; Pierquin, B, 1977) |
| "We studied 680 patients with Hodgkin's disease, treated at Stanford University Medical Center from July 1, 1968, through December 31, 1975, to determine the risk of development of hematologic neoplasia." | 1.26 | Hematologic neoplasia in patients treated for Hodgkin's disease. ( Coleman, CN; Flint, A; Glatstein, EJ; Kaplan, HS; Rosenberg, SA; Williams, CJ, 1977) |
| "Thirty-eight patients with advanced Hodgkin's disease were treated with a combination of cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP)." | 1.26 | Combinaed chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for patients with advanced Hodgkin's disease. An alternative program to MOPP. ( Bloomfield, CD; Fortuny, I; Kennedy, BJ; Vosika, G; Weiss, RB, 1976) |
| "A new treatment program for advanced Hodgkin's disease employing five-drug combination chemotherapy and low dose radiation to the sites of bulk disease (nodal or parenchymal) was designed in 1969." | 1.26 | Long term remissions with combined modality therapy for advanced Hodgkin's disease. ( Bertino, JR; Farber, LR; Fischer, DB; Fischer, JJ; Prosnitz, LR, 1976) |
| "In both, Hodgkin's disease and non-Hodgkin's lymphomas, induction of remission, relaps-free survival and prognostic significance of initial clinical stage were evaluated, in relation to the therapeutic modality." | 1.26 | Chemotherapy of advanced malignant lymphomas comparative evaluation of results with single agent and combination therapy. ( Donner, L; Klener, P; Roth, Z, 1976) |
| "This is a report of a patient with Hodgkin's disease who underwent a staging splenectomy and extensive radiation therapy and then developed "idiopathic" thrombocytopenic purpura." | 1.26 | Idiopathic thrombocytopenic purpura in Hodgkin's disease after splenectomy. ( Julia, A; Miller, SP, 1976) |
| "Forty-five children with advanced Hodgkin's disease (stages III and IV) received combination chemotherapy in three schedules: MOPP (mustargen, Oncovin, procarbazine, prednisolone); COPP (cyclophosphamide was substituted for mustargen); and CVPP (cyclophosphamide, vinblastine, procarbazine, prednisone)." | 1.26 | Combination chemotherapy of Hodgkin's disease in children. ( Kolygin, BA, 1976) |
| "A case of nodular sclerosis Hodgkin's disease, stage IVB, with lung involvement and hypertrophic pulmonary osteoarthropathy (HPOA), was treated with quadruple cytotoxic chemotherapy." | 1.26 | Hypertrophic pulmonary osteoarthropathy in Hodgkin's disease: reversal with chemotherapy. ( Atkinson, MK; McElwain, TJ; Peckham, MJ; Thomas, PP, 1976) |
| "In patients with Hodgkin's disease the excretion of pyrimidine deoxyribonucleosides in urine was followed up within the course of 92 chemotherapeutical series with cytostatics of COOP group." | 1.26 | Deoxypyrimidineuria in the course of chemotherapy in M. Hodgkin. ( Bechynĕ, M; Buric, L; Dientsbier, Z; Foltýnová, V; Kovaríková, H; Mostecký, H, 1976) |
| "Twenty-five cases of hodgkin's Disease (15 males and 10 females) aged 5 to 17 years were studied from April 1970 to July 1976 (75 month period)." | 1.26 | Staging laparotomy and splenectomy: treatment and complications of Hodgkin's disease in children. ( Aral, I; Karayalcin, G; Lanzkowsky, P; Shende, A, 1976) |
| "A 27 year old man with Hodgkin's disease experienced three separate episodes of chest pain, each occurring on the sixth day of a cycle of mustargen, oncovin, procarbazine, prednisone (MOPP) combination chermotherapy." | 1.26 | Unusual cardiac reaction to chemotherapy following mediastinal irradiation in a patient with Hodgkin's disease. ( Greenwald, ES; Grossman, J; Weinstein, P, 1976) |
| "Treatment of advanced Hodgkin's disease by associating vincristine, adriblastine, prednisone and procarbazine is compared with other widely employed protocols." | 1.25 | [Current problems in therapy of evolutive malignant granuloma. Our experience with a new scheme of polychemotherapy]. ( Buttolo, Q; Colle, R; Maiolini, E; Marinone, G; Mauro, PL, 1975) |
| "Progress in the chemotherapy of Hodgkin's disease and experimental therapeutic, pharmacologic, and clinical studies of the antitumor antibiotic, adriamycin, are presented in this abstract." | 1.25 | Progress in the chemotherapy of hematologic diseases. ( Frei, E, 1975) |
| "A study of 17 children suffering from Hodgkin's disease (H." | 1.25 | Childhood Hodgkin's disease in Israel. A study of 17 cases. ( Aghai, E; Brenner, H; Ramot, B, 1975) |
| "45%, respectively, in Hodgkin's disease, and 85% vs." | 1.25 | Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients. ( Barros, CA; Morgenfeld, MC; Palau, M; Pavlovsky, A; Pavlovsky, S; Somoza, N; Suarez, A, 1975) |
| "Thirteen patients with Wegener's granulomatosis have been treated with cytotoxic agents." | 1.25 | Treatment of Wegener's granulomatosis of lung. ( Isreal, HL; Patchfsky, AS, 1975) |
| "The accepted management of Hodgkin's disease has changed markedly in the past two decades." | 1.25 | Current management of Hodgkin's disease. ( Arrowsmith, WR, 1975) |
| "The results of modern radiotherapy for Hodgkin's disease are correlated to the stage of the disease." | 1.25 | Combination chemotherapy in Hodgkin's disease: relation to radiotherapy. ( Rosenberg, SA, 1975) |
| " Methodology and dosage schemes are discussed." | 1.25 | Towards curative treatment of advanced Hodgkin's disease. ( Falkson, G; Falkson, HC, 1975) |
| "At autopsy, generalized Hodgkin's disease of mixed cellularity was found." | 1.25 | Autoimmune hemolytic anemia terminating seven years later in Hodgkin's disease. ( Bastarache, A; Cazenave, JP; Gagnon, JA; Girouard, E, 1973) |
| "Nineteen cases of malignant lymphomata were selected for study from a group of about 1500 collected cases of malignant lymphomata because they showed histological evidence of non-infectious epithelioid-cell granulomata in one or more tissues." | 1.25 | Sarcoid reactions and sarcoidosis in Hodgkin's disease and other malignant lymphomata. ( Brincker, H, 1972) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 885 (49.41) | 18.7374 |
| 1990's | 369 (20.60) | 18.2507 |
| 2000's | 269 (15.02) | 29.6817 |
| 2010's | 225 (12.56) | 24.3611 |
| 2020's | 43 (2.40) | 2.80 |
| Authors | Studies |
|---|---|
| Chieng, H | 1 |
| Hafner, JP | 1 |
| Mccarthy, L | 1 |
| Ibrahim, A | 1 |
| Itty, R | 1 |
| Chong, WH | 1 |
| Saha, B | 1 |
| Conuel, E | 1 |
| Parikh, RR | 1 |
| Kelly, KM | 10 |
| Hodgson, DC | 6 |
| Hoppe, BS | 3 |
| McCarten, KM | 6 |
| Karolczuk, K | 1 |
| Pei, Q | 7 |
| Wu, Y | 4 |
| Cho, SY | 2 |
| Schwartz, C | 3 |
| Cole, PD | 2 |
| Roberts, K | 1 |
| Gundogan, BD | 1 |
| Taskinlar, S | 1 |
| Arikoglu, T | 1 |
| Balci, Y | 1 |
| Citak, EC | 1 |
| Parekh, A | 1 |
| Keller, FG | 2 |
| Kessel, S | 2 |
| Cho, S | 2 |
| Castellino, SM | 2 |
| Constine, LS | 9 |
| Schwartz, CL | 9 |
| Hodgson, D | 2 |
| Wen, Q | 1 |
| Ge, J | 1 |
| Lei, Y | 1 |
| Zhang, Y | 2 |
| Kong, X | 1 |
| Wang, W | 4 |
| Hou, H | 1 |
| Wang, Z | 1 |
| Qian, S | 1 |
| Ding, M | 1 |
| Dong, M | 2 |
| Zhu, L | 2 |
| Zhang, M | 2 |
| Zhang, X | 1 |
| Chen, Q | 1 |
| Zhou, Y | 1 |
| Ma, B | 1 |
| Li, T | 1 |
| Gao, Q | 1 |
| Zhao, L | 1 |
| LaCasce, AS | 3 |
| Dockter, T | 1 |
| Ruppert, AS | 1 |
| Kostakoglu, L | 5 |
| Schöder, H | 5 |
| Hsi, E | 1 |
| Bogart, J | 1 |
| Cheson, B | 1 |
| Wagner-Johnston, N | 2 |
| Abramson, J | 1 |
| Blum, K | 1 |
| Leonard, JP | 5 |
| Bartlett, NL | 15 |
| Parsons, SK | 2 |
| McCarten, K | 3 |
| Horton, T | 1 |
| Punnett, A | 2 |
| Dave, H | 1 |
| Henderson, TO | 2 |
| Charpentier, AM | 2 |
| Bröckelmann, PJ | 6 |
| Bühnen, I | 4 |
| Meissner, J | 5 |
| Trautmann-Grill, K | 2 |
| Herhaus, P | 2 |
| Halbsguth, TV | 3 |
| Schaub, V | 2 |
| Kerkhoff, A | 2 |
| Mathas, S | 2 |
| Bormann, M | 2 |
| Dickhut, A | 2 |
| Kaul, H | 3 |
| Fuchs, M | 23 |
| Kobe, C | 13 |
| Baues, C | 10 |
| Borchmann, P | 32 |
| Engert, A | 65 |
| von Tresckow, B | 15 |
| Dourthe, ME | 1 |
| Simonin, M | 1 |
| Rigaud, C | 1 |
| Haouy, S | 1 |
| Montravers, F | 2 |
| Ducou Le Pointe, H | 1 |
| Garnier, N | 1 |
| Minard-Colin, V | 1 |
| Jo Molina, T | 1 |
| Boudjemaa, S | 1 |
| Leblanc, T | 2 |
| Landman-Parker, J | 2 |
| Entrop, JP | 1 |
| Weibull, CE | 1 |
| Smedby, KE | 1 |
| Jakobsen, LH | 1 |
| Øvlisen, AK | 1 |
| Molin, D | 3 |
| Glimelius, I | 1 |
| Marklund, A | 1 |
| Holte, H | 4 |
| Fosså, A | 4 |
| Smeland, KB | 1 |
| El-Galaly, TC | 1 |
| Eloranta, S | 1 |
| Suwanban, T | 1 |
| Chamnanchanunt, S | 1 |
| Thungthong, P | 1 |
| Nakhahes, C | 1 |
| Iam-Arunthai, K | 1 |
| Akrawikrai, T | 1 |
| Bunworasate, U | 1 |
| Eichenauer, DA | 10 |
| Greil, R | 9 |
| Moccia, A | 1 |
| Zijlstra, JM | 6 |
| Hertenstein, B | 3 |
| Topp, MS | 5 |
| Just, M | 1 |
| Eich, HT | 19 |
| Dietlein, M | 11 |
| Hartmann, S | 2 |
| Wilson, MR | 1 |
| Haynes, E | 1 |
| Parsons, K | 1 |
| Hopkins, D | 1 |
| Robertson, E | 1 |
| Ferguson, G | 1 |
| Quinn, D | 1 |
| Murray, J | 1 |
| Osborne, W | 1 |
| Leach, M | 1 |
| McKay, P | 1 |
| Rossi, C | 1 |
| Casasnovas, O | 10 |
| Geel, J | 1 |
| van Zyl, A | 1 |
| Plessis, JD | 1 |
| Hendricks, M | 1 |
| Goga, Y | 1 |
| Carr, A | 1 |
| Neethling, B | 1 |
| Hramyka, A | 1 |
| Omar, F | 1 |
| Mathew, R | 1 |
| Louw, L | 1 |
| Naidoo, T | 1 |
| Ngcana, T | 1 |
| Schickerling, T | 1 |
| Netshituni, V | 1 |
| Madzhia, E | 1 |
| du Plessis, L | 1 |
| Kelsey, T | 1 |
| Ballot, DE | 1 |
| Metzger, ML | 5 |
| Mehreen, A | 1 |
| Wali, RM | 1 |
| Sindhu, II | 1 |
| Asad, M | 1 |
| Ria, S | 1 |
| O'Bryen, J | 1 |
| Anderson, NR | 1 |
| Collins, J | 1 |
| Farrugia, MK | 1 |
| Vargo, JA | 1 |
| Vijenthira, A | 1 |
| Chan, K | 1 |
| Cheung, MC | 2 |
| Prica, A | 1 |
| Sugiyama, M | 1 |
| Terashita, Y | 1 |
| Cho, Y | 1 |
| Iguchi, A | 1 |
| Arai, R | 1 |
| Takakuwa, E | 1 |
| Honda, S | 1 |
| Manabe, A | 1 |
| Reid, JH | 1 |
| Marini, BL | 1 |
| Nachar, VR | 1 |
| Brown, AM | 1 |
| Devata, S | 1 |
| Perissinotti, AJ | 1 |
| Zawati, I | 1 |
| Adouni, O | 1 |
| Finetti, P | 1 |
| Manai, M | 2 |
| Gamoudi, A | 1 |
| Birnbaum, D | 1 |
| Bertucci, F | 1 |
| Mezlini, A | 3 |
| O'Kelly, B | 1 |
| McGettrick, P | 1 |
| Angelov, D | 1 |
| Fay, M | 1 |
| McGinty, T | 1 |
| Cotter, AG | 1 |
| Sheehan, G | 1 |
| Lambert, JS | 1 |
| Mondello, P | 1 |
| Musolino, C | 1 |
| Dogliotti, I | 1 |
| Bohn, JP | 1 |
| Cavallo, F | 1 |
| Ferrero, S | 1 |
| Botto, B | 2 |
| Cerchione, C | 2 |
| Nappi, D | 1 |
| De Lorenzo, S | 1 |
| Martinelli, G | 1 |
| Wolf, D | 1 |
| Schmitt, C | 1 |
| Loseto, G | 1 |
| Cuzzocrea, S | 1 |
| Willenbacher, W | 2 |
| Mian, M | 2 |
| Straus, DJ | 16 |
| Weil, CR | 1 |
| Qian, Y | 1 |
| Von Eyben, R | 1 |
| Daadi, SE | 2 |
| Corbelli, KS | 1 |
| Rosenberg, SA | 30 |
| Advani, RH | 8 |
| Hoppe, RT | 22 |
| Charakopoulos, E | 1 |
| Spyrou, I | 1 |
| Viniou, NA | 1 |
| Giannakopoulou, N | 1 |
| Hatzidavid, S | 1 |
| Diamantopoulos, PT | 1 |
| Subtil, A | 1 |
| Gru, AA | 1 |
| Kumar, R | 1 |
| Hujairi, N | 1 |
| Mohammed, K | 1 |
| Attygalle, A | 1 |
| Alexander, E | 1 |
| Chau, I | 1 |
| Cunningham, D | 3 |
| Iyengar, S | 1 |
| El-Sharkawi, D | 1 |
| Sharma, B | 1 |
| André, MPE | 2 |
| Carde, P | 19 |
| Viviani, S | 24 |
| Bellei, M | 5 |
| Fortpied, C | 4 |
| Hutchings, M | 4 |
| Gianni, AM | 8 |
| Brice, P | 17 |
| Gobbi, PG | 11 |
| Zinzani, PL | 7 |
| Dupuis, J | 1 |
| Iannitto, E | 7 |
| Rambaldi, A | 4 |
| Brière, J | 8 |
| Clément-Filliatre, L | 1 |
| Heczko, M | 2 |
| Valagussa, P | 23 |
| Douxfils, J | 1 |
| Depaus, J | 1 |
| Federico, M | 16 |
| Mounier, N | 5 |
| Wang, J | 1 |
| Zhang, R | 1 |
| Amin, MSA | 1 |
| Brunckhorst, O | 1 |
| Scott, C | 1 |
| Wrench, D | 1 |
| Gleeson, M | 1 |
| Kazmi, M | 1 |
| Ahmed, K | 1 |
| Müller, H | 3 |
| Guhl, T | 1 |
| Behringer, K | 9 |
| Moccia, AA | 1 |
| Rank, A | 4 |
| Soekler, M | 5 |
| Vieler, T | 3 |
| Pabst, T | 5 |
| Kusumoto, S | 1 |
| Dang, T | 1 |
| Macwan, S | 1 |
| Dasanu, CA | 1 |
| Berjeb, KK | 1 |
| Debbabi, L | 1 |
| Braham, M | 1 |
| Zemni, Z | 1 |
| Chtourou, S | 1 |
| Hannachi, H | 1 |
| Hamdoun, M | 1 |
| Ayadi, M | 1 |
| Kacem, K | 1 |
| Zhioua, F | 1 |
| Fadhlaoui, A | 1 |
| Bahri, O | 1 |
| Chakroun, N | 1 |
| Frias, S | 3 |
| Van Hummelen, P | 2 |
| Meistrich, ML | 8 |
| Wyrobek, AJ | 3 |
| Giulino-Roth, L | 1 |
| Buxton, A | 2 |
| Bush, R | 4 |
| Wolden, SL | 5 |
| Friedman, DL | 8 |
| Russell, J | 1 |
| Collins, A | 1 |
| Fowler, A | 1 |
| Karanth, M | 1 |
| Saha, C | 1 |
| Docherty, S | 1 |
| Padayatty, J | 1 |
| Maw, K | 1 |
| Lentell, I | 1 |
| Cooke, L | 1 |
| Hodson, A | 1 |
| Shah, N | 1 |
| Sadullah, S | 1 |
| Grigoropoulos, N | 1 |
| Qian, W | 1 |
| Kirkwood, AA | 1 |
| Uttenthal, BJ | 1 |
| Johnson, P | 1 |
| Follows, GA | 1 |
| Kreissl, S | 4 |
| van Heek, L | 1 |
| Goergen, H | 8 |
| Novosad, O | 1 |
| Skrypets, T | 1 |
| Pastushenko, I | 1 |
| Kadnikova, T | 1 |
| Gorbach, O | 1 |
| Kozlov, V | 1 |
| Mykhalska, L | 1 |
| Kosinova, V | 1 |
| Kostiukova, N | 1 |
| Karnabeda, O | 1 |
| Stratienko, V | 1 |
| Novikov, M | 1 |
| Oliinichenko, O | 1 |
| Kmetyuk, I | 1 |
| Karpova, O | 1 |
| Ashykhmin, A | 1 |
| Lukjanec, O | 1 |
| Kriachok, I | 1 |
| Esper, A | 1 |
| Alhoulaiby, S | 1 |
| Zuhri Yafi, R | 1 |
| Alshehabi, Z | 1 |
| Kokoska, RE | 1 |
| Beltz, EE | 1 |
| Smith, JL | 1 |
| Razzouk, BI | 1 |
| Jachimowicz, RD | 1 |
| Klapper, W | 2 |
| Glehr, G | 1 |
| Haverkamp, H | 11 |
| Thorns, C | 1 |
| Hansmann, ML | 3 |
| Möller, P | 2 |
| Stein, H | 7 |
| Rehberg, T | 1 |
| Reinhardt, HC | 1 |
| Chan, FC | 1 |
| Spang, R | 1 |
| Scott, DW | 1 |
| Steidl, C | 1 |
| Altenbuchinger, M | 1 |
| Rosenwald, A | 1 |
| Yan, J | 1 |
| Cui, F | 1 |
| Zhao, S | 1 |
| Sasse, S | 8 |
| Plütschow, A | 5 |
| Buerkle, C | 1 |
| Borchmann, S | 2 |
| Diehl, V | 73 |
| Fanale, MA | 2 |
| Cheah, CY | 1 |
| Rich, A | 1 |
| Medeiros, LJ | 2 |
| Lai, CM | 1 |
| Oki, Y | 1 |
| Romaguera, JE | 4 |
| Fayad, LE | 1 |
| Hagemeister, FB | 28 |
| Samaniego, F | 1 |
| Rodriguez, MA | 7 |
| Neelapu, SS | 1 |
| Lee, HJ | 1 |
| Nastoupil, L | 1 |
| Fowler, NH | 1 |
| Turturro, F | 1 |
| Westin, JR | 1 |
| Wang, ML | 1 |
| McLaughlin, P | 13 |
| Pinnix, CC | 1 |
| Milgrom, SA | 1 |
| Dabaja, B | 1 |
| Horowitz, SB | 1 |
| Younes, A | 3 |
| Skoetz, N | 6 |
| Will, A | 2 |
| Monsef, I | 5 |
| Brillant, C | 5 |
| Dann, EJ | 5 |
| Bairey, O | 2 |
| Bar-Shalom, R | 3 |
| Mashiach, T | 1 |
| Barzilai, E | 1 |
| Kornberg, A | 1 |
| Akria, L | 1 |
| Tadmor, T | 1 |
| Filanovsky, K | 1 |
| Abadi, U | 1 |
| Kagna, O | 1 |
| Ruchlemer, R | 1 |
| Abdah-Bortnyak, R | 1 |
| Goldschmidt, N | 1 |
| Epelbaum, R | 5 |
| Horowitz, NA | 1 |
| Lavie, D | 1 |
| Ben-Yehuda, D | 1 |
| Shpilberg, O | 2 |
| Paltiel, O | 1 |
| Fermé, C | 13 |
| Thomas, J | 13 |
| Vranovsky, A | 2 |
| Bologna, S | 3 |
| Lugtenburg, PJ | 6 |
| Bouabdallah, R | 3 |
| Sebban, C | 3 |
| Eghbali, H | 13 |
| Salles, G | 4 |
| van Imhoff, GW | 1 |
| Thyss, A | 1 |
| Noordijk, EM | 10 |
| Reman, O | 4 |
| Lybeert, MLM | 2 |
| Janvier, M | 1 |
| Spina, M | 5 |
| Audhuy, B | 1 |
| Raemaekers, JMM | 1 |
| Delarue, R | 2 |
| Anglaret, B | 1 |
| de Weerdt, O | 1 |
| Marjanovic, Z | 1 |
| Tersteeg, RJHA | 1 |
| de Jong, D | 4 |
| Henry-Amar, M | 15 |
| van Eggermond, AM | 1 |
| Schaapveld, M | 1 |
| Janus, CP | 1 |
| de Boer, JP | 1 |
| Krol, AD | 2 |
| van der Maazen, RW | 4 |
| Kremer, LC | 1 |
| van Leerdam, ME | 1 |
| Louwman, MW | 1 |
| Visser, O | 1 |
| De Bruin, ML | 3 |
| Aleman, BM | 7 |
| van Leeuwen, FE | 3 |
| Zheng, SM | 1 |
| Zhou, DJ | 1 |
| Chen, YH | 2 |
| Jiang, R | 1 |
| Wang, YX | 1 |
| Xue, HL | 1 |
| Wang, HQ | 1 |
| Mou, D | 1 |
| Zeng, WZ | 1 |
| Wroblewski, KE | 1 |
| Chen, L | 4 |
| Hong, F | 8 |
| Smith, SM | 3 |
| McNeer, JL | 1 |
| Gascoyne, RD | 9 |
| Horning, S | 1 |
| Shah, B | 1 |
| Connors, JM | 19 |
| Leonard, JI | 1 |
| Kahl, BS | 10 |
| Li, H | 6 |
| Friedberg, JW | 9 |
| Gordon, LI | 7 |
| Evens, AM | 6 |
| Haefliger, S | 1 |
| Bihl, M | 1 |
| Krasniqi, F | 2 |
| Tzankov, A | 1 |
| Lohri, A | 8 |
| Markova, J | 10 |
| Feuring-Buske, M | 1 |
| Hüttmann, A | 1 |
| Dierlamm, J | 1 |
| Beck, HJ | 1 |
| Ludwig, WD | 4 |
| Hitz, F | 1 |
| Bentz, M | 2 |
| Keller, UB | 1 |
| Kühnhardt, D | 1 |
| Ostermann, H | 1 |
| Schmitz, N | 8 |
| Aulitzky, W | 2 |
| Maschmeyer, G | 2 |
| Eich, H | 2 |
| Kuhnert, G | 4 |
| Basic-Kinda, S | 1 |
| Karlak, I | 1 |
| Durakovic, N | 1 |
| Lubina, ZI | 1 |
| Livaja Radman, I | 1 |
| Dotlic, S | 1 |
| Peric, Z | 1 |
| Hude, I | 1 |
| Aurer, I | 3 |
| Morschhauser, F | 4 |
| Girinsky, T | 8 |
| Gaillard, I | 3 |
| André, M | 4 |
| Stamatoullas, A | 4 |
| Beijert, M | 1 |
| Hélias, P | 1 |
| Gabarre, J | 10 |
| van der Maazen, RWM | 1 |
| Jaubert, J | 3 |
| Bouabdallah, K | 1 |
| Boulat, O | 1 |
| Roesink, JM | 1 |
| Christian, B | 1 |
| Ong, F | 1 |
| Bordessoule, D | 3 |
| Tertian, G | 1 |
| Gonzalez, H | 1 |
| Quittet, P | 2 |
| Tirelli, U | 12 |
| Audouin, J | 1 |
| Aleman, BMP | 1 |
| Gallamini, A | 5 |
| Tarella, C | 1 |
| Rossi, A | 3 |
| Patti, C | 4 |
| Mulé, A | 3 |
| Picardi, M | 3 |
| Romano, A | 2 |
| Cantonetti, M | 4 |
| La Nasa, G | 1 |
| Trentin, L | 1 |
| Bolis, S | 1 |
| Rapezzi, D | 1 |
| Battistini, R | 1 |
| Gottardi, D | 1 |
| Gavarotti, P | 2 |
| Corradini, P | 1 |
| Cimminiello, M | 1 |
| Schiavotto, C | 1 |
| Parvis, G | 1 |
| Zanotti, R | 2 |
| Gini, G | 1 |
| Ferreri, AJM | 1 |
| Viero, P | 1 |
| Miglino, M | 1 |
| Billio, A | 1 |
| Avigdor, A | 4 |
| Biggi, A | 2 |
| Fallanca, F | 2 |
| Ficola, U | 2 |
| Gregianin, M | 1 |
| Chiaravalloti, A | 1 |
| Prosperini, G | 1 |
| Bergesio, F | 1 |
| Chauvie, S | 2 |
| Pavoni, C | 1 |
| Parrinello, NL | 1 |
| Vetro, C | 1 |
| Chiarenza, A | 1 |
| Ippolito, M | 1 |
| Palumbo, GA | 1 |
| Di Raimondo, F | 2 |
| Ben Lakhal, R | 2 |
| Hdiji, S | 1 |
| Zriba, S | 1 |
| Mokrani, A | 1 |
| Laatiri, MA | 1 |
| BenYoussef, Y | 1 |
| Ezzaier, F | 1 |
| Toumi, N | 1 |
| Ladeb, S | 1 |
| BenSalah, H | 1 |
| Tebra, S | 1 |
| Frikha, H | 1 |
| Messai, T | 1 |
| Daoued, J | 1 |
| Bouaouina, N | 3 |
| Maalej, M | 3 |
| Frikha, M | 1 |
| BenOthmen, T | 1 |
| BenAhmed, S | 1 |
| Khelif, A | 1 |
| Msaddek, F | 1 |
| Elloumi, M | 1 |
| Meddeb, B | 2 |
| Parzuchowski, A | 1 |
| FitzGerald, TJ | 4 |
| Dharmarajan, KV | 3 |
| Laurie, F | 2 |
| Kessel, SK | 3 |
| Appel, B | 1 |
| Fernandez, K | 1 |
| Cox, J | 1 |
| Terezakis, SA | 1 |
| Albano, D | 2 |
| Midiri, M | 2 |
| Galia, M | 2 |
| Böll, B | 5 |
| Neubauer, A | 1 |
| Jung, SH | 1 |
| Pitcher, B | 1 |
| Grecula, JC | 1 |
| Hsi, ED | 3 |
| Popplewell, LL | 1 |
| Chang, JE | 1 |
| Moskowitz, CH | 3 |
| Cheson, BD | 11 |
| Marks, LJ | 1 |
| Voltin, CA | 1 |
| Zijlstra, J | 3 |
| Hoekstra, O | 1 |
| Mettler, J | 1 |
| Drzezga, A | 2 |
| Fridrik, M | 1 |
| Rummel, M | 2 |
| Jung, W | 1 |
| Thiemer, J | 1 |
| Bürkle, C | 1 |
| Turan Erkek, E | 1 |
| Karaali, CN | 1 |
| Yılmaz, G | 1 |
| Gültürk, E | 1 |
| Garcia-Sanz, R | 3 |
| Sureda, A | 3 |
| de la Cruz, F | 1 |
| Canales, M | 1 |
| Gonzalez, AP | 1 |
| Pinana, JL | 1 |
| Rodriguez, A | 2 |
| Gutierrez, A | 1 |
| Domingo-Domenech, E | 2 |
| Sanchez-Gonzalez, B | 1 |
| Rodriguez, G | 1 |
| Lopez, J | 1 |
| Moreno, M | 1 |
| Rodriguez-Salazar, MJ | 1 |
| Jimenez-Cabrera, S | 1 |
| Caballero, MD | 1 |
| Martinez, C | 3 |
| Gourd, E | 1 |
| Długosz-Danecka, M | 1 |
| Szmit, S | 1 |
| Kocurek, A | 1 |
| Koźlik, P | 1 |
| Giza, A | 2 |
| Zimowska-Curyło, D | 1 |
| Małkowski, B | 2 |
| Sowa-Staszczak, A | 1 |
| Kużdżał, J | 1 |
| Jurczak, W | 2 |
| Cho, KK | 1 |
| Lyes, SM | 1 |
| Shetty, A | 1 |
| Roberts, KB | 3 |
| Abbassi, LM | 1 |
| Goudjil, F | 1 |
| Arsène-Henry, A | 1 |
| Dendale, R | 1 |
| Kirova, YM | 2 |
| Stephens, DM | 1 |
| LeBlanc, M | 2 |
| Rimsza, LM | 2 |
| Barr, PM | 2 |
| Knopp, MV | 2 |
| Xiao, Y | 1 |
| Zhu, F | 1 |
| Liu, T | 1 |
| Li, Q | 1 |
| Li, X | 2 |
| Wu, G | 2 |
| Li, J | 1 |
| Zhang, L | 2 |
| Pizarro, A | 1 |
| García, H | 3 |
| Riquelme, A | 1 |
| Carmona, J | 1 |
| Cortés, C | 1 |
| Dörffel, W | 4 |
| Rühl, U | 9 |
| Lüders, H | 1 |
| Claviez, A | 1 |
| Albrecht, M | 1 |
| Bökkerink, J | 1 |
| Karlen, J | 3 |
| Mann, G | 4 |
| Marciniak, H | 1 |
| Niggli, F | 1 |
| Schmiegelow, K | 1 |
| Schwarze, EW | 6 |
| Pötter, R | 6 |
| Wickmann, L | 1 |
| Schellong, G | 15 |
| Datsenko, PV | 7 |
| Pan'shin, GA | 7 |
| Sotnikov, VM | 7 |
| Ivashin, AV | 4 |
| Evstikheev, ÉV | 3 |
| Golub, SV | 3 |
| Gombolevskiĭ, VA | 3 |
| Merli, M | 1 |
| Maffioli, M | 1 |
| Ferrario, A | 1 |
| Passamonti, F | 1 |
| Li, WS | 1 |
| Xie, JL | 1 |
| Zhou, XG | 1 |
| Wu, B | 1 |
| Chen, P | 1 |
| Li, F | 1 |
| Zou, S | 1 |
| Cheng, Y | 1 |
| Wongso, D | 1 |
| Klimm, B | 7 |
| Dührsen, U | 1 |
| Lindemann, W | 1 |
| Filatova, LV | 5 |
| Plotnikova, AA | 1 |
| Gershanovich, ML | 7 |
| Semiglazova, TIu | 2 |
| Rancea, M | 3 |
| Trelle, S | 1 |
| Cao, H | 1 |
| Yamamoto, K | 1 |
| Yang, LX | 1 |
| Weber, R | 1 |
| Sánchez, M | 1 |
| Enríquez, R | 2 |
| Sirvent, AE | 1 |
| Heredia, L | 1 |
| Millán, I | 1 |
| Amorós, F | 1 |
| Cella, L | 1 |
| Liuzzi, R | 1 |
| D'Avino, V | 1 |
| Conson, M | 1 |
| Di Biase, A | 1 |
| Pugliese, N | 1 |
| Solla, R | 1 |
| Salvatore, M | 1 |
| Pacelli, R | 1 |
| Naidu, A | 1 |
| Kessler, HP | 1 |
| Pavelka, MA | 1 |
| Ansell, SM | 3 |
| Danielewicz, I | 1 |
| Zaucha, R | 1 |
| Zalewska, M | 1 |
| Leśniewski-Kmak, K | 1 |
| Zaucha, JM | 1 |
| Castellanos, EM | 1 |
| Barrantes, JC | 2 |
| Báez, LF | 1 |
| Gamboa, Y | 1 |
| Peña, A | 1 |
| Alabi, S | 1 |
| Bonilla, M | 1 |
| Wang, H | 2 |
| de Alarcón, PA | 2 |
| Canellos, GP | 27 |
| Lister, TA | 5 |
| Devita, VT | 40 |
| Thielen, I | 3 |
| Franklin, J | 17 |
| Halbsguth, T | 5 |
| Rothe, A | 1 |
| Schoeffler, A | 1 |
| Levy, E | 1 |
| Weinborn, M | 1 |
| Cuny, JF | 1 |
| Schmutz, JL | 1 |
| Barbaud, A | 1 |
| Cribier, B | 1 |
| Bursztejn, AC | 1 |
| Michaelson, EM | 1 |
| Silver, B | 4 |
| Tishler, RB | 1 |
| Marcus, KJ | 2 |
| Stevenson, MA | 2 |
| Ng, AK | 2 |
| MARTINEZDIAZ, J | 1 |
| Patel, RV | 1 |
| Sutton, PA | 1 |
| Colliver, D | 1 |
| Stewart, R | 1 |
| Habermann, TM | 5 |
| Hochster, H | 1 |
| Morrison, VA | 1 |
| Fisher, RI | 11 |
| Stiff, PJ | 5 |
| Crump, M | 4 |
| Horning, SJ | 18 |
| Kato, K | 1 |
| Raemaekers, JM | 6 |
| André, MP | 1 |
| Oumedaly, R | 1 |
| Brusamolino, E | 7 |
| van der Maazen, R | 2 |
| Gotti, M | 3 |
| Sebban, CJ | 1 |
| Lievens, Y | 3 |
| Re, A | 2 |
| Abruzzese, E | 1 |
| Olivier, P | 1 |
| Casasnovas, RO | 1 |
| van Imhoff, G | 2 |
| Raveloarivahy, T | 2 |
| van der Borght, T | 1 |
| Bardet, S | 1 |
| Versari, A | 2 |
| Meignan, M | 2 |
| Camellino, D | 1 |
| Morbelli, S | 1 |
| Paparo, F | 1 |
| Massollo, M | 1 |
| Sambuceti, G | 1 |
| Cimmino, MA | 1 |
| Papadopoulou, A | 1 |
| Krance, RA | 1 |
| Allen, CE | 1 |
| Lee, D | 1 |
| Rooney, CM | 1 |
| Brenner, MK | 1 |
| Leen, AM | 1 |
| Heslop, HE | 1 |
| Hallén, K | 1 |
| Sangfelt, P | 1 |
| Nilsson, T | 1 |
| Nordgren, H | 1 |
| Wanders, A | 1 |
| Tao, YX | 1 |
| Sun, SY | 1 |
| Kang, SY | 1 |
| Zhou, LQ | 5 |
| Shi, YK | 3 |
| Li, YX | 2 |
| Sun, Y | 1 |
| Shankar, A | 2 |
| Hayward, J | 1 |
| Kirkwood, A | 1 |
| McCarthy, K | 2 |
| Hewitt, M | 3 |
| Morland, B | 1 |
| Daw, S | 2 |
| Kahraman, D | 2 |
| Franke, M | 1 |
| Persigehl, T | 1 |
| Klutmann, S | 3 |
| Amthauer, H | 4 |
| Bockisch, A | 3 |
| Kluge, R | 4 |
| Wolf, HH | 1 |
| Maintz, D | 1 |
| Kurz, M | 1 |
| Stoeckle, M | 1 |
| Battegay, M | 2 |
| Marzolini, C | 1 |
| Colin, P | 2 |
| Delmer, A | 1 |
| Devidas, A | 1 |
| Bachy, E | 1 |
| Nicolas-Virelizier, E | 1 |
| Aoudjhane, A | 1 |
| Humbrecht, C | 1 |
| Khuroo, MS | 1 |
| Wang, L | 1 |
| Guo, Y | 1 |
| Zhu, X | 1 |
| Bujan, L | 1 |
| Walschaerts, M | 1 |
| Brugnon, F | 1 |
| Daudin, M | 1 |
| Berthaut, I | 1 |
| Auger, J | 2 |
| Saias, J | 1 |
| Szerman, E | 1 |
| Moinard, N | 1 |
| Rives, N | 1 |
| Hennebicq, S | 1 |
| Rota Scalabrini, D | 2 |
| Caravelli, D | 1 |
| Carnevale Schianca, F | 1 |
| D'Ambrosio, L | 1 |
| Tolomeo, F | 1 |
| Boccone, P | 1 |
| Manca, A | 1 |
| De Rosa, G | 1 |
| Nuzzo, A | 1 |
| Aglietta, M | 2 |
| Grignani, G | 2 |
| Englund, A | 1 |
| Hopstadius, C | 1 |
| Enblad, G | 4 |
| Gustafsson, G | 1 |
| Ljungman, G | 1 |
| Mauz-Körholz, C | 4 |
| Hasenclever, D | 20 |
| Holzendorf, V | 1 |
| Bernstädt, M | 1 |
| Jürgens, H | 2 |
| Burdach, S | 1 |
| Eggert, A | 1 |
| Berthold, F | 1 |
| Müller, HL | 1 |
| Frühwald, MC | 1 |
| Klingebiel, T | 1 |
| Metzler, M | 1 |
| Körholz, D | 5 |
| Maruyama, D | 1 |
| Nagai, H | 1 |
| Wolden, S | 2 |
| Chen, AR | 1 |
| Kobrinsky, N | 1 |
| Ehrlich, P | 1 |
| Hutchison, RE | 1 |
| Belada, D | 1 |
| Štěpánková, P | 1 |
| Sýkorová, A | 1 |
| Žák, P | 1 |
| Smolej, L | 1 |
| Iandoli, M | 2 |
| Deau, B | 1 |
| Franchi, P | 1 |
| Ohnona, J | 1 |
| Tamburini, J | 1 |
| Thieblemont, C | 1 |
| Fizesan, M | 1 |
| Boin, C | 1 |
| Aujoulat, O | 1 |
| Newinger, G | 1 |
| Ghergus, D | 1 |
| Watier, H | 1 |
| Lustig, H | 1 |
| Ojeda-Uribe, M | 1 |
| Ganesan, P | 1 |
| Rajendranath, R | 1 |
| Kannan, K | 1 |
| Radhakrishnan, V | 1 |
| Ganesan, TS | 2 |
| Udupa, K | 1 |
| Lakshmipathy, KM | 1 |
| Mahajan, V | 1 |
| Sundersingh, S | 1 |
| Rajaraman, S | 1 |
| Krishnakumar, R | 1 |
| Sagar, TG | 3 |
| Pielaciński, K | 1 |
| Lech-Marańda, E | 1 |
| Warzocha, K | 2 |
| Dedecjus, M | 1 |
| Prochorec-Sobieszek, M | 1 |
| Szczepanik, AB | 1 |
| Zietman, AL | 1 |
| Kriz, J | 2 |
| Reinartz, G | 1 |
| Haverkamp, U | 2 |
| Engenhart-Cabillic, R | 1 |
| Herfarth, K | 1 |
| Lukas, P | 1 |
| Schmidberger, H | 2 |
| Staar, S | 3 |
| Hegerfeld, K | 1 |
| Robinson, KS | 1 |
| Wagner, H | 4 |
| Stewart, DA | 2 |
| Blum, KA | 4 |
| Tuscano, JM | 3 |
| Panshin, GA | 1 |
| Kanakry, JA | 2 |
| Sehn, LH | 1 |
| Kritharis, A | 1 |
| Feldman, T | 2 |
| Kroll, A | 1 |
| Abramson, JS | 1 |
| Petrich, AM | 1 |
| Hernandez-Ilizaliturri, FJ | 1 |
| Al-Mansour, Z | 1 |
| Adeimy, C | 1 |
| Hemminger, J | 1 |
| Mato, A | 1 |
| Caimi, PF | 1 |
| Klein, AK | 1 |
| Nabhan, C | 1 |
| Fabregas, JC | 1 |
| Lossos, IS | 1 |
| Press, OW | 2 |
| Fenske, TS | 1 |
| Vose, JM | 1 |
| Meister, MT | 1 |
| Voss, S | 1 |
| Schwabe, D | 1 |
| Mashima, K | 1 |
| Suzuki, S | 1 |
| Mori, T | 2 |
| Shimizu, T | 1 |
| Yamada, S | 1 |
| Hirose, S | 1 |
| Okamoto, S | 1 |
| Suzuki, N | 1 |
| Liu, H | 1 |
| Xiong, W | 1 |
| Yi, S | 1 |
| Zou, D | 1 |
| Qiu, L | 1 |
| Diefenbach, CS | 1 |
| Gözdaşoğlu, S | 2 |
| Pamir, A | 1 |
| Ünal, E | 1 |
| Gökçora, İH | 1 |
| Uluoğlu, Ö | 2 |
| Ceyhan, K | 1 |
| Deda, H | 1 |
| Işıkman, E | 1 |
| Yavuz, G | 2 |
| Taçyıldız, N | 1 |
| Çavdar, A | 1 |
| Almagro-Casado, E | 1 |
| Sánchez, A | 1 |
| Cantos, B | 1 |
| Salas, C | 2 |
| Pérez-Callejo, D | 1 |
| Provencio, M | 1 |
| Kedmi, M | 1 |
| Apel, A | 1 |
| Davidson, T | 1 |
| Levi, I | 2 |
| Polliack, A | 2 |
| Ben-Bassat, I | 4 |
| Nagler, A | 4 |
| Motta, S | 1 |
| Sala, D | 1 |
| Sala, A | 2 |
| Cazzaniga, G | 1 |
| Giudici, G | 1 |
| Villa, N | 1 |
| Biondi, A | 2 |
| Selicorni, A | 1 |
| Paoli, D | 1 |
| Rizzo, F | 1 |
| Fiore, G | 1 |
| Pallotti, F | 1 |
| Pulsoni, A | 4 |
| Annechini, G | 3 |
| Lombardo, F | 1 |
| Lenzi, A | 1 |
| Gandini, L | 1 |
| Merli, F | 8 |
| Luminari, S | 7 |
| Cascavilla, N | 1 |
| Mammi, C | 3 |
| Ilariucci, F | 1 |
| Stelitano, C | 8 |
| Musso, M | 1 |
| Baldini, L | 4 |
| Galimberti, S | 1 |
| Angrilli, F | 3 |
| Polimeno, G | 2 |
| Scalzulli, PR | 1 |
| Ferrari, A | 1 |
| Marcheselli, L | 4 |
| Avagyan, A | 1 |
| Danielyan, S | 1 |
| Voskanyan, A | 1 |
| Sargsyan, L | 1 |
| Hakobyan, L | 1 |
| Zohrabyan, D | 1 |
| Safaryan, L | 1 |
| Harutyunyan, L | 1 |
| Bardakchyan, S | 1 |
| Iskanyan, S | 1 |
| Arakelyan, S | 1 |
| Tamamyan, G | 1 |
| Chavdarova, L | 1 |
| Hoffmann, M | 1 |
| Malkowski, B | 1 |
| Kurch, L | 1 |
| Georgi, T | 1 |
| Wallace, WH | 2 |
| Fernández-Teijeiro, A | 1 |
| Cepelova, M | 1 |
| Wilson, L | 1 |
| Bergstraesser, E | 1 |
| Sabri, O | 1 |
| Mittra, ES | 1 |
| Sweetenham, JW | 1 |
| Noy, A | 1 |
| Cook, JR | 1 |
| Lechowicz, MJ | 1 |
| Roemer, MG | 1 |
| Ligon, AH | 1 |
| Natkunam, Y | 2 |
| Redd, RA | 1 |
| Homer, H | 1 |
| Connelly, CF | 1 |
| Sun, HH | 1 |
| Freeman, GJ | 1 |
| Armand, P | 1 |
| Chapuy, B | 1 |
| Neuberg, DS | 1 |
| Rodig, SJ | 1 |
| Shipp, MA | 1 |
| Karrasch, M | 1 |
| Khaled, H | 1 |
| Caillot, D | 2 |
| Coiffier, B | 6 |
| Meyer, R | 1 |
| Seftel, M | 1 |
| Wolf, M | 2 |
| Glimelius, B | 4 |
| Díaz-López, A | 1 |
| Rodriguez-Calvillo, M | 1 |
| Terol, MJ | 2 |
| Pérez-Ceballos, E | 1 |
| Jiménez, MJ | 1 |
| Cantalapiedra, A | 1 |
| Rodriguez, MJ | 1 |
| Sampol, A | 1 |
| Espeso, M | 1 |
| López, FJ | 1 |
| Briones, J | 2 |
| García, JF | 1 |
| Band, ME | 1 |
| Sheldon, C | 1 |
| Brancato, J | 1 |
| Parikh, NS | 1 |
| D'Alessandri-Silva, C | 1 |
| La Grutta, L | 1 |
| Grassedonio, E | 1 |
| Brancatelli, G | 1 |
| Lagalla, R | 1 |
| Jiang, Y | 1 |
| Chen, Y | 1 |
| Huang, R | 1 |
| Chen, G | 1 |
| Song, HN | 1 |
| Kim, SJ | 1 |
| Ko, YH | 1 |
| Kim, WS | 1 |
| Gill, B | 1 |
| Sykes, J | 1 |
| Albert-Green, A | 1 |
| Littooij, AS | 1 |
| Kwee, TC | 1 |
| Enríquez, G | 1 |
| Verbeke, JI | 1 |
| Granata, C | 1 |
| Beishuizen, A | 1 |
| de Lange, C | 1 |
| Zennaro, F | 1 |
| Bruin, MC | 1 |
| Nievelstein, RA | 1 |
| Johnson, PW | 2 |
| Conway, JL | 1 |
| Tyldesley, S | 1 |
| Savage, KJ | 1 |
| Campbell, BA | 1 |
| Zheng, YY | 1 |
| Hamm, J | 2 |
| Pickles, T | 1 |
| Fourati, N | 1 |
| Kanoun Belajouza, S | 1 |
| Regaieg, H | 1 |
| Khlif, A | 1 |
| Edeline, V | 1 |
| Specht, L | 5 |
| Fiaccadori, V | 1 |
| Raemaekers, J | 2 |
| Sieniawski, M | 3 |
| Reineke, T | 4 |
| Josting, A | 15 |
| Nogova, L | 8 |
| Ziarkiewicz-Wróblewska, B | 1 |
| Górnicka, B | 1 |
| Gierej, B | 1 |
| Suleiman, W | 1 |
| Nowacka-Cieciura, E | 1 |
| Durlik, M | 1 |
| Bogdańska, M | 1 |
| Wasiutyński, A | 1 |
| Pileri, SA | 2 |
| Celkan, T | 1 |
| Yildiz, I | 1 |
| Knapp, WH | 1 |
| Weckesser, M | 1 |
| Lorenz, R | 1 |
| Schreckenberger, M | 1 |
| Bares, R | 1 |
| Mueller, RP | 4 |
| Schicha, H | 2 |
| Ribrag, V | 1 |
| Koscielny, S | 2 |
| Cazeneuve, C | 1 |
| Lenoir, G | 1 |
| Okada, S | 1 |
| Arakelyan, N | 1 |
| Berthou, C | 2 |
| Desablens, B | 3 |
| de Guibert, S | 1 |
| Delwail, V | 3 |
| Moles, MP | 1 |
| Jais, JP | 3 |
| Colonna, P | 8 |
| Andrieu, JM | 20 |
| Souza, EM | 1 |
| Baiocchi, OC | 1 |
| Zanichelli, MA | 1 |
| Alves, AC | 1 |
| Oliveira, JS | 1 |
| Müller, J | 2 |
| Molnár, Z | 5 |
| Illés, A | 5 |
| Csóka, M | 1 |
| Jakab, Z | 1 |
| Deák, B | 1 |
| Schneider, T | 4 |
| Várady, E | 1 |
| Rosta, A | 4 |
| Simon, Z | 2 |
| Keresztes, K | 2 |
| Gergely, L | 2 |
| Kovács, G | 2 |
| Alm El-Din, MA | 1 |
| El-Badawy, SA | 1 |
| Taghian, AG | 1 |
| Abuzetun, JY | 1 |
| Loberiza, F | 1 |
| Vose, J | 3 |
| Bierman, P | 1 |
| Bociek, RG | 1 |
| Enke, C | 1 |
| Bast, M | 1 |
| Weisenburger, D | 2 |
| Armitage, JO | 3 |
| Niu, Y | 1 |
| He, XH | 2 |
| Feng, FY | 1 |
| Gu, DZ | 1 |
| Montanini, A | 3 |
| La Sala, A | 3 |
| Pozzi, S | 1 |
| Scalone, R | 2 |
| Di Renzo, N | 4 |
| Musto, P | 2 |
| Cervetti, G | 1 |
| Mazza, P | 6 |
| Brugiatelli, M | 3 |
| Jovanovic, A | 1 |
| Minic, P | 1 |
| Scekic-Guc, M | 1 |
| Djuricic, S | 1 |
| Cirkovic, S | 1 |
| Weemaes, C | 1 |
| Pasic, S | 1 |
| Pass, AK | 1 |
| McLin, VA | 1 |
| Rushton, JR | 1 |
| Kearney, DL | 1 |
| Hastings, CA | 1 |
| Margolin, JF | 1 |
| Régis, A | 1 |
| Ben Salem, D | 1 |
| Lambert, A | 1 |
| Couaillier, JF | 1 |
| Piard, F | 1 |
| Krausé, D | 1 |
| Skopalova, M | 2 |
| Klaskova, K | 2 |
| Dedeckova, K | 2 |
| Kozak, T | 3 |
| Kuleva, SA | 1 |
| Uchida, T | 1 |
| Sugimoto, K | 1 |
| Koike, M | 1 |
| Valentino, F | 3 |
| Danova, M | 1 |
| Morabito, F | 2 |
| Rovati, B | 1 |
| Gentile, M | 2 |
| Quintana, G | 1 |
| van Beek, RD | 3 |
| van den Heuvel-Eibrink, MM | 3 |
| Hakvoort-Cammel, FG | 4 |
| van den Bos, C | 4 |
| van der Pal, HJ | 1 |
| Krenning, EP | 1 |
| de Rijke, YB | 1 |
| Pieters, R | 3 |
| de Muinck Keizer-Schrama, SM | 3 |
| Walewski, J | 2 |
| Lampka, E | 2 |
| Tajer, J | 1 |
| Osiadacz, W | 1 |
| Kraszewska, E | 2 |
| Krzyzanowska, JB | 2 |
| Meder, J | 2 |
| Villani, F | 4 |
| Busia, A | 2 |
| Villani, M | 1 |
| Laffranchi, A | 2 |
| Bonfante, V | 22 |
| Ding, L | 1 |
| Wang, HX | 1 |
| Xue, M | 1 |
| Liu, J | 1 |
| Yan, HM | 1 |
| Duan, LN | 1 |
| Wang, ZD | 1 |
| Weihrauch, MR | 2 |
| von Bergwelt-Baildon, MS | 1 |
| Aversa, SM | 3 |
| Trentin, C | 1 |
| Sorarů, M | 4 |
| Di Bona, E | 1 |
| Marino, D | 1 |
| Canova, F | 1 |
| Salvagno, L | 4 |
| Adami, F | 1 |
| Bulvik, S | 1 |
| Shemtov, N | 1 |
| Perez-Avraham, G | 1 |
| Shimoni, A | 1 |
| Dörken, B | 5 |
| Koch, P | 9 |
| Hänel, M | 1 |
| Pfreundschuh, M | 20 |
| Wilhelm, M | 2 |
| Trümper, L | 1 |
| Aulitzky, WE | 1 |
| Sezer, O | 1 |
| Müller-Hermelink, HK | 6 |
| Löffler, M | 10 |
| Fridrichova, M | 1 |
| Dienstbier, Z | 2 |
| Loucka, M | 1 |
| Skala, E | 1 |
| Blomannova, E | 1 |
| Eckrich, MJ | 1 |
| Domm, J | 1 |
| Ho, R | 1 |
| Whitlock, JA | 1 |
| Frangoul, H | 1 |
| Peregud-Pogorzelski, J | 1 |
| Brodkiewicz, A | 1 |
| Szychot, E | 1 |
| Zakowska, A | 1 |
| Cavalieri, E | 2 |
| Matturro, A | 1 |
| De Angelis, F | 1 |
| Frattarelli, N | 1 |
| Gentilini, F | 1 |
| Grapulin, L | 1 |
| Sacco, M | 1 |
| Torelli, F | 1 |
| Vignetti, M | 1 |
| Mandelli, F | 6 |
| Foà, R | 2 |
| Wiernik, PH | 13 |
| Glick, JH | 7 |
| Bennett, JM | 3 |
| Fernández de Larrea, C | 1 |
| Gaya, A | 1 |
| López-Guillermo, A | 2 |
| Rovira, M | 1 |
| Fernández-Avilés, F | 1 |
| Lozano, M | 1 |
| Bosch, F | 2 |
| Esteve, J | 2 |
| Nomdedeu, B | 3 |
| Montserrat, E | 5 |
| Carreras, E | 1 |
| Kleger, A | 1 |
| Bommer, M | 1 |
| Kunze, M | 1 |
| Klaus, J | 1 |
| Leithaeuser, F | 1 |
| Wegener, M | 1 |
| Adler, G | 1 |
| Dikopoulos, N | 1 |
| González-López, TJ | 1 |
| Vázquez, L | 1 |
| Hermida, G | 1 |
| Graciani, IF | 1 |
| San Miguel, JF | 1 |
| van den Belt-Dusebout, AW | 1 |
| Besseling, G | 1 |
| Hauptmann, M | 2 |
| van 't Veer, MB | 2 |
| de Wit, R | 1 |
| Ribot, JG | 1 |
| Kerst, JM | 1 |
| Gietema, JA | 1 |
| Podol'skiĭ, PN | 1 |
| Mel'nik, IuD | 1 |
| Bozhenko, VK | 1 |
| Rosti, V | 1 |
| Bonetti, E | 1 |
| Dondi, A | 1 |
| Quarta, G | 1 |
| Falorio, S | 1 |
| Niedzwiecki, D | 1 |
| Johnson, JL | 3 |
| Kuruvilla, J | 2 |
| Zhu, J | 1 |
| Song, YQ | 1 |
| Chelly, I | 1 |
| Bellil, S | 1 |
| Nfoussi, H | 1 |
| Mekni, A | 1 |
| Tangour, M | 1 |
| Kilani, H | 1 |
| Haouet, S | 1 |
| Kchir, N | 1 |
| Zitouna, M | 1 |
| Al-Tonbary, Y | 1 |
| Sarhan, MM | 1 |
| El-Ashry, RA | 1 |
| Salama, E | 1 |
| Sedki, M | 1 |
| Fouda, A | 1 |
| Wildt, L | 2 |
| Mueller, H | 4 |
| Mattle, V | 1 |
| Ganitis, P | 1 |
| van den Hoonaard, B | 1 |
| Ott, HW | 1 |
| Hofer, S | 1 |
| Pluetschow, A | 1 |
| Villalobos, M | 1 |
| Sökler, M | 1 |
| Sturm, I | 1 |
| Zenz, T | 1 |
| Vogelhuber, M | 1 |
| Flechtner, HH | 1 |
| Cristol, SM | 1 |
| Baumblatt, JG | 1 |
| Icasiano, E | 1 |
| Grajewski, AL | 1 |
| Olivier, MM | 1 |
| Parrish, RK | 1 |
| Vasilj, A | 1 |
| Kojić-Katović, S | 1 |
| Maricević, I | 1 |
| Zokvić, E | 1 |
| Kelcec, IB | 1 |
| Tomas, D | 1 |
| Curić-Jurić, S | 1 |
| Trakymiene, SS | 1 |
| Abla, O | 1 |
| Botez, SA | 1 |
| Kocharian, N | 1 |
| Logigian, EL | 1 |
| Schober, T | 4 |
| Nisters-Backes, H | 3 |
| Bauer, K | 3 |
| Herbst, C | 1 |
| Kluge, S | 1 |
| Fesler, MJ | 1 |
| Nguyen, NC | 1 |
| Petruska, PJ | 1 |
| Metwally, H | 1 |
| Courbon, F | 1 |
| David, I | 1 |
| Filleron, T | 1 |
| Blouet, A | 1 |
| Rives, M | 1 |
| Izar, F | 1 |
| Zerdoud, S | 1 |
| Plat, G | 1 |
| Vial, J | 1 |
| Robert, A | 2 |
| Laprie, A | 1 |
| Ruschke, K | 1 |
| Pelz, T | 1 |
| Voigt, A | 1 |
| Stiefel, M | 2 |
| Winkler, M | 1 |
| Vilser, C | 1 |
| Dieckmann, K | 4 |
| Bergsträsser, E | 1 |
| Hummel, M | 1 |
| Vordermark, D | 1 |
| Zhan, HQ | 1 |
| Li, XQ | 1 |
| Zhu, XZ | 1 |
| Adams, B | 1 |
| Lazarchick, J | 1 |
| Medina, AM | 1 |
| Willner, IR | 1 |
| Neville, B | 1 |
| Murphy, E | 1 |
| Stuart, R | 1 |
| Costa, LJ | 1 |
| Soricelli, A | 1 |
| Grimaldi, F | 1 |
| Nicolai, E | 1 |
| Pane, F | 1 |
| Görgen, H | 3 |
| Debus, J | 1 |
| Ho, A | 2 |
| Grosu, AL | 1 |
| Wiegel, T | 1 |
| Karstens, JH | 1 |
| Willich, N | 3 |
| Döhner, H | 3 |
| Müller, RP | 10 |
| Scholz, M | 1 |
| Loeffler, M | 17 |
| Riepenhausen, M | 3 |
| Bruch, C | 1 |
| Kotthoff, S | 1 |
| Vogt, J | 1 |
| Bölling, T | 1 |
| Heinecke, A | 1 |
| Brämswig, J | 2 |
| Keskin, EY | 1 |
| Gursel, T | 1 |
| Albayrak, M | 1 |
| Kaya, Z | 1 |
| Coskun, U | 1 |
| Kocak, U | 1 |
| Farruggia, P | 1 |
| Trizzino, A | 1 |
| Maringhini, S | 1 |
| Grigoli, A | 1 |
| Sapia, C | 1 |
| D'Alessandro, M | 1 |
| Tropia, S | 1 |
| D'Angelo, P | 1 |
| Tempescul, A | 1 |
| Ianotto, JC | 1 |
| Eveillard, JR | 1 |
| Guillerm, G | 1 |
| Sposto, R | 3 |
| Hutchinson, R | 1 |
| Massey, V | 2 |
| Perkins, S | 1 |
| Lones, M | 1 |
| Villaluna, D | 1 |
| Weiner, M | 1 |
| Chen, DB | 1 |
| Wang, Y | 1 |
| Shen, DH | 1 |
| Fiore, F | 1 |
| Sorasio, R | 1 |
| Leone, M | 1 |
| Barrington, S | 1 |
| Váróczy, L | 2 |
| Gómez-Herruz, P | 1 |
| Gil-Fernández, JJ | 2 |
| Guillen, H | 1 |
| Arizcorreta, A | 1 |
| Haberer, S | 1 |
| Belin, L | 1 |
| Le Scodan, R | 1 |
| Savignoni, A | 1 |
| Stevens, D | 1 |
| Moisson, P | 1 |
| Decaudin, D | 2 |
| Pierga, JY | 1 |
| Reyal, F | 1 |
| Campana, F | 1 |
| Fourquet, A | 1 |
| Bollet, MA | 1 |
| Yu, G | 1 |
| Kong, L | 1 |
| Qu, G | 1 |
| Zhang, Q | 1 |
| Jiang, L | 1 |
| Mocikova, H | 2 |
| Levis, A | 8 |
| Vitolo, U | 4 |
| Liberati, AM | 1 |
| Specchia, G | 1 |
| Zaja, F | 1 |
| Pogliani, EM | 1 |
| Pregno, P | 1 |
| Bonadonna, G | 34 |
| Lim, SH | 1 |
| Hohaus, S | 2 |
| Voso, MT | 2 |
| Gobbi, P | 2 |
| Bredenfeld, H | 6 |
| Keller, U | 1 |
| Graeven, U | 1 |
| Kremers, S | 1 |
| Geissler, M | 1 |
| Trenn, G | 4 |
| Fiskvik, IH | 1 |
| Kolstad, A | 2 |
| Lauritzsen, GF | 2 |
| Aurlien, E | 1 |
| Blystad, AK | 1 |
| Hole, KH | 1 |
| Ikonomou, IM | 1 |
| Blumenfeld, Z | 3 |
| Avivi, I | 3 |
| Ben-Shachar, M | 2 |
| Goor, O | 2 |
| Libster, D | 2 |
| Gaitini, D | 1 |
| Rowe, JM | 2 |
| Cerny, T | 1 |
| Ho, AD | 3 |
| Mueller-Hermelink, HK | 1 |
| Kanz, L | 2 |
| Paulus, U | 7 |
| Smardova, L | 2 |
| Huber, C | 1 |
| Nerl, C | 1 |
| Krause, SW | 1 |
| Chisesi, T | 6 |
| Pavone, V | 3 |
| Liberati, M | 2 |
| Bordonaro, R | 2 |
| Pesce, EA | 1 |
| Pinkwart, C | 1 |
| Tsukasaki, K | 1 |
| Tobinai, K | 3 |
| Hotta, T | 2 |
| Shimoyama, M | 2 |
| Marzolini, M | 1 |
| Wong, WL | 1 |
| Ardeshna, K | 1 |
| Padhani, A | 1 |
| D'Sa, S | 1 |
| Henry, M | 1 |
| Savaşan, S | 1 |
| Gualco, G | 1 |
| Bacchi, CE | 1 |
| Berrady, R | 1 |
| Baybay, H | 1 |
| Khammar, Z | 1 |
| Lahlou, M | 1 |
| Lamchachti, L | 1 |
| Gallouj, S | 1 |
| El Hatimi, A | 1 |
| Mernissi, FZ | 1 |
| Bono, W | 1 |
| Eibl, AD | 2 |
| Rosenbrock, J | 2 |
| Reiners, KS | 2 |
| Renno, JH | 2 |
| van der Ven, K | 2 |
| Kuehr, M | 2 |
| von Wolff, M | 2 |
| Kral, Z | 3 |
| Bruessow, C | 1 |
| Karrer, U | 1 |
| Gubler, J | 1 |
| Pless, M | 1 |
| Kaplan, LD | 2 |
| De Sanctis, V | 1 |
| Filippone, FR | 1 |
| Alfò, M | 1 |
| Muni, R | 1 |
| Valeriani, M | 1 |
| Osti, MF | 1 |
| Minniti, G | 1 |
| Enrici, RM | 2 |
| Niembro, A | 1 |
| Lozano, V | 1 |
| Gallardo, E | 1 |
| Molina, B | 1 |
| Sánchez, S | 1 |
| Ramos, S | 1 |
| Carnevale, A | 1 |
| Pérez-Vera, P | 1 |
| Rivera Luna, R | 1 |
| Renner, C | 2 |
| Hallek, M | 1 |
| Engel, N | 1 |
| Topp, M | 1 |
| Kratochwil, C | 1 |
| Schober, O | 1 |
| Andreesen, R | 1 |
| Kneba, M | 1 |
| Escobar, H | 1 |
| Yoshimi, A | 1 |
| Hoffmann, R | 1 |
| van Buiren, M | 1 |
| Wild, D | 1 |
| Folkens, JU | 1 |
| Pohl, M | 1 |
| Kontny, U | 1 |
| Uhm, J | 1 |
| Wang, E | 1 |
| Papavassiliou, P | 1 |
| Sebastian, S | 1 |
| García-Lozano, T | 1 |
| Lorente Alegre, P | 1 |
| Juan Bañón, JL | 1 |
| Aznar Oroval, E | 1 |
| Tarasenkova, AA | 2 |
| Ezzat, HM | 1 |
| Hicks, LK | 1 |
| Boro, J | 1 |
| Montaner, JS | 1 |
| Lima, VD | 1 |
| Harris, M | 1 |
| Leitch, HA | 1 |
| Koga, Y | 1 |
| Kumagai, M | 1 |
| Takimoto, T | 1 |
| Mimaya, J | 1 |
| Nakazawa, A | 1 |
| Horibe, K | 1 |
| Kobayashi, R | 1 |
| Tsurusawa, M | 1 |
| Inada, H | 1 |
| Li, ZM | 1 |
| Zhu, YJ | 1 |
| Xia, Y | 2 |
| Huang, JJ | 1 |
| Jiang, WQ | 1 |
| Wannesson, L | 1 |
| Bargetzi, M | 1 |
| Cairoli, A | 1 |
| Cerutti, A | 1 |
| Heim, D | 1 |
| Hess, U | 1 |
| Lerch, E | 1 |
| Samaras, P | 1 |
| Zucca, E | 1 |
| Feng, Q | 1 |
| Zak, D | 1 |
| Daya, R | 1 |
| Weinstein, HJ | 4 |
| Hudson, MM | 6 |
| Billett, AL | 2 |
| Larsen, EC | 1 |
| Friedmann, A | 1 |
| Howard, SC | 3 |
| Donaldson, SS | 9 |
| Krasin, MJ | 1 |
| Kun, LE | 2 |
| Yock, TI | 1 |
| Tarbell, N | 2 |
| Billups, CA | 1 |
| Wu, J | 1 |
| Link, MP | 8 |
| Heyden-Honerkamp, A | 1 |
| Koch, O | 1 |
| Finke, J | 1 |
| Semiglazov, TIu | 1 |
| Farsad, M | 1 |
| Pescosta, N | 1 |
| Casini, M | 1 |
| Cavattoni, IM | 1 |
| Deola, S | 1 |
| Cortelazzo, S | 2 |
| Phipps, C | 1 |
| Lee, YS | 1 |
| Hwang, W | 1 |
| Hübel, K | 1 |
| Dunleavy, K | 1 |
| Grant, C | 1 |
| Eberle, FC | 1 |
| Pittaluga, S | 1 |
| Jaffe, ES | 7 |
| Wilson, WH | 3 |
| Oriot, P | 1 |
| Malvaux, P | 1 |
| Waignein, F | 1 |
| Delcourt, A | 1 |
| Doyen, C | 2 |
| Rousseau, E | 1 |
| Baudry, G | 1 |
| Dechambre, S | 1 |
| Hentrich, M | 2 |
| Berger, M | 1 |
| Wyen, C | 1 |
| Siehl, J | 2 |
| Rockstroh, JK | 1 |
| Müller, M | 1 |
| Fätkenheuer, G | 1 |
| Seidel, E | 1 |
| Nickelsen, M | 1 |
| Wolf, T | 1 |
| Rieke, A | 1 |
| Schürmann, D | 2 |
| Schmidmaier, R | 1 |
| Planker, M | 1 |
| Alt, J | 1 |
| Mosthaf, F | 1 |
| Arasteh, K | 1 |
| Hoffmann, C | 1 |
| Krochmalczyk, D | 1 |
| Sobociński, M | 1 |
| Skotnicki, AB | 1 |
| Kochbati, L | 2 |
| Fdhila, F | 1 |
| Belaid, I | 1 |
| Rifi, H | 1 |
| Barsaoui, S | 1 |
| Ben Romdhane, N | 1 |
| Bel Hadj Ali, Z | 2 |
| Oubich, F | 1 |
| Hagihara, M | 1 |
| Inoue, M | 1 |
| Hua, J | 1 |
| Iwaki, Y | 1 |
| Baer, D | 1 |
| Mason, J | 1 |
| Warnke, R | 1 |
| Allen, J | 1 |
| Daadi, S | 1 |
| Stumpf, V | 1 |
| Wessels, C | 1 |
| Wiehlpütz, M | 1 |
| Xing, PY | 1 |
| Yang, JL | 1 |
| Liu, P | 1 |
| Gospodarowicz, M | 2 |
| Advani, R | 4 |
| Schlienger, M | 1 |
| Ferroir, JP | 1 |
| Huguet, F | 1 |
| Deluen, F | 1 |
| Pène, F | 1 |
| Marseguerra, R | 1 |
| Touboul, E | 2 |
| Sharkunov, NN | 1 |
| Moiseyeva, TN | 1 |
| Zybunova, EE | 1 |
| Vinogradova, OY | 1 |
| Kravchenko, SK | 1 |
| Koontz, MZ | 1 |
| Balise, R | 1 |
| Greenberg, PL | 1 |
| Palickova, M | 1 |
| Vernerova, Z | 1 |
| Campr, V | 1 |
| Puyade, M | 1 |
| Yacoub, M | 1 |
| Tomowiak, C | 1 |
| Diviné, M | 6 |
| Perdrisot, R | 1 |
| Guilhot, F | 2 |
| Miller, TP | 3 |
| Gellert, LL | 1 |
| Lemas, MV | 1 |
| Hsieh, WS | 1 |
| Tan, KL | 1 |
| Stiff, P | 1 |
| Ambinder, RF | 1 |
| Burger, IA | 1 |
| Vargas, HA | 1 |
| Goldman, DA | 1 |
| Gonen, M | 1 |
| Kumar, A | 1 |
| Zelenetz, AD | 1 |
| Hricak, H | 1 |
| Yahalom, J | 4 |
| Zsáry, A | 2 |
| Szücs, S | 2 |
| Sármán, P | 2 |
| Fenyvesi, T | 2 |
| Karádi, I | 2 |
| Rossi, G | 3 |
| Fasan, M | 2 |
| Schiantarelli, C | 1 |
| Nigra, E | 1 |
| Mena, M | 1 |
| Antinori, A | 1 |
| Ammassari, A | 1 |
| Talamini, R | 2 |
| Vaccher, E | 6 |
| di Gennaro, G | 1 |
| Nachman, JB | 1 |
| Herzog, P | 1 |
| Gilchrist, GS | 5 |
| Thomson, J | 1 |
| Kadin, ME | 1 |
| Pattengale, P | 1 |
| Davis, PC | 2 |
| Hutchinson, RJ | 3 |
| White, K | 1 |
| Radman, I | 2 |
| Basić, N | 1 |
| Labar, B | 1 |
| Kovacević, J | 1 |
| Bogdanić, V | 1 |
| Zupancić-Salek, S | 1 |
| Nemet, D | 1 |
| Jakić-Razumović, J | 2 |
| Mrsić, M | 1 |
| Santek, F | 1 |
| Grgić-Markulin, L | 1 |
| Boban, D | 1 |
| Macpherson, N | 2 |
| Klasa, RJ | 2 |
| Gascoyne, R | 1 |
| O'Reilly, SE | 5 |
| Voss, N | 2 |
| Basić-Jukić, N | 1 |
| Roncević, T | 1 |
| To, KW | 1 |
| Thirkill, CE | 1 |
| Jakobiec, FA | 1 |
| Lessell, S | 1 |
| Berson, EL | 1 |
| Chandra, A | 1 |
| Raman, SG | 1 |
| Atra, A | 1 |
| Higgs, E | 1 |
| Capra, M | 1 |
| Elsworth, A | 1 |
| Imeson, J | 1 |
| Radford, M | 1 |
| Trolese, A | 1 |
| Ambrosetti, A | 1 |
| Nadali, G | 1 |
| Visco, C | 1 |
| Ricetti, MM | 1 |
| Benedetti, F | 1 |
| Pizzolo, G | 3 |
| Veronesi, G | 1 |
| Spaggiari, L | 1 |
| Solli, PG | 1 |
| Leo, F | 1 |
| Villa, G | 1 |
| Pastorino, U | 1 |
| Chronowski, GM | 3 |
| Wilder, RB | 3 |
| Tucker, SL | 1 |
| Ha, CS | 6 |
| Sarris, AH | 3 |
| Barista, I | 3 |
| Hess, MA | 2 |
| Cabanillas, F | 12 |
| Cox, JD | 7 |
| Lowe, XR | 1 |
| Shelby, MD | 1 |
| Bishop, JB | 1 |
| Duggan, DB | 2 |
| Petroni, GR | 3 |
| Peterson, BA | 9 |
| Boye, J | 1 |
| Elter, T | 1 |
| Adiga, GU | 1 |
| Abebe, L | 1 |
| Bernard, P | 1 |
| Vinzio, S | 1 |
| Talarmin, F | 1 |
| Kadouri, A | 1 |
| Flocard, F | 1 |
| Osorio, G | 3 |
| Caglevic, C | 1 |
| Sieber, M | 14 |
| Rueffer, U | 3 |
| Koch, T | 2 |
| Naumann, R | 2 |
| Boissevain, F | 3 |
| Worst, P | 5 |
| Wolf, J | 6 |
| Rose, AL | 1 |
| Forsythe, AM | 1 |
| Maloney, DG | 2 |
| Dyduch, M | 1 |
| Skolyszewski, J | 1 |
| Korzeniowski, S | 1 |
| Sokolowski, A | 1 |
| Hofmann, J | 1 |
| Heinzl, H | 1 |
| Wagner, W | 2 |
| Pileckyte, M | 1 |
| Griniūte, R | 1 |
| Lathan, B | 7 |
| Tesch, H | 12 |
| Herrmann, R | 3 |
| Dühmke, E | 6 |
| Bortolus, R | 3 |
| Lybeert, ML | 3 |
| Keuning, JJ | 1 |
| Tomsic, R | 2 |
| Vovk, M | 3 |
| van Hoof, A | 2 |
| Demeestere, G | 2 |
| Schroyens, W | 1 |
| De Boeck, K | 1 |
| Baars, JW | 2 |
| Kluin-Nelemans, JC | 3 |
| Carrie, C | 2 |
| Aoudjhane, M | 1 |
| Bron, D | 1 |
| Smit, WG | 2 |
| Meerwaldt, JH | 8 |
| Hagenbeek, A | 8 |
| Pinna, A | 4 |
| Gisselbrecht, C | 9 |
| Moretti, L | 2 |
| Colombat, P | 4 |
| Fabbiano, F | 1 |
| Goldstone, A | 1 |
| Carella, AM | 5 |
| Longo, DL | 14 |
| Schiller, P | 1 |
| De Wit, M | 1 |
| Mezger, J | 1 |
| Schmidt, BF | 1 |
| Renner, H | 1 |
| Pfistner, B | 7 |
| Economopoulos, T | 2 |
| Fountzilas, G | 1 |
| Dimopoulos, MA | 1 |
| Papageorgiou, S | 1 |
| Xiros, N | 2 |
| Kalantzis, D | 1 |
| Dervenoulas, J | 1 |
| Raptis, S | 1 |
| Murphy, SB | 1 |
| Morgan, ER | 1 |
| Katzenstein, HM | 1 |
| Kletzel, M | 1 |
| MAGRASSI, F | 1 |
| CONSOLI, G | 1 |
| POLLI, E | 1 |
| CROSTI, PF | 1 |
| CARRARA, PM | 1 |
| DUBOIS-FERRIERE, H | 4 |
| RANNEY, HM | 2 |
| GELLHORN, A | 3 |
| LA MAESTRA, A | 1 |
| MUNAFO, G | 1 |
| PRINCI, P | 1 |
| KRASNIK, W | 1 |
| FUA, C | 1 |
| BONAN, R | 1 |
| RECANATINI, R | 1 |
| Ekert, H | 5 |
| Gupta, T | 1 |
| Sanghavi, V | 1 |
| Laskar, S | 1 |
| POPOVIC, L | 1 |
| STECHER, G | 1 |
| GREGORY, RL | 1 |
| SAYLE, BA | 1 |
| SANDOR, L | 1 |
| UJMAZY, V | 1 |
| CERNY, V | 2 |
| WINKLER, A | 1 |
| SUTEKOVA-UHRINOVA, M | 1 |
| AMSLER, R | 1 |
| ROYER, G | 1 |
| SCHENCKER, B | 1 |
| ZANCA, P | 1 |
| RANLOV, P | 1 |
| VIDEBAEK, A | 2 |
| ERIKSEN, KR | 1 |
| HOJGAARD, K | 1 |
| MILLER, DJ | 1 |
| HOFFBRAND, BI | 1 |
| IRVINE, RA | 1 |
| ROBERTSON, WB | 1 |
| BOOTSMA, BK | 1 |
| SAMPEY, JR | 1 |
| KARNOFSKY, DA | 1 |
| DEBLASIIS, M | 1 |
| LIBERTI, R | 1 |
| WATKIN, DM | 1 |
| STEINFELD, JL | 1 |
| MARTINEZ MALDONADO, M | 1 |
| MENENDEZ CORRADA, R | 1 |
| RIVERADESALA, A | 1 |
| WHITAKER, W | 1 |
| BREWER, D | 1 |
| FITZGERALD, M | 1 |
| HEATH, D | 1 |
| LOEHRY, CA | 1 |
| CHEEVER, AW | 1 |
| VALSAMIS, MP | 1 |
| RABSON, AS | 1 |
| RIECHE, K | 1 |
| STENFERTKROESE, WF | 1 |
| D ANGIO, GJ | 1 |
| MIUS, A | 1 |
| EVANS, AE | 1 |
| ROSEMAN, DL | 1 |
| ECONOMOU, SG | 1 |
| KUEHBOECK, J | 1 |
| REIMER, EE | 1 |
| STOIBER, T | 1 |
| Hartmann, P | 1 |
| Rehwald, U | 1 |
| Salzberger, B | 1 |
| Franzen, C | 1 |
| Wöhrmann, A | 1 |
| Stevanato, F | 1 |
| Pancotto, P | 1 |
| Reimers, P | 1 |
| Salvano, L | 1 |
| Cella, G | 1 |
| Boussen, H | 1 |
| Benna, F | 1 |
| Belhaj Ali, Z | 1 |
| Gammoudi, A | 1 |
| Besbes, M | 1 |
| Ghilen, L | 1 |
| Rahal, K | 1 |
| Ogawa, M | 4 |
| Tsang, RW | 1 |
| Pintilie, M | 2 |
| Sun, A | 2 |
| Wells, W | 2 |
| Gospodarowicz, MK | 2 |
| Gustavsson, A | 3 |
| Sundström, C | 2 |
| Rosenquist, R | 1 |
| Menestrina, F | 1 |
| Lestani, M | 1 |
| Küppers, R | 1 |
| Bräuninger, A | 1 |
| van den Berg, H | 5 |
| Furstner, F | 1 |
| Behrendt, H | 6 |
| Levy, LB | 1 |
| Atkinson, EN | 1 |
| Li, S | 1 |
| Neuberg, D | 1 |
| Fisher, DC | 1 |
| Mauch, PM | 7 |
| Munker, R | 2 |
| Hermann, R | 4 |
| Doelken, G | 2 |
| Oertel, J | 2 |
| Roller, S | 1 |
| Bischof, H | 1 |
| Glunz, A | 3 |
| von Kalle, K | 3 |
| Schalk, KP | 3 |
| Brosteanu, O | 4 |
| Duehmke, E | 3 |
| Georgii, A | 5 |
| Fischer, R | 1 |
| Koch, B | 1 |
| Gossmann, A | 2 |
| Hansemann, K | 2 |
| Skripnitchenko, R | 3 |
| Kocher, M | 2 |
| Semrau, R | 1 |
| Krug, B | 1 |
| Urano, M | 1 |
| Mizoguchi, Y | 1 |
| Nishio, T | 1 |
| Abe, M | 1 |
| Kuroda, M | 1 |
| Saito, S | 2 |
| Sakurai, K | 1 |
| Oliapuram Jose, B | 1 |
| Koerner, P | 1 |
| Bertolone, S | 1 |
| Patel, CC | 1 |
| Spanos, WJ | 1 |
| Paris, KJ | 1 |
| Silverman, CL | 1 |
| Yashar, CM | 1 |
| Fries, S | 1 |
| Mailänder, V | 1 |
| Merchant, TE | 2 |
| Nguyen, L | 1 |
| Nguyen, D | 1 |
| Wu, S | 1 |
| Kaste, SC | 1 |
| Buitendijk, S | 1 |
| van den Heuvel-Eibrink, M | 1 |
| Hählen, K | 1 |
| Vassilakopoulos, TP | 2 |
| Angelopoulou, MK | 2 |
| Siakantaris, MP | 1 |
| Kontopidou, FN | 1 |
| Dimopoulou, MN | 1 |
| Kokoris, SI | 1 |
| Kyrtsonis, MC | 1 |
| Tsaftaridis, P | 1 |
| Karkantaris, C | 1 |
| Anargyrou, K | 1 |
| Boutsis, DE | 1 |
| Variamis, E | 1 |
| Michalopoulos, T | 1 |
| Boussiotis, VA | 2 |
| Panayiotidis, P | 1 |
| Papavassiliou, C | 1 |
| Pangalis, GA | 3 |
| Di Febo, A | 1 |
| Storti, S | 1 |
| Teofili, L | 2 |
| Leone, G | 1 |
| Bordallo, MA | 2 |
| Guimarães, MM | 1 |
| Pessoa, CH | 1 |
| Carriço, MK | 2 |
| Dimetz, T | 1 |
| Gazolla, HM | 1 |
| Dobbin, J | 1 |
| Castilho, IA | 1 |
| Mazzarotto, R | 2 |
| Boso, C | 1 |
| Gaion, F | 1 |
| Chiarion-Sileni, V | 1 |
| De Franchis, G | 1 |
| Favaretto, AG | 1 |
| Crivellari, G | 1 |
| Banna, GL | 1 |
| Sotti, G | 3 |
| Monfardini, S | 5 |
| Hazar, B | 1 |
| Ergin, M | 1 |
| Seyrek, E | 1 |
| Erdoğan, S | 1 |
| Tuncer, I | 1 |
| Hakverdi, S | 1 |
| Ibrahim, D | 1 |
| Smith, MR | 2 |
| Varterasian, M | 1 |
| Karanes, C | 3 |
| Millenson, M | 1 |
| Yeslow, G | 1 |
| Pemberton, P | 1 |
| Lai, P | 1 |
| Abrams, J | 1 |
| Al-Katib, A | 2 |
| Hobbie, WL | 1 |
| Ginsberg, JP | 1 |
| Ogle, SK | 1 |
| Carlson, CA | 1 |
| Meadows, AT | 2 |
| Sevilla, J | 1 |
| Fernández-Plaza, S | 1 |
| González-Vicent, M | 1 |
| Colmenero, I | 1 |
| Echevarria, JM | 1 |
| Pérez, A | 2 |
| Díaz, MA | 1 |
| Madero, L | 1 |
| Krasin, M | 2 |
| Billups, C | 1 |
| Kun, L | 1 |
| Billet, AL | 1 |
| Kaste, S | 2 |
| Tarbell, NJ | 6 |
| Howard, S | 1 |
| Friedmann, AM | 1 |
| Hurwitz, CA | 2 |
| Young, JA | 2 |
| Marcus, KC | 3 |
| Rai, S | 1 |
| Cowan, T | 1 |
| Arya, LS | 3 |
| Dinand, V | 3 |
| Bakhshi, S | 2 |
| Thavaraj, V | 2 |
| Singh, R | 2 |
| Dawar, R | 3 |
| Ballova, V | 2 |
| Rüffer, JU | 3 |
| Wilhelmy, M | 1 |
| Glossmann, JP | 2 |
| Boettcher, HD | 1 |
| Schulz, U | 1 |
| Ikeda, T | 1 |
| Yamamoto, R | 1 |
| Hashiguchi, K | 1 |
| Iwai, A | 1 |
| Satoh, S | 1 |
| Hanaoka, N | 1 |
| Okudaira, K | 1 |
| Inoue, T | 1 |
| Miyazaki, J | 1 |
| Matsuzaki, K | 1 |
| Tsuzuki, Y | 1 |
| Kawaguchi, A | 1 |
| Nagao, S | 1 |
| Itoh, K | 1 |
| Miura, S | 1 |
| Hatano, B | 1 |
| Balwierz, W | 7 |
| Moryl-Bujakowska, A | 6 |
| Depowska, T | 7 |
| Klekawka, T | 2 |
| Stanuch, H | 2 |
| Matysiak, M | 3 |
| Sopyło, B | 3 |
| Kołakowska-Mrozowska, B | 3 |
| Krenke, K | 2 |
| Chybicka, A | 2 |
| Raś, M | 2 |
| Sońta-Jakimczyk, D | 4 |
| Moszant, A | 2 |
| Wachowiak, J | 2 |
| Kaczmarek-Kanold, M | 3 |
| Kowalczyk, J | 3 |
| Odój, T | 2 |
| Balcerska, A | 2 |
| Drozyńska, E | 2 |
| Wysocki, M | 2 |
| Kołtan, A | 2 |
| Krawczuk-Rybak, M | 2 |
| Stolarska, M | 2 |
| Wessels, G | 2 |
| Bernard Hesseling, P | 1 |
| Zhang, YJ | 1 |
| Chen, MS | 1 |
| Liang, HH | 1 |
| Xu, L | 1 |
| Zhang, YQ | 1 |
| Udvardy, M | 1 |
| Ogura, M | 1 |
| Keltai, K | 1 |
| Pásztor, E | 1 |
| Jánoskuti, L | 1 |
| Kneller, A | 1 |
| Cohen, N | 1 |
| Berkowicz, M | 2 |
| Reichart, M | 1 |
| Rosner, E | 1 |
| Sokolovski, M | 1 |
| Rechavi, G | 1 |
| Amariglio, N | 1 |
| Trakhtenbrot, L | 1 |
| Sehlen, S | 1 |
| Strijk, S | 1 |
| Meijnders, P | 1 |
| Olofsen-van Acht, MJ | 1 |
| Poortmans, PM | 1 |
| Bang, SM | 1 |
| Cheong, JW | 1 |
| Yang, WI | 1 |
| Hahn, JS | 1 |
| Campbell, B | 1 |
| Wirth, A | 2 |
| Milner, A | 1 |
| Di Iulio, J | 1 |
| MacManus, M | 1 |
| Ryan, G | 1 |
| Strobel, ES | 1 |
| Bauchmüller, K | 1 |
| Schmitt-Gräff, A | 1 |
| Engelhardt, M | 1 |
| Marisavljević, D | 1 |
| Ristić, B | 1 |
| Hajder, J | 1 |
| Rath, GK | 1 |
| Vats, TS | 1 |
| Broglia, C | 3 |
| Cavanna, L | 4 |
| Santini, G | 3 |
| Deliliers, GL | 2 |
| Angelucci, E | 1 |
| Ji, H | 1 |
| Zhang, WY | 1 |
| Liu, WP | 1 |
| Li, GD | 1 |
| Li, L | 1 |
| Breuer, K | 1 |
| May, M | 1 |
| Schmitz, T | 1 |
| Glossmann, J | 1 |
| Comella, P | 1 |
| Abate, G | 1 |
| Fiore, M | 1 |
| Di Finizio, G | 1 |
| Frezza, P | 1 |
| Scoppa, G | 1 |
| Anania, C | 1 |
| Coucourde, F | 1 |
| Zarrilli, D | 1 |
| Morbidini-Gaffney, S | 1 |
| Alpert, TE | 1 |
| Hatoum, GF | 1 |
| Sagerman, RH | 1 |
| Bashir, H | 1 |
| Motl, S | 1 |
| Krasin, MP | 1 |
| Sacchi, S | 1 |
| Corbella, F | 2 |
| Molica, S | 2 |
| Corazza, GR | 1 |
| Sonet, A | 1 |
| Bouafia, F | 1 |
| Bastard-Stamatoullas, A | 1 |
| Voillat, L | 1 |
| Blanc, M | 3 |
| Berger, D | 1 |
| Bacon, P | 1 |
| Skacel, T | 1 |
| Easton, V | 1 |
| Zhen, ZJ | 1 |
| Sun, XF | 2 |
| Wang, ZH | 1 |
| Ling, JY | 1 |
| Hsu, SC | 1 |
| Pedrosa, F | 1 |
| Lins, M | 1 |
| Pedrosa, M | 1 |
| Barros, C | 1 |
| Maciel, K | 1 |
| Pui, CH | 1 |
| Ribeiro, RC | 1 |
| Elbl, L | 3 |
| Vásová, I | 4 |
| Krejcí, M | 1 |
| Navrátil, M | 2 |
| Tomásková, I | 3 |
| Jedlicka, F | 3 |
| Chaloupka, V | 2 |
| Mayer, J | 1 |
| Vorlícek, J | 3 |
| Foltz, LM | 1 |
| Song, KW | 1 |
| Wagnerova, B | 1 |
| Dupouy, N | 2 |
| Monconduit, M | 8 |
| Bosq, J | 3 |
| Verschueren, TA | 1 |
| Pény, AM | 1 |
| Kung, FH | 1 |
| Ferree, CR | 1 |
| London, WB | 1 |
| Ternberg, JL | 2 |
| Behm, FG | 3 |
| Wharam, MD | 2 |
| Falletta, JM | 1 |
| de Alarcon, P | 1 |
| Chauvenet, AR | 2 |
| Wang, WH | 1 |
| Song, YW | 1 |
| Jin, J | 1 |
| Liu, YP | 1 |
| Wang, SL | 1 |
| Liu, XF | 1 |
| Yu, ZH | 1 |
| Han, JZ | 1 |
| Boué, F | 1 |
| Reynes, J | 1 |
| Cheret, A | 1 |
| Bonnet, F | 1 |
| Billaud, E | 1 |
| Raphael, M | 2 |
| Lancar, R | 1 |
| Costagliola, D | 1 |
| Koh, ES | 1 |
| Tran, TH | 1 |
| Tsang, R | 1 |
| Heaton, R | 1 |
| Fu, XH | 1 |
| Wang, SS | 1 |
| Huang, Y | 1 |
| Wang, B | 1 |
| Huang, HQ | 1 |
| Xu, RH | 1 |
| Lin, TY | 1 |
| Feltl, D | 1 |
| Vítek, P | 1 |
| Zámecník, J | 1 |
| Greco, M | 1 |
| Valsecchi, M | 1 |
| Niccodemi, C | 1 |
| Presas, J | 1 |
| Corrado, C | 3 |
| Winkel, M | 1 |
| Takeyama, J | 1 |
| Sato, A | 1 |
| Nakano, K | 1 |
| Abukawa, D | 1 |
| Ichinohazama, R | 1 |
| Imaizumi, M | 1 |
| Tamir, A | 1 |
| Haim, N | 5 |
| Zuckerman, T | 1 |
| Kirschbaum, M | 1 |
| Tan, EL | 1 |
| Stark, H | 1 |
| Lowinger, JS | 1 |
| Ringland, C | 1 |
| Ward, R | 1 |
| Pearson, S- | 1 |
| Goldsmith, SJ | 1 |
| Christos, P | 1 |
| Furman, RR | 1 |
| Atasever, T | 1 |
| Chandramouly, A | 1 |
| Verma, S | 2 |
| Kothari, P | 1 |
| Coleman, M | 7 |
| Niitsu, N | 2 |
| Okamoto, M | 1 |
| Tomita, N | 1 |
| Aoki, S | 1 |
| Tamaru, J | 1 |
| Miura, I | 1 |
| Hirano, M | 1 |
| Müller-Hermelink, K | 1 |
| Pivnik, AV | 1 |
| Rastrigin, NA | 1 |
| Moiseeva, TN | 1 |
| Lutsenko, IN | 1 |
| Dudarova, RG | 1 |
| Shavlokhov, VS | 1 |
| Efimov, IV | 1 |
| Kozhurin, SV | 1 |
| Shitareva, IV | 1 |
| Gemdzhian, EG | 1 |
| Tsyba, NN | 1 |
| Kolosova, LIu | 1 |
| Melikian, AL | 1 |
| Skidan, NI | 1 |
| Dotsenko, PV | 1 |
| Nechistiuk, AV | 1 |
| Majhail, NS | 1 |
| Weisdorf, DJ | 1 |
| Defor, TE | 1 |
| Miller, JS | 1 |
| McGlave, PB | 1 |
| Slungaard, A | 1 |
| Arora, M | 1 |
| Ramsay, NK | 1 |
| Orchard, PJ | 1 |
| MacMillan, ML | 1 |
| Burns, LJ | 3 |
| Tomiŝiĉ, R | 1 |
| Baaijens, MH | 1 |
| Lugtenburg, P | 1 |
| Castelo-Branco, C | 1 |
| Camus, A | 1 |
| Mercadal, S | 1 |
| Martínez de Osaba, MJ | 1 |
| Balasch, J | 1 |
| Chow, LM | 1 |
| Nathan, PC | 1 |
| Jenkin, D | 7 |
| Weitzman, S | 2 |
| Grant, RM | 1 |
| Manson, D | 1 |
| Bross, A | 1 |
| Doyle, JJ | 1 |
| Danjoux, C | 1 |
| Greenberg, ML | 1 |
| Rai, SN | 1 |
| Brain, S | 1 |
| Wilde, S | 1 |
| Jetter, A | 1 |
| Rietbrock, S | 1 |
| Kasel, D | 1 |
| Hempel, G | 1 |
| Reif, S | 1 |
| Jaehde, U | 1 |
| Merkel, U | 1 |
| Busse, D | 1 |
| Schwab, M | 1 |
| Fuhr, U | 1 |
| Mandal, S | 1 |
| Mandal, AK | 1 |
| Miltényi, Z | 1 |
| Ress, Z | 1 |
| Vadász, G | 1 |
| Malik, A | 1 |
| Unni, R | 1 |
| Pandey, RM | 1 |
| Yang, D | 1 |
| Brown, SE | 1 |
| Nguyen, K | 1 |
| Reddy, V | 1 |
| Brubaker, C | 1 |
| Winslow, KL | 1 |
| Giuseppe, L | 1 |
| Attilio, G | 1 |
| Edoardo, DN | 1 |
| Loredana, G | 1 |
| Cristina, L | 1 |
| Vincenzo, L | 1 |
| Nome, O | 1 |
| Delabie, J | 1 |
| Cabrera, ME | 1 |
| Lois, V | 1 |
| León, A | 1 |
| Peña, K | 1 |
| Rossle, A | 1 |
| Cerda, B | 1 |
| Rojas, H | 1 |
| Meneses, P | 1 |
| Merino, C | 1 |
| Aspillaga, A | 1 |
| Vittini de, C | 1 |
| Oliva, J | 1 |
| Hales, C | 1 |
| Rosas, J | 1 |
| Tanaka, PY | 1 |
| Pessoa, VP | 1 |
| Pracchia, LF | 1 |
| Buccheri, V | 1 |
| Chamone, DA | 1 |
| Calore, EE | 1 |
| Klumb, CE | 1 |
| de Rezende, LM | 1 |
| Byington, R | 1 |
| Bigni, RS | 1 |
| Apa, AG | 1 |
| Dobbin, JA | 1 |
| Maeda, L | 1 |
| Lavori, P | 1 |
| Quon, A | 1 |
| Hoppe, R | 1 |
| Breslin, S | 1 |
| Al-Ali, HK | 1 |
| Wittekind, C | 1 |
| Niederwieser, D | 1 |
| Laven, JS | 1 |
| de Jong, FH | 2 |
| Themmen, AP | 1 |
| Hall, GW | 1 |
| Katzilakis, N | 1 |
| Pinkerton, CR | 1 |
| Nicolin, G | 1 |
| Ashley, S | 1 |
| Macann, A | 1 |
| Huisbrink, J | 1 |
| Kuenen, MA | 1 |
| Ouwens, GM | 1 |
| van't Veer, MB | 2 |
| Magagnoli, M | 2 |
| Balzarotti, M | 3 |
| Siracusano, LV | 1 |
| Isa, L | 1 |
| Morenghi, E | 1 |
| Santoro, A | 26 |
| Diez, P | 1 |
| Hoskin, PJ | 1 |
| Aird, EG | 1 |
| Smit, M | 1 |
| Weber, RF | 1 |
| Rieux, C | 1 |
| Berger, F | 4 |
| Walewski, JA | 1 |
| Lederlin, P | 4 |
| Van den Neste, E | 1 |
| Gyan, E | 1 |
| Creemers, GJ | 1 |
| Vié, B | 1 |
| Viseu, F | 1 |
| Poortmans, P | 1 |
| Tan, WY | 1 |
| Hu, DS | 1 |
| Zeng, FY | 1 |
| Song, QB | 1 |
| Hu, S | 1 |
| Wei, L | 1 |
| Doganis, D | 1 |
| Baka, M | 1 |
| Pourtsidis, A | 1 |
| Bouhoutsou, D | 1 |
| Varvoutsi, M | 1 |
| Stamos, G | 1 |
| Anastasiou, N | 1 |
| Androulakakis, E | 1 |
| Vasilatou-Kosmidis, H | 1 |
| Olweny, CL | 5 |
| Ziegler, JL | 6 |
| Wedgwood, A | 1 |
| Cuttelod, M | 1 |
| Pascual, A | 1 |
| Baur Chaubert, AS | 1 |
| Cometta, A | 1 |
| Osih, R | 1 |
| Duchosal, MA | 1 |
| Cavassini, M | 1 |
| Schumacher, YO | 1 |
| Muser, K | 1 |
| Hirschberger, B | 1 |
| Roecker, K | 1 |
| Dickhuth, HH | 1 |
| Pottgiesser, T | 1 |
| Eisner, E | 1 |
| Ley, AB | 1 |
| Mayer, K | 1 |
| Perry, S | 1 |
| Thomas, LB | 1 |
| Johnson, RE | 4 |
| Carbone, PP | 8 |
| Haynes, HA | 1 |
| Brauer, MJ | 1 |
| McEvoy, BF | 1 |
| Mitus, WJ | 1 |
| Caldwell, IW | 1 |
| Montgomery, PR | 1 |
| Peachey, RD | 1 |
| Bernard, J | 13 |
| Boiron, M | 13 |
| Goguel, A | 3 |
| Jacquillat, C | 14 |
| Tanzer, J | 2 |
| Weil, M | 10 |
| Lombardi, C | 1 |
| Ragni, G | 2 |
| Lira, P | 1 |
| Grebe, G | 1 |
| Bakemeier, RF | 2 |
| Anderson, JR | 6 |
| Costello, W | 2 |
| Rosner, G | 1 |
| Horton, J | 1 |
| Hines, JD | 1 |
| Berard, CW | 4 |
| Nuss, DD | 1 |
| Myers, J | 7 |
| Passe, S | 1 |
| Young, CW | 5 |
| Nisce, LZ | 6 |
| Lee, BJ | 8 |
| Koziner, B | 7 |
| Arlin, Z | 2 |
| Kempin, S | 2 |
| Gee, T | 2 |
| Clarkson, BD | 6 |
| Rodgers, RW | 2 |
| Gamble, JF | 9 |
| Loh, KK | 1 |
| Shullenberger, CC | 9 |
| Sutcliffe, SB | 5 |
| Wrigley, PF | 3 |
| Stansfeld, AG | 2 |
| Malpas, JS | 2 |
| Kuse, R | 2 |
| Calavrezos, A | 2 |
| Hinrichs, A | 1 |
| Hausmann, K | 1 |
| Goldman, JM | 2 |
| Grozea, PN | 2 |
| De Persio, EJ | 1 |
| Coltman, CA | 8 |
| Fabian, CJ | 2 |
| Morrison, FS | 1 |
| Gehan, EA | 8 |
| Jones, SE | 6 |
| Fossati Bellani, F | 1 |
| Franchi, F | 1 |
| Banfi, A | 4 |
| Mayer, RJ | 1 |
| Bloomfield, CD | 6 |
| Pajak, TF | 6 |
| Glicksman, AS | 2 |
| Gottlieb, AJ | 6 |
| Nissen, NI | 15 |
| Rafla, S | 2 |
| Stutzman, L | 11 |
| Vinciguerra, V | 2 |
| Glidewell, OJ | 4 |
| Holland, JF | 8 |
| Prosnitz, LR | 9 |
| Farber, LR | 6 |
| Kapp, DS | 3 |
| Bertino, JR | 5 |
| Nordlund, M | 1 |
| Lawrence, R | 2 |
| DePersio, EJ | 1 |
| Dixon, DO | 2 |
| Gassmann, W | 5 |
| Löffler, H | 5 |
| Klastersky, J | 1 |
| Armata, J | 12 |
| Legutko, L | 1 |
| Cech, P | 1 |
| Testa, U | 1 |
| Dubart, A | 1 |
| Schneider, P | 1 |
| Bachmann, F | 1 |
| Guerrasio, A | 1 |
| Beuzard, Y | 1 |
| Schmidt, PM | 1 |
| Clément, F | 2 |
| Rosa, J | 1 |
| Bartual, J | 1 |
| Roquette, J | 1 |
| Gil, M | 1 |
| Magro, E | 1 |
| Bascuas, JL | 1 |
| Yarnold, JR | 1 |
| Jelliffe, AM | 2 |
| Hudson, GV | 3 |
| Doyle, TJ | 1 |
| Venkatachalam, KK | 1 |
| Maeda, K | 2 |
| Saeed, SM | 1 |
| Tilchen, EJ | 1 |
| Papa, G | 4 |
| Anselmo, AP | 7 |
| De Luca, AM | 1 |
| Maurizienrici, R | 1 |
| Mauro, F | 2 |
| Testi, AM | 2 |
| Amadori, S | 2 |
| Biagini, C | 2 |
| Haut, A | 1 |
| Weick, JK | 1 |
| Wilson, HE | 3 |
| Grozea, P | 1 |
| McKelvey, E | 1 |
| Byrne, GE | 1 |
| Hartsock, R | 1 |
| Einhorn, LH | 3 |
| Williams, SD | 1 |
| Stevens, EE | 1 |
| Bond, WH | 1 |
| Chenoweth, L | 1 |
| Moser, K | 2 |
| Pohl, A | 1 |
| Hubbard, SM | 14 |
| Moxley, JH | 4 |
| Come, SE | 3 |
| Skarin, AT | 1 |
| Weiss, J | 1 |
| von Roemeling, R | 1 |
| Peters, HD | 1 |
| Schmoll, HJ | 2 |
| Ricciardi, O | 2 |
| Dal Fior, S | 2 |
| Cappellari, F | 2 |
| Pozza, F | 2 |
| Battista, R | 1 |
| Capnist, G | 1 |
| D'Emilio, A | 1 |
| Rodeghiero, F | 1 |
| Cimino, G | 7 |
| Marzullo, A | 1 |
| Maurizi Enrici, R | 3 |
| Zanini, M | 6 |
| Zucali, R | 10 |
| Olver, IN | 2 |
| Wolf, MM | 2 |
| Bishop, JF | 1 |
| Ding, JC | 2 |
| Cooper, IA | 2 |
| Matthews, J | 2 |
| McCormick, B | 3 |
| Mertelsmann, R | 2 |
| Tannir, N | 1 |
| Hagemeister, F | 1 |
| Velasquez, W | 2 |
| Sampi, K | 3 |
| Honda, T | 2 |
| Hattori, M | 2 |
| Corder, MP | 6 |
| Clamon, GH | 2 |
| Wiesenfeld, M | 1 |
| Portlock, CS | 7 |
| Gomez, GA | 3 |
| Han, T | 5 |
| Ozer, H | 2 |
| Henderson, ES | 5 |
| Harker, WG | 1 |
| Kushlan, P | 1 |
| Teillet, F | 11 |
| D'Agay, MF | 3 |
| Warde, P | 2 |
| Powderly, WG | 1 |
| Fennelly, JJ | 2 |
| Cunningham, S | 1 |
| McKenna, TJ | 1 |
| Krikler, SH | 1 |
| Bain, GO | 1 |
| Gordon, PA | 1 |
| Liebman, HA | 1 |
| Hum, GJ | 1 |
| Sheehan, WW | 1 |
| Ryden, VM | 1 |
| Bateman, JR | 1 |
| Khayat, D | 1 |
| Desprez-Curely, JP | 3 |
| Brocheriou, C | 1 |
| Auclerc, G | 7 |
| Chamseddine, N | 1 |
| Louria, DB | 1 |
| Cooper, MR | 8 |
| Nissen, N | 3 |
| Richards, F | 1 |
| Bloomfield, C | 1 |
| Dein, RA | 1 |
| Mennuti, MT | 2 |
| Kovach, P | 1 |
| Gabbe, SG | 1 |
| Strauch, S | 1 |
| Wannenmacher, M | 5 |
| Marty, M | 2 |
| Panahon, AM | 1 |
| Recine, U | 1 |
| Longhi, C | 1 |
| Pelosio, A | 1 |
| Massini, R | 1 |
| Hansen, MM | 1 |
| Geisler, C | 1 |
| Westberg, MW | 1 |
| Burns, CP | 1 |
| Klassen, LW | 1 |
| Goeken, NE | 1 |
| Ray, TL | 1 |
| Macfarlane, DE | 1 |
| Aderka, D | 1 |
| Kraus, M | 1 |
| Avidor, I | 1 |
| Sidi, Y | 1 |
| Weinberger, A | 1 |
| Pinkhas, J | 1 |
| Tres, A | 1 |
| Fuertes, MA | 1 |
| Callén, L | 1 |
| Poderós, C | 1 |
| Rodrigo, G | 1 |
| Peleato, A | 1 |
| Polo, J | 1 |
| Gutiérrez, M | 1 |
| Kovryzhkina, TA | 1 |
| Ellwein, LB | 2 |
| Semenov, II | 2 |
| Artiushkin, AV | 1 |
| Bosa Ojeda, F | 1 |
| de Armas Trujillo, D | 1 |
| Marrero Rodríguez, F | 1 |
| Laynez Cerdeña, I | 1 |
| Domínguez Pastor, C | 1 |
| Martín Herrera, A | 1 |
| Hernández Nieto, L | 1 |
| Vorob'ev, AI | 2 |
| Brilliant, MD | 2 |
| Voltarelli, JC | 1 |
| Falcão, RP | 1 |
| Bottura, C | 1 |
| Weitberg, AB | 1 |
| Harmon, DC | 1 |
| Baĭsogolov, GD | 9 |
| Shakhtarina, SV | 7 |
| Poliakov, VE | 3 |
| Ankudinov, VA | 1 |
| Tsygankin, VI | 3 |
| Makhonova, LA | 1 |
| Bayle-Weisgerber, C | 3 |
| Lemercier, N | 1 |
| Asselain, B | 3 |
| Gout, M | 1 |
| Schweisguth, O | 1 |
| da Cunha, MF | 1 |
| Fuller, LM | 21 |
| Cundiff, JH | 1 |
| Velasquez, WS | 7 |
| Riggs, SA | 1 |
| Cabanillas, FF | 3 |
| Salvador, PG | 1 |
| Tester, WJ | 1 |
| Kinsella, TJ | 1 |
| Waller, B | 1 |
| Makuch, RW | 1 |
| Kelley, PA | 1 |
| Glatstein, E | 8 |
| Coyne, J | 1 |
| Dervan, P | 1 |
| Schmitt, K | 1 |
| Tulzer, W | 1 |
| Yosida, T | 1 |
| Nakanisi, J | 1 |
| Kobayasi, S | 1 |
| Ohtake, S | 4 |
| Ito, K | 1 |
| Nakamura, S | 3 |
| Hattori, K | 1 |
| Saito, Y | 2 |
| Tanimoto, K | 1 |
| Heinz, R | 1 |
| Hanak, H | 1 |
| Berényi, E | 1 |
| Szegedi, G | 1 |
| Tsyplenkov, VG | 2 |
| Sviridova, AV | 1 |
| Gassel, WD | 1 |
| Gropp, C | 1 |
| Havemann, K | 1 |
| Vecchi, V | 2 |
| Maccolini, E | 1 |
| Oddo Bravetti, G | 1 |
| Guidelli Guidi, S | 1 |
| Serra, L | 1 |
| Kayser, W | 2 |
| Hansz, J | 1 |
| Burchardt, K | 1 |
| Komarnicki, M | 2 |
| Trepińska, E | 1 |
| Psuja, P | 1 |
| Wiesner-Bornstein, R | 1 |
| Niesen, M | 1 |
| Grobe-Einsler, R | 1 |
| Schulte-Holtey, M | 1 |
| Bartolucci, AA | 3 |
| Liu, C | 1 |
| Durant, JR | 6 |
| Gams, RA | 5 |
| Shishkin, IP | 3 |
| Dumoulin-Lagrange, M | 1 |
| Tulliez, M | 1 |
| Diebold, J | 4 |
| Samama, M | 1 |
| Bousser, J | 1 |
| Weinstein, H | 4 |
| Botnick, L | 2 |
| Belli, J | 1 |
| Cassady, JR | 4 |
| Amiel, JL | 5 |
| Spielmann, M | 1 |
| Kerbrat, P | 1 |
| Droz, JP | 1 |
| Tursz, T | 1 |
| Ben Ayed, F | 1 |
| Auclerc, MF | 1 |
| Maral, J | 1 |
| Hawkins, KA | 1 |
| Schinella, R | 1 |
| Schwartz, M | 1 |
| Ramsey, D | 1 |
| Weintraub, AH | 1 |
| Silber, R | 1 |
| Amorosi, EL | 1 |
| Ochoa-Molina, ME | 2 |
| Kuentz, M | 3 |
| Reyes, F | 3 |
| Brun, B | 4 |
| Lebourgeois, JP | 1 |
| Bierling, P | 1 |
| Farcet, JP | 1 |
| Vernant, JP | 3 |
| Imbert, M | 1 |
| Le Bezu, M | 1 |
| Rochant, H | 3 |
| Dreyfus, B | 4 |
| Tawil, E | 1 |
| Mercier, JP | 1 |
| Denz, H | 1 |
| Lechleitner, M | 1 |
| Peschel, C | 1 |
| Peer, L | 1 |
| Huber, H | 1 |
| Kolygin, BA | 6 |
| Kharatishvili, ZV | 1 |
| Aisenberg, AC | 7 |
| Homan, R | 1 |
| Lechner, K | 2 |
| Neumann, E | 2 |
| Moritz, H | 1 |
| Czembirek, H | 1 |
| Resch, F | 1 |
| Wagener, DJ | 2 |
| Burgers, JM | 5 |
| Dekker, AW | 2 |
| Kazem, I | 1 |
| van Peperzeel, HA | 1 |
| Qasim, MM | 1 |
| Sizoo, W | 3 |
| Somers, R | 8 |
| Kroese, WF | 2 |
| Murray, F | 1 |
| Daly, PA | 1 |
| Freyne, PJ | 1 |
| Shapiro, IB | 1 |
| Lauria, F | 6 |
| Sciascia, R | 3 |
| Emiliani, E | 3 |
| Fiacchini, M | 6 |
| Baccarani, M | 6 |
| Frezza, G | 2 |
| Dominici, G | 1 |
| Cantore, M | 1 |
| Faedi, M | 1 |
| Patricio, MB | 1 |
| Ricardo, JA | 1 |
| Vilhena, M | 1 |
| Branco, F | 1 |
| De Ponte, MA | 1 |
| Cabral, R | 1 |
| Neves, M | 1 |
| De Sousa, JV | 1 |
| Waters, KD | 2 |
| Kovalenko, NS | 1 |
| Fokina, NT | 2 |
| Matusewicz, W | 1 |
| Drzewoski, J | 1 |
| Robak, T | 4 |
| Krykowski, E | 5 |
| Dini, E | 1 |
| MacKintosh, FR | 1 |
| Sullivan, JA | 4 |
| Johnston, D | 1 |
| North, L | 4 |
| Butler, JJ | 8 |
| Daly, H | 1 |
| McCann, SR | 1 |
| Hanratty, TD | 1 |
| Temperley, IJ | 1 |
| Cramer, P | 4 |
| Tea, N | 1 |
| Tricot, G | 2 |
| Flandrin, G | 2 |
| Schaison, G | 7 |
| Mantovani, G | 1 |
| Del Giacco, GS | 1 |
| Marongiu, F | 1 |
| Tognella, S | 1 |
| Carassi, UE | 1 |
| Weidenmaier, W | 1 |
| Röttinger, EM | 1 |
| Gallmeier, WM | 3 |
| Bruntsch, U | 5 |
| Tura, S | 9 |
| Cadman, E | 1 |
| Bloom, AF | 1 |
| Prosnitz, L | 1 |
| Farber, L | 1 |
| Vera, R | 2 |
| Bertino, J | 1 |
| Fischer, D | 1 |
| Diehl, LF | 1 |
| Perry, DJ | 1 |
| Terebelo, H | 1 |
| Baldwin, PE | 1 |
| Hurwitz, M | 1 |
| Kimball, DB | 1 |
| Dorn, RV | 1 |
| Simon, RM | 1 |
| Young, RC | 24 |
| Frei, E | 17 |
| Nesse, RM | 1 |
| Carli, T | 1 |
| Curtis, GC | 1 |
| Kleinman, PD | 1 |
| Kim, YH | 1 |
| Fayos, JV | 1 |
| Fil'kova, EM | 1 |
| Conrad, FG | 1 |
| Faguet, GB | 1 |
| Davis, HC | 1 |
| Pavlovsky, S | 9 |
| Morgenfeld, M | 3 |
| Somoza, N | 3 |
| Magnasco, J | 2 |
| Sackmann Muriel, F | 1 |
| Cavagnaro, F | 1 |
| Suárez, A | 3 |
| Barros, CA | 2 |
| Saslavsky, J | 1 |
| Garay, G | 1 |
| Palau, M | 2 |
| Besuschio, SC | 1 |
| Verhamme, M | 1 |
| Wynants, P | 1 |
| Van de Woestijne, KP | 1 |
| Lauweryns, J | 1 |
| McLeod, R | 1 |
| Estes, RG | 1 |
| Vialushkin, BIa | 2 |
| Koshel', IV | 1 |
| Isaev, IG | 1 |
| Casassus, P | 3 |
| Coscas, Y | 2 |
| Darmont, J | 1 |
| Goubeau, C | 1 |
| Katz, M | 4 |
| Aiba, K | 1 |
| Inagaki, J | 2 |
| Horikoshi, N | 3 |
| Ezaki, K | 1 |
| Inoue, K | 1 |
| Dohmyo, M | 1 |
| Nagata, T | 1 |
| Miyamoto, H | 1 |
| Kobayashi, T | 2 |
| Kuraishi, Y | 2 |
| Rahim, MA | 1 |
| Sarma, SK | 1 |
| Ahmed, Q | 1 |
| Manoharan, A | 1 |
| Schonell, M | 1 |
| Rosenstrauch, WJ | 1 |
| van der Merwe, AM | 1 |
| King, JB | 1 |
| van Eeden, PJ | 1 |
| Steytler, JG | 1 |
| Weiner, MJ | 1 |
| Sicular, A | 1 |
| Blaugrund, SM | 1 |
| Sattler, SM | 1 |
| Shaw, JH | 1 |
| Mulvaney, N | 1 |
| Bostick, F | 1 |
| Vanhaelen, C | 1 |
| Howser, DM | 1 |
| Nordentoft, AM | 4 |
| Brincker, H | 2 |
| Andersen, E | 2 |
| Jensen, MK | 1 |
| Nielsen, JB | 1 |
| Pedersen-Bjergaard, J | 2 |
| Jensen, TS | 1 |
| Jensen, KB | 2 |
| Pedersen, M | 1 |
| Walbom-Jørgensen, S | 2 |
| Kaplan, HS | 12 |
| Streuli, RA | 3 |
| Bayle, C | 1 |
| Clot, P | 2 |
| Dana, M | 5 |
| Gallo, JH | 1 |
| Phadke, KP | 1 |
| Sackmann-Muriel, F | 4 |
| Bonesana, AC | 1 |
| Papendieck, C | 1 |
| Penchansky, L | 1 |
| Schwartz, L | 3 |
| Kvicala, R | 1 |
| Sica, M | 1 |
| Ojeda, F | 1 |
| Barnes, JM | 1 |
| Neiman, RS | 2 |
| Orlow, EL | 1 |
| Sullivan, MP | 5 |
| Chen, T | 1 |
| Fisher, R | 1 |
| Fryer, C | 2 |
| Gehan, E | 1 |
| Hays, D | 1 |
| Hanson, W | 2 |
| Heller, R | 2 |
| Higgins, G | 1 |
| Kung, F | 1 |
| Sheehan, W | 1 |
| Tefft, M | 1 |
| Ternberg, J | 2 |
| Wharam, M | 2 |
| Chan, H | 2 |
| Freedman, M | 3 |
| Greenberg, M | 4 |
| Gribbin, M | 1 |
| McClure, P | 2 |
| Saunders, F | 3 |
| Sonley, M | 2 |
| Cunningham, J | 1 |
| Mauch, P | 11 |
| Rosenthal, DS | 9 |
| Johnston, DA | 2 |
| Perenyi, L | 1 |
| Pralle, H | 1 |
| Hellman, S | 7 |
| Gibbs, GE | 1 |
| Kennedy, BJ | 3 |
| Vosika, G | 2 |
| Stäubli, M | 1 |
| Graf, W | 1 |
| Straub, PW | 1 |
| Lawson, JP | 1 |
| Friedlaender, GE | 1 |
| Pezzimenti, JF | 1 |
| Chapman, RM | 1 |
| Strickland, P | 1 |
| Schilsky, RL | 2 |
| Sherins, RJ | 6 |
| Wesley, MN | 2 |
| Ultmann, JE | 5 |
| Fazio, M | 1 |
| Airoldi, M | 1 |
| Bellardo, A | 1 |
| Cavallero, P | 1 |
| Mastromatteo, V | 1 |
| Minnella, R | 1 |
| Pecchio, F | 1 |
| Velazquez, WS | 1 |
| North, LB | 3 |
| Martin, RG | 1 |
| Blehová, Z | 1 |
| Masopust, J | 1 |
| Sámal, M | 1 |
| Zuazu, J | 1 |
| Durán Suárez, JR | 1 |
| Triginer, AJ | 1 |
| Kaplan, HG | 1 |
| Doolittle, CH | 1 |
| Brunner, K | 3 |
| Cuttner, J | 2 |
| Falkson, G | 3 |
| Grunwald, H | 1 |
| Bank, A | 2 |
| Leone, L | 2 |
| Seligman, BR | 1 |
| Silver, RT | 2 |
| Weiss, RB | 3 |
| Haurani, F | 2 |
| Blom, J | 2 |
| Spurr, CL | 2 |
| Gordon, RA | 1 |
| Lookingbill, DP | 1 |
| Abt, AB | 1 |
| Albala, MM | 1 |
| Steinfeld, AD | 1 |
| Khilnani, MT | 1 |
| Diumenjo, MC | 1 |
| Monsterrat, E | 1 |
| Alaoui, Y | 1 |
| Baillet, F | 4 |
| Maylin, C | 2 |
| Pierquin, B | 3 |
| Jacobson, RJ | 1 |
| Klappenbach, RS | 1 |
| Clinton, C | 1 |
| de Moor, NG | 1 |
| Wong, O | 1 |
| Kotlarek-Haus, S | 4 |
| Gabryś, K | 5 |
| Potoczek, S | 1 |
| Glanzmann, C | 1 |
| Stahel, R | 2 |
| Kingreen, D | 1 |
| Dalal, BI | 1 |
| Heyman, M | 1 |
| Phillips, GL | 3 |
| Horsman, D | 1 |
| Kidd, P | 1 |
| Loughran, TP | 1 |
| Cleary, SF | 1 |
| Abboud, J | 1 |
| Nasrallah, T | 1 |
| Chahine, G | 1 |
| Nasnas, R | 1 |
| Khanuja, PS | 1 |
| Bishop, CR | 1 |
| Andersen, J | 1 |
| Hussein, ME | 1 |
| Mah, K | 1 |
| Keane, TJ | 1 |
| Van Dyk, J | 1 |
| Braban, LE | 1 |
| Poon, PY | 1 |
| Hao, Y | 1 |
| Tarayre, M | 2 |
| de Pauw, BE | 2 |
| Breed, WP | 2 |
| Verdonck, L | 1 |
| Siena, S | 2 |
| Bregni, M | 2 |
| Lombardi, F | 2 |
| Gandola, L | 1 |
| Di Nicola, M | 1 |
| Magni, M | 1 |
| Peccatori, F | 1 |
| Lobo-Sanahuja, F | 1 |
| García, I | 3 |
| Barrantes, M | 1 |
| González, M | 2 |
| Jiménez, R | 1 |
| Moreau, P | 2 |
| Milpied, N | 2 |
| Mechinaud-Lacroix, F | 1 |
| Mahe, B | 1 |
| Rapp, MJ | 1 |
| Le Tortorec, S | 1 |
| Bourdin, S | 1 |
| Dupas, B | 1 |
| Harousseau, JL | 2 |
| Lazzarino, M | 4 |
| Orlandi, E | 4 |
| Canevari, A | 2 |
| Morra, E | 3 |
| Castelli, G | 3 |
| Alessandrino, EP | 2 |
| Pagnucco, G | 4 |
| Astori, C | 3 |
| Livraghi, A | 2 |
| Mandard, AM | 1 |
| Mellink, WA | 1 |
| Santagostino, A | 1 |
| Bernasconi, C | 2 |
| Preti, A | 1 |
| Swan, F | 6 |
| Besa, P | 1 |
| Allen, PK | 2 |
| Bernasconi, P | 1 |
| Koeppel, MC | 1 |
| Horschowski, N | 1 |
| Terrier, G | 1 |
| Andrac, L | 1 |
| Stoppa, AM | 1 |
| Signoret, R | 1 |
| Sayag, J | 1 |
| Fuchs, R | 5 |
| Dölken, G | 4 |
| Gerhartz, H | 8 |
| Hagen-Aukamp, U | 3 |
| Hiller, E | 9 |
| Petsch, S | 4 |
| Pflüger, KH | 3 |
| Hunger, SP | 1 |
| Khan, SP | 1 |
| Arndt, CA | 1 |
| Smithson, WA | 1 |
| Chen, MG | 1 |
| Schomberg, PJ | 1 |
| Matsumoto, JM | 1 |
| O'Fallon, WM | 1 |
| Greminger, P | 1 |
| Dommann-Scherrer, C | 1 |
| Krestin, GP | 1 |
| Mjaaland, I | 1 |
| Ganser, D | 1 |
| Freitag, EM | 1 |
| Bohndorf, W | 1 |
| Soncini, F | 3 |
| Devizzi, L | 6 |
| Castellani, MR | 1 |
| Negretti, E | 3 |
| Crennan, E | 1 |
| D'Costa, I | 1 |
| Liew, KH | 2 |
| Thompson, J | 1 |
| Laidlaw, C | 2 |
| Cooper, I | 2 |
| Quong, G | 1 |
| Fried, G | 1 |
| Ben Arieh, Y | 1 |
| Dale, J | 1 |
| Stein, M | 1 |
| Balzarini, L | 1 |
| Kozielski, J | 1 |
| Rauer, R | 1 |
| Ziora, D | 1 |
| Spychałowicz, W | 1 |
| Myint, H | 1 |
| McGregor, J | 1 |
| Edwards, R | 1 |
| Lucie, NP | 1 |
| Hancock, SL | 2 |
| Pollicardo, N | 1 |
| Pungolino, E | 2 |
| Frassoni, F | 2 |
| Giordano, D | 3 |
| Bruni, R | 2 |
| Spriano, M | 2 |
| Rossi, E | 2 |
| Aversa, S | 1 |
| Chiarion Sileni, V | 2 |
| Scarzello, G | 1 |
| Bianco, A | 2 |
| Pappagallo, GL | 2 |
| Fiorentino, MV | 2 |
| Lévy, R | 1 |
| Tourani, JM | 3 |
| Gastaut, JA | 1 |
| Taillan, B | 1 |
| Bendandi, M | 3 |
| Zaccaria, A | 2 |
| Visani, G | 2 |
| Stefanati, V | 1 |
| Cantagalli, F | 1 |
| Mancino, A | 1 |
| Macchi, S | 1 |
| Simoncelli, F | 1 |
| Errante, D | 2 |
| Dolcetti, R | 1 |
| Gloghini, A | 1 |
| Serraino, D | 1 |
| Franceschi, S | 1 |
| Boiocchi, M | 1 |
| Carbone, A | 3 |
| Reece, DE | 2 |
| Barnett, MJ | 2 |
| Shepherd, JD | 2 |
| Hogge, DE | 1 |
| Nantel, SH | 1 |
| Sutherland, HJ | 1 |
| Klingemann, HG | 2 |
| Fairey, RN | 2 |
| Voss, NJ | 1 |
| Jekunen, A | 1 |
| Maiche, A | 1 |
| Laurila, P | 1 |
| Franssila, K | 1 |
| Elomaa, I | 1 |
| Dreger, P | 1 |
| Klöss, M | 1 |
| Petersen, B | 1 |
| Haferlach, T | 1 |
| Gui, W | 1 |
| Zhen, YP | 1 |
| Chang, XQ | 1 |
| Bates, SE | 1 |
| Fojo, A | 1 |
| Bryant, G | 1 |
| Zhan, Z | 1 |
| Regis, J | 1 |
| Wittes, RE | 2 |
| Steinberg, SM | 1 |
| Herdt, J | 1 |
| Barcos, M | 4 |
| Sullivan, JW | 1 |
| Cooper, JS | 1 |
| Völler, H | 1 |
| Kreuser, ED | 3 |
| Uhrig, A | 1 |
| Schröder, K | 1 |
| Behles, C | 2 |
| Thiel, E | 3 |
| Schröder, R | 1 |
| Martino, R | 1 |
| Nomdedeu, J | 1 |
| Brunet, S | 1 |
| Scholz, KH | 1 |
| Herrmann, C | 1 |
| Tebbe, U | 1 |
| Chemnitius, JM | 1 |
| Helmchen, U | 1 |
| Kreuzer, H | 1 |
| Spector, N | 2 |
| Costa, MA | 1 |
| Pulcheri, W | 1 |
| Salgado, RC | 1 |
| Nucci, M | 1 |
| Andrade, CA | 1 |
| de Morais, JC | 1 |
| de Castro, O | 1 |
| Scaletsky, AF | 1 |
| Brabo, E | 1 |
| Chintagumpala, MM | 1 |
| Mahoney, DH | 1 |
| McClain, K | 1 |
| Dreyer, ZE | 1 |
| Fishman, MA | 1 |
| Carrol, CL | 1 |
| Steuber, CP | 1 |
| Behar, RA | 1 |
| Pieresca, C | 1 |
| Narni, F | 1 |
| Avanzini, P | 1 |
| Partesotti, G | 1 |
| Uematsu, M | 1 |
| Coleman, CN | 5 |
| Shulman, LN | 2 |
| Canellos, G | 1 |
| Bader, SB | 1 |
| Lepage, E | 4 |
| Fermand, JP | 1 |
| Castaigne, S | 2 |
| Frija, J | 1 |
| Miot, C | 1 |
| Topilow, AA | 1 |
| Guerra, OR | 1 |
| Tarantolo, SR | 1 |
| Lerner, WA | 1 |
| Snyder, GC | 1 |
| Liang, JC | 4 |
| Bailey, NM | 2 |
| Gabriel, GJ | 1 |
| Kattan, MW | 1 |
| Wang, RY | 1 |
| Lichtman, SM | 1 |
| Brody, J | 1 |
| Kaplan, MH | 1 |
| Susin, M | 1 |
| Koduru, P | 1 |
| Goh, JC | 1 |
| Simmonds, P | 1 |
| Silberstein, M | 1 |
| McKendrick, J | 1 |
| Gerhartz, HH | 1 |
| Beykirch, M | 1 |
| Wilmanns, W | 4 |
| Pileri, S | 1 |
| Burnelli, R | 1 |
| Bontempi, N | 1 |
| Comelli, A | 1 |
| Carli, M | 1 |
| Rosati, D | 1 |
| Di Tullio, MT | 1 |
| Yong, WB | 1 |
| Zhu, XM | 1 |
| Wójtowicz, J | 1 |
| Hryniewicz, A | 1 |
| Rosłan, K | 1 |
| Chatterjee, R | 1 |
| Mills, W | 1 |
| McGarrigle, HH | 1 |
| Goldstone, AH | 2 |
| Hayat, M | 6 |
| Burgers, MJ | 1 |
| Tanguy, A | 2 |
| Le Fur, R | 2 |
| Levêque, J | 1 |
| Meunier, B | 1 |
| Poulain, P | 1 |
| Blanchot, J | 1 |
| Dugast, J | 1 |
| Le Prise, E | 1 |
| Grall, JY | 2 |
| Ilhan, I | 2 |
| Sarialioglu, F | 3 |
| Ozbarlas, N | 1 |
| Büyükpamukçu, M | 3 |
| Akyüz, C | 3 |
| Kutluk, T | 2 |
| Rysenga, E | 1 |
| Linden, MD | 1 |
| Carey, JL | 1 |
| Ross, CW | 1 |
| Schnitzer, B | 1 |
| Sawdyk, M | 1 |
| Carrión, JR | 1 |
| García Arroyo, FR | 1 |
| Salinas, P | 1 |
| Agarwal, S | 1 |
| Avasthi, R | 1 |
| Tyagi, SC | 1 |
| Singh, K | 1 |
| Ram, BK | 1 |
| Pautier, P | 1 |
| Marolleau, JP | 1 |
| Deschênes, G | 1 |
| Allard, C | 1 |
| Benoit, S | 1 |
| Lejars, O | 1 |
| Lamagnére, JP | 2 |
| Nivet, H | 1 |
| Montillo, M | 1 |
| Scarpelli, M | 1 |
| Discepoli, G | 1 |
| Catarini, M | 1 |
| Rychlicki, F | 1 |
| Leoni, P | 1 |
| Kessinger, A | 1 |
| Lee, CK | 3 |
| Levitt, SH | 1 |
| Onoshi, T | 1 |
| Robinson, BA | 1 |
| Colls, BM | 1 |
| Fitzharris, BM | 1 |
| Atkinson, CH | 1 |
| Kalish, LA | 1 |
| Dietrich, PY | 1 |
| Cosset, JM | 4 |
| Bodis, S | 1 |
| Souliotis, VL | 1 |
| Valavanis, C | 1 |
| Kyrtopoulos, SA | 1 |
| Purugganan, R | 2 |
| Fuller, L | 2 |
| Romaguera, J | 3 |
| Rodriguez, M | 2 |
| Fisher, PM | 1 |
| Dodwell, DJ | 2 |
| Bridges, LR | 1 |
| Cartwright, SC | 1 |
| Stone, J | 1 |
| Brandriff, BF | 1 |
| Gordon, LA | 1 |
| Carrano, AV | 1 |
| Bokemeyer, C | 1 |
| van Rhee, J | 1 |
| Kuczyk, M | 1 |
| Schuppert, F | 1 |
| Poliwoda, H | 1 |
| Delmez, JA | 1 |
| Safdar, SH | 2 |
| Kissane, JM | 1 |
| Brämswig, JH | 5 |
| Hörnig-Franz, I | 2 |
| Hancock, BW | 5 |
| Vaughan Hudson, G | 4 |
| Vaughan Hudson, B | 3 |
| Linch, DC | 5 |
| Anderson, L | 2 |
| MacLennan, KA | 4 |
| Podoloff, DA | 1 |
| Hess, M | 1 |
| Avilés, A | 6 |
| Arévila, N | 1 |
| Díaz Maqueo, JC | 1 |
| Gómez, T | 1 |
| García, R | 1 |
| Nambo, MJ | 1 |
| Gosselin, M | 1 |
| Podgorsak, EB | 1 |
| Evans, MD | 1 |
| Pla, M | 1 |
| Shenouda, G | 1 |
| Grundstein-Amado, R | 1 |
| Dhabhar, BN | 1 |
| Malhotra, H | 1 |
| Joseph, R | 1 |
| Garde, S | 1 |
| Bhasin, S | 1 |
| Sheth, A | 1 |
| Advani, SH | 2 |
| Cascinu, S | 1 |
| Fedeli, A | 1 |
| Catalano, G | 1 |
| Grigoraki, V | 1 |
| Lilienthal, F | 1 |
| Binet, JL | 1 |
| Merle-Béral, H | 2 |
| Hotta, O | 1 |
| Taguma, Y | 1 |
| Kurosawa, K | 1 |
| Sudo, K | 1 |
| Takahashi, H | 1 |
| Kirshner, JJ | 1 |
| Parker, B | 1 |
| Bergeron, C | 1 |
| Le Moine, P | 1 |
| Le Prise-Fleury, E | 1 |
| Jouan, H | 1 |
| Tass, P | 1 |
| Darcel, F | 1 |
| Chatel, M | 1 |
| Edan, C | 1 |
| Patte, C | 1 |
| Faivre, J | 1 |
| Kaźmierczak, M | 1 |
| Kroll, R | 1 |
| Hayashi, T | 1 |
| Yamabe, H | 1 |
| Haga, H | 1 |
| Akasaka, T | 1 |
| Kadowaki, N | 1 |
| Ohno, H | 1 |
| Okuma, M | 1 |
| Fukuhara, S | 1 |
| Yaniv, I | 1 |
| Saab, A | 1 |
| Cohen, IJ | 1 |
| Goshen, Y | 2 |
| Loven, D | 1 |
| Stark, B | 1 |
| Tamary, H | 1 |
| Zaizov, R | 2 |
| Fitzgerald, A | 1 |
| Björkholm, M | 2 |
| Axdorph, U | 1 |
| Grimfors, G | 1 |
| Merk, K | 1 |
| Johansson, B | 1 |
| Landgren, O | 1 |
| Svedmyr, E | 1 |
| Mellstedt, H | 1 |
| Holm, G | 1 |
| Ruehl, U | 1 |
| Smith, K | 2 |
| Geilen, W | 2 |
| Abdallah, JM | 1 |
| Lombardi, DP | 1 |
| Kirsch, IR | 1 |
| Naccache, P | 1 |
| Bendahmane, B | 1 |
| Munck, JN | 1 |
| Papadakis, V | 2 |
| Tan, C | 2 |
| Heller, G | 1 |
| Sklar, C | 2 |
| Bilgiç, H | 1 |
| Göçmen, A | 1 |
| Zompatori, M | 1 |
| Battista, G | 1 |
| Fanti, S | 1 |
| Barbieri, E | 3 |
| Gherlinzoni, F | 2 |
| Rimondi, MR | 1 |
| Pisi, P | 1 |
| Merla, E | 1 |
| Gozzetti, A | 1 |
| Canini, R | 1 |
| Monetti, N | 1 |
| Babini, L | 2 |
| Cervantes, F | 3 |
| Bruguera, M | 1 |
| Font, C | 1 |
| Grau, JM | 1 |
| Rozman, C | 3 |
| Burney, IA | 1 |
| Malik, IA | 1 |
| Yuen, AR | 1 |
| Hood, IM | 1 |
| Mahendra, P | 1 |
| McNeil, K | 1 |
| Marcus, RE | 2 |
| Prencipe, E | 1 |
| Lerma, E | 1 |
| Occhini, D | 2 |
| Gatti, AM | 1 |
| Nati, S | 2 |
| Pierluigi, D | 2 |
| Congiu, M | 1 |
| Vimercati, R | 1 |
| Ravetti, JL | 1 |
| Ifrah, N | 3 |
| Hunault, M | 1 |
| Le Maignan, C | 1 |
| Kalkner, M | 1 |
| Jakobsson, M | 1 |
| Branehog, I | 1 |
| Lenner, P | 1 |
| Heikens, J | 1 |
| Adriaanse, R | 1 |
| Berghout, A | 1 |
| Linn, S | 1 |
| Ben-Shahar, M | 3 |
| Solanellas, J | 1 |
| Esteban, F | 1 |
| Soldado, L | 1 |
| López-Lacomba, D | 1 |
| Hierro, C | 1 |
| Jimenez, JM | 1 |
| Kumari, PK | 1 |
| Chellam, VG | 1 |
| Madhavan, J | 1 |
| Ratheesan, K | 1 |
| Pillai, GR | 1 |
| Kumar, SR | 1 |
| Nair, MK | 1 |
| Swerdlow, AJ | 2 |
| Barber, JA | 2 |
| Horwich, A | 2 |
| Milan, S | 1 |
| Omar, RZ | 1 |
| Falchero, L | 1 |
| Guibert, B | 1 |
| Souquet, PJ | 1 |
| Isaac Pinet, S | 1 |
| Trillet-Lenoir, V | 1 |
| Harif, M | 1 |
| Trachli, A | 1 |
| Quessar, A | 1 |
| Sehraoui, S | 1 |
| Benchekroun, S | 1 |
| Benchemsi, N | 1 |
| Fickers, M | 1 |
| Theunissen, P | 1 |
| van Noord, JA | 1 |
| Redei, I | 1 |
| Mangan, KF | 1 |
| Ming, PL | 1 |
| Mullaney, MT | 1 |
| Rao, PN | 1 |
| Goldberg, SL | 1 |
| Klumpp, TR | 1 |
| Urbaniak-Kujda, D | 1 |
| Dubowik, R | 1 |
| Rüffer, U | 3 |
| Lieberz, D | 1 |
| Adler, M | 1 |
| Klasa, R | 1 |
| Hoskins, P | 2 |
| Meurman, JH | 2 |
| Laine, P | 2 |
| Keinànen, S | 1 |
| Pyrhönen, S | 2 |
| Teerenhovi, L | 2 |
| Lindqvist, C | 2 |
| Varterasian, ML | 1 |
| Aref, A | 1 |
| Baez, F | 1 |
| Ocampo, E | 1 |
| Conter, V | 1 |
| Flores, A | 1 |
| Gutierrez, T | 1 |
| Malta, A | 1 |
| Pacheco, C | 1 |
| Palacios, R | 1 |
| Riva, L | 1 |
| Silvestri, D | 1 |
| Cavalli, F | 2 |
| Sessa, C | 1 |
| Casanova, M | 1 |
| Masera, G | 1 |
| Robbins, WA | 1 |
| Moore, D | 1 |
| Weier, HU | 1 |
| Cassel, MJ | 1 |
| Wilson, G | 3 |
| Eskenazi, B | 1 |
| Stuve, W | 1 |
| Pérez del Río, MJ | 1 |
| Fresno, MF | 1 |
| Ramírez, A | 1 |
| Veiga, M | 1 |
| Herrero, A | 1 |
| Marjańska-Radziszewska, J | 1 |
| Zawiła, K | 1 |
| Cieśla, E | 1 |
| Zsiros, J | 1 |
| Bossi, G | 1 |
| Cerveri, I | 1 |
| Volpini, E | 1 |
| Corsico, A | 1 |
| Baio, A | 1 |
| Klersy, C | 2 |
| Arico, M | 1 |
| Burgers, M | 1 |
| Mandard, A | 1 |
| Breed, W | 1 |
| Noordijk, E | 1 |
| Klimo, P | 5 |
| Adams, G | 1 |
| Burns, BF | 1 |
| Meyer, RM | 1 |
| Pater, J | 1 |
| Quirt, I | 1 |
| Sadura, A | 1 |
| Shustik, C | 1 |
| Skillings, J | 1 |
| Sutcliffe, S | 1 |
| Yoshida, S | 1 |
| Zee, B | 1 |
| Creutzig, U | 1 |
| Ritter, J | 1 |
| Harbott, J | 1 |
| Gadner, H | 1 |
| Bartels, H | 2 |
| Cartoni, C | 4 |
| Enzian, J | 1 |
| Hinkelbein, H | 1 |
| Hinterberger, W | 1 |
| Kirchner, H | 5 |
| Krüger, B | 1 |
| Kamieńska, E | 1 |
| Schvartzman, E | 1 |
| Lastiri, F | 1 |
| Magnasco, H | 2 |
| Raslawski, E | 1 |
| Cancela, ME | 1 |
| Ardaiz, MC | 1 |
| Cerutti, I | 1 |
| Rosso, A | 1 |
| Bruno, S | 1 |
| Aranguren, PN | 1 |
| Salvarezza, A | 1 |
| Donato, H | 1 |
| Dibar, E | 1 |
| Zirone, S | 1 |
| Imrie, KR | 1 |
| Sheridan, B | 1 |
| Colwill, R | 1 |
| Stewart, AK | 1 |
| McCrae, J | 1 |
| Danish, R | 1 |
| Sutton, D | 1 |
| Romeyer, F | 1 |
| Keating, A | 2 |
| Weiner, MA | 3 |
| Leventhal, B | 1 |
| Brecher, ML | 1 |
| Marcus, RB | 1 |
| Cantor, A | 2 |
| Gieser, PW | 1 |
| Kulkarni, SS | 1 |
| Sastry, PS | 1 |
| Saikia, TK | 1 |
| Parikh, PM | 1 |
| Gopal, R | 1 |
| Zubizarreta, P | 1 |
| Gallo, G | 1 |
| Scopinaro, M | 1 |
| Alderete, D | 1 |
| Alfaro, E | 1 |
| Casak, S | 1 |
| Chantada, G | 1 |
| Felice, MS | 1 |
| Quinteros, R | 1 |
| Corry, J | 1 |
| Duffey, PL | 8 |
| Ihde, DC | 2 |
| Bastian, AW | 2 |
| Feng, F | 2 |
| Zhou, L | 2 |
| He, X | 1 |
| Mathur, K | 1 |
| Lipshultz, LI | 1 |
| Golden, MA | 1 |
| Vaughn, DJ | 1 |
| Crooks, GW | 1 |
| Holland, GA | 1 |
| Bavaria, JE | 1 |
| Wong, TZ | 1 |
| Levine, JD | 1 |
| Safer, M | 1 |
| Jones, EL | 1 |
| Ziółko, E | 1 |
| Young, ML | 1 |
| Harrington, D | 1 |
| Beck, T | 1 |
| Neiman, R | 1 |
| Oken, MM | 3 |
| Ritter, M | 1 |
| Shen-Orr, Z | 1 |
| Shariki, K | 1 |
| Tsodikov, A | 1 |
| Yakovlev, A | 1 |
| Fryer, CJ | 1 |
| Nachman, J | 1 |
| Krailo, MD | 1 |
| O'Brien, RT | 1 |
| Collins, RD | 1 |
| Whalen, T | 1 |
| Reardon, D | 1 |
| Trigg, ME | 1 |
| Camerini, E | 1 |
| Fornier, M | 1 |
| Verderio, P | 1 |
| Hesseling, PB | 1 |
| Van Jaarsveld, D | 1 |
| Van Riet, FA | 1 |
| Gabbay, U | 1 |
| Blickstein, D | 1 |
| Stark, P | 1 |
| Prokocimer, M | 1 |
| Epstein, O | 1 |
| Shaklai, M | 1 |
| Lahav, J | 1 |
| Dunlop, DJ | 1 |
| Eatock, MM | 1 |
| Paul, J | 1 |
| Anderson, S | 1 |
| Reed, NS | 1 |
| Soukop, M | 1 |
| Lucie, N | 1 |
| Fitzsimmons, EJ | 1 |
| Tansey, P | 1 |
| Steward, WP | 1 |
| Ohno, T | 2 |
| Abou-Elella, A | 1 |
| Reis, HE | 1 |
| Chan, WC | 1 |
| Propert, KJ | 3 |
| Glicksman, A | 1 |
| Peterson, B | 1 |
| Gottlieb, A | 3 |
| Kaufman, T | 1 |
| Mwanda, OW | 1 |
| Othieno-Abinya, N | 1 |
| Bienvenu, J | 1 |
| Ribeiro, P | 1 |
| Moullet, I | 2 |
| Dumontet, C | 1 |
| Neidhardt-Berard, EM | 1 |
| Silva, MM | 1 |
| Morais, JC | 1 |
| Maceira, J | 1 |
| Sousa, MA | 1 |
| Filgueira, AL | 1 |
| Martelli, M | 1 |
| Ronconi, F | 1 |
| Bocchia, M | 1 |
| Marra, R | 1 |
| Gobbi, M | 3 |
| Falini, B | 1 |
| De Renzo, A | 1 |
| Pavone, E | 1 |
| Sabattini, E | 1 |
| Amendola, A | 1 |
| Blaise, D | 1 |
| Fleury, J | 1 |
| Cahn, JY | 1 |
| Pico, JL | 1 |
| Bastion, Y | 2 |
| Nedellec, G | 1 |
| Attal, M | 1 |
| Arranz, R | 1 |
| Muñoz, E | 1 |
| Acevedo, A | 1 |
| Sobrino, MP | 1 |
| Fernández-Rañada, JM | 1 |
| Nyandoto, P | 1 |
| Muhonen, T | 1 |
| Joensuu, H | 1 |
| Santoro, M | 1 |
| Lunghi, F | 1 |
| Maurizi-Enrici, R | 1 |
| Baroni, CD | 1 |
| Gerres, L | 1 |
| Schlegel, W | 2 |
| Schwieder, G | 1 |
| Wulf, G | 3 |
| Tirier, C | 1 |
| Müller, U | 1 |
| Rueffer, JU | 1 |
| Sextro, M | 2 |
| Holmer, L | 2 |
| Stappert-Jahn, U | 2 |
| Winnerlein-Trump, E | 2 |
| Krause, S | 2 |
| Bischoff, H | 2 |
| Haedicke, C | 2 |
| Tsushita, K | 1 |
| Utsumi, M | 1 |
| Baron, F | 1 |
| Hermanne, JP | 1 |
| Fassotte, MF | 1 |
| Beguin, Y | 1 |
| Fillet, G | 1 |
| Klapper, SR | 1 |
| Jordan, DR | 1 |
| McLeish, W | 1 |
| Pelletier, C | 1 |
| Shimizu, K | 1 |
| Hara, K | 1 |
| Yatabe, Y | 1 |
| Yilmaz, U | 1 |
| Ridolfo, AL | 1 |
| Nosari, AM | 1 |
| Kerneis, Y | 3 |
| Mazzetti, F | 1 |
| Salloum, E | 1 |
| Tanoue, LT | 1 |
| Wackers, FJ | 1 |
| Zelterman, D | 1 |
| Hu, GL | 1 |
| Cooper, DL | 1 |
| Klein, R | 1 |
| Müllges, W | 1 |
| Bendszus, M | 1 |
| Woydt, M | 1 |
| Kreipe, H | 1 |
| Roggendorf, W | 1 |
| Vlachopapadopoulou, E | 1 |
| Van Syckle, K | 1 |
| Ganshaw, L | 1 |
| Kalmanti, M | 1 |
| Cantin, G | 1 |
| L'Espérance, B | 1 |
| Yelle, L | 2 |
| Desjardins, L | 1 |
| Couture, F | 1 |
| Bergeron, M | 1 |
| Lacroix, L | 1 |
| Dufresne, J | 1 |
| Bélanger, D | 1 |
| Ouellet, PA | 1 |
| Hewitt, LA | 1 |
| Pirc, L | 1 |
| Gyger, M | 1 |
| Osaka, M | 1 |
| Rowley, JD | 1 |
| Zeleznik-Le, NJ | 1 |
| Tormo, M | 1 |
| Marugán, I | 1 |
| Solano, C | 1 |
| Benet, I | 1 |
| Garcia-Conde, J | 1 |
| Murray, PG | 1 |
| Billingham, LJ | 1 |
| Hassan, HT | 1 |
| Flavell, JR | 1 |
| Nelson, PN | 1 |
| Scott, K | 1 |
| Reynolds, G | 1 |
| Constandinou, CM | 1 |
| Kerr, DJ | 1 |
| Devey, EC | 1 |
| Crocker, J | 1 |
| Young, LS | 1 |
| Chim, CS | 1 |
| Kwong, YL | 1 |
| Lie, AK | 1 |
| Ho, FC | 1 |
| Liang, R | 1 |
| Delain, M | 1 |
| Cartron, G | 1 |
| Bout, M | 1 |
| Benboubker, L | 1 |
| Linassier, C | 1 |
| Mwangi, JW | 1 |
| Bogusławska-Jaworska, J | 1 |
| Pisarek, J | 1 |
| Janik-Moszant, A | 1 |
| Rokicka-Milewska, R | 1 |
| Kołecki, P | 1 |
| Skomra, S | 1 |
| Newecka-Samól, T | 1 |
| Harrison, CN | 1 |
| Gregory, W | 1 |
| Devereux, S | 1 |
| Hancock, B | 1 |
| Winfield, D | 1 |
| MacMillan, AK | 1 |
| Hoskin, P | 1 |
| Newland, AC | 1 |
| Milligan, D | 1 |
| Nakayama, M | 1 |
| Umeda, M | 1 |
| Stroszczynski, C | 1 |
| Hosten, N | 1 |
| Oellinger, J | 1 |
| Spahn, G | 1 |
| Bittner, RC | 1 |
| Hierholzer, J | 1 |
| Felix, R | 1 |
| Lucas, JB | 1 |
| Horwitz, SM | 1 |
| Sayegh, A | 1 |
| Gopal, AK | 1 |
| Schuetze, SM | 1 |
| Weiden, PL | 2 |
| Prott, FJ | 1 |
| Rath, B | 1 |
| Reiter, A | 1 |
| Weissbach, G | 1 |
| Thiemann, M | 1 |
| Fouillard, L | 1 |
| Laporte, J | 1 |
| Douay, L | 1 |
| Lesage, S | 1 |
| Najman, A | 1 |
| Gourmelon, P | 1 |
| Gorin, NC | 1 |
| Keilholz, U | 1 |
| Szelényi, H | 1 |
| Foss, HD | 1 |
| Knauf, W | 2 |
| Lishner, M | 2 |
| Manor, Y | 1 |
| Kitay-Cohen, Y | 1 |
| Avishay, AE | 1 |
| Calvo Villas, J | 1 |
| Ramírez Sánchez, M | 1 |
| Sicilia Guillén, F | 1 |
| Ohshima, K | 1 |
| Suzumiya, J | 1 |
| Sato, K | 1 |
| Kanda, M | 1 |
| Simazaki, T | 1 |
| Kawasaki, C | 1 |
| Haraoka, S | 1 |
| Kikuchi, M | 2 |
| Montemurro, F | 1 |
| Fagioli, F | 1 |
| Volta, C | 1 |
| Racanelli, V | 1 |
| Ferrara, R | 1 |
| Castoldi, GL | 1 |
| Dammacco, F | 1 |
| Muwakkit, S | 1 |
| Geara, F | 1 |
| Nabbout, B | 1 |
| Farah, RA | 1 |
| Shabb, NS | 1 |
| Hajjar, T | 1 |
| Khogali, M | 1 |
| Dubey, P | 1 |
| Mathur, KK | 1 |
| Ben Abid, H | 1 |
| Hafsia, R | 1 |
| Hafsia, A | 1 |
| Hennequin, C | 1 |
| Ferrant, A | 4 |
| Ertem, M | 1 |
| Uysal, Z | 1 |
| Pacquement, H | 2 |
| Habrand, JL | 4 |
| Terrier-Lacombe, MJ | 2 |
| Bertrand, Y | 2 |
| Perel, Y | 1 |
| Coze, C | 1 |
| Thuret, I | 1 |
| Donadieu, J | 1 |
| Leverger, G | 5 |
| Lemerle, J | 5 |
| Oberlin, O | 7 |
| Smets, F | 1 |
| Vajro, P | 1 |
| Cornu, G | 2 |
| Reding, R | 1 |
| Otte, JB | 1 |
| Sokal, E | 1 |
| Montoto, S | 1 |
| Camós, M | 1 |
| Blandé, J | 1 |
| Cobo, F | 1 |
| Campo, E | 1 |
| Bertè, R | 1 |
| Petrilli, MP | 1 |
| Ghirardelli, ML | 1 |
| Ascari, E | 2 |
| Tomasević, Z | 1 |
| Jelić, S | 1 |
| Romejko-Jarosińska, J | 1 |
| Miśkiewicz, Z | 1 |
| Tal, R | 1 |
| Botchan, A | 1 |
| Hauser, R | 1 |
| Yogev, L | 1 |
| Paz, G | 1 |
| Yavetz, H | 1 |
| Sauter, C | 3 |
| Petera, J | 1 |
| Macharová, H | 1 |
| Pohanková, R | 1 |
| Malír, A | 1 |
| Coupek, P | 1 |
| Konecný, M | 1 |
| Patera, J | 1 |
| Pecina, J | 1 |
| Drbal, J | 1 |
| Koukalová, H | 1 |
| Powles, T | 1 |
| Bower, M | 1 |
| Choe, JG | 1 |
| Kong, JS | 1 |
| Oh, YK | 1 |
| Edmund, E | 1 |
| Geissler, K | 1 |
| Gisslinger, H | 1 |
| Knöbl, P | 1 |
| Sperr, W | 1 |
| Valent, P | 1 |
| Chott, A | 1 |
| Jäger, U | 1 |
| Pérez, JA | 1 |
| Ramírez, R | 1 |
| Carpio, D | 1 |
| Carrasco, C | 1 |
| Engel, C | 1 |
| Schmitz, S | 1 |
| Hardan, I | 1 |
| Raanani, P | 1 |
| Grotto, I | 1 |
| Elconin, JH | 1 |
| Rizzieri, DA | 1 |
| Vermont, C | 1 |
| Clough, RW | 1 |
| Kim, C | 1 |
| Dodge, RK | 1 |
| Soriano Guillén , L | 1 |
| Muñoz Calvo , MT | 1 |
| Pozo Román , J | 1 |
| Contra Gómez , T | 1 |
| Buño Soto , M | 1 |
| Argente Oliver , J | 1 |
| Homenda, W | 1 |
| Hellmann, A | 1 |
| Lee, KH | 1 |
| Fiedler, P | 1 |
| Passarelli, J | 1 |
| Bobrow, S | 1 |
| Maslovsky, I | 1 |
| Volchek, L | 1 |
| Blumental, R | 1 |
| Ducach, A | 1 |
| Lugassy, G | 1 |
| Delgado, M | 1 |
| Razola, P | 1 |
| Abós, MD | 1 |
| Martí, JL | 1 |
| Murillo, L | 1 |
| García, F | 1 |
| Prats, E | 1 |
| Banzo, J | 1 |
| Nicolatou-Galitis, O | 1 |
| Papadaki, T | 1 |
| Moschovi, M | 1 |
| Moshovi, M | 1 |
| Kamma, JJ | 1 |
| van Vliet-Constantinidou, C | 1 |
| Tsoumakas, C | 1 |
| Kattamis, A | 1 |
| Tzortzatou-Stathopoulou, F | 1 |
| Watanabe, H | 1 |
| Shibata, A | 1 |
| Hamilton, VM | 1 |
| Norris, C | 1 |
| Bunin, N | 1 |
| Goldwein, JW | 2 |
| Bunin, GR | 1 |
| Lange, B | 3 |
| Cazals-Hatem, D | 1 |
| Copin, MC | 1 |
| Bosly, A | 2 |
| Quesnel, B | 1 |
| Gaulard, P | 1 |
| Garaventa, A | 1 |
| Haupt, R | 1 |
| Panarello, C | 1 |
| Dodero, P | 1 |
| Gambini, C | 1 |
| Gambaro, M | 1 |
| Czuczman, MS | 1 |
| Grillo-López, AJ | 1 |
| White, CA | 1 |
| Saleh, M | 1 |
| Gordon, L | 1 |
| LoBuglio, AF | 1 |
| Rosenberg, J | 1 |
| Alkuzweny, B | 1 |
| Maloney, D | 1 |
| Schoemaker, MJ | 1 |
| Allerton, R | 1 |
| Rohatiner, AZ | 1 |
| Williams, MV | 1 |
| Cellai, E | 1 |
| Magrini, SM | 3 |
| Masala, G | 1 |
| Alterini, R | 1 |
| Costantini, AS | 1 |
| Rigacci, L | 1 |
| Olmastroni, L | 1 |
| Papi, MG | 1 |
| Spediacci, MA | 1 |
| Innocenti, F | 1 |
| Bellesi, G | 1 |
| Ferrini, PR | 1 |
| Biti, G | 1 |
| Valtuch, I | 1 |
| Faraggi, D | 1 |
| Sharabi-Nov, A | 1 |
| Ben-Arie, Y | 1 |
| Cohen, Y | 1 |
| Gregory, WM | 1 |
| Cullen, MH | 1 |
| Burton, A | 1 |
| Selby, P | 1 |
| Jack, A | 1 |
| Bessell, EM | 1 |
| Smith, P | 1 |
| Leong, T | 1 |
| Schuster, S | 1 |
| Matsubara, K | 1 |
| Nigami, H | 1 |
| Harigaya, H | 1 |
| Osaki, M | 1 |
| Baba, K | 1 |
| Lester, EP | 2 |
| Millard, FE | 1 |
| Omura, GA | 2 |
| Egerer, G | 1 |
| Witzens, M | 1 |
| Spaeth, A | 1 |
| Breitbart, A | 1 |
| Goldschmidt, H | 1 |
| de Kerviler, E | 1 |
| Bouaffia, F | 1 |
| Ciurea-Löchel, A | 1 |
| Ciurea, A | 1 |
| Stey, C | 1 |
| Pestalozzi, B | 1 |
| Regina, S | 1 |
| Fimbel, B | 1 |
| Guerois, C | 1 |
| Gruel, Y | 1 |
| Kirchner, EM | 1 |
| Ebsen, M | 1 |
| Kirchner, J | 1 |
| Theegarten, D | 1 |
| Voigtmann, R | 1 |
| Stokoe, CT | 1 |
| Ogden, J | 1 |
| Jain, VK | 1 |
| Re, D | 1 |
| Scheidhauer, K | 1 |
| Ansén, S | 1 |
| Bischoff, S | 1 |
| Bohlen, H | 1 |
| Venge, P | 1 |
| Thomson, JA | 1 |
| Seymour, JF | 1 |
| Pelizzari, A | 1 |
| Motta, M | 1 |
| Puoti, M | 1 |
| Hull, MC | 1 |
| Mendenhall, NP | 1 |
| Colgan, ME | 1 |
| Wang, Q | 1 |
| Neri, N | 2 |
| Kang, EM | 1 |
| de Witte, M | 1 |
| Malech, H | 1 |
| Morgan, RA | 1 |
| Phang, S | 1 |
| Carter, C | 1 |
| Leitman, SF | 1 |
| Childs, R | 1 |
| Barrett, AJ | 1 |
| Little, R | 1 |
| Tisdale, JF | 1 |
| Cornely, OA | 1 |
| Pels, H | 1 |
| Bethe, U | 1 |
| Seibold, M | 1 |
| Toepelt, K | 1 |
| Soehngen, D | 1 |
| Ritzkowsky, A | 1 |
| Rassidakis, GZ | 1 |
| Nadali, GP | 1 |
| Mesina, O | 1 |
| Herling, M | 1 |
| Giardini, R | 1 |
| Chilosi, M | 1 |
| Kittas, C | 2 |
| García, EL | 3 |
| Talavera, A | 2 |
| Díaz-Maqueo, JC | 3 |
| Schlembach, PJ | 1 |
| Jones, D | 1 |
| Mahmood, T | 1 |
| Mudad, R | 1 |
| Morita, M | 1 |
| Tani, S | 1 |
| Hagihara, R | 1 |
| Ryu, Y | 1 |
| Yagi, N | 1 |
| Yamashita, J | 1 |
| Imanishi, K | 1 |
| Kitazawa, S | 1 |
| Linfomi, MB | 1 |
| Lones, MA | 1 |
| Perkins, SL | 1 |
| Creager, AJ | 1 |
| Geisinger, KR | 1 |
| Bergman, S | 1 |
| Vettore, L | 1 |
| Marinone, G | 2 |
| Maiolini, E | 1 |
| Buttolo, Q | 1 |
| Mauro, PL | 1 |
| Colle, R | 2 |
| Uslenghi, C | 2 |
| Battelli, T | 1 |
| Bonsignori, M | 1 |
| Manocchi, P | 1 |
| De Lena, M | 3 |
| Osieka, R | 1 |
| Seeber, S | 2 |
| Schmidt, CG | 5 |
| Lokich, JJ | 3 |
| Jaffe, N | 5 |
| Tullis, J | 2 |
| Barduagni, A | 1 |
| Marolla, A | 1 |
| Calabresi, F | 1 |
| Terzoli, E | 1 |
| Case, DC | 2 |
| Nisce, L | 1 |
| Anderson, T | 2 |
| Klener, P | 3 |
| Donner, L | 3 |
| Walser, A | 1 |
| Alberto, P | 4 |
| Garrett, MJ | 2 |
| Das, S | 1 |
| Smith, JD | 1 |
| Freedman, LS | 1 |
| Peterson, J | 1 |
| Amare, M | 2 |
| Porzig, KJ | 1 |
| Robertson, A | 1 |
| Frenkel, JK | 2 |
| Larsen, W | 1 |
| Krikorian, JG | 1 |
| Rossof, AH | 1 |
| Kerr, RO | 1 |
| Braine, HG | 1 |
| Kurvink, K | 1 |
| Keenan, KM | 1 |
| Levitt, S | 1 |
| Cervenka, J | 1 |
| Spiegel, RJ | 1 |
| Vigersky, RA | 1 |
| Oliff, AI | 1 |
| Echelberger, CK | 1 |
| Bruton, J | 1 |
| Poplack, DG | 1 |
| Glatstein, EJ | 3 |
| Littman, P | 1 |
| Schnaufer, L | 1 |
| Evans, A | 1 |
| Mintz, U | 1 |
| Miller, JB | 2 |
| Golomb, HM | 1 |
| Kinzie, J | 1 |
| Sweet, DL | 2 |
| Variakojis, D | 1 |
| Roth, NO | 1 |
| Blough, RR | 1 |
| Ferguson, DJ | 1 |
| Wewerka, JR | 1 |
| Magrath, I | 3 |
| Henle, W | 1 |
| Owor, R | 1 |
| Olweny, C | 1 |
| Aghai, E | 3 |
| Brenner, H | 2 |
| Ramot, B | 3 |
| Sutow, WW | 1 |
| Polubiec, A | 1 |
| Greco, FA | 1 |
| Kolins, J | 1 |
| Rajjoub, RK | 1 |
| Brereton, HD | 1 |
| Klimek, A | 1 |
| Poźiak-Patewicz, E | 1 |
| Le Blanc, DH | 1 |
| Trump, DL | 1 |
| Cowall, DE | 1 |
| Grub, R | 1 |
| Heni, N | 1 |
| Baumeister, L | 1 |
| Sieber, SM | 1 |
| Lopes Cardozo, E | 1 |
| Obrecht, JP | 2 |
| Harrison, DT | 1 |
| Neiman, PE | 2 |
| Laurens, A | 2 |
| Thevenot, J | 1 |
| Charron, D | 1 |
| Jorry, F | 1 |
| Dumonchel, P | 1 |
| Martola, R | 1 |
| Stopyrowa, J | 2 |
| Depowski, M | 2 |
| Strzeszynski, J | 3 |
| Borkowski, W | 3 |
| Kaczor, Z | 2 |
| Hartwich, G | 1 |
| Neidhardt, B | 1 |
| Lewis, BJ | 1 |
| Rozencweig, M | 1 |
| Muggia, FM | 1 |
| Brücher, H | 1 |
| Glidewell, O | 2 |
| Sawitsky, A | 1 |
| Harley, JB | 1 |
| Seligman, B | 1 |
| Cornell, C | 1 |
| Henry, P | 1 |
| Senn, HJ | 4 |
| Martz, G | 1 |
| Maurice, P | 2 |
| Shapiro, L | 1 |
| James, GW | 1 |
| Briere, JF | 1 |
| de Bonesana, AC | 1 |
| Bezares, R | 1 |
| Pileggi, J | 1 |
| Lein, JM | 1 |
| Macchi, A | 1 |
| Calabria, SI | 1 |
| Garay, GE | 1 |
| de Sica, SC | 1 |
| Besuschio, S | 1 |
| Gustafson, J | 1 |
| Schimpff, SC | 1 |
| Diggs, C | 1 |
| Greenberger, JS | 1 |
| Weichselbaum, RR | 1 |
| Botnick, LE | 1 |
| Goodman, R | 4 |
| Filler, R | 2 |
| Levi, JA | 3 |
| Madoc-Jones, H | 1 |
| Fernandez, CH | 1 |
| Piro, A | 1 |
| Rosenthal, D | 2 |
| Goldstein, M | 1 |
| Desforges, JF | 1 |
| Rutherford, CJ | 1 |
| Hubbard, SP | 1 |
| Simon, R | 1 |
| Smith, PG | 1 |
| Wald, N | 1 |
| Ali, NO | 1 |
| Janes, WO | 1 |
| Piro, AJ | 1 |
| Sinniah, D | 1 |
| Lin, HP | 1 |
| Peters, V | 1 |
| Jones, RT | 1 |
| Weinerman, BH | 1 |
| Stout, R | 1 |
| Todd, ID | 2 |
| Orbuch, SJ | 1 |
| Findor, JA | 1 |
| Kluin-Neleman, JC | 1 |
| Neleman, FA | 1 |
| Meuwissen, OJ | 1 |
| Maes, RA | 1 |
| Volterrani, F | 1 |
| Sigurtà, D | 1 |
| Severini, A | 1 |
| Roeser, HP | 1 |
| Roberts, SJ | 1 |
| Kynaston, B | 1 |
| Whitaker, SV | 1 |
| Hocker, GA | 1 |
| Rifkin, SI | 1 |
| de Quesada, AM | 1 |
| Pickering, MJ | 1 |
| Shires, DL | 1 |
| Poleksic, S | 1 |
| Yeung, KY | 1 |
| Royal, JE | 1 |
| Seeler, RA | 1 |
| Horner, RJ | 1 |
| Chaffey, JT | 1 |
| Moloney, WC | 4 |
| Mombelloni, P | 1 |
| Ghatak, NR | 1 |
| Sawyer, DR | 1 |
| Franchini, A | 1 |
| Katongole-Mbidde, E | 1 |
| Kiire, C | 1 |
| Lwanga, SK | 1 |
| Chabner, BA | 3 |
| Goodman, RL | 2 |
| Rubins, J | 1 |
| Velez-Garcia, E | 3 |
| Bartolucci, A | 2 |
| Wirtschafter, D | 1 |
| Dorfman, R | 1 |
| Neretto, G | 1 |
| Giovanelli, E | 1 |
| Agricola, R | 1 |
| Furno, F | 1 |
| Zieliński, T | 1 |
| Krajewska, B | 1 |
| Solska, E | 1 |
| Karnicka-Młodkowska, H | 1 |
| Rath, P | 1 |
| Many, A | 2 |
| Hulu, N | 1 |
| Dorfman, RF | 2 |
| Klein, HO | 2 |
| O'Brien, PH | 1 |
| Wallace, K | 1 |
| Rambo, VB | 1 |
| Tasini, MF | 1 |
| Hackett, TP | 1 |
| Farney, RJ | 1 |
| Morris, AH | 1 |
| Armstrong, JD | 1 |
| Hammer, S | 1 |
| Mazurowa, A | 1 |
| Pluzańska, A | 1 |
| Dmochowska, M | 2 |
| Polkowska-Kulesza, E | 1 |
| Skorek, TO | 1 |
| Fajndt, S | 1 |
| Boguszewska, E | 1 |
| Diggs, CH | 1 |
| Kvols, LK | 1 |
| Jacquillat, Cl | 2 |
| Duchamp, C | 1 |
| Clément, R | 1 |
| Juin, P | 1 |
| Mazeron, JJ | 2 |
| Williams, CJ | 1 |
| Flint, A | 1 |
| Pinon, G | 1 |
| Gemon-Auclerc, MF | 2 |
| Chastang, C | 3 |
| Bauters, F | 2 |
| Jouet, JP | 2 |
| Caulier, MT | 1 |
| Wurtz, A | 1 |
| Ribet, M | 1 |
| Goudemand, M | 2 |
| Kühner, U | 1 |
| Bleher, EA | 1 |
| Grétillat, P | 1 |
| Gasser, M | 1 |
| Pedrinis, E | 1 |
| Tonella, A | 1 |
| Wagner, HP | 1 |
| Roth, DG | 1 |
| Desser, RK | 1 |
| Fortuny, I | 1 |
| Fischer, JJ | 3 |
| Fischer, DB | 1 |
| Weller, SA | 1 |
| Roth, Z | 1 |
| Trepel, F | 1 |
| Schick, P | 1 |
| Julia, A | 1 |
| Miller, SP | 1 |
| Atkinson, MK | 1 |
| McElwain, TJ | 3 |
| Peckham, MJ | 2 |
| Thomas, PP | 1 |
| Viollier, AF | 1 |
| Jedrzejczak, WW | 1 |
| Siekierzyński, M | 2 |
| Czarnecki, C | 1 |
| Dziuk, E | 1 |
| Sosnina, AP | 1 |
| Galkina, GV | 1 |
| Jacobs, C | 2 |
| Dientsbier, Z | 1 |
| Buric, L | 1 |
| Bechynĕ, M | 1 |
| Kovaríková, H | 1 |
| Foltýnová, V | 1 |
| Mostecký, H | 1 |
| Lanzkowsky, P | 2 |
| Shende, A | 1 |
| Karayalcin, G | 1 |
| Aral, I | 1 |
| Grant, MD | 1 |
| Patel, AR | 1 |
| Shah, PC | 1 |
| Rhee, HL | 1 |
| Sassoon, H | 1 |
| Rao, KP | 1 |
| Jochimsen, PR | 1 |
| Pearlman, NW | 1 |
| Lawton, RL | 1 |
| Bláha, M | 1 |
| Vanásek, J | 1 |
| Mazák, J | 1 |
| Matĕja, F | 1 |
| Lenhard, RE | 4 |
| Densen, P | 1 |
| Morgenfeld, MC | 1 |
| Pavlovsky, A | 1 |
| Nelson, BM | 1 |
| Arias-Stella, J | 1 |
| O'Connell, MJ | 1 |
| Brace, KC | 1 |
| Byhardt, RW | 1 |
| Greene, WH | 1 |
| Sahakian, GJ | 2 |
| Delbrück, H | 1 |
| Chastang, CL | 1 |
| Chelloul, N | 3 |
| Isreal, HL | 1 |
| Patchfsky, AS | 1 |
| Whiteside, JD | 1 |
| Begent, RH | 1 |
| Shepard, TH | 1 |
| Mellman, WJ | 1 |
| Dickerman, JD | 1 |
| Clements, JP | 1 |
| Borromeo, VD | 1 |
| Wilner, FR | 1 |
| Axelrod, AR | 1 |
| Schneider, JR | 1 |
| Fedoreev, GA | 1 |
| Arrowsmith, WR | 1 |
| Huguley, CM | 1 |
| Moores, RR | 1 |
| Chan, YK | 1 |
| Johnson, L | 1 |
| Falkson, HC | 1 |
| Chang, TC | 1 |
| Sokal, JE | 2 |
| Popov, OV | 1 |
| Garçon, C | 1 |
| Chantalou, JP | 1 |
| Delobel, J | 2 |
| Izrael, V | 1 |
| Weisgerber, C | 3 |
| De Heaulme, M | 2 |
| van Hove, W | 1 |
| Hamers, J | 1 |
| Baele, G | 1 |
| Vermeulen, A | 2 |
| Focan, C | 1 |
| Bricteux, N | 1 |
| Lemaire, M | 1 |
| Hugues, J | 1 |
| Michaux, JL | 4 |
| Hulhoven, R | 1 |
| Rodhain, J | 1 |
| Naets, E | 1 |
| Dutriéux-Fauchet, MC | 1 |
| Stenuit, L | 1 |
| Sokal, G | 2 |
| Weinstein, P | 1 |
| Greenwald, ES | 1 |
| Grossman, J | 1 |
| Karassik, SL | 1 |
| Subramanyam, L | 1 |
| Green, RE | 1 |
| Brook, J | 1 |
| Haanen, C | 2 |
| Hart, AA | 1 |
| Felsenberg, D | 1 |
| Seibt-Jung, H | 1 |
| Mielcarek, M | 1 |
| Dahmen, E | 1 |
| Fischer, RI | 1 |
| Kozai, Y | 1 |
| Ohyama, T | 1 |
| Kodo, H | 1 |
| Tomori, G | 1 |
| Robert, M | 1 |
| Averous, M | 1 |
| Lavabre-Bertrand, T | 1 |
| Iborra, F | 1 |
| Chevallier, P | 1 |
| Rebillard, X | 1 |
| Guiter, J | 1 |
| Grasset, D | 1 |
| Tenovuo, J | 1 |
| Murtomaa, H | 1 |
| Morales, MD | 1 |
| González, FA | 1 |
| Villegas, A | 1 |
| del Potro, E | 1 |
| Díaz Mediavilla, J | 1 |
| Martínez, R | 1 |
| Alvarez, A | 1 |
| Colomé, JA | 1 |
| Ayala, JR | 1 |
| Cortés, HD | 1 |
| Virgolini, L | 1 |
| De Maglio, A | 1 |
| Gaynor, J | 2 |
| Caravelli, J | 4 |
| Bajorunas, D | 1 |
| House, KW | 1 |
| Simon, SR | 1 |
| Pugh, RP | 1 |
| Maity, A | 1 |
| D'Angio, GJ | 1 |
| Auguet Quintillá, T | 1 |
| Pedro-Botet Montoya, J | 1 |
| Planas Domingo, J | 1 |
| Gallén Castillo, M | 1 |
| Tombolini, V | 1 |
| Capua, A | 1 |
| Pompili, E | 1 |
| Chan, PD | 1 |
| Berk, MA | 1 |
| Kucuk, O | 1 |
| Singh, S | 1 |
| Oza, A | 1 |
| Perry, N | 1 |
| D'Ardenne, J | 1 |
| Arnott, S | 1 |
| Shand, WS | 1 |
| de Campos, ES | 1 |
| Radford, JA | 1 |
| Saito, H | 1 |
| Mizoguchi, H | 1 |
| Wołowiec, D | 1 |
| Kuliszkiewicz-Janus, M | 1 |
| Filip, A | 1 |
| Zulian, GB | 2 |
| Mermillod, B | 1 |
| Langer, CJ | 1 |
| Keller, SM | 1 |
| Erner, SM | 1 |
| Raquin, MA | 1 |
| Chompret, A | 1 |
| Bey, P | 4 |
| Rubie, H | 1 |
| Green, MR | 1 |
| Fleischmann, T | 2 |
| Szántó, I | 1 |
| Machiels, JP | 1 |
| Martiat, P | 1 |
| Kornblith, AB | 1 |
| Anderson, J | 1 |
| Cella, DF | 1 |
| Tross, S | 1 |
| Zuckerman, E | 1 |
| Cherin, E | 1 |
| Kosty, MP | 1 |
| Tubiana, M | 4 |
| Biti, GP | 3 |
| Comer, M | 1 |
| Harvey, AR | 1 |
| Laskaris, G | 1 |
| Stergiou, G | 1 |
| Scully, C | 1 |
| Smith, LM | 1 |
| Evans, JW | 1 |
| Mori, M | 2 |
| Brown, JM | 1 |
| Marmont, AM | 1 |
| Kharchenko, VP | 1 |
| Tesoro Tess, JD | 1 |
| Santarelli, MT | 3 |
| Muriel, FS | 2 |
| Fernández, I | 1 |
| Montero, C | 2 |
| Sanahuja, FL | 2 |
| Costa, A | 1 |
| Djulbegovic, B | 1 |
| Hendler, FJ | 1 |
| Hadley, T | 1 |
| Woodcock, TM | 1 |
| Festa, RS | 2 |
| Tamaroff, MH | 2 |
| Chasalow, F | 1 |
| Adesman, AR | 1 |
| Walco, GA | 1 |
| Marín, J | 1 |
| Lasa, R | 1 |
| Egurbide, I | 1 |
| Etxebeste, MA | 1 |
| Bengoetxea, E | 1 |
| Angulo, P | 1 |
| Antigüedad, M | 1 |
| Furundarena, JR | 1 |
| Peinado, F | 1 |
| Navarro, E | 1 |
| Allavena, C | 1 |
| Conroy, T | 2 |
| Aletti, P | 1 |
| Saven, A | 1 |
| Bennett, MH | 2 |
| Haybittle, JL | 2 |
| Sen, P | 1 |
| Bezwoda, WR | 1 |
| Dansey, R | 1 |
| Bezwoda, MA | 1 |
| Gaynor, JJ | 1 |
| Merke, DP | 1 |
| Chapman, D | 2 |
| Küchler, R | 1 |
| Heilmann, HP | 1 |
| McClain, KL | 1 |
| Heise, R | 1 |
| Day, DL | 1 |
| Woods, WG | 1 |
| Aeppli, D | 1 |
| Shanley, DJ | 1 |
| Lerud, KS | 1 |
| Luetkehans, TJ | 1 |
| Kaaden, R | 1 |
| Zwack, K | 1 |
| Wienbeck, M | 1 |
| Klotz, E | 1 |
| Feuer, EJ | 1 |
| Kessler, LG | 1 |
| Baker, SG | 1 |
| Triolo, HE | 1 |
| Green, DT | 1 |
| al-Idrissi, HY | 1 |
| Ibrahim, EM | 1 |
| Guzmán, R | 1 |
| Barnett, M | 1 |
| Reece, D | 1 |
| Gianni, L | 1 |
| Gavosto, F | 1 |
| Hoerni, B | 8 |
| Orgerie, MB | 2 |
| Blanc, CM | 3 |
| David, B | 3 |
| Rojouan, J | 5 |
| Zittoun, R | 5 |
| Goodrick, MJ | 1 |
| Daniel, F | 1 |
| Prentice, AG | 1 |
| Copplestone, JA | 1 |
| Tyrrell, CJ | 1 |
| Phares, JC | 1 |
| Dabrowska, M | 1 |
| Kemona, H | 4 |
| Prokopowicz, J | 4 |
| Kretowska, J | 1 |
| Kiluk, S | 4 |
| Caggana, M | 2 |
| Liber, HL | 1 |
| Kelsey, KT | 2 |
| Leventhal, BG | 1 |
| Marcus, R | 1 |
| Brecher, M | 1 |
| Chauvenet, A | 1 |
| Andreopoulos, D | 1 |
| Klose, KC | 1 |
| Glöckner, WM | 1 |
| Carlier, P | 1 |
| Congiu, A | 1 |
| Bacigalupo, A | 1 |
| Damasio, E | 1 |
| Tigaud, JD | 1 |
| Koza, I | 2 |
| Bohunický, L | 2 |
| Mociková, K | 1 |
| Gyárfás, J | 2 |
| Svancárová, L | 2 |
| Mardiak, J | 2 |
| Spánik, S | 1 |
| Fuchsberger, P | 1 |
| Thalmeinerová, Z | 1 |
| Sufliarsky, J | 1 |
| Magnan, A | 1 |
| Jacquème, P | 1 |
| Sudan, N | 1 |
| Redding, E | 1 |
| Blanc, AP | 1 |
| Poirier, R | 1 |
| Zepeda, G | 1 |
| Cruz, J | 1 |
| Gause, A | 1 |
| Verpoort, K | 1 |
| Roschansky, V | 1 |
| Tschiersch, A | 1 |
| Schmits, R | 1 |
| Dienemann, D | 1 |
| Jautzke, G | 1 |
| Cervos-Navarro, J | 1 |
| Langford, A | 1 |
| Pohle, HD | 1 |
| Ruf, B | 1 |
| Najbar, A | 1 |
| Radwańska, U | 1 |
| Kaczmarek, M | 1 |
| Ochocka, M | 1 |
| Stańczak, E | 1 |
| Gutiérrez, J | 1 |
| Vacarezza, R | 1 |
| Cao, C | 1 |
| Zemlickis, D | 1 |
| Degendorfer, P | 1 |
| Panzarella, T | 2 |
| Koren, G | 1 |
| Bellesi, GP | 2 |
| Bosi, A | 2 |
| Giannarelli, D | 1 |
| Hovgaard, DJ | 1 |
| Korobov, KV | 1 |
| Novikov, ID | 1 |
| Demina, EA | 1 |
| Kondrat'eva, NF | 1 |
| Pirogova, NA | 1 |
| Domeyer, C | 1 |
| Schulte-Overberg, U | 1 |
| Boll, I | 1 |
| Baumgarten, E | 1 |
| Bührer, C | 1 |
| Fengler, R | 1 |
| Henze, G | 1 |
| Błasińska-Morawiec, M | 1 |
| Płuzańska, A | 2 |
| Mrówka, I | 1 |
| Rajkumar, K | 1 |
| Rajkumar, T | 1 |
| Maitreyan, V | 1 |
| Shanta, V | 1 |
| Brown, J | 1 |
| Burck, K | 1 |
| Black, D | 1 |
| Collins, C | 1 |
| Mitrou, PS | 1 |
| Serke, M | 1 |
| Pohl, C | 1 |
| Becker, K | 1 |
| Schrappe-Bächer, M | 1 |
| Westerhausen, M | 1 |
| Clemens, MR | 1 |
| Helm, EB | 1 |
| Fischer, T | 1 |
| Rosenberg, W | 1 |
| Afanasova, NV | 3 |
| Johnston, PG | 1 |
| Ruscetti, FW | 1 |
| Connaghan, DG | 1 |
| Sullivan, FJ | 1 |
| Nemunaitis, J | 1 |
| Buckner, CD | 2 |
| Appelbaum, FR | 2 |
| Higano, CS | 1 |
| Bianco, J | 1 |
| Epstein, C | 1 |
| Lipani, J | 1 |
| Hansen, J | 1 |
| Storb, R | 2 |
| Belkov, SA | 1 |
| Andriukhin, VI | 1 |
| Korsakov, VB | 1 |
| Pugachev, VF | 1 |
| Riazantsev, EA | 1 |
| Bergsagel, D | 1 |
| Basco, V | 1 |
| Brown, T | 2 |
| Gillies, J | 1 |
| Israels, L | 1 |
| Miller, A | 1 |
| Rideout, D | 1 |
| Whitelaw, D | 1 |
| Russo, A | 1 |
| Hill, JB | 1 |
| Redman, JR | 2 |
| Dixon, D | 1 |
| Silvermintz, K | 1 |
| Urba, WJ | 1 |
| Raubitschek, A | 1 |
| Petru, E | 1 |
| Schmähl, D | 1 |
| Jensen, BV | 1 |
| Carlsen, NL | 1 |
| Thompson, L | 1 |
| Heimes, U | 1 |
| Heiermann, E | 1 |
| Nieschlag, E | 1 |
| Mendeleev, IM | 1 |
| Oleĭnik, VA | 1 |
| Miasnikov, AA | 2 |
| Polezhaev, IuN | 1 |
| Li, XJ | 1 |
| Zhao, BL | 1 |
| Hou, JW | 1 |
| Xin, WJ | 1 |
| Xie, RF | 1 |
| Chen, YR | 1 |
| Hayes, TG | 1 |
| Rabin, VR | 1 |
| Rosen, T | 1 |
| Zubler, MA | 1 |
| Payen, C | 1 |
| Fermanian, J | 1 |
| Millward, MJ | 1 |
| Cohney, SJ | 1 |
| Byrne, MJ | 1 |
| Ryan, GF | 1 |
| Ortin, TT | 1 |
| Shostak, CA | 1 |
| Lavey, RS | 1 |
| Schulman, P | 1 |
| McCarroll, K | 1 |
| Norton, L | 1 |
| Maeda, O | 1 |
| Hosomi, M | 1 |
| Matsumiya, K | 1 |
| Koide, T | 1 |
| Takaha, M | 1 |
| Pinto, PC | 1 |
| Hu, E | 1 |
| Bernstein-Singer, M | 1 |
| Pinter-Brown, L | 1 |
| Govindarajan, S | 1 |
| Akyol, H | 1 |
| Brandwein, JM | 1 |
| Callum, J | 1 |
| Scott, JG | 1 |
| Roach, M | 1 |
| Brophy, N | 1 |
| Cox, R | 1 |
| Varghese, A | 1 |
| Cohen, MH | 1 |
| Brooks, BJ | 1 |
| Hendler, NB | 1 |
| Alvarez, S | 1 |
| Ancalmo, N | 1 |
| Grinton, SF | 1 |
| Givens, SS | 1 |
| Doyle, J | 2 |
| Berry, M | 1 |
| Blanchette, V | 1 |
| Doherty, M | 1 |
| Johnston, J | 1 |
| Kennedy, P | 1 |
| Hays, DM | 1 |
| Emerson, JD | 1 |
| Moses, LE | 1 |
| Bestetti, O | 1 |
| Sullivan, KM | 1 |
| Thomas, ED | 2 |
| Clift, RA | 1 |
| Deeg, HJ | 1 |
| Sanders, JE | 1 |
| Stewart, P | 1 |
| Shirakawa, S | 2 |
| Tanaka, I | 1 |
| Kita, K | 2 |
| Lowenthal, RM | 1 |
| Jestrimski, KW | 1 |
| Dumont, J | 1 |
| Villarreal, CJ | 1 |
| Delfino, A | 1 |
| LaMonte, CS | 1 |
| Yeh, SD | 1 |
| Kholin, AV | 4 |
| Tsiatis, A | 1 |
| Frizzera, G | 1 |
| Sciborski, R | 2 |
| Rusthoven, JJ | 2 |
| Kellermeyer, R | 1 |
| Raney, M | 1 |
| Berner, J | 1 |
| Kowalczyński, M | 1 |
| Dowgier-Witczak, I | 1 |
| Chmielowska, E | 1 |
| Woźniak, L | 1 |
| Pagnoni, AM | 1 |
| Musumeci, R | 1 |
| Crippa, F | 1 |
| Tilly, H | 1 |
| Menard, JF | 1 |
| Barbot, A | 1 |
| Piguet, H | 1 |
| Verlicchi, F | 1 |
| Bandini, G | 1 |
| Van Bunningen, BN | 2 |
| Van Leeuwen, EF | 1 |
| Vicente, J | 1 |
| Zori Comba, A | 1 |
| Herold, M | 2 |
| Anger, G | 2 |
| Höche, D | 2 |
| Kästner, R | 2 |
| Audebert, A | 2 |
| Debray, J | 1 |
| Buzaid, AC | 1 |
| Lippman, SM | 1 |
| Wysocka, J | 3 |
| Pfreundschuh, MG | 1 |
| Schoppe, WD | 1 |
| Kalinsky, H | 1 |
| Umiel, T | 1 |
| Pecht, M | 1 |
| Schiffer, CA | 1 |
| Scott, J | 1 |
| Cadman, EC | 1 |
| Zucker, JM | 1 |
| Olive, D | 2 |
| Schoppe, W | 2 |
| Sagher, D | 1 |
| Karrison, T | 1 |
| Schwartz, JL | 1 |
| Larson, R | 1 |
| Meier, P | 1 |
| Strauss, B | 1 |
| Pekacki, A | 1 |
| Rohloff, R | 1 |
| Kühn, G | 1 |
| Hayabuchi, N | 1 |
| Jingu, K | 1 |
| Miyoshi, M | 1 |
| Hirata, H | 1 |
| Masuda, K | 1 |
| Shibuya, T | 1 |
| Nishimura, J | 1 |
| Komiyama, S | 1 |
| Ishii, E | 1 |
| Trédaniel, J | 1 |
| Gerota, I | 1 |
| Dionet, C | 1 |
| Vilcoq, J | 1 |
| Madelain, M | 1 |
| Dutou, L | 1 |
| Lefur, R | 1 |
| Thierry, P | 1 |
| Le Floch, O | 1 |
| García Alfonso, P | 1 |
| Flores Sañudo, E | 1 |
| Carrión Galindo, R | 1 |
| Jara Sánchez, C | 1 |
| Cosín Ochaita, J | 1 |
| Congiu, AM | 1 |
| Gaozza, E | 1 |
| Ricci, P | 2 |
| Meloni, G | 1 |
| Mangoni, L | 1 |
| Coser, P | 1 |
| Reverter, JC | 1 |
| Bladé, J | 1 |
| Giguere, JK | 1 |
| Douglas, DM | 1 |
| Lupton, GP | 1 |
| Baker, JR | 1 |
| Van der Schueren, E | 2 |
| Pasqualini, T | 1 |
| Iorcansky, S | 1 |
| Gruñeiro, L | 1 |
| Diez, B | 1 |
| Rivarola, MA | 1 |
| Mefferd, JM | 1 |
| von Kalle, AK | 1 |
| Schaadt, M | 2 |
| Albisinni, U | 1 |
| Ammendolia, I | 1 |
| Tondi, L | 1 |
| Perry, RR | 1 |
| Rosenberg, RK | 1 |
| Pass, HI | 1 |
| Peiffert, D | 1 |
| Witz, F | 1 |
| Aggarwal, P | 1 |
| Sharma, SK | 1 |
| Wali, JP | 1 |
| Sahani, P | 1 |
| Fay, JW | 1 |
| Herzig, GP | 1 |
| Herzig, RH | 1 |
| Wolff, SN | 1 |
| Gulati, S | 1 |
| Shank, B | 1 |
| Clarkson, B | 1 |
| Fuks, Z | 1 |
| Lemevel, A | 1 |
| Le Prise, PY | 1 |
| Gandhour, C | 1 |
| Merke, D | 1 |
| Keinert, K | 1 |
| Wutke, K | 1 |
| Bonnet, M | 1 |
| Dufillot, D | 1 |
| de Lumley, L | 1 |
| McDougall, IR | 1 |
| Parker, BR | 1 |
| Shochat, SJ | 1 |
| Silingardi, V | 1 |
| Frassoldati, A | 1 |
| Barbieri, F | 1 |
| Palomba, G | 1 |
| Mauri, C | 2 |
| Housset, M | 1 |
| Dessard-Diana, B | 1 |
| Michel-Langlet, P | 1 |
| Alapetite, C | 1 |
| Matsumoto, N | 1 |
| Yoshimoto, K | 1 |
| Okagawa, K | 1 |
| Kosaka, M | 1 |
| Chauffert, B | 1 |
| Lorcerie, B | 1 |
| André, F | 1 |
| Besancenot, JF | 1 |
| Martin, F | 1 |
| Noguchi, Y | 1 |
| Hasegawa, Y | 1 |
| Nakazawa, M | 1 |
| Yoda, Y | 1 |
| Abe, T | 1 |
| Mori, N | 1 |
| Maschio, M | 2 |
| Schellong, GM | 1 |
| Tan, CT | 1 |
| Hamoir, V | 1 |
| Binon, J | 1 |
| Pillai, GN | 1 |
| Suon, SZ | 1 |
| Hattori, T | 1 |
| Ishikawa, Y | 1 |
| Nishi, M | 1 |
| Nakadate, H | 1 |
| Hatae, Y | 1 |
| Takeda, T | 1 |
| van Rijswijk, RE | 1 |
| de Meijer, AJ | 1 |
| Verbeek, J | 1 |
| Madanat, FF | 1 |
| Culine, S | 1 |
| Audebert, AA | 1 |
| Chomette, G | 1 |
| Prudhomme de Saint-Maur, P | 1 |
| Bernadou, A | 2 |
| Makhomova, LA | 1 |
| Goldobenko, GV | 1 |
| Susuleva, NA | 1 |
| Ohnoshi, T | 2 |
| Hayashi, K | 2 |
| Ueno, K | 1 |
| Tada, A | 1 |
| Murashima, M | 1 |
| Mizuta, J | 1 |
| Tagawa, S | 1 |
| Kimura, I | 1 |
| Pavlidis, N | 1 |
| Nikolaou, N | 1 |
| Tolis, C | 1 |
| Orfanos, S | 1 |
| Tolis, G | 1 |
| Takagi, T | 1 |
| Sawada, U | 1 |
| Kondo, M | 1 |
| Suzuki, H | 1 |
| Oyama, A | 1 |
| Hörnig, I | 1 |
| Lagarde, P | 2 |
| Bonichon, F | 2 |
| de Mascarel, I | 2 |
| Chauvergne, J | 2 |
| Mirimanoff, RO | 1 |
| Cionini, L | 1 |
| Mungai, V | 1 |
| Ponticelli, P | 1 |
| Adedeji, MO | 1 |
| Kindzel'skiĭ, LP | 1 |
| Gubareva, AA | 1 |
| Meadows, LM | 1 |
| Rosse, WR | 1 |
| Moore, JO | 1 |
| Crawford, J | 1 |
| Laszlo, J | 1 |
| Kaufman, RE | 1 |
| Schneider, K | 1 |
| Shaw, MT | 1 |
| Jacobs, SR | 1 |
| Ghouadni, R | 1 |
| Zouaoui-Benhadji, Z | 1 |
| Afiane, M | 1 |
| Kubisz, P | 2 |
| Belhadj-Merzoug, K | 1 |
| Krisch, C | 1 |
| Laugier, A | 1 |
| Druker, BJ | 1 |
| Malou, M | 1 |
| Zouaoui, Z | 1 |
| Abad, MT | 1 |
| Touhami, M | 1 |
| Faid, L | 1 |
| Marigil, MA | 1 |
| Pardo-Mindan, FJ | 1 |
| Cuesta, B | 1 |
| Rocha, E | 1 |
| Idoate, MA | 1 |
| Gómez-Bezares, MC | 1 |
| Cuzick, J | 1 |
| Bell, BA | 1 |
| Esseltine, DW | 1 |
| Freeman, CR | 1 |
| Catanese, J | 1 |
| Dutcher, JP | 1 |
| Dorfman, HD | 1 |
| Andres, DF | 1 |
| Smith, PJ | 1 |
| Toogood, I | 1 |
| Mauger, D | 1 |
| Takaue, Y | 1 |
| Ramirez, I | 1 |
| Cleary, KR | 1 |
| van Eys, J | 1 |
| Lacher, MJ | 2 |
| Toner, K | 1 |
| Chao, N | 1 |
| Levine, J | 1 |
| Hetzel, WD | 1 |
| Heimpel, H | 1 |
| Sullivan-Halley, JA | 1 |
| Homeida, M | 1 |
| Mukhtar, ED | 1 |
| Daneshmend, T | 1 |
| Omer, A | 1 |
| Keyserlingk, H | 1 |
| Seibt, H | 1 |
| Rühl, H | 1 |
| Höffken, G | 1 |
| Magnasco, O | 1 |
| Alfonso, PG | 1 |
| Sañudo, EF | 1 |
| Carretero, JM | 1 |
| Galindo, RC | 1 |
| Altozano, JG | 1 |
| Gomez, LP | 1 |
| Manga, GP | 1 |
| Lynn, WA | 1 |
| Dawson, AA | 1 |
| Bennett, B | 1 |
| Moore, NR | 1 |
| Iurlo, A | 1 |
| Mecucci, C | 1 |
| Van Orshoven, A | 1 |
| Boogaerts, M | 1 |
| Van den Berghe, H | 1 |
| Steger, GG | 1 |
| Dittrich, C | 1 |
| Hönigsmann, H | 1 |
| Schuler, D | 1 |
| Kardos, G | 1 |
| Révész, T | 1 |
| Pokorny, CS | 1 |
| Adler, GF | 1 |
| Friedlander, RJ | 1 |
| Powlis, WD | 1 |
| Goffman, T | 2 |
| De Vita, VT | 3 |
| Obrist, R | 1 |
| Zandecki, M | 1 |
| Dupriez, B | 1 |
| Laï, JL | 1 |
| Fenaux, P | 1 |
| Facon, T | 1 |
| Lepelley, P | 1 |
| Estienne, MH | 1 |
| Huart, JJ | 1 |
| Janjan, NA | 1 |
| Wilson, JF | 1 |
| Gillin, M | 1 |
| Schewe, K | 1 |
| Cold, S | 1 |
| Clausen, NT | 1 |
| Zaniboni, A | 1 |
| Simoncini, E | 1 |
| Marpicati, P | 1 |
| Montini, E | 1 |
| Marini, G | 2 |
| Rao, SV | 1 |
| Murugesan, K | 1 |
| Vij, U | 1 |
| Sarin, R | 1 |
| Kapur, BM | 1 |
| Willett, CG | 1 |
| Linggood, RM | 1 |
| Leong, JC | 1 |
| Miketic, LM | 1 |
| Stracher, MA | 1 |
| Skates, SJ | 1 |
| Kushner, DC | 1 |
| Boccaccio, P | 1 |
| Rosa, F | 1 |
| Casciaro, S | 1 |
| D'Elia, P | 1 |
| Romagnoli, M | 1 |
| Ghio, R | 1 |
| Kanaev, SV | 6 |
| Malinin, AP | 6 |
| Cruickshank, D | 1 |
| Worotniuk, V | 1 |
| Matthews, JP | 1 |
| Astapov, BM | 1 |
| Besa, EC | 1 |
| España, P | 1 |
| Bonilla, F | 1 |
| Yebra, M | 1 |
| Diego, J | 1 |
| Alvarez de Mon, M | 1 |
| Marazuela, M | 1 |
| Durántez, A | 1 |
| Armitage, J | 1 |
| Moravec, D | 1 |
| Hutchins, M | 1 |
| Howe, D | 1 |
| Sorensen, S | 1 |
| Dowling, M | 1 |
| Okerbloom, J | 1 |
| Pevnick, W | 1 |
| Henkelmann, GC | 1 |
| Dusenbery, KE | 1 |
| van der Werf, SD | 1 |
| van Berge Henegouwen, GP | 1 |
| Bronkhorst, FB | 1 |
| Werre, JM | 1 |
| Furukawa, Y | 1 |
| Takagi, S | 1 |
| Tsuboyama, A | 1 |
| Akashi, M | 1 |
| Komatsu, N | 1 |
| Takeda, K | 1 |
| Muroi, K | 1 |
| Ohsaka, A | 1 |
| Ohta, M | 1 |
| Suda, K | 1 |
| Wells, JD | 1 |
| Huskison, WT | 1 |
| Davenport, OL | 1 |
| de Gramont, A | 1 |
| Louvet, C | 1 |
| Krulik, M | 2 |
| Smadja, N | 1 |
| Donadio, D | 1 |
| Laporte, JP | 1 |
| Brissaud, P | 1 |
| Delâge, JM | 2 |
| Drolet, Y | 1 |
| Rioux, E | 1 |
| Garbes, ID | 1 |
| Larraín, C | 1 |
| Cuchacovich, M | 1 |
| Conte, G | 1 |
| Rowland, KM | 1 |
| Murthy, A | 1 |
| Wesley, M | 1 |
| Skarin, A | 1 |
| Sans-Sabrafen, J | 1 |
| Pedro Olivé, C | 1 |
| Buxó Costa, J | 1 |
| Pardo Peret, P | 1 |
| Rodríguez Ferrera, JC | 1 |
| Woessner, S | 1 |
| Galofré, M | 1 |
| Rodríguez Méndez, F | 1 |
| Baysogolov, GD | 1 |
| Chikrizov, SI | 3 |
| Ryoo, MC | 1 |
| Kagan, AR | 2 |
| Wollin, M | 1 |
| Nussbaum, H | 1 |
| Chan, PY | 1 |
| Hintz, BL | 1 |
| Rao, AR | 1 |
| McMahon, J | 1 |
| Richardson, JL | 1 |
| Marks, G | 1 |
| Johnson, CA | 1 |
| Graham, JW | 1 |
| Chan, KK | 1 |
| Selser, JN | 1 |
| Kishbaugh, C | 1 |
| Barranday, Y | 1 |
| Levine, AM | 1 |
| Blaustein, JC | 1 |
| Lewkow, L | 1 |
| Crnkovich, MJ | 1 |
| Leopold, K | 1 |
| Sauer, MV | 1 |
| Macaso, TM | 1 |
| Ishida, EH | 1 |
| Giudice, L | 1 |
| Marshall, JR | 1 |
| Buster, JE | 1 |
| Ciocca Vasino, MA | 1 |
| Cametti, G | 1 |
| Urgesi, A | 1 |
| Bertini, M | 1 |
| Canta, M | 1 |
| Monetti, U | 1 |
| Bosio, C | 1 |
| Jayme, A | 1 |
| Lyding, JM | 1 |
| Tseng, A | 1 |
| Newman, A | 1 |
| Collins, S | 1 |
| Shea, W | 1 |
| Le Pors, P | 1 |
| Tschupp, MJ | 1 |
| de Queiroz, D | 1 |
| Grosbois, B | 1 |
| Lemoine, H | 1 |
| Gurney, HP | 1 |
| Phadke, K | 1 |
| Olszańska-Skorek, T | 1 |
| Urbańska-Ryś, H | 1 |
| Chojnowski, K | 1 |
| Friedenberg, WR | 1 |
| Dirks, P | 1 |
| Beltaos, E | 1 |
| Mazza, JJ | 1 |
| Hoehn, JL | 1 |
| Greenlaw, RH | 1 |
| Russ, HH | 1 |
| Schloesser, LL | 1 |
| Griffiths, JD | 1 |
| Segal, GM | 1 |
| Duckert, LG | 1 |
| Carroll, WL | 1 |
| Berberich, FR | 1 |
| Glader, BE | 1 |
| Breĭvis, PV | 1 |
| Gar'kavyĭ, MI | 1 |
| Eridani, S | 2 |
| Singh, AK | 1 |
| Hautekeete, ML | 1 |
| Berneman, ZN | 1 |
| Bieger, R | 1 |
| Stevens, WJ | 1 |
| Bridts, C | 1 |
| Buyssens, N | 1 |
| Peetermans, ME | 1 |
| Jochelson, MS | 1 |
| Haines, IE | 1 |
| Schwarz, MA | 1 |
| Pedro-Botet, J | 1 |
| Estruch, R | 1 |
| Urbano-Márquez, A | 1 |
| Dewit, L | 1 |
| Bartelink, H | 1 |
| Cirrincione, C | 1 |
| Redman, J | 1 |
| Cunningham, I | 1 |
| Baumgartner, G | 1 |
| Duschet, P | 1 |
| Schwarz, T | 1 |
| Partsch, H | 1 |
| Gschnait, F | 1 |
| Stacher, A | 1 |
| Bubman, I | 1 |
| Kirchhoff, LV | 1 |
| Morioka, H | 1 |
| deBellis, N | 1 |
| Bender, BL | 1 |
| Mayernik, DG | 1 |
| Edington, H | 1 |
| Salwitz, J | 1 |
| Roth, JA | 1 |
| Pass, H | 1 |
| Bourke, JP | 1 |
| Duggan, J | 1 |
| Boyle, E | 1 |
| McCabe, M | 1 |
| Conroy, R | 1 |
| Greenberg, P | 1 |
| Parker, RG | 1 |
| Northrop, MF | 1 |
| Simko, TG | 1 |
| Blayney, DW | 1 |
| Greene, MH | 1 |
| Postal, MG | 1 |
| Lanzillo, JH | 1 |
| Moylan, DJ | 1 |
| Mohiuddin, M | 1 |
| Kramer, S | 1 |
| Kim, HC | 1 |
| Nosher, J | 1 |
| Haas, A | 1 |
| Sweeney, W | 1 |
| Lewis, R | 1 |
| Shetty, PA | 2 |
| Damle, SR | 1 |
| Shahane, AD | 1 |
| Schreiber, DP | 1 |
| Cox, RS | 1 |
| Parlier, Y | 1 |
| Khmelevskaia, ZI | 1 |
| Höffken, K | 2 |
| Ippisch, A | 1 |
| Pfeiffer, R | 1 |
| Becher, R | 1 |
| Perri, RT | 1 |
| Allen, JI | 1 |
| Limas, C | 1 |
| Kay, NE | 1 |
| Scherer, E | 1 |
| Müller, RD | 1 |
| Papac, R | 1 |
| Frau, A | 1 |
| Montalar, J | 1 |
| Slanina, J | 1 |
| Spratler, J | 1 |
| Blijham, GH | 1 |
| Mendes de Leon, DE | 1 |
| Dinshaw, K | 1 |
| Pande, S | 1 |
| Advani, S | 1 |
| Ramakrishnan, G | 1 |
| Nair, C | 1 |
| Talvalkar, G | 1 |
| Rao, DN | 1 |
| Notani, P | 1 |
| Rao, R | 1 |
| Desai, P | 1 |
| Bo, YK | 1 |
| Hirose, J | 1 |
| Chohtoh, S | 1 |
| Nishijima, H | 1 |
| Kobayashi, A | 1 |
| Kamimura, R | 1 |
| Takashima, T | 1 |
| Yoshida, T | 1 |
| Lucchi, T | 1 |
| Barbieri, D | 1 |
| Ferraresi, P | 1 |
| Lanza, F | 1 |
| Moe, PJ | 1 |
| Blokhina, NG | 1 |
| Aliev, BM | 1 |
| Kruglova, GV | 1 |
| Kaverzneva, MM | 1 |
| Vasygova, NF | 1 |
| MacKenzie, R | 1 |
| Cooper, D | 1 |
| Cox, EB | 1 |
| Behrens, BC | 1 |
| Leslie, NT | 1 |
| Shapiro, CM | 1 |
| Vander Laan, BF | 1 |
| Jao, W | 1 |
| Sloan, DE | 1 |
| Rudders, RA | 2 |
| Fass, L | 1 |
| Bluming, AZ | 1 |
| Magrath, IT | 1 |
| Templeton, AC | 2 |
| Antoine, HM | 1 |
| Du Bourget, F | 1 |
| Juillet, Y | 1 |
| Hiltenbrand, C | 1 |
| Flexner, JM | 1 |
| Schein, PS | 1 |
| Silverman, EM | 1 |
| Reed, RE | 1 |
| Beretta, G | 1 |
| Fossati-Bellani, F | 1 |
| Goldsmith, MA | 1 |
| Carter, SK | 3 |
| al-Mondhiry, H | 1 |
| Connolly, CE | 1 |
| Deutsch, E | 1 |
| Honetz, N | 2 |
| McLaren, JH | 1 |
| Papac, RJ | 1 |
| Pinkus, GS | 1 |
| Mathé, G | 7 |
| Mbidde, EK | 1 |
| Nkwocha, J | 1 |
| Kiely, JM | 1 |
| Stinner, G | 1 |
| Boden, B | 1 |
| Fünfhausen, G | 1 |
| Fleischer, J | 1 |
| Morgenstern, D | 1 |
| Ringel, G | 1 |
| Cardinali, G | 1 |
| Bagnara, GP | 1 |
| Gugliotta, L | 1 |
| Santucci, MA | 1 |
| Huhn, D | 1 |
| Heinze, HG | 1 |
| Steidle, C | 1 |
| Marks, RD | 1 |
| Agarwal, SK | 1 |
| Constable, WC | 1 |
| Brunet, R | 1 |
| Hoerni-Simon, G | 1 |
| Cline, MJ | 1 |
| Castellino, RA | 1 |
| Turbow, MM | 1 |
| Rosenberg, S | 1 |
| Gleason, TH | 1 |
| Hamlin, WB | 1 |
| Pauly, JL | 1 |
| Varkarakis, MJ | 1 |
| Sampson, D | 1 |
| Murphy, GP | 1 |
| Berumen, L | 2 |
| Schwarzenberg, L | 4 |
| Schneider, M | 4 |
| Cattan, A | 2 |
| Schlumberger, JR | 1 |
| Druet, P | 1 |
| Dryll, A | 1 |
| Ryckewaert, A | 1 |
| de Sèze, S | 1 |
| Kahn, MF | 1 |
| Traggis, D | 1 |
| Das, L | 1 |
| Hann, HW | 1 |
| Kim, BS | 1 |
| Nair, R | 1 |
| Goffinet, DR | 1 |
| Merigan, TC | 1 |
| Sacks, P | 1 |
| Jacobs, P | 1 |
| Gale, D | 1 |
| Lynch, SR | 1 |
| Bothwell, TH | 1 |
| Stevens, K | 1 |
| Gregl, A | 1 |
| Prindul, F | 1 |
| Weigel, F | 1 |
| Krack, U | 1 |
| Mannheimer, C | 1 |
| Zdichynec, B | 1 |
| Casassa, PM | 1 |
| Guala, A | 1 |
| Piglia, P | 1 |
| Sharer, LR | 1 |
| Barondess, JA | 1 |
| Gray, GF | 1 |
| Harrison, DF | 1 |
| Winokur, SH | 1 |
| Qazi, R | 1 |
| Korek-Amorosa, J | 1 |
| Scheinman, HZ | 1 |
| Clemett, AR | 1 |
| Amorosa, LF | 1 |
| McKenna, PJ | 1 |
| Izrall, V | 1 |
| Madon, E | 1 |
| Baroncelli, PG | 1 |
| Sacerdote, A | 1 |
| Roberi, PL | 1 |
| Cordero di Montezemolo, L | 1 |
| Storti, E | 1 |
| Casirola, G | 1 |
| Ippoliti, G | 1 |
| Ferrari, E | 1 |
| Cridland, MD | 1 |
| Mims, CH | 1 |
| Costanzi, JJ | 1 |
| Pouillart, P | 1 |
| Jasmin, C | 1 |
| Weiner, R | 1 |
| de Vassal, F | 1 |
| Beyer, HP | 1 |
| Fajbisowicz, S | 1 |
| Denton, MD | 1 |
| Glazer, HS | 1 |
| Zellner, DC | 1 |
| Smith, FG | 1 |
| Schabel, FM | 1 |
| Goldin, A | 1 |
| Ramsay, GC | 1 |
| Meyer, RD | 1 |
| Pierce, LE | 1 |
| Jenkins, RB | 1 |
| Gold, E | 1 |
| Van Thiel, DH | 1 |
| Myers, GH | 1 |
| Hamlin, JA | 1 |
| Friedman, NB | 1 |
| Stammberger, K | 1 |
| Wachtel, D | 1 |
| Walbom-Jorgensen, S | 1 |
| Con, I | 1 |
| Daiber, A | 1 |
| Donoso, A | 1 |
| Mora, F | 1 |
| Lawhorn, TI | 1 |
| Stone, HH | 1 |
| Martin, JD | 1 |
| Fortuny, IE | 1 |
| Theologides, A | 1 |
| Trueblood, HW | 1 |
| Guernsey, JM | 1 |
| Cohn, R | 1 |
| Rubin, P | 2 |
| Haim, S | 1 |
| Shafrir, A | 1 |
| Better, OS | 1 |
| Robinson, E | 1 |
| Chaimowitz, C | 1 |
| Erlik, D | 1 |
| Rodriguez, V | 3 |
| Bodey, GP | 1 |
| Freireich, EJ | 1 |
| Brace, K | 1 |
| Serpick, AA | 6 |
| Block, JB | 1 |
| Schein, PJ | 1 |
| Bagley, CM | 1 |
| Host, H | 1 |
| Abrahamsen, AF | 1 |
| Aungst, CW | 2 |
| Sterling, WA | 1 |
| Wu, LY | 1 |
| Dowling, EA | 1 |
| Diethelm, AG | 1 |
| Arseneau, JC | 3 |
| Knospe, WH | 1 |
| Fairley, GH | 5 |
| Freeman, JE | 1 |
| Thomas, F | 1 |
| Owens, L | 1 |
| Wolf, JS | 1 |
| Volk, M | 1 |
| Mendez, G | 1 |
| Lee, HM | 1 |
| Bopp, KP | 1 |
| Magdeburg, W | 1 |
| Gutterman, J | 1 |
| Livingston, RB | 1 |
| DiBiasio, AG | 1 |
| Moore, MR | 3 |
| Bull, JM | 3 |
| Brunner, KW | 2 |
| Obrecht, P | 2 |
| Sonntag, RW | 1 |
| Rubens, RD | 1 |
| Wiltshaw, E | 1 |
| Boesen, E | 1 |
| Galton, DA | 1 |
| William, LA | 2 |
| Hornung, G | 1 |
| Becker, G | 1 |
| Convit, J | 1 |
| Kerdel, F | 1 |
| Goihman, M | 1 |
| Rondon, AJ | 1 |
| Soto, JM | 1 |
| Panettiere, F | 1 |
| Luce, JK | 4 |
| Talley, R | 1 |
| Monto, RW | 3 |
| Ibrahim, E | 1 |
| Cassileth, PA | 1 |
| Trotman, BW | 1 |
| Jovicic, V | 1 |
| Wolff, SM | 1 |
| Simon, HB | 1 |
| Habib, MA | 1 |
| Donaldson, JC | 1 |
| Burningham, RA | 1 |
| Viola, MV | 1 |
| Kovi, J | 1 |
| Nukhopadhyay, M | 1 |
| Gociu, M | 1 |
| Sighetea, E | 1 |
| Tănăseanu, S | 1 |
| Berceanu, S | 1 |
| Hunter, A | 1 |
| Crowther, D | 1 |
| Smithers, DW | 1 |
| Sybesma, JP | 1 |
| Holtzer, JD | 1 |
| Borst-Eilers, E | 1 |
| Moes, M | 1 |
| Zegers, BJ | 1 |
| Cazenave, JP | 1 |
| Gagnon, JA | 1 |
| Girouard, E | 1 |
| Bastarache, A | 1 |
| Gray, JL | 1 |
| Robinson, WA | 2 |
| Constanzi, JJ | 1 |
| Talley, RW | 1 |
| Hewlett, JS | 2 |
| Delaney, FC | 1 |
| Gottlieb, JA | 1 |
| Gutterman, JU | 1 |
| McCredie, KB | 1 |
| Mubashir, BA | 1 |
| Pettavel, J | 1 |
| Rohner, A | 1 |
| Lerner, KG | 1 |
| Gerdes, A | 1 |
| Heywood, JD | 1 |
| Fefer, A | 1 |
| Khilanani, R | 1 |
| al-Sarraf, M | 1 |
| Ellman, L | 1 |
| Davis, J | 1 |
| Lichtenstein, NS | 1 |
| Smith, KL | 1 |
| Johnson, D | 1 |
| Hustu, O | 1 |
| Pratt, C | 1 |
| Fleming, I | 1 |
| Holton, C | 1 |
| DeVitra, VT | 1 |
| DeWys, D | 1 |
| Grundmann, E | 1 |
| Fritzsche, R | 1 |
| Jedrzejczak, W | 1 |
| Sood, VD | 1 |
| Pasricha, JS | 1 |
| Keelan, MH | 1 |
| Nison, DW | 1 |
| Hansen, SH | 1 |
| Vetner, M | 1 |
| Kende, G | 1 |
| Sautière-Habay, D | 1 |
| Lerche-Habart, B | 1 |
| Ezdinli, EZ | 1 |
| Firat, D | 1 |
| Esposito, R | 1 |
| Ponti, GB | 1 |
| Giangrande, A | 1 |
| Gunz, FW | 1 |
| Mani, MK | 1 |
| Ravich, RB | 1 |
| Speden, J | 1 |
| Vincent, PC | 1 |
| Logan, WS | 1 |
| Tindall, JP | 1 |
| Elson, ML | 1 |
| Lutz-Honders, M | 1 |
| Cleton, FJ | 1 |
| van Dongen, JA | 1 |
| Jorke, D | 1 |
| Wilke, D | 1 |
| Isaacs, BL | 1 |
| Palmer, RL | 1 |
| Boutis, L | 1 |
| Hoffmann, P | 1 |
| Musshoff, K | 2 |
| Cajozzo, A | 1 |
| Citarrella, P | 1 |
| Carreca, I | 1 |
| D'Eredità, F | 1 |
| Constable, W | 1 |
| Leavell, BS | 1 |
| Selim, HM | 1 |
| Kurnick, JE | 1 |
| Greenberg, LH | 1 |
| Wong, S | 1 |
| Richardson, AP | 1 |
| Dollinger, MR | 1 |
| Jezzi, B | 1 |
| Seward, CW | 1 |
| Sponzo, RW | 1 |
| Levin, DL | 1 |
| Schnipper, LE | 1 |
| Bonner, H | 1 |
| Rabe, W | 1 |
| Reimer, F | 1 |
| Hansen, I | 1 |
| Maurice, PA | 1 |
| Cipriani, D | 1 |
| White, LP | 1 |
| Winkelman, J | 1 |
| Fisher, H | 1 |
| Melnyk, J | 1 |
| Bardana, EJ | 1 |
| Pirofsky, B | 1 |
| Yim, Y | 1 |
| Kikkawa, Y | 1 |
| Tanowitz, H | 1 |
| Wittner, M | 1 |
| Rywlin, AM | 1 |
| Recher, L | 1 |
| Hoffman, EP | 1 |
| Leroy, EC | 1 |
| Sjoerdsma, A | 1 |
| Hall, TC | 1 |
| Choi, OS | 1 |
| Abadi, A | 1 |
| Krant, MJ | 1 |
| Wanebo, HJ | 1 |
| Rawson, RW | 1 |
| Mittelman, A | 1 |
| Elias, EG | 1 |
| Grace, JT | 1 |
| Steele, TH | 1 |
| Present, CA | 1 |
| Curran, RE | 1 |
| Lowenbraun, S | 3 |
| Ramsey, H | 1 |
| Sutherland, J | 1 |
| Nowak, S | 1 |
| Lewicka, T | 1 |
| Ghosh, L | 1 |
| Muehrcke, RC | 1 |
| Levitt, M | 1 |
| DeConti, RC | 1 |
| Pearson, HA | 1 |
| Marsh, JC | 1 |
| Zanes, RP | 1 |
| Mitchell, MS | 1 |
| Kaetz, HW | 1 |
| Norris, FH | 1 |
| Leonards, R | 1 |
| Calanchini, PR | 1 |
| Calder, CD | 1 |
| Blouin, R | 1 |
| Barry, A | 1 |
| Oehlert, W | 1 |
| Wunsch, B | 1 |
| Willmann, H | 1 |
| Beck, K | 1 |
| Ramsey, HE | 1 |
| Plager, J | 1 |
| Gemon, MF | 1 |
| Brunel-Kotschi, R | 1 |
| Stolinsky, DC | 1 |
| Mullins, GM | 1 |
| Gilbert, TT | 1 |
| Evjy, JT | 1 |
| Edelstein, L | 1 |
| Helbig W Röder, K | 1 |
| Danovich, FM | 1 |
| Gonoboblev, EM | 1 |
| Lefkowitz, ER | 1 |
| Heindl, E | 1 |
| Lützenberger, P | 1 |
| Brandenburg, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase III Study for the Treatment of Children and Adolescents With Newly Diagnosed Low Risk Hodgkin Disease[NCT00302003] | Phase 3 | 287 participants (Actual) | Interventional | 2006-02-28 | Completed | ||
| Phase II Trial of Response-Adapted Therapy Based on Positron Emission Tomography (PET) for Bulky Stage I and Stage II Classical Hodgkin Lymphoma (HL)[NCT01118026] | Phase 2 | 101 participants (Actual) | Interventional | 2010-09-30 | Completed | ||
| A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults[NCT02166463] | Phase 3 | 600 participants (Actual) | Interventional | 2015-03-19 | Active, not recruiting | ||
| A Phase III Groupwide Study of Dose-Intensive Response-Based Chemotherapy and Radiation Therapy for Children and Adolescents With Newly Diagnosed Intermediate Risk Hodgkin Disease[NCT00025259] | Phase 3 | 1,734 participants (Actual) | Interventional | 2002-09-30 | Completed | ||
| Prospective Controlled Trial in Clinical Stages I-II Supradiaphragmatic Hodgkin's Disease: Evaluation of Treatment Efficacy, (Long Term) Toxicity and Quality of Life in Two Different Prognostic Subgroups[NCT00005584] | Phase 3 | 1,649 participants (Actual) | Interventional | 1998-10-31 | Active, not recruiting | ||
| [NCT00515554] | Phase 3 | 1,500 participants (Actual) | Interventional | 2008-05-31 | Completed | ||
| Multicenter Clinical Study With Early Treatment Intensification In Patients With High- Risk Hodgkin Lymphoma, Identified As FDG-PET Scan Positive After 2 Conventional ABVD Courses[NCT00795613] | Phase 2 | 450 participants (Anticipated) | Interventional | 2008-06-30 | Active, not recruiting | ||
| [NCT00265018] | Phase 3 | 1,370 participants (Actual) | Interventional | 1998-05-31 | Completed | ||
| Phase II Trial of Response-Adapted Chemotherapy Based on Positron Emission Tomography for Non-Bulky Stage I and II Hodgkin Lymphoma[NCT01132807] | Phase 2 | 164 participants (Actual) | Interventional | 2010-05-31 | Completed | ||
| [NCT00265031] | Phase 3 | 0 participants | Interventional | 1999-01-31 | Completed | ||
| A Phase II Trial of Response-Adapted Therapy of Stage III-IV Hodgkin Lymphoma Using Early Interim FDG-PET Imaging[NCT00822120] | Phase 2 | 371 participants (Actual) | Interventional | 2009-07-31 | Completed | ||
| Non Randomized, Multicenter, Prospective Pediatric Hodgkin Lymphoma Treatment Trial Stratified According to Initial Risk Factors and Response to Chemotherapy, Reduced Cumulative Doses of Antineoplastic Agents and Radiotherapy.[NCT03500133] | Phase 4 | 500 participants (Anticipated) | Interventional | 2017-10-06 | Recruiting | ||
| The H10 EORTC/GELA/IIL Randomized Intergroup Trial on Early FDG-PET Scan Guided Treatment Adaptation Versus Standard Combined Modality Treatment in Patients With Supradiaphragmatic Stage I/II Hodgkin's Lymphoma[NCT00433433] | Phase 3 | 1,952 participants (Actual) | Interventional | 2006-10-31 | Active, not recruiting | ||
| A Prospective Multi-center Study for the Treatment of Chinese Children and Adolescents With Newly Diagnosed Hodgkin Lymphoma Using a Modified COG Strategy[NCT04726501] | Phase 4 | 200 participants (Anticipated) | Interventional | 2018-04-01 | Recruiting | ||
| Phase II Study of Interim PET-CT Scan-guided Response Adapted Therapy in Hodgkin's Lymphoma[NCT01304849] | 50 participants (Actual) | Interventional | 2011-01-31 | Completed | |||
| A Randomized Phase III Trial of ABVD Versus Stanford V (+/-) Radiation Therapy in Locally Extensive and Advanced Stage Hodgkin's Disease[NCT00003389] | Phase 3 | 854 participants (Actual) | Interventional | 1999-06-17 | Completed | ||
| BEACOPP (4 Cycles Escalated + 4 Cycles Baseline) Versus ABVD (8 Cycles) In Stage III & IV Hodgkin's Lymphoma[NCT00049595] | Phase 3 | 552 participants (Actual) | Interventional | 2002-08-31 | Completed | ||
| Randomisierte Phase II Studie Zum Einsatz Von Goserelin Und Oralen Kontrazeptiva Zur Reduktion Ovarieller Toxizitäten während Zytostatischer Primärtherapie Bei Fertilen Patientinnen Mit Hodgkin Lymphom in Fortgeschrittenen Stadien[NCT01014507] | Phase 2 | 60 participants (Actual) | Interventional | 2004-01-31 | Completed | ||
| [NCT00284271] | Phase 2 | 65 participants (Actual) | Interventional | 2004-01-31 | Completed | ||
| A Phase Ib/II Trial of Combined SGN-35 (BrentuximabVedotin) Therapy With Cyclophosphamide, Procarbazine, Prednisone, Etoposide and Mitoxantrone (BrEPEM) for Older Patients With Untreated Hodgkin Lymphoma (HL)[NCT03576378] | Phase 1/Phase 2 | 41 participants (Actual) | Interventional | 2018-08-08 | Active, not recruiting | ||
| [NCT00264953] | Phase 3 | 1,395 participants (Actual) | Interventional | 1998-05-31 | Completed | ||
| Pilot Study for the Treatment of Children With Newly Diagnosed Advanced Stage Hodgkin's Disease: Upfront Dose Intensive Chemotherapy[NCT00004010] | Phase 2 | 99 participants (Actual) | Interventional | 1999-10-31 | Completed | ||
| Early Chemotherapy Intensification With BEACOPP in High-risk, Interim-PET Positive Advanced-stage Hodgkin Lymphoma:a GITIL Retrospective Multicenter Clinical Study[NCT00877747] | 160 participants (Actual) | Observational | 2006-01-31 | Active, not recruiting | |||
| Prospective Randomized Comparison of ABVD Versus BEACOPP Chemotherapy With or Without Radiotherapy for Advanced Stage or Unfavorable Hodgkin's Lymphoma (HL)[NCT01251107] | Phase 3 | 331 participants (Actual) | Interventional | 2000-03-31 | Completed | ||
| PVAG - Phase I/II Dose Finding Trial in Elderly Patients (> 60 Years) With Advanced Stages Hodgkin's Lymphoma[NCT00147875] | Phase 1/Phase 2 | 60 participants (Actual) | Interventional | 2004-03-31 | Completed | ||
| Risk-Adapted Therapy for Pediatric Hodgkin's Disease[NCT00145600] | Phase 2 | 296 participants (Actual) | Interventional | 2000-03-02 | Completed | ||
| "Prospective Non Randomized Study With Chemotherapy in Patients With Hodgkin's Disease and HIV Infection: Stanford V Regimen For Low Risk Patients, EBVP Regimen For High Risk Patients"[NCT00003262] | Phase 2 | 30 participants (Anticipated) | Interventional | 1997-05-31 | Active, not recruiting | ||
| An Open-Label, One Arm, Phase I Safety Study of Anti-CD20 Antibody (Rituximab, Rituxan) Therapy in the Treatment of Primary Sjogren's Syndrome[NCT00101829] | Phase 1 | 12 participants (Actual) | Interventional | 2004-04-30 | Completed | ||
| Improving the Therapeutic Ratio by Using Proton Beam Radiation Therapy for Patients With Stage IA-IIIBX (Bulky/Non-bulky) Hodgkin Lymphoma Involving the Mediastinum Following Standard Chemotherapy[NCT00850200] | 20 participants (Actual) | Interventional | 2009-08-31 | Completed | |||
| Phase III Randomized Trial of Adjuvant Involved-Field Radiotherapy vs No Adjuvant Therapy Following Remission Induction With MOPP/ABV Hybrid Chemotherapy in Patients With Stage III/IV Hodgkin's Disease[NCT00002462] | Phase 3 | 615 participants (Actual) | Interventional | 1989-09-30 | Active, not recruiting | ||
| Protocol H8 for a Prospective Controlled Trial in Clinical Stage I-II Supradiaphragmatic Hodgkin's Disease. Evaluation of Treatment Efficacy and (Long Term) Toxicity in Three Different Prognostic Subgroups [H8 Trial][NCT00379041] | Phase 3 | 1,158 participants (Anticipated) | Interventional | 1993-09-01 | Active, not recruiting | ||
| A Phase II Pilot Study of Short Term (12 Week) Combination Chemotherapy (Stanford V) in Unfavorable Hodgkin's Disease[NCT00002715] | Phase 2 | 50 participants (Anticipated) | Interventional | 1989-04-30 | Completed | ||
| Optimization of the Primary Therapy for Patients With Hodgkin's Lymphoma and Evaluation of the Positron Emission Tomography (PET) as a Diagnostic Tool for Primary Staging and Assessment of the Effects of the Therapy[NCT00188149] | Phase 4 | 300 participants | Interventional | 2000-05-31 | Recruiting | ||
| Ovarian Tissue Freezing For Fertility Preservation In Women Facing A Fertility Threatening Medical Diagnosis Or Treatment Regimen: A Study By The National Physicians Cooperative of the Oncofertility Consortium At Northwestern University[NCT00902720] | Phase 4 | 25 participants (Anticipated) | Interventional | 2009-05-31 | Recruiting | ||
| Evaluation of Late Treatment Effects in Long-Term Survivors of Hodgkin's Disease Previously Treated at NIH: A Multi-Institutional Trial[NCT00924131] | 157 participants (Anticipated) | Observational | 2009-04-17 | Completed | |||
| Maternal Cancer Diagnosis and Treatment During Pregnancy:a Registry for Maternal, Fetal, and Neonatal Outcomes With Longitudinal Follow up of Child Development and Maternal Psychological Well Being[NCT02749474] | 400 participants (Anticipated) | Observational [Patient Registry] | 2003-07-31 | Recruiting | |||
| Allogeneic and Matched Unrelated Donor Stem Cell Transplantation for Congenital Immunodeficiencies or Patients With Autoinflammatory/Immunodysregulatory Conditions: Busulfan-Based Conditioning With Campath- 1H or h-ATG, Radiation, and Sirolimus[NCT00426517] | Early Phase 1 | 48 participants (Actual) | Interventional | 2007-01-19 | Completed | ||
| Evaluation of Efficacy and Hypothalamus-pituitary-adrenal Axis Suppression Due to a Single Intrabursal Injection of Corticosteroids in Patients With Shoulder Calcific Tendinopathy[NCT01652495] | Phase 4 | 44 participants (Actual) | Interventional | 2012-03-31 | Completed | ||
| A Multicentric Randomized Trial Comparing the Bronchial Artery Embolization Combined With Medical Measures and the Medical Measures Alone in the Treatment of Non-severe Acute Hemoptysis of Mild-to-moderate Abundance[NCT01278199] | 73 participants (Actual) | Interventional | 2011-11-30 | Completed | |||
| Phase I/II Trial of Yttrium-90-labeled Daclizumab (Anti-CD25) Radioimmunotherapy With High-dose BEAM Chemotherapy and Autologous Hematopoietic Stem Cell Rescue in Recurrent and Refractory Hodgkin's Lymphoma[NCT01468311] | Phase 1/Phase 2 | 6 participants (Actual) | Interventional | 2011-10-11 | Terminated (stopped due to Poor enrollment and ability to radioconjugate Daclizumab. Neither Center for Cancer Research (CCR) or Nuclear Medicine/Radiology wanted to do the facilities upgrade and hire personnel needed to radioconjugate the drug at the Clinical Center.) | ||
| A Pilot Study of Adherence to Oral Medication and Health Beliefs of Adolescents With HIV and Their Mothers[NCT00001699] | 45 participants | Observational | 1998-06-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Survival is defined as the minimum time from study entry to a relapse of any kind, death from any cause, or occurrence of a second malignant neoplasm. Patients without report of such events where censored at last contact. This will be used to compute event free survival (EFS). (NCT00302003)
Timeframe: At 60 months
| Intervention | Probability of survival (Number) |
|---|---|
| Group 1 | 0.79 |
Survival is defined as the minimum time from study entry to requirement for additional chemotherapy and IFRT for retrieval, occurrence of a second malignant neoplasm, or death from any cause. Patients without report of such events where censored at last contact. Patients who achieve less than CR after 3 cycles of AV-PC will require IFRT and hence will satisfy this definition at the time of response evaluation. Patients who achieve a CR but who relapse will receive addition chemotherapy and IFRT or intense retrieval and hence will satisfy this definition at the time of the first relapse of Hodgkin disease. This endpoint will be used to compute event free survival without receiving radiation therapy (EFSnoRT). (NCT00302003)
Timeframe: At 60 months
| Intervention | Probability of survival (Number) |
|---|---|
| Group 1 | 0.49 |
Survival is defined as the minimum time from study entry to a relapse of higher risk at any time, any relapse following treatment with protocol mandated IFRT, death from any cause, or the occurrence of a second malignant neoplasm. This will be used to compute intensive therapy free survival (ITFS). Patients without report of such events where censored at last contact. This differs from traditional EFS in that relapse after AVPC* x3 therapy alone that does not place the patient in a higher risk category is not considered a treatment failure. In this definition, higher-risk relapse refers to relapse involving sites and extent of disease that place the patient in the current COG definition of intermediate or high-risk disease. If a patient with CR who experiences a LR relapse is not retreated with protocol-mandated chemotherapy and IFRT, subsequent disease relapses will nevertheless be counted in the analysis of the treatment strategy. (NCT00302003)
Timeframe: At 60 months
| Intervention | Probability of survival (Number) |
|---|---|
| Group 1 | 0.89 |
Survival is defined as time from study entry to death due to any cause. Patients alive at last contact where censored at last contact. (NCT00302003)
Timeframe: At 60 months
| Intervention | Probability of survival (Number) |
|---|---|
| Group 1 | 0.99 |
A Complete Response (CR) is defined as the complete disappearance of all detectable clinical evidence of disease and disease-related symptoms if present before therapy. For this endpoint, the best response at any time post-baseline was analyzed (NCT01118026)
Timeframe: Up to 8 weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| ABVD (PET-negative) | 73 |
| ABVD + BEACOPP + Radiation (PET-positive) | 16 |
Progression-free survival (PFS) is defined as the time from first PET/CT scan to disease progression or death. Patients who are alive without disease progression will be censored at the time of their most recent disease evaluation. The Kaplan-Meier three-year (36 month) survival estimates and confidence intervals are presented below. (NCT01118026)
Timeframe: Up to 36 months
| Intervention | percentage of participants (Number) |
|---|---|
| ABVD (PET-negative) | 93.1 |
| ABVD + BEACOPP + Radiation (PET-positive) | 89.7 |
Primary analysis will be based 1-sided log rank test comparison of EFS curves between the 2 randomized arms per intention-to-treat principle. Progression is defined as an ≥50% increase of in the product of the perpendicular diameters of any of the involved nodes or nodal masses or focal organ lesions in sites that were persistently PET positive; or recurrent PET positive lesions (Deauville 4, 5) in sites that had previously been PET negative regardless of change of size, as was the development of new PET avid measurable lesion(s) >1.5cm in any axis, or new sites of assessable disease. Relapse is defined in patients who achieved a prior CR but subsequently has an increase of ≥50% of the PPD in prior nodal or extranodal sites in a recurrently PET positive lesion(s), or the development of new measurable lesion(s) >1.5cm in any axis, or new sites of assessable disease. Second malignancy is defined based on report of a cancer that is not considered to be classic Hodgkin Lymphoma. (NCT02166463)
Timeframe: Up to 48 months after the last enrollment
| Intervention | percentage of participants (Number) |
|---|---|
| Arm I (ABVE-PC) | 82.5 |
| ARM II (Bv-AVEPC) | 92.1 |
"The percentages of patients experiencing grade 3+ peripheral neuropathy assessed by the treating clinician using the modified Balis scale. The Modified Balis scale of Pediatric Neuropathy allows clinicians to assign a score for sensory or motor neuropathy symptoms separately. Scores range from 1 to 4 with 1 being the least symptomatic state and 4 indicating a severe debility. The percentages of patients (with a score >/=3) will be compared between the 2 arms by two-sample Z test at 1-sided alpha level of 0.05." (NCT02166463)
Timeframe: From the enrollment of the patient to the time of analysis or the last follow-up; an average of 3.6 years.
| Intervention | Percentage of patients (Number) |
|---|---|
| Arm I (ABVE-PC) | 5.5 |
| ARM II (Bv-AVEPC) | 6.7 |
The percentages of patients (with available PET scan) with no SRL and no PD will be compared between the two randomized arms to see if brentuximab vedotin in the chemotherapy backbone of doxorubicin hydrochloride, vincristine sulfate, etoposide, prednisone and cyclophosphamide (Bv-AVEPC) arm has a higher rate of early response compared to doxorubicin hydrochloride, bleomycin sulfate, vincristine sulfate, etoposide, prednisone, and cyclophosphamide (ABVE-PC) arm. Two-sample Z test of proportions at 1-sided alpha level of 0.05 will be used for these comparisons. (NCT02166463)
Timeframe: After 42 days of chemotherapy
| Intervention | Percentage of patients (Number) |
|---|---|
| Arm I (ABVE-PC) | 80.7 |
| ARM II (Bv-AVEPC) | 81.2 |
Number of participants with complete response and very good partial response at the end of protocol therapy. (NCT00025259)
Timeframe: Protocol therapy: the overall duration of which is: (n=1527) an average of 137.1 days, median 133.0 days, interquartile range: 101.0, 164.0 days.
| Intervention | Number of participants (Number) |
|---|---|
| Arm I (Patients Off-therapy Before Callback-Induction Only) | 5 |
| Arm II (RER With CR [ABVE-PC, IFRT]) | 370 |
| Arm III (RER With CR [ABVE-PC]) | 380 |
| Arm IV (RER With Less Than CR [ABVE-PC, IFRT]) | 538 |
| Arm V (RER With PD) | 29 |
| Arm VI (SER [DECA, ABVE-PC, IFRT]) | 105 |
| Arm VII (SER [ABVE-PC, IFRT]) | 100 |
Probability of event-Free survival which is defined as the time from study entry to treatment failure (disease progression, disease recurrence, biopsy positive residual after completion of all protocol therapy), occurrence of a second malignant neoplasm, or death from any cause. Patients without report of such events where censored at last contact. (NCT00025259)
Timeframe: 5 years
| Intervention | Probability of survival (Number) |
|---|---|
| Arm I (Patients Off-therapy Before Callback-Induction Only) | 0.89 |
| Arm II (RER With CR [ABVE-PC, IFRT]) | 0.87 |
| Arm III (RER With CR [ABVE-PC]) | 0.84 |
| Arm IV (RER With Less Than CR [ABVE-PC, IFRT]) | 0.87 |
| Arm V (RER With PD) | 0.70 |
| Arm VI (SER [DECA, ABVE-PC, IFRT]) | 0.79 |
| Arm VII (SER [ABVE-PC, IFRT]) | 0.74 |
Occurrence of any grade 4 non-hematologic toxicity or grade 3 non-hematologic toxicity which doesn't respond to treatment within 7 days despite recommended therapy modification, or toxic death, which is any death primarily attributable to treatment. Grade 3 is defined to be severe or medically significant but not immediate life-threatening; hospitalization or prolongation of hospitalization indicated; disabling; limiting self-care ADL. Grade 4 refers to toxicities with life-threatening consequences; urgent intervention indicated. (NCT00025259)
Timeframe: Protocol therapy: the overall duration of which is: (n=1684) an average of 137.3 days, median 133.0 days, interquartile range: 101.0, 164.0 days.
| Intervention | Number of participants (Number) |
|---|---|
| Arm I (Patients Off-therapy Before Callback-Induction Only) | 10 |
| Arm II (RER With CR [ABVE-PC, IFRT]) | 153 |
| Arm III (RER With CR [ABVE-PC]) | 130 |
| Arm IV (RER With Less Than CR [ABVE-PC, IFRT]) | 216 |
| Arm V (RER With PD) | 11 |
| Arm VI (SER [DECA, ABVE-PC, IFRT]) | 62 |
| Arm VII (SER [ABVE-PC, IFRT]) | 45 |
Probability of overall survival which is defined as the time from study entry to death from any cause. Patients alive where censored at last contact. (NCT00025259)
Timeframe: 5 years
| Intervention | Probability of survival (Number) |
|---|---|
| Arm I (Patients Off-therapy Before Callback-Induction Only) | 0.93 |
| Arm II (RER With CR [ABVE-PC, IFRT]) | 0.98 |
| Arm III (RER With CR [ABVE-PC]) | 0.98 |
| Arm IV (RER With Less Than CR [ABVE-PC, IFRT]) | 0.98 |
| Arm VI (SER [DECA, ABVE-PC, IFRT]) | 0.96 |
| Arm VII (SER [ABVE-PC, IFRT]) | 0.93 |
All patients received an initial 2-28 day cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) on Days 1 and 15. After the first 2 cycles of ABVD, PET/CT was performed and submitted for central review (cycle 2, days 23-25) and determined whether patients would receive 2 cycles of escalated BEACOPP and involved-field RT (IFRT) or an additional 2 cycles of ABVD. PFS for each patient is measured as the time from registration on trial to the first incident of death or progression. The PFS rate at 36 months is calculated as the number of patients who have a progression-free survival time greater than 36 months divided by the total number of patients that started treatment. For this endpoint, we compare the PFS rate between patients who received 4 cycles of ABVD and patients who received 2 cycles of ABVD and 2 cycles of IFRT. (NCT01132807)
Timeframe: at 36 months
| Intervention | proportion of participants (Number) |
|---|---|
| Treatment (ABVD:4 Cycles) | .91 |
| Escalated BEACOPP and Involved Field Radiation Therapy | .67 |
A Complete Response (CR) was defined as having the following conditions: 1. A complete disappearance of all detectable clinical evidence of disease and disease-related symptoms if present before therapy. 2. In patients with a PET scan that was positive before therapy, a post-treatment residual mass of any size is permitted as long as it is PET-negative. A Complete Response rate was defined as the number of patients who achieved a CR divided by the number of patients that were eligible for analysis in each group. The CR rate was calculated for patients that completed 4 cycles of ABVD and for patients that completed 2 cycles of ABVD and 2 cycles of BEACOPP and IFRT. (NCT01132807)
Timeframe: Up to 5 years
| Intervention | proportion of participants (Number) |
|---|---|
| Treatment (ABVD: 4 Cycles) | .97 |
| Escalated BEACOPP and Involved Field Radiation Therapy | .85 |
The primary objective of this trial is to estimate the 3 year PFS in patients who received 4 cycles of ABVD. PFS for each patient is measured as the time from registration on trial to the first incident of death or progression. The PFS at 36 months is calculated as the number of patients who have a progression-free survival time greater than 36 months divided by the total number of patients that started treatment. For this endpoint, all patients that received 4 cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) are included. (NCT01132807)
Timeframe: 36 Months
| Intervention | proportion of patients (Number) |
|---|---|
| Treatment (ABVD: 4 Cycles) | .91 |
Complete Response (CR) is a complete disappearance of all disease with the exception of the following. If no PET scan or when the PET scan was positive before therapy, a post-treatment residual mass of any size is permitted if it is PET negative. If the PET scan was negative before therapy, all nodal masses at baseline must have regressed. No new lesions. Previously enlarged organs must have regressed and not be palpable. Bone marrow (BM) must be negative if positive at baseline. Normalization of markers. Partial Response (PR) is a 50% decrease in the sum of products of greatest diameters (SPD) for up to 6 identified dominant lesions, including spleenic and hepatic nodules from baseline. No new lesions and no increase in the size of liver, spleen or other nodes. If PET scan or when the PET scan was positive before therapy, PET should be positive in at least one previously involved site. (NCT00822120)
Timeframe: 7 months after registration
| Intervention | percentage of patients (Number) |
|---|---|
| PET-negative: Continued ABVD After 2 Cycles of ABVD | 100 |
| PET-positive: BEACOPP Escalated After 2 Cycles of ABVD | 93 |
Disease progression is defined using the 2007 revised Cheson et al. criteria that is at least 50% increase in sum of the product of the diameters (SPD) of target measurable nodal lesions over the smallest sum observed, or >= 50% increase in greatest transverse diameter (GTD) of any nodal > 1 cm in shortest axis, or >= 50% increase in the SPD of other target measurable lesions over the smallest sum observed, any new bone marrow involvement, any new lesion, lymph node with long axis is > 1.5 cm or if both long and short axes are > 1 cm, PET positive if patients with no pretreatment PET scan or when PET scan was positive before therapy. Progression-free survival is measured from date of registration to date of first observation of progressive disease, or death due to any cause. Patients last known to be alive and progression-free are censored at date of last contact. (NCT00822120)
Timeframe: 2 years
| Intervention | percentage of participants (Number) |
|---|---|
| HIV-negative: 2 Cycles of ABVD Followed by Escalated BEACOPP | 64 |
Measured from date of registration to date of death due to any cause. Patients last known to be alive and are censored at date of last contact. (NCT00822120)
Timeframe: 2 years
| Intervention | percentage of participants (Number) |
|---|---|
| HIV-negative:2 Cycles of ABVD Followed by PET-directed Therapy | 98 |
Disease progression is defined using the 2007 revised Cheson et al. criteria that is at least 50% increase in sum of the product of the diameters (SPD) of target measurable nodal lesions over the smallest sum observed, or >= 50% increase in greatest transverse diameter (GTD) of any nodal > 1 cm in shortest axis, or >= 50% increase in the SPD of other target measurable lesions over the smallest sum observed, any new bone marrow involvement, any new lesion, lymph node with long axis is > 1.5 cm or if both long and short axes are > 1 cm, PET positive if patients with no pretreatment PET scan or when PET scan was positive before therapy. Progression-free survival is measured from date of registration to date of first observation of progressive disease, or death due to any cause. Patients last known to be alive and progression-free are censored at date of last contact. (NCT00822120)
Timeframe: 2 years
| Intervention | percentage of participants (Number) |
|---|---|
| HIV-negative: 2 Cycles of ABVD Followed by PET-directed Therap | 79 |
Disease progression is defined using the 2007 revised Cheson et al. criteria that is at least 50% increase in sum of the product of the diameters (SPD) of target measurable nodal lesions over the smallest sum observed, or >= 50% increase in greatest transverse diameter (GTD) of any nodal > 1 cm in shortest axis, or >= 50% increase in the SPD of other target measurable lesions over the smallest sum observed, any new bone marrow involvement, any new lesion, lymph node with long axis is >1.5 cm or if both long and short axes are > 1 cm, PET positive if patients with no pretreatment PET scan or when PET scan was positive before therapy. progression-free survival is measured from date of registration to date of first observation of progressive disease, or death due to any cause. Patients last known to be alive and progression-free are censored at date of last contact. (NCT00822120)
Timeframe: 2 years
| Intervention | percentage of patients (Number) |
|---|---|
| HIV-positive: 2 Cycles of ABVD Followed by PET-directed Therap | 83 |
Measured from date of registration to date of death due to any cause. Patients last known to be alive and are censored at date of last contact. (NCT00822120)
Timeframe: 5 years
| Intervention | percentage of participants (Number) |
|---|---|
| HIV-positive: 2 Cycles of ABVD Followed by PET-directed Therap | 89 |
Adverse Events (AEs) are reported by the NCI Common Terminology Criteria for Adverse Events (CTCAE) version 4.0. For each patient, worst grade of each event type is reported. Grade 3 = Severe, Grade 4 = Life-threatening, Grade 5 = Fatal. (NCT00822120)
Timeframe: Up to 1 year
| Intervention | Participants (Count of Participants) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALT, SGPT (serum glutamic pyruvic transaminase) | AST, SGOT | Adult respiratory distress syndrome (ARDS) | Albumin, serum-low (hypoalbuminemia) | Alkaline phosphatase | Allergic reaction/hypersensitivity | Anorexia | Arthritis (non-septic) | Carbon monoxide diffusion capacity (DL(co)) | Colitis | Colitis, infectious (e.g., Clostridium difficile) | Constipation | Cough | Creatinine | Cytokine release syndrome/acute infusion reaction | Dehydration | Diarrhea | Dizziness | Dyspnea (shortness of breath) | FEV(1) | Fatigue (asthenia, lethargy, malaise) | Febrile neutropenia | Fever in absence of neutropenia, ANC lt1.0x10e9/L | Glucose, serum-high (hyperglycemia) | Heartburn/dyspepsia | Hemoglobin | Hemolysis | Hemorrhage, pulmonary/upper respiratory - Nose | Hypotension | Hypoxia | Inf (clin/microbio) w/Gr 3-4 neuts - Blood | Inf (clin/microbio) w/Gr 3-4 neuts - Colon | Inf (clin/microbio) w/Gr 3-4 neuts - Lung | Inf (clin/microbio) w/Gr 3-4 neuts - Meninges | Inf (clin/microbio) w/Gr 3-4 neuts - Mucosa | Inf (clin/microbio) w/Gr 3-4 neuts - Skin | Inf (clin/microbio) w/Gr 3-4 neuts - Soft tissue | Inf (clin/microbio) w/Gr 3-4 neuts - UTI | Inf (clin/microbio) w/Gr 3-4 neuts - Upper airway | Inf (clin/microbio) w/Gr 3-4 neuts - Vagina | Inf w/normal ANC or Gr 1-2 neutrophils - Catheter | Inf w/normal ANC or Gr 1-2 neutrophils - Lung | Inf w/normal ANC or Gr 1-2 neutrophils - Oral cav | Inf w/normal ANC or Gr 1-2 neutrophils - Skin | Infection with normal ANC or Grade 1 or 2 neutroph | Infection with unknown ANC - Lung (pneumonia) | Left ventricular systolic dysfunction | Leukocytes (total WBC) | Lymphopenia | Metabolic/Laboratory-Other (Specify) | Mood alteration - agitation | Mood alteration - anxiety | Mood alteration - depression | Mucositis/stomatitis (clinical exam) - Oral cavity | Mucositis/stomatitis (functional/symp) - Oral cav | Muscle weakness, not d/t neuropathy - body/general | Musculoskeletal/Soft Tissue-Other (Specify) | Nausea | Neuropathy: motor | Neuropathy: sensory | Neutrophils/granulocytes (ANC/AGC) | Osteonecrosis (avascular necrosis) | Pain - Abdomen NOS | Pain - Back | Pain - Bone | Pain - Cardiac/heart | Pain - Chest wall | Pain - Chest/thorax NOS | Pain - Extremity-limb | Pain - Head/headache | Pain - Joint | Pain - Muscle | Pain - Oral cavity | Pain - Skin | Pain - Stomach | Pain - Throat/pharynx/larynx | Pain - Tumor pain | Pain-Other (Specify) | Pancreatic endocrine: glucose intolerance | Phosphate, serum-low (hypophosphatemia) | Platelets | Pneumonitis/pulmonary infiltrates | Potassium, serum-high (hyperkalemia) | Potassium, serum-low (hypokalemia) | Rash/desquamation | Rigors/chills | Sodium, serum-low (hyponatremia) | Syncope (fainting) | Thrombosis/thrombus/embolism | Vomiting | Weight gain | |
| HIV-negative and PET-negative: Continued ABVD | 0 | 0 | 2 | 0 | 0 | 2 | 1 | 0 | 2 | 1 | 0 | 0 | 1 | 0 | 0 | 2 | 1 | 0 | 9 | 1 | 15 | 17 | 3 | 1 | 0 | 4 | 0 | 0 | 0 | 3 | 1 | 0 | 4 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 3 | 0 | 0 | 0 | 1 | 1 | 86 | 30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 5 | 3 | 12 | 165 | 0 | 5 | 0 | 0 | 1 | 1 | 1 | 0 | 2 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 2 | 1 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 4 | 2 |
| HIV-negative and PET-positive: BEACOPP Escalated | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 3 | 17 | 1 | 1 | 0 | 37 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 0 | 0 | 3 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 42 | 32 | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 2 | 0 | 4 | 38 | 1 | 1 | 3 | 5 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 34 | 1 | 1 | 4 | 0 | 2 | 1 | 1 | 0 | 0 | 0 |
| HIV-negative: Initial ABVD | 3 | 1 | 0 | 1 | 1 | 2 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 4 | 0 | 10 | 8 | 0 | 0 | 1 | 10 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 73 | 15 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 7 | 2 | 4 | 206 | 0 | 2 | 1 | 0 | 0 | 1 | 0 | 1 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 5 | 0 |
Adverse Events (AEs) are reported by the NCI Common Terminology Criteria for Adverse Events (CTCAE) version 4.0. For each patient, worst grade of each event type is reported. Grade 3 = Severe, Grade 4 = Life-threatening, Grade 5 = Fatal. (NCT00822120)
Timeframe: Up to 1 year
| Intervention | Participants (Number) | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anorexia | Dizziness | Fatigue (asthenia, lethargy, malaise) | Febrile neutropenia | Hemoglobin | Inf (clin/microbio) w/Gr 3-4 neuts - Eye NOS | Inf (clin/microbio) w/Gr 3-4 neuts - Lung | Infection with unknown ANC - Urinary tract NOS | Insomnia | Leukocytes (total WBC) | Lymphopenia | Mood alteration - agitation | Mood alteration - anxiety | Muscle weakness, not d/t neuropathy - body/general | Neuropathy: motor | Neuropathy: sensory | Neutrophils/granulocytes (ANC/AGC) | Pain - Bone | Pain - Joint | Phosphate, serum-low (hypophosphatemia) | Platelets | Sodium, serum-low (hyponatremia) | Thrombosis/thrombus/embolism | |
| Initial ABVD | 0 | 0 | 1 | 3 | 1 | 1 | 0 | 0 | 1 | 7 | 1 | 1 | 1 | 1 | 0 | 1 | 8 | 1 | 1 | 1 | 0 | 1 | 0 |
| PET-negative: Continued ABVD | 1 | 1 | 1 | 3 | 3 | 0 | 1 | 0 | 0 | 6 | 2 | 0 | 0 | 0 | 1 | 1 | 7 | 0 | 1 | 1 | 1 | 0 | 1 |
| PET-positive: BEACOPP Standard | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Overall survival is defined as the time from randomization to death or last known alive. The 5-year survival rate is the probability a patient survives 5 years. (NCT00003389)
Timeframe: Assessed every 2 months if patient is < 1 year from study entry, every 3 months for the second year, every 4 months for the third year, every 6 months for years 4 and 5, and yearly for 5 years
| Intervention | Proportion of patients (Number) |
|---|---|
| Arm A (ABVD) | 0.88 |
| Arm B (Stanford V) | 0.88 |
"Failure-free survival is defined as the time from randomization to the earlier of progression/relapse or death. The 5-year failure-free survival is the probability a patient is failure-free and survives 5 years.~Progression is defined as an increase in size of 25% of the sum of the products of the pretreatment measurements or appearance of new lesions. Significant enlargement of the liver or spleen is evidence of progression. A significant increase in size is defined as > 2.0 cm in distance between costal margin and the inferior margin of either organ.~Relapse is defined as the re-appearance of any clinical evidence of Hodgkin's disease in a patient who has had a complete response. Relapse for partial responders is defined as progressive disease relative to disease status during the partial remission." (NCT00003389)
Timeframe: Assessed every 2 months if patient is < 1 year from study entry, every 3 months for the second year, every 4 months for the third year, every 6 months for years 4 and 5
| Intervention | Proportion of patients (Number) |
|---|---|
| Arm A (ABVD) | 0.74 |
| Arm B (Stanford V) | 0.71 |
Number of patients who developed second primary cancers (NCT00003389)
Timeframe: Assessed every 2 months if patient is < 1 year from study entry, every 3 months for the second year, every 4 months for the third year, every 6 months for years 4 and 5, and yearly for 5 years
| Intervention | participants (Number) |
|---|---|
| Arm A (ABVD) | 15 |
| Arm B (Stanford V) | 19 |
Assess and compare the patient reported and parent proxy cognitive problems (child + teen) quality of life across multiple time points using the Peds Quality of Life version 3. Assessment was performed across all risk groups. The QL scoring is a 5-point Likert scale from 0 (never) to 4 (almost always). Scores are transformed on a scale from 0 to 100. Items are reverse scored and linearly transformed to a 0-100 scale as follows: 0=100, 1=75, 2=50, 3=25, and 4=0. Total score is the sum of all items over the number of items answered on all scales. The higher the score, the better the quality of life. (NCT00145600)
Timeframe: At completion of 2 cycles of chemotherapy (T2), completion of 4 cycles of chemotherapy (T3), and 3-6 months after the completion of therapy (T5)
| Intervention | units on a scale (Mean) |
|---|---|
| Patient Completion of 2 Cycles of Chemotherapy (T2) | 77.6 |
| Parent Completion of 2 Cycles of Chemotherapy (T2) | 75.7 |
| Patient Completion of 4 Cycles of Chemotherapy (T3) | 78.9 |
| Parent Completion of 4 Cycles of Chemotherapy (T3) | 74.3 |
| Patient 3-6 Months After the Completion of Therapy (T5) | 80.8 |
| Parent 3-6 Months After the Completion of Therapy (T5) | 76.3 |
Assess and compare the patient reported and parent proxy communication quality of life across multiple time points using the Peds Quality of Life version 3. Assessment was performed across all risk groups. The QL scoring is a 5-point Likert scale from 0 (never) to 4 (almost always). Scores are transformed on a scale from 0 to 100. Items are reverse scored and linearly transformed to a 0-100 scale as follows: 0=100, 1=75, 2=50, 3=25, and 4=0. Total score is the sum of all items over the number of items answered on all scales. The higher the score, the better the quality of life. (NCT00145600)
Timeframe: At completion of 2 cycles of chemotherapy (T2), completion of 4 cycles of chemotherapy (T3), and 3-6 months after the completion of therapy (T5)
| Intervention | units on a scale (Mean) |
|---|---|
| Patient Completion of 2 Cycles of Chemotherapy (T2) | 78.3 |
| Parent Completion of 2 Cycles of Chemotherapy (T2) | 73.6 |
| Patient Completion of 4 Cycles of Chemotherapy (T3) | 80.6 |
| Parent Completion of 4 Cycles of Chemotherapy (T3) | 74.9 |
| Patient 3-6 Months After the Completion of Therapy (T5) | 83.7 |
| Parent 3-6 Months After the Completion of Therapy (T5) | 83.1 |
Assess and compare the patient reported and parent proxy emotional quality of life across multiple time points using the Peds Quality of Life version 4. Assessment was performed across all risk groups. The QL scoring is a 5-point Likert scale from 0 (never) to 4 (almost always). Scores are transformed on a scale from 0 to 100. Items are reverse scored and linearly transformed to a 0-100 scale as follows: 0=100, 1=75, 2=50, 3=25, and 4=0. Total score is the sum of all items over the number of items answered on all scales. The higher the score, the better the quality of life. (NCT00145600)
Timeframe: At Diagnosis (T1), completion of 2 cycles of chemotherapy (T2), completion of 4 cycles of chemotherapy (T3), and 3-6 months after the completion of therapy (T5).
| Intervention | units on a scale (Mean) |
|---|---|
| Patient At Diagnosis (T1) | 68.4 |
| Parent At Diagnosis (T1) | 62.3 |
| Patient Completion of 2 Cycles of Chemotherapy (T2) | 70.7 |
| Parent Completion of 2 Cycles of Chemotherapy (T2) | 64 |
| Patient Completion of 4 Cycles of Chemotherapy (T3) | 74.1 |
| Parent Completion of 4 Cycles of Chemotherapy (T3) | 65.7 |
| Patient 3-6 Months After the Completion of Therapy (T5) | 78.5 |
| Parent 3-6 Months After the Completion of Therapy (T5) | 77.1 |
Assess and compare the patient reported and parent proxy nausea quality of life across multiple time points using the Peds Quality of Life version 3. Assessment was performed across all risk groups. The QL scoring is a 5-point Likert scale from 0 (never) to 4 (almost always). Scores are transformed on a scale from 0 to 100. Items are reverse scored and linearly transformed to a 0-100 scale as follows: 0=100, 1=75, 2=50, 3=25, and 4=0. Total score is the sum of all items over the number of items answered on all scales. The higher the score, the better the quality of life. (NCT00145600)
Timeframe: At completion of 2 cycles of chemotherapy (T2), completion of 4 cycles of chemotherapy (T3), and 3-6 months after the completion of therapy (T5)
| Intervention | units on a scale (Mean) |
|---|---|
| Patient Completion of 2 Cycles of Chemotherapy (T2) | 60.7 |
| Parent Completion of 2 Cycles of Chemotherapy (T2) | 58.6 |
| Patient Completion of 4 Cycles of Chemotherapy (T3) | 59.7 |
| Parent Completion of 4 Cycles of Chemotherapy (T3) | 57.7 |
| Patient 3-6 Months After the Completion of Therapy (T5) | 75 |
| Parent 3-6 Months After the Completion of Therapy (T5) | 78.9 |
Assess and compare the patient reported and parent proxy pain and hurt quality of life across multiple time points using the Peds Quality of Life version 3. Assessment was performed across all risk groups. The QL scoring is a 5-point Likert scale from 0 (never) to 4 (almost always). Scores are transformed on a scale from 0 to 100. Items are reverse scored and linearly transformed to a 0-100 scale as follows: 0=100, 1=75, 2=50, 3=25, and 4=0. Total score is the sum of all items over the number of items answered on all scales. The higher the score, the better the quality of life. (NCT00145600)
Timeframe: At completion of 2 cycles of chemotherapy (T2), completion of 4 cycles of chemotherapy (T3), and 3-6 months after the completion of therapy (T5).
| Intervention | units on a scale (Mean) |
|---|---|
| Patient Completion of 2 Cycles of Chemotherapy (T2) | 67.7 |
| Parent Completion of 2 Cycles of Chemotherapy (T2) | 57.3 |
| Patient Completion of 4 Cycles of Chemotherapy (T3) | 69.4 |
| Parent Completion of 4 Cycles of Chemotherapy (T3) | 60.2 |
| Patient 3-6 Months After the Completion of Therapy (T5) | 83.4 |
| Parent 3-6 Months After the Completion of Therapy (T5) | 77 |
Assess and compare the patient reported and parent proxy Peds QL4 (composite) quality of life across multiple time points using the Peds Quality of Life version 4. Assessment was performed across all risk groups. The QL scoring is a 5-point Likert scale from 0 (never) to 4 (almost always). Scores are transformed on a scale from 0 to 100. Items are reverse scored and linearly transformed to a 0-100 scale as follows: 0=100, 1=75, 2=50, 3=25, and 4=0. Total score is the sum of all items over the number of items answered on all scales. The higher the score, the better the quality of life. (NCT00145600)
Timeframe: At Diagnosis (T1), completion of 2 cycles of chemotherapy (T2), completion of 4 cycles of chemotherapy (T3), and 3-6 months after the completion of therapy (T5).
| Intervention | units on a scale (Mean) |
|---|---|
| Patient At Diagnosis (T1) | 76.2 |
| Parent At Diagnosis (T1) | 72.4 |
| Patient Completion of 2 Cycles of Chemotherapy (T2) | 74.2 |
| Parent Completion of 2 Cycles of Chemotherapy (T2) | 69.3 |
| Patient Completion of 4 Cycles of Chemotherapy (T3) | 77 |
| Parent Completion of 4 Cycles of Chemotherapy (T3) | 70.6 |
| Patient 3-6 Months After the Completion of Therapy (T5) | 84 |
| Parent 3-6 Months After the Completion of Therapy (T5) | 80.7 |
Assess and compare the patient reported and parent proxy PedsQL3 (composite) quality of life across multiple time points using the Peds Quality of Life version 3. Assessment was performed across all risk groups. The QL scoring is a 5-point Likert scale from 0 (never) to 4 (almost always). Scores are transformed on a scale from 0 to 100. Items are reverse scored and linearly transformed to a 0-100 scale as follows: 0=100, 1=75, 2=50, 3=25, and 4=0. Total score is the sum of all items over the number of items answered on all scales. The higher the score, the better the quality of life. (NCT00145600)
Timeframe: At completion of 2 cycles of chemotherapy (T2), completion of 4 cycles of chemotherapy (T3), and 3-6 months after the completion of therapy (T5)
| Intervention | units on a scale (Mean) |
|---|---|
| Patient Completion of 2 Cycles of Chemotherapy (T2) | 72.4 |
| Parent Completion of 2 Cycles of Chemotherapy (T2) | 68.3 |
| Patient Completion of 4 Cycles of Chemotherapy (T3) | 72.7 |
| Parent Completion of 4 Cycles of Chemotherapy (T3) | 67.6 |
| Patient 3-6 Months After the Completion of Therapy (T5) | 78.1 |
| Parent 3-6 Months After the Completion of Therapy (T5) | 77.6 |
Assess and compare the patient reported and parent proxy perceived physical appearance quality of life across multiple time points using the Peds Quality of Life version 3. Assessment was performed across all risk groups. The QL scoring is a 5-point Likert scale from 0 (never) to 4 (almost always). Scores are transformed on a scale from 0 to 100. Items are reverse scored and linearly transformed to a 0-100 scale as follows: 0=100, 1=75, 2=50, 3=25, and 4=0. Total score is the sum of all items over the number of items answered on all scales. The higher the score, the better the quality of life. (NCT00145600)
Timeframe: At completion of 2 cycles of chemotherapy (T2), completion of 4 cycles of chemotherapy (T3), and 3-6 months after the completion of therapy (T5)
| Intervention | units on a scale (Mean) |
|---|---|
| Patient Completion of 2 Cycles of Chemotherapy (T2) | 77.5 |
| Parent Completion of 2 Cycles of Chemotherapy (T2) | 71.9 |
| Patient Completion of 4 Cycles of Chemotherapy (T3) | 77.6 |
| Parent Completion of 4 Cycles of Chemotherapy (T3) | 71.2 |
| Patient 3-6 Months After the Completion of Therapy (T5) | 78.4 |
| Parent 3-6 Months After the Completion of Therapy (T5) | 80.5 |
Assess and compare the patient reported and parent proxy physical quality of life across multiple time points using the Peds Quality of Life version 4. Assessment was performed across all risk groups. The QL scoring is a 5-point Likert scale from 0 (never) to 4 (almost always). Scores are transformed on a scale from 0 to 100. Items are reverse scored and linearly transformed to a 0-100 scale as follows: 0=100, 1=75, 2=50, 3=25, and 4=0. Total score is the sum of all items over the number of items answered on all scales. The higher the score, the better the quality of life. (NCT00145600)
Timeframe: At Diagnosis (T1), completion of 2 cycles of chemotherapy (T2), completion of 4 cycles of chemotherapy (T3), and 3-6 months after the completion of therapy (T5).
| Intervention | units on a scale (Mean) |
|---|---|
| Patient At Diagnosis (T1) | 77.2 |
| Parent At Diagnosis (T1) | 73.9 |
| Patient Completion of 2 Cycles of Chemotherapy (T2) | 72.3 |
| Parent Completion of 2 Cycles of Chemotherapy (T2) | 65.4 |
| Patient Completion of 4 Cycles of Chemotherapy (T3) | 74.7 |
| Parent Completion of 4 Cycles of Chemotherapy (T3) | 66.5 |
| Patient 3-6 Months After the Completion of Therapy (T5) | 84.5 |
| Parent 3-6 Months After the Completion of Therapy (T5) | 78.6 |
Assess and compare the patient reported and parent proxy procedural anxiety quality of life across multiple time points using the Peds Quality of Life version 3. Assessment was performed across all risk groups. The QL scoring is a 5-point Likert scale from 0 (never) to 4 (almost always). Scores are transformed on a scale from 0 to 100. Items are reverse scored and linearly transformed to a 0-100 scale as follows: 0=100, 1=75, 2=50, 3=25, and 4=0. Total score is the sum of all items over the number of items answered on all scales. The higher the score, the better the quality of life. (NCT00145600)
Timeframe: At completion of 2 cycles of chemotherapy (T2), completion of 4 cycles of chemotherapy (T3), and 3-6 months after the completion of therapy (T5)
| Intervention | units on a scale (Mean) |
|---|---|
| Patient Completion of 2 Cycles of Chemotherapy (T2) | 71.3 |
| Parent Completion of 2 Cycles of Chemotherapy (T2) | 70.3 |
| Patient Completion of 4 Cycles of Chemotherapy (T3) | 73.8 |
| Parent Completion of 4 Cycles of Chemotherapy (T3) | 63.2 |
| Patient 3-6 Months After the Completion of Therapy (T5) | 78.5 |
| Parent 3-6 Months After the Completion of Therapy (T5) | 72.7 |
Assess and compare the patient reported and parent proxy psychosocial quality of life across multiple time points using the Peds Quality of Life version 4. Assessment was performed across all risk groups. The QL scoring is a 5-point Likert scale from 0 (never) to 4 (almost always). Scores are transformed on a scale from 0 to 100. Items are reverse scored and linearly transformed to a 0-100 scale as follows: 0=100, 1=75, 2=50, 3=25, and 4=0. Total score is the sum of all items over the number of items answered on all scales. The higher the score, the better the quality of life. (NCT00145600)
Timeframe: At Diagnosis (T1), completion of 2 cycles of chemotherapy (T2), completion of 4 cycles of chemotherapy (T3), and 3-6 months after the completion of therapy (T5).
| Intervention | units on a scale (Mean) |
|---|---|
| Patient At Diagnosis (T1) | 75.7 |
| Parent At Diagnosis (T1) | 71.3 |
| Patient Completion of 2 Cycles of Chemotherapy (T2) | 75.1 |
| Parent Completion of 2 Cycles of Chemotherapy (T2) | 71.1 |
| Patient Completion of 4 Cycles of Chemotherapy (T3) | 77.5 |
| Parent Completion of 4 Cycles of Chemotherapy (T3) | 72.3 |
| Patient 3-6 Months After the Completion of Therapy (T5) | 83.1 |
| Parent 3-6 Months After the Completion of Therapy (T5) | 80.7 |
Assess and compare the patient reported and parent proxy school quality of life across multiple time points using the Peds Quality of Life version 4. Assessment was performed across all risk groups. The QL scoring is a 5-point Likert scale from 0 (never) to 4 (almost always). Scores are transformed on a scale from 0 to 100. Items are reverse scored and linearly transformed to a 0-100 scale as follows: 0=100, 1=75, 2=50, 3=25, and 4=0. Total score is the sum of all items over the number of items answered on all scales. The higher the score, the better the quality of life. (NCT00145600)
Timeframe: At Diagnosis (T1), completion of 2 cycles of chemotherapy (T2), completion of 4 cycles of chemotherapy (T3), and 3-6 months after the completion of therapy (T5).
| Intervention | units on a scale (Mean) |
|---|---|
| Patient At Diagnosis (T1) | 69.6 |
| Parent At Diagnosis (T1) | 66.2 |
| Patient Completion of 2 Cycles of Chemotherapy (T2) | 67.2 |
| Parent Completion of 2 Cycles of Chemotherapy (T2) | 66.7 |
| Patient Completion of 4 Cycles of Chemotherapy (T3) | 69 |
| Parent Completion of 4 Cycles of Chemotherapy (T3) | 66.7 |
| Patient 3-6 Months After the Completion of Therapy (T5) | 78.6 |
| Parent 3-6 Months After the Completion of Therapy (T5) | 76.5 |
Assess and compare the patient reported and parent proxy social quality of life across multiple time points using the Peds Quality of Life version 4. Assessment was performed across all risk groups. The QL scoring is a 5-point Likert scale from 0 (never) to 4 (almost always). Scores are transformed on a scale from 0 to 100. Items are reverse scored and linearly transformed to a 0-100 scale as follows: 0=100, 1=75, 2=50, 3=25, and 4=0. Total score is the sum of all items over the number of items answered on all scales. The higher the score, the better the quality of life. (NCT00145600)
Timeframe: At Diagnosis (T1), completion of 2 cycles of chemotherapy (T2), completion of 4 cycles of chemotherapy (T3), and 3-6 months after the completion of therapy (T5).
| Intervention | units on a scale (Mean) |
|---|---|
| Patient At Diagnosis (T1) | 87.2 |
| Parent At Diagnosis (T1) | 83 |
| Patient Completion of 2 Cycles of Chemotherapy (T2) | 87.2 |
| Parent Completion of 2 Cycles of Chemotherapy (T2) | 81.4 |
| Patient Completion of 4 Cycles of Chemotherapy (T3) | 88.2 |
| Parent Completion of 4 Cycles of Chemotherapy (T3) | 82.2 |
| Patient 3-6 Months After the Completion of Therapy (T5) | 91.5 |
| Parent 3-6 Months After the Completion of Therapy (T5) | 85.8 |
Assess and compare the patient reported and parent proxy treatment anxiety quality of life across multiple time points using the Peds Quality of Life version 3. Assessment was performed across all risk groups. The QL scoring is a 5-point Likert scale from 0 (never) to 4 (almost always). Scores are transformed on a scale from 0 to 100. Items are reverse scored and linearly transformed to a 0-100 scale as follows: 0=100, 1=75, 2=50, 3=25, and 4=0. Total score is the sum of all items over the number of items answered on all scales. The higher the score, the better the quality of life. (NCT00145600)
Timeframe: At completion of 2 cycles of chemotherapy (T2), completion of 4 cycles of chemotherapy (T3), and 3-6 months after the completion of therapy (T5)
| Intervention | units on a scale (Mean) |
|---|---|
| Patient Completion of 2 Cycles of Chemotherapy (T2) | 84.1 |
| Parent Completion of 2 Cycles of Chemotherapy (T2) | 72.8 |
| Patient Completion of 4 Cycles of Chemotherapy (T3) | 82.8 |
| Parent Completion of 4 Cycles of Chemotherapy (T3) | 71.1 |
| Patient 3-6 Months After the Completion of Therapy (T5) | 82.1 |
| Parent 3-6 Months After the Completion of Therapy (T5) | 77.6 |
Assess and compare the patient reported and parent proxy worry quality of life across multiple time points using the Peds Quality of Life version 3. Assessment was performed across all risk groups. The QL scoring is a 5-point Likert scale from 0 (never) to 4 (almost always). Scores are transformed on a scale from 0 to 100. Items are reverse scored and linearly transformed to a 0-100 scale as follows: 0=100, 1=75, 2=50, 3=25, and 4=0. Total score is the sum of all items over the number of items answered on all scales. The higher the score, the better the quality of life. (NCT00145600)
Timeframe: At completion of 2 cycles of chemotherapy (T2), completion of 4 cycles of chemotherapy (T3), and 3-6 months after the completion of therapy (T5)
| Intervention | units on a scale (Mean) |
|---|---|
| Patient Completion of 2 Cycles of Chemotherapy (T2) | 64.5 |
| Parent Completion of 2 Cycles of Chemotherapy (T2) | 64.5 |
| Patient Completion of 4 Cycles of Chemotherapy (T3) | 64.7 |
| Parent Completion of 4 Cycles of Chemotherapy (T3) | 64.7 |
| Patient 3-6 Months After the Completion of Therapy (T5) | 67.1 |
| Parent 3-6 Months After the Completion of Therapy (T5) | 68.6 |
Event-free survival (EFS) is based on the time from protocol enrollment to the occurrence of first event (relapse or progressive disease, subsequent malignancy, or death from any cause). Patients not experiencing an event are censored at their last follow-up date. Event-free Survival Probability will be estimated by Kaplan-Meier (KM) method with a 95% confidence interval calculated using the Greenwood's formula. (NCT00145600)
Timeframe: Median 6.4 year follow-up
| Intervention | probability of 5 yr. event free survival (Number) |
|---|---|
| Favorable Risk | 0.886 |
| Intermediate Risk | 0.844 |
| Unfavorable Risk, Group 1 | 0.667 |
| Unfavorable Risk, Group 2 | 0.793 |
Event-free survival (EFS) is based on the time from protocol enrollment to the occurrence of first event (relapse or progressive disease, subsequent malignancy, or death from any cause). Patients not experiencing an event are censored at their last follow-up date. Event-free Survival Probability will be estimated by Kaplan-Meier (KM) method with a 95% confidence interval calculated using the with Greenwood's formula. (NCT00145600)
Timeframe: 10-year follow-up after protocol enrollment
| Intervention | probability 10 yr. event free survival (Number) |
|---|---|
| Favorable Risk | 0.874 |
| Intermediate Risk | 0.844 |
| Unfavorable Risk, Group 1 | 0.667 |
| Unfavorable Risk, Group 2 | 0.785 |
(NCT00850200)
Timeframe: Immediately proceeding completion of each of the three treatment plans
| Intervention | percentage of body receiving 4 Gy (Median) |
|---|---|
| Proton Radiation Plan | 0.161 |
| Conventional Photon Radiation Plan | 0.291 |
| Intensity Modulated Radiation Plan | 0.355 |
Disease free survival as assessed with the Kaplan-Meier product limit method (NCT00850200)
Timeframe: 4 years after beginning of radiation therapy
| Intervention | percentage of participants (Number) |
|---|---|
| Treated Cohort | 93 |
Overall survival as assessed with the Kaplan-Meier product limit method. (NCT00850200)
Timeframe: 4 years after beginning of radiation therapy
| Intervention | percentage of participants (Number) |
|---|---|
| Treated Cohort | 92 |
Recovery is defined as an absolute neutrophil count (ANC) of ≥ 0.5 x 109 /L (500/mm3 ) for three consecutive laboratory values obtained on different days. Date of ANC recovery is the date of the first of three consecutive laboratory values where the ANC is ≥ 0.5 x 109 /L. (NCT00426517)
Timeframe: 1 year
| Intervention | Days (Mean) |
|---|---|
| Matched Related Donor Stem Cell Transplant | 19.42 |
| Matched Unrelated Donor Stem Cell Transplant | 77.44 |
| Matched Unrelated Donor Stem Cell Transplant (MUD-non CGD) | 25.5 |
| Matched Unrelated Donor Transplant (MUD-CGD) Cord Blood | NA |
Rapidity of immune reconstitution based on number of days to CD3 count greater than 100 u/L. (NCT00426517)
Timeframe: 1 year
| Intervention | Days (Mean) |
|---|---|
| Matched Related Donor Stem Cell Transplant | 355 |
| Matched Unrelated Donor Stem Cell Transplant | 284 |
| Matched Unrelated Donor Stem Cell Transplant (MUD-non CGD) | 16 |
| Matched Unrelated Donor Transplant (MUD-CGD) Cord Blood | NA |
Platelet recovery is defined as platelet value ≥ 20 × 109/L for three consecutive days and no platelet transfusions administered for previous seven consecutive days. The date of platelet recovery is the date of the first of three consecutive laboratory values ≥ 20 × 109/L. (NCT00426517)
Timeframe: 1 year
| Intervention | Days (Mean) |
|---|---|
| Matched Related Donor Stem Cell Transplant | 31 |
| Matched Unrelated Donor Stem Cell Transplant | 31.9 |
| Matched Unrelated Donor Stem Cell Transplant (MUD-non CGD) | 32.6 |
| Matched Unrelated Donor Transplant (MUD-CGD) Cord Blood | NA |
Participants who achieved engraftment without development of graft versus host disease (GVHD). (NCT00426517)
Timeframe: 1 year
| Intervention | Participants (Count of Participants) |
|---|---|
| Matched Related Donor Stem Cell Transplant | 6 |
| Matched Unrelated Donor Stem Cell Transplant | 30 |
| Matched Unrelated Donor Stem Cell Transplant (MUD-non CGD) | 3 |
| Matched Unrelated Donor Transplant (MUD-CGD) Cord Blood | NA |
Number of events of Cytomegalovirus disease based on clinical sequelae that requires treatment (not reactivation) (NCT00426517)
Timeframe: 1 year
| Intervention | Number of events (Mean) |
|---|---|
| Matched Related Donor Stem Cell Transplant | 0 |
| Matched Unrelated Donor Stem Cell Transplant | 0 |
| Matched Unrelated Donor Stem Cell Transplant (MUD-non CGD) | 0 |
| Matched Unrelated Donor Transplant (MUD-CGD) Cord Blood | 0 |
Average number of red blood cell (RBC) transfusion per subject (NCT00426517)
Timeframe: 1 year
| Intervention | transfusions per person (Mean) |
|---|---|
| Matched Related Donor Stem Cell Transplant | 1.71 |
| Matched Unrelated Donor Stem Cell Transplant | 7.08 |
| Matched Unrelated Donor Stem Cell Transplant (MUD-non CGD) | 4 |
| Matched Unrelated Donor Transplant (MUD-CGD) Cord Blood | NA |
Number of participants with myeloid chimerism of greater than 10% of donor cells at 1 year post transplant (NCT00426517)
Timeframe: 1 year
| Intervention | Participants (Count of Participants) |
|---|---|
| Matched Related Donor Stem Cell Transplant | 7 |
| Matched Unrelated Donor Stem Cell Transplant | 30 |
| Matched Unrelated Donor Stem Cell Transplant (MUD-non CGD) | 3 |
| Matched Unrelated Donor Transplant (MUD-CGD) Cord Blood | NA |
Engraftment of allogeneic or matched unrelated (including cord blood) hematopoietic progenitor cells using moderate-dose busulfan and Campath-1H with or without whole body irradiation so as to attain phenotypic correction of congenital immunodeficiencies. (NCT00426517)
Timeframe: 1 year
| Intervention | Participants (Count of Participants) |
|---|---|
| Matched Related Donor Stem Cell Transplant | 7 |
| Matched Unrelated Donor Stem Cell Transplant | 31 |
| Matched Unrelated Donor Stem Cell Transplant (MUD-non CGD) | 3 |
| Matched Unrelated Donor Transplant (MUD-CGD) Cord Blood | 0 |
"Patients will be evaluated clinically by Constant Score~Constant score: range 0 (total shoulder impairment) to 100 (non impaired shoulder). The score is obtained from two subjective (pain and relation between pain and daily-life activities) - and two objective physician-assessed (strength and range of motion) measurements~Reference: Constant CR and Murley AH. A clinical method of functional assessment of the shoulder. Clin Orthop Relat Res. 1987 Jan;(214):160-4." (NCT01652495)
Timeframe: 180 days after treatment
| Intervention | percentage of improvement Constant score (Mean) |
|---|---|
| Methylprednisolone Acetate Group | 99 |
| Triamcinolone Acetonide Group | 95 |
"Evaluation of blood cortisol and ACTH, free urinary cortisol, urinary levels of methylprednisolone or triamcinolone (depending on the administered drug) by RIA immunoassay and tandem mass assays~Persistent suppression of the HPA axis at the end of the follow up is based on the evidence of ACTH, plasmatic and urinary cortisol levels under reference values" (NCT01652495)
Timeframe: 45 days after treatment
| Intervention | % of patients with HPA suppression (Number) |
|---|---|
| Methylprednisolone Acetate Group | 0 |
| Triamcinolone Acetonide Group | 15 |
"VAS score~VAS score is a 10 -cm graduated scale with scores ranging from 0 (no pain) to 10 (unbearable pain) self- reported by patients~Reference: Langley GB and Sheppeard H. The visual analogue scale: its use in pain measurement. Rheumatol Int 1985;5(4):145-148." (NCT01652495)
Timeframe: 180 days after treatment
| Intervention | percentage of pain reduction (Mean) |
|---|---|
| Methylprednisolone Acetate Group | 82 |
| Triamcinolone Acetonide Group | 96 |
Complete response rate is defined as the time it takes a participant to achieve a complete response. Response is assessed by the Revised Response Criteria for Malignant Lymphoma. Complete response requires all of the following: complete disappearance of all detectable clinical evidence of disease and disease related symptoms if present before therapy. A post treatment residual mass is permitted as long as it is positron emission tomography (PET) negative. If a pretreatment PET scan was negative, all lymph nodes and nodal masses must have regressed on computed tomography (CT) to normal size (<1.5 cm in their greatest transverse diameter for nodes >1.5 cm before therapy); Previously involved nodes that were 1.1 to 1.5 cm in their long axis and more than 1.0 cm in their short axis before treatment must have decreased to <1.0 cm in their short axis after treatment. (NCT01468311)
Timeframe: 20 months post autologous stem cell transplant
| Intervention | months (Median) |
|---|---|
| Yttrium-90-labeled Daclizumab + Chemotherapy | 7.5 |
DFS is defined as the amount of time participants remain disease free. (NCT01468311)
Timeframe: DFS is evaluated at day 100 post autologous stem cell transplant, then 1-4 times yearly for 5 years
| Intervention | months (Median) |
|---|---|
| Yttrium-90-labeled Daclizumab + Chemotherapy | 36 |
Patients who develop either a Common Terminology Criteria in Adverse Events (CTCAE) v4.0 grade 3 or greater non-hematologic toxicity, with the exception of fatigue, of more than 5 days duration possibly, probably or definitely related to the infusion of 90Y-daclizumab prior to the start of Carmustine, Etoposide, Cytarabine, [Ara-C, Cytosine Arabinoside] and Melphalan (BEAM) chemotherapy (Day - 6) will have developed by definition a dose-limiting toxicity (DLT). (NCT01468311)
Timeframe: 30 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Yttrium-90-labeled Daclizumab + Chemotherapy | 0 |
Here is the number of participants with serious and non-serious adverse events assessed by the Common Terminology Criteria in Adverse Events (CTCAE v4.0). A non-serious adverse event is any untoward medical occurrence. A serious adverse event is an adverse event or suspected adverse reaction that results in death, a life threatening adverse drug experience, hospitalization, disruption of the ability to conduct normal life functions, congenital anomaly/birth defect or important medical events that jeopardize the patient or subject and may require medical or surgical intervention to prevent one of the previous outcomes mentioned. (NCT01468311)
Timeframe: 30 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Yttrium-90-labeled Daclizumab + Chemotherapy | 3 |
Overall survival is defined as the time from the date of registration to the date of death due to any cause or if no death occurs to the last documented information on the patient. (NCT01468311)
Timeframe: OS is evaluated at day 100 post autologous stem cell transplant, then 1-4 times yearly for 5 years
| Intervention | months (Median) |
|---|---|
| Yttrium-90-labeled Daclizumab + Chemotherapy | 36 |
190 reviews available for prednisone and Hodgkin Disease
| Article | Year |
|---|---|
Contemporary treatment options for a classical disease: Advanced Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2020 |
Contemporary treatment options for a classical disease: Advanced Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2020 |
Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, | 2020 |
Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, | 2020 |
Composite lymphoma of cervical lymph nodes with classical Hodgkin lymphoma and diffuse large B cell lymphoma: a case report and literature review.
Topics: Composite Lymphoma; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Hodgkin Disease; Humans; Ly | 2020 |
Composite lymphoma of cervical lymph nodes with classical Hodgkin lymphoma and diffuse large B cell lymphoma: a case report and literature review.
Topics: Composite Lymphoma; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Hodgkin Disease; Humans; Ly | 2020 |
ABVD and BEACOPP regimens' effects on fertility in young males with Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2021 |
ABVD and BEACOPP regimens' effects on fertility in young males with Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2021 |
[Treatment strategy for newly diagnosed classical Hodgkin lymphoma: current achievements using interim PET-guided therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease | 2020 |
[Treatment strategy for newly diagnosed classical Hodgkin lymphoma: current achievements using interim PET-guided therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease | 2020 |
Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Daca | 2017 |
Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Daca | 2017 |
Pancreatic T/histiocyte-rich large B-cell lymphoma: A case report and review of literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Ducts; Biopsy; Chemotherapy, Adjuvant; Cholangi | 2017 |
Pancreatic T/histiocyte-rich large B-cell lymphoma: A case report and review of literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Ducts; Biopsy; Chemotherapy, Adjuvant; Cholangi | 2017 |
Balancing risk and benefit in early-stage classical Hodgkin lymphoma.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazin | 2018 |
Balancing risk and benefit in early-stage classical Hodgkin lymphoma.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazin | 2018 |
Limited-stage Hodgkin lymphoma: optimal chemotherapy and the role of radiotherapy.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinic | 2013 |
Limited-stage Hodgkin lymphoma: optimal chemotherapy and the role of radiotherapy.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinic | 2013 |
Refractory Hodgkin lymphoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; | 2013 |
Refractory Hodgkin lymphoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; | 2013 |
Effect of initial treatment strategy on survival of patients with advanced-stage Hodgkin's lymphoma: a systematic review and network meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2013 |
Effect of initial treatment strategy on survival of patients with advanced-stage Hodgkin's lymphoma: a systematic review and network meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2013 |
Epstein-Barr virus-positive oral ulceration simulating Hodgkin lymphoma in a patient treated with methotrexate: case report and review of the literature.
Topics: Aged, 80 and over; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Diagnosis, | 2014 |
Epstein-Barr virus-positive oral ulceration simulating Hodgkin lymphoma in a patient treated with methotrexate: case report and review of the literature.
Topics: Aged, 80 and over; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Diagnosis, | 2014 |
Early intensification treatment approach in advanced-stage Hodgkin lymphoma.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazin | 2014 |
Early intensification treatment approach in advanced-stage Hodgkin lymphoma.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazin | 2014 |
Induction therapy for advanced-stage Hodgkin lymphoma: late intensification (ABVD chemotherapy followed by high-dose chemotherapy and autologous stem cell transplant only for those who relapse).
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami | 2014 |
Induction therapy for advanced-stage Hodgkin lymphoma: late intensification (ABVD chemotherapy followed by high-dose chemotherapy and autologous stem cell transplant only for those who relapse).
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami | 2014 |
[Malignant lymphoma and adult T-cell leukemia-lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Deoxycytidi | 2014 |
[Malignant lymphoma and adult T-cell leukemia-lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Deoxycytidi | 2014 |
Complete remission of paraneoplastic vanishing bile duct syndrome after the successful treatment of Hodgkin's lymphoma: a case report and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Diseases; Female; Hodgkin Disease; | 2014 |
Complete remission of paraneoplastic vanishing bile duct syndrome after the successful treatment of Hodgkin's lymphoma: a case report and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Diseases; Female; Hodgkin Disease; | 2014 |
[Treatment strategy of gray zone lymphomas].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymp | 2014 |
[Treatment strategy of gray zone lymphomas].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymp | 2014 |
[Treatment strategy of Hodgkin lymphoma].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; B | 2014 |
[Treatment strategy of Hodgkin lymphoma].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; B | 2014 |
Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) after treatment for Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Central Nervous System Neoplasms; Chr | 2015 |
Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) after treatment for Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Central Nervous System Neoplasms; Chr | 2015 |
Hodgkin lymphoma: MOPP chemotherapy to PD-1 blockade and beyond.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Dacarbazine; Di | 2016 |
Hodgkin lymphoma: MOPP chemotherapy to PD-1 blockade and beyond.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Dacarbazine; Di | 2016 |
Current developments in the treatment of early-stage classical Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2016 |
Current developments in the treatment of early-stage classical Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2016 |
Comparison of the efficiency of ABVD versus BEACOPP for Hodgkin lymphoma treatment: a meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2016 |
Comparison of the efficiency of ABVD versus BEACOPP for Hodgkin lymphoma treatment: a meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2016 |
Response-adapted frontline therapy for Hodgkin lymphoma: are we there yet?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Cyclophosphamide; Daca | 2016 |
Response-adapted frontline therapy for Hodgkin lymphoma: are we there yet?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Cyclophosphamide; Daca | 2016 |
FDG-PET for Early Response Assessment in Lymphomas: Part 1-Hodgkin Lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2017 |
FDG-PET for Early Response Assessment in Lymphomas: Part 1-Hodgkin Lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2017 |
[Primary osseous Hodgkin's lymphoma of the sacrum: A diagnostic and therapeutic challenge].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Combined Modality Therapy; Cyclop | 2017 |
[Primary osseous Hodgkin's lymphoma of the sacrum: A diagnostic and therapeutic challenge].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Combined Modality Therapy; Cyclop | 2017 |
Hodgkin-like lymphoma, simulating anaplastic large cell lymphoma in the patient after renal transplantation--unusual case report and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Biomarkers, Tumor; Bone Marrow; Cy | 2008 |
Hodgkin-like lymphoma, simulating anaplastic large cell lymphoma in the patient after renal transplantation--unusual case report and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Biomarkers, Tumor; Bone Marrow; Cy | 2008 |
Treatment of Hodgkin lymphoma: the past, present, and future.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase III as Topic; Cycl | 2008 |
Treatment of Hodgkin lymphoma: the past, present, and future.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase III as Topic; Cycl | 2008 |
[Recent advances and the treatment strategies of AIDS-related malignant lymphoma].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2008 |
[Recent advances and the treatment strategies of AIDS-related malignant lymphoma].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2008 |
Breast cancer after treatment of Hodgkin's lymphoma: general review.
Topics: Adolescent; Adult; Age of Onset; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast N | 2008 |
Breast cancer after treatment of Hodgkin's lymphoma: general review.
Topics: Adolescent; Adult; Age of Onset; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast N | 2008 |
Standard therapy of advanced Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cy | 2009 |
Standard therapy of advanced Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cy | 2009 |
Is BEACOPP better than ABVD?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamid | 2007 |
Is BEACOPP better than ABVD?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamid | 2007 |
[Recent advance in peripheral T-cell lymphoma, not otherwise specified].
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antige | 2010 |
[Recent advance in peripheral T-cell lymphoma, not otherwise specified].
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antige | 2010 |
Chemotherapy only for localized Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachial Plexus; Chemotherapy, Adjuvant; | 2011 |
Chemotherapy only for localized Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachial Plexus; Chemotherapy, Adjuvant; | 2011 |
Composite lymphoma in the anterior mediastinum: a case report and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Composite Lymphoma | 2011 |
Composite lymphoma in the anterior mediastinum: a case report and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Composite Lymphoma | 2011 |
Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Daca | 2011 |
Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Daca | 2011 |
Lymphoma study group of JCOG.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemother | 2012 |
Lymphoma study group of JCOG.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemother | 2012 |
HIV-associated lymphoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highl | 2012 |
HIV-associated lymphoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highl | 2012 |
Treatment of newly diagnosed advanced stage Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2012 |
Treatment of newly diagnosed advanced stage Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2012 |
Positron emission tomographic scans in lymphoma: convention and controversy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubi | 2012 |
Positron emission tomographic scans in lymphoma: convention and controversy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubi | 2012 |
Autoimmune hemolytic anemia and classical Hodgkin lymphoma: a case report and literature review.
Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Hormon | 2012 |
Autoimmune hemolytic anemia and classical Hodgkin lymphoma: a case report and literature review.
Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Hormon | 2012 |
Fourteenth biannual report of the Cochrane Haematological Malignancies Group--focus on autologous stem cell transplantation in hematological malignancies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colony-Stimulating Factors; Cyclophospham | 2012 |
Fourteenth biannual report of the Cochrane Haematological Malignancies Group--focus on autologous stem cell transplantation in hematological malignancies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colony-Stimulating Factors; Cyclophospham | 2012 |
Gray zone lymphoma: better treated like hodgkin lymphoma or mediastinal large B-cell lymphoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease | 2012 |
Gray zone lymphoma: better treated like hodgkin lymphoma or mediastinal large B-cell lymphoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease | 2012 |
Lymphocyte-depleted Hodgkin lymphoma complicating hemophagocytic lymphohistiocytosis as an initial manifestation: a case report and review of the literature.
Topics: Adrenal Cortex Hormones; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophos | 2012 |
Lymphocyte-depleted Hodgkin lymphoma complicating hemophagocytic lymphohistiocytosis as an initial manifestation: a case report and review of the literature.
Topics: Adrenal Cortex Hormones; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophos | 2012 |
[Dropped Head Syndrome after whiplash injury in a patient treated for a Hodgkin's lymphoma by mantle field radiotherapy].
Topics: Accidents, Traffic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cervical Plexus; Cerv | 2013 |
[Dropped Head Syndrome after whiplash injury in a patient treated for a Hodgkin's lymphoma by mantle field radiotherapy].
Topics: Accidents, Traffic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cervical Plexus; Cerv | 2013 |
Changing role and decreasing size: current trends in radiotherapy for Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami | 2002 |
Changing role and decreasing size: current trends in radiotherapy for Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami | 2002 |
ChlVPP chemotherapy in children with stage IV Hodgkin's disease: results of the UKCCSG HD 8201 and HD 9201 studies.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chlorambucil; F | 2002 |
ChlVPP chemotherapy in children with stage IV Hodgkin's disease: results of the UKCCSG HD 8201 and HD 9201 studies.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chlorambucil; F | 2002 |
Advanced Hodgkin's disease: ABVD is better, yet is not good enough!
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Dacarbaz | 2003 |
Advanced Hodgkin's disease: ABVD is better, yet is not good enough!
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Dacarbaz | 2003 |
An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplasti | 2003 |
An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplasti | 2003 |
Partially successful treatment of a patient with chronic lymphocytic leukemia and Hodgkin's disease: case report and literature review.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bowen's Disease; Co | 2003 |
Partially successful treatment of a patient with chronic lymphocytic leukemia and Hodgkin's disease: case report and literature review.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bowen's Disease; Co | 2003 |
[Hodgkin's disease manifesting as paraneoplastic limbic encephalitis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Diagnosis, Differential; Doxorubi | 2003 |
[Hodgkin's disease manifesting as paraneoplastic limbic encephalitis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Diagnosis, Differential; Doxorubi | 2003 |
[Erythema nodosum association with malignant lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Diagnosis, Dif | 2003 |
[Erythema nodosum association with malignant lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Diagnosis, Dif | 2003 |
NEW AND OLD DRUGS IN THE MANAGEMENT OF HODGKIN'S DISEASE.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anti-Bacterial Agents; Antineoplastic Agents; | 1964 |
NEW AND OLD DRUGS IN THE MANAGEMENT OF HODGKIN'S DISEASE.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anti-Bacterial Agents; Antineoplastic Agents; | 1964 |
[THERAPY OF HEMOLYMPHOPATHIES WITH PREDNISONE AT HIGH DOSES].
Topics: Hodgkin Disease; Humans; Leukemia; Leukemia, Myeloid; Liver; Lymphoma; Lymphoma, Large B-Cell, Diffu | 1964 |
[THERAPY OF HEMOLYMPHOPATHIES WITH PREDNISONE AT HIGH DOSES].
Topics: Hodgkin Disease; Humans; Leukemia; Leukemia, Myeloid; Liver; Lymphoma; Lymphoma, Large B-Cell, Diffu | 1964 |
[Hematologic tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dacarbazine | 2003 |
[Hematologic tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dacarbazine | 2003 |
[Treating Hodgkin's disease: for whom the more means better?].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Admin | 2004 |
[Treating Hodgkin's disease: for whom the more means better?].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Admin | 2004 |
Perspectives of the management of childhood lymphoma: experience at Tygerberg Hospital, Western Cape, South Africa.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Transfusion; Child; Combined | 2005 |
Perspectives of the management of childhood lymphoma: experience at Tygerberg Hospital, Western Cape, South Africa.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Transfusion; Child; Combined | 2005 |
[Primary treatment of advanced Hodgkin's disease].
Topics: Age Factors; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophospha | 2005 |
[Primary treatment of advanced Hodgkin's disease].
Topics: Age Factors; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophospha | 2005 |
[Progress in therapeutic strategy for malignant lymphoma].
Topics: Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined | 2005 |
[Progress in therapeutic strategy for malignant lymphoma].
Topics: Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined | 2005 |
An unusual case of spontaneous remission of Hodgkin's disease after a single cycle of COPP-ABV chemotherapy followed by infectious complications.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Hod | 2005 |
An unusual case of spontaneous remission of Hodgkin's disease after a single cycle of COPP-ABV chemotherapy followed by infectious complications.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Hod | 2005 |
ABVD, the Stanford V regimen, and BEACOPP for Hodgkin's lymphoma: what should an oncologist do?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami | 2005 |
ABVD, the Stanford V regimen, and BEACOPP for Hodgkin's lymphoma: what should an oncologist do?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami | 2005 |
Could BEACOPP be the new standard for the treatment of advanced Hodgkin's lymphoma (HL)?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamid | 2006 |
Could BEACOPP be the new standard for the treatment of advanced Hodgkin's lymphoma (HL)?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamid | 2006 |
Will BEACOPP be the standard for high risk Hodgkin lymphoma patients in advanced stages?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamid | 2007 |
Will BEACOPP be the standard for high risk Hodgkin lymphoma patients in advanced stages?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamid | 2007 |
Risk, cure and complications in advanced hodgkin disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2007 |
Risk, cure and complications in advanced hodgkin disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2007 |
Successful combination of antifungal agents and surgical resection for pulmonary aspergillosis in a child with Hodgkin disease: review of the literature.
Topics: Adolescent; Amphotericin B; Anemia; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocol | 2007 |
Successful combination of antifungal agents and surgical resection for pulmonary aspergillosis in a child with Hodgkin disease: review of the literature.
Topics: Adolescent; Amphotericin B; Anemia; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocol | 2007 |
Prophylactic use of filgrastim with ABVD and BEACOPP chemotherapy regimens for Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamid | 2007 |
Prophylactic use of filgrastim with ABVD and BEACOPP chemotherapy regimens for Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamid | 2007 |
ABVD chemotherapy in the treatment of Hodgkin's disease.
Topics: Antineoplastic Agents; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Resistanc | 1982 |
ABVD chemotherapy in the treatment of Hodgkin's disease.
Topics: Antineoplastic Agents; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Resistanc | 1982 |
[The practice of chemotherapy with the DeVita protocol].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazin | 1982 |
[The practice of chemotherapy with the DeVita protocol].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazin | 1982 |
Chemotherapy strategies to improve the control of Hodgkin's disease: the Richard and Hinda Rosenthal Foundation Award Lecture.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxor | 1982 |
Chemotherapy strategies to improve the control of Hodgkin's disease: the Richard and Hinda Rosenthal Foundation Award Lecture.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxor | 1982 |
[Recent developments in chemotherapy of malignant diseases].
Topics: Anthraquinones; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 1982 |
[Recent developments in chemotherapy of malignant diseases].
Topics: Anthraquinones; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 1982 |
The cure of Hodgkin's disease with drugs.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as | 1983 |
The cure of Hodgkin's disease with drugs.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as | 1983 |
Chemotherapy in the treatment of Hodgkin's disease.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxor | 1983 |
Chemotherapy in the treatment of Hodgkin's disease.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxor | 1983 |
Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cobalt Radioisotopes; | 1984 |
Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cobalt Radioisotopes; | 1984 |
Non-Hodgkin's lymphoma occurring after Hodgkin's disease. Four new cases and a review of the literature.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1984 |
Non-Hodgkin's lymphoma occurring after Hodgkin's disease. Four new cases and a review of the literature.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1984 |
The reproductive potential of young men and women with Hodgkin's disease.
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Congenital Abnormalities; Female; | 1984 |
The reproductive potential of young men and women with Hodgkin's disease.
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Congenital Abnormalities; Female; | 1984 |
Hodgkin's disease: biology, treatment, prognosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Neoplastic; Giant Cell Tumors; | 1981 |
Hodgkin's disease: biology, treatment, prognosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Neoplastic; Giant Cell Tumors; | 1981 |
[Malignant lymphoma].
Topics: Adolescent; Adult; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disea | 1981 |
[Malignant lymphoma].
Topics: Adolescent; Adult; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disea | 1981 |
Chronic lymphocytic leukaemia and Hodgkin's disease in the same patient: case report and review of the literature.
Topics: Aged; Bone Marrow; Chlorambucil; Cyclophosphamide; Female; Hodgkin Disease; Humans; Leukemia, Lympho | 1981 |
Chronic lymphocytic leukaemia and Hodgkin's disease in the same patient: case report and review of the literature.
Topics: Aged; Bone Marrow; Chlorambucil; Cyclophosphamide; Female; Hodgkin Disease; Humans; Leukemia, Lympho | 1981 |
[Treatment maintaining complete remission in Hodgkin's disease].
Topics: Adult; Antineoplastic Agents; Child; Chlorambucil; Cyclophosphamide; Drug Administration Schedule; D | 1981 |
[Treatment maintaining complete remission in Hodgkin's disease].
Topics: Adult; Antineoplastic Agents; Child; Chlorambucil; Cyclophosphamide; Drug Administration Schedule; D | 1981 |
[Current therapy concepts in early and intermediate stages of Hodgkin diseases in adults].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined | 1995 |
[Current therapy concepts in early and intermediate stages of Hodgkin diseases in adults].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined | 1995 |
[Hodgkin disease: should high-risk patients be selected and chemotherapy be intensified?].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D | 1995 |
[Hodgkin disease: should high-risk patients be selected and chemotherapy be intensified?].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D | 1995 |
[Hodgkin's disease and pregnancy. 3 case reports and a review of the literature].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Bone Marrow Examination; C | 1993 |
[Hodgkin's disease and pregnancy. 3 case reports and a review of the literature].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Bone Marrow Examination; C | 1993 |
Lymphomatoid papulosis and Hodgkin's disease: report of a case.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin D | 1994 |
Lymphomatoid papulosis and Hodgkin's disease: report of a case.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin D | 1994 |
[Diffuse thymus hyperplasia following chemotherapy for nodular sclerosing Hodgkin lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Diagnosis, Differential; Doxorubic | 1994 |
[Diffuse thymus hyperplasia following chemotherapy for nodular sclerosing Hodgkin lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Diagnosis, Differential; Doxorubic | 1994 |
Human immunodeficiency virus associated Hodgkin's disease: report of 45 cases from the French Registry of HIV-Associated Tumors.
Topics: Adult; AIDS-Related Opportunistic Infections; Antineoplastic Combined Chemotherapy Protocols; Bleomy | 1995 |
Human immunodeficiency virus associated Hodgkin's disease: report of 45 cases from the French Registry of HIV-Associated Tumors.
Topics: Adult; AIDS-Related Opportunistic Infections; Antineoplastic Combined Chemotherapy Protocols; Bleomy | 1995 |
[High dose chemotherapy followed by hematopoietic stem cell transplantation for malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyt | 1995 |
[High dose chemotherapy followed by hematopoietic stem cell transplantation for malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyt | 1995 |
Myocardial infarction in young patients with Hodgkin's disease--potential pathogenic role of radiotherapy, chemotherapy, and splenectomy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Coronar | 1993 |
Myocardial infarction in young patients with Hodgkin's disease--potential pathogenic role of radiotherapy, chemotherapy, and splenectomy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Coronar | 1993 |
Dose-escalation study for the treatment of Hodgkin's disease. The German Hodgkin Study Group (GHSG).
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose-Response Relations | 1993 |
Dose-escalation study for the treatment of Hodgkin's disease. The German Hodgkin Study Group (GHSG).
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose-Response Relations | 1993 |
[Recent progress in the chemotherapy of malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Cyclophosphamid | 1995 |
[Recent progress in the chemotherapy of malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Cyclophosphamid | 1995 |
[Chemotherapy of patients with Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; | 1994 |
[Chemotherapy of patients with Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; | 1994 |
Hodgkin's disease in children: combined modality treatment for stages IA, IB, and IIA. Results in 356 patients of the German/Austrian Pediatric Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Clinical Trials | 1994 |
Hodgkin's disease in children: combined modality treatment for stages IA, IB, and IIA. Results in 356 patients of the German/Austrian Pediatric Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Clinical Trials | 1994 |
Modality treatment in adult stage I-II Hodgkin's disease with large mediastinal masses: study of 30 cases and review of the literature.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female | 1993 |
Modality treatment in adult stage I-II Hodgkin's disease with large mediastinal masses: study of 30 cases and review of the literature.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female | 1993 |
Cerebral non-Hodgkin's lymphoma discovered when treating Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brain Neoplasms; Carmustine; Cyc | 1993 |
Cerebral non-Hodgkin's lymphoma discovered when treating Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brain Neoplasms; Carmustine; Cyc | 1993 |
The case against the routine use of radiation therapy in advanced-stage Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami | 1996 |
The case against the routine use of radiation therapy in advanced-stage Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami | 1996 |
Brief chemotherapy (Stanford V) and adjuvant radiotherapy for bulky or advanced Hodgkin's disease: an update.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1996 |
Brief chemotherapy (Stanford V) and adjuvant radiotherapy for bulky or advanced Hodgkin's disease: an update.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1996 |
Hodgkin's disease: management of first relapse.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Mod | 1996 |
Hodgkin's disease: management of first relapse.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Mod | 1996 |
Treatment of Hodgkin's disease: the role of radio- and/or chemotherapy in advanced stages.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dr | 1996 |
Treatment of Hodgkin's disease: the role of radio- and/or chemotherapy in advanced stages.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dr | 1996 |
[Malignant mesothelioma of the pleura following radiotherapy of Hodgkin disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Follow-Up Studies; Hodgkin Disease; Humans; | 1996 |
[Malignant mesothelioma of the pleura following radiotherapy of Hodgkin disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Follow-Up Studies; Hodgkin Disease; Humans; | 1996 |
Malignant lymphomas in the elderly.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplas | 1997 |
Malignant lymphomas in the elderly.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplas | 1997 |
Aortic dissection in a patient receiving chemotherapy for Hodgkin's disease--a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aorta; Aortic Aneurysm; Aortic Dissection; Ao | 1997 |
Aortic dissection in a patient receiving chemotherapy for Hodgkin's disease--a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aorta; Aortic Aneurysm; Aortic Dissection; Ao | 1997 |
Relapse of Hodgkin's disease after 10 years of complete remission: case report.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; | 1998 |
Relapse of Hodgkin's disease after 10 years of complete remission: case report.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; | 1998 |
[Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined | 1998 |
[Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined | 1998 |
[The management of Hodgkin's disease with chemotherapy or combined modality treatment].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D | 1998 |
[The management of Hodgkin's disease with chemotherapy or combined modality treatment].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D | 1998 |
Problems in Hodgkin's disease management.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 1999 |
Problems in Hodgkin's disease management.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 1999 |
BEACOPP: a new regimen for advanced Hodgkin's disease. German Hodgkin's Lymphoma Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1998 |
BEACOPP: a new regimen for advanced Hodgkin's disease. German Hodgkin's Lymphoma Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1998 |
Model based development of the BEACOPP regimen for advanced stage Hodgkin's disease. German Hodgkin's Lymphoma Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Division; Cyclophosphamide; Dose-Res | 1998 |
Model based development of the BEACOPP regimen for advanced stage Hodgkin's disease. German Hodgkin's Lymphoma Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Division; Cyclophosphamide; Dose-Res | 1998 |
Pediatric Hodgkin's disease: treatment in the late 1990s.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined | 1998 |
Pediatric Hodgkin's disease: treatment in the late 1990s.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined | 1998 |
Hodgkin's disease following extranodal marginal zone B-cell lymphoma in remission.
Topics: Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Combined Modality | 1999 |
Hodgkin's disease following extranodal marginal zone B-cell lymphoma in remission.
Topics: Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Combined Modality | 1999 |
Primary intracerebral Hodgkin's disease: report of a case with Epstein-Barr virus association and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain; Brain Neoplasms; Combined | 1999 |
Primary intracerebral Hodgkin's disease: report of a case with Epstein-Barr virus association and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain; Brain Neoplasms; Combined | 1999 |
HIV-associated Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; CD4 Lymphocyt | 2000 |
HIV-associated Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; CD4 Lymphocyt | 2000 |
Hodgkin's disease: clinical presentation and treatment.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined | 2001 |
Hodgkin's disease: clinical presentation and treatment.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined | 2001 |
Treatment of advanced stage Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Dacarbazine; Doxo | 2001 |
Treatment of advanced stage Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Dacarbazine; Doxo | 2001 |
Is escalated BEACOPP a standard therapy for advanced Hodgkin's disease?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Clinical Trials, Phase III | 2000 |
Is escalated BEACOPP a standard therapy for advanced Hodgkin's disease?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Clinical Trials, Phase III | 2000 |
New treatments for Hodgkin's disease.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as | 2002 |
New treatments for Hodgkin's disease.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as | 2002 |
The treatment of Hodgkin's disease: emphasizing programs at the Clinic Center, National Institutes of Health.
Topics: Adult; Bleomycin; Bone Marrow; Child; Clinical Trials as Topic; Drug Therapy, Combination; Female; H | 1977 |
The treatment of Hodgkin's disease: emphasizing programs at the Clinic Center, National Institutes of Health.
Topics: Adult; Bleomycin; Bone Marrow; Child; Clinical Trials as Topic; Drug Therapy, Combination; Female; H | 1977 |
Chemotherapy of Hodgkin's disease.
Topics: Bleomycin; Drug Therapy, Combination; Hodgkin Disease; Humans; Long-Term Care; Mechlorethamine; Pred | 1979 |
Chemotherapy of Hodgkin's disease.
Topics: Bleomycin; Drug Therapy, Combination; Hodgkin Disease; Humans; Long-Term Care; Mechlorethamine; Pred | 1979 |
The action of antitumor agents: a double-edged sword?
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Azathioprine; Burkitt Lymphoma; Choriocarcinoma; | 1977 |
The action of antitumor agents: a double-edged sword?
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Azathioprine; Burkitt Lymphoma; Choriocarcinoma; | 1977 |
[The chemotherapy of morbus hodgkin (author's transl)].
Topics: Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Immunotherapy; L | 1977 |
[The chemotherapy of morbus hodgkin (author's transl)].
Topics: Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Immunotherapy; L | 1977 |
[Chemotherapy of malignant lymphomas].
Topics: Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukopenia; Lymphoma; Neoplasm | 1978 |
[Chemotherapy of malignant lymphomas].
Topics: Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukopenia; Lymphoma; Neoplasm | 1978 |
The chemotherapy of Hodgkin's disease: past experiences and future directions.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Drug Therapy, Combination; History, 19th Century; H | 1978 |
The chemotherapy of Hodgkin's disease: past experiences and future directions.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Drug Therapy, Combination; History, 19th Century; H | 1978 |
[Chemotherapy of malignant lymphomas].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Cyclophosphamide; Drug Combinations; Hodgkin Dis | 1978 |
[Chemotherapy of malignant lymphomas].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Cyclophosphamide; Drug Combinations; Hodgkin Dis | 1978 |
Issues of controversy in radiation therapy and combined modality approaches to Hodgkin's disease.
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Laparotomy; Mechlorethamine; Neoplasm Staging; P | 1979 |
Issues of controversy in radiation therapy and combined modality approaches to Hodgkin's disease.
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Laparotomy; Mechlorethamine; Neoplasm Staging; P | 1979 |
Human models of human diseases; breast cancer and the lymphomas.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Disease Models, Animal; Drug Therapy, Combination; | 1979 |
Human models of human diseases; breast cancer and the lymphomas.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Disease Models, Animal; Drug Therapy, Combination; | 1979 |
Current status of treatment of lymphomas.
Topics: Adrenal Cortex Hormones; Antineoplastic Agents; Chlorambucil; Cyclophosphamide; Drug Therapy, Combin | 1975 |
Current status of treatment of lymphomas.
Topics: Adrenal Cortex Hormones; Antineoplastic Agents; Chlorambucil; Cyclophosphamide; Drug Therapy, Combin | 1975 |
Evaluation and treatment of Hodgkin's disease in the 70's.
Topics: Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Prognosis; Remission, Spontaneou | 1975 |
Evaluation and treatment of Hodgkin's disease in the 70's.
Topics: Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Prognosis; Remission, Spontaneou | 1975 |
Chemotherapy-induced myocardial infarction in a young man with Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Hodgkin Disease; Huma | 1992 |
Chemotherapy-induced myocardial infarction in a young man with Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Hodgkin Disease; Huma | 1992 |
Chemotherapy for Hodgkin's disease and aggressive non-Hodgkin's lymphoma. More is better, or is it?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chemotherapy, Adjuvant; | 1992 |
Chemotherapy for Hodgkin's disease and aggressive non-Hodgkin's lymphoma. More is better, or is it?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chemotherapy, Adjuvant; | 1992 |
Thymic hyperplasia with hemorrhage simulating recurrent Hodgkin disease after chemotherapy-induced complete remission.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Dacarbazine; Doxorubicin; | 1992 |
Thymic hyperplasia with hemorrhage simulating recurrent Hodgkin disease after chemotherapy-induced complete remission.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Dacarbazine; Doxorubicin; | 1992 |
[Comparative study of advanced-stage Hodgkin's lymphoma patients treated with either COPP or ABVD drug combinations].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 1992 |
[Comparative study of advanced-stage Hodgkin's lymphoma patients treated with either COPP or ABVD drug combinations].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 1992 |
The management of Hodgkin's disease in relapse after primary radiation therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Neoplasm S | 1992 |
The management of Hodgkin's disease in relapse after primary radiation therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Neoplasm S | 1992 |
Combined-modality therapy for the treatment of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 1992 |
Combined-modality therapy for the treatment of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 1992 |
Combined chemotherapy and radiotherapy for Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; | 1992 |
Combined chemotherapy and radiotherapy for Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; | 1992 |
The use of combination chemotherapy in the treatment of early stage Hodgkin's disease.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality | 1992 |
The use of combination chemotherapy in the treatment of early stage Hodgkin's disease.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality | 1992 |
Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease | 1990 |
Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease | 1990 |
Chemotherapy of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Dacarbazine; | 1990 |
Chemotherapy of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Dacarbazine; | 1990 |
Hodgkin's disease in children: correlation of clinical characteristics, staging procedures, and treatment at the University of Minnesota.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 1990 |
Hodgkin's disease in children: correlation of clinical characteristics, staging procedures, and treatment at the University of Minnesota.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 1990 |
Is there an effective salvage therapy for advanced Hodgkin's disease?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Mod | 1991 |
Is there an effective salvage therapy for advanced Hodgkin's disease?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Mod | 1991 |
Primary and salvage chemotherapy in advanced Hodgkin's disease: the Milan Cancer Institute experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Mod | 1991 |
Primary and salvage chemotherapy in advanced Hodgkin's disease: the Milan Cancer Institute experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Mod | 1991 |
[Treatment of relapses and failures in disseminated Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; | 1991 |
[Treatment of relapses and failures in disseminated Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; | 1991 |
[Visceral leishmaniasis associated with Hodgkin's disease: diagnostic difficulties].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiprotozoal Agents; Bleomycin; Dacarbazine; | 1991 |
[Visceral leishmaniasis associated with Hodgkin's disease: diagnostic difficulties].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiprotozoal Agents; Bleomycin; Dacarbazine; | 1991 |
Cytotoxic chemotherapy-induced second primary neoplasms: clinical aspects.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Hod | 1991 |
Cytotoxic chemotherapy-induced second primary neoplasms: clinical aspects.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Hod | 1991 |
Hodgkin's disease presenting in the skin: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Eczema; Hodgkin Disease; Humans; Male; Mechlorethami | 1990 |
Hodgkin's disease presenting in the skin: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Eczema; Hodgkin Disease; Humans; Male; Mechlorethami | 1990 |
Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Th | 1990 |
Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Th | 1990 |
Pulmonary toxicity following MOPP chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dyspnea; Female; Hodgkin Disease; Humans; Lung | 1990 |
Pulmonary toxicity following MOPP chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dyspnea; Female; Hodgkin Disease; Humans; Lung | 1990 |
[A case of retroperitoneal Hodgkin's disease with dysuria].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorub | 1990 |
[A case of retroperitoneal Hodgkin's disease with dysuria].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorub | 1990 |
Corticosteroid drugs: their role in oncological practice.
Topics: Adrenal Cortex Hormones; Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast | 1986 |
Corticosteroid drugs: their role in oncological practice.
Topics: Adrenal Cortex Hormones; Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast | 1986 |
Chemotherapy of malignant lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Resistance | 1985 |
Chemotherapy of malignant lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Resistance | 1985 |
[Drug therapy of malignant lymphoma].
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleo | 1985 |
[Drug therapy of malignant lymphoma].
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleo | 1985 |
[Results of the treatment of lymphogranulomatosis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami | 1986 |
[Results of the treatment of lymphogranulomatosis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami | 1986 |
Current approaches to the treatment of advanced-stage Hodgkin's disease.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality The | 1986 |
Current approaches to the treatment of advanced-stage Hodgkin's disease.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality The | 1986 |
[Rescue treatment in Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease | 1987 |
[Rescue treatment in Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease | 1987 |
Salvage therapy of advanced Hodgkin's disease. Critical appraisal of curative potential.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Dacarbazine; | 1987 |
Salvage therapy of advanced Hodgkin's disease. Critical appraisal of curative potential.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Dacarbazine; | 1987 |
[The place of bone marrow autografts in the treatment of Hodgkin's and non-Hodgkin's lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Dacarbazine; | 1988 |
[The place of bone marrow autografts in the treatment of Hodgkin's and non-Hodgkin's lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Dacarbazine; | 1988 |
European experience with ifosfamide in lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Etoposide; Europe; Hodgkin Disease; Human | 1989 |
European experience with ifosfamide in lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Etoposide; Europe; Hodgkin Disease; Human | 1989 |
Tracheoesophageal fistula in the patient with lymphoma: case report and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cycloph | 1989 |
Tracheoesophageal fistula in the patient with lymphoma: case report and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cycloph | 1989 |
Treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top | 1989 |
Treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top | 1989 |
[Immediate hematological toxicity during combination chemotherapy-radiotherapy of Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Cell Count | 1989 |
[Immediate hematological toxicity during combination chemotherapy-radiotherapy of Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Cell Count | 1989 |
Colonic carcinoma after chemotherapy of Hodgkin's disease.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colonic Neoplasms; | 1989 |
Colonic carcinoma after chemotherapy of Hodgkin's disease.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colonic Neoplasms; | 1989 |
[A suggested program of combined treatment of Hodgkin's disease in children].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Dacarba | 1988 |
[A suggested program of combined treatment of Hodgkin's disease in children].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Dacarba | 1988 |
Recent issues in chemotherapy for Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Sched | 1989 |
Recent issues in chemotherapy for Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Sched | 1989 |
Current management and controversies. The chemotherapist's view.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Hodgkin Disease; Hu | 1989 |
Current management and controversies. The chemotherapist's view.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Hodgkin Disease; Hu | 1989 |
[Cancer curable by chemotherapy: malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Hodgk | 1989 |
[Cancer curable by chemotherapy: malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Hodgk | 1989 |
[Current status of chemotherapy in the treatment of malignant lymphomas].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1989 |
[Current status of chemotherapy in the treatment of malignant lymphomas].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1989 |
Risk factor adapted treatment of Hodgkin's lymphoma in childhood: strategies and results of three consecutive multicenter studies in the Federal Republic of Germany.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Clinical Trials | 1989 |
Risk factor adapted treatment of Hodgkin's lymphoma in childhood: strategies and results of three consecutive multicenter studies in the Federal Republic of Germany.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Clinical Trials | 1989 |
Non Hodgkin's lymphomas following chemoradiotherapy for Hodgkin's disease. Two new cases and a review of the literature.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Head and | 1986 |
Non Hodgkin's lymphomas following chemoradiotherapy for Hodgkin's disease. Two new cases and a review of the literature.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Head and | 1986 |
Mediastinal osteosarcoma with extension to lungs in a patient treated for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; H | 1988 |
Mediastinal osteosarcoma with extension to lungs in a patient treated for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; H | 1988 |
Semantics and the chemotherapy of Hodgkin's disease--resistance is not relapse: alternative chemotherapy lacks effectiveness for disease not totally responsive to initial MOPP treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Resistance; Hodgk | 1988 |
Semantics and the chemotherapy of Hodgkin's disease--resistance is not relapse: alternative chemotherapy lacks effectiveness for disease not totally responsive to initial MOPP treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Resistance; Hodgk | 1988 |
The chemotherapy of lymphomas: looking back, moving forward--the Richard and Hinda Rosenthal Foundation award lecture.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Lymphoma; Mechlore | 1987 |
The chemotherapy of lymphomas: looking back, moving forward--the Richard and Hinda Rosenthal Foundation award lecture.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Lymphoma; Mechlore | 1987 |
[Acute lymphoblastic leukemia, Burkitt-cell type, after Hodgkin's disease. Study of 2 cases].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; H | 1987 |
[Acute lymphoblastic leukemia, Burkitt-cell type, after Hodgkin's disease. Study of 2 cases].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; H | 1987 |
Hodgkin's disease: long-term effects of therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Brain; Female; Genitalia, Fem | 1986 |
Hodgkin's disease: long-term effects of therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Brain; Female; Genitalia, Fem | 1986 |
Early-stage Hodgkin's disease: current approaches to treatment.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fem | 1985 |
Early-stage Hodgkin's disease: current approaches to treatment.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fem | 1985 |
[Current methods of treating patients with lymphogranulomatosis, stages I and II].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Disease; | 1985 |
[Current methods of treating patients with lymphogranulomatosis, stages I and II].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Disease; | 1985 |
Current management of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 1985 |
Current management of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 1985 |
Combination chemotherapy of advanced Hodgkin's disease. A review.
Topics: Bleomycin; Carmustine; Cyclohexanes; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; H | 1974 |
Combination chemotherapy of advanced Hodgkin's disease. A review.
Topics: Bleomycin; Carmustine; Cyclohexanes; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; H | 1974 |
Adrenal steroids in the treatment of malignant hematologic disease.
Topics: Adrenal Cortex Hormones; Anemia, Hemolytic; Antineoplastic Agents; Glucocorticoids; Hodgkin Disease; | 1973 |
Adrenal steroids in the treatment of malignant hematologic disease.
Topics: Adrenal Cortex Hormones; Anemia, Hemolytic; Antineoplastic Agents; Glucocorticoids; Hodgkin Disease; | 1973 |
Combined radiotherapy and chemotherapy in the treatment of Hodgkin's disease.
Topics: Adult; Antineoplastic Agents; Blood Sedimentation; Cyclophosphamide; Drug Therapy, Combination; Fema | 1973 |
Combined radiotherapy and chemotherapy in the treatment of Hodgkin's disease.
Topics: Adult; Antineoplastic Agents; Blood Sedimentation; Cyclophosphamide; Drug Therapy, Combination; Fema | 1973 |
[Combined chemotherapy in disseminated Hodgkin's disease].
Topics: Antineoplastic Agents; Drug Synergism; Follow-Up Studies; Hodgkin Disease; Humans; Nitrogen Mustard | 1972 |
[Combined chemotherapy in disseminated Hodgkin's disease].
Topics: Antineoplastic Agents; Drug Synergism; Follow-Up Studies; Hodgkin Disease; Humans; Nitrogen Mustard | 1972 |
Chemotherapy in solid tumors of childhood.
Topics: Abdominal Neoplasms; Adolescent; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Eye Neopla | 1972 |
Chemotherapy in solid tumors of childhood.
Topics: Abdominal Neoplasms; Adolescent; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Eye Neopla | 1972 |
Hodgkin's disease and non-Hodgkin's lymphoma--the surgeon's role in therapy.
Topics: Adolescent; Adult; Alkylating Agents; Child; Female; Hodgkin Disease; Humans; Laparotomy; Lymphoma; | 1972 |
Hodgkin's disease and non-Hodgkin's lymphoma--the surgeon's role in therapy.
Topics: Adolescent; Adult; Alkylating Agents; Child; Female; Hodgkin Disease; Humans; Laparotomy; Lymphoma; | 1972 |
A decade of combination chemotherapy of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Age Factors; Alkylating Agents; Antineoplastic Agents; Cyclophosphamide; Drug Syn | 1972 |
A decade of combination chemotherapy of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Age Factors; Alkylating Agents; Antineoplastic Agents; Cyclophosphamide; Drug Syn | 1972 |
Combination chemotherapy for lymphomas and leukemias.
Topics: Adult; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Combinations; Hodgk | 1973 |
Combination chemotherapy for lymphomas and leukemias.
Topics: Adult; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Combinations; Hodgk | 1973 |
An overview of the status of the nitrosoureas in other tumors.
Topics: Adenocarcinoma; Alkylating Agents; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Carcinoma, Br | 1973 |
An overview of the status of the nitrosoureas in other tumors.
Topics: Adenocarcinoma; Alkylating Agents; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Carcinoma, Br | 1973 |
Proceedings: Malignant lymphoma: treatment with combination chemotherapy.
Topics: Adolescent; Adult; Aged; Alkylating Agents; Antineoplastic Agents; Carmustine; Cyclophosphamide; Dru | 1972 |
Proceedings: Malignant lymphoma: treatment with combination chemotherapy.
Topics: Adolescent; Adult; Aged; Alkylating Agents; Antineoplastic Agents; Carmustine; Cyclophosphamide; Dru | 1972 |
The development of ideas on the natural history and the therapy of Hodgkin's disease.
Topics: Biopsy; Bone Marrow Examination; Drug Therapy, Combination; Hodgkin Disease; Humans; Laparotomy; Lym | 1973 |
The development of ideas on the natural history and the therapy of Hodgkin's disease.
Topics: Biopsy; Bone Marrow Examination; Drug Therapy, Combination; Hodgkin Disease; Humans; Laparotomy; Lym | 1973 |
Current chemotherapeutic combinations.
Topics: Antineoplastic Agents; Carmustine; Chlorambucil; Cyclophosphamide; Drug Evaluation; Drug Therapy, Co | 1973 |
Current chemotherapeutic combinations.
Topics: Antineoplastic Agents; Carmustine; Chlorambucil; Cyclophosphamide; Drug Evaluation; Drug Therapy, Co | 1973 |
Recently recognized complications of cancer chemotherapy.
Topics: Antineoplastic Agents; Burkitt Lymphoma; Cyclophosphamide; Death, Sudden; Drug Therapy, Combination; | 1974 |
Recently recognized complications of cancer chemotherapy.
Topics: Antineoplastic Agents; Burkitt Lymphoma; Cyclophosphamide; Death, Sudden; Drug Therapy, Combination; | 1974 |
Malignant lymphoma. 2. Therapy.
Topics: Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Hodgkin Disease; Humans; Lymphoma; Nitrogen | 1974 |
Malignant lymphoma. 2. Therapy.
Topics: Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Hodgkin Disease; Humans; Lymphoma; Nitrogen | 1974 |
[Possibilities and limitations of cortisone therapy in internal diseases].
Topics: Anemia, Hemolytic; Asthma; Bronchitis; Chronic Disease; Collagen Diseases; Dexamethasone; Endocrine | 1972 |
[Possibilities and limitations of cortisone therapy in internal diseases].
Topics: Anemia, Hemolytic; Asthma; Bronchitis; Chronic Disease; Collagen Diseases; Dexamethasone; Endocrine | 1972 |
Single-agent therapy for Hodgkin's disease.
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antimetabolites; Antineoplastic Agents; Carmustine; | 1973 |
Single-agent therapy for Hodgkin's disease.
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antimetabolites; Antineoplastic Agents; Carmustine; | 1973 |
Dilemmas in the treatment of Hodgkin's disease.
Topics: Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vincristine | 1971 |
Dilemmas in the treatment of Hodgkin's disease.
Topics: Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vincristine | 1971 |
Combination chemotherapy in malignant diseases.
Topics: Adult; Antineoplastic Agents; Asparaginase; Carmustine; Child; Cyclophosphamide; Cytarabine; Cytosin | 1971 |
Combination chemotherapy in malignant diseases.
Topics: Adult; Antineoplastic Agents; Asparaginase; Carmustine; Child; Cyclophosphamide; Cytarabine; Cytosin | 1971 |
390 trials available for prednisone and Hodgkin Disease
| Article | Year |
|---|---|
Patterns of Initial Relapse from a Phase 3 Study of Response-Based Therapy for High-Risk Hodgkin Lymphoma (AHOD0831): A Report from the Children's Oncology Group.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Doxorubic | 2022 |
Patterns of Initial Relapse from a Phase 3 Study of Response-Based Therapy for High-Risk Hodgkin Lymphoma (AHOD0831): A Report from the Children's Oncology Group.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Doxorubic | 2022 |
Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Doxorubicin; Eto | 2022 |
Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Doxorubicin; Eto | 2022 |
Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma.
Topics: Adolescent; Adult; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protoc | 2022 |
Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma.
Topics: Adolescent; Adult; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protoc | 2022 |
Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin | 2023 |
Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin | 2023 |
Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin | 2023 |
Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin | 2023 |
Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin | 2023 |
Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin | 2023 |
Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin | 2023 |
Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin | 2023 |
Cost-effectiveness of first-line treatment options for patients with advanced-stage Hodgkin lymphoma: a modelling study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Canada; Cost-Benefit Analysis; Cyc | 2020 |
Cost-effectiveness of first-line treatment options for patients with advanced-stage Hodgkin lymphoma: a modelling study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Canada; Cost-Benefit Analysis; Cyc | 2020 |
ABVD vs BEACOPP escalated in advanced-stage Hodgkin's lymphoma: Results from a multicenter European study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Austria; Bleomycin; Cyclophosphamide; D | 2020 |
ABVD vs BEACOPP escalated in advanced-stage Hodgkin's lymphoma: Results from a multicenter European study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Austria; Bleomycin; Cyclophosphamide; D | 2020 |
Subsequent malignant neoplasms among children with Hodgkin lymphoma: a report from the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Cyclophosph | 2021 |
Subsequent malignant neoplasms among children with Hodgkin lymphoma: a report from the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Cyclophosph | 2021 |
A Ukrainian multicenter prospective study of the value of PET/ CT prognostic role in primary patients with Hodgkins lymphoma in a real-life cohort.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 2020 |
A Ukrainian multicenter prospective study of the value of PET/ CT prognostic role in primary patients with Hodgkins lymphoma in a real-life cohort.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 2020 |
Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2017 |
Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2017 |
Encouraging activity for R-CHOP in advanced stage nodular lymphocyte-predominant Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherap | 2017 |
Encouraging activity for R-CHOP in advanced stage nodular lymphocyte-predominant Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherap | 2017 |
Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/CT is beneficial: a prospective multicentre trial of 355 patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Daca | 2017 |
Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/CT is beneficial: a prospective multicentre trial of 355 patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Daca | 2017 |
ABVD or BEACOPP
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2017 |
ABVD or BEACOPP
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2017 |
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Austria; Bleomycin; Cyclophospham | 2017 |
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Austria; Bleomycin; Cyclophospham | 2017 |
Comparison of 36 Gy, 20 Gy, or No Radiation Therapy After 6 Cycles of EBVP Chemotherapy and Complete Remission in Early-Stage Hodgkin Lymphoma Without Risk Factors: Results of the EORT-GELA H9-F Intergroup Randomized Trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Disease-Free Survival; | 2018 |
Comparison of 36 Gy, 20 Gy, or No Radiation Therapy After 6 Cycles of EBVP Chemotherapy and Complete Remission in Early-Stage Hodgkin Lymphoma Without Risk Factors: Results of the EORT-GELA H9-F Intergroup Randomized Trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Disease-Free Survival; | 2018 |
Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Tria
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Daca | 2018 |
Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Tria
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Daca | 2018 |
Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherap | 2018 |
Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherap | 2018 |
CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Daca | 2018 |
CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Daca | 2018 |
Pericardial effusion in Hodgkin lymphoma: a report from the Children's Oncology Group AHOD0031 protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Child; Cis | 2018 |
Pericardial effusion in Hodgkin lymphoma: a report from the Children's Oncology Group AHOD0031 protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Child; Cis | 2018 |
Outcome-based interpretation of early interim PET in advanced-stage Hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxo | 2018 |
Outcome-based interpretation of early interim PET in advanced-stage Hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxo | 2018 |
Intensive treatment strategies in advanced-stage Hodgkin's lymphoma (HD9 and HD12): analysis of long-term survival in two randomised trials.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Hodgkin Disease; Hu | 2018 |
Intensive treatment strategies in advanced-stage Hodgkin's lymphoma (HD9 and HD12): analysis of long-term survival in two randomised trials.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Hodgkin Disease; Hu | 2018 |
Brentuximab vedotin and ESHAP is highly effective as second-line therapy for Hodgkin lymphoma patients (long-term results of a trial by the Spanish GELTAMO Group).
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols | 2019 |
Brentuximab vedotin and ESHAP is highly effective as second-line therapy for Hodgkin lymphoma patients (long-term results of a trial by the Spanish GELTAMO Group).
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols | 2019 |
Response-adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cycl | 2019 |
Response-adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cycl | 2019 |
Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Daca | 2019 |
Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Daca | 2019 |
Treatment-related mortality in patients with advanced-stage hodgkin lymphoma: an analysis of the german hodgkin study group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Body Mass Index; Cyclophosph | 2013 |
Treatment-related mortality in patients with advanced-stage hodgkin lymphoma: an analysis of the german hodgkin study group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Body Mass Index; Cyclophosph | 2013 |
A chemotherapy only therapeutic approach to pediatric Hodgkin lymphoma: AHOPCA LH 1999.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cycl | 2014 |
A chemotherapy only therapeutic approach to pediatric Hodgkin lymphoma: AHOPCA LH 1999.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cycl | 2014 |
The role of body mass index in survival outcome for lymphoma patients: US intergroup experience.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 2014 |
The role of body mass index in survival outcome for lymphoma patients: US intergroup experience.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 2014 |
Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherap | 2014 |
Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherap | 2014 |
Assessment of tumor size reduction improves outcome prediction of positron emission tomography/computed tomography after chemotherapy in advanced-stage Hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Cyclop | 2014 |
Assessment of tumor size reduction improves outcome prediction of positron emission tomography/computed tomography after chemotherapy in advanced-stage Hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Cyclop | 2014 |
ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥ 4 baseline): final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Daca | 2014 |
ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥ 4 baseline): final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Daca | 2014 |
Feasibility of VECOPA, a dose-intensive chemotherapy regimen for children and adolescents with intermediate and advanced stage Hodgkin lymphoma: results of the GPOH-HD-2002/VECOPA pilot trial.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Child; Cyclophosphamid | 2015 |
Feasibility of VECOPA, a dose-intensive chemotherapy regimen for children and adolescents with intermediate and advanced stage Hodgkin lymphoma: results of the GPOH-HD-2002/VECOPA pilot trial.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Child; Cyclophosphamid | 2015 |
Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisp | 2014 |
Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisp | 2014 |
Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisp | 2014 |
Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisp | 2014 |
Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisp | 2014 |
Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisp | 2014 |
Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisp | 2014 |
Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisp | 2014 |
Patterns of relapse from a phase 3 Study of response-based therapy for intermediate-risk Hodgkin lymphoma (AHOD0031): a report from the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Ther | 2015 |
Patterns of relapse from a phase 3 Study of response-based therapy for intermediate-risk Hodgkin lymphoma (AHOD0031): a report from the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Ther | 2015 |
Radiotherapy quality assurance report from children's oncology group AHOD0031.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cycl | 2015 |
Radiotherapy quality assurance report from children's oncology group AHOD0031.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cycl | 2015 |
Phase II study of interim PET-CT-guided response-adapted therapy in advanced Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamid | 2015 |
Phase II study of interim PET-CT-guided response-adapted therapy in advanced Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamid | 2015 |
Relapse analysis of irradiated patients within the HD15 trial of the German Hodgkin Study Group.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cycloph | 2015 |
Relapse analysis of irradiated patients within the HD15 trial of the German Hodgkin Study Group.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cycloph | 2015 |
Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 Trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant | 2015 |
Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 Trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant | 2015 |
Impact of Bleomycin and Vincristine Dose Reductions in Patients With Advanced Hodgkin Lymphoma Treated With BEACOPP: An Analysis of the German Hodgkin Study Group HD12 and HD15 Trials.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Fr | 2015 |
Impact of Bleomycin and Vincristine Dose Reductions in Patients With Advanced Hodgkin Lymphoma Treated With BEACOPP: An Analysis of the German Hodgkin Study Group HD12 and HD15 Trials.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Fr | 2015 |
Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazin | 2016 |
Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazin | 2016 |
Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin's Lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Doxorubicin; Et | 2016 |
Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin's Lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Doxorubicin; Et | 2016 |
Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma: Final Analysis of a Randomized Phase II Study.
Topics: Anemia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosp | 2016 |
Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma: Final Analysis of a Randomized Phase II Study.
Topics: Anemia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosp | 2016 |
US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Daca | 2016 |
US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Daca | 2016 |
Eight Cycles of ABVD Versus Four Cycles of BEACOPPescalated Plus Four Cycles of BEACOPPbaseline in Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dis | 2016 |
Eight Cycles of ABVD Versus Four Cycles of BEACOPPescalated Plus Four Cycles of BEACOPPbaseline in Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dis | 2016 |
Phase II trial of ofatumumab plus ESHAP (O-ESHAP) as salvage treatment for patients with relapsed or refractory classical Hodgkin lymphoma after first-line chemotherapy.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic C | 2016 |
Phase II trial of ofatumumab plus ESHAP (O-ESHAP) as salvage treatment for patients with relapsed or refractory classical Hodgkin lymphoma after first-line chemotherapy.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic C | 2016 |
Predictive Factor Analysis of Response-Adapted Radiation Therapy for Chemotherapy-Sensitive Pediatric Hodgkin Lymphoma: Analysis of the Children's Oncology Group AHOD 0031 Trial.
Topics: Adolescent; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Prescho | 2016 |
Predictive Factor Analysis of Response-Adapted Radiation Therapy for Chemotherapy-Sensitive Pediatric Hodgkin Lymphoma: Analysis of the Children's Oncology Group AHOD 0031 Trial.
Topics: Adolescent; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Prescho | 2016 |
Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherap | 2017 |
Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherap | 2017 |
Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dise | 2008 |
Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dise | 2008 |
Early versus late intensification for patients with high-risk Hodgkin lymphoma-3 cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablativ
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarba | 2008 |
Early versus late intensification for patients with high-risk Hodgkin lymphoma-3 cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablativ
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarba | 2008 |
The Stanford V regimen is effective in patients with good risk Hodgkin lymphoma but radiotherapy is a necessary component.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 2009 |
The Stanford V regimen is effective in patients with good risk Hodgkin lymphoma but radiotherapy is a necessary component.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 2009 |
ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cyclophosphamide; Dac | 2009 |
ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cyclophosphamide; Dac | 2009 |
FDG-PET for assessment of early treatment response after four cycles of chemotherapy in patients with advanced-stage Hodgkin's lymphoma has a high negative predictive value.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dise | 2009 |
FDG-PET for assessment of early treatment response after four cycles of chemotherapy in patients with advanced-stage Hodgkin's lymphoma has a high negative predictive value.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dise | 2009 |
Bone marrow stem cell damage after three different chemotherapy regimens for advanced Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; | 2009 |
Bone marrow stem cell damage after three different chemotherapy regimens for advanced Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; | 2009 |
Two cycles of escalated BEACOPP followed by four cycles of ABVD utilizing early-interim PET/CT scan is an effective regimen for advanced high-risk Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Daca | 2010 |
Two cycles of escalated BEACOPP followed by four cycles of ABVD utilizing early-interim PET/CT scan is an effective regimen for advanced high-risk Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Daca | 2010 |
Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazin | 2009 |
Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazin | 2009 |
Efficacy of the BEACOPP regimen in refractory and relapsed Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bleomycin; Cyclophosphamide; D | 2009 |
Efficacy of the BEACOPP regimen in refractory and relapsed Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bleomycin; Cyclophosphamide; D | 2009 |
Radiation therapy compared with chemotherapy for consolidation of chemotherapy-induced remission of advanced Hodgkin lymphoma: a study by the Eastern Co-operative Oncology Group (E1476) with >20 years follow-up.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazi | 2009 |
Radiation therapy compared with chemotherapy for consolidation of chemotherapy-induced remission of advanced Hodgkin lymphoma: a study by the Eastern Co-operative Oncology Group (E1476) with >20 years follow-up.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazi | 2009 |
Comparative study of two mechlorethamine, vincristine, procarbazine, and prednisone derived chemotherapeutic protocols for the management of pediatric Hodgkin lymphoma (HL): single-center 5-year experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid | 2010 |
Comparative study of two mechlorethamine, vincristine, procarbazine, and prednisone derived chemotherapeutic protocols for the management of pediatric Hodgkin lymphoma (HL): single-center 5-year experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid | 2010 |
No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group.
Topics: Adolescent; Adult; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocols; Bleomycin | 2010 |
No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group.
Topics: Adolescent; Adult; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocols; Bleomycin | 2010 |
Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial.
Topics: Adolescent; Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphami | 2010 |
Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial.
Topics: Adolescent; Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphami | 2010 |
Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progressi | 2010 |
Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progressi | 2010 |
Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progressi | 2010 |
Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progressi | 2010 |
Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progressi | 2010 |
Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progressi | 2010 |
Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progressi | 2010 |
Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progressi | 2010 |
Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Ad | 2010 |
Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Ad | 2010 |
BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; | 2011 |
BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; | 2011 |
BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; | 2011 |
BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; | 2011 |
BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; | 2011 |
BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; | 2011 |
BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; | 2011 |
BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; | 2011 |
Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dox | 2011 |
Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dox | 2011 |
ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 2011 |
ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 2011 |
Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trial.
Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Bleomycin; Carbopl | 2012 |
Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trial.
Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Bleomycin; Carbopl | 2012 |
Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Thera | 2011 |
Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Thera | 2011 |
Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Thera | 2011 |
Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Thera | 2011 |
Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Thera | 2011 |
Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Thera | 2011 |
Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Thera | 2011 |
Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Thera | 2011 |
Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 trial o
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Cyc | 2011 |
Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 trial o
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Cyc | 2011 |
Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfomi.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dox | 2011 |
Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfomi.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dox | 2011 |
Dose-intensification in early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD14 trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Cyc | 2012 |
Dose-intensification in early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD14 trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Cyc | 2012 |
Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxo | 2012 |
Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxo | 2012 |
Treatment of newly diagnosed advanced stage Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2012 |
Treatment of newly diagnosed advanced stage Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2012 |
Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Disease-Free Su | 2012 |
Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Disease-Free Su | 2012 |
Comparing long-term toxicity and efficacy of combined modality treatment including extended- or involved-field radiotherapy in early-stage Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 2012 |
Comparing long-term toxicity and efficacy of combined modality treatment including extended- or involved-field radiotherapy in early-stage Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 2012 |
Treatment of advanced stage Hodgkin lymphoma--it's all about risk-benefit.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2012 |
Treatment of advanced stage Hodgkin lymphoma--it's all about risk-benefit.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2012 |
Stage-adapted treatment of HIV-associated Hodgkin lymphoma: results of a prospective multicenter study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2012 |
Stage-adapted treatment of HIV-associated Hodgkin lymphoma: results of a prospective multicenter study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2012 |
Efficacy of abbreviated Stanford V chemotherapy and involved-field radiotherapy in early-stage Hodgkin lymphoma: mature results of the G4 trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 2013 |
Efficacy of abbreviated Stanford V chemotherapy and involved-field radiotherapy in early-stage Hodgkin lymphoma: mature results of the G4 trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 2013 |
Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 2013 |
Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 2013 |
The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dac | 2013 |
The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dac | 2013 |
Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 2013 |
Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 2013 |
Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; | 2002 |
Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; | 2002 |
Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschoo | 2002 |
Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschoo | 2002 |
Treatment of elderly Hodgkin's lymphoma patients with a novel 5-drug regimen (ODBEP): a phase II study.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Eto | 2002 |
Treatment of elderly Hodgkin's lymphoma patients with a novel 5-drug regimen (ODBEP): a phase II study.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Eto | 2002 |
An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; beta 2-M | 2002 |
An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; beta 2-M | 2002 |
Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Confidence Intervals; Dacarbazine; | 2003 |
Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Confidence Intervals; Dacarbazine; | 2003 |
14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
Topics: Adolescent; Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphami | 2003 |
14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
Topics: Adolescent; Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphami | 2003 |
Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclopho | 2003 |
Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclopho | 2003 |
Involved-field radiotherapy for advanced Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2003 |
Involved-field radiotherapy for advanced Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2003 |
High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chi-Square Distributio | 2003 |
High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chi-Square Distributio | 2003 |
Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymph
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 2003 |
Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymph
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 2003 |
Treatment of intermediate and advanced stage Hodgkin's disease with modified baseline BEACOPP regimen: a Hellenic Co-operative Oncology Group Study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxo | 2003 |
Treatment of intermediate and advanced stage Hodgkin's disease with modified baseline BEACOPP regimen: a Hellenic Co-operative Oncology Group Study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxo | 2003 |
BEACOPP therapeutic regimen for patients with Hodgkin's disease and HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Antineoplastic Combined Chemotherapy Protocols; Bleomy | 2003 |
BEACOPP therapeutic regimen for patients with Hodgkin's disease and HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Antineoplastic Combined Chemotherapy Protocols; Bleomy | 2003 |
Comparison of MOPP versus ABVD as salvage therapy in patients who relapse after radiation therapy alone for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival | 2004 |
Comparison of MOPP versus ABVD as salvage therapy in patients who relapse after radiation therapy alone for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival | 2004 |
Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trial.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Com | 2004 |
Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trial.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Com | 2004 |
Severe pulmonary toxicity in patients with advanced-stage Hodgkin's disease treated with a modified bleomycin, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone, and gemcitabine (BEACOPP) regimen is probably related to the combination o
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 2004 |
Severe pulmonary toxicity in patients with advanced-stage Hodgkin's disease treated with a modified bleomycin, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone, and gemcitabine (BEACOPP) regimen is probably related to the combination o
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 2004 |
Treatment of pediatric Hodgkin disease avoiding radiotherapy: excellent outcome with the Rotterdam-HD-84-protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Daca | 2004 |
Treatment of pediatric Hodgkin disease avoiding radiotherapy: excellent outcome with the Rotterdam-HD-84-protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Daca | 2004 |
Efficacy of a modified Stanford V regimen in patients with advanced Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Eto | 2004 |
Efficacy of a modified Stanford V regimen in patients with advanced Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Eto | 2004 |
Stanford V regimen plus consolidative radiotherapy is an effective therapeutic program for bulky or advanced-stage Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2004 |
Stanford V regimen plus consolidative radiotherapy is an effective therapeutic program for bulky or advanced-stage Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2004 |
Phase II study of PEND chemotherapy in patients with refractory/relapsed Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Etoposide; Female; Follow-Up Stu | 2004 |
Phase II study of PEND chemotherapy in patients with refractory/relapsed Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Etoposide; Female; Follow-Up Stu | 2004 |
Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined | 2004 |
Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined | 2004 |
A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly).
Topics: Administration, Oral; Aged; Aging; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclop | 2005 |
A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly).
Topics: Administration, Oral; Aged; Aging; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclop | 2005 |
Biophysical analysis of the acute toxicity of radiotherapy in Hodgkin's lymphoma--a comparison between extended field and involved field radiotherapy based on the data of the German Hodgkin Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2005 |
Biophysical analysis of the acute toxicity of radiotherapy in Hodgkin's lymphoma--a comparison between extended field and involved field radiotherapy based on the data of the German Hodgkin Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2005 |
Hodgkin's disease in Indian children: outcome with chemotherapy alone.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cycl | 2006 |
Hodgkin's disease in Indian children: outcome with chemotherapy alone.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cycl | 2006 |
ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2005 |
ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2005 |
MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2006 |
MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2006 |
Long-term results and competing risk analysis of the H89 trial in patients with advanced-stage Hodgkin lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte (GELA).
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Com | 2006 |
Long-term results and competing risk analysis of the H89 trial in patients with advanced-stage Hodgkin lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte (GELA).
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Com | 2006 |
Pegfilgrastim support for full delivery of BEACOPP-14 chemotherapy for patients with high-risk Hodgkin's lymphoma: results of a phase II study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxo | 2006 |
Pegfilgrastim support for full delivery of BEACOPP-14 chemotherapy for patients with high-risk Hodgkin's lymphoma: results of a phase II study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxo | 2006 |
Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2006 |
Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2006 |
POG 8625: a randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease: a report from the Children's Oncology Group.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; | 2006 |
POG 8625: a randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease: a report from the Children's Oncology Group.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; | 2006 |
Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemo | 2006 |
Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemo | 2006 |
Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcome.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Dru | 2007 |
Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcome.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Dru | 2007 |
Multicentre phase II study of the baseline BEACOPP regimen for patients with advanced-stage Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 2006 |
Multicentre phase II study of the baseline BEACOPP regimen for patients with advanced-stage Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 2006 |
Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2007 |
Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2007 |
[Ten-year outcomes of lymphogranulomatosis treatment according to the protocol MOPP-ABVD+radiotherapy].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Dacarbaz | 2006 |
[Ten-year outcomes of lymphogranulomatosis treatment according to the protocol MOPP-ABVD+radiotherapy].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Dacarbaz | 2006 |
Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2007 |
Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2007 |
Use of gonadotropin-releasing hormone agonists in patients with Hodgkin's disease for preservation of ovarian function and reduction of gonadotoxicity related to chemotherapy.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Density; Cycl | 2007 |
Use of gonadotropin-releasing hormone agonists in patients with Hodgkin's disease for preservation of ovarian function and reduction of gonadotoxicity related to chemotherapy.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Density; Cycl | 2007 |
Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined | 2007 |
Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined | 2007 |
Population pharmacokinetics of the BEACOPP polychemotherapy regimen in Hodgkin's lymphoma and its effect on myelotoxicity.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; | 2007 |
Population pharmacokinetics of the BEACOPP polychemotherapy regimen in Hodgkin's lymphoma and its effect on myelotoxicity.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; | 2007 |
Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD).
Topics: Adolescent; Adult; Amenorrhea; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocol | 2007 |
Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD).
Topics: Adolescent; Adult; Amenorrhea; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocol | 2007 |
A Contribution to solve the problem of the need for consolidative radiotherapy after intensive chemotherapy in advanced stages of Hodgkin's lymphoma--analysis of a quality control program initiated by the radiotherapy reference center of the German Hodgki
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2007 |
A Contribution to solve the problem of the need for consolidative radiotherapy after intensive chemotherapy in advanced stages of Hodgkin's lymphoma--analysis of a quality control program initiated by the radiotherapy reference center of the German Hodgki
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2007 |
Outcome of children with nodular lymphocyte predominant Hodgkin lymphoma - a Children's Cancer and Leukaemia Group report.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chlorambucil; C | 2007 |
Outcome of children with nodular lymphocyte predominant Hodgkin lymphoma - a Children's Cancer and Leukaemia Group report.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chlorambucil; C | 2007 |
Radiotherapy does not influence the severe pulmonary toxicity observed with the administration of gemcitabine and bleomycin in patients with advanced-stage Hodgkin's lymphoma treated with the BAGCOPP regimen: a report by the German Hodgkin's Lymphoma Stud
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Deoxycytid | 2008 |
Radiotherapy does not influence the severe pulmonary toxicity observed with the administration of gemcitabine and bleomycin in patients with advanced-stage Hodgkin's lymphoma treated with the BAGCOPP regimen: a report by the German Hodgkin's Lymphoma Stud
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Deoxycytid | 2008 |
Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: a report of the German Hodgkin Study Group (GHSG).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Azoospermia; Bleomycin; Cyclophos | 2008 |
Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: a report of the German Hodgkin Study Group (GHSG).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Azoospermia; Bleomycin; Cyclophos | 2008 |
Treatment planning and delivery of involved field radiotherapy in advanced Hodgkin's disease: results from a questionnaire-based audit for the UK Stanford V regimen vs ABVD clinical trial quality assurance programme (ISRCTN 64141244).
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Hodg | 2007 |
Treatment planning and delivery of involved field radiotherapy in advanced Hodgkin's disease: results from a questionnaire-based audit for the UK Stanford V regimen vs ABVD clinical trial quality assurance programme (ISRCTN 64141244).
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Hodg | 2007 |
Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2007 |
Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2007 |
BCVPP chemotherapy for advanced Hodgkin's disease: evidence for greater duration of complete remission, greater survival, and less toxicity than with a MOPP regimen. Results of the Eastern Cooperative Oncology Group study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carmustine; Clinical Trials | 1984 |
BCVPP chemotherapy for advanced Hodgkin's disease: evidence for greater duration of complete remission, greater survival, and less toxicity than with a MOPP regimen. Results of the Eastern Cooperative Oncology Group study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carmustine; Clinical Trials | 1984 |
Herpes zoster--the best approach.
Topics: Adult; Aged; Child; Clinical Trials as Topic; Cytarabine; Herpes Zoster; Hodgkin Disease; Humans; Im | 1980 |
Herpes zoster--the best approach.
Topics: Adult; Aged; Child; Clinical Trials as Topic; Cytarabine; Herpes Zoster; Hodgkin Disease; Humans; Im | 1980 |
The eight-drug/radiation therapy program (MOPP/ABDV/RT) for advanced Hodgkin's disease: a follow-up report.
Topics: Adolescent; Adult; Antineoplastic Agents; Bleomycin; Dacarbazine; Doxorubicin; Drug Administration S | 1980 |
The eight-drug/radiation therapy program (MOPP/ABDV/RT) for advanced Hodgkin's disease: a follow-up report.
Topics: Adolescent; Adult; Antineoplastic Agents; Bleomycin; Dacarbazine; Doxorubicin; Drug Administration S | 1980 |
Combination chemotherapy for stage IV Hodgkin's disease (Report no 14).
Topics: Bleomycin; Chlorambucil; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Neopla | 1981 |
Combination chemotherapy for stage IV Hodgkin's disease (Report no 14).
Topics: Bleomycin; Chlorambucil; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Neopla | 1981 |
A Southwest Oncology Group: chemotherapy versus chemotherapy plus radiotherapy in treatment of stage III Hodgkin's disease.
Topics: Bleomycin; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Follow | 1982 |
A Southwest Oncology Group: chemotherapy versus chemotherapy plus radiotherapy in treatment of stage III Hodgkin's disease.
Topics: Bleomycin; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Follow | 1982 |
Alternating drug combinations in the treatment of advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Agents; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Th | 1982 |
Alternating drug combinations in the treatment of advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Agents; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Th | 1982 |
More than MOPP for advanced Hodgkin's disease?
Topics: Antineoplastic Agents; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Therapy, | 1982 |
More than MOPP for advanced Hodgkin's disease?
Topics: Antineoplastic Agents; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Therapy, | 1982 |
ABVD chemotherapy in the treatment of Hodgkin's disease.
Topics: Antineoplastic Agents; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Resistanc | 1982 |
ABVD chemotherapy in the treatment of Hodgkin's disease.
Topics: Antineoplastic Agents; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Resistanc | 1982 |
Chemotherapy and combined modality therapy for Hodgkin's disease: a progress report on Cancer and Leukemia Group B studies.
Topics: Adult; Antineoplastic Agents; Bleomycin; Carmustine; Doxorubicin; Drug Therapy, Combination; Female; | 1982 |
Chemotherapy and combined modality therapy for Hodgkin's disease: a progress report on Cancer and Leukemia Group B studies.
Topics: Adult; Antineoplastic Agents; Bleomycin; Carmustine; Doxorubicin; Drug Therapy, Combination; Female; | 1982 |
Combined modality therapy for advanced Hodgkin's disease: long-term followup data.
Topics: Adult; Antineoplastic Agents; Bleomycin; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female | 1982 |
Combined modality therapy for advanced Hodgkin's disease: long-term followup data.
Topics: Adult; Antineoplastic Agents; Bleomycin; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female | 1982 |
Conclusions from clinical trials of the Southwest Oncology Group.
Topics: Antibiotics, Antineoplastic; Bleomycin; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combina | 1982 |
Conclusions from clinical trials of the Southwest Oncology Group.
Topics: Antibiotics, Antineoplastic; Bleomycin; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combina | 1982 |
Cyclic delivery of MOPP and ABVD combinations in Stage IV Hodgkin's disease: rationale, background studies, and recent results.
Topics: Adult; Antineoplastic Agents; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Th | 1982 |
Cyclic delivery of MOPP and ABVD combinations in Stage IV Hodgkin's disease: rationale, background studies, and recent results.
Topics: Adult; Antineoplastic Agents; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Th | 1982 |
Comparison of adriamycin-containing chemotherapy (MOP-BAP) with MOPP-Bleomycin in the management of advanced Hodgkin's disease. A Southwest Oncology Group Study.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; | 1983 |
Comparison of adriamycin-containing chemotherapy (MOP-BAP) with MOPP-Bleomycin in the management of advanced Hodgkin's disease. A Southwest Oncology Group Study.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; | 1983 |
Treatment of MOPP-refractory Hodgkin's disease with vinblastine, doxorubicin, bleomycin, CCNU, and dacarbazine.
Topics: Adolescent; Adult; Agranulocytosis; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Prot | 1983 |
Treatment of MOPP-refractory Hodgkin's disease with vinblastine, doxorubicin, bleomycin, CCNU, and dacarbazine.
Topics: Adolescent; Adult; Agranulocytosis; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Prot | 1983 |
The cure of Hodgkin's disease with drugs.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as | 1983 |
The cure of Hodgkin's disease with drugs.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as | 1983 |
Treatment of advanced Hodgkin's disease with chemotherapy and irradiation. Controlled trial of two versus three alternating, potentially non-cross-resistant drug combinations.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top | 1984 |
Treatment of advanced Hodgkin's disease with chemotherapy and irradiation. Controlled trial of two versus three alternating, potentially non-cross-resistant drug combinations.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top | 1984 |
Vinblastine, bleomycin, and cis-platin as salvage therapy for MOPP treated patients with Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topi | 1984 |
Vinblastine, bleomycin, and cis-platin as salvage therapy for MOPP treated patients with Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topi | 1984 |
Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Top | 1983 |
Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Top | 1983 |
The effects of prior radiation therapy and age on the frequency and duration of complete remission among various four-drug treatments for advanced Hodgkin's disease.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combin | 1984 |
The effects of prior radiation therapy and age on the frequency and duration of complete remission among various four-drug treatments for advanced Hodgkin's disease.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combin | 1984 |
Combined modality in Hodgkin's disease. Comparison of six versus three courses of MOPP with clinical and surgical restaging.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as T | 1984 |
Combined modality in Hodgkin's disease. Comparison of six versus three courses of MOPP with clinical and surgical restaging.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as T | 1984 |
Simultaneous low-dose radiation and low-dose chemotherapy in the treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials | 1984 |
Simultaneous low-dose radiation and low-dose chemotherapy in the treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials | 1984 |
Acute myelogenous leukemia as a second malignant neoplasm following the successful treatment of advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Female; Hodgkin | 1983 |
Acute myelogenous leukemia as a second malignant neoplasm following the successful treatment of advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Female; Hodgkin | 1983 |
Treatment of patients with stages I and II nonmediastinal Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Drug Therapy, Combination; | 1982 |
Treatment of patients with stages I and II nonmediastinal Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Drug Therapy, Combination; | 1982 |
Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Drug Therapy, Combination; Female; Follow-Up | 1980 |
Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Drug Therapy, Combination; Female; Follow-Up | 1980 |
Treatment of stage I and II mediastinal Hodgkin disease. A comparison of involved fields, extended fields, and involved fields followed by MOPP in patients staged by laparotomy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Female; Hodgkin Disease; | 1981 |
Treatment of stage I and II mediastinal Hodgkin disease. A comparison of involved fields, extended fields, and involved fields followed by MOPP in patients staged by laparotomy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Female; Hodgkin Disease; | 1981 |
Long-term follow-up of two chemotherapy protocols in Hodgkin's disease.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Admini | 1981 |
Long-term follow-up of two chemotherapy protocols in Hodgkin's disease.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Admini | 1981 |
[Hodgkin's disease: treatment of clinical stages II3+A, IB, IIB, IIIA and IIIB with short chemotherapy (3 MOPP, or 3 CVPP), splenectomy and limited irradiation. Results after 4 years of a prospective protocol including 94 patients].
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Dru | 1982 |
[Hodgkin's disease: treatment of clinical stages II3+A, IB, IIB, IIIA and IIIB with short chemotherapy (3 MOPP, or 3 CVPP), splenectomy and limited irradiation. Results after 4 years of a prospective protocol including 94 patients].
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Dru | 1982 |
A new combination chemotherapy for recurrent Hodgkin's lymphoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Therapy, Co | 1982 |
A new combination chemotherapy for recurrent Hodgkin's lymphoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Therapy, Co | 1982 |
Radiotherapy versus radiotherapy plus chemotherapy in stages I and II Hodgkin's disease. A prospective, randomized study by the Danish National Hodgkin Study Group, LYGRA.
Topics: Adolescent; Adult; Antineoplastic Agents; Clinical Trials as Topic; Drug Therapy, Combination; Femal | 1980 |
Radiotherapy versus radiotherapy plus chemotherapy in stages I and II Hodgkin's disease. A prospective, randomized study by the Danish National Hodgkin Study Group, LYGRA.
Topics: Adolescent; Adult; Antineoplastic Agents; Clinical Trials as Topic; Drug Therapy, Combination; Femal | 1980 |
[Chemotherapy-selective nodal irradiation in Hodgkin's disease clinical stages IA-IIIB. Results of a prospective clinical trial including 334 patients (author's transl)].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Child, Preschool; Clinical Trials as Topic; D | 1981 |
[Chemotherapy-selective nodal irradiation in Hodgkin's disease clinical stages IA-IIIB. Results of a prospective clinical trial including 334 patients (author's transl)].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Child, Preschool; Clinical Trials as Topic; D | 1981 |
Hodgkin's disease in childhood: therapy results in Argentina.
Topics: Adolescent; Antineoplastic Agents; Argentina; Child; Child, Preschool; Clinical Trials as Topic; Cyc | 1981 |
Hodgkin's disease in childhood: therapy results in Argentina.
Topics: Adolescent; Antineoplastic Agents; Argentina; Child; Child, Preschool; Clinical Trials as Topic; Cyc | 1981 |
Treatment of advanced Hodgkin's disease: 10-year experience in the Eastern Cooperative Oncology group.
Topics: Adult; Antineoplastic Agents; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, | 1982 |
Treatment of advanced Hodgkin's disease: 10-year experience in the Eastern Cooperative Oncology group.
Topics: Adult; Antineoplastic Agents; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, | 1982 |
Effect of age on therapeutic response and survival in advanced Hodgkin's disease.
Topics: Adult; Age Factors; Aged; Antineoplastic Agents; Clinical Trials as Topic; Drug Therapy, Combination | 1982 |
Effect of age on therapeutic response and survival in advanced Hodgkin's disease.
Topics: Adult; Age Factors; Aged; Antineoplastic Agents; Clinical Trials as Topic; Drug Therapy, Combination | 1982 |
Chemotherapy for advanced Hodgkin's disease: conclusions from the Southeastern Cancer Study Group.
Topics: Antineoplastic Agents; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combina | 1982 |
Chemotherapy for advanced Hodgkin's disease: conclusions from the Southeastern Cancer Study Group.
Topics: Antineoplastic Agents; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combina | 1982 |
Intergroup Hodgkin's disease in children study of stages I and II: a preliminary report.
Topics: Antineoplastic Agents; Child; Clinical Trials as Topic; Drug Therapy, Combination; Hodgkin Disease; | 1982 |
Intergroup Hodgkin's disease in children study of stages I and II: a preliminary report.
Topics: Antineoplastic Agents; Child; Clinical Trials as Topic; Drug Therapy, Combination; Hodgkin Disease; | 1982 |
Hodgkin's disease in children: treatment results with MOPP and low-dose, extended-field irradiation.
Topics: Adolescent; Antineoplastic Agents; Child; Clinical Trials as Topic; Drug Therapy, Combination; Hodgk | 1982 |
Hodgkin's disease in children: treatment results with MOPP and low-dose, extended-field irradiation.
Topics: Adolescent; Antineoplastic Agents; Child; Clinical Trials as Topic; Drug Therapy, Combination; Hodgk | 1982 |
Stage I and II Hodgkin's disease: involved-field radiotherapy versus extended-field radiotherapy versus involved-field radiotherapy followed by six cycles of MOPP.
Topics: Antineoplastic Agents; Drug Therapy, Combination; Hodgkin Disease; Humans; Lymph Nodes; Mechloretham | 1982 |
Stage I and II Hodgkin's disease: involved-field radiotherapy versus extended-field radiotherapy versus involved-field radiotherapy followed by six cycles of MOPP.
Topics: Antineoplastic Agents; Drug Therapy, Combination; Hodgkin Disease; Humans; Lymph Nodes; Mechloretham | 1982 |
Radiotherapy versus combined modality treatment of stage I and II Hodgkin's disease.
Topics: Adult; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Neoplasm S | 1982 |
Radiotherapy versus combined modality treatment of stage I and II Hodgkin's disease.
Topics: Adult; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Neoplasm S | 1982 |
Radiotherapy or chemotherapy as the initial treatment for stage IIIA Hodgkin's disease (Report no 13).
Topics: Chlorambucil; Drug Therapy, Combination; Hodgkin Disease; Humans; Laparotomy; Mechlorethamine; Neopl | 1981 |
Radiotherapy or chemotherapy as the initial treatment for stage IIIA Hodgkin's disease (Report no 13).
Topics: Chlorambucil; Drug Therapy, Combination; Hodgkin Disease; Humans; Laparotomy; Mechlorethamine; Neopl | 1981 |
A new effective four-drug combination of CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) (NSC-79038), vinblastine, prednisone, and procarbazine for the treatment of advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Hemat | 1980 |
A new effective four-drug combination of CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) (NSC-79038), vinblastine, prednisone, and procarbazine for the treatment of advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Hemat | 1980 |
Hodgkin's disease in the very young.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschoo | 1994 |
Hodgkin's disease in the very young.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschoo | 1994 |
Quantitative effect of combined chemotherapy and fractionated radiotherapy on the incidence of radiation-induced lung damage: a prospective clinical study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Combined Modality | 1994 |
Quantitative effect of combined chemotherapy and fractionated radiotherapy on the incidence of radiation-induced lung damage: a prospective clinical study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Combined Modality | 1994 |
A randomized study in stage IIIB and IV Hodgkin's disease comparing eight courses of MOPP versus an alteration of MOPP with ABVD: a European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie cont
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1994 |
A randomized study in stage IIIB and IV Hodgkin's disease comparing eight courses of MOPP versus an alteration of MOPP with ABVD: a European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie cont
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1994 |
Early intensive therapy with autotransplantation for high-risk Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 1993 |
Early intensive therapy with autotransplantation for high-risk Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 1993 |
Preliminary results of the EORTC-GPMC controlled clinical trial H7 in early-stage Hodgkin's disease. EORTC Lymphoma Cooperative Group. Groupe Pierre-et-Marie-Curie.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1994 |
Preliminary results of the EORTC-GPMC controlled clinical trial H7 in early-stage Hodgkin's disease. EORTC Lymphoma Cooperative Group. Groupe Pierre-et-Marie-Curie.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1994 |
Prognosis of high dose chemotherapy/autologous bone marrow transplantation candidates not receiving this treatment after failure of primary therapy of Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1994 |
Prognosis of high dose chemotherapy/autologous bone marrow transplantation candidates not receiving this treatment after failure of primary therapy of Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1994 |
ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: the Stanford experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Coho | 1994 |
ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: the Stanford experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Coho | 1994 |
Vancouver hybrid: preliminary experience in the treatment of Hodgkin's disease in childhood and adolescence.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 1994 |
Vancouver hybrid: preliminary experience in the treatment of Hodgkin's disease in childhood and adolescence.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 1994 |
Extended-field radiotherapy in favorable stage IA-IIA Hodgkin's disease (prognostic role of stage).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1994 |
Extended-field radiotherapy in favorable stage IA-IIA Hodgkin's disease (prognostic role of stage).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1994 |
Vinorelbine: an active drug for the management of patients with heavily pretreated Hodgkin's disease.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality | 1994 |
Vinorelbine: an active drug for the management of patients with heavily pretreated Hodgkin's disease.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality | 1994 |
Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Di | 1995 |
Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Di | 1995 |
Human immunodeficiency virus associated Hodgkin's disease: report of 45 cases from the French Registry of HIV-Associated Tumors.
Topics: Adult; AIDS-Related Opportunistic Infections; Antineoplastic Combined Chemotherapy Protocols; Bleomy | 1995 |
Human immunodeficiency virus associated Hodgkin's disease: report of 45 cases from the French Registry of HIV-Associated Tumors.
Topics: Adult; AIDS-Related Opportunistic Infections; Antineoplastic Combined Chemotherapy Protocols; Bleomy | 1995 |
High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bo | 1995 |
High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bo | 1995 |
Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfa | 1995 |
Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfa | 1995 |
Etoposide, vinblastine, and doxorubicin: an active regimen for the treatment of Hodgkin's disease in relapse following MOPP. Cancer and Leukemia Group B.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Doxorubici | 1995 |
Etoposide, vinblastine, and doxorubicin: an active regimen for the treatment of Hodgkin's disease in relapse following MOPP. Cancer and Leukemia Group B.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Doxorubici | 1995 |
Optimal treatment of early-stage Hodgkin disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease | 1993 |
Optimal treatment of early-stage Hodgkin disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease | 1993 |
[Late cardiac toxicity in Hodgkin's disease. A study with pulsed Doppler echocardiography].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; C | 1993 |
[Late cardiac toxicity in Hodgkin's disease. A study with pulsed Doppler echocardiography].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; C | 1993 |
Recent advances in the therapy of Hodgkin's disease in elderly patients. The Piemonte Hodgkin's Disease Register (PHDR).
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Combined | 1993 |
Recent advances in the therapy of Hodgkin's disease in elderly patients. The Piemonte Hodgkin's Disease Register (PHDR).
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Combined | 1993 |
Combined chemotherapy-radiotherapy in advanced Hodgkin's disease: results of a prospective clinical trial with 70 stage IIIB-IV patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1993 |
Combined chemotherapy-radiotherapy in advanced Hodgkin's disease: results of a prospective clinical trial with 70 stage IIIB-IV patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1993 |
Chemotherapy dose and survival in advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dose-Response Relatio | 1993 |
Chemotherapy dose and survival in advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dose-Response Relatio | 1993 |
Treatment of pediatric Hodgkin disease tailored to stage, mediastinal mass, and age. An Italian (AIEOP) multicenter study on 215 patients.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Pr | 1993 |
Treatment of pediatric Hodgkin disease tailored to stage, mediastinal mass, and age. An Italian (AIEOP) multicenter study on 215 patients.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Pr | 1993 |
Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1993 |
Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1993 |
ChlVPP therapy for Hodgkin's disease: experience of 960 patients. The International ChlVPP Treatment Group.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Combined Mod | 1995 |
ChlVPP therapy for Hodgkin's disease: experience of 960 patients. The International ChlVPP Treatment Group.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Combined Mod | 1995 |
Infusional chemotherapy (EPOCH) in patients with refractory or relapsed lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Res | 1995 |
Infusional chemotherapy (EPOCH) in patients with refractory or relapsed lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Res | 1995 |
Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined | 1994 |
Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined | 1994 |
Hybrid LOPP/EVA is not better than LOPP alternating with EVAP: a prematurely terminated British National Lymphoma Investigation randomized trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Combined Modality T | 1994 |
Hybrid LOPP/EVA is not better than LOPP alternating with EVAP: a prematurely terminated British National Lymphoma Investigation randomized trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Combined Modality T | 1994 |
Etoposide in combination as first-line chemotherapy for advanced Hodgkin disease. A Cancer and Leukemia Group B study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide | 1993 |
Etoposide in combination as first-line chemotherapy for advanced Hodgkin disease. A Cancer and Leukemia Group B study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide | 1993 |
Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: ten-year results.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1996 |
Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: ten-year results.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1996 |
Fixed versus response-adapted MOPP/ABVD chemotherapy in Hodgkin's disease. A prospective randomized trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 1995 |
Fixed versus response-adapted MOPP/ABVD chemotherapy in Hodgkin's disease. A prospective randomized trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 1995 |
Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advance Hodgkin's disease. German Hodgkins' Study Group (GHSG).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1995 |
Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advance Hodgkin's disease. German Hodgkins' Study Group (GHSG).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1995 |
ABMT recommended for relapsed Hodgkin's disease, but better overall survival not yet proved.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Mod | 1996 |
ABMT recommended for relapsed Hodgkin's disease, but better overall survival not yet proved.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Mod | 1996 |
Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1996 |
Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1996 |
Brief chemotherapy (Stanford V) and adjuvant radiotherapy for bulky or advanced Hodgkin's disease: an update.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1996 |
Brief chemotherapy (Stanford V) and adjuvant radiotherapy for bulky or advanced Hodgkin's disease: an update.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1996 |
Twelve years experience with high-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's disease patients in first remission after MOPP/ABVD chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant | 1996 |
Twelve years experience with high-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's disease patients in first remission after MOPP/ABVD chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant | 1996 |
Treatment of Hodgkin's disease: the Swedish National Care Programme experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 1996 |
Treatment of Hodgkin's disease: the Swedish National Care Programme experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 1996 |
Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined | 1996 |
Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined | 1996 |
Chemotherapy in Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid | 1996 |
Chemotherapy in Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid | 1996 |
Chemotherapy induces transient sex chromosomal and autosomal aneuploidy in human sperm.
Topics: Adult; Aneuploidy; Antineoplastic Agents; Diploidy; Hodgkin Disease; Humans; In Situ Hybridization, | 1997 |
Chemotherapy induces transient sex chromosomal and autosomal aneuploidy in human sperm.
Topics: Adult; Aneuploidy; Antineoplastic Agents; Diploidy; Hodgkin Disease; Humans; In Situ Hybridization, | 1997 |
Treatment of childhood Hodgkin's disease without radiotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Ther | 1997 |
Treatment of childhood Hodgkin's disease without radiotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Ther | 1997 |
Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymphoma Co
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Doxorub | 1997 |
Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymphoma Co
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Doxorub | 1997 |
Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Ca | 1997 |
Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Ca | 1997 |
Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Child | 1997 |
Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Child | 1997 |
Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1997 |
Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1997 |
Randomized trial of CVPP for three versus six cycles in favorable-prognosis and CVPP versus AOPE plus radiotherapy in intermediate-prognosis untreated Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemothe | 1997 |
Randomized trial of CVPP for three versus six cycles in favorable-prognosis and CVPP versus AOPE plus radiotherapy in intermediate-prognosis untreated Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemothe | 1997 |
A phase I study of interleukin-6 after autologous bone marrow transplantation for patients with poor prognosis Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combi | 1997 |
A phase I study of interleukin-6 after autologous bone marrow transplantation for patients with poor prognosis Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combi | 1997 |
Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschoo | 1997 |
Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschoo | 1997 |
Hodgkin disease in children: results of a prospective randomized trial in a single institution in Argentina.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1997 |
Hodgkin disease in children: results of a prospective randomized trial in a single institution in Argentina.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1997 |
Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modali | 1997 |
Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modali | 1997 |
Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; H | 1997 |
Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; H | 1997 |
[A trial of applying an oily suspension of bleomycin endolymphatically in patients with Hodgkin's disease of the extraperitoneal lymph nodes].
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Proto | 1997 |
[A trial of applying an oily suspension of bleomycin endolymphatically in patients with Hodgkin's disease of the extraperitoneal lymph nodes].
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Proto | 1997 |
MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease significantly improves failure-free and overall survival: the 8-year results of the intergroup trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dis | 1998 |
MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease significantly improves failure-free and overall survival: the 8-year results of the intergroup trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dis | 1998 |
Inhibin A concentrations in the sera of young women during and after chemotherapy for lymphoma: correlation with ovarian toxicity.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1998 |
Inhibin A concentrations in the sera of young women during and after chemotherapy for lymphoma: correlation with ovarian toxicity.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1998 |
MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: results of the Children's Cancer Group Phase III Trial.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Ther | 1998 |
MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: results of the Children's Cancer Group Phase III Trial.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Ther | 1998 |
Randomized multicentre trial of filgrastim as an adjunct to combination chemotherapy for Hodgkin's disease. West of Scotland Lymphoma Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Chemotherapy, | 1998 |
Randomized multicentre trial of filgrastim as an adjunct to combination chemotherapy for Hodgkin's disease. West of Scotland Lymphoma Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Chemotherapy, | 1998 |
Are ABVD and MOPP/ABV truly equivalent for treating Hodgkin's disease at advanced stages?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxor | 1998 |
Are ABVD and MOPP/ABV truly equivalent for treating Hodgkin's disease at advanced stages?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxor | 1998 |
Augmented therapy of extensive Hodgkin's disease: radiation to known disease or prolongation of induction chemotherapy did not improve survival--results of a Cancer and Leukemia Group B study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survi | 1998 |
Augmented therapy of extensive Hodgkin's disease: radiation to known disease or prolongation of induction chemotherapy did not improve survival--results of a Cancer and Leukemia Group B study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survi | 1998 |
Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1998 |
Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1998 |
Moderate dose escalation for advanced stage Hodgkin's disease using the bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone scheme and adjuvant radiotherapy: a study of the German Hodgkin's Lymphoma Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose | 1998 |
Moderate dose escalation for advanced stage Hodgkin's disease using the bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone scheme and adjuvant radiotherapy: a study of the German Hodgkin's Lymphoma Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose | 1998 |
BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Austria; Bleomycin; Cycloph | 1998 |
BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Austria; Bleomycin; Cycloph | 1998 |
BEACOPP: a new regimen for advanced Hodgkin's disease. German Hodgkin's Lymphoma Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1998 |
BEACOPP: a new regimen for advanced Hodgkin's disease. German Hodgkin's Lymphoma Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1998 |
Pediatric Hodgkin's disease: treatment in the late 1990s.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined | 1998 |
Pediatric Hodgkin's disease: treatment in the late 1990s.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined | 1998 |
MOPP versus ABVD and low-dose versus high-dose irradiation in Hodgkin's disease at intermediate and advanced stages: analysis of a meta-analysis by clinicians.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D | 1999 |
MOPP versus ABVD and low-dose versus high-dose irradiation in Hodgkin's disease at intermediate and advanced stages: analysis of a meta-analysis by clinicians.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D | 1999 |
Assessment of cardiac and pulmonary function in adult patients with Hodgkin's disease treated with ABVD or MOPP/ABVD plus adjuvant low-dose mediastinal irradiation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1999 |
Assessment of cardiac and pulmonary function in adult patients with Hodgkin's disease treated with ABVD or MOPP/ABVD plus adjuvant low-dose mediastinal irradiation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1999 |
Two different schedules for integrating filgrastim as adjuvant therapy in the treatment of patients with advanced stage Hodgkin's lymphoma receiving MOPP/ABV hybrid chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Filgrastim; Granulocyte C | 1999 |
Two different schedules for integrating filgrastim as adjuvant therapy in the treatment of patients with advanced stage Hodgkin's lymphoma receiving MOPP/ABV hybrid chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Filgrastim; Granulocyte C | 1999 |
Treatment of stage I and II Hodgkin's disease with NOVP (mitoxantrone, vincristine, vinblastine, prednisone) and radiotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administratio | 1999 |
Treatment of stage I and II Hodgkin's disease with NOVP (mitoxantrone, vincristine, vinblastine, prednisone) and radiotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administratio | 1999 |
Effect of Epstein-Barr virus infection on response to chemotherapy and survival in Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Disease-Free Survival; England; Epstei | 1999 |
Effect of Epstein-Barr virus infection on response to chemotherapy and survival in Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Disease-Free Survival; England; Epstei | 1999 |
Intensive therapy with autologous stem cell transplantation as first-line therapy in poor-risk Hodgkin's disease and analysis of predictive factors of outcome.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Disease-Free Survival; | 1999 |
Intensive therapy with autologous stem cell transplantation as first-line therapy in poor-risk Hodgkin's disease and analysis of predictive factors of outcome.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Disease-Free Survival; | 1999 |
Childhood stage IV Hodgkin disease: therapeutic results of the Polish pediatric leukemia/lymphoma study group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 1999 |
Childhood stage IV Hodgkin disease: therapeutic results of the Polish pediatric leukemia/lymphoma study group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 1999 |
[COP-BLAM therapy for a Hodgkin's disease in the elderly].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Surv | 1999 |
[COP-BLAM therapy for a Hodgkin's disease in the elderly].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Surv | 1999 |
High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Austria; Child; Child, Preschool; Combin | 1999 |
High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Austria; Child; Child, Preschool; Combin | 1999 |
Short term treatment with Escherichia coli recombinant human granulocyte-macrophage-colony stimulating factor prior to chemotherapy for Hodgkin disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2000 |
Short term treatment with Escherichia coli recombinant human granulocyte-macrophage-colony stimulating factor prior to chemotherapy for Hodgkin disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2000 |
[Results of a prospective protocol for the treatment of adult Hodgkin's disease].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Disease Progression; D | 1999 |
[Results of a prospective protocol for the treatment of adult Hodgkin's disease].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Disease Progression; D | 1999 |
Comparison of chemotherapy to radiotherapy as consolidation of complete or good partial response after six cycles of chemotherapy for patients with advanced Hodgkin's disease: results of the groupe d'études des lymphomes de l'Adulte H89 trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 2000 |
Comparison of chemotherapy to radiotherapy as consolidation of complete or good partial response after six cycles of chemotherapy for patients with advanced Hodgkin's disease: results of the groupe d'études des lymphomes de l'Adulte H89 trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 2000 |
Localized childhood Hodgkin's disease: response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy-results of the French Society of Pediatric Oncology Study MDH90.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 2000 |
Localized childhood Hodgkin's disease: response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy-results of the French Society of Pediatric Oncology Study MDH90.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 2000 |
Lomustine and melphalan cannot be replaced by cyclophosphamide and etoposide without reducing efficacy in MOPPEBVCAD chemotherapy for advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 2000 |
Lomustine and melphalan cannot be replaced by cyclophosphamide and etoposide without reducing efficacy in MOPPEBVCAD chemotherapy for advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 2000 |
Stanford V regimen and concomitant highly active antiretroviral therapy is feasible and active in patients with Hodgkin's disease and HIV infection.
Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Etop | 2000 |
Stanford V regimen and concomitant highly active antiretroviral therapy is feasible and active in patients with Hodgkin's disease and HIV infection.
Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Etop | 2000 |
CN3OP: an active regimen in patients with relapsed/refractory Hodgkin's lymphoma.
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disea | 2000 |
CN3OP: an active regimen in patients with relapsed/refractory Hodgkin's lymphoma.
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disea | 2000 |
Agreement rates among single photon emission computed tomography using gallium-67, computed axial tomography and lymphangiography for Hodgkin disease and correlation of image findings with clinical outcome.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Citrates; | 2000 |
Agreement rates among single photon emission computed tomography using gallium-67, computed axial tomography and lymphangiography for Hodgkin disease and correlation of image findings with clinical outcome.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Citrates; | 2000 |
Acute hematologic toxicity and practicability of dose-intensified BEACOPP chemotherapy for advanced stage Hodgkin's disease. German Hodgkin's Lymphoma Study Group (GHSG).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Platelets; | 2000 |
Acute hematologic toxicity and practicability of dose-intensified BEACOPP chemotherapy for advanced stage Hodgkin's disease. German Hodgkin's Lymphoma Study Group (GHSG).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Platelets; | 2000 |
Cyclophosphamide-based, seven-drug hybrid and low-dose involved field radiation for the treatment of childhood and adolescent Hodgkin disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Ther | 2001 |
Cyclophosphamide-based, seven-drug hybrid and low-dose involved field radiation for the treatment of childhood and adolescent Hodgkin disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Ther | 2001 |
Clearing of cells bearing the bcl-2 [t(14;18)] translocation from blood and marrow of patients treated with rituximab alone or in combination with CHOP chemotherapy.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; | 2001 |
Clearing of cells bearing the bcl-2 [t(14;18)] translocation from blood and marrow of patients treated with rituximab alone or in combination with CHOP chemotherapy.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; | 2001 |
ChlVPP alternating with PABlOE is superior to PABlOE alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation/Central Lymphoma Group randomized controlled trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Di | 2001 |
ChlVPP alternating with PABlOE is superior to PABlOE alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation/Central Lymphoma Group randomized controlled trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Di | 2001 |
Bleomycin, lomustine, cyclophosphamide, vincristine, procarbazine and prednisone (BLEO-CCVPP) in patients with Hodgkin's disease who relapsed after radiotherapy alone: a long-term follow-up study of the Eastern Cooperative Oncology Group (E3481).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; | 2001 |
Bleomycin, lomustine, cyclophosphamide, vincristine, procarbazine and prednisone (BLEO-CCVPP) in patients with Hodgkin's disease who relapsed after radiotherapy alone: a long-term follow-up study of the Eastern Cooperative Oncology Group (E3481).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; | 2001 |
Cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) for advanced-stage Hodgkin's disease: CALGB 8856.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Adm | 2001 |
Cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) for advanced-stage Hodgkin's disease: CALGB 8856.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Adm | 2001 |
Advanced Hodgkin disease with large mediastinal involvement can be treated with eight cycles of chemotherapy alone after a major response to six cycles of chemotherapy: a study of 82 patients from the Groupes d'Etudes des Lymphomes de l'Adulte H89 trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Disease Progression; Doxorubicin; | 2001 |
Advanced Hodgkin disease with large mediastinal involvement can be treated with eight cycles of chemotherapy alone after a major response to six cycles of chemotherapy: a study of 82 patients from the Groupes d'Etudes des Lymphomes de l'Adulte H89 trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Disease Progression; Doxorubicin; | 2001 |
Activity of infusional etoposide, vincristine, and doxorubicin with bolus cyclophosphamide (EPOCH) in relapsed Hodgkin's disease.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; | 2001 |
Activity of infusional etoposide, vincristine, and doxorubicin with bolus cyclophosphamide (EPOCH) in relapsed Hodgkin's disease.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; | 2001 |
Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2002 |
Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2002 |
Treatment of refractory Hodgkin's disease with modified Stanford V program.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Epirubicin; Etop | 2001 |
Treatment of refractory Hodgkin's disease with modified Stanford V program.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Epirubicin; Etop | 2001 |
European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Diseas | 2002 |
European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Diseas | 2002 |
ABVD versus stanford V versus MEC in unfavourable Hodgkin's lymphoma: results of a randomised trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cytarabine; Daca | 2002 |
ABVD versus stanford V versus MEC in unfavourable Hodgkin's lymphoma: results of a randomised trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cytarabine; Daca | 2002 |
Feasibility of upfront dose-intensive chemotherapy in children with advanced-stage Hodgkin's lymphoma: preliminary results from the Children's Cancer Group Study CCG-59704.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschoo | 2002 |
Feasibility of upfront dose-intensive chemotherapy in children with advanced-stage Hodgkin's lymphoma: preliminary results from the Children's Cancer Group Study CCG-59704.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschoo | 2002 |
Current clinical trials for the treatment of advanced-stage Hodgkin's disease: BEACOPP.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami | 2002 |
Current clinical trials for the treatment of advanced-stage Hodgkin's disease: BEACOPP.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami | 2002 |
Recent trends in the medical treatment of Hodgkin's disease.
Topics: Adolescent; Antineoplastic Agents; Bleomycin; Child; Clinical Trials as Topic; Dactinomycin; Dose-Re | 1975 |
Recent trends in the medical treatment of Hodgkin's disease.
Topics: Adolescent; Antineoplastic Agents; Bleomycin; Child; Clinical Trials as Topic; Dactinomycin; Dose-Re | 1975 |
Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP.
Topics: Adolescent; Adult; Bleomycin; Child; Doxorubicin; Drug Therapy, Combination; Drug Tolerance; Female; | 1975 |
Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP.
Topics: Adolescent; Adult; Bleomycin; Child; Doxorubicin; Drug Therapy, Combination; Drug Tolerance; Female; | 1975 |
Initial treatment of stage IIIA Hodgkin's disease. Comparison of radiotherapy with combined chemotherapy. British National Lymphoma Investigation.
Topics: Adolescent; Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin Disease; Humans; La | 1976 |
Initial treatment of stage IIIA Hodgkin's disease. Comparison of radiotherapy with combined chemotherapy. British National Lymphoma Investigation.
Topics: Adolescent; Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin Disease; Humans; La | 1976 |
Combined therapy with bleomycin and some immunological implications.
Topics: Adolescent; Adult; Bleomycin; Cell Division; Clinical Trials as Topic; Drug Administration Schedule; | 1976 |
Combined therapy with bleomycin and some immunological implications.
Topics: Adolescent; Adult; Bleomycin; Cell Division; Clinical Trials as Topic; Drug Administration Schedule; | 1976 |
Eight-drug combination chemotherapy (MOPP and ABDV) and local radiotherapy for advanced Hodgkin's Disease.
Topics: Adolescent; Adult; Bleomycin; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Hodgkin D | 1976 |
Eight-drug combination chemotherapy (MOPP and ABDV) and local radiotherapy for advanced Hodgkin's Disease.
Topics: Adolescent; Adult; Bleomycin; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Hodgkin D | 1976 |
The treatment of Hodgkin's disease: emphasizing programs at the Clinic Center, National Institutes of Health.
Topics: Adult; Bleomycin; Bone Marrow; Child; Clinical Trials as Topic; Drug Therapy, Combination; Female; H | 1977 |
The treatment of Hodgkin's disease: emphasizing programs at the Clinic Center, National Institutes of Health.
Topics: Adult; Bleomycin; Bone Marrow; Child; Clinical Trials as Topic; Drug Therapy, Combination; Female; H | 1977 |
Combined chemotherapy (MOPP or ABVD)-radiotherapy approach in advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Bleomycin; Child; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug | 1977 |
Combined chemotherapy (MOPP or ABVD)-radiotherapy approach in advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Bleomycin; Child; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug | 1977 |
ABVD treatment of MOPP failures in Hodgkin's disease: a re-examination of goals of salvage therapy.
Topics: Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Resistance; Drug Therapy, Combin | 1978 |
ABVD treatment of MOPP failures in Hodgkin's disease: a re-examination of goals of salvage therapy.
Topics: Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Resistance; Drug Therapy, Combin | 1978 |
Prolonged disease-free survival in MOPP-resistant Hodgkin's disease after treatment with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD).
Topics: Adult; Aged; Antineoplastic Agents; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; D | 1979 |
Prolonged disease-free survival in MOPP-resistant Hodgkin's disease after treatment with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD).
Topics: Adult; Aged; Antineoplastic Agents; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; D | 1979 |
Combined modality therapy of Hodgkin's disease: a report on the Stanford Trials.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Drug Therapy, Combination; Female; Hodgkin Disease; | 1978 |
Combined modality therapy of Hodgkin's disease: a report on the Stanford Trials.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Drug Therapy, Combination; Female; Hodgkin Disease; | 1978 |
Pathologic stage I and II Hodgkin's disease, 1968--1975: relapse and results of retreatment.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Fema | 1979 |
Pathologic stage I and II Hodgkin's disease, 1968--1975: relapse and results of retreatment.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Fema | 1979 |
Primary treatment of disseminated Hodgkin's disease with BCNU alone and in combination with vincristine, procarbazine, and prednisone.
Topics: Adult; Blood Cell Count; Carmustine; Clinical Trials as Topic; Drug Therapy, Combination; Female; Ho | 1977 |
Primary treatment of disseminated Hodgkin's disease with BCNU alone and in combination with vincristine, procarbazine, and prednisone.
Topics: Adult; Blood Cell Count; Carmustine; Clinical Trials as Topic; Drug Therapy, Combination; Female; Ho | 1977 |
MVPP chemotherapy combined with radiotherapy in the treatment of Hodgkin's disease in children.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Clinical Trials as Topic; Drug Evaluatio | 1978 |
MVPP chemotherapy combined with radiotherapy in the treatment of Hodgkin's disease in children.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Clinical Trials as Topic; Drug Evaluatio | 1978 |
The chemotherapy of Hodgkin's disease: past experiences and future directions.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Drug Therapy, Combination; History, 19th Century; H | 1978 |
The chemotherapy of Hodgkin's disease: past experiences and future directions.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Drug Therapy, Combination; History, 19th Century; H | 1978 |
A comparative study of a BCNU containing 4-drug program versus MOPP versus 3-drug combinations in advanced Hodgkin's disease: a cooperative study by the Cancer and Leukemia Group B.
Topics: Adult; Antineoplastic Agents; Carmustine; Clinical Trials as Topic; Drug Therapy, Combination; Femal | 1979 |
A comparative study of a BCNU containing 4-drug program versus MOPP versus 3-drug combinations in advanced Hodgkin's disease: a cooperative study by the Cancer and Leukemia Group B.
Topics: Adult; Antineoplastic Agents; Carmustine; Clinical Trials as Topic; Drug Therapy, Combination; Femal | 1979 |
Alternating chemotherapy and irradiation in the treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Marrow; Clinical Trials as Topic; Drug Therapy, Combi | 1979 |
Alternating chemotherapy and irradiation in the treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Marrow; Clinical Trials as Topic; Drug Therapy, Combi | 1979 |
The chemotherapy--radiotherapy sequence in the management of Hodgkin's disease. Results of a clinical trial.
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Clinical Trials as Topic; Drug Therapy, Combination | 1979 |
The chemotherapy--radiotherapy sequence in the management of Hodgkin's disease. Results of a clinical trial.
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Clinical Trials as Topic; Drug Therapy, Combination | 1979 |
Combined chemotherapy cyclophosphamide, vinblastine, procarbazine and prednisone (CVPP) vs. CVPP plus CCNU (CCVPP) in Hodgin's disease.
Topics: Adolescent; Adult; Antineoplastic Agents; Clinical Trials as Topic; Cyclophosphamide; Drug Administr | 1979 |
Combined chemotherapy cyclophosphamide, vinblastine, procarbazine and prednisone (CVPP) vs. CVPP plus CCNU (CCVPP) in Hodgin's disease.
Topics: Adolescent; Adult; Antineoplastic Agents; Clinical Trials as Topic; Cyclophosphamide; Drug Administr | 1979 |
Combined modality treatment of Hodgkin's disease confined to lymph nodes. Results eight years later.
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Clinical Trials as Topic; Cobalt Radioisotopes; Dru | 1979 |
Combined modality treatment of Hodgkin's disease confined to lymph nodes. Results eight years later.
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Clinical Trials as Topic; Cobalt Radioisotopes; Dru | 1979 |
The therapeutic implications of splenic involvement in stage IIIA Hodgkin's disease.
Topics: Abdomen; Adolescent; Adult; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lymph | 1977 |
The therapeutic implications of splenic involvement in stage IIIA Hodgkin's disease.
Topics: Abdomen; Adolescent; Adult; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lymph | 1977 |
New assessment of the prognostic significance of histopathology in Hodgkin's disease for laparotomy-negative stage I and stage II patients.
Topics: Adolescent; Adult; Clinical Trials as Topic; Drug Therapy, Combination; Female; Hodgkin Disease; Hum | 1977 |
New assessment of the prognostic significance of histopathology in Hodgkin's disease for laparotomy-negative stage I and stage II patients.
Topics: Adolescent; Adult; Clinical Trials as Topic; Drug Therapy, Combination; Female; Hodgkin Disease; Hum | 1977 |
Randomised trial of two-drug and four-drug maintenance chemotherapy in advanced or recurrent Hodgkin's disease. Medical Research Council's working party on lymphomas.
Topics: Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlore | 1979 |
Randomised trial of two-drug and four-drug maintenance chemotherapy in advanced or recurrent Hodgkin's disease. Medical Research Council's working party on lymphomas.
Topics: Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlore | 1979 |
delta 9-Tetrahydrocannabinol (THC) as an antiemetic in patients treated with cancerchemotherapy; a double-blind cross-over trial against placebo.
Topics: Adult; Antiemetics; Antineoplastic Agents; Double-Blind Method; Dronabinol; Drug Therapy, Combinatio | 1979 |
delta 9-Tetrahydrocannabinol (THC) as an antiemetic in patients treated with cancerchemotherapy; a double-blind cross-over trial against placebo.
Topics: Adult; Antiemetics; Antineoplastic Agents; Double-Blind Method; Dronabinol; Drug Therapy, Combinatio | 1979 |
BCNU, velban, cyclophosphamide, procarbazine, and prednisone (BVCPP) in advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Marrow; Carmustine; Child; Cyclophosphamide; Dr | 1978 |
BCNU, velban, cyclophosphamide, procarbazine, and prednisone (BVCPP) in advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Marrow; Carmustine; Child; Cyclophosphamide; Dr | 1978 |
Southeastern Cancer Study Group trials with nitrosoureas in Hodgkin's disease.
Topics: Administration, Oral; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Drug | 1976 |
Southeastern Cancer Study Group trials with nitrosoureas in Hodgkin's disease.
Topics: Administration, Oral; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Drug | 1976 |
The management of stages I, II, and III Hodgkin's disease with combined radiotherapy and chemotherapy.
Topics: Drug Therapy, Combination; Evaluation Studies as Topic; Hodgkin Disease; Humans; Mechlorethamine; Pr | 1975 |
The management of stages I, II, and III Hodgkin's disease with combined radiotherapy and chemotherapy.
Topics: Drug Therapy, Combination; Evaluation Studies as Topic; Hodgkin Disease; Humans; Mechlorethamine; Pr | 1975 |
[Treatment of Hodgkin's disease stages I, II, and III].
Topics: Hodgkin Disease; Humans; Laparotomy; Mechlorethamine; Prednisone; Procarbazine; Splenectomy; Time Fa | 1977 |
[Treatment of Hodgkin's disease stages I, II, and III].
Topics: Hodgkin Disease; Humans; Laparotomy; Mechlorethamine; Prednisone; Procarbazine; Splenectomy; Time Fa | 1977 |
Value of prednisone in combination chemotherapy of stage IV Hodgkin's disease. Report from the British National Lymphoma Investigation.
Topics: Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechl | 1975 |
Value of prednisone in combination chemotherapy of stage IV Hodgkin's disease. Report from the British National Lymphoma Investigation.
Topics: Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechl | 1975 |
A combined modality approach to the treatment of Hodgkin's disease. Preliminary results of a prospectively randomized clinical trial.
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Cobalt Radioisotopes; Drug Therapy, Combination; Ev | 1975 |
A combined modality approach to the treatment of Hodgkin's disease. Preliminary results of a prospectively randomized clinical trial.
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Cobalt Radioisotopes; Drug Therapy, Combination; Ev | 1975 |
[Polychemotherapy of Hodgkin's disease (author's transl)].
Topics: Adolescent; Adult; Age Factors; Aged; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Ma | 1975 |
[Polychemotherapy of Hodgkin's disease (author's transl)].
Topics: Adolescent; Adult; Age Factors; Aged; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Ma | 1975 |
A comparison of nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) vs. nitrogen mustard in advanced Hodgkin's disease.
Topics: Drug Evaluation; Drug Therapy, Combination; Follow-Up Studies; Hodgkin Disease; Humans; Mechloretham | 1975 |
A comparison of nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) vs. nitrogen mustard in advanced Hodgkin's disease.
Topics: Drug Evaluation; Drug Therapy, Combination; Follow-Up Studies; Hodgkin Disease; Humans; Mechloretham | 1975 |
Role of additional radiotherapy in advanced stages of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami | 1992 |
Role of additional radiotherapy in advanced stages of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami | 1992 |
[Recurrence of Hodgkin's disease after advanced primary stages. German Hodgkin's Study Group].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 1992 |
[Recurrence of Hodgkin's disease after advanced primary stages. German Hodgkin's Study Group].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 1992 |
Four cycles of chemotherapy and regional radiation therapy for clinical early-stage and intermediate-stage Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1992 |
Four cycles of chemotherapy and regional radiation therapy for clinical early-stage and intermediate-stage Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1992 |
[Early results of the treatment of Hodgkin's disease in adults using the seven-drug cytostatic protocol].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Protoco | 1992 |
[Early results of the treatment of Hodgkin's disease in adults using the seven-drug cytostatic protocol].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Protoco | 1992 |
Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology.
Topics: Actuarial Analysis; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Ch | 1992 |
Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology.
Topics: Actuarial Analysis; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Ch | 1992 |
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Adm | 1992 |
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Adm | 1992 |
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Adm | 1992 |
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Adm | 1992 |
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Adm | 1992 |
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Adm | 1992 |
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Adm | 1992 |
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Adm | 1992 |
[Comparative study of advanced-stage Hodgkin's lymphoma patients treated with either COPP or ABVD drug combinations].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 1992 |
[Comparative study of advanced-stage Hodgkin's lymphoma patients treated with either COPP or ABVD drug combinations].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 1992 |
A prospective randomized study of two alternating, non cross-resistant chemotherapies for advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Dacarbazine; Doxorubic | 1992 |
A prospective randomized study of two alternating, non cross-resistant chemotherapies for advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Dacarbazine; Doxorubic | 1992 |
Comparison of psychosocial adaptation and sexual function of survivors of advanced Hodgkin disease treated by MOPP, ABVD, or MOPP alternating with ABVD.
Topics: Adaptation, Psychological; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarba | 1992 |
Comparison of psychosocial adaptation and sexual function of survivors of advanced Hodgkin disease treated by MOPP, ABVD, or MOPP alternating with ABVD.
Topics: Adaptation, Psychological; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarba | 1992 |
The EORTC trials for limited stage Hodgkin's disease. The EORTC Lymphoma Cooperative Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Prednisone; Prognosis; Sple | 1992 |
The EORTC trials for limited stage Hodgkin's disease. The EORTC Lymphoma Cooperative Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Prednisone; Prognosis; Sple | 1992 |
Chemotherapy versus radiotherapy in early-stage Hodgkin's disease: evidence of a more difficult rescue for patients relapsed after chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Prednisone | 1992 |
Chemotherapy versus radiotherapy in early-stage Hodgkin's disease: evidence of a more difficult rescue for patients relapsed after chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Prednisone | 1992 |
Treatment of children with Hodgkin's disease--results of the German Pediatric Oncology Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cyclop | 1992 |
Treatment of children with Hodgkin's disease--results of the German Pediatric Oncology Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cyclop | 1992 |
NOVP and radiotherapy for early-staged Hodgkin's disease: an interim analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Tolerance; Hodgkin D | 1992 |
NOVP and radiotherapy for early-staged Hodgkin's disease: an interim analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Tolerance; Hodgkin D | 1992 |
Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage III-IV A & B Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C | 1992 |
Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage III-IV A & B Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C | 1992 |
The use of combination chemotherapy in the treatment of early stage Hodgkin's disease.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality | 1992 |
The use of combination chemotherapy in the treatment of early stage Hodgkin's disease.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality | 1992 |
LOPP alternating with EVAP is superior to LOPP alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation trial.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy | 1992 |
LOPP alternating with EVAP is superior to LOPP alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation trial.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy | 1992 |
Cooperative trials of Hodgkin's lymphoma in the Federal Republic of Germany.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top | 1990 |
Cooperative trials of Hodgkin's lymphoma in the Federal Republic of Germany.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top | 1990 |
Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; | 1990 |
Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; | 1990 |
Chemotherapy of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Dacarbazine; | 1990 |
Chemotherapy of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Dacarbazine; | 1990 |
Alternating versus hybrid MOPP-ABVD in Hodgkin's disease: the Milan experience.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarba | 1991 |
Alternating versus hybrid MOPP-ABVD in Hodgkin's disease: the Milan experience.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarba | 1991 |
Management of relapse and survival in advanced stage Hodgkin's disease: the EORTC experience.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; | 1991 |
Management of relapse and survival in advanced stage Hodgkin's disease: the EORTC experience.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; | 1991 |
Novel combination of epirubicin, bleomycin, vinblastine and prednisone (EBVP II) before radical radiotherapy in localized stages (I-IIIA) of Hodgkin's disease. Early results in 100 consecutive patients. Pierre-et-Marie-Curie Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined | 1991 |
Novel combination of epirubicin, bleomycin, vinblastine and prednisone (EBVP II) before radical radiotherapy in localized stages (I-IIIA) of Hodgkin's disease. Early results in 100 consecutive patients. Pierre-et-Marie-Curie Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined | 1991 |
Treatment of advanced-stage Hodgkin's disease: alternating noncrossresistant MOPP/CABS is not superior to MOPP.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dose-Re | 1991 |
Treatment of advanced-stage Hodgkin's disease: alternating noncrossresistant MOPP/CABS is not superior to MOPP.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dose-Re | 1991 |
Autologous bone marrow transplantation as adjuvant treatment for high-risk Hodgkin's disease in first complete remission after MOPP/ABVD protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 1991 |
Autologous bone marrow transplantation as adjuvant treatment for high-risk Hodgkin's disease in first complete remission after MOPP/ABVD protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 1991 |
Comparison of two non-cross-resistant combinations (ABVP/LOPP) with COPP plus bleomycin in the treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; | 1991 |
Comparison of two non-cross-resistant combinations (ABVP/LOPP) with COPP plus bleomycin in the treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; | 1991 |
The clinical significance of serum CD8 antigen levels in adult patients with Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD8 Antigens; Cyclopho | 1991 |
The clinical significance of serum CD8 antigen levels in adult patients with Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD8 Antigens; Cyclopho | 1991 |
Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: eight-year update of an Italian prospective randomized study.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; | 1992 |
Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: eight-year update of an Italian prospective randomized study.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; | 1992 |
Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with Hodgkin's disease: a phase I/II study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Dose- | 1992 |
Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with Hodgkin's disease: a phase I/II study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Dose- | 1992 |
[Late results of the treatment of advanced Hodgkin's disease by the MOPP/COPP programs (chlormethine or cyclophosphamide, vincristine, procarbazine and prednisone)].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; H | 1991 |
[Late results of the treatment of advanced Hodgkin's disease by the MOPP/COPP programs (chlormethine or cyclophosphamide, vincristine, procarbazine and prednisone)].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; H | 1991 |
[Malignant lymphoma associated with HIV infection].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modalit | 1991 |
[Malignant lymphoma associated with HIV infection].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modalit | 1991 |
Will doxorubicin-containing regimens replace MOPP and its variants?
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Hodgkin Disease; Humans; Mechlorethamin | 1991 |
Will doxorubicin-containing regimens replace MOPP and its variants?
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Hodgkin Disease; Humans; Mechlorethamin | 1991 |
Phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor following allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; | 1991 |
Phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor following allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; | 1991 |
Combined modality therapy of Hodgkin's disease: 10-year results of National Cancer Institute of Canada Clinical Trials Group multicenter clinical trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1991 |
Combined modality therapy of Hodgkin's disease: 10-year results of National Cancer Institute of Canada Clinical Trials Group multicenter clinical trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1991 |
British National Lymphoma Investigation randomised study of MOPP (mustine, Oncovin, procarbazine, prednisolone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease--long term results.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Female; Follow-Up S | 1991 |
British National Lymphoma Investigation randomised study of MOPP (mustine, Oncovin, procarbazine, prednisolone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease--long term results.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Female; Follow-Up S | 1991 |
Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: seven-year results of a prospective randomized trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Follow-Up Studies; | 1991 |
Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: seven-year results of a prospective randomized trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Follow-Up Studies; | 1991 |
Chemotherapy alone for the treatment of early-stage Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Hodgkin Disease; Humans; Mechlorethami | 1990 |
Chemotherapy alone for the treatment of early-stage Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Hodgkin Disease; Humans; Mechlorethami | 1990 |
Phase II study of MOPLACE chemotherapy for patients with previously treated Hodgkin's disease: a CALGB study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabin | 1990 |
Phase II study of MOPLACE chemotherapy for patients with previously treated Hodgkin's disease: a CALGB study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabin | 1990 |
The intergroup Hodgkin's disease in children. A study of stages I and II.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Hodgki | 1990 |
The intergroup Hodgkin's disease in children. A study of stages I and II.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Hodgki | 1990 |
A note on the Wilcoxon-Mann-Whitney test for 2 X kappa ordered tables.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biometry; Bleomycin; Clinical Trials as Topic; Dacar | 1985 |
A note on the Wilcoxon-Mann-Whitney test for 2 X kappa ordered tables.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biometry; Bleomycin; Clinical Trials as Topic; Dacar | 1985 |
Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubic | 1985 |
Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubic | 1985 |
Autologous bone marrow transplantation in Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 1985 |
Autologous bone marrow transplantation in Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 1985 |
Salvage chemotherapy in Hodgkin's disease irradiation failures: superiority of doxorubicin-containing regimens over MOPP.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubic | 1986 |
Salvage chemotherapy in Hodgkin's disease irradiation failures: superiority of doxorubicin-containing regimens over MOPP.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubic | 1986 |
Long-term follow-up of cardiac function in patients with Hodgkin's disease treated with mediastinal irradiation and combination chemotherapy including doxorubicin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Pressure; Clinical Trials as | 1986 |
Long-term follow-up of cardiac function in patients with Hodgkin's disease treated with mediastinal irradiation and combination chemotherapy including doxorubicin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Pressure; Clinical Trials as | 1986 |
Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dox | 1986 |
Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dox | 1986 |
MOPP/ABVD chemotherapy for advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Dacarbaz | 1986 |
MOPP/ABVD chemotherapy for advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Dacarbaz | 1986 |
Alternating cycles of combination chemotherapy for patients with recurrent Hodgkin's disease following radiotherapy. A prospectively randomized study by the Cancer and Leukemia Group B.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Clinical Trials as T | 1986 |
Alternating cycles of combination chemotherapy for patients with recurrent Hodgkin's disease following radiotherapy. A prospectively randomized study by the Cancer and Leukemia Group B.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Clinical Trials as T | 1986 |
[Intermediate results of the German Hodgkin's disease therapy study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami | 1986 |
[Intermediate results of the German Hodgkin's disease therapy study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami | 1986 |
Alternating sequential combination chemotherapy in the management of advanced Hodgkin's disease. A Southeastern Cancer Study Group trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Clinical Trials as Top | 1986 |
Alternating sequential combination chemotherapy in the management of advanced Hodgkin's disease. A Southeastern Cancer Study Group trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Clinical Trials as Top | 1986 |
Evaluation of therapeutic modalities in the control of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modali | 1986 |
Evaluation of therapeutic modalities in the control of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modali | 1986 |
[Treatment of Hodgkin's disease in children. Results of the Polish Group for the Treatment of Leukemia and Neoplastic Diseases in Children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Clin | 1986 |
[Treatment of Hodgkin's disease in children. Results of the Polish Group for the Treatment of Leukemia and Neoplastic Diseases in Children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Clin | 1986 |
Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined | 1987 |
Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined | 1987 |
[Therapy studies of the German Hodgkin's Study Group. Intermediate results of the study protocols HD1, HD2, and HD3].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modali | 1987 |
[Therapy studies of the German Hodgkin's Study Group. Intermediate results of the study protocols HD1, HD2, and HD3].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modali | 1987 |
[Treatment of Hodgkin's disease in children with chemotherapy and low-dose radiation].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 1987 |
[Treatment of Hodgkin's disease in children with chemotherapy and low-dose radiation].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 1987 |
[Preliminary results of cyclically alternating chemotherapy (CVPP/DBVCy) in advanced Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bleomycin; Clinic | 1987 |
[Preliminary results of cyclically alternating chemotherapy (CVPP/DBVCy) in advanced Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bleomycin; Clinic | 1987 |
Combined modality therapy for advanced Hodgkin's disease: 15-year follow-up data.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined | 1988 |
Combined modality therapy for advanced Hodgkin's disease: 15-year follow-up data.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined | 1988 |
[Therapy of Hodgkin's lymphomas. Results of the German Hodgkin's Disease Study Group].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top | 1988 |
[Therapy of Hodgkin's lymphomas. Results of the German Hodgkin's Disease Study Group].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top | 1988 |
Prognostic risk factors in advanced Hodgkin's lymphoma. Report of the German Hodgkin Study Group.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; | 1988 |
Prognostic risk factors in advanced Hodgkin's lymphoma. Report of the German Hodgkin Study Group.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; | 1988 |
Initial chemotherapy and low-dose radiation in limited fields in childhood Hodgkin's disease: results of a joint cooperative study by the French Society of Pediatric Oncology (SFOP) and Hôpital Saint-Louis, Paris.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 1988 |
Initial chemotherapy and low-dose radiation in limited fields in childhood Hodgkin's disease: results of a joint cooperative study by the French Society of Pediatric Oncology (SFOP) and Hôpital Saint-Louis, Paris.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 1988 |
Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined | 1989 |
Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined | 1989 |
Treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top | 1989 |
Treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top | 1989 |
Chemotherapy of Hodgkin's lymphoma with alternating cycles of COPP (cyclophosphamide, vincristin, procarbazine, prednisone) and ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine). Results of the HD1 and HD3 trials of the German Hodgkin Study Group
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials | 1989 |
Chemotherapy of Hodgkin's lymphoma with alternating cycles of COPP (cyclophosphamide, vincristin, procarbazine, prednisone) and ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine). Results of the HD1 and HD3 trials of the German Hodgkin Study Group
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials | 1989 |
Hodgkin's disease: the Milan Cancer Institute experience with MOPP and ABVD.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D | 1989 |
Hodgkin's disease: the Milan Cancer Institute experience with MOPP and ABVD.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D | 1989 |
Results and prognostic factors following optimal treatment of advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarba | 1989 |
Results and prognostic factors following optimal treatment of advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarba | 1989 |
Hodgkin's disease in children: adaptation of treatment to risk factors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Clin | 1989 |
Hodgkin's disease in children: adaptation of treatment to risk factors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Clin | 1989 |
[Controversy regarding the treatment of Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Clinical Trials as Topic; C | 1989 |
[Controversy regarding the treatment of Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Clinical Trials as Topic; C | 1989 |
Clinical investigations of children with Hodgkin's disease at Stanford University Medical Center. A preliminary overview using low-dose irradiation and alternating ABVD/MOPP chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Clin | 1989 |
Clinical investigations of children with Hodgkin's disease at Stanford University Medical Center. A preliminary overview using low-dose irradiation and alternating ABVD/MOPP chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Clin | 1989 |
Current management and controversies. The chemotherapist's view.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Hodgkin Disease; Hu | 1989 |
Current management and controversies. The chemotherapist's view.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Hodgkin Disease; Hu | 1989 |
Results of therapy for Hodgkin's disease in childhood. The Argentine Group for Treatment of Acute Leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Doxorubicin; Female; Hodgkin Dise | 1989 |
Results of therapy for Hodgkin's disease in childhood. The Argentine Group for Treatment of Acute Leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Doxorubicin; Female; Hodgkin Dise | 1989 |
The German cooperative therapy studies. An approach to minimize treatment modalities and invasive staging procedures.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1989 |
The German cooperative therapy studies. An approach to minimize treatment modalities and invasive staging procedures.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1989 |
Hodgkin's disease in children and adolescents. Experiences from the Memorial Sloan-Kettering Cancer Center, New York.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Clinical Trials as Top | 1989 |
Hodgkin's disease in children and adolescents. Experiences from the Memorial Sloan-Kettering Cancer Center, New York.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Clinical Trials as Top | 1989 |
Relationship of histological subtypes to prognosis in early stage Hodgkin's disease: a review of 312 cases in a controlled clinical trial. The Groupe Pierre et Marie Curie.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; C | 1989 |
Relationship of histological subtypes to prognosis in early stage Hodgkin's disease: a review of 312 cases in a controlled clinical trial. The Groupe Pierre et Marie Curie.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; C | 1989 |
[Evaluation of 5-year results of the scheduled treatment of lymphogranulomatosis in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Clinical Trials | 1989 |
[Evaluation of 5-year results of the scheduled treatment of lymphogranulomatosis in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Clinical Trials | 1989 |
[Chemotherapy of stage III-IV Hodgkin's disease. A retrospective analysis of the 53 cases collected from 9 institutions in Japan].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic | 1989 |
[Chemotherapy of stage III-IV Hodgkin's disease. A retrospective analysis of the 53 cases collected from 9 institutions in Japan].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic | 1989 |
Risk factor adapted treatment of Hodgkin's lymphoma in childhood: strategies and results of three consecutive multicenter studies in the Federal Republic of Germany.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Clinical Trials | 1989 |
Risk factor adapted treatment of Hodgkin's lymphoma in childhood: strategies and results of three consecutive multicenter studies in the Federal Republic of Germany.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Clinical Trials | 1989 |
MOPP chemotherapy versus extended-field radiotherapy in the management of pathological stages I-IIA Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female | 1989 |
MOPP chemotherapy versus extended-field radiotherapy in the management of pathological stages I-IIA Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female | 1989 |
Treatment with MOPP or ChlVPP chemotherapy only for all stages of childhood Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chlorambucil; C | 1988 |
Treatment with MOPP or ChlVPP chemotherapy only for all stages of childhood Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chlorambucil; C | 1988 |
Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage I-II Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined | 1988 |
Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage I-II Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined | 1988 |
The adjuvant role of two cycles of MOPP and low-dose lung irradiation in stage IA through IIB Hodgkin's disease: preliminary results.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Follow-Up Studies; Hodgkin | 1988 |
The adjuvant role of two cycles of MOPP and low-dose lung irradiation in stage IA through IIB Hodgkin's disease: preliminary results.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Follow-Up Studies; Hodgkin | 1988 |
An approach to reduce treatment and invasive staging in childhood Hodgkin's disease: the sequence of the German DAL multicenter studies.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Clinical Trials | 1988 |
An approach to reduce treatment and invasive staging in childhood Hodgkin's disease: the sequence of the German DAL multicenter studies.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Clinical Trials | 1988 |
Intercurrent death after Hodgkin disease therapy in radiotherapy and adjuvant MOPP trials.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Diseases; Clinica | 1988 |
Intercurrent death after Hodgkin disease therapy in radiotherapy and adjuvant MOPP trials.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Diseases; Clinica | 1988 |
Comparison of total nodal irradiation versus combined sequence of mantle irradiation with mechlorethamine, vincristine, procarbazine, and prednisone in clinical stages I and II Hodgkin's disease: experience of the European Organization for Research and Tr
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di | 1988 |
Comparison of total nodal irradiation versus combined sequence of mantle irradiation with mechlorethamine, vincristine, procarbazine, and prednisone in clinical stages I and II Hodgkin's disease: experience of the European Organization for Research and Tr
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di | 1988 |
Twenty years of MOPP therapy for Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as T | 1986 |
Twenty years of MOPP therapy for Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as T | 1986 |
Randomised study of MOPP (mustine, Oncovin, procarbazine, prednisone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease. British National Lymphoma Investigation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Clinical Trials as | 1986 |
Randomised study of MOPP (mustine, Oncovin, procarbazine, prednisone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease. British National Lymphoma Investigation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Clinical Trials as | 1986 |
The efficiency of different combined treatment programs (combination chemotherapy-radiotherapy) used for stage I-II Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 1987 |
The efficiency of different combined treatment programs (combination chemotherapy-radiotherapy) used for stage I-II Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 1987 |
Treatment of stages I and II Hodgkin's disease with three different therapeutic modalities.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di | 1986 |
Treatment of stages I and II Hodgkin's disease with three different therapeutic modalities.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di | 1986 |
Extended versus involved fields irradiation combined with MOPP chemotherapy in early clinical stages of Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1985 |
Extended versus involved fields irradiation combined with MOPP chemotherapy in early clinical stages of Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1985 |
The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Combine | 1985 |
The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Combine | 1985 |
[Treatment of patients with lymphogranulomatosis, stages I and II (preliminary results of a randomized study--radiation and complex therapy)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; | 1985 |
[Treatment of patients with lymphogranulomatosis, stages I and II (preliminary results of a randomized study--radiation and complex therapy)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; | 1985 |
Treatment selection for stage IIIA Hodgkin's disease patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality T | 1985 |
Treatment selection for stage IIIA Hodgkin's disease patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality T | 1985 |
Hodgkin's disease in childhood and adolescence: results of chemotherapy-radiotherapy in clinical stages IA-IIB.
Topics: Actuarial Analysis; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Tria | 1985 |
Hodgkin's disease in childhood and adolescence: results of chemotherapy-radiotherapy in clinical stages IA-IIB.
Topics: Actuarial Analysis; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Tria | 1985 |
Maintenance chemotherapy for advanced Hodgkin's disease in remission.
Topics: Blood Cell Count; Blood Platelets; Hodgkin Disease; Humans; Lymphocytes; Mechlorethamine; Nitrosoure | 1973 |
Maintenance chemotherapy for advanced Hodgkin's disease in remission.
Topics: Blood Cell Count; Blood Platelets; Hodgkin Disease; Humans; Lymphocytes; Mechlorethamine; Nitrosoure | 1973 |
[Place of Vinca rosea alkaloids (Catharanthus roseus) in the treatment of Hodgkin's disease].
Topics: Clinical Trials as Topic; Evaluation Studies as Topic; Hodgkin Disease; Humans; Prednisone; Vinblast | 1973 |
[Place of Vinca rosea alkaloids (Catharanthus roseus) in the treatment of Hodgkin's disease].
Topics: Clinical Trials as Topic; Evaluation Studies as Topic; Hodgkin Disease; Humans; Prednisone; Vinblast | 1973 |
Combination chemotherapy and survival in advanced Hodgkin's disease.
Topics: Antineoplastic Agents; Benzoates; Clinical Trials as Topic; Evaluation Studies as Topic; Follow-Up S | 1973 |
Combination chemotherapy and survival in advanced Hodgkin's disease.
Topics: Antineoplastic Agents; Benzoates; Clinical Trials as Topic; Evaluation Studies as Topic; Follow-Up S | 1973 |
Combination radiotherapy and chemotherapy in the treatment of early Hodgkin's disease.
Topics: Adolescent; Adult; Child; Clinical Trials as Topic; Cobalt Radioisotopes; Drug Therapy, Combination; | 1973 |
Combination radiotherapy and chemotherapy in the treatment of early Hodgkin's disease.
Topics: Adolescent; Adult; Child; Clinical Trials as Topic; Cobalt Radioisotopes; Drug Therapy, Combination; | 1973 |
International Symposium on Hodgkin's Disease. Session 5. Treatment. Current status of clinical trials: Stanford experience, 1962-72.
Topics: Biopsy; Clinical Trials as Topic; Drug Therapy, Combination; Follow-Up Studies; Gold Colloid, Radioa | 1973 |
International Symposium on Hodgkin's Disease. Session 5. Treatment. Current status of clinical trials: Stanford experience, 1962-72.
Topics: Biopsy; Clinical Trials as Topic; Drug Therapy, Combination; Follow-Up Studies; Gold Colloid, Radioa | 1973 |
Combination chemotherapy and radiotherapy for Hodgkin's disease.
Topics: Adult; Antineoplastic Agents; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; | 1972 |
Combination chemotherapy and radiotherapy for Hodgkin's disease.
Topics: Adult; Antineoplastic Agents; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; | 1972 |
[On the therapy of lymphogranuloma. CCNU (1(2-chlorethyl)-3-cyclohexyl-1-nitrosourea) and BCNU (1,3-bis(2-chlorethyl)-1-nitrosourea) as well as BCNU combinations in Hodgkin's lymphogranuloma, stage 3 and 4].
Topics: Carmustine; Chlorambucil; Cyclohexanes; Drug Resistance; Drug Synergism; Hodgkin Disease; Humans; Ni | 1972 |
[On the therapy of lymphogranuloma. CCNU (1(2-chlorethyl)-3-cyclohexyl-1-nitrosourea) and BCNU (1,3-bis(2-chlorethyl)-1-nitrosourea) as well as BCNU combinations in Hodgkin's lymphogranuloma, stage 3 and 4].
Topics: Carmustine; Chlorambucil; Cyclohexanes; Drug Resistance; Drug Synergism; Hodgkin Disease; Humans; Ni | 1972 |
Chemotherapy of Hodgkin's disease in studies by acute leukemia group B.
Topics: Antineoplastic Agents; Carmustine; Chlorambucil; Evaluation Studies as Topic; Hodgkin Disease; Human | 1973 |
Chemotherapy of Hodgkin's disease in studies by acute leukemia group B.
Topics: Antineoplastic Agents; Carmustine; Chlorambucil; Evaluation Studies as Topic; Hodgkin Disease; Human | 1973 |
Chemotherapy of Hodgkin's disease. Maintenance therapy vs no maintenance after remission induction with combination chemotherapy.
Topics: Adult; Age Factors; Antineoplastic Agents; Benzoates; Blood Cell Count; Bone Marrow; Evaluation Stud | 1973 |
Chemotherapy of Hodgkin's disease. Maintenance therapy vs no maintenance after remission induction with combination chemotherapy.
Topics: Adult; Age Factors; Antineoplastic Agents; Benzoates; Blood Cell Count; Bone Marrow; Evaluation Stud | 1973 |
Multiple chemotherapeutic agents for Hodgkin disease. Comparison of three routines: a cooperative study by acute leukemia group B.
Topics: Adult; Age Factors; Benzoates; Drug Synergism; Female; Hodgkin Disease; Humans; Leukocytes; Male; Me | 1973 |
Multiple chemotherapeutic agents for Hodgkin disease. Comparison of three routines: a cooperative study by acute leukemia group B.
Topics: Adult; Age Factors; Benzoates; Drug Synergism; Female; Hodgkin Disease; Humans; Leukocytes; Male; Me | 1973 |
Combination chemotherapy in advanced Hodgkin's disease. Induction and maintenance of remission.
Topics: Adult; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Age | 1973 |
Combination chemotherapy in advanced Hodgkin's disease. Induction and maintenance of remission.
Topics: Adult; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Age | 1973 |
Combined cyclophosphamide vincristine, and prednisone therapy of malignant lymphoma.
Topics: Adolescent; Adult; Age Factors; Aged; Bone Marrow Examination; Child; Child, Preschool; Cyclophospha | 1971 |
Combined cyclophosphamide vincristine, and prednisone therapy of malignant lymphoma.
Topics: Adolescent; Adult; Age Factors; Aged; Bone Marrow Examination; Child; Child, Preschool; Cyclophospha | 1971 |
Sequential radiotherapy and chemotherapy in the treatment of Hodgkin's disease. A progress report.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Benzoates; Child; Drug Combinations; Female; Follow- | 1972 |
Sequential radiotherapy and chemotherapy in the treatment of Hodgkin's disease. A progress report.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Benzoates; Child; Drug Combinations; Female; Follow- | 1972 |
[Chemotherapy of Hodgkin's disease with drug combinations].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Child, Preschool; Female; Hodgkin Disease; Hu | 1971 |
[Chemotherapy of Hodgkin's disease with drug combinations].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Child, Preschool; Female; Hodgkin Disease; Hu | 1971 |
1226 other studies available for prednisone and Hodgkin Disease
| Article | Year |
|---|---|
A 51-Year-Old Man With a Large Posterior Mediastinal Mass.
Topics: Cough; Cytoreduction Surgical Procedures; Decompression, Surgical; Disease Progression; Dyspnea; For | 2021 |
A 51-Year-Old Man With a Large Posterior Mediastinal Mass.
Topics: Cough; Cytoreduction Surgical Procedures; Decompression, Surgical; Disease Progression; Dyspnea; For | 2021 |
Bleomycin-induced Pneumonitis in a Child Treated With Nintedanib: Report of the First Case in a Childhood.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubic | 2022 |
Bleomycin-induced Pneumonitis in a Child Treated With Nintedanib: Report of the First Case in a Childhood.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubic | 2022 |
Real-world evidence of ABVD-like regimens compared with ABVD in classical Hodgkin lymphoma: a 10-year study from China.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; China; Dacarbazine; Doxorubicin; Et | 2023 |
Real-world evidence of ABVD-like regimens compared with ABVD in classical Hodgkin lymphoma: a 10-year study from China.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; China; Dacarbazine; Doxorubicin; Et | 2023 |
Immune-related pneumonitis requiring low-dose prednisone maintenance in one patient with durable complete response.
Topics: Glucocorticoids; Hodgkin Disease; Humans; Pneumonia; Prednisone; Remission Induction | 2023 |
Immune-related pneumonitis requiring low-dose prednisone maintenance in one patient with durable complete response.
Topics: Glucocorticoids; Hodgkin Disease; Humans; Pneumonia; Prednisone; Remission Induction | 2023 |
Positron Emission Tomography-Adapted Therapy in Bulky Stage I/II Classic Hodgkin Lymphoma: CALGB 50801 (Alliance).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; | 2023 |
Positron Emission Tomography-Adapted Therapy in Bulky Stage I/II Classic Hodgkin Lymphoma: CALGB 50801 (Alliance).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; | 2023 |
[Strategy of the French Society of Childhood Cancer (SFCE) for pediatric nodular lymphocyte predominant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Hodgkin Disease; Humans; Ly | 2023 |
[Strategy of the French Society of Childhood Cancer (SFCE) for pediatric nodular lymphocyte predominant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Hodgkin Disease; Humans; Ly | 2023 |
Reproduction patterns among classical Hodgkin lymphoma survivors treated with BEACOPP and ABVD in Sweden, Denmark and Norway-A population-based matched cohort study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cohort Studies; Cyclophosphamide; | 2023 |
Reproduction patterns among classical Hodgkin lymphoma survivors treated with BEACOPP and ABVD in Sweden, Denmark and Norway-A population-based matched cohort study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cohort Studies; Cyclophosphamide; | 2023 |
Survival rates of adult patients with Hodgkin lymphoma who underwent ABVD versus escalated BEACOPP in a resource-limited country: An observational study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dox | 2023 |
Survival rates of adult patients with Hodgkin lymphoma who underwent ABVD versus escalated BEACOPP in a resource-limited country: An observational study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dox | 2023 |
Interim PET-guided treatment for early-stage NLPHL: a subgroup analysis of the randomized GHSG HD16 and HD17 studies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2023 |
Interim PET-guided treatment for early-stage NLPHL: a subgroup analysis of the randomized GHSG HD16 and HD17 studies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2023 |
'ACOPP' chemotherapy for older and less fit patients with Hodgkin lymphoma-A multicentre, retrospective study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etop | 2023 |
'ACOPP' chemotherapy for older and less fit patients with Hodgkin lymphoma-A multicentre, retrospective study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etop | 2023 |
[Frontline therapy for classical Hodgkin lymphoma patients].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease | 2023 |
[Frontline therapy for classical Hodgkin lymphoma patients].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease | 2023 |
Improved survival of children and adolescents with classical Hodgkin lymphoma treated on a harmonised protocol in South Africa.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubic | 2024 |
Improved survival of children and adolescents with classical Hodgkin lymphoma treated on a harmonised protocol in South Africa.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubic | 2024 |
Retrospective analysis of clinical features and treatment outcomes of children with Hodgkin's Lymphoma treated with different chemotherapy protocols at a tertiary care center in Pakistan.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Chlo | 2019 |
Retrospective analysis of clinical features and treatment outcomes of children with Hodgkin's Lymphoma treated with different chemotherapy protocols at a tertiary care center in Pakistan.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Chlo | 2019 |
Heart on the wrong side.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2019 |
Heart on the wrong side.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2019 |
What to Do With Deauville 3 Interim Positron Emission Tomography/Computed Tomography Response in a Young Woman With Classic Unfavorable Hodgkin's Lymphoma: To Irradiate or Not to Irradiate?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dox | 2020 |
What to Do With Deauville 3 Interim Positron Emission Tomography/Computed Tomography Response in a Young Woman With Classic Unfavorable Hodgkin's Lymphoma: To Irradiate or Not to Irradiate?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dox | 2020 |
Successful treatment of dumbbell-shaped Hodgkin lymphoma with massive sacral bone destruction.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Female; Hodgkin Disease; Hu | 2020 |
Successful treatment of dumbbell-shaped Hodgkin lymphoma with massive sacral bone destruction.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Female; Hodgkin Disease; Hu | 2020 |
Adolescents and young adults with classical Hodgkin lymphoma in northern Tunisia: insights from an adult single-institutional study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protoc | 2020 |
Adolescents and young adults with classical Hodgkin lymphoma in northern Tunisia: insights from an adult single-institutional study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protoc | 2020 |
Outcome of a patient with refractory Hodgkin lymphoma on pembrolizumab, infected with SARS-CoV-2.
Topics: Adult; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherap | 2020 |
Outcome of a patient with refractory Hodgkin lymphoma on pembrolizumab, infected with SARS-CoV-2.
Topics: Adult; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherap | 2020 |
Long-term outcomes of patients with unfavorable stage I-II classic Hodgkin lymphoma treated with Stanford V chemotherapy and limited field irradiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Hodg | 2020 |
Long-term outcomes of patients with unfavorable stage I-II classic Hodgkin lymphoma treated with Stanford V chemotherapy and limited field irradiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Hodg | 2020 |
A case report of Hodgkin lymphoma in a patient treated with ustekinumab for psoriasis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dermatologic Agents; Do | 2020 |
A case report of Hodgkin lymphoma in a patient treated with ustekinumab for psoriasis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dermatologic Agents; Do | 2020 |
Secondary cutaneous involvement by direct extension in high-grade B-cell lymphomas.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Transplantation; Cyclophos | 2021 |
Secondary cutaneous involvement by direct extension in high-grade B-cell lymphomas.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Transplantation; Cyclophos | 2021 |
Early interval and serial positron emission tomography-computed tomography (PET-CT) after an indeterminate response defined by a PET scored 4 on the Deauville scale in lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 2020 |
Early interval and serial positron emission tomography-computed tomography (PET-CT) after an indeterminate response defined by a PET scored 4 on the Deauville scale in lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 2020 |
Relapse After Early-Stage, Favorable Hodgkin Lymphoma: Disease Characteristics and Outcomes With Conventional or High-Dose Chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophos | 2021 |
Relapse After Early-Stage, Favorable Hodgkin Lymphoma: Disease Characteristics and Outcomes With Conventional or High-Dose Chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophos | 2021 |
Late-onset double-seronegative myasthenia gravis syndrome and myasthenic crisis due to nivolumab use for Hodgkin's lymphoma.
Topics: Dysarthria; Female; Hodgkin Disease; Humans; Myasthenia Gravis; Nivolumab; Prednisone | 2021 |
Late-onset double-seronegative myasthenia gravis syndrome and myasthenic crisis due to nivolumab use for Hodgkin's lymphoma.
Topics: Dysarthria; Female; Hodgkin Disease; Humans; Myasthenia Gravis; Nivolumab; Prednisone | 2021 |
Evaluation of ovarian reserve before and after chemotherapy.
Topics: Adolescent; Adult; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocols; Bleomycin | 2021 |
Evaluation of ovarian reserve before and after chemotherapy.
Topics: Adolescent; Adult; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocols; Bleomycin | 2021 |
Meiotic susceptibility for induction of sperm with chromosomal aberrations in patients receiving combination chemotherapy for Hodgkin lymphoma.
Topics: Adult; Adult Germline Stem Cells; Antineoplastic Combined Chemotherapy Protocols; Cancer Survivors; | 2020 |
Meiotic susceptibility for induction of sperm with chromosomal aberrations in patients receiving combination chemotherapy for Hodgkin lymphoma.
Topics: Adult; Adult Germline Stem Cells; Antineoplastic Combined Chemotherapy Protocols; Cancer Survivors; | 2020 |
Advanced Hodgkin lymphoma in the East of England: a 10-year comparative analysis of outcomes for real-world patients treated with ABVD or escalated-BEACOPP, aged less than 60 years, compared with 5-year extended follow-up from the RATHL trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top | 2021 |
Advanced Hodgkin lymphoma in the East of England: a 10-year comparative analysis of outcomes for real-world patients treated with ABVD or escalated-BEACOPP, aged less than 60 years, compared with 5-year extended follow-up from the RATHL trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top | 2021 |
PET-2-guided escalated BEACOPP for advanced nodular lymphocyte-predominant Hodgkin lymphoma: a subgroup analysis of the randomized German Hodgkin Study Group HD18 study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; | 2021 |
PET-2-guided escalated BEACOPP for advanced nodular lymphocyte-predominant Hodgkin lymphoma: a subgroup analysis of the randomized German Hodgkin Study Group HD18 study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; | 2021 |
Composite lymphoma of T-cell rich, histiocyte-rich diffuse large B-cell lymphoma and nodular lymphocyte predominant Hodgkin lymphoma: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Composite Lymphoma; Doxorubicin; Histiocytes; | 2021 |
Composite lymphoma of T-cell rich, histiocyte-rich diffuse large B-cell lymphoma and nodular lymphocyte predominant Hodgkin lymphoma: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Composite Lymphoma; Doxorubicin; Histiocytes; | 2021 |
Pineal gland hypermetabolic involvement without central nervous system symptoms in a pediatric patient with primary nodular sclerosis subtype classical Hodgkin Lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Doxorubicin; Etoposide; Hod | 2022 |
Pineal gland hypermetabolic involvement without central nervous system symptoms in a pediatric patient with primary nodular sclerosis subtype classical Hodgkin Lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Doxorubicin; Etoposide; Hod | 2022 |
Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemokine CCL17; Cyclo | 2021 |
Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemokine CCL17; Cyclo | 2021 |
Small lymphocytic lymphoma secondary to young patient with a history of classical Hodgkin Lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dox | 2022 |
Small lymphocytic lymphoma secondary to young patient with a history of classical Hodgkin Lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dox | 2022 |
Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colon; Colo | 2017 |
Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colon; Colo | 2017 |
Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine | 2018 |
Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine | 2018 |
PET-positive bone lesion due to Langerhans cell histiocytosis after BEACOPP therapy for Hodgkin lymphoma: how anamnesis, histopathological accuracy, and molecular analysis could resolve a clinical dilemma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Bone Marrow; Causality | 2018 |
PET-positive bone lesion due to Langerhans cell histiocytosis after BEACOPP therapy for Hodgkin lymphoma: how anamnesis, histopathological accuracy, and molecular analysis could resolve a clinical dilemma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Bone Marrow; Causality | 2018 |
High incidence of aseptic hip necrosis in Hodgkin lymphoma patients treated with escalated BEACOPP receiving methylprednisolone.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cross-Sectional Studies; Cyclophos | 2018 |
High incidence of aseptic hip necrosis in Hodgkin lymphoma patients treated with escalated BEACOPP receiving methylprednisolone.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cross-Sectional Studies; Cyclophos | 2018 |
Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy.
Topics: Adolescent; Adult; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bloo | 2018 |
Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy.
Topics: Adolescent; Adult; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bloo | 2018 |
[Tunisian National Protocol for Adult Hodgkin's Lymphoma Treatment: Results of a therapeutic regimen adapted to the 2-cycle CT response, about 444 patients].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Protoco | 2018 |
[Tunisian National Protocol for Adult Hodgkin's Lymphoma Treatment: Results of a therapeutic regimen adapted to the 2-cycle CT response, about 444 patients].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Protoco | 2018 |
Patterns of Involved-Field Radiation Therapy Protocol Deviations in Pediatric Versus Adolescent and Young Adults With Hodgkin Lymphoma: A Report From the Children's Oncology Group AHOD0031.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisp | 2018 |
Patterns of Involved-Field Radiation Therapy Protocol Deviations in Pediatric Versus Adolescent and Young Adults With Hodgkin Lymphoma: A Report From the Children's Oncology Group AHOD0031.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisp | 2018 |
Osteonecrosis in Hodgkin lymphoma treated by BEACOPP.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; | 2018 |
Osteonecrosis in Hodgkin lymphoma treated by BEACOPP.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; | 2018 |
Bleomycin-Induced Flagellate Dermatitis
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Dru | 2019 |
Bleomycin-Induced Flagellate Dermatitis
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Dru | 2019 |
Promising new second-line therapy for Hodgkin lymphoma.
Topics: Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Ve | 2019 |
Promising new second-line therapy for Hodgkin lymphoma.
Topics: Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Ve | 2019 |
Early chemotherapy de-escalation strategy in patients with advanced-stage Hodgkin lymphoma with negative positron emission tomography scan after 2 escalated BEACOPP cycles.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose-Response Re | 2019 |
Early chemotherapy de-escalation strategy in patients with advanced-stage Hodgkin lymphoma with negative positron emission tomography scan after 2 escalated BEACOPP cycles.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose-Response Re | 2019 |
Sarcoidosis following escalated BEACOPP chemotherapy for stage IV Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Diagnosis, Diffe | 2019 |
Sarcoidosis following escalated BEACOPP chemotherapy for stage IV Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Diagnosis, Diffe | 2019 |
Protontherapy versus best photon for mediastinal Hodgkin lymphoma: Dosimetry comparison and treatment using ILROG guidelines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; | 2019 |
Protontherapy versus best photon for mediastinal Hodgkin lymphoma: Dosimetry comparison and treatment using ILROG guidelines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; | 2019 |
Beneficial effect of consolidative radiotherapy for patients with lymphoma and skeletal involvement.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Case-Control Studies; Combine | 2019 |
Beneficial effect of consolidative radiotherapy for patients with lymphoma and skeletal involvement.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Case-Control Studies; Combine | 2019 |
[Lymphomas associated with HIV infection in patients at the Hospital San Borja Arriarán /Fundación Arriarán 2001-2008, Santiago, Chile].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chile; Cyclophosphamide; Doxorubicin; F | 2013 |
[Lymphomas associated with HIV infection in patients at the Hospital San Borja Arriarán /Fundación Arriarán 2001-2008, Santiago, Chile].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chile; Cyclophosphamide; Doxorubicin; F | 2013 |
Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Child; Child, Prescho | 2013 |
Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Child; Child, Prescho | 2013 |
[The optimal total focal radiotherapy dosage after first-line chemotherapy in patients with Hodgkin lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazin | 2012 |
[The optimal total focal radiotherapy dosage after first-line chemotherapy in patients with Hodgkin lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazin | 2012 |
Looking for familial nodular lymphocyte-predominant Hodgkin lymphoma.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclo | 2013 |
Looking for familial nodular lymphocyte-predominant Hodgkin lymphoma.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclo | 2013 |
[EBV-positive diffuse large B-cell lymphoma in young individual: report of a case].
Topics: Adult; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; CD3 Complex; Cyclophosphamide | 2013 |
[EBV-positive diffuse large B-cell lymphoma in young individual: report of a case].
Topics: Adult; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; CD3 Complex; Cyclophosphamide | 2013 |
[Treatment of advanced Hodgkin lymphoma].
Topics: Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Cause of | 2013 |
[Treatment of advanced Hodgkin lymphoma].
Topics: Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Cause of | 2013 |
IgA monoclonal gammopathy accompanying extranodal B cell lymphomas.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclop | 2014 |
IgA monoclonal gammopathy accompanying extranodal B cell lymphomas.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclop | 2014 |
[Effectiveness and toxicity of MOPP, ABVD, BEACOPP chemotherapy in first-diagnosed Hodgkin lymphoma with a poor prognosis].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 2013 |
[Effectiveness and toxicity of MOPP, ABVD, BEACOPP chemotherapy in first-diagnosed Hodgkin lymphoma with a poor prognosis].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 2013 |
Fifteenth biannual report of the Cochrane Haematological Malignancies Group--focus on non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2013 |
Fifteenth biannual report of the Cochrane Haematological Malignancies Group--focus on non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2013 |
Brentuximab vedotin: first-line agent for advanced Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Cyclophosphamide; Da | 2013 |
Brentuximab vedotin: first-line agent for advanced Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Cyclophosphamide; Da | 2013 |
Membranous glomerulonephritis in a patient with Hodgkin's lymphoma in remission.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D | 2013 |
Membranous glomerulonephritis in a patient with Hodgkin's lymphoma in remission.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D | 2013 |
Pulmonary damage in Hodgkin's lymphoma patients treated with sequential chemo-radiotherapy: Predictors of radiation-induced lung injury.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bleomycin; Chem | 2014 |
Pulmonary damage in Hodgkin's lymphoma patients treated with sequential chemo-radiotherapy: Predictors of radiation-induced lung injury.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bleomycin; Chem | 2014 |
Early treatment intensification with escalated BEACOPP in patients with Hodgkins lymphoma not responding to ABVD therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Eto | 2014 |
Early treatment intensification with escalated BEACOPP in patients with Hodgkins lymphoma not responding to ABVD therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Eto | 2014 |
Treatment of Hodgkin lymphoma: a 50-year perspective.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Clinical Trials as Top | 2014 |
Treatment of Hodgkin lymphoma: a 50-year perspective.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Clinical Trials as Top | 2014 |
Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 2014 |
Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 2014 |
[Stevens-Johnson syndrome and Hodgkin's disease: A fortuitous association or paraneoplastic syndrome?].
Topics: Adrenal Cortex Hormones; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Causality | 2014 |
[Stevens-Johnson syndrome and Hodgkin's disease: A fortuitous association or paraneoplastic syndrome?].
Topics: Adrenal Cortex Hormones; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Causality | 2014 |
Thyroid malignancies in survivors of Hodgkin lymphoma.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protoc | 2014 |
Thyroid malignancies in survivors of Hodgkin lymphoma.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protoc | 2014 |
[ON HODGKIN'S DISEASE. PERSONAL EXPERIENCE].
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Aziridines; Biopsy; Chlorambucil; Classification; Hodg | 1964 |
[ON HODGKIN'S DISEASE. PERSONAL EXPERIENCE].
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Aziridines; Biopsy; Chlorambucil; Classification; Hodg | 1964 |
Pneumoperitoneum and pneumatosis cystoides intestinalis (PCI) following chemotherapy in an adolescent with Hodgkin's lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Hodgkin D | 2014 |
Pneumoperitoneum and pneumatosis cystoides intestinalis (PCI) following chemotherapy in an adolescent with Hodgkin's lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Hodgkin D | 2014 |
Polymyalgia rheumatica or lymphoma recurrence? Positron emission tomography/computed tomography is a specific imaging technique that helps differential diagnosis.
Topics: Aged; Diagnosis, Differential; Hodgkin Disease; Humans; Male; Multimodal Imaging; Polymyalgia Rheuma | 2014 |
Polymyalgia rheumatica or lymphoma recurrence? Positron emission tomography/computed tomography is a specific imaging technique that helps differential diagnosis.
Topics: Aged; Diagnosis, Differential; Hodgkin Disease; Humans; Male; Multimodal Imaging; Polymyalgia Rheuma | 2014 |
Systemic inflammatory response syndrome after administration of unmodified T lymphocytes.
Topics: Anti-Inflammatory Agents; Cytokines; Epstein-Barr Virus Nuclear Antigens; Etanercept; Herpesvirus 4, | 2014 |
Systemic inflammatory response syndrome after administration of unmodified T lymphocytes.
Topics: Anti-Inflammatory Agents; Cytokines; Epstein-Barr Virus Nuclear Antigens; Etanercept; Herpesvirus 4, | 2014 |
Vanishing bile duct-like syndrome in a patient with Hodgkin lymphoma - pathological development and restitution.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 2014 |
Vanishing bile duct-like syndrome in a patient with Hodgkin lymphoma - pathological development and restitution.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 2014 |
Comparison of dose-dense ABVD and standard ABVD in the treatment of early unfavorable and advanced Hodgkin's lymphoma: a retrospective analysis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarba | 2014 |
Comparison of dose-dense ABVD and standard ABVD in the treatment of early unfavorable and advanced Hodgkin's lymphoma: a retrospective analysis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarba | 2014 |
Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Child; Chlorambuc | 2014 |
Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Child; Chlorambuc | 2014 |
Etravirine: a good option for concomitant use with chemotherapy for Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Cyclophosphamide; Doxorubicin; Et | 2015 |
Etravirine: a good option for concomitant use with chemotherapy for Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Cyclophosphamide; Doxorubicin; Et | 2015 |
Hodgkin's lymphoma rectosigmoid in a patient with ulcerative colitis on long-term azathioprine therapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Colitis, Ulcerative; Hodgkin Dis | 2014 |
Hodgkin's lymphoma rectosigmoid in a patient with ulcerative colitis on long-term azathioprine therapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Colitis, Ulcerative; Hodgkin Dis | 2014 |
Which Hodgkin's patients in the Unites States should be treated with BEACOPP?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Cyclophosphamide; Da | 2014 |
Which Hodgkin's patients in the Unites States should be treated with BEACOPP?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Cyclophosphamide; Da | 2014 |
[Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: clinicopathologic characterization of 16 cases showing different patterns].
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Comb | 2014 |
[Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: clinicopathologic characterization of 16 cases showing different patterns].
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Comb | 2014 |
Impact of lymphoma treatments on spermatogenesis and sperm deoxyribonucleic acid: a multicenter prospective study from the CECOS network.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Combined Mod | 2014 |
Impact of lymphoma treatments on spermatogenesis and sperm deoxyribonucleic acid: a multicenter prospective study from the CECOS network.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Combined Mod | 2014 |
Hodgkin lymphoma--a survey of children and adolescents treated in Sweden 1985-2009.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Daca | 2015 |
Hodgkin lymphoma--a survey of children and adolescents treated in Sweden 1985-2009.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Daca | 2015 |
Ten years' experience with four cycles of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone, procarbazine (BEACOPP)-escalated followed by four cycles of baseline-dose BEACOPP in patients with advanced stage Hodgkin lymphoma: a s
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose | 2015 |
Ten years' experience with four cycles of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone, procarbazine (BEACOPP)-escalated followed by four cycles of baseline-dose BEACOPP in patients with advanced stage Hodgkin lymphoma: a s
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose | 2015 |
PET2 -driven de-escalation therapy in 64 high-risk Hodgkin Lymphoma patients treated with escalated BEACOPP.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; | 2015 |
PET2 -driven de-escalation therapy in 64 high-risk Hodgkin Lymphoma patients treated with escalated BEACOPP.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; | 2015 |
Successful rapid desensitization to the antibody-drug conjugate brentuximab vedotin in a patient with refractory Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Cyclophospham | 2016 |
Successful rapid desensitization to the antibody-drug conjugate brentuximab vedotin in a patient with refractory Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Cyclophospham | 2016 |
[Necrotizing gastritis in a patient in severe neutropenia].
Topics: Abdominal Pain; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; | 2014 |
[Necrotizing gastritis in a patient in severe neutropenia].
Topics: Abdominal Pain; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; | 2014 |
Final analysis of a randomized phase II study with prednisone, vinblastine, doxorubicin, and gemcitabine in patients with early unfavorable Hodgkin lymphoma-PVAG-14 pilot.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topi | 2014 |
Final analysis of a randomized phase II study with prednisone, vinblastine, doxorubicin, and gemcitabine in patients with early unfavorable Hodgkin lymphoma-PVAG-14 pilot.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topi | 2014 |
Fifty years from Paris: the remarkable story of the lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Congresses as Topic; History, 19th Century; History, | 2015 |
Fifty years from Paris: the remarkable story of the lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Congresses as Topic; History, 19th Century; History, | 2015 |
Does interim PET increase the value of ABVD in advanced-stage Hodgkin lymphoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2015 |
Does interim PET increase the value of ABVD in advanced-stage Hodgkin lymphoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2015 |
[Hodgkin's lymphoma and radiotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, A | 2015 |
[Hodgkin's lymphoma and radiotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, A | 2015 |
Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2015 |
Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2015 |
[The effectiveness and toxicity of therapy in primary Hodgkin's lymphoma with extranodal lesions].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleo | 2015 |
[The effectiveness and toxicity of therapy in primary Hodgkin's lymphoma with extranodal lesions].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleo | 2015 |
Treatment of EBV-associated nodular sclerosing Hodgkin lymphoma in a patient with ataxia telangiectasia with brentuximab vedotin and reduced COPP plus rituximab.
Topics: Antineoplastic Combined Chemotherapy Protocols; Ataxia Telangiectasia; Brentuximab Vedotin; Cyclopho | 2015 |
Treatment of EBV-associated nodular sclerosing Hodgkin lymphoma in a patient with ataxia telangiectasia with brentuximab vedotin and reduced COPP plus rituximab.
Topics: Antineoplastic Combined Chemotherapy Protocols; Ataxia Telangiectasia; Brentuximab Vedotin; Cyclopho | 2015 |
[Rituximab combined with second line regimens for treatment of seven relapsed and refractory Hodgkin lymphoma patients].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Cycl | 2015 |
[Rituximab combined with second line regimens for treatment of seven relapsed and refractory Hodgkin lymphoma patients].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Cycl | 2015 |
Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bleomycin; Clinical T | 2015 |
Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bleomycin; Clinical T | 2015 |
Secondary Neoplasms in Children with Hodgkin's Lymphoma Receiving C-MOPP and Radiotherapy: Presentation of Four Cases.
Topics: Adenoma; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Du | 2016 |
Secondary Neoplasms in Children with Hodgkin's Lymphoma Receiving C-MOPP and Radiotherapy: Presentation of Four Cases.
Topics: Adenoma; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Du | 2016 |
Lung cancer and other second neoplasms after treatment of Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dox | 2016 |
Lung cancer and other second neoplasms after treatment of Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dox | 2016 |
High-Risk, Advanced-Stage Hodgkin Lymphoma: The Impact of Combined Escalated BEACOPP and ABVD Treatment in Patients Who Rapidly Achieve Metabolic Complete Remission on Interim FDG-PET/CT Scan.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2016 |
High-Risk, Advanced-Stage Hodgkin Lymphoma: The Impact of Combined Escalated BEACOPP and ABVD Treatment in Patients Who Rapidly Achieve Metabolic Complete Remission on Interim FDG-PET/CT Scan.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2016 |
Hodgkin lymphoma in a patient with mosaic trisomy 18: First clinical observation.
Topics: Abnormalities, Multiple; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Hu | 2016 |
Hodgkin lymphoma in a patient with mosaic trisomy 18: First clinical observation.
Topics: Abnormalities, Multiple; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Hu | 2016 |
Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2016 |
Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2016 |
Treating Adults with Hodgkin Lymphoma in the Developing World: a Hospital-Based Cohort Study from Armenia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Armenia; Bleomycin; Combine | 2016 |
Treating Adults with Hodgkin Lymphoma in the Developing World: a Hospital-Based Cohort Study from Armenia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Armenia; Bleomycin; Combine | 2016 |
PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Bleomycin; C | 2016 |
PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Bleomycin; C | 2016 |
A 17-Year-Old With Steroid-Resistant Nephrotic Syndrome.
Topics: Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Biopsy; Diagnosis, Differential; Drug | 2016 |
A 17-Year-Old With Steroid-Resistant Nephrotic Syndrome.
Topics: Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Biopsy; Diagnosis, Differential; Drug | 2016 |
Osteonecrosis detected by whole body magnetic resonance in patients with Hodgkin Lymphoma treated by BEACOPP.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose | 2017 |
Osteonecrosis detected by whole body magnetic resonance in patients with Hodgkin Lymphoma treated by BEACOPP.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose | 2017 |
Mediastinal Gray Zone Lymphoma with Features Intermediate between Classical Hodgkin Lymphoma and Primary Mediastinal B-Cell Lymphoma.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclo | 2016 |
Mediastinal Gray Zone Lymphoma with Features Intermediate between Classical Hodgkin Lymphoma and Primary Mediastinal B-Cell Lymphoma.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclo | 2016 |
Whole-body MRI reveals high incidence of osteonecrosis in children treated for Hodgkin lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Doxorubicin; Epiphyses; Etoposide | 2017 |
Whole-body MRI reveals high incidence of osteonecrosis in children treated for Hodgkin lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Doxorubicin; Epiphyses; Etoposide | 2017 |
Secondary Breast Cancer Risk by Radiation Volume in Women With Hodgkin Lymphoma.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 2017 |
Secondary Breast Cancer Risk by Radiation Volume in Women With Hodgkin Lymphoma.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 2017 |
[Features of clinical course of combination chemotherapy for liver involvement in Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 2008 |
[Features of clinical course of combination chemotherapy for liver involvement in Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 2008 |
Assessment of male fertility in patients with Hodgkin's lymphoma treated in the German Hodgkin Study Group (GHSG) clinical trials.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Azoospermia; Bleomycin; Combined | 2008 |
Assessment of male fertility in patients with Hodgkin's lymphoma treated in the German Hodgkin Study Group (GHSG) clinical trials.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Azoospermia; Bleomycin; Combined | 2008 |
Prognostic factors in children with Hodgkin disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Hodgkin Disease; Humans; Mechlorethamine; Pre | 2008 |
Prognostic factors in children with Hodgkin disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Hodgkin Disease; Humans; Mechlorethamine; Pre | 2008 |
Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 2009 |
Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 2009 |
Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Dacarbaz | 2009 |
Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Dacarbaz | 2009 |
[Hodgkin's lymphoma in adolescents: where to treat it--in an adult or pediatric institution?].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cancer Care Facilities | 2008 |
[Hodgkin's lymphoma in adolescents: where to treat it--in an adult or pediatric institution?].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cancer Care Facilities | 2008 |
[Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; | 2008 |
[Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; | 2008 |
Successful treatment of hodgkin lymphoma in nijmegen breakage syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child, Preschool; Cyclophosphamide; Doxor | 2009 |
Successful treatment of hodgkin lymphoma in nijmegen breakage syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child, Preschool; Cyclophosphamide; Doxor | 2009 |
Vanishing bile duct syndrome and Hodgkin disease: a case series and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cholestasis; Combined Modality The | 2008 |
Vanishing bile duct syndrome and Hodgkin disease: a case series and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cholestasis; Combined Modality The | 2008 |
[Concomitant pulmonary Langerhans cell histiocytosis and malignant lymphoma: report of two cases].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Combined Modality Therapy; | 2009 |
[Concomitant pulmonary Langerhans cell histiocytosis and malignant lymphoma: report of two cases].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Combined Modality Therapy; | 2009 |
[Use of risk-adapted programs of treatment of Hodgkin's disease in children and adolescents].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child; Child, Pr | 2008 |
[Use of risk-adapted programs of treatment of Hodgkin's disease in children and adolescents].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child; Child, Pr | 2008 |
[Composite lymphoma consisting of Hodgkin lymphoma and follicular lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Groin; Hodgkin Disease; Humans; Ly | 2009 |
[Composite lymphoma consisting of Hodgkin lymphoma and follicular lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Groin; Hodgkin Disease; Humans; Ly | 2009 |
Bone mineral density, growth, and thyroid function in long-term survivors of pediatric Hodgkin's lymphoma treated with chemotherapy only.
Topics: Adolescent; Adult; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Body Compo | 2009 |
Bone mineral density, growth, and thyroid function in long-term survivors of pediatric Hodgkin's lymphoma treated with chemotherapy only.
Topics: Adolescent; Adult; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Body Compo | 2009 |
CHOP-21 for unfavorable Hodgkin's lymphoma. An exploratory study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fe | 2010 |
CHOP-21 for unfavorable Hodgkin's lymphoma. An exploratory study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fe | 2010 |
Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Com | 2009 |
Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Com | 2009 |
Bortezomib in combination with IGEV chemotherapy regimen for a primary refractory Hodgkin's lymphoma of bone.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Boronic Acids; Bortezomib; Co | 2009 |
Bortezomib in combination with IGEV chemotherapy regimen for a primary refractory Hodgkin's lymphoma of bone.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Boronic Acids; Bortezomib; Co | 2009 |
Nail dystrophy due to dose-intensive chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclopho | 2009 |
Nail dystrophy due to dose-intensive chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclopho | 2009 |
Acute promyelocytic leukemia after Stanford V plus radiotherapy for advanced Hodgkin lymphoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin | 2009 |
Acute promyelocytic leukemia after Stanford V plus radiotherapy for advanced Hodgkin lymphoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin | 2009 |
Long-term survival of patients treated for Hodgkin's disease in 1971-1996 depending on the clinical stage of the disease, patient's fertility after therapy and cause of death analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Child; Combi | 2009 |
Long-term survival of patients treated for Hodgkin's disease in 1971-1996 depending on the clinical stage of the disease, patient's fertility after therapy and cause of death analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Child; Combi | 2009 |
Autologous stem cell transplant in a patient with Down syndrome and relapsed Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Child; Combined Modality Ther | 2009 |
Autologous stem cell transplant in a patient with Down syndrome and relapsed Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Child; Combined Modality Ther | 2009 |
Hodgkin's disease--the rare cause of nephrotic syndrome in children.
Topics: Adolescent; Female; Hodgkin Disease; Humans; Nephrotic Syndrome; Prednisone; Proteinuria; Remission | 2008 |
Hodgkin's disease--the rare cause of nephrotic syndrome in children.
Topics: Adolescent; Female; Hodgkin Disease; Humans; Nephrotic Syndrome; Prednisone; Proteinuria; Remission | 2008 |
Is there a role for BEACOPP (bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, prednisone) in relapsed Hodgkin lymphoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Resis | 2009 |
Is there a role for BEACOPP (bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, prednisone) in relapsed Hodgkin lymphoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Resis | 2009 |
Salvage chemotherapy with alternating MINE-ESHAP regimen in relapsed or refractory Hodgkin's lymphoma followed by autologous stem-cell transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Ther | 2010 |
Salvage chemotherapy with alternating MINE-ESHAP regimen in relapsed or refractory Hodgkin's lymphoma followed by autologous stem-cell transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Ther | 2010 |
First reported case of disease: peliosis hepatis as cardinal symptom of Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Etoposide; Femal | 2009 |
First reported case of disease: peliosis hepatis as cardinal symptom of Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Etoposide; Femal | 2009 |
The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin's lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemo | 2010 |
The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin's lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemo | 2010 |
Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cohort Studies; Combine | 2009 |
Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cohort Studies; Combine | 2009 |
[Multivariate analysis of risk of cardiac complications in Hodgkin's lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Female; Heart; | 2009 |
[Multivariate analysis of risk of cardiac complications in Hodgkin's lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Female; Heart; | 2009 |
The early- and intermediate-term toxicity to primitive hematopoietic progenitor cells of three chemotherapy regimens for advanced hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Daca | 2009 |
The early- and intermediate-term toxicity to primitive hematopoietic progenitor cells of three chemotherapy regimens for advanced hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Daca | 2009 |
Long-term follow-up of survival in Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Follow-Up Studi | 2009 |
Long-term follow-up of survival in Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Follow-Up Studi | 2009 |
[Management of lymphoma with respect to pathologic classification: updates and controversies].
Topics: Anaplastic Lymphoma Kinase; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineopl | 2009 |
[Management of lymphoma with respect to pathologic classification: updates and controversies].
Topics: Anaplastic Lymphoma Kinase; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineopl | 2009 |
[Ganglionnar Hodgkin lymphoma associated to a Castleman's disease].
Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Hormonal; Castleman Disease; Follow-Up Studies; Glu | 2009 |
[Ganglionnar Hodgkin lymphoma associated to a Castleman's disease].
Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Hormonal; Castleman Disease; Follow-Up Studies; Glu | 2009 |
Bilateral acute angle-closure associated with systemic lymphoma: a report of 2 cases.
Topics: Acute Disease; Aged; Antihypertensive Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy | 2011 |
Bilateral acute angle-closure associated with systemic lymphoma: a report of 2 cases.
Topics: Acute Disease; Aged; Antihypertensive Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy | 2011 |
Hodgkin's lymphoma variant of Richter's syndrome.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2010 |
Hodgkin's lymphoma variant of Richter's syndrome.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2010 |
Hodgkin lymphoma presenting with hair graying.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin | 2010 |
Hodgkin lymphoma presenting with hair graying.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin | 2010 |
An unusual case of finger buzzing and dysarthria.
Topics: Deglutition Disorders; Dysarthria; Dysphonia; Dyspnea; Fingers; Hodgkin Disease; Humans; Isaacs Synd | 2010 |
An unusual case of finger buzzing and dysarthria.
Topics: Deglutition Disorders; Dysarthria; Dysphonia; Dyspnea; Fingers; Hodgkin Disease; Humans; Isaacs Synd | 2010 |
Eleventh biannual report of the Cochrane Haematological Malignancies Group: Focus on Hodgkin lymphoma.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bendamustine Hydrochloride; Ble | 2010 |
Eleventh biannual report of the Cochrane Haematological Malignancies Group: Focus on Hodgkin lymphoma.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bendamustine Hydrochloride; Ble | 2010 |
Modified escalated BEACOPP as salvage chemotherapy in classic Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Eto | 2010 |
Modified escalated BEACOPP as salvage chemotherapy in classic Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Eto | 2010 |
Coregistration of prechemotherapy PET-CT for planning pediatric Hodgkin's disease radiotherapy significantly diminishes interobserver variability of clinical target volume definition.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Doxo | 2011 |
Coregistration of prechemotherapy PET-CT for planning pediatric Hodgkin's disease radiotherapy significantly diminishes interobserver variability of clinical target volume definition.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Doxo | 2011 |
Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid | 2010 |
Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid | 2010 |
Iatrogenic immunodeficiency-associated lymphoproliferative disease of the Hodgkin lymphoma-like variant in a patient treated with mycophenolate mofetil for autoimmune hepatitis.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Diagnosis, Diff | 2010 |
Iatrogenic immunodeficiency-associated lymphoproliferative disease of the Hodgkin lymphoma-like variant in a patient treated with mycophenolate mofetil for autoimmune hepatitis.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Diagnosis, Diff | 2010 |
Fused FDG-PET/contrast-enhanced CT detects occult subdiaphragmatic involvement of Hodgkin's lymphoma thereby identifying patients requiring six cycles of anthracycline-containing chemotherapy and consolidation radiation of spleen.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2011 |
Fused FDG-PET/contrast-enhanced CT detects occult subdiaphragmatic involvement of Hodgkin's lymphoma thereby identifying patients requiring six cycles of anthracycline-containing chemotherapy and consolidation radiation of spleen.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2011 |
Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL--experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesis.
Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine | 2011 |
Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL--experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesis.
Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine | 2011 |
Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 2010 |
Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 2010 |
Parathyroid adenoma and chondrosarcoma after treatment of pediatric Hodgkin disease.
Topics: Adenoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child, Preschool; Chondrosarcoma | 2010 |
Parathyroid adenoma and chondrosarcoma after treatment of pediatric Hodgkin disease.
Topics: Adenoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child, Preschool; Chondrosarcoma | 2010 |
Hodgkin lymphoma and nephrotic syndrome in childhood.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Comorbidity; Cyclophosphamide; Fe | 2010 |
Hodgkin lymphoma and nephrotic syndrome in childhood.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Comorbidity; Cyclophosphamide; Fe | 2010 |
Cardiopulmonary toxicity of different chemoradiotherapy combined regimens for Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Com | 2010 |
Cardiopulmonary toxicity of different chemoradiotherapy combined regimens for Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Com | 2010 |
ESHAP chemotherapy regimen associated to lenalidomide induces complete isotopic remission in Hodgkin's lymphoma relapsing after autologous stem cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Hematopoiet | 2011 |
ESHAP chemotherapy regimen associated to lenalidomide induces complete isotopic remission in Hodgkin's lymphoma relapsing after autologous stem cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Hematopoiet | 2011 |
[Diffuse large B-cell lymphoma following nodular lymphocyte predominant Hodgkin's lymphoma: report of a case].
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Antineoplastic | 2010 |
[Diffuse large B-cell lymphoma following nodular lymphocyte predominant Hodgkin's lymphoma: report of a case].
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Antineoplastic | 2010 |
Adolescent hodgkin lymphoma: are treatment results more favorable with pediatric than with adult regimens?
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine | 2011 |
Adolescent hodgkin lymphoma: are treatment results more favorable with pediatric than with adult regimens?
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine | 2011 |
[Fatal Bacillus cereus sepsis and rhabdomyolysis in a patient with Hodgkin's disease].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bacillus cereus; Bacteremia; Bleomycin; Combin | 2011 |
[Fatal Bacillus cereus sepsis and rhabdomyolysis in a patient with Hodgkin's disease].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bacillus cereus; Bacteremia; Bleomycin; Combin | 2011 |
Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms | 2012 |
Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms | 2012 |
Role of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography in early and late therapy assessment of patients with advanced Hodgkin lymphoma treated with bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine and prednisone.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxo | 2012 |
Role of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography in early and late therapy assessment of patients with advanced Hodgkin lymphoma treated with bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine and prednisone.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxo | 2012 |
Hodgkin's lymphoma--the great teacher.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2011 |
Hodgkin's lymphoma--the great teacher.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2011 |
Chemotherapy: Advanced Hodgkin lymphoma--balancing toxicity and cure.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Consolidation | 2011 |
Chemotherapy: Advanced Hodgkin lymphoma--balancing toxicity and cure.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Consolidation | 2011 |
Two escalated followed by six standard BEACOPP in advanced-stage high-risk classical Hodgkin lymphoma: high cure rates but increased risk of aseptic osteonecrosis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant | 2012 |
Two escalated followed by six standard BEACOPP in advanced-stage high-risk classical Hodgkin lymphoma: high cure rates but increased risk of aseptic osteonecrosis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant | 2012 |
A 10-year experience with treatment of high and standard risk Hodgkin disease: six cycles of tailored BEACOPP, with interim scintigraphy, are effective and female fertility is preserved.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxo | 2012 |
A 10-year experience with treatment of high and standard risk Hodgkin disease: six cycles of tailored BEACOPP, with interim scintigraphy, are effective and female fertility is preserved.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxo | 2012 |
Chemotherapy: Hodgkin lymphoma--absence of evidence not evidence of absence!
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Combined Modality Therapy; Cy | 2011 |
Chemotherapy: Hodgkin lymphoma--absence of evidence not evidence of absence!
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Combined Modality Therapy; Cy | 2011 |
More is not necessarily better when treating Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; | 2011 |
More is not necessarily better when treating Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; | 2011 |
Acute psychosis in an adolescent girl during treatment for advanced nodular lymphocyte-predominant Hodgkin's lymphom.
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Antipsychotic Agents; Com | 2011 |
Acute psychosis in an adolescent girl during treatment for advanced nodular lymphocyte-predominant Hodgkin's lymphom.
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Antipsychotic Agents; Com | 2011 |
Diffusion-weighted MRI compared to FDG PET-CT in the staging and response assessment of Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Diffusion Magnet | 2012 |
Diffusion-weighted MRI compared to FDG PET-CT in the staging and response assessment of Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Diffusion Magnet | 2012 |
Eruptive pseudoangiomatosis in a child undergoing chemotherapy for Hodgkin lymphoma.
Topics: Adolescent; Angiomatosis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamid | 2012 |
Eruptive pseudoangiomatosis in a child undergoing chemotherapy for Hodgkin lymphoma.
Topics: Adolescent; Angiomatosis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamid | 2012 |
The spectrum of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a description of 10 cases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic C | 2012 |
The spectrum of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a description of 10 cases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic C | 2012 |
[Acquired ichthyosis and haematological malignancies: five cases].
Topics: Adult; Aged; Allopurinol; Anemia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Ant | 2012 |
[Acquired ichthyosis and haematological malignancies: five cases].
Topics: Adult; Aged; Allopurinol; Anemia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Ant | 2012 |
Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial.
Topics: Adult; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosp | 2012 |
Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial.
Topics: Adult; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosp | 2012 |
Homonymous hemianopsia in a patient with Hodgkin's lymphoma in remission after BEACOPP chemotherapy.
Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bleomycin; | 2012 |
Homonymous hemianopsia in a patient with Hodgkin's lymphoma in remission after BEACOPP chemotherapy.
Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bleomycin; | 2012 |
Impact of different treatment approaches on pregnancy outcomes in 99 women treated for Hodgkin lymphoma.
Topics: Abortion, Spontaneous; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Congenital | 2012 |
Impact of different treatment approaches on pregnancy outcomes in 99 women treated for Hodgkin lymphoma.
Topics: Abortion, Spontaneous; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Congenital | 2012 |
Persistent genomic instability in peripheral blood lymphocytes from Hodgkin lymphoma survivors.
Topics: Adult; Aneuploidy; Case-Control Studies; Chromosomal Instability; Chromosome Aberrations; Chromosome | 2012 |
Persistent genomic instability in peripheral blood lymphocytes from Hodgkin lymphoma survivors.
Topics: Adult; Aneuploidy; Case-Control Studies; Chromosomal Instability; Chromosome Aberrations; Chromosome | 2012 |
Escalated BEACOPP in advanced Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; | 2012 |
Escalated BEACOPP in advanced Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; | 2012 |
Nephrotic syndrome leading to the diagnosis of classical Hodgkin's lymphoma in a 13-year-old girl.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Female; Fluorode | 2012 |
Nephrotic syndrome leading to the diagnosis of classical Hodgkin's lymphoma in a 13-year-old girl.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Female; Fluorode | 2012 |
A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstei
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Epst | 2012 |
A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstei
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Epst | 2012 |
[First case in Spain of bacteremia by Methylobacterium thiocyanatum from Hickmann catheter in an immunosuppressed patient with Hodgkin's lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Biofilms; Bleomycin; Carmustine; | 2012 |
[First case in Spain of bacteremia by Methylobacterium thiocyanatum from Hickmann catheter in an immunosuppressed patient with Hodgkin's lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Biofilms; Bleomycin; Carmustine; | 2012 |
[The optimal radiation volume after first-line chemotherapy in Hodgkin lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazin | 2012 |
[The optimal radiation volume after first-line chemotherapy in Hodgkin lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazin | 2012 |
[Role of response to first-line chemotherapy and of the primary lesion in Hodgkin lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazin | 2012 |
[Role of response to first-line chemotherapy and of the primary lesion in Hodgkin lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazin | 2012 |
[Primary refractory and relapsed Hodgkin lymphoma with unfavorable prognosis].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Daca | 2012 |
[Primary refractory and relapsed Hodgkin lymphoma with unfavorable prognosis].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Daca | 2012 |
Incidence, predictors and significance of severe toxicity in patients with human immunodeficiency virus-associated Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomy | 2012 |
Incidence, predictors and significance of severe toxicity in patients with human immunodeficiency virus-associated Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomy | 2012 |
[Retrospective analysis of 157 patients with pediatric Hodgkin lymphoma in Japan: investigation by four pediatric cancer study groups].
Topics: Adolescent; Age Factors; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleom | 2012 |
[Retrospective analysis of 157 patients with pediatric Hodgkin lymphoma in Japan: investigation by four pediatric cancer study groups].
Topics: Adolescent; Age Factors; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleom | 2012 |
Clinical characteristics of the patients with Hodgkin's lymphoma involving extranodal sites.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; | 2012 |
Clinical characteristics of the patients with Hodgkin's lymphoma involving extranodal sites.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; | 2012 |
Autotransplant for Hodgkin lymphoma after failure of upfront BEACOPP escalated (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine and prednisone).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 2013 |
Autotransplant for Hodgkin lymphoma after failure of upfront BEACOPP escalated (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine and prednisone).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 2013 |
[Relapse in Hodgkin lymphoma].
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclop | 2012 |
[Relapse in Hodgkin lymphoma].
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclop | 2012 |
Bendamustine salvage for the treatment of relapsed Hodgkin's lymphoma after allogeneic bone marrow transplantation.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Alkylating; Antineoplastic Combined C | 2013 |
Bendamustine salvage for the treatment of relapsed Hodgkin's lymphoma after allogeneic bone marrow transplantation.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Alkylating; Antineoplastic Combined C | 2013 |
Nodular sclerosing Hodgkin's disease mimicking Riedel's invasive fibrous thyroiditis.
Topics: Adrenal Cortex Hormones; Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Fine-Needle; | 2012 |
Nodular sclerosing Hodgkin's disease mimicking Riedel's invasive fibrous thyroiditis.
Topics: Adrenal Cortex Hormones; Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Fine-Needle; | 2012 |
[Escalated BEACOPP as an alternative in high risk Hodgkin lymphoma].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxo | 2012 |
[Escalated BEACOPP as an alternative in high risk Hodgkin lymphoma].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxo | 2012 |
[Pediatric Hodgkin disease in North Tunisia: clinical and therapeutic study].
Topics: Adolescent; Anemia, Aplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiomyopa | 2012 |
[Pediatric Hodgkin disease in North Tunisia: clinical and therapeutic study].
Topics: Adolescent; Anemia, Aplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiomyopa | 2012 |
Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dox | 2013 |
Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dox | 2013 |
[Clinical analysis of childhood and adolescent Hodgkin's lymphoma: a report of 88 cases].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 2012 |
[Clinical analysis of childhood and adolescent Hodgkin's lymphoma: a report of 88 cases].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 2012 |
[Successful treatment for Hodgkin's lymphoma in a female patient with Ph+ chronic myeloid leukemia].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bleomycin; Cyclophosphamide; Doxo | 2012 |
[Successful treatment for Hodgkin's lymphoma in a female patient with Ph+ chronic myeloid leukemia].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bleomycin; Cyclophosphamide; Doxo | 2012 |
Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials.
Topics: Academic Medical Centers; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Californ | 2013 |
Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials.
Topics: Academic Medical Centers; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Californ | 2013 |
BEACOPP escalated and rituximab in the treatment of Hodgkin lymphoma occurring concurrently with diffuse large B-cell non-Hodgkin lymphoma.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleom | 2013 |
BEACOPP escalated and rituximab in the treatment of Hodgkin lymphoma occurring concurrently with diffuse large B-cell non-Hodgkin lymphoma.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleom | 2013 |
Failure of fluorodeoxyglucose positron emission tomography to detect the high-grade transformation of nodular lymphocyte predominant Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnostic Errors; Doxorubi | 2013 |
Failure of fluorodeoxyglucose positron emission tomography to detect the high-grade transformation of nodular lymphocyte predominant Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnostic Errors; Doxorubi | 2013 |
The impact of systemic chemotherapy on testicular FDG activity in young men with Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biological Transport; Bleomycin; | 2013 |
The impact of systemic chemotherapy on testicular FDG activity in young men with Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biological Transport; Bleomycin; | 2013 |
Role of endothelin-1 in the development of a special type of cardiomyopathy.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; | 2002 |
Role of endothelin-1 in the development of a special type of cardiomyopathy.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; | 2002 |
Long-term results of conventional-dose salvage chemotherapy in patients with refractory and relapsed Hodgkin's disease (Croatian experience).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Croatia; Dacarba | 2002 |
Long-term results of conventional-dose salvage chemotherapy in patients with refractory and relapsed Hodgkin's disease (Croatian experience).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Croatia; Dacarba | 2002 |
Hodgkin s disease with nephrotic syndrome as a complication of ulcerative colitis: case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colitis, Ulcerative; Cyclophospham | 2002 |
Hodgkin s disease with nephrotic syndrome as a complication of ulcerative colitis: case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colitis, Ulcerative; Cyclophospham | 2002 |
Lymphoma-associated retinopathy.
Topics: Adult; Antineoplastic Agents; Autoantibodies; Blotting, Western; Electroretinography; Eye Proteins; | 2002 |
Lymphoma-associated retinopathy.
Topics: Adult; Antineoplastic Agents; Autoantibodies; Blotting, Western; Electroretinography; Eye Proteins; | 2002 |
Childhood Hodgkin disease treated with COPP/ABV hybrid chemotherapy: a progress report.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cycl | 2003 |
Childhood Hodgkin disease treated with COPP/ABV hybrid chemotherapy: a progress report.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cycl | 2003 |
Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bioma | 2002 |
Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bioma | 2002 |
Postpneumonectomy-like syndrome after chemoradiation therapy for lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarba | 2002 |
Postpneumonectomy-like syndrome after chemoradiation therapy for lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarba | 2002 |
NOVP chemotherapy for Hodgkin's disease transiently induces sperm aneuploidies associated with the major clinical aneuploidy syndromes involving chromosomes X, Y, 18, and 21.
Topics: Adult; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 18; Chro | 2003 |
NOVP chemotherapy for Hodgkin's disease transiently induces sperm aneuploidies associated with the major clinical aneuploidy syndromes involving chromosomes X, Y, 18, and 21.
Topics: Adult; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 18; Chro | 2003 |
[Relapse of Hodgkin disease after 17 years of complete remission. A case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2003 |
[Relapse of Hodgkin disease after 17 years of complete remission. A case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2003 |
Agranulocytosis unresponsive to growth factors following rituximab in vivo purging.
Topics: Agranulocytosis; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agen | 2003 |
Agranulocytosis unresponsive to growth factors following rituximab in vivo purging.
Topics: Agranulocytosis; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agen | 2003 |
Analysis of treatment results in advanced Hodgkin's disease: the case for adjuvant radiotherapy.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleom | 2003 |
Analysis of treatment results in advanced Hodgkin's disease: the case for adjuvant radiotherapy.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleom | 2003 |
Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Trial DAL-HD-90.
Topics: Adolescent; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Pres | 2003 |
Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Trial DAL-HD-90.
Topics: Adolescent; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Pres | 2003 |
Hodgkin's disease--clinical trials and travails.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami | 2003 |
Hodgkin's disease--clinical trials and travails.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami | 2003 |
Radiation therapy in the treatment of Hodgkin's disease--do you see what I see?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Chemotherapy, Adjuvant; | 2003 |
Radiation therapy in the treatment of Hodgkin's disease--do you see what I see?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Chemotherapy, Adjuvant; | 2003 |
Results of little or no treatment for lymphocyte-predominant Hodgkin disease in children and adolescents.
Topics: Adolescent; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Child; Child, Pres | 2003 |
Results of little or no treatment for lymphocyte-predominant Hodgkin disease in children and adolescents.
Topics: Adolescent; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Child; Child, Pres | 2003 |
[Study of the use of prednisone in therapy of malignant hemopathies and neoplasms].
Topics: Hodgkin Disease; Humans; Leukemia; Neoplasms; Prednisone; Steroids | 1955 |
[Study of the use of prednisone in therapy of malignant hemopathies and neoplasms].
Topics: Hodgkin Disease; Humans; Leukemia; Neoplasms; Prednisone; Steroids | 1955 |
[Prednisone and hemopathy].
Topics: Anemia; Anemia, Hemolytic; Hodgkin Disease; Humans; Leukemia; Prednisone; Steroids | 1955 |
[Prednisone and hemopathy].
Topics: Anemia; Anemia, Hemolytic; Hodgkin Disease; Humans; Leukemia; Prednisone; Steroids | 1955 |
[Treatment of acute leukemia in adult, myeloblastic development of chronic leukemia, erythroleukemia and malignant lymphogranuloma caused by massive doses of cortisone or prednisone].
Topics: Acute Disease; Adult; Chronic Disease; Cortisone; Granulocyte Precursor Cells; Hodgkin Disease; Huma | 1956 |
[Treatment of acute leukemia in adult, myeloblastic development of chronic leukemia, erythroleukemia and malignant lymphogranuloma caused by massive doses of cortisone or prednisone].
Topics: Acute Disease; Adult; Chronic Disease; Cortisone; Granulocyte Precursor Cells; Hodgkin Disease; Huma | 1956 |
[Treatment of acute leukemia in adult, myeloblastic development of chronic leukemia, erythroleukemia and malignant lymphogranuloma caused by massive doses of cortisone or prednisone].
Topics: Acute Disease; Adult; Chronic Disease; Cortisone; Granulocyte Precursor Cells; Hodgkin Disease; Huma | 1956 |
[Treatment of acute leukemia in adult, myeloblastic development of chronic leukemia, erythroleukemia and malignant lymphogranuloma caused by massive doses of cortisone or prednisone].
Topics: Acute Disease; Adult; Chronic Disease; Cortisone; Granulocyte Precursor Cells; Hodgkin Disease; Huma | 1956 |
[Treatment of acute leukemia in adult, myeloblastic development of chronic leukemia, erythroleukemia and malignant lymphogranuloma caused by massive doses of cortisone or prednisone].
Topics: Acute Disease; Adult; Chronic Disease; Cortisone; Granulocyte Precursor Cells; Hodgkin Disease; Huma | 1956 |
[Treatment of acute leukemia in adult, myeloblastic development of chronic leukemia, erythroleukemia and malignant lymphogranuloma caused by massive doses of cortisone or prednisone].
Topics: Acute Disease; Adult; Chronic Disease; Cortisone; Granulocyte Precursor Cells; Hodgkin Disease; Huma | 1956 |
[Treatment of acute leukemia in adult, myeloblastic development of chronic leukemia, erythroleukemia and malignant lymphogranuloma caused by massive doses of cortisone or prednisone].
Topics: Acute Disease; Adult; Chronic Disease; Cortisone; Granulocyte Precursor Cells; Hodgkin Disease; Huma | 1956 |
[Treatment of acute leukemia in adult, myeloblastic development of chronic leukemia, erythroleukemia and malignant lymphogranuloma caused by massive doses of cortisone or prednisone].
Topics: Acute Disease; Adult; Chronic Disease; Cortisone; Granulocyte Precursor Cells; Hodgkin Disease; Huma | 1956 |
The effect of massive prednisone and prednisolone therapy on acute leukemia and malignant lymphomas.
Topics: Acute Disease; Hodgkin Disease; Humans; Leukemia; Lymphoma; Prednisolone; Prednisone | 1957 |
The effect of massive prednisone and prednisolone therapy on acute leukemia and malignant lymphomas.
Topics: Acute Disease; Hodgkin Disease; Humans; Leukemia; Lymphoma; Prednisolone; Prednisone | 1957 |
The effect of massive prednisone and prednisolone therapy on acute leukemia and malignant lymphomas.
Topics: Acute Disease; Hodgkin Disease; Humans; Leukemia; Lymphoma; Prednisolone; Prednisone | 1957 |
The effect of massive prednisone and prednisolone therapy on acute leukemia and malignant lymphomas.
Topics: Acute Disease; Hodgkin Disease; Humans; Leukemia; Lymphoma; Prednisolone; Prednisone | 1957 |
The effect of massive prednisone and prednisolone therapy on acute leukemia and malignant lymphomas.
Topics: Acute Disease; Hodgkin Disease; Humans; Leukemia; Lymphoma; Prednisolone; Prednisone | 1957 |
The effect of massive prednisone and prednisolone therapy on acute leukemia and malignant lymphomas.
Topics: Acute Disease; Hodgkin Disease; Humans; Leukemia; Lymphoma; Prednisolone; Prednisone | 1957 |
The effect of massive prednisone and prednisolone therapy on acute leukemia and malignant lymphomas.
Topics: Acute Disease; Hodgkin Disease; Humans; Leukemia; Lymphoma; Prednisolone; Prednisone | 1957 |
The effect of massive prednisone and prednisolone therapy on acute leukemia and malignant lymphomas.
Topics: Acute Disease; Hodgkin Disease; Humans; Leukemia; Lymphoma; Prednisolone; Prednisone | 1957 |
[Massive dosage of prednisone in lymphogranuloma, lymphosarcoma and reticulum cell sarcoma].
Topics: Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neoplasms | 1957 |
[Massive dosage of prednisone in lymphogranuloma, lymphosarcoma and reticulum cell sarcoma].
Topics: Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neoplasms | 1957 |
[Acute malignant lymphogranuloma and its treatment with prednisone].
Topics: Hodgkin Disease; Humans; Prednisone | 1957 |
[Acute malignant lymphogranuloma and its treatment with prednisone].
Topics: Hodgkin Disease; Humans; Prednisone | 1957 |
[Case of malignant granulome treated by massive doses of prednisone].
Topics: Hodgkin Disease; Humans; Prednisone | 1958 |
[Case of malignant granulome treated by massive doses of prednisone].
Topics: Hodgkin Disease; Humans; Prednisone | 1958 |
[Galloping tuberculosis in a case of Hodgkin's disease treated with prednisone].
Topics: Hodgkin Disease; Humans; Prednisone; Tuberculosis; Tuberculosis, Pulmonary | 1959 |
[Galloping tuberculosis in a case of Hodgkin's disease treated with prednisone].
Topics: Hodgkin Disease; Humans; Prednisone; Tuberculosis; Tuberculosis, Pulmonary | 1959 |
Chemotherapy for Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2003 |
Chemotherapy for Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2003 |
Radiotherapy for advanced Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Doxorubicin; H | 2003 |
Radiotherapy for advanced Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Doxorubicin; H | 2003 |
[Combined use of prednisone and cytostatics as well as irradiation in the treatment of chronic lymphadenosis and lymphogranulomatosis].
Topics: Antineoplastic Agents; Cytostatic Agents; Hodgkin Disease; Humans; Lymphadenitis; Prednisone; Sarcoi | 1960 |
[Combined use of prednisone and cytostatics as well as irradiation in the treatment of chronic lymphadenosis and lymphogranulomatosis].
Topics: Antineoplastic Agents; Cytostatic Agents; Hodgkin Disease; Humans; Lymphadenitis; Prednisone; Sarcoi | 1960 |
[Treatment of lymphogranulomatosis in the advanced stage with high doses of prednisone].
Topics: Hodgkin Disease; Humans; Prednisone; Sarcoidosis | 1959 |
[Treatment of lymphogranulomatosis in the advanced stage with high doses of prednisone].
Topics: Hodgkin Disease; Humans; Prednisone; Sarcoidosis | 1959 |
Steroid diabetes.
Topics: Adrenocorticotropic Hormone; Diabetes Mellitus; Hodgkin Disease; Prednisone; Purpura; Purpura, Throm | 1962 |
Steroid diabetes.
Topics: Adrenocorticotropic Hormone; Diabetes Mellitus; Hodgkin Disease; Prednisone; Purpura; Purpura, Throm | 1962 |
[Effect of large doses of prednisone on the clinical course of advanced forms of Hodgkin's disease].
Topics: Hodgkin Disease; Humans; Prednisone | 1962 |
[Effect of large doses of prednisone on the clinical course of advanced forms of Hodgkin's disease].
Topics: Hodgkin Disease; Humans; Prednisone | 1962 |
[TUBERCULOSIS INDUCED BY CORTICOTHERAPY].
Topics: Asthma; Geriatrics; Hodgkin Disease; Pneumothorax; Pneumothorax, Artificial; Prednisone; Rheumatic D | 1963 |
[TUBERCULOSIS INDUCED BY CORTICOTHERAPY].
Topics: Asthma; Geriatrics; Hodgkin Disease; Pneumothorax; Pneumothorax, Artificial; Prednisone; Rheumatic D | 1963 |
CHEMOTHERAPY IN RETICULOSES.
Topics: Chlorambucil; Cyclophosphamide; Genetic Diseases, X-Linked; Hodgkin Disease; Humans; Leukemia, Hairy | 1963 |
CHEMOTHERAPY IN RETICULOSES.
Topics: Chlorambucil; Cyclophosphamide; Genetic Diseases, X-Linked; Hodgkin Disease; Humans; Leukemia, Hairy | 1963 |
PULMONARY MONILIASIS. A PLEA FOR LUNG BIOPSY.
Topics: Amphotericin B; Biopsy; Candidiasis; Chlorambucil; Diagnosis, Differential; Hodgkin Disease; Humans; | 1963 |
PULMONARY MONILIASIS. A PLEA FOR LUNG BIOPSY.
Topics: Amphotericin B; Biopsy; Candidiasis; Chlorambucil; Diagnosis, Differential; Hodgkin Disease; Humans; | 1963 |
CYCLIC HAEMOLYTIC ANAEMIA SYNCHRONOUS WITH PEL-EBSTEIN FEVER IN A CASE OF HODGKIN'S DISEASE.
Topics: Anemia; Anemia, Hemolytic; Antineoplastic Agents; Blood Transfusion; Bronchopneumonia; Fever; Hodgki | 1963 |
CYCLIC HAEMOLYTIC ANAEMIA SYNCHRONOUS WITH PEL-EBSTEIN FEVER IN A CASE OF HODGKIN'S DISEASE.
Topics: Anemia; Anemia, Hemolytic; Antineoplastic Agents; Blood Transfusion; Bronchopneumonia; Fever; Hodgki | 1963 |
[DISSEMINATED MUCORMYCOSIS].
Topics: Antifibrinolytic Agents; Blood Transfusion; Diagnosis; Hodgkin Disease; Mucormycosis; Neoplasms; Pat | 1963 |
[DISSEMINATED MUCORMYCOSIS].
Topics: Antifibrinolytic Agents; Blood Transfusion; Diagnosis; Hodgkin Disease; Mucormycosis; Neoplasms; Pat | 1963 |
GENERALIZED EXFOLIATIVE ERYTHRODERMA OF TWO YEARS' DURATION.
Topics: Dermatitis, Exfoliative; Diagnosis, Differential; Hodgkin Disease; Humans; Neoplasms; Pathology; Pre | 1964 |
GENERALIZED EXFOLIATIVE ERYTHRODERMA OF TWO YEARS' DURATION.
Topics: Dermatitis, Exfoliative; Diagnosis, Differential; Hodgkin Disease; Humans; Neoplasms; Pathology; Pre | 1964 |
HODGKIN'S DISEASE AND HYPOGAMMAGLOBULINAEMIA: A RARE ASSOCIATION.
Topics: Agammaglobulinemia; Anti-Bacterial Agents; Antibiotics, Antitubercular; Chickenpox; Child; Diagnosis | 1964 |
HODGKIN'S DISEASE AND HYPOGAMMAGLOBULINAEMIA: A RARE ASSOCIATION.
Topics: Agammaglobulinemia; Anti-Bacterial Agents; Antibiotics, Antitubercular; Chickenpox; Child; Diagnosis | 1964 |
SPINAL-CORD COMPRESSION IN THE MALIGNANT LYMPHOMAS.
Topics: Chlorambucil; Hematopoiesis; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Mercaptopurin | 1964 |
SPINAL-CORD COMPRESSION IN THE MALIGNANT LYMPHOMAS.
Topics: Chlorambucil; Hematopoiesis; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Mercaptopurin | 1964 |
[EXPERIENCES IN THE TREATMENT OF MALIGNANT DISEASES OF THE RETICULOENDOTHELIAL SYSTEM AND LEUKEMIAS. (I)].
Topics: Antineoplastic Agents; Cortisone; Hodgkin Disease; Leukemia; Lung Neoplasms; Lymphoma; Lymphoma, Lar | 1964 |
[EXPERIENCES IN THE TREATMENT OF MALIGNANT DISEASES OF THE RETICULOENDOTHELIAL SYSTEM AND LEUKEMIAS. (I)].
Topics: Antineoplastic Agents; Cortisone; Hodgkin Disease; Leukemia; Lung Neoplasms; Lymphoma; Lymphoma, Lar | 1964 |
NONSURGICAL TREATMENT OF PULMONARY CANCER.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Adrenal Cortex Hormones; Alkylating Agents; Antineoplastic Agen | 1964 |
NONSURGICAL TREATMENT OF PULMONARY CANCER.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Adrenal Cortex Hormones; Alkylating Agents; Antineoplastic Agen | 1964 |
[THE RETICULO-ENDOTHELIAL SYSTEM AND LYMPHOSARCOMAS].
Topics: Adolescent; Adrenal Cortex Hormones; Geriatrics; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Follic | 1964 |
[THE RETICULO-ENDOTHELIAL SYSTEM AND LYMPHOSARCOMAS].
Topics: Adolescent; Adrenal Cortex Hormones; Geriatrics; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Follic | 1964 |
METABOLIC RELATIONSHIPS BETWEEN TUMOR AND HOST DURING MASSIVE DOSES OF PREDNISONE IN HUMAN NEOPLASTIC DISEASE.
Topics: 17-Ketosteroids; Adenocarcinoma; Biomedical Research; Blood; Calcium; Chlorides; Creatine; Creatinin | 1964 |
METABOLIC RELATIONSHIPS BETWEEN TUMOR AND HOST DURING MASSIVE DOSES OF PREDNISONE IN HUMAN NEOPLASTIC DISEASE.
Topics: 17-Ketosteroids; Adenocarcinoma; Biomedical Research; Blood; Calcium; Chlorides; Creatine; Creatinin | 1964 |
DIAGNOSTIC VALUE OF ALKALINE PHOSPHATASE IN LEUKOCYTES.
Topics: Alkaline Phosphatase; Busulfan; Celiac Disease; Diagnosis, Differential; Drug Therapy; Gout; Heart D | 1964 |
DIAGNOSTIC VALUE OF ALKALINE PHOSPHATASE IN LEUKOCYTES.
Topics: Alkaline Phosphatase; Busulfan; Celiac Disease; Diagnosis, Differential; Drug Therapy; Gout; Heart D | 1964 |
CLINICAL PATHOLOGIC CONFERENCE. TAKAYASHU'S SYNDROME; HODGKIN'S DISEASE.
Topics: Aortic Arch Syndromes; Chlorambucil; Drug Therapy; Hodgkin Disease; Humans; Pathology; Prednisone; T | 1964 |
CLINICAL PATHOLOGIC CONFERENCE. TAKAYASHU'S SYNDROME; HODGKIN'S DISEASE.
Topics: Aortic Arch Syndromes; Chlorambucil; Drug Therapy; Hodgkin Disease; Humans; Pathology; Prednisone; T | 1964 |
HODGKIN'S DISEASE LIMITED TO THE LIVER.
Topics: Adolescent; Diagnosis, Differential; Hodgkin Disease; Humans; Liver Neoplasms; Neoplasms; Pathology; | 1964 |
HODGKIN'S DISEASE LIMITED TO THE LIVER.
Topics: Adolescent; Diagnosis, Differential; Hodgkin Disease; Humans; Liver Neoplasms; Neoplasms; Pathology; | 1964 |
NECROTIZING TOXOPLASMIC ENCEPHALITIS AND HERPETIC PNEUMONIA COMPLICATING TREATED HODGKIN'S DISEASE. REPORT OF A CASE.
Topics: Alkylating Agents; Antineoplastic Agents; Cyclophosphamide; Encephalitis; Herpesviridae Infections; | 1965 |
NECROTIZING TOXOPLASMIC ENCEPHALITIS AND HERPETIC PNEUMONIA COMPLICATING TREATED HODGKIN'S DISEASE. REPORT OF A CASE.
Topics: Alkylating Agents; Antineoplastic Agents; Cyclophosphamide; Encephalitis; Herpesviridae Infections; | 1965 |
[DATA TO THE DIAGNOSTIC VALUE OF FIBRINOGEN DETERMINATION IN MALIGNANT DISEASES].
Topics: Cyclophosphamide; Fibrinogen; Hodgkin Disease; Humans; Metaplasia; Myeloproliferative Disorders; Neo | 1964 |
[DATA TO THE DIAGNOSTIC VALUE OF FIBRINOGEN DETERMINATION IN MALIGNANT DISEASES].
Topics: Cyclophosphamide; Fibrinogen; Hodgkin Disease; Humans; Metaplasia; Myeloproliferative Disorders; Neo | 1964 |
[THE USE OF CYTOSTATICS IN MALIGNANT LYMPHOGRANULOMA].
Topics: Busulfan; Chlorambucil; Cyclophosphamide; Cytostatic Agents; Drug Therapy; Hodgkin Disease; Humans; | 1964 |
[THE USE OF CYTOSTATICS IN MALIGNANT LYMPHOGRANULOMA].
Topics: Busulfan; Chlorambucil; Cyclophosphamide; Cytostatic Agents; Drug Therapy; Hodgkin Disease; Humans; | 1964 |
THE SUPERIOR MEDIASTINAL SYNDROME IN CHILDREN WITH CANCER.
Topics: Adolescent; Child; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Mediastinal N | 1965 |
THE SUPERIOR MEDIASTINAL SYNDROME IN CHILDREN WITH CANCER.
Topics: Adolescent; Child; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Mediastinal N | 1965 |
TREATMENT OF COMPLICATIONS OF GASTRODUODENAL "STEROID ULCERS".
Topics: Adenocarcinoma; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Arthritis; Arthritis, Rheumato | 1965 |
TREATMENT OF COMPLICATIONS OF GASTRODUODENAL "STEROID ULCERS".
Topics: Adenocarcinoma; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Arthritis; Arthritis, Rheumato | 1965 |
[On high-dose prednisone therapy of malignant blood diseases].
Topics: Genetic Diseases, X-Linked; Hematologic Diseases; Hodgkin Disease; Leukemia; Leukemia, Hairy Cell; L | 1960 |
[On high-dose prednisone therapy of malignant blood diseases].
Topics: Genetic Diseases, X-Linked; Hematologic Diseases; Hodgkin Disease; Leukemia; Leukemia, Hairy Cell; L | 1960 |
Revascularization for acute coronary occlusion in a young woman following radiation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Coronar | 2003 |
Revascularization for acute coronary occlusion in a young woman following radiation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Coronar | 2003 |
[Second malignancies following Hodgkin's disease treatment in Tunisia. Retrospective study of 26 cases observed at the institute Salah-Azaïz].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Do | 2003 |
[Second malignancies following Hodgkin's disease treatment in Tunisia. Retrospective study of 26 cases observed at the institute Salah-Azaïz].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Do | 2003 |
Impact of chest wall and lung invasion on outcome of stage I-II Hodgkin's lymphoma after combined modality therapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2003 |
Impact of chest wall and lung invasion on outcome of stage I-II Hodgkin's lymphoma after combined modality therapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2003 |
Patients above sixty years of age with Hodgkin's lymphoma treated with a new strategy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Administr | 2002 |
Patients above sixty years of age with Hodgkin's lymphoma treated with a new strategy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Administr | 2002 |
Indications for peripheral light-chain revision and somatic hypermutation without a functional B-cell receptor in precursors of a composite diffuse large B-cell and Hodgkin's lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Clone Cells; Cyclophosphamide; | 2004 |
Indications for peripheral light-chain revision and somatic hypermutation without a functional B-cell receptor in precursors of a composite diffuse large B-cell and Hodgkin's lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Clone Cells; Cyclophosphamide; | 2004 |
45th annual meeting of the American Society of Hematology. December 6-9, 2003, San Diego, California.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Anti | 2003 |
45th annual meeting of the American Society of Hematology. December 6-9, 2003, San Diego, California.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Anti | 2003 |
Decreasing the number of MOPP courses reduces gonadal damage in survivors of childhood Hodgkin disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Daca | 2004 |
Decreasing the number of MOPP courses reduces gonadal damage in survivors of childhood Hodgkin disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Daca | 2004 |
Second malignancies after chemotherapy and radiotherapy for Hodgkin disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Combin | 2004 |
Second malignancies after chemotherapy and radiotherapy for Hodgkin disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Combin | 2004 |
Centralized radiation oncologic review of cross-sectional imaging of Hodgkin's disease leads to significant changes in required involved field-results of a quality assurance program of the German Hodgkin Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami | 2004 |
Centralized radiation oncologic review of cross-sectional imaging of Hodgkin's disease leads to significant changes in required involved field-results of a quality assurance program of the German Hodgkin Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami | 2004 |
Composite lymphoma arising in the parotid gland: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Hodgkin Disease; Huma | 2004 |
Composite lymphoma arising in the parotid gland: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Hodgkin Disease; Huma | 2004 |
Low acute hematological toxicity during chemotherapy predicts reduced disease control in advanced Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cohort Studies; Cyclophospha | 2004 |
Low acute hematological toxicity during chemotherapy predicts reduced disease control in advanced Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cohort Studies; Cyclophospha | 2004 |
Pediatric Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 2004 |
Pediatric Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 2004 |
Differential attenuation of clavicle growth after asymmetric mantle radiotherapy.
Topics: Abnormalities, Radiation-Induced; Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Prot | 2004 |
Differential attenuation of clavicle growth after asymmetric mantle radiotherapy.
Topics: Abnormalities, Radiation-Induced; Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Prot | 2004 |
Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemothera | 2004 |
Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemothera | 2004 |
Decreased serum inhibin B/FSH ratio as a marker of Sertoli cell function in male survivors after chemotherapy in childhood and adolescence.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Case-Control Studies; Child; Chil | 2004 |
Decreased serum inhibin B/FSH ratio as a marker of Sertoli cell function in male survivors after chemotherapy in childhood and adolescence.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Case-Control Studies; Child; Chil | 2004 |
Cyclooxygenase-2 (Cox-2) expression in lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclooxygenase 2; Cyclophosp | 2004 |
Cyclooxygenase-2 (Cox-2) expression in lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclooxygenase 2; Cyclophosp | 2004 |
Fertility in males treated for Hodgkins disease with COPP/ABV hybrid.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamid | 2005 |
Fertility in males treated for Hodgkins disease with COPP/ABV hybrid.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamid | 2005 |
Fatal hepatic failure secondary to acute herpes simplex virus infection.
Topics: Adolescent; Antibodies, Viral; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposid | 2004 |
Fatal hepatic failure secondary to acute herpes simplex virus infection.
Topics: Adolescent; Antibodies, Viral; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposid | 2004 |
Significance of splenomegaly in childhood Hodgkin disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cycl | 2004 |
Significance of splenomegaly in childhood Hodgkin disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cycl | 2004 |
Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Lymphoma Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 2005 |
Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Lymphoma Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 2005 |
[The choice of second-line chemotherapy for malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration S | 2005 |
[The choice of second-line chemotherapy for malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration S | 2005 |
[A case of secondary non-Hodgkin's lymphoma of the colon after the treatment for Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; | 2005 |
[A case of secondary non-Hodgkin's lymphoma of the colon after the treatment for Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; | 2005 |
[Influence of age on treatment results in children and adolescents with Hodgkin's disease].
Topics: Adolescent; Age Distribution; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin | 2004 |
[Influence of age on treatment results in children and adolescents with Hodgkin's disease].
Topics: Adolescent; Age Distribution; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin | 2004 |
[Over 30-year experience of Polish Pediatric Leukemia/Lymphoma Study Group for treatment of Hodgkin's disease in children and adolescents: improvement curability and decrease of serious complications].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child | 2004 |
[Over 30-year experience of Polish Pediatric Leukemia/Lymphoma Study Group for treatment of Hodgkin's disease in children and adolescents: improvement curability and decrease of serious complications].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child | 2004 |
[Clinicopathologic features and treatment outcomes of primary hepatic lymphoma: a report of four cases].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modali | 2005 |
[Clinicopathologic features and treatment outcomes of primary hepatic lymphoma: a report of four cases].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modali | 2005 |
Endothelin-1 and cardiac function in anthracycline-treated patients: a 1-year follow-up.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazin | 2004 |
Endothelin-1 and cardiac function in anthracycline-treated patients: a 1-year follow-up.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazin | 2004 |
Acquisition of a Ph chromosome with minor BCR/ABL fusion in treatment-related myelodysplastic syndrome with chromosome 7 abnormalities in a patient treated for Hodgkin disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosome Aberrations; Chromosome | 2005 |
Acquisition of a Ph chromosome with minor BCR/ABL fusion in treatment-related myelodysplastic syndrome with chromosome 7 abnormalities in a patient treated for Hodgkin disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosome Aberrations; Chromosome | 2005 |
Survival in Hodgkin's disease patients--report of 25 years of experience at the Milan Cancer Institute.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Dacarbazine; Disea | 2005 |
Survival in Hodgkin's disease patients--report of 25 years of experience at the Milan Cancer Institute.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Dacarbazine; Disea | 2005 |
Quality control of involved-field radiotherapy in patients with advanced Hodgkin's lymphoma (EORTC 20884).
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Doxorubicin; H | 2005 |
Quality control of involved-field radiotherapy in patients with advanced Hodgkin's lymphoma (EORTC 20884).
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Doxorubicin; H | 2005 |
Long-term follow-up of salvage radiotherapy in Hodgkin's lymphoma after chemotherapy failure.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Pr | 2005 |
Long-term follow-up of salvage radiotherapy in Hodgkin's lymphoma after chemotherapy failure.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Pr | 2005 |
Occurrence of multiple myeloma 13 years after Hodgkin's disease: chance or consequence?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carmustine; Combined Modality | 2005 |
Occurrence of multiple myeloma 13 years after Hodgkin's disease: chance or consequence?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carmustine; Combined Modality | 2005 |
Gemcitabine-induced radiation recall dermatitis in a patient with resistant Hodgkin lymphoma.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidin | 2005 |
Gemcitabine-induced radiation recall dermatitis in a patient with resistant Hodgkin lymphoma.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidin | 2005 |
Current status of the treatment of HIV-associated lymphoma.
Topics: Anti-HIV Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Comb | 2004 |
Current status of the treatment of HIV-associated lymphoma.
Topics: Anti-HIV Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Comb | 2004 |
[Mediastinal (thymic) large B-cell lymphoma: three cases reports].
Topics: Adolescent; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Diffe | 2005 |
[Mediastinal (thymic) large B-cell lymphoma: three cases reports].
Topics: Adolescent; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Diffe | 2005 |
Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
Topics: Adolescent; Adult; Age Factors; Aged; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Bl | 2005 |
Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
Topics: Adolescent; Adult; Age Factors; Aged; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Bl | 2005 |
BEACOPP and COPP/ABVD as salvage treatment after primary extended field radiation therapy of early stage Hodgkins disease - results of the German Hodgkin Study Group.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyc | 2005 |
BEACOPP and COPP/ABVD as salvage treatment after primary extended field radiation therapy of early stage Hodgkins disease - results of the German Hodgkin Study Group.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyc | 2005 |
Evolving approaches to primary treatment of Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; | 2005 |
Evolving approaches to primary treatment of Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; | 2005 |
Therapies for relapsed Hodgkin lymphoma: transplant and non-transplant approaches including immunotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cycloph | 2005 |
Therapies for relapsed Hodgkin lymphoma: transplant and non-transplant approaches including immunotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cycloph | 2005 |
Comparison of MOPP/MOPP +/- RT vs. MOPp/ABVD +/- RT in poor prognosis Hodgkin's disease. Long-term results.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1989 |
Comparison of MOPP/MOPP +/- RT vs. MOPp/ABVD +/- RT in poor prognosis Hodgkin's disease. Long-term results.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1989 |
Benign pleural schwannoma secondary to radiotherapy for Hodgkin disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Basal Cell; Combin | 2005 |
Benign pleural schwannoma secondary to radiotherapy for Hodgkin disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Basal Cell; Combin | 2005 |
Itraconazole-enhanced chemotherapy toxicity in a patient with Hodgkin lymphoma.
Topics: Adolescent; Antibiotics, Antineoplastic; Antifungal Agents; Antineoplastic Agents, Hormonal; Antineo | 2006 |
Itraconazole-enhanced chemotherapy toxicity in a patient with Hodgkin lymphoma.
Topics: Adolescent; Antibiotics, Antineoplastic; Antifungal Agents; Antineoplastic Agents, Hormonal; Antineo | 2006 |
[Clinical analysis of reactive thymic hyperplasia following chemotherapy for childhood malignant lymphoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Daca | 2006 |
[Clinical analysis of reactive thymic hyperplasia following chemotherapy for childhood malignant lymphoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Daca | 2006 |
Comparison of treatment outcomes of childhood Hodgkin lymphoma in two US centers and a center in Recife, Brazil.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Child; Child, | 2007 |
Comparison of treatment outcomes of childhood Hodgkin lymphoma in two US centers and a center in Recife, Brazil.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Child; Child, | 2007 |
Will it be another 20 years before Hodgkin lymphoma patients benefit from BEACOPP therapy?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamid | 2006 |
Will it be another 20 years before Hodgkin lymphoma patients benefit from BEACOPP therapy?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamid | 2006 |
[Effect of high-dose chemotherapy with subsequent transplantation of blood-forming cells on left ventricle function in patients with malignant lymphomas treated with doxorubicin in primary chemotherapy].
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols | 2006 |
[Effect of high-dose chemotherapy with subsequent transplantation of blood-forming cells on left ventricle function in patients with malignant lymphomas treated with doxorubicin in primary chemotherapy].
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols | 2006 |
Hodgkin's lymphoma in adolescents.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; British Columbia; Chem | 2006 |
Hodgkin's lymphoma in adolescents.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; British Columbia; Chem | 2006 |
Evaluation of acute and early cardiotoxicity in survivors of Hodgkin's disease treated with ABVD or BEACOPP regimens.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; D | 2006 |
Evaluation of acute and early cardiotoxicity in survivors of Hodgkin's disease treated with ABVD or BEACOPP regimens.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; D | 2006 |
[Late cardiotoxicity in patients with malignant lymphoma treated with doxorubicin chemotherapy].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; | 2006 |
[Late cardiotoxicity in patients with malignant lymphoma treated with doxorubicin chemotherapy].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; | 2006 |
[Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2006 |
[Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2006 |
Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Cyclop | 2006 |
Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Cyclop | 2006 |
[Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Pr | 2006 |
[Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Pr | 2006 |
Hodgkin's lymphoma in the elderly: the results of 10 years of follow-up.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modal | 2006 |
Hodgkin's lymphoma in the elderly: the results of 10 years of follow-up.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modal | 2006 |
[Limphomatous meningitis as recurrence site in Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bleomycin; Cisplatin; Cycloph | 2006 |
[Limphomatous meningitis as recurrence site in Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bleomycin; Cisplatin; Cycloph | 2006 |
Epstein-Barr virus associated Hodgkin lymphoma in a 9-year-old girl receiving long-term methotrexate therapy for juvenile idiopathic arthritis.
Topics: Arthritis, Juvenile; Child; Drug Therapy, Combination; Epstein-Barr Virus Infections; Female; Herpes | 2006 |
Epstein-Barr virus associated Hodgkin lymphoma in a 9-year-old girl receiving long-term methotrexate therapy for juvenile idiopathic arthritis.
Topics: Arthritis, Juvenile; Child; Drug Therapy, Combination; Epstein-Barr Virus Infections; Female; Herpes | 2006 |
Information sources used by New South Wales cancer clinicians: a qualitative study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Dru | 2006 |
Information sources used by New South Wales cancer clinicians: a qualitative study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Dru | 2006 |
FDG-PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic | 2006 |
FDG-PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic | 2006 |
Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 2006 |
Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 2006 |
Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 2006 |
Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 2006 |
Malignant fibrous histiocytoma following radiation therapy and chemotherapy for Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adju | 2007 |
Malignant fibrous histiocytoma following radiation therapy and chemotherapy for Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adju | 2007 |
[Our experiences in treating patients with Hodgkin disease in the last decade].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Ad | 2007 |
[Our experiences in treating patients with Hodgkin disease in the last decade].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Ad | 2007 |
Proliferative index and CD15 expression in pediatric classical Hodgkin lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Growth Processes; Child; | 2008 |
Proliferative index and CD15 expression in pediatric classical Hodgkin lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Growth Processes; Child; | 2008 |
Live birth after the transfer of human embryos developed from cryopreserved oocytes harvested before cancer treatment.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Fertilization in Vi | 2007 |
Live birth after the transfer of human embryos developed from cryopreserved oocytes harvested before cancer treatment.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Fertilization in Vi | 2007 |
Standard CHOP-21 as first line therapy for elderly patients with Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cyclophosph | 2007 |
Standard CHOP-21 as first line therapy for elderly patients with Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cyclophosph | 2007 |
[Hodgkin lymphoma in Chile: experience of the national adult cancer program].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 2007 |
[Hodgkin lymphoma in Chile: experience of the national adult cancer program].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 2007 |
Hodgkin lymphoma among patients infected with HIV in post-HAART era.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomy | 2007 |
Hodgkin lymphoma among patients infected with HIV in post-HAART era.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomy | 2007 |
Long-term outcome of children and adolescents treated with the COPP-ABV hybrid protocol for Hodgkin's disease: balance of risks.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; | 2007 |
Long-term outcome of children and adolescents treated with the COPP-ABV hybrid protocol for Hodgkin's disease: balance of risks.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; | 2007 |
Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Disease Progression; Doxorubicin; | 2007 |
Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Disease Progression; Doxorubicin; | 2007 |
[Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplasti | 2007 |
[Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplasti | 2007 |
Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood.
Topics: Adolescent; Adult; Age Factors; Age of Onset; Anti-Mullerian Hormone; Antineoplastic Combined Chemot | 2007 |
Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood.
Topics: Adolescent; Adult; Age Factors; Age of Onset; Anti-Mullerian Hormone; Antineoplastic Combined Chemot | 2007 |
Treatment-related risk factors for premature menopause following Hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 2008 |
Treatment-related risk factors for premature menopause following Hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 2008 |
High relapse rate after a brief chemotherapy course and involved-field radiotherapy in early-stage Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2007 |
High relapse rate after a brief chemotherapy course and involved-field radiotherapy in early-stage Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2007 |
Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Child; Dacarbazine; Do | 2007 |
Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Child; Dacarbazine; Do | 2007 |
[Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Co | 2007 |
[Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Co | 2007 |
Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 2008 |
Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 2008 |
Hemophagocytic syndrome after highly active antiretroviral therapy initiation: a life-threatening event related to immune restoration inflammatory syndrome?
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Inflammatory Agents; Antiretroviral Therapy, High | 2008 |
Hemophagocytic syndrome after highly active antiretroviral therapy initiation: a life-threatening event related to immune restoration inflammatory syndrome?
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Inflammatory Agents; Antiretroviral Therapy, High | 2008 |
Hodgkin's Lymphoma in an elite endurance athlete.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Eto | 2008 |
Hodgkin's Lymphoma in an elite endurance athlete.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Eto | 2008 |
Coombs'-positive hemolytic anemia in Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Anemia, Hemolytic, Autoimmune; Bilirubin; Child; Coombs Test; Erythrocyte A | 1967 |
Coombs'-positive hemolytic anemia in Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Anemia, Hemolytic, Autoimmune; Bilirubin; Child; Coombs Test; Erythrocyte A | 1967 |
Hodgkin's disease. Combined clinical staff conference at the National Institutes of Health.
Topics: Chlorambucil; Cyclophosphamide; Drug Synergism; Hodgkin Disease; Humans; Hypersensitivity, Delayed; | 1967 |
Hodgkin's disease. Combined clinical staff conference at the National Institutes of Health.
Topics: Chlorambucil; Cyclophosphamide; Drug Synergism; Hodgkin Disease; Humans; Hypersensitivity, Delayed; | 1967 |
Hypersensitivity to nitrogen mustards in the form of erythema multiforme. A unique adverse reaction.
Topics: Chlorambucil; Drug Hypersensitivity; Erythema Multiforme; Hodgkin Disease; Humans; Male; Mechloretha | 1967 |
Hypersensitivity to nitrogen mustards in the form of erythema multiforme. A unique adverse reaction.
Topics: Chlorambucil; Drug Hypersensitivity; Erythema Multiforme; Hodgkin Disease; Humans; Male; Mechloretha | 1967 |
Toxic epidermal necrolysis and malignant lymphoma.
Topics: Adult; Aged; Bendroflumethiazide; Chloramphenicol; Cyclizine; Female; Hodgkin Disease; Humans; Lymph | 1967 |
Toxic epidermal necrolysis and malignant lymphoma.
Topics: Adult; Aged; Bendroflumethiazide; Chloramphenicol; Cyclizine; Female; Hodgkin Disease; Humans; Lymph | 1967 |
[Treatment of Hodgkin's disease by polychemotherapy combining nitrogen mustard, vincristine, methylhydrazine and prednisone].
Topics: Hodgkin Disease; Humans; Hydrazines; Mechlorethamine; Prednisone; Vincristine | 1967 |
[Treatment of Hodgkin's disease by polychemotherapy combining nitrogen mustard, vincristine, methylhydrazine and prednisone].
Topics: Hodgkin Disease; Humans; Hydrazines; Mechlorethamine; Prednisone; Vincristine | 1967 |
Gonadal damage in Hodgkin's disease from cancer chemotherapeutic regimens.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Castration; Dacarbazin | 1984 |
Gonadal damage in Hodgkin's disease from cancer chemotherapeutic regimens.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Castration; Dacarbazin | 1984 |
[Acute non-lymphatic leukemia after treatment of Hodgkin's lymphoma with chemotherapy and radiotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cytarabine; Dacarbazine; Daunorubi | 1984 |
[Acute non-lymphatic leukemia after treatment of Hodgkin's lymphoma with chemotherapy and radiotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cytarabine; Dacarbazine; Daunorubi | 1984 |
Adriamycin, bleomycin, DIC, CCNU, and prednisone (ABDIC) chemotherapy in MOPP-resistant Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bleomycin; Dacarbazine; Doxorubicin; Drug Administra | 1980 |
Adriamycin, bleomycin, DIC, CCNU, and prednisone (ABDIC) chemotherapy in MOPP-resistant Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bleomycin; Dacarbazine; Doxorubicin; Drug Administra | 1980 |
Prognosis of Hodgkin's disease: patients who fail to remit or who relapse after combination chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bleomycin; Child; Child, Preschool; Drug Therapy, Co | 1980 |
Prognosis of Hodgkin's disease: patients who fail to remit or who relapse after combination chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bleomycin; Child; Child, Preschool; Drug Therapy, Co | 1980 |
[Stage IIIB and IVB Hodgkin's disease. Response to chemotherapy, relapses, survival rates (author's transl)].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 1981 |
[Stage IIIB and IVB Hodgkin's disease. Response to chemotherapy, relapses, survival rates (author's transl)].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 1981 |
The treatment of advanced hodgkin's disease.
Topics: Adolescent; Adult; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechl | 1981 |
The treatment of advanced hodgkin's disease.
Topics: Adolescent; Adult; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechl | 1981 |
Salvage chemotherapy with ABVD in MOPP-resistant Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleo | 1982 |
Salvage chemotherapy with ABVD in MOPP-resistant Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleo | 1982 |
Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Aged; Bleomycin; Child; Child, Preschool; Daca | 1982 |
Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Aged; Bleomycin; Child; Child, Preschool; Daca | 1982 |
[Lymphomas. Treatment of malignant lymphomas. Current observations and future prospects].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; | 1982 |
[Lymphomas. Treatment of malignant lymphomas. Current observations and future prospects].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; | 1982 |
Alternating drug combinations for advanced Hodgkin's disease.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxor | 1982 |
Alternating drug combinations for advanced Hodgkin's disease.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxor | 1982 |
[B-DOPA chemotherapy associated with local radiotherapy in children with malignant lymphoma].
Topics: Antineoplastic Agents; Bleomycin; Child; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Hodgki | 1982 |
[B-DOPA chemotherapy associated with local radiotherapy in children with malignant lymphoma].
Topics: Antineoplastic Agents; Bleomycin; Child; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Hodgki | 1982 |
Lasting Hb F reactivation and Hb A2 reduction induced by the treatment of Hodgkin's disease in a woman heterozygous for beta-thalassemia and the Swiss type of the heterocellular hereditary persistence of Hb F.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Fetal Hemoglobin; Globins; Hemoglobin | 1982 |
Lasting Hb F reactivation and Hb A2 reduction induced by the treatment of Hodgkin's disease in a woman heterozygous for beta-thalassemia and the Swiss type of the heterocellular hereditary persistence of Hb F.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Fetal Hemoglobin; Globins; Hemoglobin | 1982 |
Twelve years of experience with cytotoxic therapy in malignant tumors of the neck and head.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; | 1982 |
Twelve years of experience with cytotoxic therapy in malignant tumors of the neck and head.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; | 1982 |
Factors affecting relapse following chemotherapy for Hodgkin's disease.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dru | 1982 |
Factors affecting relapse following chemotherapy for Hodgkin's disease.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dru | 1982 |
Hodgkin's disease in renal transplant recipients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Drug Therapy, Combination; Hodgkin Diseas | 1983 |
Hodgkin's disease in renal transplant recipients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Drug Therapy, Combination; Hodgkin Diseas | 1983 |
Treatment of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD).
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; | 1982 |
Treatment of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD).
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; | 1982 |
[Chemotherapy in pretreated Hodgkin's disease with lomustine, bleomycin, vinblastine and dexamethasone].
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosph | 1983 |
[Chemotherapy in pretreated Hodgkin's disease with lomustine, bleomycin, vinblastine and dexamethasone].
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosph | 1983 |
Combination chemotherapy for the treatment of Hodgkin's disease in relapse. Results with lomustine (CCNU), melphalan (Alkeran), and vindesine (DVA) alone (CAD) and in alternation with MOPP and doxorubicin (Adriamycin), bleomycin, and vinblastine (ABV).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Female; H | 1983 |
Combination chemotherapy for the treatment of Hodgkin's disease in relapse. Results with lomustine (CCNU), melphalan (Alkeran), and vindesine (DVA) alone (CAD) and in alternation with MOPP and doxorubicin (Adriamycin), bleomycin, and vinblastine (ABV).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Female; H | 1983 |
Treatment of 49 unrandomized patients with advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1983 |
Treatment of 49 unrandomized patients with advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1983 |
MOPP treatment of resistant Hodgkin's disease following ABVD failure.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Do | 1983 |
MOPP treatment of resistant Hodgkin's disease following ABVD failure.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Do | 1983 |
Bone and soft tissue sarcomas in the follow-up of Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child, | 1983 |
Bone and soft tissue sarcomas in the follow-up of Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child, | 1983 |
Adriamycin combinations as salvage therapy in advanced MOPP-resistant Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Drug Resi | 1983 |
Adriamycin combinations as salvage therapy in advanced MOPP-resistant Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Drug Resi | 1983 |
Long-term follow-up with ABDIC salvage chemotherapy of MOPP-resistant Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Res | 1983 |
Long-term follow-up with ABDIC salvage chemotherapy of MOPP-resistant Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Res | 1983 |
[Adriamycin-based combination chemotherapy in the treatment of advanced malignant lymphoma. A progress report].
Topics: Adolescent; Adult; Aged; Anthraquinones; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; | 1984 |
[Adriamycin-based combination chemotherapy in the treatment of advanced malignant lymphoma. A progress report].
Topics: Adolescent; Adult; Aged; Anthraquinones; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; | 1984 |
Treatment of refractory lymphoproliferative diseases with daily, low-dose vincristine, continuous infusion of bleomycin, and high-dose prednisone.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Cell Count; Female; Ho | 1984 |
Treatment of refractory lymphoproliferative diseases with daily, low-dose vincristine, continuous infusion of bleomycin, and high-dose prednisone.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Cell Count; Female; Ho | 1984 |
Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1984 |
Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1984 |
[Hodgkin's disease: analysis of a reduction of chemotherapy].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Th | 1983 |
[Hodgkin's disease: analysis of a reduction of chemotherapy].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Th | 1983 |
Hypothalamic-pituitary-adrenal function in patients receiving intermittent high dose prednisone therapy for lymphoma.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Di | 1984 |
Hypothalamic-pituitary-adrenal function in patients receiving intermittent high dose prednisone therapy for lymphoma.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Di | 1984 |
Burkitt cell leukemia following treatment of Hodgkin's disease: report of a case and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Hodgkin Disease; Humans; Leuke | 1984 |
Burkitt cell leukemia following treatment of Hodgkin's disease: report of a case and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Hodgkin Disease; Humans; Leuke | 1984 |
Symposium on infectious complications of neoplastic disease (Part I). Introduction and epidemiology.
Topics: Abscess; Adult; Bacterial Infections; Bacteroides Infections; Cyclophosphamide; Escherichia coli Inf | 1984 |
Symposium on infectious complications of neoplastic disease (Part I). Introduction and epidemiology.
Topics: Abscess; Adult; Bacterial Infections; Bacteroides Infections; Cyclophosphamide; Escherichia coli Inf | 1984 |
[Graded chemotherapy and reduced radiotherapy in Hodgkin's disease in childhood. Intermediate report on the cooperative HD 82 therapy study].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Austria; Child; Child, Preschool; Combin | 1984 |
[Graded chemotherapy and reduced radiotherapy in Hodgkin's disease in childhood. Intermediate report on the cooperative HD 82 therapy study].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Austria; Child; Child, Preschool; Combin | 1984 |
An unusually severe subacute motor neuronopathy in Hodgkin's disease.
Topics: Female; Hodgkin Disease; Humans; Lumbosacral Region; Middle Aged; Motor Neurons; Neuromuscular Disea | 1984 |
An unusually severe subacute motor neuronopathy in Hodgkin's disease.
Topics: Female; Hodgkin Disease; Humans; Lumbosacral Region; Middle Aged; Motor Neurons; Neuromuscular Disea | 1984 |
Ovarian function in young women in long-term remission after treatment for Hodgkin's disease stage I or II.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Estrad | 1984 |
Ovarian function in young women in long-term remission after treatment for Hodgkin's disease stage I or II.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Estrad | 1984 |
Acute graft-versus-host disease resulting from normal donor blood transfusions.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Graft vs Host Disease; Histocompatibi | 1984 |
Acute graft-versus-host disease resulting from normal donor blood transfusions.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Graft vs Host Disease; Histocompatibi | 1984 |
Hodgkin's and non-Hodgkin's lymphomas masquerading as "idiopathic" liver granulomas.
Topics: Adult; Aged; Diagnosis, Differential; Female; Granuloma; Hepatitis; Hodgkin Disease; Humans; Lymphom | 1984 |
Hodgkin's and non-Hodgkin's lymphomas masquerading as "idiopathic" liver granulomas.
Topics: Adult; Aged; Diagnosis, Differential; Female; Granuloma; Hepatitis; Hodgkin Disease; Humans; Lymphom | 1984 |
[Myocardial infarction after mediastinal radiotherapy of Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 1984 |
[Myocardial infarction after mediastinal radiotherapy of Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 1984 |
[Treatment of recurrences of lymphogranulomatosis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Prednisone | 1984 |
[Treatment of recurrences of lymphogranulomatosis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Prednisone | 1984 |
A decision-analysis methodology for consideration of morbidity factors in clinical decision-making.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Decision Making; Hodgkin Disease; Huma | 1984 |
A decision-analysis methodology for consideration of morbidity factors in clinical decision-making.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Decision Making; Hodgkin Disease; Huma | 1984 |
Comparison of treatments for symptomatic Hodgkin's lymphoma employing decision analysis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Decision Making; Health Service | 1984 |
Comparison of treatments for symptomatic Hodgkin's lymphoma employing decision analysis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Decision Making; Health Service | 1984 |
[Aseptic necrosis of the femur head as a complication of intensive cytostatic, glucocorticoid and radiation therapy of lymphogranulomatosis].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Femur Head Necrosis; Gluc | 1984 |
[Aseptic necrosis of the femur head as a complication of intensive cytostatic, glucocorticoid and radiation therapy of lymphogranulomatosis].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Femur Head Necrosis; Gluc | 1984 |
[Hodgkin's disease of primary pericardial origin].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 1984 |
[Hodgkin's disease of primary pericardial origin].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 1984 |
[Various disputable problems of ambulatory treatment of tumors of the blood system].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Doxorubicin; Hodgkin | 1984 |
[Various disputable problems of ambulatory treatment of tumors of the blood system].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Doxorubicin; Hodgkin | 1984 |
Antibody-dependent cellular cytotoxicity in some lymphoreticular diseases.
Topics: Antibody-Dependent Cell Cytotoxicity; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphami | 1984 |
Antibody-dependent cellular cytotoxicity in some lymphoreticular diseases.
Topics: Antibody-Dependent Cell Cytotoxicity; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphami | 1984 |
Autoimmune neutropenia, hemolytic anemia, and reticulocytopenia in Hodgkin's disease.
Topics: Adult; Agranulocytosis; Anemia, Hemolytic, Autoimmune; Antineoplastic Combined Chemotherapy Protocol | 1984 |
Autoimmune neutropenia, hemolytic anemia, and reticulocytopenia in Hodgkin's disease.
Topics: Adult; Agranulocytosis; Anemia, Hemolytic, Autoimmune; Antineoplastic Combined Chemotherapy Protocol | 1984 |
[3-year results of the combined treatment of stage I and II lymphogranulomatosis patients].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 1984 |
[3-year results of the combined treatment of stage I and II lymphogranulomatosis patients].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 1984 |
[A combined therapy program for children with lymphogranulomatosis].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Child; Child, Preschool; Combine | 1984 |
[A combined therapy program for children with lymphogranulomatosis].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Child; Child, Preschool; Combine | 1984 |
Hodgkin's disease in children. Results of therapy in a mixed group of 178 clinical and pathologically staged patients over 13 years.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1984 |
Hodgkin's disease in children. Results of therapy in a mixed group of 178 clinical and pathologically staged patients over 13 years.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1984 |
Recovery of spermatogenesis after treatment for Hodgkin's disease: limiting dose of MOPP chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined M | 1984 |
Recovery of spermatogenesis after treatment for Hodgkin's disease: limiting dose of MOPP chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined M | 1984 |
Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combine | 1984 |
Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combine | 1984 |
Composite lymphoma: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma | 1984 |
Composite lymphoma: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma | 1984 |
[CVP or C-MOPP combination chemotherapy in the treatment of advanced Hodgkin's disease and non-Hodgkin's lymphoma (intermediate grade of working formulation)].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Hodgkin Disease; Hum | 1984 |
[CVP or C-MOPP combination chemotherapy in the treatment of advanced Hodgkin's disease and non-Hodgkin's lymphoma (intermediate grade of working formulation)].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Hodgkin Disease; Hum | 1984 |
[Second tumor following Hodgkin's disease].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child, Presc | 1984 |
[Second tumor following Hodgkin's disease].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child, Presc | 1984 |
[Treatment of Hodgkin's disease including the staging laparotomy].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female | 1984 |
[Treatment of Hodgkin's disease including the staging laparotomy].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female | 1984 |
Non-Hodgkin lymphoma following Hodgkin's disease. A case report.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Hodgkin Dis | 1984 |
Non-Hodgkin lymphoma following Hodgkin's disease. A case report.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Hodgkin Dis | 1984 |
[Experience with the management of patients with therapy-resistant Hodgkin's disease].
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Comb | 1984 |
[Experience with the management of patients with therapy-resistant Hodgkin's disease].
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Comb | 1984 |
[Evaluation of the efficacy of radiotherapy in the combined treatment of generalized Hodgkin's disease in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1984 |
[Evaluation of the efficacy of radiotherapy in the combined treatment of generalized Hodgkin's disease in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1984 |
Acute allergic reaction due to vincristine sulfate. A case report.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Drug Hyperse | 1984 |
Acute allergic reaction due to vincristine sulfate. A case report.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Drug Hyperse | 1984 |
Transient optic neuropathy secondary to MOPP chemotherapy in Hodgkin's disease: report of a case.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Female; Hodgkin Disease; Humans; Mechloretham | 1984 |
Transient optic neuropathy secondary to MOPP chemotherapy in Hodgkin's disease: report of a case.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Female; Hodgkin Disease; Humans; Mechloretham | 1984 |
Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line; Combined Modality Therapy; Drug Resistanc | 1984 |
Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line; Combined Modality Therapy; Drug Resistanc | 1984 |
[Prognostic value of the results of short-term polychemotherapy by the MOPP program of Hodgkin's disease stages III and IV].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; | 1984 |
[Prognostic value of the results of short-term polychemotherapy by the MOPP program of Hodgkin's disease stages III and IV].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; | 1984 |
[Chemotherapy for Hodgkin's disease during pregnancy--a case report].
Topics: Adult; Doxorubicin; Female; Fetal Growth Retardation; Hodgkin Disease; Humans; Prednisone; Pregnancy | 1983 |
[Chemotherapy for Hodgkin's disease during pregnancy--a case report].
Topics: Adult; Doxorubicin; Female; Fetal Growth Retardation; Hodgkin Disease; Humans; Prednisone; Pregnancy | 1983 |
[Secondary malignant tumors following treatment of Hodgkin's disease].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophospha | 1984 |
[Secondary malignant tumors following treatment of Hodgkin's disease].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophospha | 1984 |
[Thrombotic thrombopenic purpura associated with Hodgkin's disease].
Topics: Adult; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Prednisone | 1983 |
[Thrombotic thrombopenic purpura associated with Hodgkin's disease].
Topics: Adult; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Prednisone | 1983 |
An evaluation of long-term survival and treatment complications in children with Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Drug Therapy, Combination; Evalua | 1983 |
An evaluation of long-term survival and treatment complications in children with Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Drug Therapy, Combination; Evalua | 1983 |
[Chemotherapy of Hodgkin disease with modified MOPP].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Dose-Res | 1983 |
[Chemotherapy of Hodgkin disease with modified MOPP].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Dose-Res | 1983 |
[Acute leukemias and solid tumors in the course of Hodgkin disease].
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protoco | 1983 |
[Acute leukemias and solid tumors in the course of Hodgkin disease].
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protoco | 1983 |
Diagnosis and management of Hodgkin's disease in the adult.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Ho | 1983 |
Diagnosis and management of Hodgkin's disease in the adult.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Ho | 1983 |
Simultaneous occurrence of mycosis fungoides and Hodgkin disease: clinical and histologic correlations in three cases with ultrastructural studies in two.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Lymph | 1983 |
Simultaneous occurrence of mycosis fungoides and Hodgkin disease: clinical and histologic correlations in three cases with ultrastructural studies in two.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Lymph | 1983 |
Stage I-II Hodgkin's disease: current therapeutic options and recommendations.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Laparotomy; Mechlorethamine | 1983 |
Stage I-II Hodgkin's disease: current therapeutic options and recommendations.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Laparotomy; Mechlorethamine | 1983 |
Menstrual cycle, pregnancies and offspring before and after MOPP therapy for Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Thera | 1983 |
Menstrual cycle, pregnancies and offspring before and after MOPP therapy for Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Thera | 1983 |
[Myocardial infarct, acute coronary insufficiency and sudden death in lymphogranulomatosis patients after irradiation of the mediastinum].
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Coronary Disease; Cyclophospha | 1983 |
[Myocardial infarct, acute coronary insufficiency and sudden death in lymphogranulomatosis patients after irradiation of the mediastinum].
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Coronary Disease; Cyclophospha | 1983 |
Early response to chemotherapy as a prognostic factor in Hodgkin's disease.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Ho | 1983 |
Early response to chemotherapy as a prognostic factor in Hodgkin's disease.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Ho | 1983 |
Second malignancy complicating Hodgkin's disease.
Topics: Acute Disease; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cycloph | 1983 |
Second malignancy complicating Hodgkin's disease.
Topics: Acute Disease; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cycloph | 1983 |
[Recurrence in Hodgkin's disease: incidence, therapy and prognosis. (Experience with 134 patients)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Mediastina | 1983 |
[Recurrence in Hodgkin's disease: incidence, therapy and prognosis. (Experience with 134 patients)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Mediastina | 1983 |
[Peculiarities of the recurrence of lymphogranulomatosis in children following combined chemotherapy].
Topics: Age Factors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophos | 1983 |
[Peculiarities of the recurrence of lymphogranulomatosis in children following combined chemotherapy].
Topics: Age Factors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophos | 1983 |
Acute nonlymphocytic leukemia after treatment for Hodgkin's disease.
Topics: Acute Disease; Adult; Age Factors; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 1983 |
Acute nonlymphocytic leukemia after treatment for Hodgkin's disease.
Topics: Acute Disease; Adult; Age Factors; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 1983 |
Primary Hodgkin's disease of the lung. Case report and review of the literature.
Topics: Adult; Alcohol Drinking; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Lu | 1983 |
Primary Hodgkin's disease of the lung. Case report and review of the literature.
Topics: Adult; Alcohol Drinking; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Lu | 1983 |
Sequential non-cross-resistant chemotherapy regimens (MOPP and CAVmP) in Hodgkin's disease stage IIIB and IV.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1983 |
Sequential non-cross-resistant chemotherapy regimens (MOPP and CAVmP) in Hodgkin's disease stage IIIB and IV.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1983 |
Osteonecrosis of the femoral head following treatment for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Femur Head | 1983 |
Osteonecrosis of the femoral head following treatment for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Femur Head | 1983 |
[Radiation pericarditis following treatment of lymphogranulomatosis].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclop | 1983 |
[Radiation pericarditis following treatment of lymphogranulomatosis].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclop | 1983 |
Prognostic significance of large mediastinal involvement in Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female | 1983 |
Prognostic significance of large mediastinal involvement in Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female | 1983 |
Hodgkin disease clinical stages I, II, and III (A, B): results of radiotherapy with or without chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cesi | 1983 |
Hodgkin disease clinical stages I, II, and III (A, B): results of radiotherapy with or without chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cesi | 1983 |
Results of treatment of 18 children with Hodgkin disease with MOPP chemotherapy as the only treatment modality.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Growth | 1983 |
Results of treatment of 18 children with Hodgkin disease with MOPP chemotherapy as the only treatment modality.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Growth | 1983 |
[Recurrences in lymphogranulomatosis].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Fe | 1983 |
[Recurrences in lymphogranulomatosis].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Fe | 1983 |
[Myocardial infarct in a patient with Hodgkin's disease treated with cyclic polychemotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Male; Mechlorethamin | 1983 |
[Myocardial infarct in a patient with Hodgkin's disease treated with cyclic polychemotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Male; Mechlorethamin | 1983 |
Treatment of early stage Hodgkin's disease with radiation therapy plus short-cycle (3 MOPP) adjuvant chemotherapy.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Evaluation S | 1983 |
Treatment of early stage Hodgkin's disease with radiation therapy plus short-cycle (3 MOPP) adjuvant chemotherapy.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Evaluation S | 1983 |
A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Dose-Response Relationship, Drug | 1983 |
A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Dose-Response Relationship, Drug | 1983 |
Successful pregnancy during combination chemotherapy for Hodgkin's disease.
Topics: Adult; Cyclophosphamide; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Prednisone; Pre | 1980 |
Successful pregnancy during combination chemotherapy for Hodgkin's disease.
Topics: Adult; Cyclophosphamide; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Prednisone; Pre | 1980 |
Chemotherapy-radiotherapy versus chemotherapy in Hodgkin's disease with bone marrow involvement. Retrospective analysis of 32 cases.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Child | 1981 |
Chemotherapy-radiotherapy versus chemotherapy in Hodgkin's disease with bone marrow involvement. Retrospective analysis of 32 cases.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Child | 1981 |
[Hodgkin's disease in children: long-term therapeutic results (author's transl)].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Hodgkin | 1981 |
[Hodgkin's disease in children: long-term therapeutic results (author's transl)].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Hodgkin | 1981 |
Acute erythroblastic leukemia terminating a very long-lasting (27 years) Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Leukemia, Er | 1982 |
Acute erythroblastic leukemia terminating a very long-lasting (27 years) Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Leukemia, Er | 1982 |
[Radiotherapy of lymphogranulomatosis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Hodgkin Disease; Humans; | 1982 |
[Radiotherapy of lymphogranulomatosis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Hodgkin Disease; Humans; | 1982 |
[Chemotherapy of Hodgkin disease].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Ho | 1982 |
[Chemotherapy of Hodgkin disease].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Ho | 1982 |
[Clinical and hematological characteristics and MOPP tolerance of patients with Hodgkin's lymphoma in the bone marrow].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Drug | 1982 |
[Clinical and hematological characteristics and MOPP tolerance of patients with Hodgkin's lymphoma in the bone marrow].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Drug | 1982 |
The effective use of combined modality therapy for the treatment of patients with Hodgkin's disease who relapsed following radiotherapy.
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Recur | 1983 |
The effective use of combined modality therapy for the treatment of patients with Hodgkin's disease who relapsed following radiotherapy.
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Recur | 1983 |
Radiation as salvage therapy for patients with Hodgkin's disease relapsing after MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy.
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vincr | 1983 |
Radiation as salvage therapy for patients with Hodgkin's disease relapsing after MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy.
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vincr | 1983 |
Pretreatment nausea in cancer chemotherapy: a conditioned response?
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Conditioning, Psycholo | 1980 |
Pretreatment nausea in cancer chemotherapy: a conditioned response?
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Conditioning, Psycholo | 1980 |
Irradiation in the treatment of Hodgkin disease: a follow-up report.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Co | 1981 |
Irradiation in the treatment of Hodgkin disease: a follow-up report.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Co | 1981 |
[Results with MOPP combination chemotherapy in Hodgkin's disease (author's transl)].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Female; Hodgkin Dise | 1981 |
[Results with MOPP combination chemotherapy in Hodgkin's disease (author's transl)].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Female; Hodgkin Dise | 1981 |
[Combined therapy of lymphogranulomatosis].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Drug The | 1981 |
[Combined therapy of lymphogranulomatosis].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Drug The | 1981 |
Survival in Hodgkin's disease: the role of immunocompetence and other major risk factors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Female; Hodgkin Di | 1982 |
Survival in Hodgkin's disease: the role of immunocompetence and other major risk factors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Female; Hodgkin Di | 1982 |
Reasons for failure of MOPP to cure Hodgkin's disease: The importance of dose and schedule.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Dose-Response Relati | 1982 |
Reasons for failure of MOPP to cure Hodgkin's disease: The importance of dose and schedule.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Dose-Response Relati | 1982 |
[10 years of DeVita protocol].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Hodgkin Disease; Humans; | 1982 |
[10 years of DeVita protocol].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Hodgkin Disease; Humans; | 1982 |
[Lymphoid interstitial pneumonia. Presentation of 2 cases with follow-up].
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diag | 1982 |
[Lymphoid interstitial pneumonia. Presentation of 2 cases with follow-up].
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diag | 1982 |
Microbicidal activity of peripheral blood monocytes from patients with Hodgkin's disease for Toxoplasma gondii.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cells, Cultured; Chlorambucil; Hodgkin Disease; Huma | 1982 |
Microbicidal activity of peripheral blood monocytes from patients with Hodgkin's disease for Toxoplasma gondii.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cells, Cultured; Chlorambucil; Hodgkin Disease; Huma | 1982 |
[Hodgkin's disease in childhood: long term results].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Drug Therapy, C | 1982 |
[Hodgkin's disease in childhood: long term results].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Drug Therapy, C | 1982 |
[Treatment procedure in generalized lymphogranulomatosis in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid | 1982 |
[Treatment procedure in generalized lymphogranulomatosis in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid | 1982 |
[Treatment of lymphogranulomatosis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Hodgkin Disease; Humans; | 1982 |
[Treatment of lymphogranulomatosis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Hodgkin Disease; Humans; | 1982 |
[3-Year results of the combined (polychemo- and radio-) therapy of stage IIIB-IV lymphogranulomatosis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Therapy, Combination; Hodgkin | 1982 |
[3-Year results of the combined (polychemo- and radio-) therapy of stage IIIB-IV lymphogranulomatosis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Therapy, Combination; Hodgkin | 1982 |
[Pregnancies and offspring after MOPP therapy].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Fertility; Fetus; Hodgkin | 1982 |
[Pregnancies and offspring after MOPP therapy].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Fertility; Fetus; Hodgkin | 1982 |
[Combination chemotherapy of Hodgkin's disease with vincristine, cyclophosphamide, procarbazine, and prednisolone].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Ther | 1982 |
[Combination chemotherapy of Hodgkin's disease with vincristine, cyclophosphamide, procarbazine, and prednisolone].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Ther | 1982 |
Radiation pneumonia complicating adjuvant cytotoxic chemotherapy.
Topics: Adult; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Pneumonia; Prednisone; Radiation | 1980 |
Radiation pneumonia complicating adjuvant cytotoxic chemotherapy.
Topics: Adult; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Pneumonia; Prednisone; Radiation | 1980 |
Hodgkin's disease and acute promyelocytic leukaemia. A case report.
Topics: Adult; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Male; Mechloret | 1980 |
Hodgkin's disease and acute promyelocytic leukaemia. A case report.
Topics: Adult; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Male; Mechloret | 1980 |
Hodgkin's disease; tracheoesophageal fistula during MOPP chemotherapy.
Topics: Adult; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Mechloreth | 1981 |
Hodgkin's disease; tracheoesophageal fistula during MOPP chemotherapy.
Topics: Adult; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Mechloreth | 1981 |
Hodgkin's lymphoma: a complication of small bowel Crohn's disease.
Topics: Adenocarcinoma; Adult; Crohn Disease; Hodgkin Disease; Humans; Jejunal Diseases; Jejunal Neoplasms; | 1982 |
Hodgkin's lymphoma: a complication of small bowel Crohn's disease.
Topics: Adenocarcinoma; Adult; Crohn Disease; Hodgkin Disease; Humans; Jejunal Diseases; Jejunal Neoplasms; | 1982 |
[Chemotherapy of malignant lymphoma].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; | 1982 |
[Chemotherapy of malignant lymphoma].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; | 1982 |
Persistent immunologic abnormalities in long-term survivors of advanced Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Erythrocytes; Hodgkin Disease; Humans | 1980 |
Persistent immunologic abnormalities in long-term survivors of advanced Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Erythrocytes; Hodgkin Disease; Humans | 1980 |
[Drug therapy of Hodgkin's disease].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Ho | 1981 |
[Drug therapy of Hodgkin's disease].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Ho | 1981 |
Long-term complications of MOPP chemotherapy in patients with Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; Female | 1982 |
Long-term complications of MOPP chemotherapy in patients with Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; Female | 1982 |
Prognostic factors in COPP-treated patients with Hodgkin's disease.
Topics: Cyclophosphamide; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Leukocyte Count; Male; | 1982 |
Prognostic factors in COPP-treated patients with Hodgkin's disease.
Topics: Cyclophosphamide; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Leukocyte Count; Male; | 1982 |
Supradiaphragmatic Hodgkin's disease: is there a role for MOPP chemotherapy in patients with bulky mediastinal disease?
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Mediastinal Neoplasms; Predniso | 1980 |
Supradiaphragmatic Hodgkin's disease: is there a role for MOPP chemotherapy in patients with bulky mediastinal disease?
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Mediastinal Neoplasms; Predniso | 1980 |
Long-term survival of patients with Hodgkin's disease. Treatment with cyclophosphamide, vinblastine, procarbazine, and prednisone.
Topics: Adult; Age Factors; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin | 1981 |
Long-term survival of patients with Hodgkin's disease. Treatment with cyclophosphamide, vinblastine, procarbazine, and prednisone.
Topics: Adult; Age Factors; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin | 1981 |
[Pruritus in Hodgkin's disease responding to cimetidine].
Topics: Adult; Cimetidine; Female; Guanidines; Hodgkin Disease; Humans; Lomustine; Prednisone; Procarbazine; | 1981 |
[Pruritus in Hodgkin's disease responding to cimetidine].
Topics: Adult; Cimetidine; Female; Guanidines; Hodgkin Disease; Humans; Lomustine; Prednisone; Procarbazine; | 1981 |
Avascular necrosis of bone in Hodgkin's disease patients treated with combined modality therapy.
Topics: Adult; Antineoplastic Agents; Drug Therapy, Combination; Female; Femur Head Necrosis; Hodgkin Diseas | 1981 |
Avascular necrosis of bone in Hodgkin's disease patients treated with combined modality therapy.
Topics: Adult; Antineoplastic Agents; Drug Therapy, Combination; Female; Femur Head Necrosis; Hodgkin Diseas | 1981 |
Protection of ovarian function by oral contraceptives in women receiving chemotherapy for Hodgkin's disease.
Topics: Adolescent; Adult; Contraceptives, Oral; Female; Hodgkin Disease; Humans; Mechlorethamine; Menstruat | 1981 |
Protection of ovarian function by oral contraceptives in women receiving chemotherapy for Hodgkin's disease.
Topics: Adolescent; Adult; Contraceptives, Oral; Female; Hodgkin Disease; Humans; Mechlorethamine; Menstruat | 1981 |
Long-term follow up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's disease.
Topics: Adolescent; Adult; Amenorrhea; Antineoplastic Agents; Female; Follow-Up Studies; Hodgkin Disease; Ho | 1981 |
Long-term follow up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's disease.
Topics: Adolescent; Adult; Amenorrhea; Antineoplastic Agents; Female; Follow-Up Studies; Hodgkin Disease; Ho | 1981 |
[The current state of curability of Hodgkin's disease].
Topics: Chromosome Aberrations; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukemia; Mechlorethamin | 1981 |
[The current state of curability of Hodgkin's disease].
Topics: Chromosome Aberrations; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukemia; Mechlorethamin | 1981 |
[Evaluation of serum BuChe activity during polychemotherapy based on COP and C-MOPP protocols].
Topics: Cholinesterases; Cyclophosphamide; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Ovari | 1981 |
[Evaluation of serum BuChe activity during polychemotherapy based on COP and C-MOPP protocols].
Topics: Cholinesterases; Cyclophosphamide; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Ovari | 1981 |
Evaluation of the significance of prognostic factors in stage III Hodgkin's disease treated with MOPP and radiotherapy.
Topics: Adult; Antineoplastic Agents; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Hepati | 1980 |
Evaluation of the significance of prognostic factors in stage III Hodgkin's disease treated with MOPP and radiotherapy.
Topics: Adult; Antineoplastic Agents; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Hepati | 1980 |
Individual changes of DNA catabolite excretion in the course of antitumor therapy of Hodgkin's disease.
Topics: Cyclophosphamide; Deoxycytidine; Deoxyuridine; Hodgkin Disease; Humans; Prednisone; Procarbazine; Th | 1980 |
Individual changes of DNA catabolite excretion in the course of antitumor therapy of Hodgkin's disease.
Topics: Cyclophosphamide; Deoxycytidine; Deoxyuridine; Hodgkin Disease; Humans; Prednisone; Procarbazine; Th | 1980 |
[Bilateral total hip prosthesis in an aseptic osteonecrosis following intermittent steroid therapy in hodgkin's disease (author's transl)].
Topics: Adult; Female; Femur Head Necrosis; Hip Prosthesis; Hodgkin Disease; Humans; Prednisone | 1980 |
[Bilateral total hip prosthesis in an aseptic osteonecrosis following intermittent steroid therapy in hodgkin's disease (author's transl)].
Topics: Adult; Female; Femur Head Necrosis; Hip Prosthesis; Hodgkin Disease; Humans; Prednisone | 1980 |
The cure of disseminated Hodgkin's disease: prospects and problems.
Topics: Antineoplastic Agents; Drug Administration Schedule; Drug Therapy, Combination; Hodgkin Disease; Hum | 1980 |
The cure of disseminated Hodgkin's disease: prospects and problems.
Topics: Antineoplastic Agents; Drug Administration Schedule; Drug Therapy, Combination; Hodgkin Disease; Hum | 1980 |
Hodgkin's disease presenting as steroid-responsive pancytopenia.
Topics: Adult; Antineoplastic Agents; Blood Cell Count; Drug Therapy, Combination; Hodgkin Disease; Humans; | 1980 |
Hodgkin's disease presenting as steroid-responsive pancytopenia.
Topics: Adult; Antineoplastic Agents; Blood Cell Count; Drug Therapy, Combination; Hodgkin Disease; Humans; | 1980 |
Skin infiltration in Hodgkin's disease.
Topics: Adult; Drug Therapy, Combination; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Procar | 1980 |
Skin infiltration in Hodgkin's disease.
Topics: Adult; Drug Therapy, Combination; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Procar | 1980 |
Osteonecrosis in patients with Hodgkin disease following combination chemotherapy.
Topics: Adult; Drug Therapy, Combination; Female; Femur Head Necrosis; Hodgkin Disease; Humans; Mechloretham | 1980 |
Osteonecrosis in patients with Hodgkin disease following combination chemotherapy.
Topics: Adult; Drug Therapy, Combination; Female; Femur Head Necrosis; Hodgkin Disease; Humans; Mechloretham | 1980 |
[Aseptic osteonecrosis in Hodgkin's disease].
Topics: Adult; Femur Head Necrosis; Hodgkin Disease; Humans; Male; Prednisone | 1980 |
[Aseptic osteonecrosis in Hodgkin's disease].
Topics: Adult; Femur Head Necrosis; Hodgkin Disease; Humans; Male; Prednisone | 1980 |
[Comments about use of polychemotherapy MOPP associated with radiotherapy in the treatment of early stages of Hodgkin's disease. Preliminary report of 58 patients (author's transl)].
Topics: Adolescent; Adult; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans | 1980 |
[Comments about use of polychemotherapy MOPP associated with radiotherapy in the treatment of early stages of Hodgkin's disease. Preliminary report of 58 patients (author's transl)].
Topics: Adolescent; Adult; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans | 1980 |
Hodgkin's disease in South African children.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Follo | 1981 |
Hodgkin's disease in South African children.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Follo | 1981 |
[Evaluation of early treatment results in Hodgkin's disease during the cytostatic protocol containing methotrexate].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Ep | 1995 |
[Evaluation of early treatment results in Hodgkin's disease during the cytostatic protocol containing methotrexate].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Ep | 1995 |
Lymphocytosis of large granular lymphocytes in patients with Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD3 Complex; Dacarbazine; Doxorubicin; Et | 1995 |
Lymphocytosis of large granular lymphocytes in patients with Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD3 Complex; Dacarbazine; Doxorubicin; Et | 1995 |
Continuous infusion ABDIC therapy for relapsed or refractory Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Fe | 1994 |
Continuous infusion ABDIC therapy for relapsed or refractory Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Fe | 1994 |
High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease--a 6-year update.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Tr | 1993 |
High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease--a 6-year update.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Tr | 1993 |
Pediatric Hodgkin's disease in Costa Rica: twelve years' experience of primary treatment by chemotherapy alone, without staging laparotomy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cyta | 1994 |
Pediatric Hodgkin's disease in Costa Rica: twelve years' experience of primary treatment by chemotherapy alone, without staging laparotomy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cyta | 1994 |
Early-stage Hodgkin's disease: long-term results with radiotherapy alone or combined radiotherapy and chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Combin | 1994 |
Early-stage Hodgkin's disease: long-term results with radiotherapy alone or combined radiotherapy and chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Combin | 1994 |
Analysis of long-term results and prognostic factors among 138 patients with advanced Hodgkin's disease treated with the alternating MOPP/ABVD chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Sedimentation; B | 1994 |
Analysis of long-term results and prognostic factors among 138 patients with advanced Hodgkin's disease treated with the alternating MOPP/ABVD chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Sedimentation; B | 1994 |
Hodgkin's disease with a mediastinal mass greater than 10 cm: results of four different treatment approaches.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1994 |
Hodgkin's disease with a mediastinal mass greater than 10 cm: results of four different treatment approaches.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1994 |
Results of CAV regimen (CCNU, melphalan, and VP-16) as third-line salvage therapy for Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dox | 1994 |
Results of CAV regimen (CCNU, melphalan, and VP-16) as third-line salvage therapy for Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dox | 1994 |
[A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined | 1994 |
[A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined | 1994 |
Lymphocyte predominant Hodgkin's disease: a clinicopathologic comparative study of histologic and immunophenotypic subtypes.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; B-L | 1995 |
Lymphocyte predominant Hodgkin's disease: a clinicopathologic comparative study of histologic and immunophenotypic subtypes.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; B-L | 1995 |
Primary Hodgkin's disease of the bone.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Doxorubicin; Femal | 1995 |
Primary Hodgkin's disease of the bone.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Doxorubicin; Femal | 1995 |
[Lung fibrosis after bleomycin therapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Hodgkin Disease; Humans | 1994 |
[Lung fibrosis after bleomycin therapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Hodgkin Disease; Humans | 1994 |
Spontaneous fracture of the outlet catheter of a totally implanted catheter system (Port-A-Cath).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Catheterization, Central Veno | 1994 |
Spontaneous fracture of the outlet catheter of a totally implanted catheter system (Port-A-Cath).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Catheterization, Central Veno | 1994 |
Autologous stem cell transplantation as adjuvant treatment vs no further therapy for poor-risk Hodgkin's disease in first complete remission after MOPP/ABVD.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubic | 1995 |
Autologous stem cell transplantation as adjuvant treatment vs no further therapy for poor-risk Hodgkin's disease in first complete remission after MOPP/ABVD.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubic | 1995 |
Hybrid MOPP/ABVD and radiotherapy in advanced Hodgkin's disease.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomyc | 1995 |
Hybrid MOPP/ABVD and radiotherapy in advanced Hodgkin's disease.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomyc | 1995 |
Factor VIII inhibitor prior to and during secondary acute nonlymphocytic leukemia in a patient with cured Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Blood Transfusion; Combined Modality | 1995 |
Factor VIII inhibitor prior to and during secondary acute nonlymphocytic leukemia in a patient with cured Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Blood Transfusion; Combined Modality | 1995 |
Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Base Sequ | 1995 |
Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Base Sequ | 1995 |
[Hodgkin disease and amyloidosis].
Topics: Adult; Amyloidosis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubi | 1994 |
[Hodgkin disease and amyloidosis].
Topics: Adult; Amyloidosis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubi | 1994 |
Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Cells; Bone Marr | 1995 |
Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Cells; Bone Marr | 1995 |
[Analysis of prognostic factors of Hodgkin's disease with Cox model].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Co | 1994 |
[Analysis of prognostic factors of Hodgkin's disease with Cox model].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Co | 1994 |
MOPP, ABVD, or both to treat Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease | 1993 |
MOPP, ABVD, or both to treat Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease | 1993 |
MOPP, ABVD, or both to treat Hodgkin's disease.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxor | 1993 |
MOPP, ABVD, or both to treat Hodgkin's disease.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxor | 1993 |
C-MOPP/ABV yields good results in a public hospital population with Hodgkin disease in Brazil.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Cyclophosphami | 1993 |
C-MOPP/ABV yields good results in a public hospital population with Hodgkin disease in Brazil.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Cyclophosphami | 1993 |
Hodgkin's disease associated with central pontine myelinolysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Demyelinating Disease | 1993 |
Hodgkin's disease associated with central pontine myelinolysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Demyelinating Disease | 1993 |
Hodgkin's disease with bulky mediastinal involvement: effective management with combined modality therapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1993 |
Hodgkin's disease with bulky mediastinal involvement: effective management with combined modality therapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1993 |
MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavorably presenting Hodgkin's disease: a report from the Italian Lymphoma Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1993 |
MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavorably presenting Hodgkin's disease: a report from the Italian Lymphoma Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1993 |
Are alkylating agents a necessary component in the therapy of Hodgkin's disease.
Topics: Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Hodgkin Disease; Human | 1993 |
Are alkylating agents a necessary component in the therapy of Hodgkin's disease.
Topics: Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Hodgkin Disease; Human | 1993 |
Wide-field radiation therapy with or without chemotherapy for patients with Hodgkin disease in relapse after initial combination chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child, Preschool | 1993 |
Wide-field radiation therapy with or without chemotherapy for patients with Hodgkin disease in relapse after initial combination chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child, Preschool | 1993 |
Pediatric stage IV Hodgkin disease. Long-term survival.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Ther | 1993 |
Pediatric stage IV Hodgkin disease. Long-term survival.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Ther | 1993 |
COP-BLAM multidrug infusion chemotherapies for lymphoma: results in a community hospital setting.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 1993 |
COP-BLAM multidrug infusion chemotherapies for lymphoma: results in a community hospital setting.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 1993 |
A new chemotherapy regimen for treatment of Hodgkin's disease associated with minimal genotoxicity.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Cycle; Chro | 1993 |
A new chemotherapy regimen for treatment of Hodgkin's disease associated with minimal genotoxicity.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Cycle; Chro | 1993 |
Hodgkin's disease and non-Hodgkin's lymphoma in an HIV positive patient.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Dexametha | 1993 |
Hodgkin's disease and non-Hodgkin's lymphoma in an HIV positive patient.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Dexametha | 1993 |
Thymic hyperplasia in adults following chemotherapy for malignancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin | 1993 |
Thymic hyperplasia in adults following chemotherapy for malignancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin | 1993 |
[Effectiveness of chemotherapy and radiotherapy in 60 cases of Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cobalt Ra | 1993 |
[Effectiveness of chemotherapy and radiotherapy in 60 cases of Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cobalt Ra | 1993 |
[Cardiomyopathy in the course of treating Hodgkin's disease in a 12-year old girl].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Female; | 1993 |
[Cardiomyopathy in the course of treating Hodgkin's disease in a 12-year old girl].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Female; | 1993 |
Induction of ovarian function by using short-term human menopausal gonadotrophin in patients with ovarian failure following cytotoxic chemotherapy for haematological malignancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmu | 1993 |
Induction of ovarian function by using short-term human menopausal gonadotrophin in patients with ovarian failure following cytotoxic chemotherapy for haematological malignancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmu | 1993 |
Late relapses in Hodgkin's disease: outcome of patients relapsing more than twelve months after primary chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; | 1993 |
Late relapses in Hodgkin's disease: outcome of patients relapsing more than twelve months after primary chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; | 1993 |
[Breast cancer after treatment of Hodgkin's disease].
Topics: Adenocarcinoma; Adult; Aftercare; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; | 1995 |
[Breast cancer after treatment of Hodgkin's disease].
Topics: Adenocarcinoma; Adult; Aftercare; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; | 1995 |
Late cardiac effects after treatment for childhood Hodgkin's disease with chemotherapy and low-dose radiotherapy.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Com | 1995 |
Late cardiac effects after treatment for childhood Hodgkin's disease with chemotherapy and low-dose radiotherapy.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Com | 1995 |
Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Lymphocytes; Lymphoma, B-Ce | 1995 |
Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Lymphocytes; Lymphoma, B-Ce | 1995 |
Hodgkin's disease presenting as nephrotic syndrome.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Hodgkin Diseas | 1994 |
Hodgkin's disease presenting as nephrotic syndrome.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Hodgkin Diseas | 1994 |
Pregnancy after autologous bone marrow transplantation for malignant lymphomas.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cyt | 1994 |
Pregnancy after autologous bone marrow transplantation for malignant lymphomas.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cyt | 1994 |
Hodgkin's disease following steroid-resistant idiopathic nephrotic syndrome.
Topics: Child; Cyclosporine; Drug Resistance; Hodgkin Disease; Humans; Lymph Nodes; Male; Mediastinum; Nephr | 1994 |
Hodgkin's disease following steroid-resistant idiopathic nephrotic syndrome.
Topics: Child; Cyclosporine; Drug Resistance; Hodgkin Disease; Humans; Lymph Nodes; Male; Mediastinum; Nephr | 1994 |
Meningioma-like cerebral relapse of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fatal Outcome; Female; Ho | 1994 |
Meningioma-like cerebral relapse of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fatal Outcome; Female; Ho | 1994 |
Myelodysplastic syndrome after autologous transplant for lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hematopoietic Stem Cell Transplantation; Hodgkin Dis | 1994 |
Myelodysplastic syndrome after autologous transplant for lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hematopoietic Stem Cell Transplantation; Hodgkin Dis | 1994 |
Curative radiotherapy is the best single treatment modality for the favorable early stage Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Disease; | 1994 |
Curative radiotherapy is the best single treatment modality for the favorable early stage Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Disease; | 1994 |
Second malignant neoplasms in patients with Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Combined Moda | 1994 |
Second malignant neoplasms in patients with Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Combined Moda | 1994 |
Second primary cancers in patients continuously disease-free from Hodgkin's disease: a protective role for the spleen?
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modal | 1994 |
Second primary cancers in patients continuously disease-free from Hodgkin's disease: a protective role for the spleen?
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modal | 1994 |
Comparative dosimetry of O6-methylguanine in humans and rodents treated with procarbazine.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; DNA; Guanine; Hodgkin Disease; Humans; Leuk | 1994 |
Comparative dosimetry of O6-methylguanine in humans and rodents treated with procarbazine.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; DNA; Guanine; Hodgkin Disease; Humans; Leuk | 1994 |
Treatment of early stages of Hodgkin's disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 1994 |
Treatment of early stages of Hodgkin's disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 1994 |
Malignant schwannoma following treatment for Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Female | 1994 |
Malignant schwannoma following treatment for Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Female | 1994 |
Chromosomal damage in sperm of patients surviving Hodgkin's disease following MOPP (nitrogen mustard, vincristine, procarbazine, and prednisone) therapy with and without radiotherapy.
Topics: Adolescent; Adult; Aneuploidy; Animals; Antineoplastic Combined Chemotherapy Protocols; Chromosome A | 1994 |
Chromosomal damage in sperm of patients surviving Hodgkin's disease following MOPP (nitrogen mustard, vincristine, procarbazine, and prednisone) therapy with and without radiotherapy.
Topics: Adolescent; Adult; Aneuploidy; Animals; Antineoplastic Combined Chemotherapy Protocols; Chromosome A | 1994 |
Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclop | 1994 |
Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclop | 1994 |
The successful treatment of recurrent nephrotic syndrome with the MOPP regimen in a patient with a remote history of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Male; Mechlorethamine; Midd | 1994 |
The successful treatment of recurrent nephrotic syndrome with the MOPP regimen in a patient with a remote history of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Male; Mechlorethamine; Midd | 1994 |
The gallium scan predicts relapse in patients with Hodgkin's disease treated with combined modality therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Gallium; Hodgkin Disease; | 1994 |
The gallium scan predicts relapse in patients with Hodgkin's disease treated with combined modality therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Gallium; Hodgkin Disease; | 1994 |
Late cardiac toxicity of doxorubicin, epirubicin, and mitoxantrone therapy for Hodgkin's disease in adults.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Epirubicin; Female; Follow-Up St | 1993 |
Late cardiac toxicity of doxorubicin, epirubicin, and mitoxantrone therapy for Hodgkin's disease in adults.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Epirubicin; Female; Follow-Up St | 1993 |
A technique using parallel-opposed high energy electron beams for reirradiation of tumors near the spinal cord.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Mechloretham | 1993 |
A technique using parallel-opposed high energy electron beams for reirradiation of tumors near the spinal cord.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Mechloretham | 1993 |
Ethical decision-making processes used by health care providers.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Decision Making; Decision Theory; Ethical Ana | 1993 |
Ethical decision-making processes used by health care providers.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Decision Making; Decision Theory; Ethical Ana | 1993 |
Gonadal function in prepubertal boys following treatment for Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid | 1993 |
Gonadal function in prepubertal boys following treatment for Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid | 1993 |
Breast cancer developing after therapy for Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intr | 1993 |
Breast cancer developing after therapy for Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intr | 1993 |
Membranous nephropathy associated with nodular sclerosing Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Glomerulonephritis, Membranous; Ho | 1993 |
Membranous nephropathy associated with nodular sclerosing Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Glomerulonephritis, Membranous; Ho | 1993 |
Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di | 1993 |
Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di | 1993 |
[Non-Hodgkin's lymphoma in a patient after many years of remission of Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Lymphoma, No | 1995 |
[Non-Hodgkin's lymphoma in a patient after many years of remission of Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Lymphoma, No | 1995 |
Synchronous presentation of Epstein-Barr virus-associated Hodgkin's disease and adult T-cell leukemia/lymphoma (ATLL) in a patient from an endemic area of ATLL.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazi | 1995 |
Synchronous presentation of Epstein-Barr virus-associated Hodgkin's disease and adult T-cell leukemia/lymphoma (ATLL) in a patient from an endemic area of ATLL.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazi | 1995 |
Hodgkin disease in children: reduced tailored chemotherapy for stage I-II disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 1996 |
Hodgkin disease in children: reduced tailored chemotherapy for stage I-II disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 1996 |
Second malignant tumours in childhood Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Protocols; Cohort | 1996 |
Second malignant tumours in childhood Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Protocols; Cohort | 1996 |
Is ABVD the standard regimen for Hodgkin's disease based on randomized CALGB comparison of MOPP, ABVD and MOPP alternating with ABVD?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease | 1996 |
Is ABVD the standard regimen for Hodgkin's disease based on randomized CALGB comparison of MOPP, ABVD and MOPP alternating with ABVD?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease | 1996 |
Genetic instability in patients with Hodgkin's disease undergoing chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dox | 1995 |
Genetic instability in patients with Hodgkin's disease undergoing chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dox | 1995 |
[Semen preservation and gonadal toxicity in the treatment of non Hodgkin lymphoma. Experience at the Gustave-Roussy Institute from 1980 to 1993].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1996 |
[Semen preservation and gonadal toxicity in the treatment of non Hodgkin lymphoma. Experience at the Gustave-Roussy Institute from 1980 to 1993].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1996 |
Growth and final height after treatment for childhood Hodgkin disease.
Topics: Adolescent; Age of Onset; Antineoplastic Combined Chemotherapy Protocols; Body Height; Child; Child, | 1996 |
Growth and final height after treatment for childhood Hodgkin disease.
Topics: Adolescent; Age of Onset; Antineoplastic Combined Chemotherapy Protocols; Body Height; Child; Child, | 1996 |
Long-term pulmonary function in children with Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Hodgkin | 1996 |
Long-term pulmonary function in children with Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Hodgkin | 1996 |
Hodgkin's disease presenting as a cholestatic febrile illness: incidence and main characteristics in a series of 421 patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cholestas | 1996 |
Hodgkin's disease presenting as a cholestatic febrile illness: incidence and main characteristics in a series of 421 patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cholestas | 1996 |
Chemotherapy-induced non-Hodgkin's lymphoma in a patient with Hodgkin's disease--a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bleomycin; Cyclophosphamide; D | 1996 |
Chemotherapy-induced non-Hodgkin's lymphoma in a patient with Hodgkin's disease--a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bleomycin; Cyclophosphamide; D | 1996 |
Hodgkin's disease after cardiac transplant: a report of two cases.
Topics: Adult; Antibodies, Viral; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Chlorambuci | 1996 |
Hodgkin's disease after cardiac transplant: a report of two cases.
Topics: Adult; Antibodies, Viral; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Chlorambuci | 1996 |
Infradiaphragmatic Hodgkin's disease: long term results of combined modality therapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top | 1996 |
Infradiaphragmatic Hodgkin's disease: long term results of combined modality therapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top | 1996 |
Irreversible gonadal damage in male survivors of pediatric Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Follicle Stimulating Hormone; Fol | 1996 |
Irreversible gonadal damage in male survivors of pediatric Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Follicle Stimulating Hormone; Fol | 1996 |
Treatment of children and adolescents with Hodgkin's disease: the experience of the German-Austrian Paediatric Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Austria; Child; Combined Modality Therap | 1996 |
Treatment of children and adolescents with Hodgkin's disease: the experience of the German-Austrian Paediatric Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Austria; Child; Combined Modality Therap | 1996 |
Hodgkin's disease of middle ear and mastoid.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dox | 1996 |
Hodgkin's disease of middle ear and mastoid.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dox | 1996 |
Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protoc | 1997 |
Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protoc | 1997 |
[Hodgkin's disease in the very young child. Apropos of 11 cases].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 1996 |
[Hodgkin's disease in the very young child. Apropos of 11 cases].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 1996 |
Pulmonary sarcoid-like granulomata in a patient treated for extrapulmonary Hodgkin's disease.
Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bronchoalveo | 1997 |
Pulmonary sarcoid-like granulomata in a patient treated for extrapulmonary Hodgkin's disease.
Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bronchoalveo | 1997 |
Detection of a dormant 20q- leukemia clone in bone marrow cultures with hematopoietic growth factors: implications for secondary leukemia post-transplant.
Topics: Acute Disease; Adult; Anemia, Refractory, with Excess of Blasts; Antimetabolites, Antineoplastic; An | 1997 |
Detection of a dormant 20q- leukemia clone in bone marrow cultures with hematopoietic growth factors: implications for secondary leukemia post-transplant.
Topics: Acute Disease; Adult; Anemia, Refractory, with Excess of Blasts; Antimetabolites, Antineoplastic; An | 1997 |
Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; | 1997 |
Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; | 1997 |
[Preliminary results of conservative combination radiotherapy and chemotherapy in early stages of Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cycloph | 1996 |
[Preliminary results of conservative combination radiotherapy and chemotherapy in early stages of Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cycloph | 1996 |
BEACOPP: an intensified chemotherapy regimen in advanced Hodgkin's disease. The German Hodgkin's Lymphoma Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubici | 1997 |
BEACOPP: an intensified chemotherapy regimen in advanced Hodgkin's disease. The German Hodgkin's Lymphoma Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubici | 1997 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 13-1997. A 32-year-old man with IgG antibody and Coombs'-positive hemolytic anemia resistant to corticosteroid therapy.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Coombs Test; Diagnosis, Differential; Drug Resistance; Glucoco | 1997 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 13-1997. A 32-year-old man with IgG antibody and Coombs'-positive hemolytic anemia resistant to corticosteroid therapy.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Coombs Test; Diagnosis, Differential; Drug Resistance; Glucoco | 1997 |
Five-year follow-up of saliva in patients treated for lymphomas.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Amylases; Analysis of Variance; Antineoplastic Combined Ch | 1997 |
Five-year follow-up of saliva in patients treated for lymphomas.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Amylases; Analysis of Variance; Antineoplastic Combined Ch | 1997 |
A blood stem cell transplant in a person with concomitant Hodgkin disease and testicular carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Germinoma; Hematopoietic | 1997 |
A blood stem cell transplant in a person with concomitant Hodgkin disease and testicular carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Germinoma; Hematopoietic | 1997 |
Treatment of childhood Hodgkin's disease with COPP or COPP-ABV (hybrid) without radiotherapy in Nicaragua.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cycl | 1997 |
Treatment of childhood Hodgkin's disease with COPP or COPP-ABV (hybrid) without radiotherapy in Nicaragua.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cycl | 1997 |
Treatment of Hodgkin's disease in children with alternating mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) and adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) courses without radiotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Daca | 1997 |
Treatment of Hodgkin's disease in children with alternating mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) and adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) courses without radiotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Daca | 1997 |
[Coexistence of chronic lymphoid leukemia and Hodgkin's disease. Immunohistochemical study].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Hodgkin Disease; Humans; Immunop | 1996 |
[Coexistence of chronic lymphoid leukemia and Hodgkin's disease. Immunohistochemical study].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Hodgkin Disease; Humans; Immunop | 1996 |
[A case of Hodgkin's disease with an uncommon clinical course. Predominant localization in the liver].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Female; Hodgkin Disease; Huma | 1996 |
[A case of Hodgkin's disease with an uncommon clinical course. Predominant localization in the liver].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Female; Hodgkin Disease; Huma | 1996 |
Long-term pulmonary sequelae after treatment of childhood Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 1997 |
Long-term pulmonary sequelae after treatment of childhood Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 1997 |
[Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bleomycin; Child; Child, P | 1996 |
[Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bleomycin; Child; Child, P | 1996 |
Gonadal function following ABVD therapy for Hodgkin's disease.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkyla | 1997 |
Gonadal function following ABVD therapy for Hodgkin's disease.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkyla | 1997 |
G-CSF (filgrastim) as an adjunct to MOPP/ABVD therapy in Hodgkin's disease.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antine | 1997 |
G-CSF (filgrastim) as an adjunct to MOPP/ABVD therapy in Hodgkin's disease.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antine | 1997 |
Salvage radiotherapy for Hodgkin's disease following chemotherapy failure.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Di | 1997 |
Salvage radiotherapy for Hodgkin's disease following chemotherapy failure.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Di | 1997 |
[Etoposide combination chemotherapy for malignant lymphoma: a report of 91 cases].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophos | 1996 |
[Etoposide combination chemotherapy for malignant lymphoma: a report of 91 cases].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophos | 1996 |
Steroid premedication before i.v. contrast-enhanced CT resulting in resolution of lymphadenopathy.
Topics: Adult; Anaphylaxis; Contraindications; Contrast Media; Female; Glucocorticoids; Hodgkin Disease; Hum | 1998 |
Steroid premedication before i.v. contrast-enhanced CT resulting in resolution of lymphadenopathy.
Topics: Adult; Anaphylaxis; Contraindications; Contrast Media; Female; Glucocorticoids; Hodgkin Disease; Hum | 1998 |
A cure model with time-changing risk factor: an application to the analysis of secondary leukaemia. A report from the International Database on Hodgkin's Disease.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Fr | 1998 |
A cure model with time-changing risk factor: an application to the analysis of secondary leukaemia. A report from the International Database on Hodgkin's Disease.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Fr | 1998 |
Should MOPP-ABVD alone be standard for childhood Hodgkin's?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Hodgkin | 1998 |
Should MOPP-ABVD alone be standard for childhood Hodgkin's?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Hodgkin | 1998 |
Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomyci | 1998 |
Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomyci | 1998 |
Hodgkin's disease in children in southern Africa: epidemiological characteristics, morbidity and long-term outcome.
Topics: Adolescent; Age Distribution; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Chil | 1997 |
Hodgkin's disease in children in southern Africa: epidemiological characteristics, morbidity and long-term outcome.
Topics: Adolescent; Age Distribution; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Chil | 1997 |
Levels of proteins C and S do not decline subsequent to first line chemotherapy in lymphoma patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; alpha-2-Antiplasmin; Antineoplastic Combined Chemotherap | 1997 |
Levels of proteins C and S do not decline subsequent to first line chemotherapy in lymphoma patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; alpha-2-Antiplasmin; Antineoplastic Combined Chemotherap | 1997 |
The clonal relationship between nodular sclerosis Hodgkin's disease with a clonal Reed-Sternberg cell population and a subsequent B-cell small noncleaved cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Combined Modality Therapy; Cycloph | 1998 |
The clonal relationship between nodular sclerosis Hodgkin's disease with a clonal Reed-Sternberg cell population and a subsequent B-cell small noncleaved cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Combined Modality Therapy; Cycloph | 1998 |
Plasma levels of tumour necrosis factor and its soluble receptors correlate with clinical features and outcome of Hodgkin's disease patients.
Topics: Adolescent; Adult; Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Co | 1998 |
Plasma levels of tumour necrosis factor and its soluble receptors correlate with clinical features and outcome of Hodgkin's disease patients.
Topics: Adolescent; Adult; Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Co | 1998 |
Lymphomatoid papulosis followed by Hodgkin's disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Hodg | 1998 |
Lymphomatoid papulosis followed by Hodgkin's disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Hodg | 1998 |
Treatment-related deaths and second cancer risk after autologous stem-cell transplantation for Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Female; Hematopoietic Stem | 1998 |
Treatment-related deaths and second cancer risk after autologous stem-cell transplantation for Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Female; Hematopoietic Stem | 1998 |
Second cancer among long-term survivors from Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleom | 1998 |
Second cancer among long-term survivors from Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleom | 1998 |
Hodgkin's disease and the risk of acute leukemia in successfully treated patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D | 1998 |
Hodgkin's disease and the risk of acute leukemia in successfully treated patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D | 1998 |
The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-con
Topics: Abdomen; Actuarial Analysis; Acute Disease; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; | 1998 |
The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-con
Topics: Abdomen; Actuarial Analysis; Acute Disease; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; | 1998 |
The effects of etoposide on testicular function in boys treated for Hodgkin's disease.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemother | 1998 |
The effects of etoposide on testicular function in boys treated for Hodgkin's disease.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemother | 1998 |
[Clinical case of the month. The association of Hodgkin's disease and nephrotic syndrome].
Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineop | 1998 |
[Clinical case of the month. The association of Hodgkin's disease and nephrotic syndrome].
Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineop | 1998 |
Unilateral proptosis in an immunocompetent man as the initial clinical manifestation of systemic Hodgkin disease.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Exophthalmos; | 1999 |
Unilateral proptosis in an immunocompetent man as the initial clinical manifestation of systemic Hodgkin disease.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Exophthalmos; | 1999 |
Hodgkin's disease in 35 patients with HIV infection: an experience with epirubicin, bleomycin, vinblastine and prednisone chemotherapy in combination with antiretroviral therapy and primary use of G-CSF.
Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Epirubicin; Femal | 1999 |
Hodgkin's disease in 35 patients with HIV infection: an experience with epirubicin, bleomycin, vinblastine and prednisone chemotherapy in combination with antiretroviral therapy and primary use of G-CSF.
Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Epirubicin; Femal | 1999 |
Gonadal function in young patients successfully treated for Hodgkin disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclopho | 1999 |
Gonadal function in young patients successfully treated for Hodgkin disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclopho | 1999 |
MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25).
Topics: Acute Disease; Amino Acid Sequence; Animals; Antineoplastic Combined Chemotherapy Protocols; Base Se | 1999 |
MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25).
Topics: Acute Disease; Amino Acid Sequence; Animals; Antineoplastic Combined Chemotherapy Protocols; Base Se | 1999 |
Advanced stage and unfavorable Hodgkin's disease in the Chinese-a 20-year experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Daca | 1999 |
Advanced stage and unfavorable Hodgkin's disease in the Chinese-a 20-year experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Daca | 1999 |
HIV-associated lymphoma: report of three cases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; CD4-CD8 Ratio; Cyclophosphamide; Doxorubicin; | 1999 |
HIV-associated lymphoma: report of three cases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; CD4-CD8 Ratio; Cyclophosphamide; Doxorubicin; | 1999 |
High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; | 1999 |
High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; | 1999 |
[Malignant lymphoma: magnetic resonance tomography findings in residual supradiaphragmatic space-occupying lesions].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; | 1999 |
[Malignant lymphoma: magnetic resonance tomography findings in residual supradiaphragmatic space-occupying lesions].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; | 1999 |
Gemcitabine is active in relapsed Hodgkin's disease.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; D | 1999 |
Gemcitabine is active in relapsed Hodgkin's disease.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; D | 1999 |
Large cell non-Hodgkin's lymphoma and Hodgkin's disease arising synchronously in a patient with chronic lymphocytic leukemia: importance of immunocytochemistry.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Combined Modality Therapy | 1999 |
Large cell non-Hodgkin's lymphoma and Hodgkin's disease arising synchronously in a patient with chronic lymphocytic leukemia: importance of immunocytochemistry.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Combined Modality Therapy | 1999 |
In vivo expansion of reinfused autologous peripheral blood stem cells after a myeloablative regimen, as an alternative to ex vivo expansion pretransplantation: an intriguing observation in apatient autografted twice.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Busulfan; Cyclophosphamide; Doxoru | 1999 |
In vivo expansion of reinfused autologous peripheral blood stem cells after a myeloablative regimen, as an alternative to ex vivo expansion pretransplantation: an intriguing observation in apatient autografted twice.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Busulfan; Cyclophosphamide; Doxoru | 1999 |
Rapid regression of chemotherapy refractory lymphocyte predominant Hodgkin's disease after administration of rituximab (anti CD 20 mono- clonal antibody) and interleukin-2.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antigens, Neoplasm; | 1999 |
Rapid regression of chemotherapy refractory lymphocyte predominant Hodgkin's disease after administration of rituximab (anti CD 20 mono- clonal antibody) and interleukin-2.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antigens, Neoplasm; | 1999 |
Association between alopecia and response to aggressive chemotherapy in patients with Hodgkin's disease.
Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin | 1999 |
Association between alopecia and response to aggressive chemotherapy in patients with Hodgkin's disease.
Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin | 1999 |
[Chronic lymphatic leukemia and Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Dacarbazine; Doxorubicin; F | 1999 |
[Chronic lymphatic leukemia and Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Dacarbazine; Doxorubicin; F | 1999 |
Survival of patients with HTLV-I-associated lymph node lesions.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cyclophosphamide; Doxorubicin; Hodgkin Di | 1999 |
Survival of patients with HTLV-I-associated lymph node lesions.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cyclophosphamide; Doxorubicin; Hodgkin Di | 1999 |
Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cycl | 1999 |
Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cycl | 1999 |
Recovery of sperm production following radiation therapy for Hodgkin's disease after induction chemotherapy with mitoxantrone, vincristine, vinblastine, and prednisone (NOVP).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Male; Mi | 2000 |
Recovery of sperm production following radiation therapy for Hodgkin's disease after induction chemotherapy with mitoxantrone, vincristine, vinblastine, and prednisone (NOVP).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Male; Mi | 2000 |
Immune thrombocytopenia and hemolytic anemia as a presenting manifestation of Hodgkin disease.
Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphami | 2000 |
Immune thrombocytopenia and hemolytic anemia as a presenting manifestation of Hodgkin disease.
Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphami | 2000 |
Indications and results of chemotherapy in children with posttransplant lymphoproliferative disease after liver transplantation.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineopl | 2000 |
Indications and results of chemotherapy in children with posttransplant lymphoproliferative disease after liver transplantation.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineopl | 2000 |
Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylati | 2000 |
Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylati | 2000 |
Circulating immune complexes in advanced Hodgkin's disease: qualitative analysis and prognostic significance.
Topics: Adult; Antigen-Antibody Complex; Antineoplastic Combined Chemotherapy Protocols; C-Reactive Protein; | 2000 |
Circulating immune complexes in advanced Hodgkin's disease: qualitative analysis and prognostic significance.
Topics: Adult; Antigen-Antibody Complex; Antineoplastic Combined Chemotherapy Protocols; C-Reactive Protein; | 2000 |
Follow-up of sperm concentration and motility in patients with lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cryopreservation; Daca | 2000 |
Follow-up of sperm concentration and motility in patients with lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cryopreservation; Daca | 2000 |
[Diagnostic problems due to alternative medicine].
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast N | 2000 |
[Diagnostic problems due to alternative medicine].
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast N | 2000 |
Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined | 2000 |
Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined | 2000 |
Efficacy of standard treatment in patients with Hodgkin's disease--a single center experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 2000 |
Efficacy of standard treatment in patients with Hodgkin's disease--a single center experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 2000 |
[Thyroid lymphoma. A case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Follow-Up Studies; | 2000 |
[Thyroid lymphoma. A case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Follow-Up Studies; | 2000 |
[High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Ther | 2000 |
[High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Ther | 2000 |
Radiation dose selection in Hodgkin's disease patients with large mediastinal adenopathy treated with combined modality therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 2000 |
Radiation dose selection in Hodgkin's disease patients with large mediastinal adenopathy treated with combined modality therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 2000 |
[Changes in gonadal function in post-pubertal male survivors of acute lymphoblastic leukemia and Hodgkin's disease].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Child; Cycl | 2000 |
[Changes in gonadal function in post-pubertal male survivors of acute lymphoblastic leukemia and Hodgkin's disease].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Child; Cycl | 2000 |
[Hodgkin's disease with systemic vasculitis and Lambert-Eaton myasthenic syndrome--case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Hodgkin Disease; Humans; Lam | 2000 |
[Hodgkin's disease with systemic vasculitis and Lambert-Eaton myasthenic syndrome--case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Hodgkin Disease; Humans; Lam | 2000 |
Autoimmune hemolytic anemia associated with postirradiation malignant stromal tumor (leiomyosarcoma) of the jejunum.
Topics: Anemia, Hemolytic, Autoimmune; Chemotherapy, Adjuvant; Hodgkin Disease; Humans; Intestinal Obstructi | 2000 |
Autoimmune hemolytic anemia associated with postirradiation malignant stromal tumor (leiomyosarcoma) of the jejunum.
Topics: Anemia, Hemolytic, Autoimmune; Chemotherapy, Adjuvant; Hodgkin Disease; Humans; Intestinal Obstructi | 2000 |
Persistent paraneoplastic neurologic syndrome after successful therapy of Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Ataxia; Bleomycin; Combined Modality Therapy; | 2001 |
Persistent paraneoplastic neurologic syndrome after successful therapy of Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Ataxia; Bleomycin; Combined Modality Therapy; | 2001 |
[Can 67Ga citrate predict the efficacy of chemotherapy early in Hodgkin's lymphoma?].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Citrates; Combined Modality Therapy; Cyc | 2001 |
[Can 67Ga citrate predict the efficacy of chemotherapy early in Hodgkin's lymphoma?].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Citrates; Combined Modality Therapy; Cyc | 2001 |
Gingival overgrowth as the initial paraneoplastic manifestation of Hodgkin's lymphoma in a child. A case report.
Topics: Alveolar Bone Loss; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Child; Dacarb | 2001 |
Gingival overgrowth as the initial paraneoplastic manifestation of Hodgkin's lymphoma in a child. A case report.
Topics: Alveolar Bone Loss; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Child; Dacarb | 2001 |
[An autopsy case of intravascular malignant lymphomatosis treated with combination chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Hodgkin Disease | 2000 |
[An autopsy case of intravascular malignant lymphomatosis treated with combination chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Hodgkin Disease | 2000 |
Pathologic and clinical features of 77 Hodgkin's lymphoma patients treated in a lymphoma protocol (LNH87): a GELA study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarke | 2001 |
Pathologic and clinical features of 77 Hodgkin's lymphoma patients treated in a lymphoma protocol (LNH87): a GELA study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarke | 2001 |
Early occurrence of a secondary thyroid carcinoma in a child treated for Hodgkin disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary; Chemotherapy, Adjuvant; Child; | 2001 |
Early occurrence of a secondary thyroid carcinoma in a child treated for Hodgkin disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary; Chemotherapy, Adjuvant; Child; | 2001 |
Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Female; Hodgkin D | 2001 |
Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Female; Hodgkin D | 2001 |
The risk of second malignant tumors and its consequences for the overall survival of Hodgkin's disease patients and for the choice of their treatment at presentation: analysis of a series of 1524 cases consecutively treated at the Florence University Hosp
Topics: Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Confidence Intervals; F | 2001 |
The risk of second malignant tumors and its consequences for the overall survival of Hodgkin's disease patients and for the choice of their treatment at presentation: analysis of a series of 1524 cases consecutively treated at the Florence University Hosp
Topics: Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Confidence Intervals; F | 2001 |
[The chemotherapeutic treatment of advanced Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 2001 |
[The chemotherapeutic treatment of advanced Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 2001 |
Peroneal mononeuropathy in pediatric Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Hodgkin Disease; Humans; Ma | 2000 |
Peroneal mononeuropathy in pediatric Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Hodgkin Disease; Humans; Ma | 2000 |
Successful treatment of bronchiolitis obliterans organizing pneumonia with low-dose methotrexate in a patient with Hodgkin's disease.
Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Cryptogenic Organiz | 2001 |
Successful treatment of bronchiolitis obliterans organizing pneumonia with low-dose methotrexate in a patient with Hodgkin's disease.
Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Cryptogenic Organiz | 2001 |
[Lung infiltrations in Hodgkin lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Diagnosis, Differential; Hodgkin D | 2001 |
[Lung infiltrations in Hodgkin lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Diagnosis, Differential; Hodgkin D | 2001 |
Acquired inhibitor to factor VIII in a patient with Hodgkin's disease following treatment with interferon-alpha.
Topics: Autoantibodies; Factor VIII; Female; Hemorrhage; Hodgkin Disease; Humans; Interferon-alpha; Middle A | 2001 |
Acquired inhibitor to factor VIII in a patient with Hodgkin's disease following treatment with interferon-alpha.
Topics: Autoantibodies; Factor VIII; Female; Hemorrhage; Hodgkin Disease; Humans; Interferon-alpha; Middle A | 2001 |
Transformation of Hodgkin's disease to high-grade B-cell lymphoma: remission after Rituximab monotherapy.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplasti | 2001 |
Transformation of Hodgkin's disease to high-grade B-cell lymphoma: remission after Rituximab monotherapy.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplasti | 2001 |
ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of Hodgkin's disease.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modali | 2001 |
ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of Hodgkin's disease.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modali | 2001 |
Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cy | 2001 |
Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cy | 2001 |
The serum levels of eosinophil cationic protein (ECP) are related to the infiltration of eosinophils in the tumours of patients with Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomyci | 2001 |
The serum levels of eosinophil cationic protein (ECP) are related to the infiltration of eosinophils in the tumours of patients with Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomyci | 2001 |
Hodgkin's disease complicated by the nephrotic syndrome in a man with Kugelberg-Welander disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Cyclophosphamide; Doxorubi | 2001 |
Hodgkin's disease complicated by the nephrotic syndrome in a man with Kugelberg-Welander disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Cyclophosphamide; Doxorubi | 2001 |
Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cy | 2001 |
Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cy | 2001 |
Subdiaphragmatic Hodgkin's disease: the University of Florida experience.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Di | 2002 |
Subdiaphragmatic Hodgkin's disease: the University of Florida experience.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Di | 2002 |
[Treatment of advanced Hodgkin's disease: an analysis of 128 cases].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; CCAAT-Enhancer-Binding Prot | 2000 |
[Treatment of advanced Hodgkin's disease: an analysis of 128 cases].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; CCAAT-Enhancer-Binding Prot | 2000 |
Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Behavior; Bleomyci | 2001 |
Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Behavior; Bleomyci | 2001 |
Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Adult; Anti-Bacterial Agents; Antiretroviral Ther | 2002 |
Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Adult; Anti-Bacterial Agents; Antiretroviral Ther | 2002 |
A novel type of metastatically spreading subcutaneous aspergillosis without epidermal lesions following allogeneic stem cell transplantation.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillo | 2001 |
A novel type of metastatically spreading subcutaneous aspergillosis without epidermal lesions following allogeneic stem cell transplantation.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillo | 2001 |
CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigens, CD20; Antineoplastic Combined Chemotherapy Pro | 2002 |
CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigens, CD20; Antineoplastic Combined Chemotherapy Pro | 2002 |
Pulmonary toxicity secondary to procarbazine.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Male | 2002 |
Pulmonary toxicity secondary to procarbazine.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Male | 2002 |
[A case of Hodgkin's disease of mesenteric origin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2002 |
[A case of Hodgkin's disease of mesenteric origin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2002 |
Neutrophil-rich Ki-1-positive anaplastic large cell lymphoma: a study by fine-needle aspiration biopsy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carcinoma; Cyclophosphamide; | 2002 |
Neutrophil-rich Ki-1-positive anaplastic large cell lymphoma: a study by fine-needle aspiration biopsy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carcinoma; Cyclophosphamide; | 2002 |
Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation.
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbaz | 2002 |
Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation.
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbaz | 2002 |
[Criteria for choice of therapeutic procedures in lymphomas].
Topics: Antineoplastic Agents; Bleomycin; Cobalt Radioisotopes; Doxorubicin; Drug Therapy, Combination; Hodg | 1975 |
[Criteria for choice of therapeutic procedures in lymphomas].
Topics: Antineoplastic Agents; Bleomycin; Cobalt Radioisotopes; Doxorubicin; Drug Therapy, Combination; Hodg | 1975 |
[Current problems in therapy of evolutive malignant granuloma. Our experience with a new scheme of polychemotherapy].
Topics: Antineoplastic Agents; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Hodgkin | 1975 |
[Current problems in therapy of evolutive malignant granuloma. Our experience with a new scheme of polychemotherapy].
Topics: Antineoplastic Agents; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Hodgkin | 1975 |
[Treatment of malignant lymphomas with shock doses of peptichemio].
Topics: Adult; Aged; Antineoplastic Agents; Bleomycin; Blood Cells; Drug Therapy, Combination; Hodgkin Disea | 1975 |
[Treatment of malignant lymphomas with shock doses of peptichemio].
Topics: Adult; Aged; Antineoplastic Agents; Bleomycin; Blood Cells; Drug Therapy, Combination; Hodgkin Disea | 1975 |
Progress in the chemotherapy of hematologic diseases.
Topics: Antineoplastic Agents; Bleomycin; Daunorubicin; DNA Replication; Doxorubicin; Drug Therapy, Combinat | 1975 |
Progress in the chemotherapy of hematologic diseases.
Topics: Antineoplastic Agents; Bleomycin; Daunorubicin; DNA Replication; Doxorubicin; Drug Therapy, Combinat | 1975 |
[Post-MOPP chemotherapy of Hodgkin's disease (author's transl)].
Topics: Adult; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Hod | 1976 |
[Post-MOPP chemotherapy of Hodgkin's disease (author's transl)].
Topics: Adult; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Hod | 1976 |
New multiple-agent chemotherapy (B-DOPA) for advanced Hodgkin's disease.
Topics: Adult; Aged; Bleomycin; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combin | 1976 |
New multiple-agent chemotherapy (B-DOPA) for advanced Hodgkin's disease.
Topics: Adult; Aged; Bleomycin; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combin | 1976 |
Imidazole carboxamide (DTIC) in the treatment of advanced lymphomas. Efficacy of DTIC in cases which fail to respond to conventional chemotherupetic combinations.
Topics: Adult; Bleomycin; Cyclophosphamide; Dacarbazine; Drug Evaluation; Drug Resistance; Drug Therapy, Com | 1977 |
Imidazole carboxamide (DTIC) in the treatment of advanced lymphomas. Efficacy of DTIC in cases which fail to respond to conventional chemotherupetic combinations.
Topics: Adult; Bleomycin; Cyclophosphamide; Dacarbazine; Drug Evaluation; Drug Resistance; Drug Therapy, Com | 1977 |
Combination chemotherapy of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, dacarbazine and vinblastine (ABDV).
Topics: Adult; Bleomycin; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Hodgkin Disease; Huma | 1977 |
Combination chemotherapy of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, dacarbazine and vinblastine (ABDV).
Topics: Adult; Bleomycin; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Hodgkin Disease; Huma | 1977 |
[Effect of combined chemotherapy on the prognosis of Hodgkin's disease: retrospective study of 74 cases from 1959-1973].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bleomycin; Child; Cyclophosphamide; Dacarbazine; Dac | 1977 |
[Effect of combined chemotherapy on the prognosis of Hodgkin's disease: retrospective study of 74 cases from 1959-1973].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bleomycin; Child; Cyclophosphamide; Dacarbazine; Dac | 1977 |
Long term experience with combination chemotherapy in advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Agents; Bleomycin; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; | 1977 |
Long term experience with combination chemotherapy in advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Agents; Bleomycin; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; | 1977 |
[Chemotherapy program for treatment of Hodgkin's disease refractory to MOPP or MVPP].
Topics: Antineoplastic Agents; Bleomycin; Doxorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; M | 1977 |
[Chemotherapy program for treatment of Hodgkin's disease refractory to MOPP or MVPP].
Topics: Antineoplastic Agents; Bleomycin; Doxorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; M | 1977 |
Hodgkin's disease: combination chemotherapy in resistant Hodgkin's disease.
Topics: Adolescent; Adult; Bleomycin; Dacarbazine; Doxorubicin; Drug Resistance; Drug Therapy, Combination; | 1977 |
Hodgkin's disease: combination chemotherapy in resistant Hodgkin's disease.
Topics: Adolescent; Adult; Bleomycin; Dacarbazine; Doxorubicin; Drug Resistance; Drug Therapy, Combination; | 1977 |
Treatment of advanced Hodgkin's disease with B-CAVE following MOPP failure.
Topics: Adolescent; Adult; Bleomycin; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Female; Hodgk | 1978 |
Treatment of advanced Hodgkin's disease with B-CAVE following MOPP failure.
Topics: Adolescent; Adult; Bleomycin; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Female; Hodgk | 1978 |
Immune competence in a patient with Hodgkin's disease and relapsing toxoplasmosis.
Topics: Adult; Bleomycin; Cyclophosphamide; Female; Hodgkin Disease; Humans; Immunity; Prednisone; Pyrimetha | 1978 |
Immune competence in a patient with Hodgkin's disease and relapsing toxoplasmosis.
Topics: Adult; Bleomycin; Cyclophosphamide; Female; Hodgkin Disease; Humans; Immunity; Prednisone; Pyrimetha | 1978 |
Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapy.
Topics: Adolescent; Adult; Bleomycin; Dacarbazine; Doxorubicin; Drug Resistance; Drug Therapy, Combination; | 1978 |
Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapy.
Topics: Adolescent; Adult; Bleomycin; Dacarbazine; Doxorubicin; Drug Resistance; Drug Therapy, Combination; | 1978 |
A kinetically designed chemotherapeutic regimen for advanced refractory lymphoma patients.
Topics: Adolescent; Adult; Aged; Bleomycin; Doxorubicin; Drug Administration Schedule; Female; Hodgkin Disea | 1978 |
A kinetically designed chemotherapeutic regimen for advanced refractory lymphoma patients.
Topics: Adolescent; Adult; Aged; Bleomycin; Doxorubicin; Drug Administration Schedule; Female; Hodgkin Disea | 1978 |
Sister chromatid exchange in lymphocytes from patients with malignant lymphoma.
Topics: Adolescent; Adult; Aged; Bleomycin; Chromosomes, Human; Crossing Over, Genetic; Cyclophosphamide; Do | 1978 |
Sister chromatid exchange in lymphocytes from patients with malignant lymphoma.
Topics: Adolescent; Adult; Aged; Bleomycin; Chromosomes, Human; Crossing Over, Genetic; Cyclophosphamide; Do | 1978 |
Adrenal suppression after short-term corticosteroid therapy.
Topics: Adolescent; Adrenal Cortex Function Tests; Adrenal Glands; Adrenal Insufficiency; Adrenocorticotropi | 1979 |
Adrenal suppression after short-term corticosteroid therapy.
Topics: Adolescent; Adrenal Cortex Function Tests; Adrenal Glands; Adrenal Insufficiency; Adrenocorticotropi | 1979 |
Treatment of advanced Hodgkin's disease in pediatric patients.
Topics: Adolescent; Amenorrhea; Antineoplastic Agents; Bone Marrow; Child; Cyclophosphamide; Female; Hodgkin | 1978 |
Treatment of advanced Hodgkin's disease in pediatric patients.
Topics: Adolescent; Amenorrhea; Antineoplastic Agents; Bone Marrow; Child; Cyclophosphamide; Female; Hodgkin | 1978 |
[Hodgkin's disease: classification, staging, therapy].
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Laparoscopy; Life Expectancy; Mechlorethamine; N | 1978 |
[Hodgkin's disease: classification, staging, therapy].
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Laparoscopy; Life Expectancy; Mechlorethamine; N | 1978 |
Antibodies to Epstein-Barr-virus antigens before and after the development of Burkitt's lymphoma in a patient treated for Hodgkin's disease.
Topics: Antibodies, Viral; Antigens, Viral; Burkitt Lymphoma; Child; Herpesvirus 4, Human; Hodgkin Disease; | 1975 |
Antibodies to Epstein-Barr-virus antigens before and after the development of Burkitt's lymphoma in a patient treated for Hodgkin's disease.
Topics: Antibodies, Viral; Antigens, Viral; Burkitt Lymphoma; Child; Herpesvirus 4, Human; Hodgkin Disease; | 1975 |
Childhood Hodgkin's disease in Israel. A study of 17 cases.
Topics: Adolescent; Antibodies, Neoplasm; Antibodies, Viral; Antineoplastic Agents; Child; Drug Therapy, Com | 1975 |
Childhood Hodgkin's disease in Israel. A study of 17 cases.
Topics: Adolescent; Antibodies, Neoplasm; Antibodies, Viral; Antineoplastic Agents; Child; Drug Therapy, Com | 1975 |
Childhood cancer: the improving prognosis.
Topics: Asparaginase; Child; Cyclophosphamide; Cytosine; Daunorubicin; Doxorubicin; Drug Therapy, Combinatio | 1976 |
Childhood cancer: the improving prognosis.
Topics: Asparaginase; Child; Cyclophosphamide; Cytosine; Daunorubicin; Doxorubicin; Drug Therapy, Combinatio | 1976 |
[Zitostop in cyclical treatment of malignant lymphoma in combination with vinblastine, natulan and prednisone].
Topics: Adolescent; Adult; Drug Evaluation; Drug Therapy, Combination; Hodgkin Disease; Humans; Mesylates; M | 1976 |
[Zitostop in cyclical treatment of malignant lymphoma in combination with vinblastine, natulan and prednisone].
Topics: Adolescent; Adult; Drug Evaluation; Drug Therapy, Combination; Hodgkin Disease; Humans; Mesylates; M | 1976 |
Hodgkin's disease and granulomatous angiitis of the central nervous system.
Topics: Adult; Brain Diseases; Cerebral Cortex; Chickenpox; Dexamethasone; Herpesvirus 3, Human; Hodgkin Dis | 1976 |
Hodgkin's disease and granulomatous angiitis of the central nervous system.
Topics: Adult; Brain Diseases; Cerebral Cortex; Chickenpox; Dexamethasone; Herpesvirus 3, Human; Hodgkin Dis | 1976 |
[Polyneuropathy in patients with Hodgkin's disease and acute leukemia treated by the combined cyclic method according to the MOPP and POMP schedules].
Topics: Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Leuk | 1976 |
[Polyneuropathy in patients with Hodgkin's disease and acute leukemia treated by the combined cyclic method according to the MOPP and POMP schedules].
Topics: Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Leuk | 1976 |
People with Hodgkin disease: the nursing challenge.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Hodgkin Disease; Humans; Male; Mechlorethamine; | 1978 |
People with Hodgkin disease: the nursing challenge.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Hodgkin Disease; Humans; Male; Mechlorethamine; | 1978 |
Cancer chemotherapy.
Topics: Chlorambucil; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Female; Hodgkin Disease; Humans; Leuk | 1977 |
Cancer chemotherapy.
Topics: Chlorambucil; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Female; Hodgkin Disease; Humans; Leuk | 1977 |
Acute myelogenous leukemia as a late complication of the multimodality therapy for Hodgkin's disease.
Topics: Adult; Biopsy; Bone Marrow; Cytarabine; Daunorubicin; Hodgkin Disease; Humans; Leukemia, Myeloid, Ac | 1977 |
Acute myelogenous leukemia as a late complication of the multimodality therapy for Hodgkin's disease.
Topics: Adult; Biopsy; Bone Marrow; Cytarabine; Daunorubicin; Hodgkin Disease; Humans; Leukemia, Myeloid, Ac | 1977 |
[Aseptic necrosis of the femoral head in lymphogranulomatosis and chronic myeloic leukemia treated intermittently with cytostatic agents and steroids (author's transl)].
Topics: Adult; Antineoplastic Agents; Femur Head Necrosis; Hodgkin Disease; Humans; Humerus; Leukemia, Myelo | 1978 |
[Aseptic necrosis of the femoral head in lymphogranulomatosis and chronic myeloic leukemia treated intermittently with cytostatic agents and steroids (author's transl)].
Topics: Adult; Antineoplastic Agents; Femur Head Necrosis; Hodgkin Disease; Humans; Humerus; Leukemia, Myelo | 1978 |
[Epidural localization of malignant lymphomas with pressure on the spinal cord].
Topics: Aged; Cyclophosphamide; Female; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Midd | 1977 |
[Epidural localization of malignant lymphomas with pressure on the spinal cord].
Topics: Aged; Cyclophosphamide; Female; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Midd | 1977 |
[Combination of adriamycin, VM 26, cyclophosphamide and prednisone in the treatment of hematosarcomas].
Topics: Adolescent; Adult; Aged; Cyclophosphamide; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; | 1977 |
[Combination of adriamycin, VM 26, cyclophosphamide and prednisone in the treatment of hematosarcomas].
Topics: Adolescent; Adult; Aged; Cyclophosphamide; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; | 1977 |
Fulminant sepsis after the successful treatment of Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Agents; Female; Haemophilus Infections; Hodgkin Disease; Humans; M | 1977 |
Fulminant sepsis after the successful treatment of Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Agents; Female; Haemophilus Infections; Hodgkin Disease; Humans; M | 1977 |
Stages I--III Hodgkin's disease in children: results of staging and treatment.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lym | 1977 |
Stages I--III Hodgkin's disease in children: results of staging and treatment.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lym | 1977 |
Stages IIB and IIIB Hodgkin's disease. Results of combined modality treatment.
Topics: Adolescent; Adult; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlore | 1977 |
Stages IIB and IIIB Hodgkin's disease. Results of combined modality treatment.
Topics: Adolescent; Adult; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlore | 1977 |
Management of Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Agents; Drug Therapy, Combination; Hodgkin Disease; Humans; Lympha | 1979 |
Management of Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Agents; Drug Therapy, Combination; Hodgkin Disease; Humans; Lympha | 1979 |
Prolonged disease-free survival in Hodgkin's disease with MOPP reinduction after first relapse.
Topics: Adolescent; Adult; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans | 1979 |
Prolonged disease-free survival in Hodgkin's disease with MOPP reinduction after first relapse.
Topics: Adolescent; Adult; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans | 1979 |
Malignant myelosclerosis (acute myelofibrosis): report of two cases following cytotoxic chemotherapy.
Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Glom | 1979 |
Malignant myelosclerosis (acute myelofibrosis): report of two cases following cytotoxic chemotherapy.
Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Glom | 1979 |
An evaluation of total nodal irradiation as treatment for stage III A Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Administration Schedule; Drug Therapy, Combinat | 1979 |
An evaluation of total nodal irradiation as treatment for stage III A Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Administration Schedule; Drug Therapy, Combinat | 1979 |
Extrapyramidal tract syndrome following intensive MOPP therapy for stage IV-B Hodgkin's disease in childhood.
Topics: Antineoplastic Agents; Basal Ganglia Diseases; Child; Drug Therapy, Combination; Hodgkin Disease; Hu | 1979 |
Extrapyramidal tract syndrome following intensive MOPP therapy for stage IV-B Hodgkin's disease in childhood.
Topics: Antineoplastic Agents; Basal Ganglia Diseases; Child; Drug Therapy, Combination; Hodgkin Disease; Hu | 1979 |
Hodgkin's disease in children: treatment with low dose radiation and MOPP without staging laparotomy: a preliminary report.
Topics: Antineoplastic Agents; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mech | 1979 |
Hodgkin's disease in children: treatment with low dose radiation and MOPP without staging laparotomy: a preliminary report.
Topics: Antineoplastic Agents; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mech | 1979 |
[Cooperative therapy study HD 78 for Hodgkin's disease in children and adolescents].
Topics: Adolescent; Child; Doxorubicin; Hodgkin Disease; Humans; Prednisone; Procarbazine; Vincristine | 1979 |
[Cooperative therapy study HD 78 for Hodgkin's disease in children and adolescents].
Topics: Adolescent; Child; Doxorubicin; Hodgkin Disease; Humans; Prednisone; Procarbazine; Vincristine | 1979 |
MOPP (nitrogen mustard, vincristine, procarbazine, and prednisone) given during pregnancy.
Topics: Adult; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Infant, Ne | 1979 |
MOPP (nitrogen mustard, vincristine, procarbazine, and prednisone) given during pregnancy.
Topics: Adult; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Infant, Ne | 1979 |
The treatment of advanced and recurrent Hodgkin's disease with chlorambucil, vinblastine, procarbazine and prednisone in combination.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Marrow; Child; Chlorambucil; Drug Therapy, Comb | 1979 |
The treatment of advanced and recurrent Hodgkin's disease with chlorambucil, vinblastine, procarbazine and prednisone in combination.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Marrow; Child; Chlorambucil; Drug Therapy, Comb | 1979 |
The role of combined modality therapy in the treatment of stage IIIA Hodgkin's disease.
Topics: Antineoplastic Agents; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Predniso | 1979 |
The role of combined modality therapy in the treatment of stage IIIA Hodgkin's disease.
Topics: Antineoplastic Agents; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Predniso | 1979 |
[Hodgkin's disease developing in the course of a chronic liver disease with ulcerative colitis immunosuppressed with azathioprine].
Topics: Azathioprine; Colitis, Ulcerative; Hepatitis B; Hepatitis B Surface Antigens; Hodgkin Disease; Human | 1979 |
[Hodgkin's disease developing in the course of a chronic liver disease with ulcerative colitis immunosuppressed with azathioprine].
Topics: Azathioprine; Colitis, Ulcerative; Hepatitis B; Hepatitis B Surface Antigens; Hodgkin Disease; Human | 1979 |
Feasibility of different combinations of chemotherapy (6 MOPP) plus radiotherapy in Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; | 1979 |
Feasibility of different combinations of chemotherapy (6 MOPP) plus radiotherapy in Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; | 1979 |
Hodgkin's disease: results of treatment with combination chemotherapy.
Topics: Adolescent; Adult; Aged; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Me | 1977 |
Hodgkin's disease: results of treatment with combination chemotherapy.
Topics: Adolescent; Adult; Aged; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Me | 1977 |
Deafness associated with oral furosemide.
Topics: Aged; Audiometry; Deafness; Furosemide; Hodgkin Disease; Humans; Male; Nephrotic Syndrome; Prednison | 1978 |
Deafness associated with oral furosemide.
Topics: Aged; Audiometry; Deafness; Furosemide; Hodgkin Disease; Humans; Male; Nephrotic Syndrome; Prednison | 1978 |
Rapid development of keratoacanthoma and accelerated transformation into squamous cell carcinoma of the skin: a mutagenic effect of polychemotherapy in a patient with Hodgkin's disease?
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Therapy, Combination; Hodgkin Disease; Humans; | 1978 |
Rapid development of keratoacanthoma and accelerated transformation into squamous cell carcinoma of the skin: a mutagenic effect of polychemotherapy in a patient with Hodgkin's disease?
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Therapy, Combination; Hodgkin Disease; Humans; | 1978 |
Impact of salvage treatment on initial relapses in patients with Hodgkin disease, stages I-III.
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vincr | 1978 |
Impact of salvage treatment on initial relapses in patients with Hodgkin disease, stages I-III.
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vincr | 1978 |
Hemorrhagic cystitis with MOPP therapy.
Topics: Child; Cyclophosphamide; Cystitis; Drug Therapy, Combination; Hematuria; Hodgkin Disease; Humans; Ma | 1978 |
Hemorrhagic cystitis with MOPP therapy.
Topics: Child; Cyclophosphamide; Cystitis; Drug Therapy, Combination; Hematuria; Hodgkin Disease; Humans; Ma | 1978 |
Relapse of Hodgkin disease after extended-field radiotherapy.
Topics: Adolescent; Adult; Aged; Bone Marrow; Child; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lym | 1978 |
Relapse of Hodgkin disease after extended-field radiotherapy.
Topics: Adolescent; Adult; Aged; Bone Marrow; Child; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lym | 1978 |
Gynecomastia and gonadal dysfunction in adolescent boys treated with combination chemotherapy for Hodgkin's disease.
Topics: Adolescent; Age Factors; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; | 1978 |
Gynecomastia and gonadal dysfunction in adolescent boys treated with combination chemotherapy for Hodgkin's disease.
Topics: Adolescent; Age Factors; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; | 1978 |
[ Long-term evaluation of the effect of a chemotherapy protocol using vincristine, adriamycin, procarbazine and prednisone (VAPP) on advanced Hodgkin's disease].
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Doxorubicin; Drug Therapy, Combination; Female; Hod | 1978 |
[ Long-term evaluation of the effect of a chemotherapy protocol using vincristine, adriamycin, procarbazine and prednisone (VAPP) on advanced Hodgkin's disease].
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Doxorubicin; Drug Therapy, Combination; Female; Hod | 1978 |
A morphologic study of opportunistic cerebral toxoplasmosis.
Topics: Aged; Brain Diseases; Carmustine; Hodgkin Disease; Humans; Male; Prednisone; Procarbazine; Radionucl | 1978 |
A morphologic study of opportunistic cerebral toxoplasmosis.
Topics: Aged; Brain Diseases; Carmustine; Hodgkin Disease; Humans; Male; Prednisone; Procarbazine; Radionucl | 1978 |
[MVPP multiple drug therapy combined with conventional radiotherapy in children with Hodgkin's disease].
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Mal | 1978 |
[MVPP multiple drug therapy combined with conventional radiotherapy in children with Hodgkin's disease].
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Mal | 1978 |
[Relapses in Hodgkin's disease and their radiochemotherapy (author's transl)].
Topics: Adult; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mech | 1978 |
[Relapses in Hodgkin's disease and their radiochemotherapy (author's transl)].
Topics: Adult; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mech | 1978 |
Childhood Hodgkin's disease in Uganda: a ten year experience.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Gynec | 1978 |
Childhood Hodgkin's disease in Uganda: a ten year experience.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Gynec | 1978 |
Patterns of relapse in advanced Hodgkin's disease treated with combination chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Drug Therapy, Combination; Female; Hodgkin Di | 1978 |
Patterns of relapse in advanced Hodgkin's disease treated with combination chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Drug Therapy, Combination; Female; Hodgkin Di | 1978 |
The place of radiation therapy in the treatment of Hodgkin's disease.
Topics: Adult; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Myocardial | 1978 |
The place of radiation therapy in the treatment of Hodgkin's disease.
Topics: Adult; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Myocardial | 1978 |
Cutaneous Hodgkin's disease: indolent course and control with chemotherapy.
Topics: Aged; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Neoplastic Cells, Circulating; Pre | 1978 |
Cutaneous Hodgkin's disease: indolent course and control with chemotherapy.
Topics: Aged; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Neoplastic Cells, Circulating; Pre | 1978 |
[Polychemotherapy of lymphomas. Results of a selection of 32 cases diagnosed in stage III and stage IV and not previously treated].
Topics: Antineoplastic Agents; Drug Therapy, Combination; Hodgkin Disease; Humans; Lymphoma; Mechlorethamine | 1978 |
[Polychemotherapy of lymphomas. Results of a selection of 32 cases diagnosed in stage III and stage IV and not previously treated].
Topics: Antineoplastic Agents; Drug Therapy, Combination; Hodgkin Disease; Humans; Lymphoma; Mechlorethamine | 1978 |
[MOPP chemotherapy of generalized Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; | 1978 |
[MOPP chemotherapy of generalized Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; | 1978 |
Selective splenectomy in Hodgkin's disease, stages I and II. Results of treatment.
Topics: Adolescent; Adult; Child; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neopl | 1978 |
Selective splenectomy in Hodgkin's disease, stages I and II. Results of treatment.
Topics: Adolescent; Adult; Child; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neopl | 1978 |
[Combination chemotherapy and synchronization therapy in lymphogranulomatosis and non-Hodgkin's lymphomas].
Topics: Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Lymphom | 1976 |
[Combination chemotherapy and synchronization therapy in lymphogranulomatosis and non-Hodgkin's lymphomas].
Topics: Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Lymphom | 1976 |
Recent advances and controversies in the management of Hodgkin's disease.
Topics: Adult; Drug Therapy, Combination; Hodgkin Disease; Humans; Laparotomy; Lymphography; Mechlorethamine | 1975 |
Recent advances and controversies in the management of Hodgkin's disease.
Topics: Adult; Drug Therapy, Combination; Hodgkin Disease; Humans; Laparotomy; Lymphography; Mechlorethamine | 1975 |
[Combination chemotherapy (MOPP) in 60 patients with Hodgkin's disease (five years results) (author's transl)].
Topics: Adolescent; Adult; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine | 1975 |
[Combination chemotherapy (MOPP) in 60 patients with Hodgkin's disease (five years results) (author's transl)].
Topics: Adolescent; Adult; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine | 1975 |
Hypnosis in the treatment of warts in immunodeficient children.
Topics: Adolescent; Child; Female; Follow-Up Studies; Hodgkin Disease; Humans; Hypnosis; Hypnosis, Anestheti | 1977 |
Hypnosis in the treatment of warts in immunodeficient children.
Topics: Adolescent; Child; Female; Follow-Up Studies; Hodgkin Disease; Humans; Hypnosis; Hypnosis, Anestheti | 1977 |
Diffuse pulmonary disease after therapy with nitrogen mustard, vincristine, procarbazine, and prednisone.
Topics: Adult; Biopsy; Drug Hypersensitivity; Female; Hodgkin Disease; Humans; Lung Diseases; Mechlorethamin | 1977 |
Diffuse pulmonary disease after therapy with nitrogen mustard, vincristine, procarbazine, and prednisone.
Topics: Adult; Biopsy; Drug Hypersensitivity; Female; Hodgkin Disease; Humans; Lung Diseases; Mechlorethamin | 1977 |
[Combined cyclic treatment of generalized Hodgkin's disease by the MOPP program. Preliminary results and observed complications].
Topics: Adult; Aged; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Midd | 1977 |
[Combined cyclic treatment of generalized Hodgkin's disease by the MOPP program. Preliminary results and observed complications].
Topics: Adult; Aged; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Midd | 1977 |
Cyclophosphamide, vinblastine, procarbazine and prednisone with CCNU and vinblastine maintenance for advanced Hodgkin's disease.
Topics: Adult; Bone Marrow; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Femal | 1977 |
Cyclophosphamide, vinblastine, procarbazine and prednisone with CCNU and vinblastine maintenance for advanced Hodgkin's disease.
Topics: Adult; Bone Marrow; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Femal | 1977 |
[Initial treatment of Hodgkin's disease with polychemotherapy. Long-term results in 226 cases (1- to 10-year follow-up)].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Drug Evaluation; Drug Therapy, Combination; F | 1977 |
[Initial treatment of Hodgkin's disease with polychemotherapy. Long-term results in 226 cases (1- to 10-year follow-up)].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Drug Evaluation; Drug Therapy, Combination; F | 1977 |
[The results of radiotherapy managements in Hodgkin's disease (author's transl)].
Topics: Adolescent; Adult; Aged; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Me | 1977 |
[The results of radiotherapy managements in Hodgkin's disease (author's transl)].
Topics: Adolescent; Adult; Aged; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Me | 1977 |
[81 cases of Hodgkin's disease treated with extensive radiotherapy, including 65 with primary MOPP chemiotherapy (author's transl)].
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Retro | 1977 |
[81 cases of Hodgkin's disease treated with extensive radiotherapy, including 65 with primary MOPP chemiotherapy (author's transl)].
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Retro | 1977 |
Limited extranodal Hodgkin's disease. Unfavorable prognosis and therapeutic implications.
Topics: Adolescent; Adult; Aged; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lung Neo | 1977 |
Limited extranodal Hodgkin's disease. Unfavorable prognosis and therapeutic implications.
Topics: Adolescent; Adult; Aged; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lung Neo | 1977 |
[Recent progress in the treatment of Hodgkin's disease].
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vinbl | 1977 |
[Recent progress in the treatment of Hodgkin's disease].
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vinbl | 1977 |
Hematologic neoplasia in patients treated for Hodgkin's disease.
Topics: Adult; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Leukemia; Male; Mechloreth | 1977 |
Hematologic neoplasia in patients treated for Hodgkin's disease.
Topics: Adult; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Leukemia; Male; Mechloreth | 1977 |
[Chemotherapy-radiotherapy association in the treatment of localized forms of Hodgkin's disease. Prognosis of polychemotherapy after three trials of M.O.P.P].
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Laparotomy; Mechlorethamine; Prednisone; Procarb | 1977 |
[Chemotherapy-radiotherapy association in the treatment of localized forms of Hodgkin's disease. Prognosis of polychemotherapy after three trials of M.O.P.P].
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Laparotomy; Mechlorethamine; Prednisone; Procarb | 1977 |
[Polychemotherapy of Hodgkin's disease. Long-term results in 226 cases].
Topics: Drug Therapy, Combination; Follow-Up Studies; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; | 1977 |
[Polychemotherapy of Hodgkin's disease. Long-term results in 226 cases].
Topics: Drug Therapy, Combination; Follow-Up Studies; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; | 1977 |
[Laparotomy in the therapy of Hodgkin's disease].
Topics: Cobalt Radioisotopes; Diaphragm; Drug Therapy, Combination; Hodgkin Disease; Humans; Laparotomy; Mec | 1977 |
[Laparotomy in the therapy of Hodgkin's disease].
Topics: Cobalt Radioisotopes; Diaphragm; Drug Therapy, Combination; Hodgkin Disease; Humans; Laparotomy; Mec | 1977 |
[Diagnosis and therapy of Hodgkin's disease in childhood].
Topics: Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Female; Hodgkin Disease; Human | 1976 |
[Diagnosis and therapy of Hodgkin's disease in childhood].
Topics: Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Female; Hodgkin Disease; Human | 1976 |
Avascular necrosis of the femoral head with combination therapy.
Topics: Adult; Antineoplastic Agents; Cyclophosphamide; Female; Femur Head; Femur Head Necrosis; Hodgkin Dis | 1976 |
Avascular necrosis of the femoral head with combination therapy.
Topics: Adult; Antineoplastic Agents; Cyclophosphamide; Female; Femur Head; Femur Head Necrosis; Hodgkin Dis | 1976 |
Combinaed chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for patients with advanced Hodgkin's disease. An alternative program to MOPP.
Topics: Adolescent; Adult; Age Factors; Aged; Alopecia; Antineoplastic Agents; Cyclophosphamide; Drug Therap | 1976 |
Combinaed chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for patients with advanced Hodgkin's disease. An alternative program to MOPP.
Topics: Adolescent; Adult; Age Factors; Aged; Alopecia; Antineoplastic Agents; Cyclophosphamide; Drug Therap | 1976 |
Long term remissions with combined modality therapy for advanced Hodgkin's disease.
Topics: Adult; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Age | 1976 |
Long term remissions with combined modality therapy for advanced Hodgkin's disease.
Topics: Adult; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Age | 1976 |
Initial relapses in previously treated Hodgkin's disease. I. Results of second treatment.
Topics: Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Neoplasm Metastasis; Neoplasm Recurrence, Lo | 1976 |
Initial relapses in previously treated Hodgkin's disease. I. Results of second treatment.
Topics: Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Neoplasm Metastasis; Neoplasm Recurrence, Lo | 1976 |
Chemotherapy of advanced malignant lymphomas comparative evaluation of results with single agent and combination therapy.
Topics: Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lymphoma; Male; N | 1976 |
Chemotherapy of advanced malignant lymphomas comparative evaluation of results with single agent and combination therapy.
Topics: Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lymphoma; Male; N | 1976 |
[Proliferation and growth of lymphatic cell population in malignant lymphomas].
Topics: Chlorambucil; Cytogenetics; Hematopoiesis; Hodgkin Disease; Humans; Leukemia, Lymphoid; Lymphocytes; | 1976 |
[Proliferation and growth of lymphatic cell population in malignant lymphomas].
Topics: Chlorambucil; Cytogenetics; Hematopoiesis; Hodgkin Disease; Humans; Leukemia, Lymphoid; Lymphocytes; | 1976 |
Idiopathic thrombocytopenic purpura in Hodgkin's disease after splenectomy.
Topics: Adult; Hodgkin Disease; Humans; Male; Prednisone; Purpura, Thrombocytopenic; Splenectomy | 1976 |
Idiopathic thrombocytopenic purpura in Hodgkin's disease after splenectomy.
Topics: Adult; Hodgkin Disease; Humans; Male; Prednisone; Purpura, Thrombocytopenic; Splenectomy | 1976 |
Combination chemotherapy of Hodgkin's disease in children.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combinat | 1976 |
Combination chemotherapy of Hodgkin's disease in children.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combinat | 1976 |
Hypertrophic pulmonary osteoarthropathy in Hodgkin's disease: reversal with chemotherapy.
Topics: Adult; Antineoplastic Agents; Drug Therapy, Combination; Hodgkin Disease; Humans; Lung Diseases; Mal | 1976 |
Hypertrophic pulmonary osteoarthropathy in Hodgkin's disease: reversal with chemotherapy.
Topics: Adult; Antineoplastic Agents; Drug Therapy, Combination; Hodgkin Disease; Humans; Lung Diseases; Mal | 1976 |
[Curative aspects of modern combination chemotherapy in generalized malignant lymphomas].
Topics: Agranulocytosis; Cyclophosphamide; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Life | 1976 |
[Curative aspects of modern combination chemotherapy in generalized malignant lymphomas].
Topics: Agranulocytosis; Cyclophosphamide; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Life | 1976 |
Patterns of changes in peripheral blood composition in the course of combination chemotherapy of cancer.
Topics: Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Female; Hematopoies | 1976 |
Patterns of changes in peripheral blood composition in the course of combination chemotherapy of cancer.
Topics: Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Female; Hematopoies | 1976 |
[Side effects of corticosteroid treatment of lymphogranulomatosis in children].
Topics: Adolescent; Child; Child, Preschool; Cushing Syndrome; Hodgkin Disease; Humans; Peptic Ulcer; Predni | 1976 |
[Side effects of corticosteroid treatment of lymphogranulomatosis in children].
Topics: Adolescent; Child; Child, Preschool; Cushing Syndrome; Hodgkin Disease; Humans; Peptic Ulcer; Predni | 1976 |
Prednisone in MOPP chemotherapy for Hodgkin's disease.
Topics: Adult; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone | 1976 |
Prednisone in MOPP chemotherapy for Hodgkin's disease.
Topics: Adult; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone | 1976 |
Deoxypyrimidineuria in the course of chemotherapy in M. Hodgkin.
Topics: Cyclophosphamide; Deoxycytidine; Deoxyuridine; Drug Therapy, Combination; Female; Hodgkin Disease; H | 1976 |
Deoxypyrimidineuria in the course of chemotherapy in M. Hodgkin.
Topics: Cyclophosphamide; Deoxycytidine; Deoxyuridine; Drug Therapy, Combination; Female; Hodgkin Disease; H | 1976 |
Staging laparotomy and splenectomy: treatment and complications of Hodgkin's disease in children.
Topics: Adolescent; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Female; Hodgkin Di | 1976 |
Staging laparotomy and splenectomy: treatment and complications of Hodgkin's disease in children.
Topics: Adolescent; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Female; Hodgkin Di | 1976 |
Hodgkin disease with acute lymphoblastic leukemia.
Topics: Acute Disease; Adolescent; Daunorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukemi | 1975 |
Hodgkin disease with acute lymphoblastic leukemia.
Topics: Acute Disease; Adolescent; Daunorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukemi | 1975 |
Cyclophosphamide therapy and interstitial pulmonary fibrosis.
Topics: Adult; Aged; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Female; Hodgkin Disease; | 1976 |
Cyclophosphamide therapy and interstitial pulmonary fibrosis.
Topics: Adult; Aged; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Female; Hodgkin Disease; | 1976 |
Pancreatic carcinoma as a sequel to therapy of lymphoma.
Topics: Adenocarcinoma; Adolescent; Adult; Antineoplastic Agents; Carmustine; Cyclophosphamide; Female; Hodg | 1976 |
Pancreatic carcinoma as a sequel to therapy of lymphoma.
Topics: Adenocarcinoma; Adolescent; Adult; Antineoplastic Agents; Carmustine; Cyclophosphamide; Female; Hodg | 1976 |
Experience in the treatment of malignant lymphomas.
Topics: Adolescent; Adult; Aged; Female; Hodgkin Disease; Humans; Lymphoma; Male; Middle Aged; Nitrogen Must | 1976 |
Experience in the treatment of malignant lymphomas.
Topics: Adolescent; Adult; Aged; Female; Hodgkin Disease; Humans; Lymphoma; Male; Middle Aged; Nitrogen Must | 1976 |
Salmonella empyema and Hodgkin's disease.
Topics: Adult; Cyclophosphamide; Drug Therapy, Combination; Empyema; Female; Hodgkin Disease; Humans; Immuno | 1975 |
Salmonella empyema and Hodgkin's disease.
Topics: Adult; Cyclophosphamide; Drug Therapy, Combination; Empyema; Female; Hodgkin Disease; Humans; Immuno | 1975 |
Trichlortriethylamine (TS-160 Spofa) in combination chemotherapy of malignant lymphomas.
Topics: Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lymp | 1975 |
Trichlortriethylamine (TS-160 Spofa) in combination chemotherapy of malignant lymphomas.
Topics: Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lymp | 1975 |
Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Femal | 1975 |
Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Femal | 1975 |
Immunosuppression and toxoplasmic encephalitis: clinical and experimental aspects.
Topics: Adult; Animals; Cortisone; Cricetinae; Cyclophosphamide; Encephalitis; Female; Hodgkin Disease; Huma | 1975 |
Immunosuppression and toxoplasmic encephalitis: clinical and experimental aspects.
Topics: Adult; Animals; Cortisone; Cricetinae; Cyclophosphamide; Encephalitis; Female; Hodgkin Disease; Huma | 1975 |
Management of Hodgkin's and non-Hodgkin's lymphomas.
Topics: Administration, Oral; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Injectio | 1975 |
Management of Hodgkin's and non-Hodgkin's lymphomas.
Topics: Administration, Oral; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Injectio | 1975 |
Treatment of Wegener's granulomatosis of lung.
Topics: Azathioprine; Cyclophosphamide; Drug Evaluation; Granuloma; Granulomatosis with Polyangiitis; Hodgki | 1975 |
Treatment of Wegener's granulomatosis of lung.
Topics: Azathioprine; Cyclophosphamide; Drug Evaluation; Granuloma; Granulomatosis with Polyangiitis; Hodgki | 1975 |
Toxoplasma encephalitis complicating Hodgkin's disease.
Topics: Adult; Electroencephalography; Encephalitis; England; Female; Hemiplegia; Hodgkin Disease; Humans; I | 1975 |
Toxoplasma encephalitis complicating Hodgkin's disease.
Topics: Adult; Electroencephalography; Encephalitis; England; Female; Hemiplegia; Hodgkin Disease; Humans; I | 1975 |
Fetal renal malformation following treatment of Hodgkin's disease during pregnancy.
Topics: Abnormalities, Drug-Induced; Abortion, Induced; Adult; Autopsy; Female; Fetus; Hodgkin Disease; Huma | 1975 |
Fetal renal malformation following treatment of Hodgkin's disease during pregnancy.
Topics: Abnormalities, Drug-Induced; Abortion, Induced; Adult; Autopsy; Female; Fetus; Hodgkin Disease; Huma | 1975 |
Abnormal spleen scan following MOPP therapy in a patient with Hodgkin's disease: case report.
Topics: Adolescent; Female; Hodgkin Disease; Humans; Mustard Compounds; Prednisone; Procarbazine; Radionucli | 1975 |
Abnormal spleen scan following MOPP therapy in a patient with Hodgkin's disease: case report.
Topics: Adolescent; Female; Hodgkin Disease; Humans; Mustard Compounds; Prednisone; Procarbazine; Radionucli | 1975 |
Combination chemotherapy in the treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechloret | 1975 |
Combination chemotherapy in the treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechloret | 1975 |
Combination chemotherapy of Hodgkin disease in children.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Mal | 1975 |
Combination chemotherapy of Hodgkin disease in children.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Mal | 1975 |
Current management of Hodgkin's disease.
Topics: Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Nitrogen Mustard Compounds; Pr | 1975 |
Current management of Hodgkin's disease.
Topics: Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Nitrogen Mustard Compounds; Pr | 1975 |
Combination chemotherapy in Hodgkin's disease: relation to radiotherapy.
Topics: Drug Therapy, Combination; Evaluation Studies as Topic; Hodgkin Disease; Humans; Mechlorethamine; Pr | 1975 |
Combination chemotherapy in Hodgkin's disease: relation to radiotherapy.
Topics: Drug Therapy, Combination; Evaluation Studies as Topic; Hodgkin Disease; Humans; Mechlorethamine; Pr | 1975 |
Towards curative treatment of advanced Hodgkin's disease.
Topics: Chlorambucil; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Proca | 1975 |
Towards curative treatment of advanced Hodgkin's disease.
Topics: Chlorambucil; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Proca | 1975 |
Correlation of delayed hypersensitivity responses with chemotherapeutic results in advanced Hodgkin's disease.
Topics: Carmustine; Drug Therapy, Combination; Hodgkin Disease; Hypersensitivity, Delayed; Prednisone; Proca | 1975 |
Correlation of delayed hypersensitivity responses with chemotherapeutic results in advanced Hodgkin's disease.
Topics: Carmustine; Drug Therapy, Combination; Hodgkin Disease; Hypersensitivity, Delayed; Prednisone; Proca | 1975 |
[Antipyretic effect of corticosteroids in patients with Hodgkin's disease complicated by fever].
Topics: Adult; Analgesics; Female; Fever; Glucocorticoids; Hodgkin Disease; Humans; Male; Prednisolone; Pred | 1975 |
[Antipyretic effect of corticosteroids in patients with Hodgkin's disease complicated by fever].
Topics: Adult; Analgesics; Female; Fever; Glucocorticoids; Hodgkin Disease; Humans; Male; Prednisolone; Pred | 1975 |
Chemotherapy as a primary treatment of Hodgkin's disease (204 new cases, 1 to 8 years of follow-up).
Topics: Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlore | 1975 |
Chemotherapy as a primary treatment of Hodgkin's disease (204 new cases, 1 to 8 years of follow-up).
Topics: Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlore | 1975 |
[Polychemotherapy in generalized form of Hodgkin's disease].
Topics: Adult; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Nitrogen Mustard Compounds; | 1975 |
[Polychemotherapy in generalized form of Hodgkin's disease].
Topics: Adult; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Nitrogen Mustard Compounds; | 1975 |
Combination chemotherapy in Hodgkin's disease at advanced stages.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechloret | 1975 |
Combination chemotherapy in Hodgkin's disease at advanced stages.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechloret | 1975 |
[Chemotherapy of advanced stages (IIIB and IV) of Hodgkin's disease].
Topics: Adolescent; Adult; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlore | 1975 |
[Chemotherapy of advanced stages (IIIB and IV) of Hodgkin's disease].
Topics: Adolescent; Adult; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlore | 1975 |
The management of advanced Hodgkin's disease.
Topics: Antineoplastic Agents; Hodgkin Disease; Humans; Nitrogen Mustard Compounds; Prednisone; Procarbazine | 1975 |
The management of advanced Hodgkin's disease.
Topics: Antineoplastic Agents; Hodgkin Disease; Humans; Nitrogen Mustard Compounds; Prednisone; Procarbazine | 1975 |
Effect of splenectomy on tolerance to combination chemotherapy in patients with lymphoma.
Topics: Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Lymphoma; Mechlorethamine; Pos | 1976 |
Effect of splenectomy on tolerance to combination chemotherapy in patients with lymphoma.
Topics: Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Lymphoma; Mechlorethamine; Pos | 1976 |
Herpes zoster in children with stage I-III Hodgkin's disease.
Topics: Adolescent; Child; Female; Herpes Zoster; Hodgkin Disease; Humans; Male; Nitrogen Mustard Compounds; | 1976 |
Herpes zoster in children with stage I-III Hodgkin's disease.
Topics: Adolescent; Child; Female; Herpes Zoster; Hodgkin Disease; Humans; Male; Nitrogen Mustard Compounds; | 1976 |
Unusual cardiac reaction to chemotherapy following mediastinal irradiation in a patient with Hodgkin's disease.
Topics: Adult; Drug Therapy, Combination; Heart; Hodgkin Disease; Humans; Male; Mechlorethamine; Mediastinal | 1976 |
Unusual cardiac reaction to chemotherapy following mediastinal irradiation in a patient with Hodgkin's disease.
Topics: Adult; Drug Therapy, Combination; Heart; Hodgkin Disease; Humans; Male; Mechlorethamine; Mediastinal | 1976 |
Disseminated Nocardia brasiliensis infection.
Topics: Adult; Hodgkin Disease; Humans; Male; Nafcillin; Nitrogen Mustard Compounds; Nocardia Infections; Pr | 1976 |
Disseminated Nocardia brasiliensis infection.
Topics: Adult; Hodgkin Disease; Humans; Male; Nafcillin; Nitrogen Mustard Compounds; Nocardia Infections; Pr | 1976 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 27-1976.
Topics: Acute Disease; Adult; Bronchopneumonia; Cryptococcosis; Diagnosis, Differential; Hodgkin Disease; Hu | 1976 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 27-1976.
Topics: Acute Disease; Adult; Bronchopneumonia; Cryptococcosis; Diagnosis, Differential; Hodgkin Disease; Hu | 1976 |
[Combined chemotherapy in Hodgkin's disease].
Topics: Antineoplastic Agents; Blood Cell Count; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlor | 1976 |
[Combined chemotherapy in Hodgkin's disease].
Topics: Antineoplastic Agents; Blood Cell Count; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlor | 1976 |
Long-term gonadal dysfunction and its impact on bone mineralization in patients following COPP/ABVD chemotherapy for Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Density; Cobalt R | 1992 |
Long-term gonadal dysfunction and its impact on bone mineralization in patients following COPP/ABVD chemotherapy for Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Density; Cobalt R | 1992 |
The Second International Symposium on Hodgkin's Disease. Workshop III: Recommendations for future clinical trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modali | 1992 |
The Second International Symposium on Hodgkin's Disease. Workshop III: Recommendations for future clinical trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modali | 1992 |
[Four cases of Hodgkin's disease treated with MOPP/ABV hybrid regimen using nitrogen mustard-N-oxide hydrochloride].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Drug Administra | 1992 |
[Four cases of Hodgkin's disease treated with MOPP/ABV hybrid regimen using nitrogen mustard-N-oxide hydrochloride].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Drug Administra | 1992 |
[Cancer of the testis after Hodgkin's disease. Apropos of 2 cases].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Dysgermi | 1992 |
[Cancer of the testis after Hodgkin's disease. Apropos of 2 cases].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Dysgermi | 1992 |
Salivary flow and composition in lymphoma patients before, during and after treatment with cytostatic drugs.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols | 1992 |
Salivary flow and composition in lymphoma patients before, during and after treatment with cytostatic drugs.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols | 1992 |
[Second neoplasms as a late complication of the treatment of Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinom | 1992 |
[Second neoplasms as a late complication of the treatment of Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinom | 1992 |
Hodgkin's disease and acute leukemia. Is it a true association?
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil | 1992 |
Hodgkin's disease and acute leukemia. Is it a true association?
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil | 1992 |
Bilateral aseptic necrosis of the humeral head following combined therapy for Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di | 1992 |
Bilateral aseptic necrosis of the humeral head following combined therapy for Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di | 1992 |
Mediastinal masses in children with Hodgkin's disease. An analysis of the Children's Hospital of Philadelphia and the Hospital of the University of Pennsylvania experience.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Ad | 1992 |
Mediastinal masses in children with Hodgkin's disease. An analysis of the Children's Hospital of Philadelphia and the Hospital of the University of Pennsylvania experience.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Ad | 1992 |
[Hodgkin's disease and infection with human immunodeficiency virus].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dox | 1992 |
[Hodgkin's disease and infection with human immunodeficiency virus].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dox | 1992 |
Avascular necrosis of the femoral head after treatment of Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubic | 1992 |
Avascular necrosis of the femoral head after treatment of Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubic | 1992 |
Simultaneously occurring alopecia areata and Hodgkin's lymphoma: complete remission of both diseases with MOPP/ABV chemotherapy.
Topics: Adult; Alopecia Areata; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Bleomyc | 1992 |
Simultaneously occurring alopecia areata and Hodgkin's lymphoma: complete remission of both diseases with MOPP/ABV chemotherapy.
Topics: Adult; Alopecia Areata; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Bleomyc | 1992 |
Management of stage II Hodgkin's disease: 15 years experience at St. Bartholomew's Hospital.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1992 |
Management of stage II Hodgkin's disease: 15 years experience at St. Bartholomew's Hospital.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1992 |
[Treatment of elderly patients with hematological malignancies].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1992 |
[Treatment of elderly patients with hematological malignancies].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1992 |
ABEP as primary chemotherapy for Hodgkin's disease.
Topics: Aclarubicin; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cytarabin | 1992 |
ABEP as primary chemotherapy for Hodgkin's disease.
Topics: Aclarubicin; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cytarabin | 1992 |
[Initial results of hybrid chemotherapy of Hodgkin's disease using COPP/VBA].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Hodgkin Di | 1992 |
[Initial results of hybrid chemotherapy of Hodgkin's disease using COPP/VBA].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Hodgkin Di | 1992 |
[Radiotherapy vs. chemotherapy in early-stage Hodgkin's disease: a justified approach?].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Decision Making; Hodgkin D | 1992 |
[Radiotherapy vs. chemotherapy in early-stage Hodgkin's disease: a justified approach?].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Decision Making; Hodgkin D | 1992 |
Remission of scleroderma during chemotherapy for lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Mechloretham | 1992 |
Remission of scleroderma during chemotherapy for lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Mechloretham | 1992 |
Hodgkin's disease involving the gingiva in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophos | 1992 |
Hodgkin's disease involving the gingiva in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophos | 1992 |
The frequency of translocations after treatment for Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 4; Combined Modality Therap | 1992 |
The frequency of translocations after treatment for Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 4; Combined Modality Therap | 1992 |
Selective metaphasic arrest of erythroblasts by vincristine in patients receiving high doses of recombinant human erythropoietin for myelosuppressive anemia.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Erythroblasts; Erythropoietin; Hodgkin Disea | 1992 |
Selective metaphasic arrest of erythroblasts by vincristine in patients receiving high doses of recombinant human erythropoietin for myelosuppressive anemia.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Erythroblasts; Erythropoietin; Hodgkin Disea | 1992 |
[An expanded radical program of radiation therapy with prophylactic irradiation of the lungs in lymphogranulomatosis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Hodgkin | 1992 |
[An expanded radical program of radiation therapy with prophylactic irradiation of the lungs in lymphogranulomatosis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Hodgkin | 1992 |
Early stage Hodgkin's disease: ten-year results of a non-randomised study with radiotherapy alone or combined with MOPP.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1992 |
Early stage Hodgkin's disease: ten-year results of a non-randomised study with radiotherapy alone or combined with MOPP.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1992 |
Role of radiation therapy in advanced Hodgkin's disease--as yet, an answer? Still a question?
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 1992 |
Role of radiation therapy in advanced Hodgkin's disease--as yet, an answer? Still a question?
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 1992 |
Residual mediastinal mass after treatment of Hodgkin's disease: a decision analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Decision Trees; Hodgkin D | 1992 |
Residual mediastinal mass after treatment of Hodgkin's disease: a decision analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Decision Trees; Hodgkin D | 1992 |
Therapeutic adherence to oral medication regimens by adolescents with cancer. I. Laboratory assessment.
Topics: Administration, Oral; Adolescent; Adult; Ambulatory Care; Biological Assay; Dehydroepiandrosterone; | 1992 |
Therapeutic adherence to oral medication regimens by adolescents with cancer. I. Laboratory assessment.
Topics: Administration, Oral; Adolescent; Adult; Ambulatory Care; Biological Assay; Dehydroepiandrosterone; | 1992 |
Therapeutic adherence to oral medication regimens by adolescents with cancer. II. Clinical and psychologic correlates.
Topics: Administration, Oral; Adolescent; Adult; Ambulatory Care; Attitude to Health; Denial, Psychological; | 1992 |
Therapeutic adherence to oral medication regimens by adolescents with cancer. II. Clinical and psychologic correlates.
Topics: Administration, Oral; Adolescent; Adult; Ambulatory Care; Attitude to Health; Denial, Psychological; | 1992 |
[Hodgkin's disease. Our 9-year experience with the 1980 protocol].
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy | 1992 |
[Hodgkin's disease. Our 9-year experience with the 1980 protocol].
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy | 1992 |
To CHOP or not to CHOP ... is that the question?
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubi | 1992 |
To CHOP or not to CHOP ... is that the question?
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubi | 1992 |
Late cardiopulmonary toxicity after treatment for Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Exerci | 1992 |
Late cardiopulmonary toxicity after treatment for Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Exerci | 1992 |
Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Hodgkin Disease; Humans; Prednisone; P | 1992 |
Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Hodgkin Disease; Humans; Prednisone; P | 1992 |
Radiation therapy is better than chemotherapy in early-stage Hodgkin's disease? Not so fast.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Prednisone | 1992 |
Radiation therapy is better than chemotherapy in early-stage Hodgkin's disease? Not so fast.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Prednisone | 1992 |
Induction of chromosome breaks and sister chromatid exchanges in patients with Hodgkin's disease by two combination chemotherapy regimens of different leukemogenic potential.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Cycle; Chromosomes; Dacarbazi | 1990 |
Induction of chromosome breaks and sister chromatid exchanges in patients with Hodgkin's disease by two combination chemotherapy regimens of different leukemogenic potential.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Cycle; Chromosomes; Dacarbazi | 1990 |
Treatment of Hodgkin's disease with MOPP chemotherapy: effect of dose and schedule modification on treatment outcome.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dose-Response R | 1990 |
Treatment of Hodgkin's disease with MOPP chemotherapy: effect of dose and schedule modification on treatment outcome.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dose-Response R | 1990 |
Secondary uncommon solid neoplasms in cured Hodgkin's disease and follow-up of the original B-DOPA chemotherapy patient group.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Dacarbaz | 1990 |
Secondary uncommon solid neoplasms in cured Hodgkin's disease and follow-up of the original B-DOPA chemotherapy patient group.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Dacarbaz | 1990 |
[High dose intensity with COP-BLAM in Hodgkin's disease with unfavorable risk factors].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1990 |
[High dose intensity with COP-BLAM in Hodgkin's disease with unfavorable risk factors].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1990 |
Development of pulmonary histiocytosis X after chemotherapy for Hodgkin disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Fem | 1990 |
Development of pulmonary histiocytosis X after chemotherapy for Hodgkin disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Fem | 1990 |
[Icteric cholestasis as an early symptom in Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Cholestasis; Cyclophospham | 1990 |
[Icteric cholestasis as an early symptom in Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Cholestasis; Cyclophospham | 1990 |
The impact of breakthrough clinical trials on survival in population based tumor registries.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topic; Hodg | 1991 |
The impact of breakthrough clinical trials on survival in population based tumor registries.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topic; Hodg | 1991 |
Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Et | 1990 |
Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Et | 1990 |
Hodgkin's disease in adults in Saudi Arabia. Clinical features, prognostic factors and an analysis of therapy. Outcome of combination chemotherapy only, for both localized and advanced disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Dacarbazine; Doxorubi | 1991 |
Hodgkin's disease in adults in Saudi Arabia. Clinical features, prognostic factors and an analysis of therapy. Outcome of combination chemotherapy only, for both localized and advanced disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Dacarbazine; Doxorubi | 1991 |
Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Behavior; Bleomyci | 1991 |
Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Behavior; Bleomyci | 1991 |
Development of effective salvage treatment programs for Hodgkin's disease: an ongoing clinical challenge.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Mod | 1991 |
Development of effective salvage treatment programs for Hodgkin's disease: an ongoing clinical challenge.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Mod | 1991 |
Outcome of treatment of first relapse of Hodgkin's disease after primary chemotherapy: identification of risk factors from the British Columbia experience 1970 to 1988.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 1991 |
Outcome of treatment of first relapse of Hodgkin's disease after primary chemotherapy: identification of risk factors from the British Columbia experience 1970 to 1988.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 1991 |
MACOP-B and VACOP-B in diffuse large cell lymphomas and MOPP/ABV in Hodgkin's disease.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomyc | 1991 |
MACOP-B and VACOP-B in diffuse large cell lymphomas and MOPP/ABV in Hodgkin's disease.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomyc | 1991 |
Hodgkin's disease in 63 intravenous drug users infected with human immunodeficiency virus. Gruppo Italiano Cooperativo AIDS & Tumori (GICAT).
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin | 1991 |
Hodgkin's disease in 63 intravenous drug users infected with human immunodeficiency virus. Gruppo Italiano Cooperativo AIDS & Tumori (GICAT).
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin | 1991 |
Haematological toxicity compromises MOPP/ABVD chemotherapy in Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1991 |
Haematological toxicity compromises MOPP/ABVD chemotherapy in Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1991 |
Serum antithrombin III and alpha-2-antiplasmin concentrations in patients with Hodgkin's disease in the course of chemotherapy.
Topics: Adult; Aged; alpha-Macroglobulins; Antineoplastic Combined Chemotherapy Protocols; Antithrombin III; | 1991 |
Serum antithrombin III and alpha-2-antiplasmin concentrations in patients with Hodgkin's disease in the course of chemotherapy.
Topics: Adult; Aged; alpha-Macroglobulins; Antineoplastic Combined Chemotherapy Protocols; Antithrombin III; | 1991 |
In vivo somatic mutation in the lymphocytes of Hodgkin's disease patients.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols | 1991 |
In vivo somatic mutation in the lymphocytes of Hodgkin's disease patients.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols | 1991 |
Intensive chemotherapy and low-dose radiotherapy for the treatment of advanced-stage Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschoo | 1991 |
Intensive chemotherapy and low-dose radiotherapy for the treatment of advanced-stage Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschoo | 1991 |
[Thymus hyperplasia after chemotherapy in a case of Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Eto | 1991 |
[Thymus hyperplasia after chemotherapy in a case of Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Eto | 1991 |
[Hodgkin's disease during pregnancy. Study of late effects in the newborn infants].
Topics: Abnormalities, Drug-Induced; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chrom | 1991 |
[Hodgkin's disease during pregnancy. Study of late effects in the newborn infants].
Topics: Abnormalities, Drug-Induced; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chrom | 1991 |
Malignant lymphomas in HIV-seropositive patients. Frequency, features, and prognosis. Report on 31 cases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central Nervous System Neoplasms; | 1991 |
Malignant lymphomas in HIV-seropositive patients. Frequency, features, and prognosis. Report on 31 cases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central Nervous System Neoplasms; | 1991 |
Chemotherapy combined with involved-field radiotherapy for 177 children with Hodgkin's disease treated in 1983-1987.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child | 1991 |
Chemotherapy combined with involved-field radiotherapy for 177 children with Hodgkin's disease treated in 1983-1987.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child | 1991 |
[Treatment of Hodgkin's disease. National Protocol of Antineoplastic Drugs: preliminary report].
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomyc | 1991 |
[Treatment of Hodgkin's disease. National Protocol of Antineoplastic Drugs: preliminary report].
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomyc | 1991 |
Maternal and foetal outcome following Hodgkin's disease in pregnancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Birth Weight; Case-Control Studies; Cesarean | 1992 |
Maternal and foetal outcome following Hodgkin's disease in pregnancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Birth Weight; Case-Control Studies; Cesarean | 1992 |
[Risk factors and survival prognosis in lymphogranulomatosis: a statistical analysis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Electro | 1991 |
[Risk factors and survival prognosis in lymphogranulomatosis: a statistical analysis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Electro | 1991 |
[The combined therapy of stage-II lymphogranulomatosis: the effect of splenectomy and the time period for achieving full remission on treatment efficacy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 1991 |
[The combined therapy of stage-II lymphogranulomatosis: the effect of splenectomy and the time period for achieving full remission on treatment efficacy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 1991 |
Erythroblastopenia in two patients after splenectomy and polychemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cross Infection; C | 1991 |
Erythroblastopenia in two patients after splenectomy and polychemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cross Infection; C | 1991 |
Cryptococcal meningitis in a patient with Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Susceptibility; Hod | 1991 |
Cryptococcal meningitis in a patient with Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Susceptibility; Hod | 1991 |
Treatment of cytarabine acral erythema with corticosteroids.
Topics: Adult; Cytarabine; Erythema; Facial Dermatoses; Foot Dermatoses; Hand Dermatoses; Hodgkin Disease; H | 1991 |
Treatment of cytarabine acral erythema with corticosteroids.
Topics: Adult; Cytarabine; Erythema; Facial Dermatoses; Foot Dermatoses; Hand Dermatoses; Hodgkin Disease; H | 1991 |
[The combined (polychemical and radiation) and drug treatment of lymphogranulomatosis patients with generalized lung involvement (stage IV)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Hodgkin | 1991 |
[The combined (polychemical and radiation) and drug treatment of lymphogranulomatosis patients with generalized lung involvement (stage IV)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Hodgkin | 1991 |
Transient reversal of bone marrow aplasia associated with lymphocyte depleted Hodgkin's disease after combination chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Female; Hodgkin Disease; | 1991 |
Transient reversal of bone marrow aplasia associated with lymphocyte depleted Hodgkin's disease after combination chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Female; Hodgkin Disease; | 1991 |
[Plasmapheresis in the treatment of cytostatic disease in patients with lymphogranulomatosis].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 1991 |
[Plasmapheresis in the treatment of cytostatic disease in patients with lymphogranulomatosis].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 1991 |
Sister chromatid exchange frequency in Hodgkin's disease patients with elevated in vivo hprt mutant frequencies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemothera | 1991 |
Sister chromatid exchange frequency in Hodgkin's disease patients with elevated in vivo hprt mutant frequencies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemothera | 1991 |
Treatment of advanced-stage massive mediastinal Hodgkin's disease: the case for combined modality treatment.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; | 1991 |
Treatment of advanced-stage massive mediastinal Hodgkin's disease: the case for combined modality treatment.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; | 1991 |
Treatment of childhood Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Hodgkin Disease; Humans; Me | 1991 |
Treatment of childhood Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Hodgkin Disease; Humans; Me | 1991 |
Two cycles of MOPP and radiotherapy: effective treatment for stage IIIA and IIIB Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di | 1991 |
Two cycles of MOPP and radiotherapy: effective treatment for stage IIIA and IIIB Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di | 1991 |
Early-stage Hodgkin's disease: a choice of treatments or a treatment of choice?
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; | 1991 |
Early-stage Hodgkin's disease: a choice of treatments or a treatment of choice?
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; | 1991 |
Influence of age and duration of follow-up on lung function after combined chemotherapy for Hodgkin's disease.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Femal | 1990 |
Influence of age and duration of follow-up on lung function after combined chemotherapy for Hodgkin's disease.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Femal | 1990 |
Thoracic irradiation in Hodgkin's disease: disease control and long-term complications.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined | 1990 |
Thoracic irradiation in Hodgkin's disease: disease control and long-term complications.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined | 1990 |
The effects of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for Hodgkin's disease during childhood or adolescence.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Doxorubicin; Fo | 1990 |
The effects of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for Hodgkin's disease during childhood or adolescence.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Doxorubicin; Fo | 1990 |
[The efficacy of treatment using expanded programs of megavolt irradiation and polychemotherapy in patients with lymphogranulomatosis in stages I, II and IIIA].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Evaluat | 1990 |
[The efficacy of treatment using expanded programs of megavolt irradiation and polychemotherapy in patients with lymphogranulomatosis in stages I, II and IIIA].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Evaluat | 1990 |
Active oxygen radicals produced by leukocytes of malignant lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Electron Spin Resonan | 1990 |
Active oxygen radicals produced by leukocytes of malignant lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Electron Spin Resonan | 1990 |
Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: the Stanford experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1990 |
Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: the Stanford experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1990 |
Acute nonlymphocytic leukemia after radiation and MOPP chemotherapy for Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 1990 |
Acute nonlymphocytic leukemia after radiation and MOPP chemotherapy for Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 1990 |
[The late sequelae of the combined treatment of lymphogranulomatosis patients].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined | 1990 |
[The late sequelae of the combined treatment of lymphogranulomatosis patients].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined | 1990 |
NOVP: a novel chemotherapeutic regimen with minimal toxicity for treatment of Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Follow-Up Studies; | 1990 |
NOVP: a novel chemotherapeutic regimen with minimal toxicity for treatment of Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Follow-Up Studies; | 1990 |
Acute hepatic injury after the withdrawal of immunosuppressive chemotherapy in patients with hepatitis B.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Female; Hepatitis B; Hepatit | 1990 |
Acute hepatic injury after the withdrawal of immunosuppressive chemotherapy in patients with hepatitis B.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Female; Hepatitis B; Hepatit | 1990 |
Cytotoxic drug-induced fever: a report on procarbazine-induced hyperpyrexia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Diagnosis, Differential; Fe | 1990 |
Cytotoxic drug-induced fever: a report on procarbazine-induced hyperpyrexia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Diagnosis, Differential; Fe | 1990 |
Evaluation of cytoreductive therapy prior to high dose treatment with autologous bone marrow transplantation in relapsed and refractory Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carm | 1990 |
Evaluation of cytoreductive therapy prior to high dose treatment with autologous bone marrow transplantation in relapsed and refractory Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carm | 1990 |
Prognostic factors for patients relapsing after radiotherapy for early-stage Hodgkin's disease.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combine | 1990 |
Prognostic factors for patients relapsing after radiotherapy for early-stage Hodgkin's disease.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combine | 1990 |
MOPP dose intensity and survival: flawed analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Prednisone | 1990 |
MOPP dose intensity and survival: flawed analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Prednisone | 1990 |
[Treatment of Hodgkin's disease with lesions of the mediastinal lymph nodes and involvement in pulmonary processes].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Hodgkin | 1990 |
[Treatment of Hodgkin's disease with lesions of the mediastinal lymph nodes and involvement in pulmonary processes].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Hodgkin | 1990 |
Delayed life-threatening pneumonitis secondary to procarbazine.
Topics: Adult; Alveolitis, Extrinsic Allergic; Antineoplastic Combined Chemotherapy Protocols; Diagnosis, Di | 1990 |
Delayed life-threatening pneumonitis secondary to procarbazine.
Topics: Adult; Alveolitis, Extrinsic Allergic; Antineoplastic Combined Chemotherapy Protocols; Diagnosis, Di | 1990 |
Treatment of lower torso stages I and II Hodgkin's disease with radiation with or without adjuvant mechlorethamine, vincristine, procarbazine, and prednisone.
Topics: Abdominal Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therap | 1990 |
Treatment of lower torso stages I and II Hodgkin's disease with radiation with or without adjuvant mechlorethamine, vincristine, procarbazine, and prednisone.
Topics: Abdominal Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therap | 1990 |
Hodgkin's disease in children: treatment with MOPP and low-dose, extended field irradiation without laparotomy. Late results and toxicity.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1990 |
Hodgkin's disease in children: treatment with MOPP and low-dose, extended field irradiation without laparotomy. Late results and toxicity.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1990 |
Laparotomy and splenectomy in Hodgkin's disease: a reappraisal after twenty years.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D | 1985 |
Laparotomy and splenectomy in Hodgkin's disease: a reappraisal after twenty years.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D | 1985 |
MOPP/ABV hybrid program: combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin's disease.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomyc | 1985 |
MOPP/ABV hybrid program: combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin's disease.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomyc | 1985 |
Allogeneic marrow transplantation in the treatment of MOPP-resistant Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combi | 1985 |
Allogeneic marrow transplantation in the treatment of MOPP-resistant Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combi | 1985 |
[Malignant lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cycloph | 1985 |
[Malignant lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cycloph | 1985 |
CCNU, etoposide, and prednimustine (CEP) in refractory Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Hodg | 1986 |
CCNU, etoposide, and prednimustine (CEP) in refractory Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Hodg | 1986 |
[Early results of the treatment of Hodgkin's disease with alternating use in the CVPP and ABVD protocol].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubic | 1986 |
[Early results of the treatment of Hodgkin's disease with alternating use in the CVPP and ABVD protocol].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubic | 1986 |
Prognosis of bulky Hodgkin's disease treated with chemotherapy alone or combined with radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D | 1985 |
Prognosis of bulky Hodgkin's disease treated with chemotherapy alone or combined with radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D | 1985 |
[Laparotomy with splenectomy in the evaluation of the results of cytostatic treatment of patients with advanced Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dox | 1986 |
[Laparotomy with splenectomy in the evaluation of the results of cytostatic treatment of patients with advanced Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dox | 1986 |
ABVD versus MOPP: which is better?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D | 1987 |
ABVD versus MOPP: which is better?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D | 1987 |
Prognostic value of response after three MOPP cycles in Hodgkin's disease--stage III and IV.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Resistance | 1987 |
Prognostic value of response after three MOPP cycles in Hodgkin's disease--stage III and IV.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Resistance | 1987 |
Hodgkin's disease (HD): a historical perspective.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarba | 1986 |
Hodgkin's disease (HD): a historical perspective.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarba | 1986 |
[Contribution of anthracyclines in treatment of lymphoproliferative disorders].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 1987 |
[Contribution of anthracyclines in treatment of lymphoproliferative disorders].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 1987 |
Treatment of Hodgkin's disease in children with or without radiotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Daca | 1987 |
Treatment of Hodgkin's disease in children with or without radiotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Daca | 1987 |
[Controversial aspects in the current treatment of Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D | 1987 |
[Controversial aspects in the current treatment of Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D | 1987 |
MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Dru | 1987 |
MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Dru | 1987 |
[The combination of epirubicin, bleomycin, vinblastine and prednisone (EBVP) before radiotherapy in localized stages of Hodgkin's disease. Phase II trials].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1987 |
[The combination of epirubicin, bleomycin, vinblastine and prednisone (EBVP) before radiotherapy in localized stages of Hodgkin's disease. Phase II trials].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1987 |
Serum lysozyme activity in patients with Hodgkin's disease undergoing chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Hu | 1987 |
Serum lysozyme activity in patients with Hodgkin's disease undergoing chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Hu | 1987 |
Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the Ge
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Daca | 1987 |
Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the Ge
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Daca | 1987 |
[Autoimmune thrombocytopenic purpura preceding Hodgkin lymphoma].
Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Bleomy | 1987 |
[Autoimmune thrombocytopenic purpura preceding Hodgkin lymphoma].
Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Bleomy | 1987 |
Long-term follow-up of advanced Hodgkin's disease patients treated with a combination of streptozotocin, lomustine (CCNU), doxorubicin and bleomycin (SCAB).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Female; Follow-Up Stu | 1988 |
Long-term follow-up of advanced Hodgkin's disease patients treated with a combination of streptozotocin, lomustine (CCNU), doxorubicin and bleomycin (SCAB).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Female; Follow-Up Stu | 1988 |
[Hodgkin's disease in children. Current therapeutic strategies].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 1988 |
[Hodgkin's disease in children. Current therapeutic strategies].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 1988 |
Low O6-alkylguanine DNA alkyltransferase activity in the peripheral blood lymphocytes of patients with therapy-related acute nonlymphocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease | 1988 |
Low O6-alkylguanine DNA alkyltransferase activity in the peripheral blood lymphocytes of patients with therapy-related acute nonlymphocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease | 1988 |
Is first salvage chemotherapy the last-line chemotherapy in children with Hodgkin's disease? A tentative answer based on long observation of two patients.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Child; Combined Modal | 1987 |
Is first salvage chemotherapy the last-line chemotherapy in children with Hodgkin's disease? A tentative answer based on long observation of two patients.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Child; Combined Modal | 1987 |
[Improved survival rates in Hodgkin's disease].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; D | 1988 |
[Improved survival rates in Hodgkin's disease].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; D | 1988 |
An update on the Vancouver experience in the management of advanced Hodgkin's disease treated with the MOPP/ABV Hybrid program.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Doxorubicin; D | 1988 |
An update on the Vancouver experience in the management of advanced Hodgkin's disease treated with the MOPP/ABV Hybrid program.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Doxorubicin; D | 1988 |
[Hodgkin's disease and AIDS. Presentation of 5 cases].
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin | 1988 |
[Hodgkin's disease and AIDS. Presentation of 5 cases].
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin | 1988 |
High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combi | 1988 |
High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combi | 1988 |
[Treatment with CEP (CCNU, VP-16 and prednimustine) in Hodgkin's disease resistant to CVPP and ABVD. Results in 21 patients].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Do | 1988 |
[Treatment with CEP (CCNU, VP-16 and prednimustine) in Hodgkin's disease resistant to CVPP and ABVD. Results in 21 patients].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Do | 1988 |
[New combination of epirubicine, bleomycin, vinblastine and prednisone (EBVP II) before radiotherapy in localized stages of Hodgkin's disease. Phase II trial in 50 patients].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1988 |
[New combination of epirubicine, bleomycin, vinblastine and prednisone (EBVP II) before radiotherapy in localized stages of Hodgkin's disease. Phase II trial in 50 patients].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1988 |
Procarbazine hypersensitivity manifested as a fixed drug eruption.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Eru | 1988 |
Procarbazine hypersensitivity manifested as a fixed drug eruption.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Eru | 1988 |
Thyroid dysfunction in Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modali | 1989 |
Thyroid dysfunction in Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modali | 1989 |
Pediatric Hodgkin's disease: pulmonary, cardiac, and thyroid function following combined modality therapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 1989 |
Pediatric Hodgkin's disease: pulmonary, cardiac, and thyroid function following combined modality therapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 1989 |
[Treatment of Hodgkin's disease with alternately used drug combinations CVPP/ABVD].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubic | 1988 |
[Treatment of Hodgkin's disease with alternately used drug combinations CVPP/ABVD].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubic | 1988 |
[Femoral osteonecrosis in patients treated with radiochemotherapy of Hodgkin's lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cobalt Radioisotopes; Combined Mod | 1989 |
[Femoral osteonecrosis in patients treated with radiochemotherapy of Hodgkin's lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cobalt Radioisotopes; Combined Mod | 1989 |
Allogeneic marrow transplantation for refractory Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 1989 |
Allogeneic marrow transplantation for refractory Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 1989 |
Total lymphoid irradiation, high-dose chemotherapy and autologous bone marrow transplantation for chemotherapy-resistant Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combi | 1989 |
Total lymphoid irradiation, high-dose chemotherapy and autologous bone marrow transplantation for chemotherapy-resistant Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combi | 1989 |
[Treatment of localized forms of Hodgkin's disease with 3 courses of chemotherapy (ABVD-MP) in combination with wide focal and prophylactic lumbo-splenic radiotherapy. The POF 81/12 protocol].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Pr | 1989 |
[Treatment of localized forms of Hodgkin's disease with 3 courses of chemotherapy (ABVD-MP) in combination with wide focal and prophylactic lumbo-splenic radiotherapy. The POF 81/12 protocol].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Pr | 1989 |
Reduced combined radiotherapy and chemotherapy for Hodgkin's disease--risk-adapted treatment approach.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1989 |
Reduced combined radiotherapy and chemotherapy for Hodgkin's disease--risk-adapted treatment approach.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1989 |
Conventional salvage therapy for Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Mod | 1989 |
Conventional salvage therapy for Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Mod | 1989 |
Treatment of childhood Hodgkin's disease with chemotherapy alone. Experiences from the Royal Children's Hospital, Melbourne.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Daca | 1989 |
Treatment of childhood Hodgkin's disease with chemotherapy alone. Experiences from the Royal Children's Hospital, Melbourne.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Daca | 1989 |
Free-from-failure survival in Hodgkin's disease. Long-term analysis of 148 cases treated with a MOPP-modified protocol.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combine | 1989 |
Free-from-failure survival in Hodgkin's disease. Long-term analysis of 148 cases treated with a MOPP-modified protocol.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combine | 1989 |
[Radiotherapy with neoadjuvant chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Doxorub | 1989 |
[Radiotherapy with neoadjuvant chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Doxorub | 1989 |
[A case of Hodgkin's disease exhibiting erythrodermia probably due to allergic reaction to vinca alkaloids].
Topics: Antineoplastic Combined Chemotherapy Protocols; Dermatitis, Exfoliative; Drug Eruptions; Hodgkin Dis | 1989 |
[A case of Hodgkin's disease exhibiting erythrodermia probably due to allergic reaction to vinca alkaloids].
Topics: Antineoplastic Combined Chemotherapy Protocols; Dermatitis, Exfoliative; Drug Eruptions; Hodgkin Dis | 1989 |
[Recurrent paralysis induced by vincristine during the treatment of Hodgkin's disease].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Male; Mechlorethamine | 1989 |
[Recurrent paralysis induced by vincristine during the treatment of Hodgkin's disease].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Male; Mechlorethamine | 1989 |
[Hodgkin's disease diagnosed from the numerous Reed-Sternberg cells in the bone marrow].
Topics: Antigens, Differentiation; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bone | 1989 |
[Hodgkin's disease diagnosed from the numerous Reed-Sternberg cells in the bone marrow].
Topics: Antigens, Differentiation; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bone | 1989 |
Pediatric Hodgkin's disease. Later results and toxicity--the Toronto experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Follow | 1989 |
Pediatric Hodgkin's disease. Later results and toxicity--the Toronto experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Follow | 1989 |
Combined modality therapy for mediastinal Hodgkin's disease. Prognostic significance of constitutional symptoms and size of disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Comb | 1985 |
Combined modality therapy for mediastinal Hodgkin's disease. Prognostic significance of constitutional symptoms and size of disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Comb | 1985 |
Prognostic factors for Stage IV Hodgkin's disease treated with MOPP, with or without bleomycin.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Hodgkin Disease; | 1985 |
Prognostic factors for Stage IV Hodgkin's disease treated with MOPP, with or without bleomycin.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Hodgkin Disease; | 1985 |
Third-line salvage chemotherapy in Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dox | 1985 |
Third-line salvage chemotherapy in Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dox | 1985 |
[Advances in the chemotherapy of malignant lymphoma 1. Chemotherapy of Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D | 1985 |
[Advances in the chemotherapy of malignant lymphoma 1. Chemotherapy of Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D | 1985 |
[Treatment of malignant lymphoma in childhood].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 1985 |
[Treatment of malignant lymphoma in childhood].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 1985 |
How much MOPP?
Topics: Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Hodgkin Disease; H | 1989 |
How much MOPP?
Topics: Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Hodgkin Disease; H | 1989 |
Dose intensity of MOPP chemotherapy and survival in Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Sedimentation; Discriminant Analysis; Dose-Res | 1989 |
Dose intensity of MOPP chemotherapy and survival in Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Sedimentation; Discriminant Analysis; Dose-Res | 1989 |
[Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Th | 1989 |
[Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Th | 1989 |
Two cycles of MOPP and definitive radiotherapy for stage IIIA and IIIB Hodgkin's disease.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fert | 1989 |
Two cycles of MOPP and definitive radiotherapy for stage IIIA and IIIB Hodgkin's disease.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fert | 1989 |
Treatment of advanced Hodgkin's disease with modified MOPP regimens. A long-term observation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Hu | 1989 |
Treatment of advanced Hodgkin's disease with modified MOPP regimens. A long-term observation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Hu | 1989 |
MOPP therapy in children with Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Hodgkin Disease; Hu | 1989 |
MOPP therapy in children with Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Hodgkin Disease; Hu | 1989 |
Is androgen substitution necessary in hypogonadal patients when they are treated with chemotherapy for malignant diseases?
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Diseases; Hodgkin Dis | 1989 |
Is androgen substitution necessary in hypogonadal patients when they are treated with chemotherapy for malignant diseases?
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Diseases; Hodgkin Dis | 1989 |
Influence of dose intensity and density on therapeutic and toxic effects in Hodgkin's disease.
Topics: Adolescent; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Hodg | 1989 |
Influence of dose intensity and density on therapeutic and toxic effects in Hodgkin's disease.
Topics: Adolescent; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Hodg | 1989 |
Ten-year nodular sclerosis Hodgkin's disease and second malignancies.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di | 1989 |
Ten-year nodular sclerosis Hodgkin's disease and second malignancies.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di | 1989 |
The malignant lymphomas in Benin City, Nigeria.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fe | 1989 |
The malignant lymphomas in Benin City, Nigeria.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fe | 1989 |
[Indirect endolymphatic chemotherapy of patients with lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Hodgkin Disease; Humans; Injection | 1989 |
[Indirect endolymphatic chemotherapy of patients with lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Hodgkin Disease; Humans; Injection | 1989 |
Hodgkin's disease presenting as myelofibrosis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Diagnosis, Differential; Female; | 1989 |
Hodgkin's disease presenting as myelofibrosis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Diagnosis, Differential; Female; | 1989 |
[A case from practice (148). 1. Hodgkin disease, nodular sclerosing, Stage Ia. 2. Status following minimal-change glomerulonephritis with nephrotic syndrome 1980--status following endoxan and prednisone therapy].
Topics: Adult; Cyclophosphamide; Diagnosis, Differential; Hodgkin Disease; Humans; Male; Nephrosis, Lipoid; | 1989 |
[A case from practice (148). 1. Hodgkin disease, nodular sclerosing, Stage Ia. 2. Status following minimal-change glomerulonephritis with nephrotic syndrome 1980--status following endoxan and prednisone therapy].
Topics: Adult; Cyclophosphamide; Diagnosis, Differential; Hodgkin Disease; Humans; Male; Nephrosis, Lipoid; | 1989 |
Cutaneous Hodgkin's disease in a patient with human immunodeficiency virus infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; H | 1989 |
Cutaneous Hodgkin's disease in a patient with human immunodeficiency virus infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; H | 1989 |
MOPP chemotherapy alone: a suitable treatment for early stages of Hodgkin's disease?
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Female; Hodgkin Dise | 1985 |
MOPP chemotherapy alone: a suitable treatment for early stages of Hodgkin's disease?
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Female; Hodgkin Dise | 1985 |
Advanced Hodgkin disease (clinical stages IIIB and IV): low relapse rate after brief chemotherapy followed by high-dose total lymphoid irradiation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; | 1989 |
Advanced Hodgkin disease (clinical stages IIIB and IV): low relapse rate after brief chemotherapy followed by high-dose total lymphoid irradiation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; | 1989 |
Chlorambucil, vinblastine, procarbazine, and prednisone. An effective but less toxic regimen than MOPP for advanced-stage Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Chlorambucil; Female; Hodg | 1989 |
Chlorambucil, vinblastine, procarbazine, and prednisone. An effective but less toxic regimen than MOPP for advanced-stage Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Chlorambucil; Female; Hodg | 1989 |
[Treatment of Hodgkin's disease by chemotherapy with MOPP alone. Long-term results].
Topics: Adolescent; Adult; Algeria; Antineoplastic Combined Chemotherapy Protocols; Child; Female; Follow-Up | 1986 |
[Treatment of Hodgkin's disease by chemotherapy with MOPP alone. Long-term results].
Topics: Adolescent; Adult; Algeria; Antineoplastic Combined Chemotherapy Protocols; Child; Female; Follow-Up | 1986 |
A method for analysing case-control studies with ordinal exposure variables.
Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biometry; Burkitt Lymphoma; Cl | 1985 |
A method for analysing case-control studies with ordinal exposure variables.
Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biometry; Burkitt Lymphoma; Cl | 1985 |
Hodgkin's disease following Wilms' tumor: a case report.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgk | 1987 |
Hodgkin's disease following Wilms' tumor: a case report.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgk | 1987 |
Second malignant neoplasm in treated Hodgkin's disease. Report of a patient and scope of the problem.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Combined Modality Therapy; G | 1986 |
Second malignant neoplasm in treated Hodgkin's disease. Report of a patient and scope of the problem.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Combined Modality Therapy; G | 1986 |
Pregnancies and menstrual function before and after combined radiation (RT) and chemotherapy (TVPP) for Hodgkin's disease.
Topics: Adolescent; Adult; Age Factors; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Combined | 1986 |
Pregnancies and menstrual function before and after combined radiation (RT) and chemotherapy (TVPP) for Hodgkin's disease.
Topics: Adolescent; Adult; Age Factors; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Combined | 1986 |
Retroperitoneal fibrosis following treatment for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; H | 1987 |
Retroperitoneal fibrosis following treatment for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; H | 1987 |
Reproductive and endocrine gonadal capacity in patients treated with COPP chemotherapy for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Follicle Stimulatin | 1987 |
Reproductive and endocrine gonadal capacity in patients treated with COPP chemotherapy for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Follicle Stimulatin | 1987 |
Regression of mediastinal Hodgkin disease after therapy: evaluation of time interval.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Follow-Up Studies | 1987 |
Regression of mediastinal Hodgkin disease after therapy: evaluation of time interval.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Follow-Up Studies | 1987 |
Case report: multiagent chemotherapy of Hodgkin's disease associated with red cell aplasia, acquired ichthyosis and anhidrosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Hypohidrosis; Ichthyosis; M | 1987 |
Case report: multiagent chemotherapy of Hodgkin's disease associated with red cell aplasia, acquired ichthyosis and anhidrosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Hypohidrosis; Ichthyosis; M | 1987 |
Atypical presentation of Hodgkin's disease in a patient at risk for the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophos | 1988 |
Atypical presentation of Hodgkin's disease in a patient at risk for the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophos | 1988 |
Hodgkin's disease in HIV-infected patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophos | 1988 |
Hodgkin's disease in HIV-infected patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophos | 1988 |
Glomerulonephritis preceding late relapse of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Glomerulonephritis; Glomerulosclerosis, Foca | 1988 |
Glomerulonephritis preceding late relapse of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Glomerulonephritis; Glomerulosclerosis, Foca | 1988 |
The effects of four drug regimens on sister chromatid exchange frequency in patients with lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; DNA Damage; Doxorubicin; Hodgkin D | 1988 |
The effects of four drug regimens on sister chromatid exchange frequency in patients with lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; DNA Damage; Doxorubicin; Hodgkin D | 1988 |
The karyotype in secondary hematologic disorders after treatment for Hodgkin's disease. A study of 19 patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Female; Hodgkin Disea | 1988 |
The karyotype in secondary hematologic disorders after treatment for Hodgkin's disease. A study of 19 patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Female; Hodgkin Disea | 1988 |
Permanent cure of hydroa vacciniforme after chemotherapy for Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Hodgkin Disease; Humans; Hydroa Va | 1988 |
Permanent cure of hydroa vacciniforme after chemotherapy for Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Hodgkin Disease; Humans; Hydroa Va | 1988 |
Dibromdulcitol containing chemotherapeutic regimen in the treatment of childhood Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Hodgkin | 1988 |
Dibromdulcitol containing chemotherapeutic regimen in the treatment of childhood Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Hodgkin | 1988 |
Hodgkin's disease occurring in a patient treated successfully for Goodpasture's syndrome.
Topics: Adult; Anti-Glomerular Basement Membrane Disease; Chlorambucil; Hodgkin Disease; Humans; Male; Predn | 1988 |
Hodgkin's disease occurring in a patient treated successfully for Goodpasture's syndrome.
Topics: Adult; Anti-Glomerular Basement Membrane Disease; Chlorambucil; Hodgkin Disease; Humans; Male; Predn | 1988 |
Treatment of patients with "minimal" stage IIIA Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 1987 |
Treatment of patients with "minimal" stage IIIA Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 1987 |
[10 years' therapy of Hodgkin's disease in the Oncology Department of the Basel Canton Hospital: a retrospective study].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1987 |
[10 years' therapy of Hodgkin's disease in the Oncology Department of the Basel Canton Hospital: a retrospective study].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1987 |
Mammary carcinoma developing after radiotherapy and chemotherapy for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Female; Hodgkin | 1988 |
Mammary carcinoma developing after radiotherapy and chemotherapy for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Female; Hodgkin | 1988 |
Tumor burden as the most important prognostic factor in early stage Hodgkin's disease. Relations to other prognostic factors and implications for choice of treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Sedimentation; Combined Modality Therapy; Fema | 1988 |
Tumor burden as the most important prognostic factor in early stage Hodgkin's disease. Relations to other prognostic factors and implications for choice of treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Sedimentation; Combined Modality Therapy; Fema | 1988 |
Severe delayed neurotoxicity after accidental high-dose nitrogen mustard.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Mechlorethamine; Me | 1988 |
Severe delayed neurotoxicity after accidental high-dose nitrogen mustard.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Mechlorethamine; Me | 1988 |
Effect of cancer polychemotherapy on gonadal function in Hodgkin's disease in adult men.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Hodgkin D | 1988 |
Effect of cancer polychemotherapy on gonadal function in Hodgkin's disease in adult men.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Hodgkin D | 1988 |
Stage IA to IIB mediastinal Hodgkin's disease: three-dimensional volumetric assessment of response to treatment.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Dose-Response Relationship | 1988 |
Stage IA to IIB mediastinal Hodgkin's disease: three-dimensional volumetric assessment of response to treatment.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Dose-Response Relationship | 1988 |
[Acute leukemia in patients treated for Hodgkin's disease].
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Human | 1988 |
[Acute leukemia in patients treated for Hodgkin's disease].
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Human | 1988 |
[Comparative evaluation of the efficacy of chemotherapy and chemoradiotherapy of stage IIIB Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 1988 |
[Comparative evaluation of the efficacy of chemotherapy and chemoradiotherapy of stage IIIB Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 1988 |
Nitrogen mustard, vincristine, procarbazine, and prednisolone for relapse after radiation in Hodgkin's disease. An analysis of long-term follow-up.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Child; Fema | 1988 |
Nitrogen mustard, vincristine, procarbazine, and prednisolone for relapse after radiation in Hodgkin's disease. An analysis of long-term follow-up.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Child; Fema | 1988 |
[Status of the heart during a combined method of treating patients with stage I to II lymphogranulomatosis].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 1988 |
[Status of the heart during a combined method of treating patients with stage I to II lymphogranulomatosis].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 1988 |
[Prognostic factors in the chemoradiation treatment of III-stage lymphogranulomatosis].
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Th | 1988 |
[Prognostic factors in the chemoradiation treatment of III-stage lymphogranulomatosis].
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Th | 1988 |
Rapid transient reversal of anemia and long-term effects of maintenance intravenous immunoglobulin for autoimmune hemolytic anemia in patients with lymphoproliferative disorders.
Topics: Adult; Aged; Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Autoantibodies; Combined Modality The | 1988 |
Rapid transient reversal of anemia and long-term effects of maintenance intravenous immunoglobulin for autoimmune hemolytic anemia in patients with lymphoproliferative disorders.
Topics: Adult; Aged; Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Autoantibodies; Combined Modality The | 1988 |
[Second tumors in patients treated for Hodgkin's disease].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modali | 1988 |
[Second tumors in patients treated for Hodgkin's disease].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modali | 1988 |
ChlVPP--an effective and well-tolerated alternative to MOPP therapy for Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Female; Hodgk | 1988 |
ChlVPP--an effective and well-tolerated alternative to MOPP therapy for Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Female; Hodgk | 1988 |
Two cycles of MOPP and radiotherapy for stage III1A and stage III1B Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedul | 1988 |
Two cycles of MOPP and radiotherapy for stage III1A and stage III1B Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedul | 1988 |
Chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for Hodgkin disease: fourteen-year follow-up results.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Dr | 1988 |
Chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for Hodgkin disease: fourteen-year follow-up results.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Dr | 1988 |
Brief chemotherapy associated with extended field radiotherapy in Hodgkin's disease. Long-term results in a series of 102 patients with clinical stages I-IIIA.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Follow-Up | 1988 |
Brief chemotherapy associated with extended field radiotherapy in Hodgkin's disease. Long-term results in a series of 102 patients with clinical stages I-IIIA.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Follow-Up | 1988 |
Chemotherapy responsive collagenous colitis in a patient with Hodgkin's disease: a possible paraneoplastic phenomenon.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Basement Membrane; Colitis; Collagen Diseases; | 1987 |
Chemotherapy responsive collagenous colitis in a patient with Hodgkin's disease: a possible paraneoplastic phenomenon.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Basement Membrane; Colitis; Collagen Diseases; | 1987 |
[Treatment of malignant lymphoma: 12 years' experience with 109 patients. 1). Treatment of Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; H | 1987 |
[Treatment of malignant lymphoma: 12 years' experience with 109 patients. 1). Treatment of Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; H | 1987 |
Gallium citrate Ga 67 accumulation in pulmonary lesions after chemotherapy (MOPP).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Gallium Radioisotopes; Hodgkin Diseas | 1986 |
Gallium citrate Ga 67 accumulation in pulmonary lesions after chemotherapy (MOPP).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Gallium Radioisotopes; Hodgkin Diseas | 1986 |
Erythrocyte mean corpuscular volume during cytotoxic therapy is a predictive parameter of secondary leukemia in Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Erythrocyte Indices; Hodgkin Disease; Humans; Leukem | 1987 |
Erythrocyte mean corpuscular volume during cytotoxic therapy is a predictive parameter of secondary leukemia in Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Erythrocyte Indices; Hodgkin Disease; Humans; Leukem | 1987 |
Salvage chemotherapy for advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Dr | 1987 |
Salvage chemotherapy for advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Dr | 1987 |
[Effect of chemotherapy with C-MOPP in Hodgkin's disease in stages III B and IV B].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C | 1987 |
[Effect of chemotherapy with C-MOPP in Hodgkin's disease in stages III B and IV B].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C | 1987 |
Plasma and leukocytic bactericidal activity in the course of chemotherapy of Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Bactericidal Activity | 1987 |
Plasma and leukocytic bactericidal activity in the course of chemotherapy of Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Bactericidal Activity | 1987 |
Wide-field radiation therapy alone or with chemotherapy for Hodgkin's disease in relapse from combination chemotherapy.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child, Presch | 1987 |
Wide-field radiation therapy alone or with chemotherapy for Hodgkin's disease in relapse from combination chemotherapy.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child, Presch | 1987 |
[Hodgkin's disease. Study of 100 cases].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Th | 1987 |
[Hodgkin's disease. Study of 100 cases].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Th | 1987 |
Nitroblue tetrazolium test in patients with Hodgkin's disease in the course of chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Granulocytes; Hodgk | 1987 |
Nitroblue tetrazolium test in patients with Hodgkin's disease in the course of chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Granulocytes; Hodgk | 1987 |
Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1987 |
Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1987 |
[Evaluation of the effectiveness of chemoradiotherapy of stage IIIA Hodgkin's disease].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female | 1987 |
[Evaluation of the effectiveness of chemoradiotherapy of stage IIIA Hodgkin's disease].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female | 1987 |
[Role of radiotherapy in the treatment of stage IIIB Hodgkin's disease in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1987 |
[Role of radiotherapy in the treatment of stage IIIB Hodgkin's disease in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1987 |
Observations on the treatment of mediastinal masses in Hodgkin's disease emphasizing site of failure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C | 1987 |
Observations on the treatment of mediastinal masses in Hodgkin's disease emphasizing site of failure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C | 1987 |
Path model of multidimensional compliance with cancer therapy.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Antineoplastic Combin | 1987 |
Path model of multidimensional compliance with cancer therapy.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Antineoplastic Combin | 1987 |
Recurrent "syncytial variant" of Hodgkin's disease: an immunohistologic diagnosis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Hodgkin Disease; Hu | 1987 |
Recurrent "syncytial variant" of Hodgkin's disease: an immunohistologic diagnosis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Hodgkin Disease; Hu | 1987 |
Stage I to IIB Hodgkin's disease: the combined experience at Stanford University and the Joint Center for Radiation Therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di | 1987 |
Stage I to IIB Hodgkin's disease: the combined experience at Stanford University and the Joint Center for Radiation Therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di | 1987 |
Pregnancy following nonsurgical donor ovum transfer to a functionally agonadal woman.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Embryo Transfer; Estradiol; Female; Hodgkin D | 1987 |
Pregnancy following nonsurgical donor ovum transfer to a functionally agonadal woman.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Embryo Transfer; Estradiol; Female; Hodgkin D | 1987 |
Predictive value of the early response to chemotherapy in high-risk stages II and III Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di | 1987 |
Predictive value of the early response to chemotherapy in high-risk stages II and III Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di | 1987 |
Intramedullary spinal cord metastasis in Hodgkin's disease. Rapid diagnosis and treatment resulting in neurologic recovery.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di | 1987 |
Intramedullary spinal cord metastasis in Hodgkin's disease. Rapid diagnosis and treatment resulting in neurologic recovery.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di | 1987 |
[Clinical studies of the diagnosis and treatment of Hodgkin's disease (1967-1986)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Female; | 1987 |
[Clinical studies of the diagnosis and treatment of Hodgkin's disease (1967-1986)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Female; | 1987 |
[Twin pregnancy after iatrogenic menopause].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Estrogens; Female; Hodgkin Disease; Humans; I | 1987 |
[Twin pregnancy after iatrogenic menopause].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Estrogens; Female; Hodgkin Disease; Humans; I | 1987 |
Hodgkins disease: a personal account.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Mechloretham | 1987 |
Hodgkins disease: a personal account.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Mechloretham | 1987 |
Hodgkin's disease presenting with central nervous system involvement.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Hodgkin Disease; Humans; Mal | 1987 |
Hodgkin's disease presenting with central nervous system involvement.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Hodgkin Disease; Humans; Mal | 1987 |
[Use of lomustine, teniposide, procarbazine and prednisone (LTPP) in the treatment of terminal-state Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Hu | 1986 |
[Use of lomustine, teniposide, procarbazine and prednisone (LTPP) in the treatment of terminal-state Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Hu | 1986 |
Improved survival in the treatment of advanced Hodgkin's disease at a nonuniversity institution (1970-1979).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Hodgkin Disease; Hu | 1986 |
Improved survival in the treatment of advanced Hodgkin's disease at a nonuniversity institution (1970-1979).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Hodgkin Disease; Hu | 1986 |
Mallory-Weiss tear and cytotoxic-induced emesis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Male; Mallory-Weiss | 1986 |
Mallory-Weiss tear and cytotoxic-induced emesis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Male; Mallory-Weiss | 1986 |
Reversible mechlorethamine-associated hearing loss in a patient with Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Audiometry; Auditory Threshold; Cyclophospham | 1986 |
Reversible mechlorethamine-associated hearing loss in a patient with Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Audiometry; Auditory Threshold; Cyclophospham | 1986 |
Pancytopenia with myelofibrosis. An unusual presentation of childhood Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Female; Hodgkin Disease; Humans; | 1986 |
Pancytopenia with myelofibrosis. An unusual presentation of childhood Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Female; Hodgkin Disease; Humans; | 1986 |
[Clinico-biochemical aspects of the polychemotherapy of disseminated lymphogranulomatosis resistant to the COPP protocol].
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide | 1986 |
[Clinico-biochemical aspects of the polychemotherapy of disseminated lymphogranulomatosis resistant to the COPP protocol].
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide | 1986 |
Gastric non-Hodgkin's lymphoma after successful treatment of Hodgkin's disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Celiac Disease; Hodgkin Disease; Humans; Immun | 1986 |
Gastric non-Hodgkin's lymphoma after successful treatment of Hodgkin's disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Celiac Disease; Hodgkin Disease; Humans; Immun | 1986 |
[Clinical features and treatment of Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Immunity, Cellular; | 1986 |
[Clinical features and treatment of Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Immunity, Cellular; | 1986 |
Purpura fulminans in pneumococcal sepsis.
Topics: Acute Kidney Injury; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Fema | 1986 |
Purpura fulminans in pneumococcal sepsis.
Topics: Acute Kidney Injury; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Fema | 1986 |
Unusual thoracic radiographic findings in children treated for Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; | 1986 |
Unusual thoracic radiographic findings in children treated for Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; | 1986 |
A rare opportunity to observe aspects of the natural history of untreated Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Lymph Nodes; | 1986 |
A rare opportunity to observe aspects of the natural history of untreated Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Lymph Nodes; | 1986 |
[Hodgkin's disease in children; treatment results with or without radiotherapy].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1986 |
[Hodgkin's disease in children; treatment results with or without radiotherapy].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1986 |
Prognostic significance of tumour burden in Hodgkin's disease PS I and II.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Mediastina | 1986 |
Prognostic significance of tumour burden in Hodgkin's disease PS I and II.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Mediastina | 1986 |
Thrombocytopenic purpura as first manifestation of an inapparent Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cerebral Hemorrhage; Cyclophosphamide; Hodgkin Disea | 1986 |
Thrombocytopenic purpura as first manifestation of an inapparent Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cerebral Hemorrhage; Cyclophosphamide; Hodgkin Disea | 1986 |
[Hodgkin's disease in children; treatment results with or without radiotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Hodgkin Disease; Humans; Mechlorethamine; Pre | 1986 |
[Hodgkin's disease in children; treatment results with or without radiotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Hodgkin Disease; Humans; Mechlorethamine; Pre | 1986 |
Lymphomatoid papulosis: remission following intravenously administered acyclovir.
Topics: Acyclovir; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Injections, Intr | 1986 |
Lymphomatoid papulosis: remission following intravenously administered acyclovir.
Topics: Acyclovir; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Injections, Intr | 1986 |
[The role of radiotherapy in the treatment of stage I-II Hodgkin's disease in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1986 |
[The role of radiotherapy in the treatment of stage I-II Hodgkin's disease in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1986 |
MOPP after two decades.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Prednisone | 1986 |
MOPP after two decades.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Prednisone | 1986 |
Treatment of Hodgkin's disease stages I and II with chemotherapy alone.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Female; Hodgkin Disease; H | 1986 |
Treatment of Hodgkin's disease stages I and II with chemotherapy alone.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Female; Hodgkin Disease; H | 1986 |
Hodgkin's disease presenting with isolated craniospinal involvement.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; D | 1986 |
Hodgkin's disease presenting with isolated craniospinal involvement.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; D | 1986 |
Thymic hyperplasia masquerading as recurrent Hodgkin's disease: case report and review of the literature.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Diagnosis, Differential; Hodgkin Disease | 1986 |
Thymic hyperplasia masquerading as recurrent Hodgkin's disease: case report and review of the literature.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Diagnosis, Differential; Hodgkin Disease | 1986 |
[The role of radiotherapy in the treatment of Stage IIIA Hodgkin's disease in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1986 |
[The role of radiotherapy in the treatment of Stage IIIA Hodgkin's disease in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1986 |
Chemotherapy treated Hodgkins disease--a fifteen year review.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Female; Follow-Up Studies; Hodg | 1986 |
Chemotherapy treated Hodgkins disease--a fifteen year review.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Female; Follow-Up Studies; Hodg | 1986 |
Treatment of pathologically staged IIIA Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Disease; | 1986 |
Treatment of pathologically staged IIIA Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Disease; | 1986 |
MOPP after two decades.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Prednisone | 1987 |
MOPP after two decades.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Prednisone | 1987 |
Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Combined Modality Therapy; | 1987 |
Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Combined Modality Therapy; | 1987 |
Radiotherapy of stage I and II Hodgkin disease with inguinal presentation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1985 |
Radiotherapy of stage I and II Hodgkin disease with inguinal presentation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1985 |
Cystic degeneration of thymic Hodgkin's disease following radiation therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cysts; Diagnosis, Differential; Hodgkin Disea | 1985 |
Cystic degeneration of thymic Hodgkin's disease following radiation therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cysts; Diagnosis, Differential; Hodgkin Disea | 1985 |
Clinical significance of heat labile Regan isoenzyme variant in Hodgkin's disease.
Topics: Adult; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; GPI-Linked Proteins; Ho | 1985 |
Clinical significance of heat labile Regan isoenzyme variant in Hodgkin's disease.
Topics: Adult; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; GPI-Linked Proteins; Ho | 1985 |
The potential benefits of therapeutic splenectomy for patients with Hodgkin's disease and non-Hodgkin's lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Tolerance; Female; Hod | 1985 |
The potential benefits of therapeutic splenectomy for patients with Hodgkin's disease and non-Hodgkin's lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Tolerance; Female; Hod | 1985 |
[Changes in the lungs in patients with lymphogranulomatosis, Stages I-II, following combination therapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 1985 |
[Changes in the lungs in patients with lymphogranulomatosis, Stages I-II, following combination therapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 1985 |
Hodgkin's disease in adults: the challenge.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Laparotomy; Mechlore | 1985 |
Hodgkin's disease in adults: the challenge.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Laparotomy; Mechlore | 1985 |
[Chemotherapy of advanced lymphogranulomatosis. Results of MOPP/COPP treatment at the West German Tumor Center, Essen].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Hodgkin Disease; Hu | 1985 |
[Chemotherapy of advanced lymphogranulomatosis. Results of MOPP/COPP treatment at the West German Tumor Center, Essen].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Hodgkin Disease; Hu | 1985 |
Simultaneous presentation of relapsing Hodgkin's disease and treatment-related non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 1985 |
Simultaneous presentation of relapsing Hodgkin's disease and treatment-related non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 1985 |
[Treatment possibilities of recurrences of lymphogranulomatosis].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclop | 1985 |
[Treatment possibilities of recurrences of lymphogranulomatosis].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclop | 1985 |
Hodgkin's disease, intracranial involvement. Report of a case and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Hodgkin Disease; Humans; Mal | 1985 |
Hodgkin's disease, intracranial involvement. Report of a case and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Hodgkin Disease; Humans; Mal | 1985 |
Stage III Hodgkin's disease: improved survival with combined modality therapy as compared with radiation therapy alone.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; | 1985 |
Stage III Hodgkin's disease: improved survival with combined modality therapy as compared with radiation therapy alone.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; | 1985 |
[MOPP therapy of Hodgkin's disease previously treated with MOPP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Prednisone | 1985 |
[MOPP therapy of Hodgkin's disease previously treated with MOPP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Prednisone | 1985 |
[Pregnancy and fetal development after therapy of Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Embryonic and Fetal Develop | 1985 |
[Pregnancy and fetal development after therapy of Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Embryonic and Fetal Develop | 1985 |
Therapeutic implications of mediastinal involvement in advanced Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Follow-Up Studies; Hodgkin Disease; Humans; Mechlore | 1985 |
Therapeutic implications of mediastinal involvement in advanced Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Follow-Up Studies; Hodgkin Disease; Humans; Mechlore | 1985 |
Osteonecrosis of sternum and rib in a patient treated for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; H | 1985 |
Osteonecrosis of sternum and rib in a patient treated for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; H | 1985 |
[The main stages in the complex treatment of children with lymphogranulomatosis (Hodgkin's disease)].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid | 1985 |
[The main stages in the complex treatment of children with lymphogranulomatosis (Hodgkin's disease)].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid | 1985 |
Pediatric Hodgkin's disease in India.
Topics: Actuarial Analysis; Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; | 1985 |
Pediatric Hodgkin's disease in India.
Topics: Actuarial Analysis; Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; | 1985 |
[Primary gastric Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; H | 1985 |
[Primary gastric Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; H | 1985 |
[The role of radiotherapy in the treatment of Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Th | 1985 |
[The role of radiotherapy in the treatment of Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Th | 1985 |
[Acute lymphoblastic leukemia L3 in Hodgkin's disease in remission: primary or secondary leukosis?].
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Karyotyping; Leukemia, Lymp | 1985 |
[Acute lymphoblastic leukemia L3 in Hodgkin's disease in remission: primary or secondary leukosis?].
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Karyotyping; Leukemia, Lymp | 1985 |
Varicella in immunodepressed children.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chickenpox; Child; Female; Hodgkin Disease; Humans; | 1985 |
Varicella in immunodepressed children.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chickenpox; Child; Female; Hodgkin Disease; Humans; | 1985 |
Reduction of fatal complications from combined modality therapy in Hodgkin's disease.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Pro | 1985 |
Reduction of fatal complications from combined modality therapy in Hodgkin's disease.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Pro | 1985 |
Current status and new vistas in combination chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Hodgkin Disease; H | 1985 |
Current status and new vistas in combination chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Hodgkin Disease; H | 1985 |
Stage IA to IIB supradiaphragmatic Hodgkin's disease. Long-term survival and relapse frequency.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Presch | 1985 |
Stage IA to IIB supradiaphragmatic Hodgkin's disease. Long-term survival and relapse frequency.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Presch | 1985 |
Nephrotic syndrome in two patients with cured Hodgkin's disease.
Topics: Adult; Chlorambucil; Gallium Radioisotopes; Hodgkin Disease; Humans; Male; Nephrosis, Lipoid; Nephro | 1985 |
Nephrotic syndrome in two patients with cured Hodgkin's disease.
Topics: Adult; Chlorambucil; Gallium Radioisotopes; Hodgkin Disease; Humans; Male; Nephrosis, Lipoid; Nephro | 1985 |
Treatment of advanced malignant lymphomas with bleomycin.
Topics: Antibiotics, Antineoplastic; Bleomycin; Cyclophosphamide; Drug Combinations; Hodgkin Disease; Humans | 1972 |
Treatment of advanced malignant lymphomas with bleomycin.
Topics: Antibiotics, Antineoplastic; Bleomycin; Cyclophosphamide; Drug Combinations; Hodgkin Disease; Humans | 1972 |
Chemotherapy oif childhood Hodgkin's disease in Uganda.
Topics: Adolescent; Antineoplastic Agents; Benzoates; Child; Child, Preschool; Dosage Forms; Drug Combinatio | 1972 |
Chemotherapy oif childhood Hodgkin's disease in Uganda.
Topics: Adolescent; Antineoplastic Agents; Benzoates; Child; Child, Preschool; Dosage Forms; Drug Combinatio | 1972 |
[Chylous ascites and chylothorax, rare complications of Hodgkin's disease: do they represent a complication of the future?].
Topics: Adult; Antineoplastic Agents; Chylothorax; Chylous Ascites; Hodgkin Disease; Humans; Hydrazines; Lym | 1972 |
[Chylous ascites and chylothorax, rare complications of Hodgkin's disease: do they represent a complication of the future?].
Topics: Adult; Antineoplastic Agents; Chylothorax; Chylous Ascites; Hodgkin Disease; Humans; Hydrazines; Lym | 1972 |
Management of malignant lymphomas: a practical and philosophical approach.
Topics: Bleomycin; Cyclophosphamide; Hodgkin Disease; Hospitals, Special; Humans; Laparotomy; Lymphoma; Mech | 1973 |
Management of malignant lymphomas: a practical and philosophical approach.
Topics: Bleomycin; Cyclophosphamide; Hodgkin Disease; Hospitals, Special; Humans; Laparotomy; Lymphoma; Mech | 1973 |
The nitroblue tetrazolium test in lymphoma.
Topics: Adult; Diagnosis, Differential; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, | 1973 |
The nitroblue tetrazolium test in lymphoma.
Topics: Adult; Diagnosis, Differential; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, | 1973 |
Clinical trials with intensive chemotherapy and radiotherapy in Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bleomycin; Child; Doxorubicin; Drug Therapy, Combina | 1973 |
Clinical trials with intensive chemotherapy and radiotherapy in Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bleomycin; Child; Doxorubicin; Drug Therapy, Combina | 1973 |
International Symposium on Hodgkin's Disease. Session 4. Small group workshops. Report on workshop: Chemotherapy.
Topics: Antineoplastic Agents; Bleomycin; Carmustine; Doxorubicin; Drug Therapy, Combination; Hodgkin Diseas | 1973 |
International Symposium on Hodgkin's Disease. Session 4. Small group workshops. Report on workshop: Chemotherapy.
Topics: Antineoplastic Agents; Bleomycin; Carmustine; Doxorubicin; Drug Therapy, Combination; Hodgkin Diseas | 1973 |
[Internistic management of malignant lymphoma].
Topics: Antigens, Neoplasm; Bleomycin; Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Di | 1973 |
[Internistic management of malignant lymphoma].
Topics: Antigens, Neoplasm; Bleomycin; Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Di | 1973 |
Acute leukemia in Hodgkin's disease.
Topics: Adult; Bleomycin; Carmustine; Chlorambucil; Drug Therapy, Combination; Female; Hodgkin Disease; Huma | 1974 |
Acute leukemia in Hodgkin's disease.
Topics: Adult; Bleomycin; Carmustine; Chlorambucil; Drug Therapy, Combination; Female; Hodgkin Disease; Huma | 1974 |
[After-care examinations in Hodgkin's disease. Internal medicine and chemotherapy].
Topics: Aftercare; Bleomycin; Blood Sedimentation; Cyclophosphamide; Doxorubicin; Fibrinogen; Hodgkin Diseas | 1973 |
[After-care examinations in Hodgkin's disease. Internal medicine and chemotherapy].
Topics: Aftercare; Bleomycin; Blood Sedimentation; Cyclophosphamide; Doxorubicin; Fibrinogen; Hodgkin Diseas | 1973 |
Treatment of Hodgkin's disease.
Topics: Drug-Related Side Effects and Adverse Reactions; Female; Hodgkin Disease; Humans; Laparotomy; Male; | 1974 |
Treatment of Hodgkin's disease.
Topics: Drug-Related Side Effects and Adverse Reactions; Female; Hodgkin Disease; Humans; Laparotomy; Male; | 1974 |
Prognosis and survival with extranodal Hodgkin's disease.
Topics: Adult; Carmustine; Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Human | 1974 |
Prognosis and survival with extranodal Hodgkin's disease.
Topics: Adult; Carmustine; Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Human | 1974 |
Hodgkin's disease in the elderly.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Liver Neoplasms | 1974 |
Hodgkin's disease in the elderly.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Liver Neoplasms | 1974 |
[Chemotherapy of Hodgkin's disease].
Topics: Antineoplastic Agents; Bleomycin; Drug Hypersensitivity; Drug Therapy, Combination; Hodgkin Disease; | 1974 |
[Chemotherapy of Hodgkin's disease].
Topics: Antineoplastic Agents; Bleomycin; Drug Hypersensitivity; Drug Therapy, Combination; Hodgkin Disease; | 1974 |
Letter: Chemotherapy of Hodgkin's disease.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin D | 1974 |
Letter: Chemotherapy of Hodgkin's disease.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin D | 1974 |
Symptomatic control of fever in lymphoma and leukemia.
Topics: Adolescent; Adult; Aged; Aminopyrine; Analgesics; Aspirin; Female; Fever; Hodgkin Disease; Humans; I | 1969 |
Symptomatic control of fever in lymphoma and leukemia.
Topics: Adolescent; Adult; Aged; Aminopyrine; Analgesics; Aspirin; Female; Fever; Hodgkin Disease; Humans; I | 1969 |
[Serological studies after homologous bone marrow transfusion].
Topics: Adult; Autoradiography; Azathioprine; Blood Group Antigens; Bone Marrow Transplantation; Female; Hem | 1969 |
[Serological studies after homologous bone marrow transfusion].
Topics: Adult; Autoradiography; Azathioprine; Blood Group Antigens; Bone Marrow Transplantation; Female; Hem | 1969 |
[The treatment of lymphogranulomatosis].
Topics: Adult; Cyclophosphamide; Female; Hodgkin Disease; Humans; Liver Cirrhosis; Liver Function Tests; Mal | 1970 |
[The treatment of lymphogranulomatosis].
Topics: Adult; Cyclophosphamide; Female; Hodgkin Disease; Humans; Liver Cirrhosis; Liver Function Tests; Mal | 1970 |
[General considerations on therapeutic strategy in malignant granuloma].
Topics: Antineoplastic Agents; Drug Combinations; Hodgkin Disease; Humans; Methods; Prednisone; Procarbazine | 1973 |
[General considerations on therapeutic strategy in malignant granuloma].
Topics: Antineoplastic Agents; Drug Combinations; Hodgkin Disease; Humans; Methods; Prednisone; Procarbazine | 1973 |
[Polychemotherapy of Hodgkin's lymphoma. 3. Stage IV].
Topics: Adult; Aged; Antineoplastic Agents; Blood Platelets; Drug Combinations; Female; Hodgkin Disease; Hum | 1972 |
[Polychemotherapy of Hodgkin's lymphoma. 3. Stage IV].
Topics: Adult; Aged; Antineoplastic Agents; Blood Platelets; Drug Combinations; Female; Hodgkin Disease; Hum | 1972 |
[Diagnosis and therapy of Hodgkin's disease].
Topics: Antineoplastic Agents; Biopsy; Germany, West; Hodgkin Disease; Humans; Laparotomy; Lymphography; Pre | 1973 |
[Diagnosis and therapy of Hodgkin's disease].
Topics: Antineoplastic Agents; Biopsy; Germany, West; Hodgkin Disease; Humans; Laparotomy; Lymphography; Pre | 1973 |
Radiation induced pericarditis in Hodgkin's disease.
Topics: Adolescent; Adult; Cobalt Radioisotopes; Female; Heart; Hodgkin Disease; Humans; Male; Pericardial E | 1973 |
Radiation induced pericarditis in Hodgkin's disease.
Topics: Adolescent; Adult; Cobalt Radioisotopes; Female; Heart; Hodgkin Disease; Humans; Male; Pericardial E | 1973 |
[Richter's syndrome. 4 cases and an attempt at analysis].
Topics: Aged; Carcinoma, Squamous Cell; Chlorambucil; Cyclophosphamide; Deglutition Disorders; Drug Therapy, | 1973 |
[Richter's syndrome. 4 cases and an attempt at analysis].
Topics: Aged; Carcinoma, Squamous Cell; Chlorambucil; Cyclophosphamide; Deglutition Disorders; Drug Therapy, | 1973 |
Latent radiation injury of lungs or heart activated by steroid withdrawal.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Middle Ag | 1974 |
Latent radiation injury of lungs or heart activated by steroid withdrawal.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Middle Ag | 1974 |
Disseminated toxoplasmosis in the compromised host. A report of five cases.
Topics: Adult; Aged; Anemia, Hemolytic, Autoimmune; Autopsy; Azathioprine; Brain; Breast Neoplasms; Female; | 1974 |
Disseminated toxoplasmosis in the compromised host. A report of five cases.
Topics: Adult; Aged; Anemia, Hemolytic, Autoimmune; Autopsy; Azathioprine; Brain; Breast Neoplasms; Female; | 1974 |
[Clinical manifestation and chemotherapy in Hodgkin's disease].
Topics: Chlorambucil; Cyclophosphamide; Hodgkin Disease; Humans; Laparotomy; Methods; Methotrexate; Predniso | 1972 |
[Clinical manifestation and chemotherapy in Hodgkin's disease].
Topics: Chlorambucil; Cyclophosphamide; Hodgkin Disease; Humans; Laparotomy; Methods; Methotrexate; Predniso | 1972 |
Leukocyte (3H) thymidine uptake in short-term whole-blood cultures of human and canine renal allograft recipients.
Topics: Animals; Azathioprine; Cadaver; Dogs; Graft Rejection; Hodgkin Disease; Humans; Immunity, Cellular; | 1973 |
Leukocyte (3H) thymidine uptake in short-term whole-blood cultures of human and canine renal allograft recipients.
Topics: Animals; Azathioprine; Cadaver; Dogs; Graft Rejection; Hodgkin Disease; Humans; Immunity, Cellular; | 1973 |
[Trial treatment of generalized Hodgkin's disease by multiple chemotherapy].
Topics: Adolescent; Adult; Aged; Child; Female; Hodgkin Disease; Humans; Hydrazines; Male; Middle Aged; Pred | 1966 |
[Trial treatment of generalized Hodgkin's disease by multiple chemotherapy].
Topics: Adolescent; Adult; Aged; Child; Female; Hodgkin Disease; Humans; Hydrazines; Male; Middle Aged; Pred | 1966 |
[Rheumatoid polyarthritis and chronic lymphoid leukemia. Studies of 7 cases of association of these 2 diseases].
Topics: Adult; Age Factors; Aged; Animals; Antibodies; Arthritis, Rheumatoid; Autoimmune Diseases; Chlorambu | 1969 |
[Rheumatoid polyarthritis and chronic lymphoid leukemia. Studies of 7 cases of association of these 2 diseases].
Topics: Adult; Age Factors; Aged; Animals; Antibodies; Arthritis, Rheumatoid; Autoimmune Diseases; Chlorambu | 1969 |
L-asparaginase in the treatment of neoplastic diseases in children.
Topics: Adolescent; Antineoplastic Agents; Asparaginase; Bone Marrow Examination; Bone Neoplasms; Burkitt Ly | 1971 |
L-asparaginase in the treatment of neoplastic diseases in children.
Topics: Adolescent; Antineoplastic Agents; Asparaginase; Bone Marrow Examination; Bone Neoplasms; Burkitt Ly | 1971 |
Herpes Zoster-Varicella infections and lymphoma.
Topics: Age Factors; Herpes Zoster; Herpesvirus 3, Human; Hodgkin Disease; Humans; Nitrogen Mustard Compound | 1972 |
Herpes Zoster-Varicella infections and lymphoma.
Topics: Age Factors; Herpes Zoster; Herpesvirus 3, Human; Hodgkin Disease; Humans; Nitrogen Mustard Compound | 1972 |
Combination chemotherapy in the treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Benzoates; Female; Hodgkin Disease; Humans; Leukopen | 1973 |
Combination chemotherapy in the treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Benzoates; Female; Hodgkin Disease; Humans; Leukopen | 1973 |
[Therapy and course of malignant diseases of the lymphoreticular system in infancy and early childhood].
Topics: Age Factors; Antineoplastic Agents; Child, Preschool; Hodgkin Disease; Humans; Infant; Infant, Newbo | 1973 |
[Therapy and course of malignant diseases of the lymphoreticular system in infancy and early childhood].
Topics: Age Factors; Antineoplastic Agents; Child, Preschool; Hodgkin Disease; Humans; Infant; Infant, Newbo | 1973 |
[Confusion of uncertain etiology in Hodgkin's disease].
Topics: Aged; Cognition Disorders; Female; Herpes Zoster; Hodgkin Disease; Humans; Mechlorethamine; Predniso | 1974 |
[Confusion of uncertain etiology in Hodgkin's disease].
Topics: Aged; Cognition Disorders; Female; Herpes Zoster; Hodgkin Disease; Humans; Mechlorethamine; Predniso | 1974 |
[Some methods in clinical distinction and treatment of lymphogranulomatosis of the stomach].
Topics: Cyclophosphamide; Hodgkin Disease; Humans; Prednisone; Procarbazine; Stomach Neoplasms; Vincristine | 1974 |
[Some methods in clinical distinction and treatment of lymphogranulomatosis of the stomach].
Topics: Cyclophosphamide; Hodgkin Disease; Humans; Prednisone; Procarbazine; Stomach Neoplasms; Vincristine | 1974 |
[Relations between Hodgkin's disease and leukemia. Clinical case].
Topics: Adult; Antineoplastic Agents; Blood Transfusion; Hodgkin Disease; Humans; Leukemia, Lymphoid; Male; | 1974 |
[Relations between Hodgkin's disease and leukemia. Clinical case].
Topics: Adult; Antineoplastic Agents; Blood Transfusion; Hodgkin Disease; Humans; Leukemia, Lymphoid; Male; | 1974 |
Association of Hodgkin disease and Gaucher disease.
Topics: Adult; Autopsy; Biopsy; Gaucher Disease; Hodgkin Disease; Humans; Liver; Lymph Nodes; Lymphocytes; M | 1974 |
Association of Hodgkin disease and Gaucher disease.
Topics: Adult; Autopsy; Biopsy; Gaucher Disease; Hodgkin Disease; Humans; Liver; Lymph Nodes; Lymphocytes; M | 1974 |
Non-healing granulomata of the upper respiratory tract.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Blood Sedimentation; Child; Female; | 1974 |
Non-healing granulomata of the upper respiratory tract.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Blood Sedimentation; Child; Female; | 1974 |
Letter: Chemotherapy of Hodgkin's disease.
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Remis | 1974 |
Letter: Chemotherapy of Hodgkin's disease.
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Remis | 1974 |
Abdominal involvement at the onset of Hodgkin's disease.
Topics: Alkaline Phosphatase; Axilla; Hodgkin Disease; Humans; Laparotomy; Lymph Nodes; Lymphography; Medias | 1974 |
Abdominal involvement at the onset of Hodgkin's disease.
Topics: Alkaline Phosphatase; Axilla; Hodgkin Disease; Humans; Laparotomy; Lymph Nodes; Lymphography; Medias | 1974 |
Hypercalcaemia and extensive lymph-node calcification in a patient with Hodgkin's disease prior to therapy.
Topics: Aged; Calcinosis; Hodgkin Disease; Humans; Hypercalcemia; Lymph Nodes; Male; Prednisone; Radiography | 1974 |
Hypercalcaemia and extensive lymph-node calcification in a patient with Hodgkin's disease prior to therapy.
Topics: Aged; Calcinosis; Hodgkin Disease; Humans; Hypercalcemia; Lymph Nodes; Male; Prednisone; Radiography | 1974 |
[Initial therapy of Hodgkin's disease using polychemotherapy. Long-term results of 204 cases (1-8 year follow-up)].
Topics: Adolescent; Adult; Age Factors; Aged; Drug Therapy, Combination; Electronic Data Processing; Female; | 1974 |
[Initial therapy of Hodgkin's disease using polychemotherapy. Long-term results of 204 cases (1-8 year follow-up)].
Topics: Adolescent; Adult; Age Factors; Aged; Drug Therapy, Combination; Electronic Data Processing; Female; | 1974 |
[Treatment of Hodgkin's disease. Experience of the Hôpital Saint-Louis].
Topics: Antineoplastic Agents; Drug Evaluation; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlore | 1974 |
[Treatment of Hodgkin's disease. Experience of the Hôpital Saint-Louis].
Topics: Antineoplastic Agents; Drug Evaluation; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlore | 1974 |
[Clinico-therapeutic aspects of Hodgkin's disease in childhood].
Topics: Adolescent; Antineoplastic Agents; Biopsy; Bone Marrow Examination; Cell Count; Child; Child, Presch | 1974 |
[Clinico-therapeutic aspects of Hodgkin's disease in childhood].
Topics: Adolescent; Antineoplastic Agents; Biopsy; Bone Marrow Examination; Cell Count; Child; Child, Presch | 1974 |
Hodgkin's disease of the spleen: some clinical aspects and problems.
Topics: Adrenal Cortex Hormones; Adult; Cyclophosphamide; Endoscopy; Female; Hodgkin Disease; Humans; Kerato | 1974 |
Hodgkin's disease of the spleen: some clinical aspects and problems.
Topics: Adrenal Cortex Hormones; Adult; Cyclophosphamide; Endoscopy; Female; Hodgkin Disease; Humans; Kerato | 1974 |
Chemotherapy of Hodgkin's disease.
Topics: Adrenal Cortex Hormones; Aged; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; | 1974 |
Chemotherapy of Hodgkin's disease.
Topics: Adrenal Cortex Hormones; Aged; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; | 1974 |
Conversion of Hodgkin's disease to lymphoblastic lymphosarcoma.
Topics: Aged; Cyclophosphamide; Doxorubicin; Female; Hodgkin Disease; Humans; Liver; Lymph Node Excision; Ly | 1974 |
Conversion of Hodgkin's disease to lymphoblastic lymphosarcoma.
Topics: Aged; Cyclophosphamide; Doxorubicin; Female; Hodgkin Disease; Humans; Liver; Lymph Node Excision; Ly | 1974 |
[Clinical trial of chemotherapeutic combinations based on the notion of attempted cellular synchronization. Preliminary administration of an antimitotic followed by the use of cycle-dependent or phase dependent product(s)].
Topics: Amino Sugars; Anthraquinones; Antineoplastic Agents; Asparaginase; Cyclophosphamide; Daunorubicin; D | 1972 |
[Clinical trial of chemotherapeutic combinations based on the notion of attempted cellular synchronization. Preliminary administration of an antimitotic followed by the use of cycle-dependent or phase dependent product(s)].
Topics: Amino Sugars; Anthraquinones; Antineoplastic Agents; Asparaginase; Cyclophosphamide; Daunorubicin; D | 1972 |
Gas-chromatographic measurement of urinary polyamines in cancer patients.
Topics: Chromatography, Gas; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Methods; Polyamines; Prednis | 1973 |
Gas-chromatographic measurement of urinary polyamines in cancer patients.
Topics: Chromatography, Gas; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Methods; Polyamines; Prednis | 1973 |
Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
Topics: Animals; Antineoplastic Agents; Biological Assay; Carmustine; Cyclohexanes; Cyclophosphamide; Cytara | 1974 |
Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
Topics: Animals; Antineoplastic Agents; Biological Assay; Carmustine; Cyclohexanes; Cyclophosphamide; Cytara | 1974 |
Cavitary fungus disease of the lungs.
Topics: Adult; Aged; Aspergillosis; Child; Cryptococcosis; Female; Hodgkin Disease; Humans; Immunosuppressiv | 1973 |
Cavitary fungus disease of the lungs.
Topics: Adult; Aged; Aspergillosis; Child; Cryptococcosis; Female; Hodgkin Disease; Humans; Immunosuppressiv | 1973 |
[Chemotherapy of malignant tumors and acute leukoses. New developments and results].
Topics: Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukemi | 1972 |
[Chemotherapy of malignant tumors and acute leukoses. New developments and results].
Topics: Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukemi | 1972 |
Herpes zoster ophthalmicus treated with cytarabine.
Topics: Adult; Cytarabine; Drug Resistance; Edema; Erythema; Herpes Zoster Ophthalmicus; Hodgkin Disease; Hu | 1973 |
Herpes zoster ophthalmicus treated with cytarabine.
Topics: Adult; Cytarabine; Drug Resistance; Edema; Erythema; Herpes Zoster Ophthalmicus; Hodgkin Disease; Hu | 1973 |
Infections associated with immunologic deficiency diseases.
Topics: Acute Kidney Injury; Adult; Agammaglobulinemia; Anti-Bacterial Agents; Antibody Formation; Aspergill | 1974 |
Infections associated with immunologic deficiency diseases.
Topics: Acute Kidney Injury; Adult; Agammaglobulinemia; Anti-Bacterial Agents; Antibody Formation; Aspergill | 1974 |
Depletion of thymus dependent lymphocytes in Hodgkin's disease.
Topics: Animals; Cyclophosphamide; Erythrocytes; Female; Hodgkin Disease; Humans; Immune Adherence Reaction; | 1974 |
Depletion of thymus dependent lymphocytes in Hodgkin's disease.
Topics: Animals; Cyclophosphamide; Erythrocytes; Female; Hodgkin Disease; Humans; Immune Adherence Reaction; | 1974 |
Evidence for a specific seminiferous tubular factor affecting follicle-stimulating hormone secretion in man.
Topics: Adult; Biopsy; Cell Count; Clomiphene; Cyclophosphamide; Follicle Stimulating Hormone; Hodgkin Disea | 1972 |
Evidence for a specific seminiferous tubular factor affecting follicle-stimulating hormone secretion in man.
Topics: Adult; Biopsy; Cell Count; Clomiphene; Cyclophosphamide; Follicle Stimulating Hormone; Hodgkin Disea | 1972 |
Lymphomas of the testicle.
Topics: Adult; Aged; Cyclophosphamide; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma; Lymphoma, Large B-Cel | 1972 |
Lymphomas of the testicle.
Topics: Adult; Aged; Cyclophosphamide; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma; Lymphoma, Large B-Cel | 1972 |
[Stability of the toxoplasmin tests in patients treated with immunosuppressive agents].
Topics: Adult; Antigens; Antineoplastic Agents; Complement Fixation Tests; False Negative Reactions; Hodgkin | 1972 |
[Stability of the toxoplasmin tests in patients treated with immunosuppressive agents].
Topics: Adult; Antigens; Antineoplastic Agents; Complement Fixation Tests; False Negative Reactions; Hodgkin | 1972 |
[Hodgkin's disease and other malignant lymphomas].
Topics: Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prednison | 1972 |
[Hodgkin's disease and other malignant lymphomas].
Topics: Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prednison | 1972 |
[Multiple drug therapy in Hodgkin's disease, lymphosarcoma and reticulosarcoma].
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Female; Hodg | 1972 |
[Multiple drug therapy in Hodgkin's disease, lymphosarcoma and reticulosarcoma].
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Female; Hodg | 1972 |
Single, combined and sequential use of uracil mustard and prednisone in the treatment of lymphoreticular tumors.
Topics: Drug Synergism; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Prednisone; Urac | 1972 |
Single, combined and sequential use of uracil mustard and prednisone in the treatment of lymphoreticular tumors.
Topics: Drug Synergism; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Prednisone; Urac | 1972 |
Management of patients with non-Hodgkin's lymphoma.
Topics: Antineoplastic Agents; Burkitt Lymphoma; Cyclophosphamide; Hodgkin Disease; Humans; Lymphography; Ly | 1973 |
Management of patients with non-Hodgkin's lymphoma.
Topics: Antineoplastic Agents; Burkitt Lymphoma; Cyclophosphamide; Hodgkin Disease; Humans; Lymphography; Ly | 1973 |
Updated Hodgkin's disease. C. Advanced disease and special problems. Comment: the non-Hodgkin's lymphomas.
Topics: Burkitt Lymphoma; Cyclophosphamide; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Large B-C | 1973 |
Updated Hodgkin's disease. C. Advanced disease and special problems. Comment: the non-Hodgkin's lymphomas.
Topics: Burkitt Lymphoma; Cyclophosphamide; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Large B-C | 1973 |
Kaposi's sarcoma in association with immunosuppressive therapy. Report of two cases.
Topics: Adult; Aged; Azathioprine; Hodgkin Disease; Humans; Immunosuppressive Agents; Kidney Transplantation | 1972 |
Kaposi's sarcoma in association with immunosuppressive therapy. Report of two cases.
Topics: Adult; Aged; Azathioprine; Hodgkin Disease; Humans; Immunosuppressive Agents; Kidney Transplantation | 1972 |
Effect of drug treatment for lymphoma on male reproductive capacity. Studies of men in remission after therapy.
Topics: Adolescent; Adult; Antineoplastic Agents; Biopsy; Burkitt Lymphoma; Cyclophosphamide; Germ Cells; Ho | 1973 |
Effect of drug treatment for lymphoma on male reproductive capacity. Studies of men in remission after therapy.
Topics: Adolescent; Adult; Antineoplastic Agents; Biopsy; Burkitt Lymphoma; Cyclophosphamide; Germ Cells; Ho | 1973 |
Combination chemotherapy with cyclophosphamide, vinblastine, procarbazine and prednisone in the treatment of malignant lymphomas.
Topics: Administration, Oral; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Injectio | 1973 |
Combination chemotherapy with cyclophosphamide, vinblastine, procarbazine and prednisone in the treatment of malignant lymphomas.
Topics: Administration, Oral; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Injectio | 1973 |
Treatment of Hodgkin's disease and other malignant lymphomas.
Topics: Alkylating Agents; Antineoplastic Agents; Carmustine; Chlorambucil; Cyclohexanes; Cyclophosphamide; | 1973 |
Treatment of Hodgkin's disease and other malignant lymphomas.
Topics: Alkylating Agents; Antineoplastic Agents; Carmustine; Chlorambucil; Cyclohexanes; Cyclophosphamide; | 1973 |
Hodgkin's disease in a renal transplant recipient. A case report.
Topics: Antilymphocyte Serum; Autopsy; Azathioprine; B-Lymphocytes; Cytotoxicity Tests, Immunologic; Hodgkin | 1974 |
Hodgkin's disease in a renal transplant recipient. A case report.
Topics: Antilymphocyte Serum; Autopsy; Azathioprine; B-Lymphocytes; Cytotoxicity Tests, Immunologic; Hodgkin | 1974 |
[Chemotherapy of lymphogranulomatosis].
Topics: Adolescent; Age Factors; Antineoplastic Agents; Chlorambucil; Cyclophosphamide; Drug Combinations; D | 1974 |
[Chemotherapy of lymphogranulomatosis].
Topics: Adolescent; Age Factors; Antineoplastic Agents; Chlorambucil; Cyclophosphamide; Drug Combinations; D | 1974 |
Blood and neoplastic diseases. Treatment of the lymphomas.
Topics: Alopecia; Bone Marrow; Cyclophosphamide; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Follicular; Ne | 1974 |
Blood and neoplastic diseases. Treatment of the lymphomas.
Topics: Alopecia; Bone Marrow; Cyclophosphamide; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Follicular; Ne | 1974 |
Differential effect of immunosuppressive agents on T and B lymphocytes.
Topics: Animals; Antilymphocyte Serum; Azathioprine; B-Lymphocytes; Bacterial Infections; Concanavalin A; De | 1974 |
Differential effect of immunosuppressive agents on T and B lymphocytes.
Topics: Animals; Antilymphocyte Serum; Azathioprine; B-Lymphocytes; Bacterial Infections; Concanavalin A; De | 1974 |
Combination chemotherapy of advanced lymphoma.
Topics: Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Drug Synergism; Female; Hodgkin Disease; Human | 1972 |
Combination chemotherapy of advanced lymphoma.
Topics: Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Drug Synergism; Female; Hodgkin Disease; Human | 1972 |
The MOPP controversy.
Topics: Drug Combinations; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vincristine | 1972 |
The MOPP controversy.
Topics: Drug Combinations; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vincristine | 1972 |
[Therapy of generalized Hodgkin's disease. Results of cooperative studies (1967-1972)].
Topics: Antineoplastic Agents; Chlorambucil; Hodgkin Disease; Humans; Interprofessional Relations; Nitrogen | 1972 |
[Therapy of generalized Hodgkin's disease. Results of cooperative studies (1967-1972)].
Topics: Antineoplastic Agents; Chlorambucil; Hodgkin Disease; Humans; Interprofessional Relations; Nitrogen | 1972 |
Multiple-drug therapy in Hodgkin's disease.
Topics: Antiemetics; Drug Synergism; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Pro | 1972 |
Multiple-drug therapy in Hodgkin's disease.
Topics: Antiemetics; Drug Synergism; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Pro | 1972 |
Chemotherapy of Hodgkin's disease.
Topics: Alkylating Agents; Drug Synergism; Hodgkin Disease; Humans; Prednisone; Procarbazine; Vinca Alkaloid | 1972 |
Chemotherapy of Hodgkin's disease.
Topics: Alkylating Agents; Drug Synergism; Hodgkin Disease; Humans; Prednisone; Procarbazine; Vinca Alkaloid | 1972 |
The treatment of Hodgkin's disease.
Topics: Agranulocytosis; Antineoplastic Agents; Bone Marrow Diseases; Chlorambucil; Drug Combinations; Hodgk | 1972 |
The treatment of Hodgkin's disease.
Topics: Agranulocytosis; Antineoplastic Agents; Bone Marrow Diseases; Chlorambucil; Drug Combinations; Hodgk | 1972 |
Treatment of Hodgkin's disease.
Topics: Hodgkin Disease; Humans; Mechlorethamine; Medicine; Prednisone; Procarbazine; Referral and Consultat | 1972 |
Treatment of Hodgkin's disease.
Topics: Hodgkin Disease; Humans; Mechlorethamine; Medicine; Prednisone; Procarbazine; Referral and Consultat | 1972 |
Combination chemotherapy of acute leukemia and Hodgkin's disease.
Topics: Antineoplastic Agents; Drug Combinations; Hodgkin Disease; Humans; Leukemia; Mechlorethamine; Predni | 1972 |
Combination chemotherapy of acute leukemia and Hodgkin's disease.
Topics: Antineoplastic Agents; Drug Combinations; Hodgkin Disease; Humans; Leukemia; Mechlorethamine; Predni | 1972 |
Hodgkin's disease therapeutic program.
Topics: Antineoplastic Agents; Drug Combinations; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Proc | 1972 |
Hodgkin's disease therapeutic program.
Topics: Antineoplastic Agents; Drug Combinations; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Proc | 1972 |
[Treatment of Hodgkin's disease of the stomach].
Topics: Adult; Cyclophosphamide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Metastasis; Pr | 1973 |
[Treatment of Hodgkin's disease of the stomach].
Topics: Adult; Cyclophosphamide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Metastasis; Pr | 1973 |
Progressive, atrophying, chronic granulomatous dermohypodermitis. Autoimmune disease?
Topics: Adult; Atrophy; Autoimmune Diseases; Axilla; Azathioprine; BCG Vaccine; Chronic Disease; Cutis Laxa; | 1973 |
Progressive, atrophying, chronic granulomatous dermohypodermitis. Autoimmune disease?
Topics: Adult; Atrophy; Autoimmune Diseases; Axilla; Azathioprine; BCG Vaccine; Chronic Disease; Cutis Laxa; | 1973 |
Splenectomy effects on chemotherapy in Hodgkin's disease.
Topics: Antineoplastic Agents; Benzoates; Blood Cell Count; Blood Platelets; Evaluation Studies as Topic; Ho | 1973 |
Splenectomy effects on chemotherapy in Hodgkin's disease.
Topics: Antineoplastic Agents; Benzoates; Blood Cell Count; Blood Platelets; Evaluation Studies as Topic; Ho | 1973 |
Eastern cooperative oncology group studies.
Topics: Antineoplastic Agents; Blood Cell Count; Carmustine; Cyclophosphamide; Hodgkin Disease; Humans; Mech | 1973 |
Eastern cooperative oncology group studies.
Topics: Antineoplastic Agents; Blood Cell Count; Carmustine; Cyclophosphamide; Hodgkin Disease; Humans; Mech | 1973 |
Combined chemotherapy radiotherapy management of stage 3 Hodgkin's disease.
Topics: Adult; Antineoplastic Agents; Benzoates; Blood Cell Count; Blood Platelets; Cyclophosphamide; Evalua | 1973 |
Combined chemotherapy radiotherapy management of stage 3 Hodgkin's disease.
Topics: Adult; Antineoplastic Agents; Benzoates; Blood Cell Count; Blood Platelets; Cyclophosphamide; Evalua | 1973 |
Combination chemotherapy in Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Carmustine; Child; Female; Hodgkin Disease; Humans; | 1973 |
Combination chemotherapy in Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Carmustine; Child; Female; Hodgkin Disease; Humans; | 1973 |
Low dose radiation therapy and combination chemotherapy in the treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Female; Hodgkin Disease; Humans; Male; Mechlorethami | 1973 |
Low dose radiation therapy and combination chemotherapy in the treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Female; Hodgkin Disease; Humans; Male; Mechlorethami | 1973 |
Inappropriate antidiuretic hormone in Hodgkin's disease.
Topics: Adult; Diuresis; Hodgkin Disease; Humans; Male; Nitrogen Mustard Compounds; Osmolar Concentration; P | 1973 |
Inappropriate antidiuretic hormone in Hodgkin's disease.
Topics: Adult; Diuresis; Hodgkin Disease; Humans; Male; Nitrogen Mustard Compounds; Osmolar Concentration; P | 1973 |
[Problems in steroid-induced ulcers].
Topics: Acute Disease; Adolescent; Adult; Aged; Child; Chronic Disease; Duodenal Ulcer; Female; Hodgkin Dise | 1973 |
[Problems in steroid-induced ulcers].
Topics: Acute Disease; Adolescent; Adult; Aged; Child; Chronic Disease; Duodenal Ulcer; Female; Hodgkin Dise | 1973 |
MOPP chemotherapy for advanced Hodgkin's disease. Prognostic factors in 81 patients.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Agents; Benzoates; Evaluation Studies as Topic; | 1973 |
MOPP chemotherapy for advanced Hodgkin's disease. Prognostic factors in 81 patients.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Agents; Benzoates; Evaluation Studies as Topic; | 1973 |
Chemotherapy in Hodgkin's disease (lymphadenoma).
Topics: Drug Combinations; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vinca Alkaloi | 1973 |
Chemotherapy in Hodgkin's disease (lymphadenoma).
Topics: Drug Combinations; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vinca Alkaloi | 1973 |
Granulomatous hepatitis and prolonged fever of unknown origin.
Topics: Adult; Dexamethasone; Female; Fever; Fever of Unknown Origin; Granuloma; Hepatitis; Hodgkin Disease; | 1973 |
Granulomatous hepatitis and prolonged fever of unknown origin.
Topics: Adult; Dexamethasone; Female; Fever; Fever of Unknown Origin; Granuloma; Hepatitis; Hodgkin Disease; | 1973 |
Hodgkin's disease of the colon.
Topics: Adult; Biopsy; Colonic Neoplasms; Female; Hodgkin Disease; Humans; Lymph Nodes; Mechlorethamine; Pre | 1973 |
Hodgkin's disease of the colon.
Topics: Adult; Biopsy; Colonic Neoplasms; Female; Hodgkin Disease; Humans; Lymph Nodes; Mechlorethamine; Pre | 1973 |
Reversal of myelofibrosis in Hodgkin disease.
Topics: Adult; Anemia, Aplastic; Biopsy, Needle; Cyclophosphamide; Female; Hodgkin Disease; Humans; Predniso | 1973 |
Reversal of myelofibrosis in Hodgkin disease.
Topics: Adult; Anemia, Aplastic; Biopsy, Needle; Cyclophosphamide; Female; Hodgkin Disease; Humans; Predniso | 1973 |
Status and perspectives in chemotherapy of Hodgkin's disease.
Topics: Animals; Antineoplastic Agents; Benzoates; Breast Neoplasms; Burkitt Lymphoma; Cyclophosphamide; Cyt | 1973 |
Status and perspectives in chemotherapy of Hodgkin's disease.
Topics: Animals; Antineoplastic Agents; Benzoates; Breast Neoplasms; Burkitt Lymphoma; Cyclophosphamide; Cyt | 1973 |
Updated Hodgkin's disease. C. Advanced disease and special problems. Management with combination therapy.
Topics: Antineoplastic Agents; Benzoates; Carmustine; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; | 1973 |
Updated Hodgkin's disease. C. Advanced disease and special problems. Management with combination therapy.
Topics: Antineoplastic Agents; Benzoates; Carmustine; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; | 1973 |
Updated Hodgkins' disease. C. Advanced disease and special problems. Advances in chemotherapy.
Topics: Antineoplastic Agents; Benzoates; Cyclophosphamide; Evaluation Studies as Topic; Hodgkin Disease; Hu | 1973 |
Updated Hodgkins' disease. C. Advanced disease and special problems. Advances in chemotherapy.
Topics: Antineoplastic Agents; Benzoates; Cyclophosphamide; Evaluation Studies as Topic; Hodgkin Disease; Hu | 1973 |
Updated Hodgkin's disease. C. Advanced disease and special problems. Combined chemotherapy-radiotherapy program.
Topics: Antineoplastic Agents; Benzoates; Cyclophosphamide; Evaluation Studies as Topic; Hodgkin Disease; Hu | 1973 |
Updated Hodgkin's disease. C. Advanced disease and special problems. Combined chemotherapy-radiotherapy program.
Topics: Antineoplastic Agents; Benzoates; Cyclophosphamide; Evaluation Studies as Topic; Hodgkin Disease; Hu | 1973 |
Combination chemotherapy in advanced Hodgkin's disease.
Topics: Adolescent; Adult; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Middle Aged; Mu | 1973 |
Combination chemotherapy in advanced Hodgkin's disease.
Topics: Adolescent; Adult; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Middle Aged; Mu | 1973 |
Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal.
Topics: Adult; Age Factors; Antineoplastic Agents; Biopsy; Carmustine; Chlorambucil; Cyclophosphamide; Dacti | 1973 |
Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal.
Topics: Adult; Age Factors; Antineoplastic Agents; Biopsy; Carmustine; Chlorambucil; Cyclophosphamide; Dacti | 1973 |
Combination chemotherapy in advanced and recurrent Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; | 1973 |
Combination chemotherapy in advanced and recurrent Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; | 1973 |
Intensive chemotherapy for Hodgkin's disease: long-term complications.
Topics: Antineoplastic Agents; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; E | 1973 |
Intensive chemotherapy for Hodgkin's disease: long-term complications.
Topics: Antineoplastic Agents; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; E | 1973 |
Antibody response in Hodgkin's disease and other lymphomas related to HL-A antigens, immunoglobulin levels and therapy.
Topics: Antibiotics, Antineoplastic; Antibody Formation; Complement Fixation Tests; Hemagglutination Inhibit | 1973 |
Antibody response in Hodgkin's disease and other lymphomas related to HL-A antigens, immunoglobulin levels and therapy.
Topics: Antibiotics, Antineoplastic; Antibody Formation; Complement Fixation Tests; Hemagglutination Inhibit | 1973 |
Autoimmune hemolytic anemia terminating seven years later in Hodgkin's disease.
Topics: Anemia, Hemolytic, Autoimmune; Autoantibodies; Autoimmune Diseases; Blood Transfusion; Bone Marrow; | 1973 |
Autoimmune hemolytic anemia terminating seven years later in Hodgkin's disease.
Topics: Anemia, Hemolytic, Autoimmune; Autoantibodies; Autoimmune Diseases; Blood Transfusion; Bone Marrow; | 1973 |
Combination chemotherapy of advanced Hodgkin's disease.
Topics: Colorado; Cyclophosphamide; Drug Combinations; Follow-Up Studies; Hodgkin Disease; Humans; Prednison | 1973 |
Combination chemotherapy of advanced Hodgkin's disease.
Topics: Colorado; Cyclophosphamide; Drug Combinations; Follow-Up Studies; Hodgkin Disease; Humans; Prednison | 1973 |
Chemotherapy of malignant lymphoma with adriamycin.
Topics: Cyclophosphamide; Cytarabine; Doxorubicin; Drug Therapy, Combination; Hematopoietic System; Hodgkin | 1973 |
Chemotherapy of malignant lymphoma with adriamycin.
Topics: Cyclophosphamide; Cytarabine; Doxorubicin; Drug Therapy, Combination; Hematopoietic System; Hodgkin | 1973 |
Treatment of advanced Hodgkin's disease with combination chemotherapy.
Topics: Adult; Antineoplastic Agents; Dactinomycin; Drug Therapy, Combination; Female; Hodgkin Disease; Huma | 1973 |
Treatment of advanced Hodgkin's disease with combination chemotherapy.
Topics: Adult; Antineoplastic Agents; Dactinomycin; Drug Therapy, Combination; Female; Hodgkin Disease; Huma | 1973 |
[Surgery in the therapeutic strategy for Hodgkin's disease].
Topics: Antineoplastic Agents; Evaluation Studies as Topic; Hodgkin Disease; Humans; Postoperative Complicat | 1973 |
[Surgery in the therapeutic strategy for Hodgkin's disease].
Topics: Antineoplastic Agents; Evaluation Studies as Topic; Hodgkin Disease; Humans; Postoperative Complicat | 1973 |
[Progress in combination chemotherapy of malignant lymphomas (author's transl)].
Topics: Carmustine; Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Nitr | 1973 |
[Progress in combination chemotherapy of malignant lymphomas (author's transl)].
Topics: Carmustine; Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Nitr | 1973 |
Pancytopenia and leukemia in Hodgkin's disease: report of three cases.
Topics: Adolescent; Adult; Anemia, Aplastic; Aorta, Abdominal; Bone Marrow Examination; Chromosome Aberratio | 1973 |
Pancytopenia and leukemia in Hodgkin's disease: report of three cases.
Topics: Adolescent; Adult; Anemia, Aplastic; Aorta, Abdominal; Bone Marrow Examination; Chromosome Aberratio | 1973 |
The use of different drugs and combinations in the treatment of Hodgkin's disease.
Topics: Administration, Oral; Anemia; Drug Evaluation; Drug Therapy, Combination; Hodgkin Disease; Humans; I | 1973 |
The use of different drugs and combinations in the treatment of Hodgkin's disease.
Topics: Administration, Oral; Anemia; Drug Evaluation; Drug Therapy, Combination; Hodgkin Disease; Humans; I | 1973 |
Hodgkin's disease in childhood.
Topics: Adolescent; Antineoplastic Agents; Child; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Pr | 1973 |
Hodgkin's disease in childhood.
Topics: Adolescent; Antineoplastic Agents; Child; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Pr | 1973 |
The association of autoimmune thrombocytopenia and Hodgkin's disease.
Topics: Adult; Autoantibodies; Autoimmune Diseases; Complement Fixation Tests; Cyclophosphamide; Hodgkin Dis | 1973 |
The association of autoimmune thrombocytopenia and Hodgkin's disease.
Topics: Adult; Autoantibodies; Autoimmune Diseases; Complement Fixation Tests; Cyclophosphamide; Hodgkin Dis | 1973 |
Uremia due to occult lymphomatous infiltration of the kidneys.
Topics: Biopsy; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Kidney Neoplasms; Mechlorethamin | 1974 |
Uremia due to occult lymphomatous infiltration of the kidneys.
Topics: Biopsy; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Kidney Neoplasms; Mechlorethamin | 1974 |
Concurrent chemotherapy and radiation therapy in the treatment of childhood and adolescent Hodgkin's disease.
Topics: Adolescent; Adult; Age Factors; Alopecia; Child; Child, Preschool; Cobalt Radioisotopes; Cyclophosph | 1974 |
Concurrent chemotherapy and radiation therapy in the treatment of childhood and adolescent Hodgkin's disease.
Topics: Adolescent; Adult; Age Factors; Alopecia; Child; Child, Preschool; Cobalt Radioisotopes; Cyclophosph | 1974 |
Letter: Therapy for Hodgkin's disease.
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vincr | 1974 |
Letter: Therapy for Hodgkin's disease.
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vincr | 1974 |
[Pathology of treated Hodgkin's disease. A retrospective study (author's transl)].
Topics: Adolescent; Adult; Age Factors; Aged; Autopsy; Child; Child, Preschool; Drug Therapy, Combination; D | 1974 |
[Pathology of treated Hodgkin's disease. A retrospective study (author's transl)].
Topics: Adolescent; Adult; Age Factors; Aged; Autopsy; Child; Child, Preschool; Drug Therapy, Combination; D | 1974 |
[Treatment of neoplasms with partial synchronization of cell proliferation].
Topics: Antineoplastic Agents; Drug Interactions; Hodgkin Disease; Humans; Methods; Mitosis; Neoplasms; Nitr | 1974 |
[Treatment of neoplasms with partial synchronization of cell proliferation].
Topics: Antineoplastic Agents; Drug Interactions; Hodgkin Disease; Humans; Methods; Mitosis; Neoplasms; Nitr | 1974 |
Protection from chemotherapeutic epilation by prior irradiation.
Topics: Adolescent; Alopecia; Antineoplastic Agents; Child; Cyclophosphamide; Drug Therapy, Combination; Fem | 1974 |
Protection from chemotherapeutic epilation by prior irradiation.
Topics: Adolescent; Alopecia; Antineoplastic Agents; Child; Cyclophosphamide; Drug Therapy, Combination; Fem | 1974 |
Pemphigus and Hodgkin's disease.
Topics: Acantholysis; Adult; Biopsy; Blister; Cyclophosphamide; Hodgkin Disease; Humans; Lymph Nodes; Male; | 1974 |
Pemphigus and Hodgkin's disease.
Topics: Acantholysis; Adult; Biopsy; Blister; Cyclophosphamide; Hodgkin Disease; Humans; Lymph Nodes; Male; | 1974 |
Successful treatment of radiation pericarditis with corticosteroids.
Topics: Female; Hodgkin Disease; Humans; Lymph Nodes; Pericarditis; Prednisone; Radiography; Radiotherapy | 1974 |
Successful treatment of radiation pericarditis with corticosteroids.
Topics: Female; Hodgkin Disease; Humans; Lymph Nodes; Pericarditis; Prednisone; Radiography; Radiotherapy | 1974 |
Combination chemotherapy of Hodgkin's disease.
Topics: Age Factors; Bone Marrow; Drug Therapy, Combination; Evaluation Studies as Topic; Follow-Up Studies; | 1974 |
Combination chemotherapy of Hodgkin's disease.
Topics: Age Factors; Bone Marrow; Drug Therapy, Combination; Evaluation Studies as Topic; Follow-Up Studies; | 1974 |
[Fatal varicella infection in two patients with malignant systemic disease in cytostatic therapy].
Topics: Chickenpox; Chlorambucil; Hodgkin Disease; Humans; Leukemia, Lymphoid; Male; Middle Aged; Prednisone | 1974 |
[Fatal varicella infection in two patients with malignant systemic disease in cytostatic therapy].
Topics: Chickenpox; Chlorambucil; Hodgkin Disease; Humans; Leukemia, Lymphoid; Male; Middle Aged; Prednisone | 1974 |
[Results of combined chemotherapy (MOPP) in the treatment of patients with generalized Hodgkin's disease].
Topics: Adolescent; Adult; Child; Child, Preschool; Disseminated Intravascular Coagulation; Drug Therapy, Co | 1974 |
[Results of combined chemotherapy (MOPP) in the treatment of patients with generalized Hodgkin's disease].
Topics: Adolescent; Adult; Child; Child, Preschool; Disseminated Intravascular Coagulation; Drug Therapy, Co | 1974 |
Medical grand rounds. From the Department of Medicine, University of Virginia Medical Center. Hodgkin's disease.
Topics: Adult; Female; Hodgkin Disease; Humans; Lymph Nodes; Lymphography; Nitrogen Mustard Compounds; Predn | 1974 |
Medical grand rounds. From the Department of Medicine, University of Virginia Medical Center. Hodgkin's disease.
Topics: Adult; Female; Hodgkin Disease; Humans; Lymph Nodes; Lymphography; Nitrogen Mustard Compounds; Predn | 1974 |
Combination chemotherapy.
Topics: Antineoplastic Agents; Bone Marrow; Bone Marrow Cells; Chemical Phenomena; Chemistry; Daunorubicin; | 1974 |
Combination chemotherapy.
Topics: Antineoplastic Agents; Bone Marrow; Bone Marrow Cells; Chemical Phenomena; Chemistry; Daunorubicin; | 1974 |
Chemotherapy of the lymphomas.
Topics: Adult; Burkitt Lymphoma; Child; Chlorambucil; Cyclophosphamide; Doxorubicin; Drug Therapy, Combinati | 1974 |
Chemotherapy of the lymphomas.
Topics: Adult; Burkitt Lymphoma; Child; Chlorambucil; Cyclophosphamide; Doxorubicin; Drug Therapy, Combinati | 1974 |
[Association of nitrogen mustard, vincristine, methylhydrazine and prednisone in treatment of diffuse forms of Hodgkin's disease and ganglionic sarcomas].
Topics: Adolescent; Adult; Child; Child, Preschool; Drug Synergism; Female; Hodgkin Disease; Humans; Hydrazi | 1968 |
[Association of nitrogen mustard, vincristine, methylhydrazine and prednisone in treatment of diffuse forms of Hodgkin's disease and ganglionic sarcomas].
Topics: Adolescent; Adult; Child; Child, Preschool; Drug Synergism; Female; Hodgkin Disease; Humans; Hydrazi | 1968 |
Corticosteroid therapy for lymphomas and chronic lymphocytic leukemia.
Topics: Cortisone; Glucocorticoids; Hodgkin Disease; Hydrocortisone; Leukemia, Lymphoid; Lymphoma, Large B-C | 1969 |
Corticosteroid therapy for lymphomas and chronic lymphocytic leukemia.
Topics: Cortisone; Glucocorticoids; Hodgkin Disease; Hydrocortisone; Leukemia, Lymphoid; Lymphoma, Large B-C | 1969 |
Experimental therapeutic trials of leukemia and hematosarcomas: technologic and philosophic aspects.
Topics: Aminopterin; Attitude of Health Personnel; Blood Transfusion; Bone Marrow Transplantation; Death; Ho | 1969 |
Experimental therapeutic trials of leukemia and hematosarcomas: technologic and philosophic aspects.
Topics: Aminopterin; Attitude of Health Personnel; Blood Transfusion; Bone Marrow Transplantation; Death; Ho | 1969 |
[The role of vinblastine in the treatment of malignant lymphomas].
Topics: Adolescent; Adult; Aged; Cyclophosphamide; Female; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Larg | 1968 |
[The role of vinblastine in the treatment of malignant lymphomas].
Topics: Adolescent; Adult; Aged; Cyclophosphamide; Female; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Larg | 1968 |
The use of etiocholanolone for the measurement of marrow granulocyte reserves.
Topics: Acute Kidney Injury; Adolescent; Adult; Agranulocytosis; Blood Urea Nitrogen; Bone Marrow; Bone Marr | 1970 |
The use of etiocholanolone for the measurement of marrow granulocyte reserves.
Topics: Acute Kidney Injury; Adolescent; Adult; Agranulocytosis; Blood Urea Nitrogen; Bone Marrow; Bone Marr | 1970 |
Combined chemotherapy and radiotherapy for advanced Hodgkin's disease and reticulum cell sarcoma: a preliminary report.
Topics: Adolescent; Adult; Aged; Blood Cell Count; Cyclophosphamide; Female; Hodgkin Disease; Humans; Lympho | 1971 |
Combined chemotherapy and radiotherapy for advanced Hodgkin's disease and reticulum cell sarcoma: a preliminary report.
Topics: Adolescent; Adult; Aged; Blood Cell Count; Cyclophosphamide; Female; Hodgkin Disease; Humans; Lympho | 1971 |
Chronic cutaneous herpes simplex.
Topics: Adult; Agammaglobulinemia; Chronic Disease; Facial Dermatoses; Herpes Simplex; Hodgkin Disease; Huma | 1971 |
Chronic cutaneous herpes simplex.
Topics: Adult; Agammaglobulinemia; Chronic Disease; Facial Dermatoses; Herpes Simplex; Hodgkin Disease; Huma | 1971 |
[Quantitative-qualitative studies of a local inflammation].
Topics: Acute Disease; Arthritis, Rheumatoid; Cell Count; Cell Movement; Culture Techniques; Drug Hypersensi | 1971 |
[Quantitative-qualitative studies of a local inflammation].
Topics: Acute Disease; Arthritis, Rheumatoid; Cell Count; Cell Movement; Culture Techniques; Drug Hypersensi | 1971 |
[Symptomatic thrombopenias. Difficulties of early diagnosis and therapeutic possibilities].
Topics: Adult; Blood Platelets; Hemorrhagic Disorders; Hodgkin Disease; Humans; Hydrazines; Immunoelectropho | 1966 |
[Symptomatic thrombopenias. Difficulties of early diagnosis and therapeutic possibilities].
Topics: Adult; Blood Platelets; Hemorrhagic Disorders; Hodgkin Disease; Humans; Hydrazines; Immunoelectropho | 1966 |
[Changes in ther peripheral blood picture during and after a systematic irradiation in lymphogranulomatosis].
Topics: Adult; Antineoplastic Agents; Blood Cell Count; Blood Platelets; Erythrocytes; Hemoglobins; Hodgkin | 1967 |
[Changes in ther peripheral blood picture during and after a systematic irradiation in lymphogranulomatosis].
Topics: Adult; Antineoplastic Agents; Blood Cell Count; Blood Platelets; Erythrocytes; Hemoglobins; Hodgkin | 1967 |
[Effectiveness of polychemotherapeutic treatments of lymphoproliferative diseases].
Topics: Adult; Antineoplastic Agents; Cyclophosphamide; Drug Synergism; Hodgkin Disease; Humans; Leukemia; L | 1970 |
[Effectiveness of polychemotherapeutic treatments of lymphoproliferative diseases].
Topics: Adult; Antineoplastic Agents; Cyclophosphamide; Drug Synergism; Hodgkin Disease; Humans; Leukemia; L | 1970 |
The management of Hodgkin's disease.
Topics: Diagnosis, Differential; Drug Therapy, Combination; Hodgkin Disease; Humans; Lymphatic Diseases; Lym | 1970 |
The management of Hodgkin's disease.
Topics: Diagnosis, Differential; Drug Therapy, Combination; Hodgkin Disease; Humans; Lymphatic Diseases; Lym | 1970 |
Quadruple chemotherapy in Hodgkin's disease.
Topics: Hodgkin Disease; Humans; Prednisone; Procarbazine; Remission, Spontaneous; Vinblastine; Vincristine | 1972 |
Quadruple chemotherapy in Hodgkin's disease.
Topics: Hodgkin Disease; Humans; Prednisone; Procarbazine; Remission, Spontaneous; Vinblastine; Vincristine | 1972 |
Effect of sera from patients with Hodgkin's disease on normal lymphocyte response to phytohemagglutinin.
Topics: Adolescent; Adult; Aged; Blood; Cells, Cultured; Depression, Chemical; Female; Hodgkin Disease; Huma | 1972 |
Effect of sera from patients with Hodgkin's disease on normal lymphocyte response to phytohemagglutinin.
Topics: Adolescent; Adult; Aged; Blood; Cells, Cultured; Depression, Chemical; Female; Hodgkin Disease; Huma | 1972 |
Sarcoid reactions and sarcoidosis in Hodgkin's disease and other malignant lymphomata.
Topics: Adult; Aged; Autoimmune Diseases; Child; Female; Hodgkin Disease; Humans; Lymphoma; Male; Middle Age | 1972 |
Sarcoid reactions and sarcoidosis in Hodgkin's disease and other malignant lymphomata.
Topics: Adult; Aged; Autoimmune Diseases; Child; Female; Hodgkin Disease; Humans; Lymphoma; Male; Middle Age | 1972 |
Combination chemotherapy of advanced lymphomas.
Topics: Adult; Age Factors; Benzoates; Blood Cell Count; Blood Platelets; Cyclophosphamide; Drug Combination | 1972 |
Combination chemotherapy of advanced lymphomas.
Topics: Adult; Age Factors; Benzoates; Blood Cell Count; Blood Platelets; Cyclophosphamide; Drug Combination | 1972 |
Combination chemotherapy of Hodgkin's disease in private practice.
Topics: Adolescent; Adult; Aged; Anemia; Biopsy; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Mid | 1972 |
Combination chemotherapy of Hodgkin's disease in private practice.
Topics: Adolescent; Adult; Aged; Anemia; Biopsy; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Mid | 1972 |
Treatment of Hodgkin's disease in private practice.
Topics: Hodgkin Disease; Humans; Mechlorethamine; Medicine; Prednisone; Private Practice; Procarbazine; Refe | 1972 |
Treatment of Hodgkin's disease in private practice.
Topics: Hodgkin Disease; Humans; Mechlorethamine; Medicine; Prednisone; Private Practice; Procarbazine; Refe | 1972 |
[Controlled clinical trial of a preparation with steroid activity (prednisone) associated with xylamide, protective drug for the gastric mucosa].
Topics: Adolescent; Adult; Aged; Amides; Arthritis, Rheumatoid; Asthma; Benzoates; Bronchitis; Chronic Disea | 1972 |
[Controlled clinical trial of a preparation with steroid activity (prednisone) associated with xylamide, protective drug for the gastric mucosa].
Topics: Adolescent; Adult; Aged; Amides; Arthritis, Rheumatoid; Asthma; Benzoates; Bronchitis; Chronic Disea | 1972 |
Hodgkin's disease: premature report?
Topics: Hodgkin Disease; Humans; Nitrogen Mustard Compounds; Prednisone; Procarbazine; Vincristine | 1972 |
Hodgkin's disease: premature report?
Topics: Hodgkin Disease; Humans; Nitrogen Mustard Compounds; Prednisone; Procarbazine; Vincristine | 1972 |
Endobronchial Hodgkin's disease presenting as a primary pulmonary lesion.
Topics: Bronchial Neoplasms; Bronchoscopy; Diagnosis, Differential; Hodgkin Disease; Humans; Lung; Lung Neop | 1972 |
Endobronchial Hodgkin's disease presenting as a primary pulmonary lesion.
Topics: Bronchial Neoplasms; Bronchoscopy; Diagnosis, Differential; Hodgkin Disease; Humans; Lung; Lung Neop | 1972 |
Nonlymphomatous malignant tumors complicating Hodgkin's disease. Possible association with intensive therapy.
Topics: Adolescent; Adult; Antineoplastic Agents; Carcinoma, Squamous Cell; Cyclophosphamide; Drug-Related S | 1972 |
Nonlymphomatous malignant tumors complicating Hodgkin's disease. Possible association with intensive therapy.
Topics: Adolescent; Adult; Antineoplastic Agents; Carcinoma, Squamous Cell; Cyclophosphamide; Drug-Related S | 1972 |
Adult Hodgkin's disease in Uganda.
Topics: Adolescent; Adult; Child; Female; Hodgkin Disease; Humans; Male; Middle Aged; Nitrogen Mustard Compo | 1971 |
Adult Hodgkin's disease in Uganda.
Topics: Adolescent; Adult; Child; Female; Hodgkin Disease; Humans; Male; Middle Aged; Nitrogen Mustard Compo | 1971 |
[Meningoencephalitis due to cryptococcus neoformans].
Topics: Adult; Autopsy; Central Nervous System; Cerebrospinal Fluid; Cryptococcosis; Cryptococcus; Cyclophos | 1971 |
[Meningoencephalitis due to cryptococcus neoformans].
Topics: Adult; Autopsy; Central Nervous System; Cerebrospinal Fluid; Cryptococcosis; Cryptococcus; Cyclophos | 1971 |
Hodgkin's disease of the bone marrow.
Topics: Alkaline Phosphatase; Blood Platelets; Bone Marrow; Drug Combinations; Hematocrit; Hodgkin Disease; | 1971 |
Hodgkin's disease of the bone marrow.
Topics: Alkaline Phosphatase; Blood Platelets; Bone Marrow; Drug Combinations; Hematocrit; Hodgkin Disease; | 1971 |
[Hematologic therapy of malignant lymphoma].
Topics: Anemia; Blood Platelets; Blood Transfusion; Erythrocytes; Female; Hodgkin Disease; Humans; Lymphoma; | 1971 |
[Hematologic therapy of malignant lymphoma].
Topics: Anemia; Blood Platelets; Blood Transfusion; Erythrocytes; Female; Hodgkin Disease; Humans; Lymphoma; | 1971 |
[Vinblastine in the treatment of Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Female; Hodgkin Disease; Humans; Leukopenia; Male; Middle Aged; Prednisone; | 1971 |
[Vinblastine in the treatment of Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Female; Hodgkin Disease; Humans; Leukopenia; Male; Middle Aged; Prednisone; | 1971 |
[Treatment of malignant lymphoma].
Topics: Alkylating Agents; Antineoplastic Agents; Diagnostic Techniques, Surgical; Hodgkin Disease; Humans; | 1971 |
[Treatment of malignant lymphoma].
Topics: Alkylating Agents; Antineoplastic Agents; Diagnostic Techniques, Surgical; Hodgkin Disease; Humans; | 1971 |
Progress in treatment for the leukemias and lymphomas.
Topics: Antineoplastic Agents; Drug Synergism; Hodgkin Disease; Humans; Leukemia, Lymphoid; Leukemia, Myeloi | 1965 |
Progress in treatment for the leukemias and lymphomas.
Topics: Antineoplastic Agents; Drug Synergism; Hodgkin Disease; Humans; Leukemia, Lymphoid; Leukemia, Myeloi | 1965 |
[Life expectancy of hemoblastosis patients].
Topics: Adrenal Cortex Hormones; Adult; Antimetabolites; Antineoplastic Agents; Blood Transfusion; Child; Ho | 1966 |
[Life expectancy of hemoblastosis patients].
Topics: Adrenal Cortex Hormones; Adult; Antimetabolites; Antineoplastic Agents; Blood Transfusion; Child; Ho | 1966 |
[Clinical experience with vinblastine and vincristine].
Topics: Adolescent; Adult; Daunorubicin; Female; Hodgkin Disease; Humans; Leukemia, Lymphoid; Leukemia, Myel | 1968 |
[Clinical experience with vinblastine and vincristine].
Topics: Adolescent; Adult; Daunorubicin; Female; Hodgkin Disease; Humans; Leukemia, Lymphoid; Leukemia, Myel | 1968 |
Leukemia and lymphoma.
Topics: Antineoplastic Agents; BCG Vaccine; Burkitt Lymphoma; Busulfan; Chlorambucil; Cyclophosphamide; Cyta | 1970 |
Leukemia and lymphoma.
Topics: Antineoplastic Agents; BCG Vaccine; Burkitt Lymphoma; Busulfan; Chlorambucil; Cyclophosphamide; Cyta | 1970 |
Testing for Ph 1 chromosome on mailed specimens of peripheral blood.
Topics: Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Antimetabolites; Blood Specimen Collection; Bo | 1971 |
Testing for Ph 1 chromosome on mailed specimens of peripheral blood.
Topics: Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Antimetabolites; Blood Specimen Collection; Bo | 1971 |
Autoimmune hemolytic anemia and ulcerative colitis: a multisystem immunodeficiency disease?
Topics: Adolescent; Adult; Anemia, Hemolytic, Autoimmune; Antibodies, Anti-Idiotypic; Blood Cell Count; Bloo | 1970 |
Autoimmune hemolytic anemia and ulcerative colitis: a multisystem immunodeficiency disease?
Topics: Adolescent; Adult; Anemia, Hemolytic, Autoimmune; Antibodies, Anti-Idiotypic; Blood Cell Count; Bloo | 1970 |
Fatal strongyloidiasis in Hodgkin's disease after immunosuppressive therapy.
Topics: Cyclophosphamide; Gastrointestinal Hemorrhage; Hemorrhage; Hodgkin Disease; Humans; Immunosuppressiv | 1970 |
Fatal strongyloidiasis in Hodgkin's disease after immunosuppressive therapy.
Topics: Cyclophosphamide; Gastrointestinal Hemorrhage; Hemorrhage; Hodgkin Disease; Humans; Immunosuppressiv | 1970 |
Lymphoma-like presentation of Kaposi's sarcoma. Three cases without characteristic skin lesions.
Topics: Aged; Blood; Blood Protein Electrophoresis; Diagnosis, Differential; Female; Hodgkin Disease; Humans | 1966 |
Lymphoma-like presentation of Kaposi's sarcoma. Three cases without characteristic skin lesions.
Topics: Aged; Blood; Blood Protein Electrophoresis; Diagnosis, Differential; Female; Hodgkin Disease; Humans | 1966 |
Elevated plasma levels of a hydroxyproline-containing protein in Hodgkin's disease and their relation to disease activity.
Topics: Adolescent; Adult; Blood Proteins; Cyclophosphamide; Female; Hodgkin Disease; Humans; Hydroxyproline | 1966 |
Elevated plasma levels of a hydroxyproline-containing protein in Hodgkin's disease and their relation to disease activity.
Topics: Adolescent; Adult; Blood Proteins; Cyclophosphamide; Female; Hodgkin Disease; Humans; Hydroxyproline | 1966 |
High-dose corticoid therapy in Hodgkin's disease and other lymphomas.
Topics: Adolescent; Adult; Aged; Cortisone; Diabetes Mellitus; Female; Gastrointestinal Diseases; Hodgkin Di | 1967 |
High-dose corticoid therapy in Hodgkin's disease and other lymphomas.
Topics: Adolescent; Adult; Aged; Cortisone; Diabetes Mellitus; Female; Gastrointestinal Diseases; Hodgkin Di | 1967 |
Lupus erythematosus complicated by the Chiari-Frommel syndrome and autoimmune thyroiditis.
Topics: Adult; Arthritis, Rheumatoid; Autoimmune Diseases; Chiari-Frommel Syndrome; Diagnosis, Differential; | 1969 |
Lupus erythematosus complicated by the Chiari-Frommel syndrome and autoimmune thyroiditis.
Topics: Adult; Arthritis, Rheumatoid; Autoimmune Diseases; Chiari-Frommel Syndrome; Diagnosis, Differential; | 1969 |
Further experience with splenectomy in Hodgkin's Disease.
Topics: Bone Marrow Examination; Hodgkin Disease; Humans; Hypersplenism; Leukopenia; Methods; Prednisone; Sp | 1969 |
Further experience with splenectomy in Hodgkin's Disease.
Topics: Bone Marrow Examination; Hodgkin Disease; Humans; Hypersplenism; Leukopenia; Methods; Prednisone; Sp | 1969 |
Chemotherapy of the lymphomas.
Topics: Antimetabolites; Cyclophosphamide; Female; Hodgkin Disease; Humans; Hydrazines; Lymphoma; Mechloreth | 1970 |
Chemotherapy of the lymphomas.
Topics: Antimetabolites; Cyclophosphamide; Female; Hodgkin Disease; Humans; Hydrazines; Lymphoma; Mechloreth | 1970 |
A reversible concentrating defect in predominantly unilateral renal Hodgkin's disease.
Topics: Adult; Aminohippuric Acids; Antineoplastic Agents; Antitubercular Agents; Blood; Blood Urea Nitrogen | 1970 |
A reversible concentrating defect in predominantly unilateral renal Hodgkin's disease.
Topics: Adult; Aminohippuric Acids; Antineoplastic Agents; Antitubercular Agents; Blood; Blood Urea Nitrogen | 1970 |
Tolerance to chemotherapy after prior irradiation for Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Agents; Cyclophosphamide; Drug Tolerance; Female; Hodgkin Disease; | 1970 |
Tolerance to chemotherapy after prior irradiation for Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Agents; Cyclophosphamide; Drug Tolerance; Female; Hodgkin Disease; | 1970 |
Diagnostic laparotomy and splenectomy for staging Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Biopsy; Blood Cell Count; Blood Platelets; Blood Ure | 1970 |
Diagnostic laparotomy and splenectomy for staging Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Biopsy; Blood Cell Count; Blood Platelets; Blood Ure | 1970 |
[Results of combined treatment of generalized Hodgkin's disease with several cytostatic agents and corticosteroids].
Topics: Adrenal Cortex Hormones; Adult; Chronic Disease; Cyclophosphamide; Drug Synergism; Female; Hodgkin D | 1970 |
[Results of combined treatment of generalized Hodgkin's disease with several cytostatic agents and corticosteroids].
Topics: Adrenal Cortex Hormones; Adult; Chronic Disease; Cyclophosphamide; Drug Synergism; Female; Hodgkin D | 1970 |
Nephrotic syndrome: a prodrome to lymphoma.
Topics: Adolescent; Aged; Biopsy; Hodgkin Disease; Humans; Kidney; Lymphoma, Non-Hodgkin; Male; Microscopy, | 1970 |
Nephrotic syndrome: a prodrome to lymphoma.
Topics: Adolescent; Aged; Biopsy; Hodgkin Disease; Humans; Kidney; Lymphoma, Non-Hodgkin; Male; Microscopy, | 1970 |
Current status: the management of lymphoma.
Topics: Antimetabolites; Asparaginase; Benzoates; Biopsy; Cyclophosphamide; Drug Synergism; Hodgkin Disease; | 1970 |
Current status: the management of lymphoma.
Topics: Antimetabolites; Asparaginase; Benzoates; Biopsy; Cyclophosphamide; Drug Synergism; Hodgkin Disease; | 1970 |
Combination chemotherapy with nitrogen mustard, vincristine, procarbazine and prednisone in previously treated patients with Hodgkin's disease.
Topics: Adolescent; Adult; Antimetabolites; Antineoplastic Agents; Benzoates; Child; Female; Hodgkin Disease | 1970 |
Combination chemotherapy with nitrogen mustard, vincristine, procarbazine and prednisone in previously treated patients with Hodgkin's disease.
Topics: Adolescent; Adult; Antimetabolites; Antineoplastic Agents; Benzoates; Child; Female; Hodgkin Disease | 1970 |
The Yale combination chemotherapy program for advanced Hodgkin's disease. A preliminary report.
Topics: Adolescent; Adult; Antimetabolites; Benzoates; Female; Hodgkin Disease; Humans; Male; Middle Aged; N | 1970 |
The Yale combination chemotherapy program for advanced Hodgkin's disease. A preliminary report.
Topics: Adolescent; Adult; Antimetabolites; Benzoates; Female; Hodgkin Disease; Humans; Male; Middle Aged; N | 1970 |
Herpes-zoster meningoencephalitis.
Topics: Adult; Aged; Central Nervous System; Female; Herpes Zoster; Hodgkin Disease; Humans; Male; Meningoen | 1970 |
Herpes-zoster meningoencephalitis.
Topics: Adult; Aged; Central Nervous System; Female; Herpes Zoster; Hodgkin Disease; Humans; Male; Meningoen | 1970 |
[Polychemotherapy of Hodgkin's disease].
Topics: Antineoplastic Agents; Drug Synergism; Hodgkin Disease; Humans; Hydrazines; Nitrogen Mustard Compoun | 1970 |
[Polychemotherapy of Hodgkin's disease].
Topics: Antineoplastic Agents; Drug Synergism; Hodgkin Disease; Humans; Hydrazines; Nitrogen Mustard Compoun | 1970 |
Procarbazine hydrochloride (Matulane) for Hodgkin's disease.
Topics: Antineoplastic Agents; Benzoates; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Vincristine | 1970 |
Procarbazine hydrochloride (Matulane) for Hodgkin's disease.
Topics: Antineoplastic Agents; Benzoates; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Vincristine | 1970 |
[Nonspecific mesenchymal reactions and parenchymal damages in the liver of patients with Hodgkin's disease].
Topics: Adolescent; Adult; Age Factors; Aged; Alkaline Phosphatase; Bilirubin; Blood Proteins; Cholestasis; | 1970 |
[Nonspecific mesenchymal reactions and parenchymal damages in the liver of patients with Hodgkin's disease].
Topics: Adolescent; Adult; Age Factors; Aged; Alkaline Phosphatase; Bilirubin; Blood Proteins; Cholestasis; | 1970 |
Treatment of Hodgkin's disease: with what and by whom?
Topics: Cyclophosphamide; Drug Synergism; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine | 1970 |
Treatment of Hodgkin's disease: with what and by whom?
Topics: Cyclophosphamide; Drug Synergism; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine | 1970 |
Combination chemotherapy in the treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Child; Cyclophosphamide; Drug Synerg | 1970 |
Combination chemotherapy in the treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Child; Cyclophosphamide; Drug Synerg | 1970 |
Splenectomy in Hodgkin's Disease for splenomegaly, cytopenias and intolerance to myelosuppressive chemotherapy.
Topics: Adolescent; Adult; Anemia, Aplastic; Antineoplastic Agents; Blood Cell Count; Bone Marrow Diseases; | 1971 |
Splenectomy in Hodgkin's Disease for splenomegaly, cytopenias and intolerance to myelosuppressive chemotherapy.
Topics: Adolescent; Adult; Anemia, Aplastic; Antineoplastic Agents; Blood Cell Count; Bone Marrow Diseases; | 1971 |
Acute nephrotic syndrome as a manifestation of active Hodgkin's Disease. Report of four cases and review of the literature.
Topics: Adolescent; Adult; Aged; Antigen-Antibody Complex; Blood Urea Nitrogen; Child; Child, Preschool; Cho | 1971 |
Acute nephrotic syndrome as a manifestation of active Hodgkin's Disease. Report of four cases and review of the literature.
Topics: Adolescent; Adult; Aged; Antigen-Antibody Complex; Blood Urea Nitrogen; Child; Child, Preschool; Cho | 1971 |
Chemotherapy for Hodgkin's.
Topics: Antineoplastic Agents; Hodgkin Disease; Humans; Isoniazid; Prednisone | 1971 |
Chemotherapy for Hodgkin's.
Topics: Antineoplastic Agents; Hodgkin Disease; Humans; Isoniazid; Prednisone | 1971 |
Digital clubbing in Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Agents; Female; Fingers; Hodgkin Disease; Humans; Lung Neoplasms; | 1971 |
Digital clubbing in Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Agents; Female; Fingers; Hodgkin Disease; Humans; Lung Neoplasms; | 1971 |
Hodgkin's disease associated with Kaposi's sarcoma and malignant melanoma. Case report of multiple primary malignancies.
Topics: Aged; Arm; Fingers; Foot; Hand; Hodgkin Disease; Humans; Intestinal Neoplasms; Jejunum; Male; Melano | 1971 |
Hodgkin's disease associated with Kaposi's sarcoma and malignant melanoma. Case report of multiple primary malignancies.
Topics: Aged; Arm; Fingers; Foot; Hand; Hodgkin Disease; Humans; Intestinal Neoplasms; Jejunum; Male; Melano | 1971 |
Prolongation of survival in Hodgkin's disease.
Topics: Adolescent; Adult; Age Factors; Aged; Alkylating Agents; Benzoates; Child; Female; Hodgkin Disease; | 1971 |
Prolongation of survival in Hodgkin's disease.
Topics: Adolescent; Adult; Age Factors; Aged; Alkylating Agents; Benzoates; Child; Female; Hodgkin Disease; | 1971 |
[1st experience with vinblastine therapy in lymphogranulomatosis as based on clinical and lymphographic control examinations].
Topics: Adolescent; Adult; Cyclophosphamide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymphograph | 1967 |
[1st experience with vinblastine therapy in lymphogranulomatosis as based on clinical and lymphographic control examinations].
Topics: Adolescent; Adult; Cyclophosphamide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymphograph | 1967 |
[Diseases of the thyroid gland].
Topics: Daunorubicin; Goiter; Graves Disease; Hematologic Diseases; Hodgkin Disease; Humans; Hyperthyroidism | 1967 |
[Diseases of the thyroid gland].
Topics: Daunorubicin; Goiter; Graves Disease; Hematologic Diseases; Hodgkin Disease; Humans; Hyperthyroidism | 1967 |
[Long-term survivals in lymphomas and generalized lymphosarcomas treated by chemo- and hormonal therapy].
Topics: Antineoplastic Agents; Cyclophosphamide; Drug Synergism; Hodgkin Disease; Humans; Hydrazines; Longev | 1967 |
[Long-term survivals in lymphomas and generalized lymphosarcomas treated by chemo- and hormonal therapy].
Topics: Antineoplastic Agents; Cyclophosphamide; Drug Synergism; Hodgkin Disease; Humans; Hydrazines; Longev | 1967 |
[On perforated ulcers of the gastrointestinal tract in corticosteroid therapy].
Topics: Adult; Hodgkin Disease; Humans; Male; Peptic Ulcer Perforation; Prednisolone; Prednisone; Psoriasis | 1968 |
[On perforated ulcers of the gastrointestinal tract in corticosteroid therapy].
Topics: Adult; Hodgkin Disease; Humans; Male; Peptic Ulcer Perforation; Prednisolone; Prednisone; Psoriasis | 1968 |
[Hodgkin's disease].
Topics: Cyclophosphamide; Hodgkin Disease; Hydrazines; Prednisone; Vinblastine | 1968 |
[Hodgkin's disease].
Topics: Cyclophosphamide; Hodgkin Disease; Hydrazines; Prednisone; Vinblastine | 1968 |
Perforation of transverse colon in a patient with Hodgkin's disease.
Topics: Adolescent; Colonic Neoplasms; Cyclophosphamide; Female; Hodgkin Disease; Humans; In Vitro Technique | 1965 |
Perforation of transverse colon in a patient with Hodgkin's disease.
Topics: Adolescent; Colonic Neoplasms; Cyclophosphamide; Female; Hodgkin Disease; Humans; In Vitro Technique | 1965 |
[Erythema nodosum staphylogenes in lymphogranulomatosis].
Topics: Adult; Anti-Bacterial Agents; Erythema Nodosum; Female; Hodgkin Disease; Humans; Leg Dermatoses; Pre | 1965 |
[Erythema nodosum staphylogenes in lymphogranulomatosis].
Topics: Adult; Anti-Bacterial Agents; Erythema Nodosum; Female; Hodgkin Disease; Humans; Leg Dermatoses; Pre | 1965 |
Advanced Hodgkin's disease. Management with chemotherapeutic agents.
Topics: Chlorambucil; Cyclophosphamide; Hodgkin Disease; Humans; Hydrazines; Mechlorethamine; Prednisone; Vi | 1965 |
Advanced Hodgkin's disease. Management with chemotherapeutic agents.
Topics: Chlorambucil; Cyclophosphamide; Hodgkin Disease; Humans; Hydrazines; Mechlorethamine; Prednisone; Vi | 1965 |
Approaches to improving the chemotherapy of Hodgkin's disease.
Topics: Cyclophosphamide; Hodgkin Disease; Humans; Mercaptopurine; Methotrexate; Prednisone; Vincristine | 1966 |
Approaches to improving the chemotherapy of Hodgkin's disease.
Topics: Cyclophosphamide; Hodgkin Disease; Humans; Mercaptopurine; Methotrexate; Prednisone; Vincristine | 1966 |
[Lymphogranulomatosis and pregnancy].
Topics: Adult; Cyclophosphamide; Female; Hodgkin Disease; Humans; Mannomustine; Prednisone; Pregnancy; Pregn | 1966 |
[Lymphogranulomatosis and pregnancy].
Topics: Adult; Cyclophosphamide; Female; Hodgkin Disease; Humans; Mannomustine; Prednisone; Pregnancy; Pregn | 1966 |
[Combinations and sequences of multiple chemotherapeutic compounds in leukemia and hematosarcoma].
Topics: Antineoplastic Agents; Hodgkin Disease; Humans; Hydrazines; Leukemia; Prednisone; Triethylenemelamin | 1966 |
[Combinations and sequences of multiple chemotherapeutic compounds in leukemia and hematosarcoma].
Topics: Antineoplastic Agents; Hodgkin Disease; Humans; Hydrazines; Leukemia; Prednisone; Triethylenemelamin | 1966 |